<SEC-DOCUMENT>0000891092-21-007087.txt : 20221014
<SEC-HEADER>0000891092-21-007087.hdr.sgml : 20221014

<ACCEPTANCE-DATETIME>20211102071921

<PRIVATE-TO-PUBLIC>

ACCESSION NUMBER:		0000891092-21-007087

CONFORMED SUBMISSION TYPE:	DRS/A

PUBLIC DOCUMENT COUNT:		160

FILED AS OF DATE:		20211102

<PUBLIC-REL-DATE>20220210

DATE AS OF CHANGE:		20211102


FILER:


	COMPANY DATA:	

		COMPANY CONFORMED NAME:			Nexalin Technology, Inc.

		CENTRAL INDEX KEY:			0001527352

		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]

		IRS NUMBER:				275566468

		STATE OF INCORPORATION:			NV

		FISCAL YEAR END:			1231



	FILING VALUES:

		FORM TYPE:		DRS/A

		SEC ACT:		1933 Act

		SEC FILE NUMBER:	377-05501

		FILM NUMBER:		211369252



	BUSINESS ADDRESS:	

		STREET 1:		26072 MERIT CIRCLE, SUITE 106

		CITY:			LAGUNA NIGUEL

		STATE:			CA

		ZIP:			92653

		BUSINESS PHONE:		949-260-8090



	MAIL ADDRESS:	

		STREET 1:		26072 MERIT CIRCLE, SUITE 106

		CITY:			LAGUNA NIGUEL

		STATE:			CA

		ZIP:			92653



</SEC-HEADER>

<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
   <head>

      <title>EDGAR HTML</title>
   </head>
   <body style=" ">



      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">As confidentially submitted to the Securities and Exchange Commission on </font><font style="font-weight:bold; "></font><font style="font-weight:bold; ">November 1,</font><font style="font-weight:bold; "> 2021.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:20pt; margin-bottom:0pt; "><font style="font-weight:bold; ">This draft registration statement has not been publicly filed with the</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Securities and Exchange Commission and all information herein remains strictly confidential.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Registration No. 333-</font>
      </p>
      				<hr style="border-top:2pt solid #000000; width:100%; " align="left"><hr style="border-top:1pt solid #000000; width:100%; margin-top:-5pt; " align="left">
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">UNITED STATES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">SECURITIES AND EXCHANGE COMMISSION</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Washington, D.C. 20549</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">___________________ </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:18pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Pre-Effective Amendment No. 1 to </font><font style="font-weight:bold; ">FORM S-1</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">REGISTRATION STATEMENT</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">UNDER THE SECURITIES ACT OF 1933</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">___________________ </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:18pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Nexalin Technology, Inc.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(Exact name of registrant as specified in its charter) </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">








            <tr class="odd" style=" ">

               <td style="width:32%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Nevada</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:32%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">3845</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:32%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">27-5566468</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:32%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(State or other jurisdiction of</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">incorporation or organization) </p>

               </td>

               <td style="width:2%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:32%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(Primary Standard Industrial</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Classification Code Number) </p>

               </td>

               <td style="width:2%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:32%; vertical-align:middle; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(I.R.S. Employer</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Identification No.) </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">1776 Yorktown, Suite 550</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Houston, TX 77056</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(713) 660-1100</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(Address, including zip code, and telephone number, including area code, of registrant&apos;s principal executive offices) </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Mark White</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Chief Executive Officer</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Nexalin Technology, Inc.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">1776 Yorktown, Suite 550</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Houston, TX 77056</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(281) 830-8900</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(Name, address, including zip code, and telephone number, including area code, of agent for service) </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Copies to:</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:50%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Martin Siegel, Esq.</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Warshaw Burstein, LLP</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">575 Lexington Avenue</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">New York, NY 10022</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Telephone: (212) 984-7741</font>
                  </p>

               </td>

               <td style="width:50%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Andrew M. Tucker, Esq.</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Nelson Mullins Riley &amp; Scarborough LLP</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">101 Constitution Avenue NW, Suite 900</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Washington, D.C. 20001</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Telephone: (202) 689-2987</font>
                  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this </font><font style="font-weight:bold; ">registration statement.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; margin-bottom:0pt; "></p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>
      <div style="width:100%; clear:both;">

         <p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p>

      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. &#xF06F; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#xF06F; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#xF06F; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. &#xF06F; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">See the definitions of &#x201C;large accelerated filer,&#x201D; &#x201C;accelerated filer,&#x201D; &#x201C;smaller reporting company,&#x201D; and &#x201C;emerging growth company&#x201D; in Rule 12b-2 of the Exchange Act. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">








            <tr class="odd" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:45%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:25%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:20%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Large accelerated filer </p>

               </td>

               <td style="width:45%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x2610; </p>

               </td>

               <td style="width:25%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accelerated filer </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#x2610; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Non-accelerated filer </p>

               </td>

               <td style="width:45%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x2612; </p>

               </td>

               <td style="width:25%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Smaller reporting company </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#x2612; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:45%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:25%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Emerging growth company </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#x2612; </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. &#xF0FD; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">___________________ </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CALCULATION OF REGISTRATION FEE</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">









            <tr class="odd" style=" ">

               <td colspan="6" style="width:100%; border-bottom:3px double #000000; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:56%; border-bottom:0.5pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Title of Securities being Registered</font>
                  </p>

               </td>

               <td style="width:1%; border-bottom:0.5pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; border-bottom:0.5pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Proposed Maximum</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Aggregate </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Offering Price(1)</font>
                  </p>

               </td>

               <td style="width:3%; border-bottom:0.5pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; border-bottom:0.5pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Amount of </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Registration Fee(2)</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td colspan="2" style="width:56%; vertical-align:middle; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Common stock, par value $0.001 per share </p>

               </td>

               <td style="width:1%; vertical-align:middle; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:middle; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:3%; vertical-align:middle; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:middle; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(1)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td colspan="2" style="width:97%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Estimated solely for purposes of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes the aggregate offering price of additional shares that the underwriters have the option to purchase. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:97%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(2)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td colspan="2" style="width:97%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, based on an estimate of the proposed maximum aggregate offering price. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">___________________ </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective </font><font style="font-weight:bold; ">date until the registrant shall file a further amendment that specifically states that this registration statement shall thereafter </font><font style="font-weight:bold; ">become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement </font><font style="font-weight:bold; ">shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">
            				<hr style="border-top:1pt solid #000000; width:100%; " align="left"><hr style="border-top:2pt solid #000000; width:100%; margin-top:-5pt; " align="left">
            <p style="font-family:Times New Roman, Times, serif; font-size:13.03pt; text-align:left; "></p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="color:#FF0000; ">The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the </font><font style="color:#FF0000; ">registration statement filed with the Securities and Exchange Commission is declared effective. This preliminary prospectus is not an </font><font style="color:#FF0000; ">offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is </font><font style="color:#FF0000; ">not permitted.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="color:#FF0000; ">SUBJECT TO COMPLETION, DATED </font><font style="color:#FF0000; "></font><font style="color:#FF0000; ">NOVEMBER 1,</font><font style="color:#FF0000; "> 2021</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="color:#FF0000; ">&#xA0;</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="color:#FF0000; ">PRELIMINARY PROSPECTUS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:13pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Shares </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#xA0; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><img src="logo.jpg" alt="image provided by client" style="width:259.5px; height:234px; ">&#x2009;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:13pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">Common Stock </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">_______________ </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This is the initial public offering of shares of common stock of Nexalin Technology, Inc. We are selling &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; shares of our common stock. Prior to this offering, there has been no public market for our common stock. We anticipate that the initial public offering price will be between $&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; and $&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; per share. We have applied to list our common stock on The Nasdaq Capital Market under the symbol &#x201C;NXL.&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are an &#x201C;emerging growth company&#x201D; under the federal securities laws and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. See the section titled &#x201C;Prospectus Summary&#x2014;Implications of Being an Emerging Growth Company and a Smaller Reporting Company.&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Investing in our common stock involves a high degree of risk. Before buying any shares, you should carefully read the </font><font style="font-weight:bold; ">discussion of the material risks of investing in our common stock under the heading &#x201C;Risk Factors&#x201D; beginning on page </font><font style="font-weight:bold; "></font><font style="font-weight:bold; ">12</font><font style="font-weight:bold; "> of this </font><font style="font-weight:bold; ">prospectus.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Neither the Securities and Exchange Commission, any state securities commission, nor any other regulatory body has </font><font style="font-weight:bold; ">approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the </font><font style="font-weight:bold; ">contrary is a criminal offense.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Certain of our stockholders (or their affiliates), including those affiliated with certain of our directors, have indicated an interest in purchasing up to an aggregate of approximately $&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; shares of our common stock in this offering at the public offering price. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, fewer, or no shares in this offering to these entities, or these entities may determine to purchase more, fewer, or no shares of common stock in this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">













            <tr class="odd" style=" ">

               <td colspan="2" style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Per share</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td colspan="2" style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Public offering price<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Underwriting discounts and commissions (1)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td colspan="2" style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Proceeds, before expenses, to us<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(1)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">See &#x201C;Underwriting&#x201D; beginning on page [&#x2022;] of this prospectus for additional information regarding the compensation payable to the underwriters. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have granted the underwriters a 30-day option to purchase up to&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; additional shares of common stock from us to cover over- allotments at the initial public offering price, less the underwriting discounts and commissions. If the underwriters exercise the option in full, the total underwriting discounts and commissions payable by us with be $&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; and the total proceeds to us, before expenses, will be $&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0;. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The underwriters expect to deliver the shares of common stock on or about &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0;, 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-style:italic; ">Sole Book-Running Manager</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:11pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Maxim Group LLC</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The date of this prospectus is &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0;, &#xA0; &#xA0; &#xA0; 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">TABLE OF CONTENTS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:94%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p>

               </td>

               <td style="width:6%; border-bottom:0.5pt solid #000000; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Page</font></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e904_anchor">ABOUT THIS PROSPECTUS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>2</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e944_anchor">PROSPECTUS SUMMARY</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>3</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e2896_anchor">RISK FACTORS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>9</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e4542_anchor">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>30</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e4648_anchor">USE OF PROCEEDS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>31</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e4813_anchor">DIVIDEND POLICY</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>32</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e4828_anchor">CORPORATE REORGANIZATION</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>32</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e4851_anchor">CAPITALIZATION</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>33</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e5317_anchor">DILUTION</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>34</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e6213_anchor">MANAGEMENT&#x2019;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>35</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e8619_anchor">BUSINESS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>45</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e10895_anchor">MANAGEMENT</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>61</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e11508_anchor">EXECUTIVE AND DIRECTOR COMPENSATION</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>67</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e12000_anchor">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>69</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e12126_anchor">PRINCIPAL STOCKHOLDERS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>71</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e12542_anchor">DESCRIPTION OF CAPITAL STOCK</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>72</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e12796_anchor">SHARES ELIGIBLE FOR FUTURE SALE</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>75</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e13089_anchor">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS OF COMMON STOCK</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>77</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e13325_anchor">UNDERWRITING</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>80</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e13916_anchor">LEGAL MATTERS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>84</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e13931_anchor">EXPERTS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>84</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e13949_anchor">WHERE YOU CAN FIND ADDITIONAL INFORMATION</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>84</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:94%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="#d1e13980_anchor">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</a></font></p>

               </td>

               <td style="width:6%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><font style>F-1</font></p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Neither we nor the underwriters have authorized anyone to provide you with information that is different from, or in </font><font style="font-weight:bold; ">addition to, that contained in this prospectus, any amendment or supplement to this perspective or any free writing prospectus </font><font style="font-weight:bold; ">prepared by or on behalf of us or to which we have referred you, and neither we nor the underwriters take responsibility for, </font><font style="font-weight:bold; ">and can provide no assurances as to the reliability of, any other information others may give you. We are offering to sell, and </font><font style="font-weight:bold; ">seeking offers to buy, shares of our common stock only in jurisdictions where such offers and sales are permitted. The </font><font style="font-weight:bold; ">information in this prospectus or in any free writing prospectus is accurate only as of its date, regardless of its time of delivery </font><font style="font-weight:bold; ">or the time of any sale of shares of our common stock. Our business, financial condition, results of operations and future growth </font><font style="font-weight:bold; ">prospects may have changed since that date.</font>      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Until and including &#xA0;&#xA0;&#xA0;, 2021 (25 days after the date of this prospectus), all dealers that buy, sell or trade shares of our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#x2019; obligation to deliver a prospectus when acting as an underwriter and with respect to unsold allotments or subscriptions. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">For investors outside of the United States</font>: Neither we nor any of the underwriters have done anything that would permit this offering or possession or distribution of this prospectus or any free writing prospectus we may provide to you in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus are required to inform themselves about, and to observe any restrictions relating to, the offering of the shares of our common stock and the distribution of this prospectus and any such free writing prospectus outside of the United States.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">1</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e904_anchor"><font style="font-weight:bold; ">ABOUT THIS PROSPECTUS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On [&#x2022;], 2021, we completed the corporate reorganization described under the section titled &#x201C;Corporate Reorganization,&#x201D; pursuant to which our existing shareholders exchanged their shares in Nexalin Technology, Inc., a Nevada corporation (&#x201C;Nexalin Nevada&#x201D;) for the same number and classes of newly issued shares in the newly incorporated Delaware company of the same name, Nexalin Technology, Inc. (&#x201C;Nexalin,&#x201D; &#x201C;Nexalin Technology&#x201D; or &#x201C;Nexalin Technology, Inc.&#x201D;) and, as a result, Nexalin Nevada became a wholly owned subsidiary of Nexalin. Nexalin had nominal assets and liabilities and did not conduct any operations prior to the reorganization other than its incorporation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Unless otherwise indicated or the context otherwise requires, all references in this prospectus to the terms &#x201C;Nexalin,&#x201D; &#x201C;Nexalin Technology,&#x201D; &#x201C;the Company,&#x201D; &#x201C;we,&#x201D; &#x201C;us&#x201D; and &#x201C;our&#x201D; refer to (i) Nexalin Nevada, prior to the completion of the corporate reorganization discussed herein, and (ii) Nexalin Technology, after the completion of such corporate reorganization. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">References in this prospectus to &#x201C;ordinary shares&#x201D; refer to the historic share capital of Nexalin Nevada prior to the completion of the corporate reorganization. All references to &#x201C;common stock&#x201D; refer to the capital structure of Nexalin upon completion of the corporate reorganization. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon this completion of the corporate reorganization on [&#x2022;], 2021, the historical consolidated financial statements of Nexalin Nevada became the historical consolidated financial statements of Nexalin, the entity whose shares of common stock are being sold in this offering, though such historical financial data do not give effect to the corporation reorganization. We expect that the corporate reorganization will not have a material effect on our financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Except as otherwise indicated or the context otherwise requires, all information included in this prospectus is presented giving effect to the corporate reorganization. See the section titled &#x201C;Corporate Reorganization&#x201D; for more information. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have proprietary rights to a number of trademarks and tradenames used in this prospectus which are important to our business, including Nexalin&#xAE; and the Nexalin logo. Solely for convenience, trademarks, service marks and tradenames referred to in this prospectus may appear without the &#xAE;, <sup>TM</sup> or <sup>SM</sup> symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks, service marks and tradenames. This prospectus may also contain trademarks, service marks, tradenames and copyrights of other companies, which are the property of their respective owners. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">2</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e944_anchor"><font style="font-weight:bold; ">PROSPECTUS SUMMARY</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">This summary highlights information contained in greater detail elsewhere in this prospectus and does not contain all of the </font><font style="font-style:italic; ">information that you should consider in making your investment decision. Before investing in our common stock, you should carefully </font><font style="font-style:italic; ">read this entire prospectus including the &#x201C;Risk Factors,&#x201D; &#x201C;Special Note Regarding Forward-Looking Statements and Industry Data&#x201D; and </font><font style="font-style:italic; ">&#x201C;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201D; and the financial statements and the notes </font><font style="font-style:italic; ">to those financial statements in each case included in this prospectus.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Overview</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Through our existing &#x201C;Gen-1&#x201D; device, we provide an FDA-cleared, easy-to-administer treatment that utilizes bioelectronic medical technology to safely and successfully treat anxiety and insomnia, without the need for drugs or psychotherapy. Our Gen-1 device is classified by the FDA as a Class II device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All our products are non-invasive and undetectable and, critically, can provide relief to those afflicted with mental health issues without adverse side effects. Moreover, our proprietary design of varying voltages, currents, electromagnetic fields and various frequencies&#x2014;referred to collectively as waveform&#x2014;particularly our proprietary, patented symmetrical alternating current waveform, based on responses from our clinical providers, has proven to be highly effective in stimulating a positive response from the mid-brain structures associated with various mental health disorders and distinguishes our devices from all comparable neurostimulation technologies currently available. Our devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head. The features of this waveform make the application of the stimulation undetectable to the human body and this technique is proprietary to our devices, which enables the use of a higher current than all other devices in the market. Our design of an advanced waveform that is safely administered to the human brain is the basis of our treatment and our continuing evolution. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As aforementioned, we currently sell a medical device to medical professionals which is administered by them to patients in a clinical setting and which emits our original waveform at 4 milliamps during treatment&#x2014;referred to as Generation 1 or Gen-1. This device has been cleared in the United States to treat anxiety and insomnia, two prevalent and serious diseases. Prior to a regulatory change, our Gen-1 device was also used to treat depression. We have already begun designing and developing new advanced waveform technology to be emitted at 15 milliamps through our existing medical device improved with a modern enclosure&#x2014;referred to as Generation 2 or Gen-2&#x2014;which can penetrate deeper into the brain and the associated structures of mental illness, which we believe will generate enhanced patient response. Gen-2 is presently being tested in clinical trials, for anxiety, insomnia and depression in the United States and China, and preliminary data provided by the University of California San Diego supports the safety of utilizing our waveform technology at an increased power. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are also currently designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer&#x2019;s disease and dementia. In part due to increasing incidence attributed to the devastating impacts of the COVID-19 pandemic, mental health and cognitive disorders are widespread across the globe and cause substantial health, social and economic losses and hardships accordingly. Our focus is on the continued development of our innovative bioelectronic medical technologies and rapid regulatory approval to help reverse these losses and hardships by safely and effectively treating various mental health disorders.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Beginning in the fourth quarter of 2021, we will begin designing and implementing two new clinical trials on our Gen-2 15 milliamp device for the treatment of anxiety and insomnia. Additionally, we will design a new clinical trial strategy with our new Gen-2 device at 15 milliamps for the treatment of major depressive disorder (MDD). Our regulatory team will schedule a &#x201C;pre-sub&#x201D; meeting with the FDA to begin soliciting guidance on the new PMA for the treatment of depression.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We recognize that an additional barrier to treatment in today&#x2019;s mental health treatment landscape&#x2014;beyond the concerns about safety, efficacy and discomfort that have been associated with conventional mental health treatments such as drugs, psychotherapy and other forms of electrical stimulation&#x2014;is stigma. Therefore, we are developing a new headset design to emit our waveform technology which will offer medical professionals the opportunity to prescribe the headset device for use in a patient&#x2019;s home&#x2014;referred to as Generation 3 or Gen-3&#x2014;to increase access to mental health treatment. We believe that in order to preserve product safety and integrity in the United States, the headset device will require physician oversight including prescriptions for use, monthly authorization for continued patient use and monthly physician monitoring through our digital management platform. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">According to Infinium Global Research, the global neurostimulation devices market is projected to grow from approximately $4.7 billion in 2018 to approximately $9.8 billion for a CAGR of 10.9% from 2019-2025. There are several drivers of this growth. First, many mental health disorders are treated with psychotherapy or pharmaceutical intervention and have limited efficacy and, in the case of the latter increased awareness of the side effects of medication. Second, the rising number of geriatric patients, particularly with respect to Alzheimer&#x2019;s disease, will increase demand for mental health treatments. Third, increased diagnosis of cases of anxiety, depression and various other mental health disorders in all age populations will contribute to the market development. Doctors and patients will seek effective, safer and more cost-effective alternatives to current care standards. Advancements in neurostimulation techniques, such as those we are developing, will provide safe and effective treatment options that address irregularities in the brain&#x2019;s functional health. These functional brain health issues are believed to be the underlying cause of many mental health disorders and chronic diseases. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Overall, we believe that sustained growth in the sale and use of our existing Gen-1 device in combination with our advanced waveform, technological upgrades and the development of a modern headset monitored with our IT management platform, evidenced in our Gen-2 and Gen-3 devices, will position us to disrupt the traditional mental health treatment model. The stigma of expensive psychotherapy or pharmaceutical medication with side effects and dependency issues will be replaced with clinically proven, safe and cost-effective technology that is undetectable to the patient during treatment.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">3</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Market and Industry Background</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Historically, pharmaceutical solutions have been the first line of treatment for those who suffer from anxiety, insomnia, depression, and other mental health disorders. Beginning in 1950, for patients that were not responding to medication, ECT, also called &#x201C;shock therapy,&#x201D; became available. Over time, researchers began to look at alternative ways to inject electricity into the human brain. One such method was via implantable neurostimulators that required invasive surgery procedures associated with high cost and high risk. Implantable devices became the potential solution for those who would not take or could no longer take pharmaceuticals. The interest in electricity continued with the creation of small handheld devices powered by a direct current (DC) battery that the consumer could buy without any medical supervision. Clinical versions of DC stimulators, known as transcranial direct current stimulation (tDCS), were developed by researchers; many of these devices are still in research settings without industry support.</p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In 1992, a new neurostimulation technique emerged called trans-cranial magnetic stimulation (TMS). This technique evolved into repetitive trans-cranial magnetic stimulation (rTMS), which utilized repetitive magnetic pulse energy to stimulate the brain of patients struggling with depression. The American pharmaceutical industry embraced and funded this technology. The FDA cleared rTMS only for patients who had failed to respond to anti-depressants. Side effects, high cost and moderate efficacy continue to burden this technology sector. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Both insurance companies and healthcare providers are looking for alternative ways to decrease costs while still providing safe and effective treatments. Again, according to Infinium Global Research, the global neurostimulation devices market is projected to grow from approximately $4.7 billion in 2018 to approximately $9.8 billion for a CAGR of 10.9% from 2019-2025. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Chinese Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In September 2018, we entered into an agreement with Wider Come Limited, a company formed under the laws of China (&#x201C;Wider&#x201D;), pursuant to which we and Wider shall form a joint venture entity to be domiciled in Hong Kong (the &#x201C;Joint Venture&#x201D;). The Joint Venture will be formed following the completion of certain funding, clinical study, and publication milestones, which Wider has undertaken. Following its formation, the Joint Venture will design and implement a comprehensive business model and distribution plan for our devices in China, Hong Kong, Macau and Taiwan. The first phase of distribution in China includes implementation of a sales strategy by Wider for mainland China and other territories serviced by Wider. In September 2021, the China National Medical Products Administration (NMPA), the equivalent of the United States FDA, granted clearance for sale of the 15 milliamps power parameters in China. No other regulatory of governmental approvals are required for the sale of our devices by Wider in China, Hong Kong, Macau and Taiwan. When the Joint Venture is formed and Wider completes sales of our devices in China, there are no regulatory or other restrictions that would restrict either (i) the transfer from China of any proceeds resulting from such sales by Wider to the Joint Venture in Hong Kong, other than standard compliance with China&#x2019;s State Administration of Foreign Exchange policies, or (ii) our receipt of our share of such proceeds from Hong Kong to us in the United States. We expect to consummate the formation of the Joint Venture in the fourth quarter of 2021. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Associated with Our Business</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">An investment in our common stock involves a high degree of risk. You should carefully consider the risks summarized below. These risks are discussed more fully in the section titled &#x201C;Risk Factors&#x201D; following this prospectus summary. These risks include, but are not limited to, the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">We have incurred significant losses since our inception. We expect to continue to incur significant expenses and operating losses over the next several years. Our net losses may fluctuate significantly from quarter to quarter and year to year. If we do achieve profitability, we may not be able to sustain it; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">We have a limited operating history, which may make it difficult for you to evaluate our current business and predict our future success and viability; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">We currently rely on our existing Gen-1 device, which can only be marketed in the United States for use with anxiety and insomnia and which emits our original waveform only at 4 milliamps during treatment. If we are not successful in enhancing awareness of our technologies and existing and future products, driving adoption across our current target population and expanding the population of eligible patients, our business will be negatively affected; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">We depend to a large degree on the success of our existing and future products, some of which are in clinical development but have not completed advanced clinical trials. If we lose our exiting or cannot obtain future regulatory approval for and successfully commercialize one or more of our products or if we experience significant delays in doing so, we may never become profitable; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Public health threats, including those related to COVID-19, could adversely impact our operations and especially our research and development efforts; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Our reliance on third parties to provide us with supplies to produce our products, to assist in future approved product manufacturing and/or distribution and to provide reimbursement for our products, may result in increased costs, shortages, delays or interruptions in the supply of our products for our clinical trials and approved products for our consumers. Further, arrangements entered into with third-party collaborators to help us develop and commercialize our products expose us to various risks if they fail to perform in accordance with our expectations or at all; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Our commercial success will continue to depend on attaining significant market acceptance of our technologies and existing and future products among healthcare providers, physicians, clinicians, patients, and third-party payors. If we are unable to successfully achieve substantial market acceptance and adoption of our technologies and existing and future products, our business would be harmed; </p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">4</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">If adequate reimbursement remains unavailable in connection with the use of our products and for healthcare providers, physicians and clinicians to provide services for patients treated with our products, it could diminish our sales or affect our ability to sell our products profitably; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">If we are not able to recruit and retain qualified management and scientific personnel, we may fail in developing our technologies and products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">If we are unable to obtain, maintain and protect our intellectual property rights for our technologies and our products, or if our intellectual property rights are inadequate, our competitive position could be harmed, and our ability to continue clinical trials and commercially market products could be adversely affected; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Our commercial success depends in part on our avoiding infringement of the patents and proprietary rights of third parties; if one or more third parties were to assert that we infringe their patents or are otherwise employing their proprietary technology without authorization, it could impair our ability to commercialize our products and otherwise significantly harm our business; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Our foreign operations pose additional risks, including obtaining approval from foreign regulatory authorities, or with respect to FDA accepting data from trials conducted in foreign jurisdictions; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">We may face difficulties relating to compliance with various laws, including those relating to health and safety, and from changes to current and future legislation, both in the U.S. as well as in other foreign jurisdictions where we may be operating; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Our collection, use, storage, disclosure, transfer and other processing of sensitive and personal information could give rise to significant costs, liabilities and other risks, including as a result of investigations, inquiries, litigation, fines, legislative and regulatory action and negative press about our privacy and data protection practices, which may harm our business; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the other factors described in &#x201C;Risk Factors.&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Furthermore, our accompanying unaudited condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. At June 30, 2021, we had a significant accumulated deficit of approximately $68,300,000 and working capital deficit of approximately $1,617,000. For the six months ended June 30, 2021, we had a loss from operations of approximately $3,700,000 and negative cash flows from operations of approximately $428,000. The Company&#x2019;s operating activities consume the majority of its cash resources. We will continue to promote our services to existing and potential customers, but we anticipate that we will continue to incur operating losses as we execute our development plans through 2023, as well as other potential strategic and business development initiatives. In addition, we have had and expect to have negative cash flows from operations, at least into the near future. The Company previously funded these losses primarily through the sale of equity and issuance of convertible notes. The accompanying unaudited consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.</p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management intends to raise significant funds through this proposed Initial Public Offering. Management believes that the actions presently being taken to further implement its business plan will enable the Company to continue as a going concern. While the Company believes in its viability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon our ability to further implement our business plan and raise additional funds through the Initial Public Offering or otherwise.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Although no assurances can be given as to our ability to deliver on our revenue plans or that unforeseen expenses may arise, management believes that the revenue to be generated from operations, together with the potential closing of the Initial Public Offering in the near term, will provide the necessary funding for us to continue as a going concern. Management cannot guarantee any such Initial Public Offering will be available on favorable terms. As such, these matters raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of twelve months from the issue date of this filing. If adequate funds are not available on acceptable terms, or at all, we will need to curtail operations or cease operations.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Corporate Information</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We were originally formed as a Nevada corporation on October 19, 2010 as Nexalin Technology, Inc. On [&#x2022;], 2021, we completed the corporate reorganization described under the section titled &#x201C;Corporate Reorganization,&#x201D; pursuant to which our existing shareholders exchanged their shares in Nexalin Nevada for the same number and classes of newly issued shares in the newly incorporated Delaware company of the same name, Nexalin Technology, Inc. Our principal executive offices are located at 1776 Yorktown, Suite 550, Houston, Texas 77056. Our phone number is (281) 830-8900. Our website address is www.nexalin.com. We do not incorporate the information on or accessible through our website into this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">5</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Implications of Being an Emerging Growth Company and a Smaller Reporting Company</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We qualify as an &#x201C;emerging growth company,&#x201D; as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from some of the reporting requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">being permitted to present only two years of audited financial statements and only two years of related management&#x2019;s discussion and analysis of financial condition and results of operations disclosures in this prospectus; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">not being required to comply with any requirements that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#x2019;s report providing additional information about the audit and the financial statements; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We may take advantage of these exemptions until the last day of our fiscal year following the fifth anniversary of the completion of this offering. However, if any of the following events occur prior to the end of such five-year period, (i) our annual gross revenue exceeds $1.07 billion, (ii) we issue more than $1.0 billion of non-convertible debt in any three-year period or (iii) we become a &#x201C;large accelerated filer,&#x201D; (as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;)), we will cease to be an emerging growth company prior to the end of such five-year period. We will be deemed to be a &#x201C;large accelerated filer&#x201D; at such time that we (a) have an aggregate worldwide market value of common equity securities held by non-affiliates of $700 million or more as of the last business day of our most recently completed second fiscal quarter, (b) have been required to file annual and quarterly reports under the Exchange Act, for a period of at least twelve months and (c) have filed at least one annual report pursuant to the Exchange Act. Even after we no longer qualify as an emerging growth company, we may still qualify as a &#x201C;smaller reporting company,&#x201D; which would allow us to take advantage of many of the same exemptions from disclosure requirements including reduced disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy statements. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. We have elected to take advantage of this extended transition period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are also a &#x201C;smaller reporting company&#x201D; as defined in the Exchange Act. We may take advantage of certain of the scaled disclosures available to smaller reporting companies until the fiscal year following the determination that our voting and non-voting common stock held by non-affiliates is more than $250 million measured on the last business day of our second fiscal quarter, or our annual revenues are less than $100 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700 million measured on the last business day of our second fiscal quarter. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">6</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">THE OFFERING</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Common stock offered by us:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;shares </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Common stock to be outstanding </font><font style="font-weight:bold; ">immediately following this offering:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;shares (&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares if the underwriters exercise their option to purchase additional shares in full) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Underwriters&#x2019; option to purchase </font><font style="font-weight:bold; ">additional shares from us:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">We have granted the underwriters a 30-day option to purchase up to an aggregate of&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; additional shares of common stock from us at the public offering price, less underwriting discounts and commissions, on the same terms as set forth in this prospectus. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Use of proceeds:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">We estimate that we will receive net proceeds from this offering of approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million, or approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million if the underwriters exercise their option to purchase additional shares in full, assuming an a initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We currently intend to use the net proceeds from this offering, together with our existing cash, to, among other things, fund the research and development of our technologies and products and for working capital and other general corporate purposes. See &#x201C;Use of Proceeds&#x201D; below. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Dividend policy:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">We do not currently intend to pay dividends on our common stock. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risk factors:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">An investment in our common stock involves a high degree of risk. You should read this prospectus carefully, including the section entitled &#x201C;Risk Factors&#x201D; and the consolidated financial statements and the related notes to those statements included in this prospectus, before investing in our common stock before deciding to invest in shares of our common stock. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Proposed Nasdaq Capital Market </font><font style="font-weight:bold; ">Symbol:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:66%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x201C;NXL&#x201D; &#x2013; We intend to apply to list our common stock on The Nasdaq Capital Market under the symbol &#x201C;NXL.&#x201D; We will not proceed with this offering in the event the common stock is not approved for listing on Nasdaq. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Certain of our stockholders (or their affiliates), including those affiliated with certain of our directors, have indicated an interest in purchasing up to an aggregate of approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares of our common stock in this offering at the public offering price. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, fewer or no shares in this offering to these entities, or these entities may determine to purchase more, fewer or no shares of common stock in this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The number of shares of our common stock that will be outstanding after this offering is based on 88,124,701 shares of common stock outstanding as of June 30, 2021, and excludes the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">816,000 warrants with an exercise price of $0.50 per share; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">shares to be issued to U.S. Asian Consulting Group, LLC to hold 15% of the total outstanding shares immediately prior to this offering as consideration for waiving previous anti-dilution rights. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Unless otherwise indicated, all information in this prospectus reflects or assumes: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">no exercise by the underwriters of their option to purchase up to &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; additional shares of common stock in this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">7</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">SUMMARY FINANCIAL DATA</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In the tables below, we provide you with our summary consolidated financial data for the periods indicated. We have derived the following summary of our consolidated statement of operations data for the year ended December 31, 2020, and the balance sheet data as of December 31, 2020, from our audited consolidated financial statements appearing elsewhere in this prospectus. We have derived the following summary of our consolidated statement of operations data for the six months ended June 30, 2021 and 2020, and the balance sheet data as of June 30, 2021, from our unaudited interim consolidated financial statements appearing elsewhere in this prospectus. The unaudited interim consolidated financial statements have been prepared on a basis consistent with our audited consolidated financial statements included in this prospectus and include, in our opinion, all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the financial information in those statements. Our historical results are not necessarily indicative of the results to be expected in the future. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">You should read this summary consolidated financial data together with our consolidated financial statements and related notes to those statements, as well as the sections titled &#x201C;Selected Financial Data&#x201D; and &#x201C;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations,&#x201D; which are included elsewhere in this prospectus. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Results of Operations</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table summarizes our results of operations for the years ended December 31, 2020 and 2019 and the six months ended June 30, 2021 and 2020: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">




















            <tr class="odd" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Six Months </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Ended </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2021 </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Unaudited)</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Six Months </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Ended </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020 </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Unaudited)</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">242,914 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">207,383 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">64,096 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">173,505 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cost of revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">29,039 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">61,813 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">13,142 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,748 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross profit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">213,875 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">145,570 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50,954 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">162,758 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,509,329 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,633,405 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,696,617 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,311,901 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss from operations<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,295,454 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,487,835 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,645,663 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,149,143 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expense<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(108,032 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,533,355 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,705 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">39,652 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,403,486 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,021,190 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,682,368 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,188,795 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted-average common shares o/s, basic and diluted<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">71,665,615 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">60,909,306 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">79,151,987 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">65,875,892 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:42%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Basic and diluted net loss per common share<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.05 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.08 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.05 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.03 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">
















            <tr class="odd" style=" ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">As of </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:27%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">As of June 30, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2021</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Unaudited)</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Actual</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Actual</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">As </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Adjusted</font><sup><font style="font-weight:bold; ">(1)(2)</font></sup>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance Sheet Data:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,436 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">307,946 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Working capital deficit<sup>(3)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,449,667 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,616,674 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total assets<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">118,461 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">359,046 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total liabilities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,708,791 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,090,265 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accumulated deficit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(64,613,520 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(68,295,888 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:56%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total deficit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,590,330 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,731,219 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(1)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">The as adjusted balance sheet data gives effect to the issuance and sale of common stock in this offering at an assumed initial public offering price of $________ per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(2)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Each $1.00 increase (decrease) in the assumed initial public offering price of $ _________ per shares, would increase (decrease) as adjusted cash and cash equivalents, working capital, total assets, and total equity by approximately $ _________ million, assuming that the number of Units offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of _________ shares offered by us at the assumed initial public offering price of $_________ per share, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us would increase (decrease) as adjusted cash and cash equivalents, working capital, total assets, and total equity by approximately $ _________ million. The as adjusted information discussed above is illustrative only and will be adjusted based on the actual initial public offering price and other terms of our initial public offering determined at pricing. </p>
               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">(3)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">We define working capital as current assets less deferred offering costs and less current liabilities. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">8</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e2896_anchor"><font style="font-weight:bold; ">RISK FACTORS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Investing in our common stock is speculative and involves a high degree of risk including the risk of a loss of your entire </font><font style="font-style:italic; ">investment. Before you invest in our common stock, you should carefully consider the following risk factors. These risk factors contain, </font><font style="font-style:italic; ">in addition to historical information, forward looking statements that involve risks and uncertainties. Our actual results could differ </font><font style="font-style:italic; ">significantly from the results discussed in the forward-looking statements. The occurrence of any of the adverse developments described </font><font style="font-style:italic; ">in the following risk factors and in the documents incorporated herein by reference could materially and adversely harm our business, </font><font style="font-style:italic; ">financial condition, results of operations or prospects. In such event, the value of our common stock could decline, and you could lose </font><font style="font-style:italic; ">all or a substantial portion of the money that you pay for our common stock. In addition, the risks and uncertainties discussed below </font><font style="font-style:italic; ">are not the only ones we face. Our business, financial condition, results of operations or prospects could also be harmed by risks and </font><font style="font-style:italic; ">uncertainties not currently known to us or that we currently do not believe are material, and these risks and uncertainties could result in </font><font style="font-style:italic; ">a complete loss of your investment. In assessing the risks and uncertainties described below, you should also refer to the other </font><font style="font-style:italic; ">information contained in this prospectus (as supplemented or amended).</font>      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to Our Financial Position and Capital Needs</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We have incurred significant losses since our inception. We expect to incur losses over the next several years and may never achieve </font><font style="font-weight:bold; font-style:italic; ">or maintain profitability.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are a Delaware corporation with a limited operating history. We have funded our operations to date primarily with proceeds from the sale of our stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have devoted substantially all our financial resources and efforts to research and development, including preclinical studies and clinical trials. We are still in the early stages of development of our products. Currently, we market a first-Generation medical device cleared by the U.S. Food and Drug Administration (&#x201C;FDA&#x201D;) for the treatment of anxiety and insomnia. We are presently amending our previous application under Section 510(k) of the Federal Food, Drug and Cosmetic Act (&#x201C;510(k) Application&#x201D;) for such treatment of anxiety and insomnia in accordance with the FDA reclassification ruling in December 2019. We have begun to structure the special control clinical trials for anxiety and insomnia at the University California San Diego required for the amendment of our 510(k) Application. We are additionally developing a second-Generation medical device that has not completed development or regulatory filings with the FDA. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Relatedly, we expect to continue to incur significant expenses and operating losses over the next several years. Our net losses may &#xFB02;uctuate substantially from quarter to quarter and year to year. We anticipate that our expenses will increase significantly as we: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">continue our ongoing and planned preclinical and clinical development of our existing and next Generation products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">initiate preclinical studies and clinical trials for any additional products that we may pursue in the future; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">seek to discover and develop additional treatment indications; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">seek regulatory approvals for any products that successfully complete clinical trials; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">ultimately establish sales, marketing and distribution infrastructure and scale up external manufacturing capabilities to commercialize any product for which we may obtain regulatory approval and intend to commercialize on our own; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">maintain, expand and protect our intellectual property portfolio; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">hire additional clinical, scientific, manufacturing and controls personnel; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">add operational, financial and management information systems and personnel, including personnel to support our product development and planned future commercialization efforts; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">incur additional legal, accounting and other expenses associated with operating as a public company. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">To become and remain profitable, we and our collaborators must succeed in developing and eventually commercializing future and existing products that generate significant revenue. This will require us to be successful in a range of challenging activities, including completing preclinical studies and clinical trials of our products and preclinical program, obtaining regulatory approval, manufacturing, marketing and selling any products for which we may obtain regulatory approval, as well as discovering and developing additional products. Again, we are only in the preliminary stages of most of these activities. We may never succeed in these activities and, even if we do, may never generate revenues that are significant enough to achieve profitability. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Because of the numerous risks and uncertainties associated with product development, we are unable to accurately predict the timing or amount of expenses or when, or if, we will be able to achieve profitability. If we are required by regulatory authorities to perform studies in addition to those currently expected, or if there are any delays in the initiation and completion of our clinical trials or the development of any of our products, our expenses could increase. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Even if we achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would depress the value of our common stock and could impair our ability to raise capital, expand our business, maintain our research and development efforts or continue our operations. A decline in the value of our common stock could also cause you to lose all or part of your investment. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">9</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">The report of our independent registered public accounting firm included a &#x201C;going concern&#x201D; explanatory paragraph prior to this </font><font style="font-weight:bold; font-style:italic; ">offering.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our accompanying unaudited condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. At June 30, 2021, we had a significant accumulated deficit of approximately $68,300,000 and working capital deficit of approximately $1,617,000. For the six months ended June 30, 2021, we had a loss from operations of approximately $3,700,000 and negative cash flows from operations of approximately $428,000. The Company&#x2019;s operating activities consume the majority of its cash resources. We will continue to promote our services to existing and potential customers but anticipate that we will continue to incur operating losses as we execute our development plans through 2023, as well as other potential strategic and business development initiatives. In addition, we have had and expect to have negative cash flows from operations, at least into the near future. The Company previously funded these losses primarily through the sale of equity and issuance of convertible notes. The accompanying unaudited consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.</p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management intends to raise significant funds through this proposed offering. Management believes that the actions presently being taken to further implement its business plan will enable the Company to continue as a going concern. While the Company believes in its viability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon our ability to further implement our business plan and raise additional funds through this offering or otherwise.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Although no assurances can be given as to our ability to deliver on our revenue plans or that unforeseen expenses may arise, management believes that the revenue to be generated from operations, together with the potential closing of this offering in the near term, will provide the necessary funding for us to continue as a going concern. Management cannot guarantee any such offering will be available on favorable terms. As such, these matters raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of twelve months from the issue date of this filing. If adequate funds are not available on acceptable terms, or at all, we will need to curtail operations or cease operations.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Our limited operating history may make it difficult for you to evaluate the success of our business to date and to assess our future </font><font style="font-weight:bold; font-style:italic; ">viability.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We commenced active operations in 2010, and our operations to date have been largely focused on raising capital, identifying and developing our products and preclinical program, broadening our expertise in the development of our products and undertaking preclinical studies and conducting early-stage clinical trials. Currently, we market a first-Generation medical device cleared by the FDA for the treatment of anxiety and insomnia. We are presently amending our previous 510(k) Application for such treatment of anxiety and insomnia in accordance with the FDA reclassification ruling in December 2019. We are additionally developing a second-Generation medical device that has not completed development or regulatory filings with the FDA. Consequently, any predictions you make about our future success or viability may not be as accurate as they could be if we had a longer operating history. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We may encounter unforeseen expenses, difficulties, complications, delays and other known or unknown factors in achieving our business objectives. We will need to transition at some point from a company with a research and development focus to a company capable of supporting commercial activities. We may not be successful in such a transition. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We expect our financial condition and operating results to continue to &#xFB02;uctuate significantly from quarter to quarter and year to year due to a variety of factors, many of which are beyond our control. Accordingly, you should not rely upon the results of any quarterly or annual periods as indications of future operating performance. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We may require substantial additional funding to meet our financial needs and to pursue our business objectives. If we are unable to </font><font style="font-weight:bold; font-style:italic; ">raise capital when needed, we could be forced to delay, reduce or altogether cease our product development programs or </font><font style="font-weight:bold; font-style:italic; ">commercialization efforts.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are currently not cash flow positive and do not expect to be cash flow positive until 2023. While we believe that the net proceeds from this offering and the use of such net proceeds described elsewhere in this report will enable us to fund our operating expenses and capital expenditure requirements through calendar year 2023, we may still need to obtain substantial additional funding in connection with our continuing operations and planned activities. Our future capital requirements will depend on many factors, including:</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">10</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the timing, progress and results of our ongoing clinical trials of our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the scope, progress, results and costs of preclinical development, laboratory testing and clinical trials of other products that we may pursue; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the number and development requirements of other products that we may pursue; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our ability to establish collaborations on favorable terms, if at all; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the costs, timing and outcome of regulatory review of our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales and distribution, for any of our products for which we receive marketing approval; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the revenue, if any, received from commercial sales of our products for which we receive marketing approval; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the costs of operating as a public company. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Identifying potential products and conducting preclinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to continue our regulatory approvals and achieve product sales. In addition, our products, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that are currently cleared under FDA review. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce or altogether cease our research and development programs or future commercialization efforts. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">11</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Raising additional capital may cause dilution to our stockholders, including purchasers of shares of our common stock in this </font><font style="font-weight:bold; font-style:italic; ">offering, restrict our operations or require us to relinquish rights to our technologies or products.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our cash needs through equity offerings. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a stockholder. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our technologies, future revenue streams, research programs or products or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to a third party to develop and market products that we would otherwise prefer to develop and market ourselves. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to the Development of Our Products and Preclinical Program</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We depend to a large degree on the success of our existing and future products, some of which are in clinical development but have </font><font style="font-weight:bold; font-style:italic; ">not completed advanced clinical trials. If we lose our existing or cannot obtain future regulatory approval for and successfully </font><font style="font-weight:bold; font-style:italic; ">commercialize one or more of our products or if we experience significant delays in doing so, we may never become profitable.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The success of our products and preclinical program will depend on several additional factors, including: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">successful completion of preclinical studies and requisite clinical trials; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">performing preclinical studies and clinical trials in compliance with the FDA or any comparable regulatory authority requirements; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">receipt of marketing approvals from applicable regulatory authorities; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the ability of collaborators to manufacture sufficient quantity of product for development, clinical trials or potential commercialization; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">obtaining and maintaining patent, trademark and trade secret protection, and regulatory exclusivity for our products and preclinical program; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">making arrangements with third parties for manufacturing capabilities; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">launching commercial sales of products, if and when approved, whether alone or in collaboration with others; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">acceptance of the therapies, if and when approved, by healthcare providers, physicians, clinicians, patients and third-party payors; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">competing effectively with other therapies; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">obtaining and maintaining healthcare coverage and adequate reimbursement; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">protecting our rights in our intellectual property portfolio. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize our products, which would harm our business. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Our products and product candidates may be subject to reclassification by the FDA, and a change in the classification may have an </font><font style="font-weight:bold; font-style:italic; ">adverse impact on our revenues or our abilities to obtain necessary regulatory approvals.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Originally, our technology was cleared for the treatment of anxiety, depression and insomnia. Each treatment indication with this technology was classified as class three from a risk tolerance standpoint at the FDA. In December of 2019, the FDA passed a new ruling that separated anxiety and insomnia from the treatment of depression. Anxiety and insomnia were reclassified as class two medical devices and require special control trials to be initiated, as well as the filing of a new 510(k). The FDA left the treatment of depression for cranial stimulation as a class three high risk device. In order to receive approval for treatment for depression, a new pre-market application will be required for this indication. We decided not to pursue a depression indication for our Gen-1 device at such time. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Any further such reclassification by the FDA of an indication from a certain class of device to another during our development or post-commercialization for that indication could have a significant adverse impact due to the more rigorous and lengthy approval process required for a higher risk class medical device. Such a change in classification can significantly increase development costs and prolong the time for development and approval, thus delaying revenues. A reclassification of an indication after approval from a certain class of device to another could result in a change in classification for reimbursement, and there could be a significant negative impact on our revenues relatedly. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Success in preclinical studies or clinical trials may not be indicative of results in future clinical trials.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Success in preclinical testing and early clinical trials does not ensure that later clinical trials will generate the same results or otherwise provide adequate data to demonstrate the efficacy and safety of a product candidate. Our products may fail to show the desired safety and efficacy in all clinical trials. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">12</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">If we experience delays or difficulties in the enrollment of patients in clinical trials, our receipt of necessary regulatory approvals </font><font style="font-weight:bold; font-style:italic; ">could be delayed or prevented.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We may not be able to initiate, continue or complete clinical trials of any product candidate that we develop if we and our collaborators are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA or other comparable regulatory authority. We have limited experience enrolling patients in our clinical trials and cannot predict how successful we will be in enrolling patients in future clinical trials. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Public health threats, including those related to the novel strain of coronavirus, SARS-CoV-2 (which causes the disease now called </font><font style="font-weight:bold; font-style:italic; ">COVID-19), have had, and could continue to have an adverse effect on our operations.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Public health threats have, and could continue to, adversely affect our ongoing or planned research and development activities. In particular, SARS-CoV-2, which causes the disease now called COVID-19, was first reported to have surfaced in Wuhan, China in December 2019, and has since spread globally, including to every state in the United States. On January 31, 2020, the Secretary of Health and Human Services (HHS) issued a Public Health Emergency determination in response to the spread of COVID-19. A Public Health Emergency determination remains in effect for 90 days and can be renewed for additional 90-day periods, which the Secretary of HHS has since done multiple times. The outbreak of COVID-19 has severely impacted global economic activity and caused significant volatility and negative pressure in financial markets. The global impact of the outbreak has been rapidly evolving and many countries, including the United States, have reacted by instituting quarantines, mandating business and school closures and restricting travel. As a result, the COVID-19 pandemic is negatively impacting almost every industry directly or indirectly. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The COVID-19 pandemic has delayed our clinical trials and our receipt of marketing approvals from the FDA. Such pandemic also might have reduced, and continue to reduce, participation in our clinical trials, due to both travel restrictions and a general unwillingness of subjects to travel. We cannot presently predict the scope and severity of any other potential business shutdowns or disruptions, but if we or any of the third parties with whom we engage, including the suppliers, clinical trial sites, regulators and other third parties with whom we conduct business, were to experience shutdowns or other business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively impacted. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Relatedly, the spread of an infectious disease, including COVID-19, may also result in the inability of our suppliers to deliver components or raw materials on a timely basis. Such events may result in a period of business and manufacturing disruption, and in reduced operations, any of which could materially affect our business, financial condition and results of operations. The extent to which the coronavirus impacts our business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain the coronavirus or treat its impact, among others. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to Our Dependence on Third Parties</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We rely on third parties to conduct the clinical trials for our products, and those third parties may not perform satisfactorily, </font><font style="font-weight:bold; font-style:italic; ">including failing to meet deadlines for the completion of such trials or failing to comply with applicable regulatory requirements.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We rely on third parties, such as research institutions, to conduct our clinical trials. Our reliance upon research institutions, including hospitals, clinics and academics, provides us with less control over the timing and cost of clinical trials and the ability to recruit subjects. If we are unable to reach agreement with suitable research institutions on acceptable terms, or if any resulting agreement is terminated, we may be unable to quickly replace the research institution with another qualified institution on acceptable terms. Even if we do replace the institution, we may incur additional costs to conduct the trial at the new institution. We may not be able to secure and maintain suitable research institutions to conduct our clinical trials. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We rely on </font><font style="font-weight:bold; font-style:italic; "></font><font style="font-weight:bold; font-style:italic; ">a collaboration with a third party for the quality assurance </font><font style="font-weight:bold; font-style:italic; ">of our products, and we may seek additional collaborations in </font><font style="font-weight:bold; font-style:italic; ">the future. If those collaborations are not successful, we may not be able to capitalize on the market potential of these products.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are a party to a quality assurance agreement with a third party for the quality assurance of our products, and may enter into additional collaborations in the future. We are dependent upon the success of our current and any future collaborators in performing their responsibilities in connection with the relevant collaboration. If we fail to maintain these collaborative relationships for any reason, we would need to perform the activities that we currently anticipate would be performed by our collaborators on our own at our sole expense. This could substantially increase our capital needs, and we may not have the capability or financial capacity to undertake these activities on our own, or we may not be able to find other collaborators on acceptable terms, or at all. This may limit the programs we are able to pursue and result in significant delays in the development, sale and manufacture of our product candidates and products, and may have a material adverse effect on our business, financial condition and results of operations. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our dependence upon our current and potential future collaborations exposes us to a number of risks, including that our collaborators (i) may fail to cooperate or perform their contractual obligations, including financial obligations, (ii) may choose to undertake differing business strategies or pursue alternative technologies or (iii) may take an opposing view regarding ownership of clinical trial results or intellectual property. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Due to these factors and other possible events, we could suffer delays in the research, development or commercialization of our product candidates and future products or we may become involved in litigation or arbitration, which could be time consuming and expensive. We additionally may be compelled to split revenue with our collaborators, which could have a material adverse effect on our business, financial condition, and results of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">13</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to the Commercialization of Our Products</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Even if any of our products receives marketing approval, it may fail to achieve the degree of market acceptance by healthcare </font><font style="font-weight:bold; font-style:italic; ">providers, physicians, clinicians, patients, third-party payors and others in the medical community necessary for commercial success.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The degree of market acceptance of our products, if approved for commercial sale, will depend on a number of factors, including: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the efficacy and potential advantages compared to alternative treatments; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the potential and perceived advantages and disadvantages of the products, including cost and clinical benefit relative to alternative treatments; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the convenience and ease of administration compared to alternative treatments; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the willingness of the target patient population to try new therapies and of healthcare providers, physicians, and clinicians to prescribe these therapies; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">acceptance by healthcare providers, physicians, clinicians, patients, operators of hospitals, including in-hospital formularies, and treatment facilities and parties responsible for coverage and reimbursement of the product; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the availability of coverage and adequate reimbursement by third-party payors and government authorities; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the ability to manufacture our product in sufficient quantities and yields; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the strength and effectiveness of marketing and distribution support; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the prevalence and severity of any side effects; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">limitations or warnings, including distribution or use restrictions, contained in the product&#x2019;s approved labeling; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the approval of other new products for the same indications; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the timing of market introduction of the approved product as well as competitive products. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Any failure by any of our existing or future products that obtain regulatory approval to achieve market acceptance or commercial success would have a material adverse effect on our business prospects. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We may eventually compete for product sales with other companies, many of which will have greater resources or capabilities than </font><font style="font-weight:bold; font-style:italic; ">we have, or may succeed in developing better products or in developing products more quickly than we do, and we may not compete </font><font style="font-weight:bold; font-style:italic; ">successfully with them.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our industry is competitive and has been evolving rapidly with not only existing treatment options, but also the introduction of new technologies and products as well as the market activities of industry participants. We compete or may eventually compete with other companies and organizations that are marketing or developing therapies for our targeted disease indications, based on traditional pharmaceutical, medical device, or other neurostimulation therapy and technologies. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We also face competition in the neurostimulation field from academic institutions and governmental agencies. Many of our current and potential competitors have greater financial and human resources than we have, including more experience in research and development and more established sales, marketing and distribution capabilities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We anticipate that competition in our industry will increase. In addition, the health care industry is characterized by rapid technological change, resulting in new product introductions and other technological advancements. Our competitors may develop and market products that render product candidates now or under development by us in the future, or any products manufactured or marketed by us, non-competitive or otherwise obsolete. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Coverage and adequate reimbursement may not be available for our current or any future products, which could make it difficult for </font><font style="font-weight:bold; font-style:italic; ">us to sell profitably, if approved.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Market acceptance and sales of any products that we commercialize, if approved, will depend in part on the extent to which reimbursement for these products and related treatments will be available from third-party payors, including government health administration authorities, managed care organizations and other private health insurers. Third-party payors decide which therapies they will pay for and establish reimbursement levels. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own coverage and reimbursement policies. However, decisions regarding the extent of coverage and amount of reimbursement to be provided for any products that we develop will be made on a payor-by-payor basis. One payor&#x2019;s determination to provide coverage for a product does not assure that other payors will also provide coverage and adequate reimbursement for the product. Additionally, a third-party payor&#x2019;s decision to provide coverage for a therapy does not imply that an adequate reimbursement rate will be approved. Each payor determines whether it will provide coverage for a therapy, what amount it will pay for the therapy and on what tier of its list of covered products, or formulary, it will be placed. The position on a payor&#x2019;s formulary, generally determines the co-payment that a patient will need to make to obtain the therapy and can strongly in&#xFB02;uence the adoption of such therapy by patients and physicians. Patients who are prescribed treatments for their conditions and providers prescribing such services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use our products, and providers are unlikely to prescribe our products, unless coverage is provided, and reimbursement is adequate to cover a significant portion of the cost of our products and their administration. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">14</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Third-party payors have attempted to control costs by limiting coverage and limited reimbursement for medications and certain treatments utilizing digital technologies. We cannot be sure that coverage and reimbursement will be available for any product that we commercialize and, if reimbursement is available, what the level of reimbursement will be. Inadequate coverage and reimbursement may impact the demand for, or the price of, any product for which we obtain marketing approval. If coverage and adequate reimbursement are not available, or are available only to limited levels, we may not be able to successfully commercialize our current and any future products that we develop. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that </font><font style="font-weight:bold; font-style:italic; ">we may develop.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We face an inherent risk of product liability exposure related to the testing of our products in human clinical trials and will face an even greater risk if we commercially sell any products that we may develop. If we cannot successfully defend ourselves against claims that our products or products caused injuries, we will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">reduced resources of our management to pursue our business strategy; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">decreased demand for any products or products that we may develop; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">injury to our reputation and significant negative media attention; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">withdrawal of clinical trial participants; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">initiation of investigations by regulators; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">product recalls, withdrawals or labeling, marketing or promotional restrictions; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">significant costs to defend the resulting litigation; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">substantial monetary awards paid to clinical trial participants or patients; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">loss of revenue; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the inability to commercialize any products that we may develop. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We currently hold $1 million in product liability insurance coverage in the aggregate, with a per incident limit of $1 million, which may not be adequate to cover all liabilities that we may incur. We may need to increase our insurance coverage as we expand our clinical trials or if we commence commercialization of our products. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:16pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to Our Business and Managing Our Growth</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Our future success depends on our ability to retain key executives and to attract, retain and motivate qualified personnel.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Recruiting and retaining qualified scientific and clinical personnel and, if we progress the development of any of our products, commercialization, manufacturing and sales and marketing personnel, will be critical to our success. The loss of the services of our executive officers or other key employees could impede the achievement of our research, development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of and commercialize our products. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. If we are unable to continue to attract and retain high-quality personnel, our ability to pursue our growth strategy will be limited. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We expect to expand our development and regulatory capabilities and potentially implement sales, marketing and distribution </font><font style="font-weight:bold; font-style:italic; ">capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As of June 30, 2021, we had two full-time employees and six consultants. As the clinical development of our products progresses, we also expect to experience significant growth in the number of our employees and the scope of our operations, particularly in the areas of research, product development and regulatory affairs, including a sales and marketing team for our existing products. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">15</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Significant disruptions of our information technology systems or data security incidents could result in significant financial, legal, </font><font style="font-weight:bold; font-style:italic; ">regulatory, business and reputational harm to us.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are increasingly dependent on information technology systems and infrastructure, including mobile technologies, to operate our business. In the ordinary course of our business, we collect, store, process and transmit large amounts of sensitive information, including intellectual property, proprietary business information, personal information and other confidential information. It is critical that we do so in a secure manner to maintain the confidentiality, integrity and availability of such sensitive information. We have also outsourced elements of our operations, including elements of our information technology infrastructure, to third parties and, as a result, we manage a number of third-party vendors who may or could have access to our computer networks or our confidential information. In addition, many of those third parties in turn subcontract or outsource some of their responsibilities to other third parties. While all information technology operations are inherently vulnerable to inadvertent or intentional security breaches, incidents, attacks and exposures, the accessibility and distributed nature of our information technology systems, and the sensitive information stored on those systems, make such systems potentially vulnerable to unintentional or malicious, internal and external attacks on our technology environment. Potential vulnerabilities can be exploited from inadvertent or intentional actions of our employees, third-party vendors, or business partners or by malicious third parties. Attacks of this nature are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives (including industrial espionage) and expertise, including organized criminal groups, &#x201C;hacktivists,&#x201D; nation states and others. In addition to the extraction of sensitive information, such attacks could include the deployment of harmful malware, ransomware, denial-of-service attacks, social engineering and other means to affect service reliability and threaten the confidentiality, integrity and availability of information. In addition, the prevalent use of mobile devices increases the risk of data security incidents. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Significant disruptions of our, our third-party vendors&#x2019; or our business partners&#x2019; information technology systems or other similar data security incidents could adversely affect our business operations and result in the loss, misappropriation and unauthorized access, use or disclosure of, or the prevention of access to, sensitive information, which could result in financial, legal, regulatory, business and reputational harm to us. In addition, information technology system disruptions, whether from attacks on our technology environment or from computer viruses, natural disasters, terrorism, war or telecommunication and electrical failures, could result in a material disruption of our development programs and our business operations. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There is no way of knowing with certainty whether we have experienced any data security incidents that have not been discovered. While we have no reason to believe this to be the case, attackers have become very sophisticated in the way they conceal access to systems, and many companies that have been attacked are not aware that they have been attacked. Any event that leads to unauthorized access, use or disclosure of personal information, including personal information regarding our patients or employees, could disrupt our business, harm our reputation, compel us to comply with applicable federal and state breach notification laws and foreign law equivalents, subject us to time-consuming, distracting and expensive litigation, regulatory investigation and oversight or mandatory corrective action, require us to verify the correctness of database contents or otherwise subject us to liability under laws, regulations and contractual obligations, including those that protect the privacy and security of personal information. This could result in increased costs to us, and result in significant legal and financial exposure and reputational harm. In addition, any failure or perceived failure by us or our vendors or business partners to comply with our privacy, confidentiality or data security-related legal or other obligations to third parties, or any further security incidents or other inappropriate access events that result in the unauthorized access, release or transfer of sensitive information, which could include personally identifiable information, may result in governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us by advocacy groups or others, and could cause third parties, including clinical sites, regulators or current and potential partners, to lose trust in us, or we could be subject to claims by third parties that we have breached our privacy- or confidentiality-related obligations. Moreover, data security incidents and other inappropriate access can be difficult to detect, and any delay in identifying them may lead to increased harm of the type described above. While we have implemented security measures intended to protect our information technology systems and infrastructure, there can be no assurance that such measures will successfully prevent service interruptions or security incidents. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">If we engage in future acquisitions or strategic collaborations, this may increase our capital requirements, dilute our stockholders, </font><font style="font-weight:bold; font-style:italic; ">cause us to incur debt or assume contingent liabilities and subject us to other risks.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">From time to time, we may evaluate various acquisitions and strategic collaborations, including licensing or acquiring intellectual property rights, technologies or businesses, as deemed appropriate to carry out our business plan. Any potential acquisition or strategic collaboration may entail numerous risks, including: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">increased operating expenses and cash requirements; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the assumption of additional indebtedness or contingent liabilities; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">assimilation of operations, intellectual property and products of an acquired company, including difficulties associated with integrating new personnel; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the diversion of our management&#x2019;s attention from our existing product programs and initiatives in pursuing such a strategic partnership, merger or acquisition; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">retention of key employees, the loss of key personnel and uncertainties in our ability to maintain key business relationships; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or products and regulatory approvals; and </p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">16</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">our inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to Doing Business in China</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">The medical industry in China is highly regulated and such regulations are subject to change which may affect approval and </font><font style="font-weight:bold; font-style:italic; ">commercialization of our products.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A material portion of our research is expected to be conducted in China through a joint venture, which we believe confers clinical, commercial and regulatory advantages. The medical industry in China is subject to comprehensive government regulation and supervision, encompassing the approval, registration, manufacturing, packaging, licensing and marketing of new drugs. In recent years, the regulatory framework in China regarding the medical industry has undergone significant changes, and we expect that it will continue to undergo significant changes. Any such changes or amendments may result in increased compliance costs on our business or cause delays in or prevent the successful development or commercialization of our products in China and reduce the current benefits we believe are available to us from researching our products in China. The People&#x2019;s Republic of China, or PRC, authorities have become increasingly vigilant in enforcing laws in the medical industry and any failure by us or our partners to maintain compliance with applicable laws and regulations or obtain and maintain required licenses and permits may result in the suspension or termination of our business activities in China. We believe our strategy and approach are aligned with the PRC government&#x2019;s regulatory policies, but we cannot ensure that our strategy and approach will continue to be aligned. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China </font><font style="font-weight:bold; font-style:italic; ">against us based on foreign laws.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We expect to conduct a material portion of our research in China through a joint venture. As a result, it may be difficult for you to effect service of process upon us inside China. It may also be difficult for you to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws against us. In addition, there is uncertainty as to whether the courts of the PRC would recognize or enforce judgments of U.S. courts against us predicated upon the civil liability provisions of the securities laws of the United States or any state. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The recognition and enforcement of foreign judgments are provided for under the PRC Civil Procedures Law. PRC courts may recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures Law based either on treaties between China and the country where the judgment is made or on principles of reciprocity between jurisdictions. China does not have any treaties or other forms of written arrangement with the United States that provide for the reciprocal recognition and enforcement of foreign judgments. In addition, according to the PRC Civil Procedures Law, the PRC courts will not enforce a foreign judgment against us if they decide that the judgment violates the basic principles of PRC laws or national sovereignty, security or the public interest. As a result, it is uncertain whether and on what basis a PRC court would enforce a judgment rendered by a court in the United States. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">It may be difficult for overseas regulators to conduct investigations or collect evidence within China.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">It may be difficult for you or overseas regulators, such as the Securities and Exchange Commission (SEC), the Department of Justice (DOJ) and other authorities of the United States, to conduct investigations or collect evidence within China. For example, in China, there are significant legal and other obstacles to obtaining information, documents and materials needed for regulatory investigations or litigation outside China or otherwise with respect to foreign entities. Although the authorities in China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another country or region to implement cross-border supervision and administration, such regulatory cooperation with the securities regulatory authorities in the Unities States may not be efficient in the absence of mutual and practical cooperation mechanism. Furthermore, according to Article 177 of the PRC Securities Law, which became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the PRC. Accordingly, without the consent of the competent PRC securities regulators and relevant authorities, no entity or individual may provide the documents and materials relating to securities business activities to overseas parties. While detailed interpretation of or implementing rules under Article 177 have yet to be promulgated, the inability for an overseas securities regulator to directly conduct investigation or evidence collection activities within China may further increase difficulties faced by you in protecting your interests. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">The PRC&#x2019;s economic, political and social conditions, as well as governmental policies, could affect the business environment and </font><font style="font-weight:bold; font-style:italic; ">financial markets in China, and our ability to operate our business, maintain our liquidity and keep our access to capital.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We expect that a portion of our operations will be conducted in China through a joint venture. Accordingly, our business, results of operations, financial condition and prospects may be influenced to a significant degree by economic, political, legal and social conditions in China. China&#x2019;s economy differs from the economies of developed countries in many respects, including with respect to the amount of government involvement, level of development, growth rate, control of foreign exchange and allocation of resources. While the PRC economy has experienced significant growth over the past thirty years, growth has been uneven across different regions and among various economic sectors of China. The PRC government has implemented various measures to encourage economic development and guide the allocation of resources. Some of these measures may benefit the overall PRC economy, but may have a negative effect on us. For example, our financial condition and results of operations may be adversely affected by government control over capital investments or changes in tax regulations that are currently applicable to us. In addition, in the past the PRC government implemented certain measures, including interest rate increases, to control the pace of economic growth. These measures may cause decreased economic activity in China, which may adversely affect our business and results of operation. More generally, if the business environment in China deteriorates from the perspective of domestic or international investment, our business in China may also be adversely affected.</p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Uncertainties with respect to the PRC legal system could adversely affect us.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The PRC legal system is a civil law system based on written statutes. Unlike the common law system, prior court decisions under the civil law system may be cited for reference but have limited precedential value. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In 1979, the PRC government began to promulgate a comprehensive system of laws and regulations governing economic matters in general. The overall effect of legislation over the past four decades has significantly enhanced the protection afforded to various forms of foreign investments in China. However, China has not developed a fully integrated legal system, and recently enacted laws and regulations may not sufficiently cover all aspects of economic activities in China. In particular, the interpretation and enforcement of these laws and regulations involve uncertainties. Since PRC administrative and court authorities have significant discretion in interpreting and implementing statutory provisions and contractual terms, it may be difficult to evaluate the outcome of administrative </p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">17</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; ">and court proceedings and the level of legal protection we enjoy. These uncertainties may affect our judgment on the relevance of legal requirements and our ability to enforce our contractual rights or tort claims. In addition, the regulatory uncertainties may be exploited through unmerited or frivolous legal actions or threats in attempts to extract payments or benefits from us. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, any administrative and court proceedings in China may be protracted, resulting in substantial costs and diversion of resources and management attention. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Uncertainties in the interpretation and enforcement of Chinese laws and regulations could limit the legal protections available </font><font style="font-weight:bold; font-style:italic; "></font><font style="font-weight:bold; font-style:italic; ">to us.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The PRC legal system is based on written statutes and prior court decisions have limited value as precedents. Since these laws and regulations are relatively new and the PRC legal system continues to rapidly evolve, the interpretations of many laws, regulations and rules are not always uniform and enforcement of these laws, regulations and rules involves uncertainties. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">From time to time, we may have to resort to administrative and court proceedings to enforce our legal rights. However, since PRC administrative and court authorities have significant discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection we enjoy than in more developed legal systems. Furthermore, the PRC legal system is based in part on government policies and internal rules. As a result, we may not be able to keep ourselves updated with these policies and rules in time. Such uncertainties, including uncertainty over the scope and effect of our contractual, property (including intellectual property) and procedural rights, could materially and adversely affect our business and impede our ability to continue our operations. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Restrictions on foreign currency may limit our ability to receive and use our revenue effectively.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The PRC government imposes controls on the conversion of the Renminbi into foreign currencies and, in certain cases, the remittance of foreign currency out of China. We may receive part of our revenue in Renminbi. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, can be made in foreign currencies without prior approval of SAFE, by complying with certain procedural requirements. However, approval from or registration with appropriate government authorities is required where Renminbi is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of loans denominated in foreign currencies. As a result, we would need to obtain approval from SAFE to use cash generated from our operations to pay off any debt in a currency other than Renminbi owed to entities outside China, or to make other capital expenditure payments outside China in a currency other than Renminbi. The PRC government may restrict access to foreign currencies for current account transactions in the future. The foreign exchange control system could prevent us from obtaining sufficient foreign currencies to satisfy our foreign currency demands. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Fluctuation in exchange rates could have a negative effect on our results of operations and the value of your investment.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The value of the Renminbi against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in political and economic conditions in China and by China&#x2019;s foreign exchange policies. Since June 2010, the Renminbi has fluctuated against the U.S. dollar, at times significantly and unpredictably. On November 30, 2015, the Executive Board of the International Monetary Fund, or IMF, completed the regular five-year review of the basket of currencies that make up the Special Drawing Right, or the SDR, and decided that with effect from October 1, 2016, the Renminbi is determined to be a freely usable currency and will be included in the SDR basket as a fifth currency, along with the U.S. dollar, the euro, the Japanese yen and the British pound. Since the fourth quarter of 2016, the Renminbi has depreciated significantly in the backdrop of a surging U.S. dollar and persistent capital outflows of China. With the development of the foreign exchange market and progress toward interest rate liberalization and Renminbi internationalization, the PRC government may in the future announce further changes to the exchange rate system, and we cannot assure you that the Renminbi will not appreciate or depreciate significantly in value against the U.S. dollar in the future. It is difficult to predict how market forces or PRC or U.S. government policy may impact the exchange rate between the Renminbi and the U.S. dollar in the future. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Very limited hedging options are available in China to reduce our exposure to exchange rate fluctuations. As of the date of this prospectus, we have not entered into any hedging transactions in an effort to reduce our exposure to foreign currency exchange risk. While we may decide to enter into hedging transactions in the future, the availability and effectiveness of these hedges may be limited and we may not be able to adequately hedge our exposure or at all. In addition, our currency exchange losses may be magnified by PRC exchange control regulations that restrict our ability to convert Renminbi into foreign currency or to convert foreign currency into Renminbi.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">18</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to Our Intellectual Property</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">If we are unable to obtain and maintain patent protection for our technologies and products, or if the scope of the patent protection </font><font style="font-weight:bold; font-style:italic; ">obtained is not sufficiently broad, our competitors could develop and commercialize technologies and products similar or identical to </font><font style="font-weight:bold; font-style:italic; ">ours, and our ability to successfully commercialize our technologies and products may be impaired.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect to our products. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our technologies and products. If we do not adequately protect our intellectual property, competitors may be able to use our technologies and erode or negate any competitive advantage that we may have, which could harm our business and ability to achieve profitability. To protect our proprietary positions, we file patent applications in the United States and abroad related to our novel technologies and products that are important to our business. The patent application and prosecution processes are expensive and time-consuming. We and our current licensees, or any future licensors and licensees may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. We or our current licensees, or any future licensors or licensees may also fail to identify patentable aspects of our research and development before it is too late to obtain patent protection. Therefore, these and any of our patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. It is possible that defects of form in the preparation or filing of our patents or patent applications may exist, or may arise in the future, such as with respect to proper priority claims, inventorship, claim scope or patent term adjustments. If our current licensees, or any future licensors or licensees, are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised and we might not be able to prevent third parties from making, using and selling competing products. If there are material defects in the form or preparation of our patents or patent applications, such patents or applications may be invalid and unenforceable. Moreover, our competitors may independently develop equivalent knowledge, methods and know-how. Any of these outcomes could impair our ability to prevent competition from third parties. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. Furthermore, recent changes in patent laws in the United States, including the America Invents Act of 2011, may affect the scope, strength and enforceability of our patent rights or the nature of proceedings that may be brought by us related to our patent rights. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We may not be aware of all third-party intellectual property rights potentially relating to our current and future our products. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until eighteen months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions. Similarly, should we own any patents or patent applications in the future, we may not be certain that we were the first to file for patent protection for the inventions claimed in such patents or patent applications. As a result, the issuance, scope, validity and commercial value of our patent rights cannot be predicted with any certainty. Moreover, we may be subject to a third-party preissuance submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or become involved in opposition, derivation, re-examination, <font style="font-style:italic; ">inter partes </font>review or interference proceedings, in the United States or elsewhere, challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights.      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our pending and future patent applications may not result in patents being issued that protect our technology or products, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. Even if our patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection against competing products or processes sufficient to achieve our business objectives, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our owned or licensed patents by developing similar or alternative technologies or products in a non-infringing manner. Alternatively, our competitors may seek approval to market their own products similar to or otherwise competitive with our products. In these circumstances, we may need to defend and/or assert our patents, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or other agency with jurisdiction may find our patents invalid and/or unenforceable. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technologies and products, or limit the duration of the patent protection of our technologies and products. In addition, given the amount of time required for the development, testing and regulatory review of new products, patents protecting such candidates might expire before or shortly after such candidates are commercialized. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, </font><font style="font-weight:bold; font-style:italic; ">time-consuming and unsuccessful.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Competitors may infringe our issued patents, trademarks, copyrights or other intellectual property. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming and divert the time and attention of our management and scientific personnel. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents, trademarks, copyrights or other intellectual property. In addition, in a patent infringement proceeding, there is a risk that a court will decide that a patent of ours is invalid or unenforceable, in whole or in part, and that we do not have the right to stop the other party from using the invention at issue. There is also a risk that, even if the validity of such patents is upheld, the court will construe the patent&#x2019;s claims narrowly or decide that we do not have the right to stop the other party from using the invention at issue on the grounds that our patents do not cover the invention. An adverse outcome in a litigation or proceeding involving our patents could limit our ability to assert our patents against those parties or other competitors, and may curtail or preclude our ability to exclude third parties from making and selling similar or competitive products. Similarly, if we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks. </p>

      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">19</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In any infringement litigation, any award of monetary damages we receive may not be commercially valuable. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Moreover, there can be no assurance that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for years before they are concluded. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Even if we ultimately prevail in such claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive as a result of the proceedings. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Accordingly, despite our efforts, we may not be able to prevent third parties from infringing, misappropriating or successfully challenging our intellectual property rights. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a negative impact on our ability to compete in the marketplace. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which </font><font style="font-weight:bold; font-style:italic; ">would be uncertain and could significantly harm our business.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our commercial success depends, in part, on our ability to develop, manufacture, market and sell our products and use our proprietary technologies without infringing the intellectual property and other proprietary rights of third parties. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There is potential for a substantial amount of intellectual property litigation in our industry, and we may become party to, or threatened with, litigation or other adversarial proceedings regarding intellectual property rights with respect to our technology or products, including interference proceedings before the USPTO. Intellectual property disputes arise in a number of areas including with respect to patents, use of other proprietary rights and the contractual terms of license arrangements. Third parties may assert claims against us based on existing or future intellectual property rights. The outcome of intellectual property litigation is subject to uncertainties that cannot be adequately quantified in advance. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we are found to infringe a third party&#x2019;s intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the infringing product candidate or product. Alternatively, we may be required to obtain a license from such third party in order to use the infringing technology and continue developing, manufacturing or marketing the infringing product candidate. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#x2019; fees if we are found to have wilfully infringed a patent. A finding of infringement could prevent us from commercializing our products or force us to cease some of our business operations. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative effect on our business. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition to seeking patent and trademark protection for our products, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets. Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property will be effective. In addition, we may not be able to obtain adequate remedies for any such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Moreover, our competitors may independently develop knowledge, methods and know-how equivalent to our trade secrets. Competitors could purchase our products and replicate some or all of the competitive advantages we derive from our development efforts for technologies on which we do not have patent protection. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We may not be able to protect our intellectual property rights throughout the world.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Filing, prosecuting and defending patents on products in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States could be less extensive than those in the United States. In some cases, we may not be able to obtain patent protection for certain licensed technology outside the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States, even in jurisdictions where we do pursue patent protection. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, even in jurisdictions where we do pursue patent protection or from selling or importing products made using our inventions in and into the United States or other jurisdictions. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Competitors may use our technologies in jurisdictions where we have not pursued and obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our products and preclinical programs and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">20</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement of our patents, if pursued and obtained, or marketing of competing products in violation of our proprietary rights generally. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to Regulatory Approval of Our Products and Other Legal Compliance Matters</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Even if we complete the necessary preclinical studies and clinical trials, the regulatory approval process is expensive, </font><font style="font-weight:bold; font-style:italic; ">time-consuming and uncertain and may prevent us or any future collaborators from obtaining approvals for the commercialization </font><font style="font-weight:bold; font-style:italic; ">of some or all of our products. As a result, we cannot predict when or if, and in which territories, we, or any future collaborators, </font><font style="font-weight:bold; font-style:italic; ">will obtain marketing approval to commercialize a product candidate.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our products and the activities associated with their development and commercialization, including their design, research, testing, manufacture, safety, efficacy, quality control, recordkeeping, labeling, packaging, storage, approval, advertising, promotion, sale, distribution, import, export and reporting of safety and other post-market information, are subject to comprehensive regulation by the FDA and other foreign regulatory agencies. Failure to obtain marketing approval for a product candidate will prevent us from commercializing the product candidate. Currently, we market a first-Generation medical device cleared by the FDA for the treatment of anxiety and insomnia. We are presently amending our previous 510(k) Application for such treatment of anxiety and insomnia in accordance with the FDA reclassification ruling in December 2019. We are additionally developing a second-Generation medical device that has not completed development or regulatory filings with the FDA. Securing marketing approval requires the submission of extensive preclinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&apos;s safety and efficacy. Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. Our products may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations or changes in regulatory review for each submitted product application may cause delays in the approval or rejection of an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data is insufficient for approval and require additional preclinical, clinical, or other studies. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit, or prevent marketing approval of a product candidate. Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we experience delays in obtaining approval or if we fail to obtain approval of our products, the commercial prospects for our products may be harmed and our ability to generate revenues will be impaired. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Failure to obtain marketing approval in foreign jurisdictions would prevent our products from being marketed in these territories. </font><font style="font-weight:bold; font-style:italic; ">Any approval we are granted for our products in the United States would not assure approval of our products in foreign </font><font style="font-weight:bold; font-style:italic; ">jurisdictions.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">To market and sell our products in China and any other jurisdictions, we must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain approval from the FDA. The regulatory approval process outside the United States generally includes all the risks associated with obtaining approval from the FDA. In addition, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country. We may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. However, failure to obtain approval in one jurisdiction may impact our ability to obtain approval elsewhere. We may not be able to file for marketing approvals and may not receive necessary approvals to commercialize our products in any market. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">The U.S. FDA, Chinese National Medical Products Administration and other comparable foreign regulatory authorities may not </font><font style="font-weight:bold; font-style:italic; ">accept data from trials conducted in locations outside of their jurisdiction.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have chosen, and may continue to choose, to conduct international clinical trials. The acceptance of study data by the U.S. FDA, Chinese National Medical Products Administration (NMPA) or other comparable foreign regulatory authority from clinical trials conducted outside of their respective jurisdictions may be subject to certain conditions. In cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (1) the data are applicable to the United States population and United States medical practice; (2) the trials are performed by clinical investigators of recognized competence and pursuant to Current Good Clinical Practice requirements; and (3) the FDA is able to validate the data through an on-site inspection or other appropriate means. The FDA may accept the use of some foreign data to support a marketing approval if the clinical trial meets certain requirements. Additionally, the FDA&#x2019;s clinical trial requirements, including the adequacy of the subject population studied and statistical powering, must be met. Furthermore, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA, NMPA or any applicable foreign regulatory authority will accept data from trials conducted outside of its respective jurisdiction. If the FDA, NMPA or any applicable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our product candidates not receiving approval for commercialization in the applicable jurisdiction. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">21</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Even if we obtain marketing approvals for our products, the terms of approvals and ongoing regulation of our products may limit </font><font style="font-weight:bold; font-style:italic; ">how we manufacture and market our products and compliance with such requirements may involve substantial resources, which </font><font style="font-weight:bold; font-style:italic; ">could materially impair our ability to generate revenue.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Even if marketing approval of a product candidate is granted, an approved product and its manufacturer and marketer are subject to ongoing review and extensive regulation, including the potential requirements to implement a risk evaluation and mitigation strategy or to conduct costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product. We must also comply with requirements concerning advertising and promotion for any of our products for which we obtain marketing approval. Promotional communications are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#x2019;s approved labeling. Thus, we will not be able to promote any products we develop for indications or uses for which they are not approved. In addition, manufacturers of approved products and those manufacturers&#x2019; facilities are required to comply with extensive FDA requirements including ensuring quality control and manufacturing procedures, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. We and our contract manufacturers could be subject to periodic unannounced inspections by the FDA to monitor and ensure compliance. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Our employees, independent contractors, principal investigators, consultants, commercial partners and vendors may engage in </font><font style="font-weight:bold; font-style:italic; ">misconduct or other improper activities, including non-compliance with regulatory standards and requirements.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are exposed to the risk of employee fraud or other misconduct or failure to comply with applicable regulatory requirements. Misconduct by employees and independent contractors, such as principal investigators, consultants, commercial partners and vendors, could include failures to comply with regulations of the FDA and other comparable regulatory authorities, to provide accurate information to such regulators, to comply with manufacturing standards we have established, to comply with healthcare fraud and abuse laws, to report financial information or data accurately or to disclose unauthorized activities to us. In particular, sales, marketing and other business arrangements in the healthcare industry are subject to extensive laws intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws may restrict or prohibit a wide range of business activities, including, but not limited to, research, manufacturing, distribution, pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee and independent contractor misconduct could also involve the improper use of individually identifiable information, including, without limitation, information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. In addition, federal procurement laws impose substantial penalties for misconduct in connection with government contracts and require certain contractors to maintain a code of business ethics and conduct. It is not always possible to identify and deter employee and independent contractor misconduct, and any precautions we take to detect and prevent improper activities may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws. If any such actions are instituted against us, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, additional reporting or oversight obligations if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with the law and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Our current and future relationships with healthcare professionals, principal investigators, consultants, customers and third-party </font><font style="font-weight:bold; font-style:italic; ">payors in the United States and elsewhere may be subject, directly or indirectly, to applicable anti-kickback, fraud and abuse, false </font><font style="font-weight:bold; font-style:italic; ">claims, physician payment transparency, health information privacy and security and other healthcare laws and regulations, which </font><font style="font-weight:bold; font-style:italic; ">could expose us to penalties.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Healthcare providers, physicians, clinicians, and third-party payors in the United States and elsewhere will play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. Our current and future arrangements with healthcare professionals, principal investigators, consultants, customers and third-party payors may expose us to broadly applicable fraud and abuse and other healthcare laws, including, without limitation, the federal Anti-Kickback Statute and the federal False Claims Act, that may constrain the business or financial arrangements and relationships through which we research, sell, market and distribute any products for which we obtain marketing approval. In addition, we may be subject to physician payment transparency laws and patient privacy and security regulation by the federal government and by the states and foreign jurisdictions in which we conduct our business. The applicable federal, state and foreign healthcare laws that may affect our ability to operate include the following: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which payment may be made, in whole or in part, under federal and state healthcare programs such as Medicare and Medicaid; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">federal civil and criminal false claims laws, including the federal False Claims Act, which impose criminal and civil penalties, including through civil whistleblower or <font style="font-style:italic; ">qui tam </font>actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, to the federal government, including the Medicare and Medicaid programs, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the civil monetary penalties statute, which imposes penalties against any person or entity who, among other things, is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent; </p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">22</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of whether the payor is public or private, knowingly and willfully embezzling or stealing from a health care benefit program, willfully obstructing a criminal investigation of a health care offense and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters; </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, which impose obligations on &#x201C;covered entities,&#x201D; including certain healthcare providers, health plans, and healthcare clearinghouses, as well as their respective &#x201C;business associates&#x201D; that create, receive, maintain or transmit individually identifiable health information for or on behalf of a covered entity, with respect to safeguarding the privacy, security and transmission of individually identifiable health information; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">the federal Physician Payments Sunshine Act, created under Section 6002 of Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA, and its implementing regulations, created annual reporting requirements for manufacturers of products, devices, biologicals and medical supplies for certain payments and &#x201C;transfers of value&#x201D; provided to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">analogous state and foreign laws, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; state and foreign laws that require companies to comply with voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or to adopt compliance programs as prescribed by state laws and regulations, or that otherwise restrict payments that may be made to healthcare providers; state and foreign laws that require manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not pre-empted by HIPAA, thus complicating compliance efforts. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Further, the ACA, among other things, amended the intent requirement of the federal Anti-Kickback Statute and certain criminal statutes governing healthcare fraud. A person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it. In addition, the ACA provided that the government may assert that a claim including items or services resulting from a violation of the federal Anti- Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Efforts to ensure that our future business arrangements with third parties will comply with applicable healthcare laws and regulations may involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, including, without limitation, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, additional reporting or oversight obligations if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with the law and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and pursue our strategy. If any of the physicians or other healthcare providers or entities with whom we expect to do business, including future collaborators, are found not to comply with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from participation in government healthcare programs, which could also affect our business. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Recently enacted and future legislation may increase the difficulty and cost for us and our collaborators to obtain marketing </font><font style="font-weight:bold; font-style:italic; ">approval of and commercialize our products and affect the prices we may obtain.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent, alter or delay marketing approval of our existing or future products, restrict or regulate post-approval activities and affect our ability to profitably sell any products for which we obtain marketing approval. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. For example, the ACA, which was enacted in the United States in March 2010, includes measures to change health care delivery, decrease the number of individuals without insurance, ensure access to certain basic health care services, and contain the rising cost of care. The healthcare reform movement, including the enactment of the ACA, has significantly changed health care financing by both governmental and private insurers in the United States. With respect to pharmaceutical manufacturers, the ACA increased the number of individuals with access to health care coverage, but it simultaneously imposed, among other things, increased liability for rebates and discounts owed to certain entities and government health care programs, and new transparency reporting requirements under the Physician Payments Sunshine Act. For a detailed discussion of the ACA&#x2019;s provisions of importance to the pharmaceutical industry, as well as a description of reform legislation passed subsequent to the ACA, see the section titled &#x201C;Business&#x2014; Government Regulation&#x2014;Healthcare Reform Efforts.&#x201D; </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA, as well as efforts to repeal or replace certain aspects of the ACA. We continue to evaluate the effect that the ACA and its possible repeal and replacement has on our business. It is uncertain the extent to which any such changes may impact our business or financial condition. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">23</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition to the ACA, other federal health reform measures have been proposed and adopted in the United States. For example, legislation has been enacted to reduce the level of reimbursement paid to providers under the Medicare program over time, as well as phase in alternative payment models for provider services under the Medicare program with the goal of incentivizing the attainment of pre-defined quality measures. As these measures are not fully in effect, and since the U.S. Congress could intervene to prevent their full implementation, at this time, it is unclear how payment reductions or the introduction of the quality payment program will impact overall physician reimbursement under the Medicare program. It is also unclear if changes in Medicare payments to providers would impact such providers&#x2019; willingness to prescribe and administer our existing or future products, if approved. Further, there has been heightened governmental scrutiny over the manner in which companies set prices for their marketed products. For example, there have been several recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, review the relationship between pricing and patient programs, and reform government program reimbursement methodologies for products. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for products. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our products, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#x2019;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Various new healthcare reform proposals are emerging at the federal and state level. It is also possible that additional governmental action will be taken in response to the COVID-19 pandemic. Any new federal and state healthcare initiatives that may be adopted could limit the amounts that federal and state governments will pay for healthcare products and services, and could harm our business, financial condition and results of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Our business activities may be subject to the U.S. Foreign Corrupt Practices Act, or the FCPA, and similar anti-bribery and </font><font style="font-weight:bold; font-style:italic; ">anti-corruption laws of other countries in which we operate, as well as U.S. and certain foreign export controls, trade sanctions and </font><font style="font-weight:bold; font-style:italic; ">import laws and regulations. Compliance with these legal requirements could limit our ability to compete in foreign markets and </font><font style="font-weight:bold; font-style:italic; ">subject us to liability if we violate them.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we further expand our operations outside of the United States, we must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which we plan to operate. Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate. The FCPA generally prohibits companies and their employees and third-party intermediaries from offering, promising, giving or authorizing the provision of anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many other countries, hospitals owned and operated by the government and doctors and other hospital employees would be considered foreign officials under the FCPA. Recently the SEC and DOJ have increased their FCPA enforcement activities with respect to biotechnology and pharmaceutical companies. There is no certainty that all our employees, agents or contractors, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or our employees, disgorgement and other sanctions and remedial measures and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international activities, our ability to attract and retain employees and our business, prospects, operating results and financial condition. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, our products and technology may be subject to U.S. and foreign export controls, trade sanctions and import laws and regulations. Governmental regulation of the import or export of our products and technology, or our failure to obtain any required import or export authorization for our products, when applicable, could harm our international sales and adversely affect our revenue. Compliance with applicable regulatory requirements regarding the export of our products may create delays in the introduction of our products in international markets or, in some cases, prevent the export of our products to some countries altogether. Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products and services to countries, governments and persons targeted by U.S. sanctions. If we fail to comply with export and import regulations and such economic sanctions, penalties could be imposed, including fines and/or denial of certain export privileges. Moreover, any new export or import restrictions, new legislation or shifting approaches in the enforcement or scope of existing regulations, or in the countries, persons or products targeted by such regulations, could result in decreased use of our products by, or in our decreased ability to export our products to, existing or potential customers with international operations. Any decreased use of our products or limitation on our ability to export or sell access to our products would likely adversely affect our business. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Risks Related to this Offering, Ownership of Our Common Stock and Our Status as a Public Company</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">An active trading market for our common stock may not develop and you may not be able to resell your shares at or above the </font><font style="font-weight:bold; font-style:italic; ">initial offering price, if at all.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This offering constitutes the initial public offering of our common stock, and no public market has previously existed for our common stock. We have applied to list our common stock on Nasdaq. Any delay in the commencement of trading of our common stock on Nasdaq would impair the liquidity of the market for the shares and make it more difficult for holders to sell their shares of our common stock. If our common stock is listed and quoted on Nasdaq, there can be no assurance that an active trading market for the shares will develop or be sustained after this offering is completed. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">24</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The initial offering price will be determined by negotiations among the lead underwriters and us. Among the factors to be considered in determining the initial public offering price are our future prospects and the prospects of our industry in general, our revenue, net income and certain other financial and operating information in recent periods, and the market prices of securities and certain financial and operating information of companies engaged in activities similar to ours. However, there can be no assurance that, following the completion of this offering, the shares of our common stock will trade at a price equal to or greater than the public offering price. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">The trading price of our common stock may be volatile, and you could lose all or part of your investment.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The trading price of our common stock following this offering is likely to be highly volatile and could be subject to wide &#xFB02;uctuations in response to various factors, some of which are beyond our control, including limited trading volume. The stock market in general and the market for companies in our industry in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, investors may not be able to sell their shares at or above the price paid for the shares. In addition to the factors discussed in this &#x201C;Risk Factors&#x201D; section and elsewhere in this prospectus, these factors include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the commencement, enrollment or results of our planned and future clinical trials; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the loss of any of our key scientific or management personnel; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">regulatory or legal developments in the United States, China and other countries; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the success of competitive products or technologies; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">adverse actions taken by regulatory agencies with respect to our clinical trials or manufacturers; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">changes or developments in laws or regulations applicable to our products and preclinical program; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">changes to our relationships with collaborators, manufacturers or suppliers; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the results of our testing and clinical trials; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">unanticipated safety concerns; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">announcements concerning our competitors or our industry in general; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">actual or anticipated &#xFB02;uctuations in our operating results; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">changes in financial estimates or recommendations by securities analysts; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">potential acquisitions; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the results of our efforts to discover, develop, acquire or in-license additional products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the trading volume of our common stock on Nasdaq; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">sales of our common stock by us, our executive officers and directors or our stockholders or the anticipation that such sales may occur in the future; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">general economic, political and market conditions and overall &#xFB02;uctuations in the financial markets in the United States or China; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">stock market price and volume &#xFB02;uctuations of comparable companies and, in particular, those that operate in our industry; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">investors&#x2019; general perception of us and our business. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">These and other market and industry factors may cause the market price and demand for our common stock to &#xFB02;uctuate substantially, regardless of our actual operating performance, which may limit or prevent investors from selling their shares of our common stock at or above the price paid for the shares and may otherwise negatively affect the liquidity of our common stock. In addition, the stock market in general, and companies in our industry in particular, have experienced extreme price and volume &#xFB02;uctuations that have often been unrelated or disproportionate to the operating performance of these companies. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Some companies that have experienced volatility in the trading price of their shares have been the subject of securities class action litigation. Any lawsuit to which we are a party, with or without merit, may result in an unfavorable judgment. We also may decide to settle lawsuits on unfavorable terms. Any such negative outcome could result in payments of substantial damages or fines, damage to our reputation or adverse changes to our business practices. Defending against litigation is costly and time-consuming and could divert our management&#x2019;s attention and our resources. Furthermore, during litigation, there could be negative public announcements of the results of hearings, motions or other interim proceedings or developments, which could have a negative effect on the market price of our common stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">25</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or </font><font style="font-weight:bold; font-style:italic; ">our market, our stock price and trading volume could decline.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The trading market for our common stock will be in&#xFB02;uenced by the research and reports that equity research analysts publish about us and our business. We do not currently have and may never obtain research coverage by equity research analysts. Equity research analysts may elect not to provide research coverage of our common stock after the completion of this offering, and such lack of research coverage may adversely affect the market price of our common stock. In the event we do have equity research analyst coverage, we will not have any control over the analysts or the content and opinions included in their reports. The price of our shares could decline if one or more equity research analysts downgrade our shares or issue other unfavorable commentary or research about us. If one or more equity research analysts ceases coverage of us or fails to publish reports on us regularly, demand for our shares could decrease, which in turn could cause the trading price or trading volume of our common stock to decline. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">If you purchase common stock in this offering, you will suffer immediate dilution of your investment.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The initial public offering price per share of our common stock is substantially higher than the as adjusted net tangible book value per share. Therefore, if you purchase common stock in this offering, you will pay a price per share that substantially exceeds our as adjusted net tangible book value per share after this offering. Based on an assumed initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, you will experience immediate dilution of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;per share, representing the difference between our as adjusted net tangible book value per share after this offering and the assumed initial public offering price per share. After this offering, we will also have outstanding options to purchase shares of our common stock with exercise prices lower than the initial public offering price. To the extent these outstanding options are exercised, there will be further dilution to investors in this offering. For further information regarding the dilution resulting from this offering, see the section titled &#x201C;Dilution&#x201D; in this prospectus. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">A significant portion of our total outstanding shares are restricted from immediate resale but may be sold into the market in the near </font><font style="font-weight:bold; font-style:italic; ">future. This could cause the market price of our common stock to drop significantly, even if our business is doing well.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Sales of a substantial number of shares of our common stock in the public market could occur at any time. If our stockholders sell, or the market perceives that our stockholders intend to sell, substantial amounts of our common stock in the public market following this offering, the market price of our common stock could decline significantly. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon completion of this offering, we will have outstanding&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares of our common stock, based on the number of shares of common stock outstanding as of June 30, 2021. Of these shares, the&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares sold in this offering will be freely tradable, and&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; additional shares of our common stock will be available for sale in the public market beginning 180 days after the date of this prospectus following the expiration of lock-up agreements between our stockholders and the underwriters. The representatives of the underwriters may release these stockholders from their lock-up agreements with the underwriters at any time, which would allow for earlier sales of shares in the public market. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Additionally, after this offering, the holders of an aggregate of&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares of our common stock, or their transferees, will have rights, subject to some conditions, to require us to file one or more registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. If we were to register the resale of these shares, they could be freely sold in the public market. If these additional shares are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Concentration of ownership of our common stock among our existing executive officers, directors and principal stockholders may </font><font style="font-weight:bold; font-style:italic; ">prevent new investors from in&#xFB02;uencing significant corporate decisions and matters submitted to stockholders for approval.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon completion of this offering, our executive officers, directors and current beneficial owners of 5% or more of our common stock and their respective affiliates will, in the aggregate, beneficially own approximately &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;% of our outstanding common stock, based on the number of shares of our common stock outstanding as of June 30, 2021. As a result, these persons, acting together, would be able to significantly in&#xFB02;uence all matters requiring stockholder approval, including the election and removal of directors, any merger, consolidation or sale of all or substantially all of our assets or other significant corporate transactions. In addition, these persons, acting together, may have the ability to control the management and affairs of our company. Accordingly, this concentration of ownership may harm the market price of our common stock by: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">delaying, deferring or preventing a change in control; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">entrenching our management and/or the board of directors; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">impeding a merger, consolidation, takeover or other business combination involving us; or </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, some of these persons or entities may have interests different than yours. For example, because many of these stockholders purchased their shares at prices substantially below the price at which shares are being sold in this offering and have held their shares for a longer period, they may be more interested in selling our company to an acquirer than other investors, or they may want us to pursue strategies that deviate from the interests of other stockholders. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">26</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Provisions in our corporate charter documents and under Delaware law could make an acquisition of our company, which may be </font><font style="font-weight:bold; font-style:italic; ">beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current </font><font style="font-weight:bold; font-style:italic; ">management.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Provisions in our amended and restated certificate of incorporation and our amended and restated bylaws that will become effective upon the completion of this offering may discourage, delay or prevent a merger, acquisition or other change in control of our company that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. These provisions also could limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our board of directors is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors. Among other things, these provisions: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">establish a classified board of directors such that not all members of the board are elected at one time; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">allow the authorized number of our directors to be changed only by resolution of our board of directors; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">limit the manner in which stockholders can remove directors from the board; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to our board of directors; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">require that stockholder actions must be effected at a duly called stockholder meeting and prohibit actions by our stockholders by written consent; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">limit who may call stockholder meetings; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">require the approval of the holders of at least 66.66% of the votes that all our stockholders would be entitled to cast to amend or repeal certain provisions of our charter or bylaws. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which the person acquired more than 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner. These provisions could discourage potential acquisition proposals and could delay or prevent a change in control transaction. They could also have the effect of discouraging others from making tender offers for our common stock, including transactions that may be in your best interests. These provisions may also prevent changes in our management or limit the price that investors are willing to pay for our stock. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Our amended and restated certificate of incorporation will provide that the Court of Chancery of the State of Delaware and the </font><font style="font-weight:bold; font-style:italic; ">federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our </font><font style="font-weight:bold; font-style:italic; ">stockholders, including claims under the Securities Act, which could limit our stockholders&#x2019; ability to obtain a favorable judicial </font><font style="font-weight:bold; font-style:italic; ">forum for disputes with us or our directors, officers or employees.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our amended and restated certificate of incorporation will provide that the Court of Chancery of the State of Delaware is the exclusive forum for: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">any derivative action or proceeding brought on our behalf; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">any action asserting a breach of fiduciary duty; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">any action asserting a claim against us or any of our directors, officers, employees or agents arising under the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">any action or proceeding to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or our amended and restated bylaws; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">any action asserting a claim against us or any of our directors, officers, employees or agents that is governed by the internal-affairs doctrine. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our amended and restated certificate of incorporation will further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">These exclusive-forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive-forum provision in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions. We note that there is uncertainty as to whether a court would enforce such exclusive-forum provision and that provision may result in increased costs for investors to bring a claim. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We are an &#x201C;emerging growth company&#x201D; and as a result of the reduced disclosure and governance requirements applicable to </font><font style="font-weight:bold; font-style:italic; ">emerging growth companies, our common stock may be less attractive to investors.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are an &#x201C;emerging growth company&#x201D; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, we do not intend to take advantage of some of the exemptions from reporting requirements that are applicable to other public companies that are not emerging growth companies, including: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act;</p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">27</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">not being required to comply with any requirements that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#x2019;s report providing additional information about the audit and the financial statements; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our share price may be more volatile. We may take advantage of these exemptions until the last day of our fiscal year following the fifth anniversary of the completion of this offering. However, if any of the following events occur prior to the end of such five-year period, (i) our annual gross revenue exceeds $1.07 billion, (ii) we issue more than $1.0 billion of non-convertible debt in any three-year period or (iii) we become a &#x201C;large accelerated filer,&#x201D; (as defined in Rule 12b-2 under the Exchange Act), we will cease to be an emerging growth company prior to the end of such five-year period. We will be deemed to be a &#x201C;large accelerated filer&#x201D; at such time that we (a) have an aggregate worldwide market value of common equity securities held by non-affiliates of $700 million or more as of the last business day of our most recently completed second fiscal quarter, (b) have been required to file annual and quarterly reports under the Exchange Act, for a period of at least twelve months and (c) have filed at least one annual report pursuant to the Exchange Act. Even after we no longer qualify as an emerging growth company, we may still qualify as a &#x201C;smaller reporting company,&#x201D; which would allow us to take advantage of many of the same exemptions from disclosure requirements including reduced disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy statements. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are emerging growth companies. As a result, changes in rules of U.S. generally accepted accounting principles or their interpretation, the adoption of new guidance or the application of existing guidance to changes in our business could significantly affect our financial position and results of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis </font><font style="font-weight:bold; font-style:italic; ">could be impaired.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">After the completion of this offering, we will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, the Sarbanes-Oxley Act and the rules and regulations of The Nasdaq Capital Market, or Nasdaq. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. Beginning with our second annual report following our initial public offering, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting in our Form 10-K filing for that year, as required by Section 404 of the Sarbanes-Oxley Act. This will require that we incur substantial additional professional fees and internal costs to expand our accounting and finance functions and that we expend significant management efforts. Prior to this offering, we have never been required to test our internal controls within a specified period, and, as a result, we may experience difficulty in meeting these reporting requirements in a timely manner. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We may discover weaknesses in our system of internal financial and accounting controls and procedures that could result in a material misstatement of our consolidated financial statements. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#x2019;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements. If that were to happen, the market price of our common stock could decline and we could be subject to sanctions or investigations by Nasdaq, the SEC, or other regulatory authorities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We will have broad discretion in the use of proceeds from this offering and may invest or spend the proceeds in ways with which you </font><font style="font-weight:bold; font-style:italic; ">do not agree and in ways that may not increase the value of your investment.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our management will have broad discretion in the application of our cash, including the net proceeds from this offering, and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our common stock. The failure by our management to apply these funds effectively could result in financial losses that could have a negative impact on our business, cause the price of our common stock to decline and delay the development of our products and preclinical program. Pending their use, we may invest our cash, including the net proceeds from this offering, in a manner that does not produce income or that loses value. See the section titled &#x201C;Use of Proceeds&#x201D; for additional information. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">28</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Because we do not anticipate paying any cash dividends on our common stock in the foreseeable future, capital appreciation, if any, </font><font style="font-weight:bold; font-style:italic; ">will be your sole source of gains and you may never receive a return on your investment.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">You should not rely on an investment in our common stock to provide dividend income. We have never declared or paid a dividend on our common stock to date, and we currently intend to retain our future earnings, if any, to fund the development and growth of our business. As a result, capital appreciation, if any, on our common stock will be your sole source of gains for the foreseeable future. Investors seeking cash dividends should not purchase our common stock in this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Recent and potential future changes to U.S. and non-U.S. tax laws could materially adversely affect our company.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Existing, new or future changes in tax laws, regulations and treaties, or the interpretation thereof, in addition to tax policy initiatives and reforms under consideration in the United States or internationally and other initiatives could have an adverse effect on the taxation of international businesses. Furthermore, countries where we are subject to taxes, including the United States, are independently evaluating their tax policy and we may see significant changes in legislation and regulations concerning taxation. On December 22, 2019, President Trump signed into law new legislation, commonly referred to as the Tax Cuts and Jobs Act, that significantly revises the Code. The Tax Cuts and Jobs Act, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a &#xFB02;at rate of 21%, limitation of the tax deduction for interest expense to 30% of adjusted earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and elimination of net operating loss carry backs, one time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits. Notwithstanding the reduction in the corporate income tax rate, the overall impact of the Tax Cuts and Jobs Act is uncertain and our business and financial condition could be adversely affected. The impact of this tax reform on holders of our common stock is also uncertain and could be adverse. Other legislative changes could also affect the taxation of holders of our common stock. We are unable to predict what tax reform may be proposed or enacted in the future or what effect such changes would have on our business, but such changes, to the extent they are brought into tax legislation, regulations, policies or practices, could affect our effective tax rates in the future in countries where we have operations and have an adverse effect on our overall tax rate in the future, along with increasing the complexity, burden and cost of tax compliance. We urge our stockholders to consult with their legal and tax advisors with respect to any such legislative changes and the potential tax consequences of investing in or holding our common stock. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Tax authorities may disagree with our positions and conclusions regarding certain tax positions, resulting in unanticipated costs, </font><font style="font-weight:bold; font-style:italic; ">taxes or non-realization of expected benefits.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A tax authority may disagree with tax positions that we have taken, which could result in increased tax liabilities. For example, the Internal Revenue Service or another tax authority could challenge our allocation of income by tax jurisdiction and the amounts paid between our affiliated companies pursuant to our intercompany arrangements and transfer pricing policies, including amounts paid with respect to our intellectual property development. Similarly, a tax authority could assert that we are subject to tax in a jurisdiction where we believe we have not established a taxable connection, often referred to as a &#x201C;permanent establishment&#x201D; under international tax treaties, and such an assertion, if successful, could increase our expected tax liability in one or more jurisdictions. The foregoing are only selected examples of potential challenges, and other tax positions we have taken or may take in the future could become the subject of disputes with one or more tax authorities. A tax authority may take the position that material income tax liabilities, interest and penalties are payable by us, in which case, we expect that we might contest such assessment. Contesting such an assessment may be lengthy and costly and if we were unsuccessful in disputing the assessment, the implications could increase our anticipated effective tax rate, where applicable. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">We will incur significantly increased costs as a result of operating as a company whose common stock is publicly traded in the </font><font style="font-weight:bold; font-style:italic; ">United States, and our management will be required to devote substantial time to new compliance initiatives.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As a public company in the United States, we will incur significant legal, accounting and other expenses that we did not incur previously. These expenses will likely be even more significant after we no longer qualify as an emerging growth company. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of Nasdaq and other applicable securities rules and regulations impose various requirements on public companies in the United States, including the establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our senior management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance, which in turn could make it more difficult for us to attract and retain qualified senior management personnel or members for our board of directors. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">However, these rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to Section 404, we will be required to furnish a report by our senior management on our internal control over financial reporting. However, while we remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To prepare for eventual compliance with Section 404, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is effective as required by Section 404. If we identify one or more material weaknesses, it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated financial statements. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">29</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e4542_anchor"><font style="font-weight:bold; ">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This prospectus contains forward-looking statements that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy, prospective products, product approvals, research and development costs, future revenue, timing and likelihood of success, plans and objectives of management for future operations, and future results of anticipated products and prospects are forward-looking statements. In some cases, you can identify forward-looking statements by the words &#x201C;may,&#x201D; &#x201C;might,&#x201D; &#x201C;will,&#x201D; &#x201C;could,&#x201D; &#x201C;would,&#x201D; &#x201C;should,&#x201D; &#x201C;expect,&#x201D; &#x201C;intend,&#x201D; &#x201C;plan,&#x201D; &#x201C;objective,&#x201D; &#x201C;anticipate,&#x201D; &#x201C;believe,&#x201D; &#x201C;estimate,&#x201D; &#x201C;predict,&#x201D; &#x201C;project,&#x201D; &#x201C;potential,&#x201D; &#x201C;continue&#x201D; and &#x201C;ongoing,&#x201D; or the negative of these terms, or other comparable terminology intended to identify statements about the future. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our plans to develop and commercialize our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our planned clinical trials for our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the timing of the availability of data from our clinical trials; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the timing of our selection of an initial clinical candidate from our program; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">our ability to take advantage of benefits offered by current and pending legislation related to the development of products addressing antimicrobial resistance; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the timing of our planned regulatory filings; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the timing of and our ability to obtain and maintain regulatory approvals for our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">the clinical utility of our products and their potential advantages compared to other treatments; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our commercialization, marketing and distribution capabilities and strategy; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our ability to establish and maintain arrangements for the manufacture of our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our ability to establish and maintain collaborations and to recognize the potential benefits of such collaborations; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our estimates regarding the market opportunities for our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our intellectual property position and the duration of our patent rights; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our estimates regarding future expenses, capital requirements and needs for additional financing; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">our expected use of proceeds from this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">You should read this prospectus (as it may be supplemented or amended) and the documents that we reference herein and have filed as exhibits to the registration statement, of which this prospectus is part, completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this prospectus is accurate as of the date on the front cover of this prospectus only. In particular, you should refer to the &#x201C;Risk Factors&#x201D; section of this prospectus for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This prospectus also contains estimates, projections and other information concerning our industry, our business, and the markets for our products. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from our own internal estimates and research as well as from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources. While we believe our internal company research is reliable and the market definitions are appropriate, neither such research nor definitions have been verified by an independent source. While we believe that each of these studies and publications is reliable, we have not independently verified market and industry data from third-party sources. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, assumptions and estimates of our and our industry&#x2019;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the section titled &#x201C;Risk Factors.&#x201D; These and other factors could cause our future performance to differ materially from our assumptions and estimates. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">30</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e4648_anchor"><font style="font-weight:bold; ">USE OF PROCEEDS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We estimate that the net proceeds to us from this offering will be approximately $12.5 million, assuming combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. If the underwriters&#x2019; option to purchase additional shares is exercised in full, we estimate that our net proceeds will be approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million. Each $1.00 increase (decrease) in the assumed combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock would increase (decrease) the net proceeds to us from this offering by approximately $ million, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Each increase (decrease) of 100,000 in the number of shares of common stock we are offering would increase (decrease) the net proceeds to us from this offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, by approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million, assuming the assumed initial public offering price stays the same. The principal purposes of this offering are to increase our capitalization and financial flexibility, to create a public market for our common stock and to facilitate our future access to the capital markets. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds we receive from this offering. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">However, we currently intend to use the net proceeds we receive from this offering as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">approximately $3.85 million to fund clinical research, trials and development work for future product candidates; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">approximately $3.80 million in working capital; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">approximately $1.10 million to invest in developing our sales and internal infrastructure; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">approximately $1.95 million for engineering, manufacturing and consultant expenses; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">approximately $1.00 million for regulatory and certification costs; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">approximately $0.80 million for legal, accounting, general &amp; administrative. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The $3.85 million to be spent on clinical research, trials and development work for future product candidates includes:</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">Special control trials for the Gen1 - 4 milliamp device that are intended to be completed for treatment indications of anxiety and insomnia; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">Special control trials for the Gen 2 - 15 milliamp clinical device that are intended to be completed for treatment indications of anxiety and insomnia; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">Clinical trials using the Gen 2 - 15 milliamp clinical device for the treatment of substance use disorder (SUD) that are intended to be completed and support the application for a breakthrough device designation with FDA for opiate addiction and SUD; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">Pilot trials for safety and efficacy for concussion related to TBI that are intended to be completed at a major university utilizing Gen-2 &#x2013; 15 milliamp; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">Prototype design and clinical safety testing for Gen - 3 outpatient headset; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">Virtual clinic digital platform that is intended to begin with specific focus on user experience and medical professional experience. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The $3.80 million to be spent on working capital includes adding several full-time professional staff members including, but not limited to, a director of sales, regulatory and quality control, as well as additional staff and office space.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We will have broad discretion over how to use the net proceeds we receive from this offering. We intend to invest the net proceeds we receive from this offering that are not used as described above in a variety of capital preservation investments, including short-term, investment-grade, interest bearing instruments and U.S. government securities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve. We may also use a portion of the net proceeds to in-license, acquire or invest in additional businesses, technologies, products or assets, although currently we have no specific agreements, commitments or understandings in this regard. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the closing of this offering or the amounts that we will actually spend on the uses set forth above. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are currently not cash flow positive and do not expect to be cash flow positive until 2023. While we believe that the net proceeds from this offering will enable us to fund our operating expenses and capital expenditure requirements through calendar year 2023, if our operations are not cash flow positive by 2023, we may need to obtain substantial additional funding in connection with our continuing operations and planned activities. We have based this estimate on assumptions that may prove to be incorrect, and we could use our available capital resources sooner than we currently expect. We may satisfy our future cash needs through the sale of equity securities, debt financings, working capital lines of credit, corporate collaborations or license agreements, grant funding, interest income earned on invested cash balances or a combination of one or more of these sources.</p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">31</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e4813_anchor"><font style="font-weight:bold; ">DIVIDEND POLICY</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have never declared or paid a dividend, and we do not anticipate declaring or paying dividends in the foreseeable future. We currently intend to retain our future earnings, if any, to fund the development and growth of our business. Any future determination related to our dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, business prospects and other factors the board of directors deems relevant, and subject to the restrictions contained in any future financing instruments. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e4828_anchor"><font style="font-weight:bold; ">CORPORATE REORGANIZATION</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We completed a corporate reorganization on [&#x2022;], 2021. As part of the corporate reorganization, we formed Nexalin Technology, Inc., a Delaware corporation, in [&#x2022;], 2021 with nominal assets and liabilities for the purpose of consummating the corporate reorganization described herein. In connection with the corporate reorganization, our existing shareholders of Nexalin Technology, Inc., a Nevada corporation, exchanged their shares for the same number and classes of newly issued shares in Nexalin Technology Inc, a Delaware corporation. As a result, Nexalin Nevada became a wholly owned subsidiary of Nexalin. Nexalin had nominal assets and liabilities and did not conduct any operations prior to the reorganization other than its incorporation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon this completion of the corporate reorganization on [&#x2022;], 2021, the historical consolidated financial statements of Nexalin Nevada became the historical consolidated financial statements of Nexalin, the entity whose shares of common stock are being sold in this offering, though such historical financial data do not give effect to the corporation reorganization. We expect that the corporate reorganization will not have a material effect on our financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Investors in this offering will only acquire, and this prospectus only describes the offering of, shares of the common stock of Nexalin. We refer to the reorganization described herein as our &#x201C;corporate reorganization.&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">32</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e4851_anchor"><font style="font-weight:bold; ">CAPITALIZATION</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table sets forth our cash and capitalization as of June 30, 2021, as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">on an actual basis; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">on an as adjusted basis to give further effect to our issuance and sale of shares of&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; our common stock in this offering at an assumed combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us and therefore providing net proceeds of approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Information below on as adjusted basis is illustrative only, and our capitalization following the closing of this offering will be adjusted based on the actual initial public offering price and other terms of this offering determined at pricing. You should read this information in conjunction with our financial statements and the related notes included elsewhere in this prospectus and the &#x201C;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201D; section and other financial information contained in this prospectus. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">











            <tr class="odd" style=" ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="5" style="width:36%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">As of June 30, 2021 (Unaudited)</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Actual</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">As</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Adjusted</font><sup><font style="font-weight:bold; ">(1)</font></sup>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">307,946 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total indebtedness<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">696,913 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stockholders&#x2019; Deficit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:20pt !important; margin-top:0pt; margin-bottom:0pt; ">Common Stock, $0.001 per share; 100,000,000 shares authorized; ________ shares issued and outstanding<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">88,125 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Additional paid-in capital<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">66,476,544 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accumulated deficit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(68,295,888) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total stockholders&#x2019; deficit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,731,219) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:60%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total capitalization<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,034,306) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#xA0; </p>


      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; ">





            <tr class="odd" style=" ">

               <td style="width:4%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:6.1pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><sup>(1)</sup> </p>

               </td>

               <td style="width:96%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Each $1.00 increase (decrease) in the assumed combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the as adjusted amount of each of cash, total equity and total capitalization by approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 100,000 shares in the number of shares of common stock offered by us at the assumed combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the as adjusted amount of each of cash, total equity and total capitalization by approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million. </p>
               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The number of shares of our common stock on an as adjusted basis set forth in the table above is based on 88,124,701 shares of our common stock outstanding as of June 30, 2021, and excludes the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:57pt; margin-top:-12pt; margin-bottom:0pt; ">816,000 warrants with an exercise price of $0.50 per share; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">[*] shares to be issued to U.S. Asian Consulting Group, LLC to hold 15% of the total outstanding shares immediately prior to this offering as consideration for waiving previous anti-dilution rights. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">33</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e5317_anchor"><font style="font-weight:bold; ">DILUTION</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between the assumed initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock (the midpoint of the range appearing on the front cover of this prospectus) and the as adjusted net tangible book value per share of our common stock immediately upon the consummation of this offering. Net tangible book value per share represents the book value of our tangible assets less the book value of our total liabilities divided by the number of shares of common stock then issued and outstanding. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our net tangible book value as of June 30, 2021 was $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; or $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, based on an assumed initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock (the midpoint of the range appearing on the front cover of this prospectus). After giving effect to our sale&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; of shares of common stock in this offering at an assumed combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net tangible book value as of June 30, 2021 would have been approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; , or approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share (assuming no exercise of the underwriters&#x2019; over-allotment option). This amount represents an immediate and substantial dilution of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share to new investors purchasing common stock in this offering. The following table illustrates this dilution per share: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Assumed initial public offering price per share of common stock<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Net tangible book value per share as of June 30, 2021<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Increase in net tangible book value per share attributable to this offering<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">As adjusted net tangible book value per share after giving effect to this offering<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dilution per share to new investors participating in this offering<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:100%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A $1.00 increase (decrease) in the assumed combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of our common stock (the midpoint of the range appearing on the front cover of this prospectus) would increase (decrease) the as adjusted net tangible book value by approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million, or approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, and increase (decrease) the dilution per share to new investors by approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares of common stock we are offering. An increase of 100,000 shares in the number of shares of common stock offered by us would increase our as adjusted net tangible book value by approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million, or $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share and the dilution per share to investors purchasing common stock in this offering would be $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, assuming the assumed combined initial public offering price remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, a decrease of 100,000 shares in the number of shares of common stock offered by us would decrease our as adjusted net tangible book value by approximately $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million, or $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share and the dilution per share to investors purchasing common stock in this offering would be $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, assuming the assumed combined initial public offering price remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The as adjusted information discussed above is illustrative only and will change based on the actual initial public offering price and other terms of this offering determined at pricing. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If the underwriters exercise their option in full to purchase&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; additional shares of our common stock to purchase up to shares of common stock in this offering, the as adjusted net tangible book value per share after this offering would be $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, and the as adjusted dilution to new investors would be $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share, in each case assuming a combined initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and the estimated offering expenses payable by us. The following table summarizes, on an as adjusted basis described above, as of June 30, 2021, the differences between the number of shares of common stock purchased from us, the total consideration paid and the average price per share paid by existing stockholders and by new investors participating in this offering at an assumed initial public offering price of $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share of common stock, which is the midpoint of the price range set forth on the cover page of this prospectus, before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. As the table shows, new investors purchasing common stock in this offering will pay an average price per share substantially higher than our existing stockholders paid. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">



















            <tr class="odd" style=" ">

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="5" style="width:24%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shares Purchased</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="5" style="width:24%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Consideration</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Percent</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Amount</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Percent</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Average </font><font style="font-weight:bold; ">Share Price</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Existing stockholders<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:9%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:9%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">New investors<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:9%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:9%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:9%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:9%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If the underwriters exercise their option to purchase additional shares of our common stock full, the percentage of shares of common stock held by existing stockholders will decrease to approximately &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;% of the total number of shares of our common stock outstanding after this offering, and the number of shares held by new investors will increase to &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;, or approximately &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;% of the total number of shares of our common stock outstanding after this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The foregoing tables and calculations are based on shares of our common stock outstanding as of June 30, 2021 and excludes the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">816,000 warrants with an exercise price of $0.50 per share; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">[*] shares to be issued to U.S. Asian Consulting Group, LLC to hold 15% of the total outstanding shares immediately prior to this offering as consideration for waiving previous anti-dilution rights.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">34</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e6213_anchor"><font style="font-weight:bold; ">MANAGEMENT&#x2019;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">The following discussion and analysis of the consolidated results of operations and financial condition of </font><font style="font-style:italic; ">Nexalin Technology, Inc. </font><font style="font-style:italic; ">and </font><font style="font-style:italic; ">its subsidiary as of June 30, 2021 and for the six months ended June 30, 2021 and 2020 and as of December 31, 2020 and 2019 and </font><font style="font-style:italic; ">for the years ended December 31, 2020 and 2019 should be read in conjunction with our financial statements and the notes to those </font><font style="font-style:italic; ">financial statements that are included elsewhere in this prospectus. </font><font style="font-style:italic; ">References in this &#x201C;Management&#x2019;s Discussion and Analysis of </font><font style="font-style:italic; ">Financial Condition and Results of Operations&#x201D; to &#x201C;us,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and similar terms refer to </font><font style="font-style:italic; ">Nexalin Technology, Inc. </font><font style="font-style:italic; ">This </font><font style="font-style:italic; ">prospectus contains forward-looking statements as that term is defined in the federal securities laws. </font><font style="font-style:italic; ">The events described in </font><font style="font-style:italic; ">forward-looking statements contained in this prospectus may not occur. </font><font style="font-style:italic; ">Generally</font> <font style="font-style:italic; ">, </font><font style="font-style:italic; ">these statements relate to business plans or </font><font style="font-style:italic; ">strategies, projected or anticipated benefits or other consequences of our plans or strategies, projected or anticipated benefits from </font><font style="font-style:italic; ">acquisitions that may be made by us, or projections involving anticipated revenues, earnings or other aspects of our operating results. </font><font style="font-style:italic; ">The words &#x201C;may,&#x201D; &#x201C;will,&#x201D; &#x201C;expect,&#x201D; &#x201C;believe,&#x201D; &#x201C;anticipate,&#x201D; &#x201C;project,&#x201D; &#x201C;plan,&#x201D; &#x201C;intend,&#x201D; &#x201C;estimate,&#x201D; and &#x201C;continue,&#x201D; and their </font><font style="font-style:italic; ">opposites and similar expressions, are intended to identify forward-looking statements. </font><font style="font-style:italic; ">We caution you that these statements are not </font><font style="font-style:italic; ">guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are </font><font style="font-style:italic; ">beyond our control, which may influence the accuracy of the statements and the projections upon which the statements are based. </font><font style="font-style:italic; ">Reference is made to &#x201C;Risk Factors&#x201D; beginning on page [&#x2022;] of this prospectus for a discussion of some of the uncertainties and risks </font><font style="font-style:italic; ">associated with these statements.</font>      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Overview</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Through our existing &#x201C;Gen-1&#x201D; device, we provide an FDA-cleared, easy-to-administer treatment that utilizes bioelectronic medical technology to safely and successfully treat anxiety and insomnia, without the need for drugs or psychotherapy. Our Gen-1 device is classified by the FDA as a Class II device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All our products are non-invasive and undetectable and, critically, can provide relief to those afflicted with mental health issues without adverse side effects. Moreover, our proprietary design of varying voltages, currents, electromagnetic fields and various frequencies&#x2014;referred to collectively as waveform&#x2014;particularly our proprietary, patented symmetrical alternating current waveform, based on responses from our clinical providers, has proven to be highly effective in stimulating a positive response from the mid-brain structures associated with various mental health disorders and distinguishes our devices from all comparable neurostimulation technologies currently available. Our devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head. The features of this waveform make the application of the stimulation undetectable to the human body and this technique is proprietary to our devices, which enables the use of a higher current than all other devices in the market. Our design of an advanced waveform that is safely administered to the human brain is the basis of our treatment and our continuing evolution. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As aforementioned, we currently sell a medical device to medical professionals which is administered by them to patients in a clinical setting and which emits our original waveform at 4 milliamps during treatment&#x2014;referred to as Generation 1 or Gen-1. This device has been cleared in the United States to treat anxiety and insomnia, two prevalent and serious diseases. Prior to a regulatory change, our Gen-1 device was also used to treat depression. We have already begun designing and developing new advanced waveform technology to be emitted at 15 milliamps through our existing medical device improved with a modern enclosure&#x2014;referred to as Generation 2 or Gen-2&#x2014;which can penetrate deeper into the brain and the associated structures of mental illness, which we believe will generate enhanced patient response. Gen-2 is presently being tested in clinical trials, for anxiety, insomnia and depression in the United States and China, and preliminary data provided by the University of California San Diego supports the safety of utilizing our waveform technology at an increased power. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are also currently designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer&#x2019;s disease and dementia. In part due to increasing incidence attributed to the devastating impacts of the COVID-19 pandemic, mental health and cognitive disorders are widespread across the globe and cause substantial health, social and economic losses and hardships accordingly. Our focus is on the continued development of our innovative bioelectronic medical technologies and rapid regulatory approval to help reverse these losses and hardships by safely and effectively treating various mental health disorders. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We recognize that an additional barrier to treatment in today&#x2019;s mental health treatment landscape&#x2014;beyond the concerns about safety, efficacy and discomfort that have been associated with conventional mental health treatments such as drugs, psychotherapy and other forms of electrical stimulation&#x2014;is stigma. Therefore, we are developing a new headset design to emit our waveform technology which will offer medical professionals the opportunity to prescribe the headset device for use in a patient&#x2019;s home&#x2014;referred to as Generation 3 or Gen-3&#x2014;to increase access to mental health treatment. We believe that in order to preserve product safety and integrity in the United States, the headset device will require physician oversight including prescriptions for use, monthly authorization for continued patient use and monthly physician monitoring through our digital management platform.</p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">35</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">According to Infinium Global Research, the global neurostimulation devices market is projected to grow from approximately $4.7 billion in 2018 to approximately $9.8 billion for a CAGR of 10.9% from 2019-2025. There are several drivers of this growth. First, many mental health disorders are treated with psychotherapy or pharmaceutical intervention and have limited efficacy and, in the case of the latter increased awareness of the side effects of medication. Second, the rising number of geriatric patients, particularly with respect to Alzheimer&#x2019;s disease, will increase demand for mental health treatments. Third, increased diagnosis of cases of anxiety, depression and various other mental health disorders in all age populations will contribute to the market development. Doctors and patients will seek effective, safer and more cost-effective alternatives to current care standards. Advancements in neurostimulation techniques, such as those we are developing, will provide safe and effective treatment options that address irregularities in the brain&#x2019;s functional health. These functional brain health issues are believed to be the underlying cause of many mental health disorders and chronic diseases.</p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Overall, we believe that sustained growth in the sale and use of our existing Gen-1 device in combination with our advanced waveform, technological upgrades and the development of a modern headset monitored with our IT management platform, evidenced in our Gen-2 and Gen-3 devices, will position us to disrupt the traditional mental health treatment model. The stigma of expensive psychotherapy or pharmaceutical medication with side effects and dependency issues will be replaced with clinically proven, safe and cost-effective technology that is undetectable to the patient during treatment.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Since our inception, we have generated significant losses, we expect to continue to incur significant expenses and increasing operating losses for at least the next several years. Our net losses may &#xFB02;uctuate significantly from period to period, depending on the timing of our planned clinical trials and expenditures on other research and development activities. We expect our expenses will increase substantially over time as we: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">continue our ongoing and planned preclinical and clinical development of our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">initiate preclinical studies and clinical trials for any additional products that we may pursue in the future; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">seek to discover and develop additional products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">amend our previous 510(k) Application for anxiety and insomnia in accordance with the FDA and seek other regulatory approvals for any future products that successfully complete clinical trials; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">ultimately establish a sales, marketing and distribution infrastructure and scale up external manufacturing capabilities to commercialize any product candidate for which we may obtain regulatory approval and intend to commercialize on our own; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">maintain, expand and protect our intellectual property portfolio; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">hire additional clinical, scientific, manufacturing and controls personnel; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">add additional operational, financial and management information systems and personnel, including personnel to support our product development and planned future commercialization efforts. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Furthermore, following the completion of this offering, we expect to incur additional costs associated with operating as a public company, including significant legal, accounting, investor relations and other expenses that we did not incur as a private company. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">36</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Corporate Reorganization</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As more fully described in the section of this prospectus titled &#x201C;Corporate Reorganization,&#x201D; we completed a corporate reorganization on [&#x2022;], 2021. As part of the corporate reorganization, we formed Nexalin Technology, Inc., a Delaware corporation, in [&#x2022;], 2021 with nominal assets and liabilities for the purpose of consummating the corporate reorganization described herein. In connection with the corporate reorganization, our existing shareholders of Nexalin Technology, Inc., a Nevada corporation, exchanged their shares for the same number and classes of newly issued shares in Nexalin Technology Inc, a Delaware corporation. As a result, our Nevada corporation became a wholly owned subsidiary of our Delaware corporation. Our Delaware corporation had nominal assets and liabilities and did not conduct any operations prior to the reorganization other than its incorporation. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon the completion of the corporate reorganization, the historical consolidated financial statements of our Nevada corporation became the historical consolidated financial statements of our Delaware corporation. The common shares of our Delaware corporation are now the shares being sold in the offering as part of this prospectus. We expect that the corporate reorganization will not have a material effect on our financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Recent Developments</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Impact of COVID-19 Pandemic</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We continue to monitor how the COVID-19 pandemic is affecting our employees, business and clinical trials. Such pandemic has delayed our clinical trials and our receipt of marketing approvals from the FDA. Such pandemic also might have reduced, and continue to reduce, participation in our clinical trials, due to both travel restrictions and a general unwillingness of subjects to travel. We cannot presently predict the scope and severity of any other potential business shutdowns or disruptions, but if we or any of the third parties with whom we engage, including the suppliers, clinical trial sites, regulators and other third parties with whom we conduct business, were to experience shutdowns or other business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively impacted. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, the spread of an infectious disease, including COVID-19, may also result in the inability of our suppliers to deliver components or raw materials on a timely basis. Such events may result in a period of business and manufacturing disruption, and in reduced operations, any of which could materially affect our business, financial condition and results of operations. The extent to which the coronavirus impacts our business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain the coronavirus or treat its impact, among others. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Chinese Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In September 2018, we entered into an agreement with Wider, pursuant to which we and Wider shall form the Joint Venture. The Joint Venture will be formed following the completion of certain funding, clinical study, and publication milestones, which Wider has undertaken. Following its formation, the Joint Venture will design and implement a comprehensive business model and distribution plan for our devices in China, Hong Kong, Macau and Taiwan. The first phase of distribution in China includes implementation of a sales strategy by Wider for mainland China and other territories serviced by Wider. In September 2021, the China National Medical Products Administration (NMPA), the equivalent of the United States FDA, granted clearance for sale of the 15 milliamps power parameters in China. No other regulatory of governmental approvals are required for the sale of our devices by Wider in China, Hong Kong, Macau and Taiwan. When the Joint Venture is formed and Wider completes sales of our devices in China, there are no regulatory or other restrictions that would restrict either (i) the transfer from China of any proceeds resulting from such sales by Wider to the Joint Venture in Hong Kong, other than standard compliance with China&#x2019;s State Administration of Foreign Exchange policies, or (ii) our receipt of our share of such proceeds from Hong Kong to us in the United States. We expect to consummate the formation of the Joint Venture in the fourth quarter of 2021. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Results of Operations</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Six Months Ended June 30, 2021 Compared to the Six Months Ended June 30, 2020</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table presents selected items in our unaudited condensed consolidated statements of operations for the six months ended June 30, 2021 and 2020, respectively: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:34%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">For The Six Months Ended</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:34%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2021</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Revenues<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">64,096 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">173,505 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cost of revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">13,142 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,748 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross profit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50,954 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">162,758 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Operating Expenses:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional fees<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">302,362 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">99,886 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and benefits<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">96,525 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">37,596 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock-based compensation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,863,230 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,962,022 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Selling, general and administrative<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">434,500 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">212,397 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total Operating Expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,696,617 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,311,901 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss From Operations<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,645,663 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,149,143 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Other Expense:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Interest expense, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,705 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">39,652 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total Other Expense<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,705 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">39,652 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Net Loss</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,682,368 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,188,795 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">37</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Revenues</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For the six months ended June 30, 2021 and 2020, we generated $64,096 and $173,505, respectively, of revenue from licensing and treatment fee agreements with our customers by charging a monthly licensing fee for the duration of the agreement. The decrease in revenue for 2021 compared to 2020 was due to a large purchase from a single customer in 2020. We also generated revenue from treatment fee agreements by collecting fees based on the number of treatments per month the customer performs. In addition, we also derive revenues from equipment by selling additional individual nodes to customers for use with our device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Cost of Revenue and Gross Profit</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For the six months ended June 30, 2021 and 2020, cost of revenues were $13,142 and $10,748, respectively, yielding a gross profit of $50,954 and $162,758, respectively, or 79.5% and 93.8%, respectively. Such decrease was due to our need in 2021 to meet specific standards for shipping that did not apply in 2020. In addition, tooling expenses related to package design and foam molding and then the initial inventory purchase of shipping containers contributed to such decrease. Furthermore, patient cable inventory due to re-design and expenses related to inventory adjustments of usable/current patient cables also contributed to such decrease. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Operating Expenses</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Total operating expenses for the six months ended June 30, 2021 and 2020 were $3,696,617 and $2,311,901, respectively. The increase was primarily due to increases in professional fees for legal and accounting, as well as the impact of stock-based compensation for the issuance of our common stock to various employees and consultants for services. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Other Expense</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Other expense for the six months ended June 30, 2021 and 2020 was $36,705 and $39,652, respectively, consisting of interest expense from notes payable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended December 31, 2020 Compared to the Year Ended December 31, 2019</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table presents selected items in our audited consolidated statements of operations for the years ended December 31, 2021 and 2020, respectively: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:34%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">For Year Ended</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:34%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Revenues<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">242,914 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">207,383 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cost of revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">29,039 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">61,813 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross profit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">213,875 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">145,570 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Operating Expenses:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Professional fees<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">299,187 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,133 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Salaries and benefits<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">137,847 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">156,397 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Selling, General and Administrative Expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,035,248 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,377,204 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss on impairment of right o use of assets<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">37,047 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">21,671 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total Operating Expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,509,329 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,633,405 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss From Operations<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,295,454 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,487,835 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Other Expense:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Interest expense, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,681 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">80,989 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss on extinguishment of debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">29,351 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,452,366 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total Other Expense<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">108,032 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,533,355 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Net Loss</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,403,486 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,021,190 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Revenues</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For the year ended December 31, 2020 and 2019, we generated $242,914 and $207,383, respectively, of revenue from licensing and treatment fee agreements with our customers by charging a monthly licensing fee for the duration of the agreement. We also generated revenue from treatment fee agreements by collecting fees based on the number of treatments per month the customer performs. In addition, we also derive revenues from equipment by selling additional individual nodes to customers for use with our device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Cost of Revenue and Gross Profit</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For the year ended December 31, 2020 and 2019, cost of revenues were $29,039 and $61,813, respectively, yielding a gross profit of $213,875 and $145,570, respectively, or 88.0% and 70.2%, respectively. The increase was primarily attributable to the decreased cost of electrodes in 2020 as compared to 2019. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Operating Expenses</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Total operating expenses for the year ended December 31, 2020 and 2019 were $3,509,329 and $1,633,405, respectively. The increase was primarily due to increases in professional fees for legal and accounting, the impact of stock-based compensation for the issuance of our common stock to various employees and consultants for services and for the accrual of certain potential legal claims. We devoted substantially all the financial resources and efforts to research and development which includes $1.8 million paid to consultants and professional fees of $296,000. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Other Expense</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Other expense for the years ended December 31, 2020 and 2019 was $108,032 and $3,533,355, respectively, consisting of interest expense from notes payable and, primarily, a loss on extinguishment of debt in 2019 totaling $3,452,366. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">38</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Liquidity and Capital Resources</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Working Capital</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">
















            <tr class="odd" style=" ">

               <td style="width:61%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, 2021</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:24%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:61%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(unaudited)</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:61%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Current assets<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">357,739 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">116,885 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">111,149 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:61%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Current liabilities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,974,413 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,566,552 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,041,880 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:61%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Working capital (deficiency)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,616,674 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,449,667 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(930,731 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Current assets increased from December 31, 2019 and 2020 to June 30, 2021, primarily as a result of (i) an increase in cash and cash equivalents and (ii) an increase in prepaid expenses. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Current liabilities increased December 31, 2019 and 2020 to June 30, 2021, which was primarily attributable to an increase in accounts payable and accrued expenses. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Cash Flows</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">




















            <tr class="odd" style=" ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, 2021</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, 2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:24%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(unaudited)</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(unaudited)</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,682,368) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,188,795) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,403,486 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,021,190 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash used in operating activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(428,430) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(129,151) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(863,474 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(678,336 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash used in investing activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(648 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash provided by financing activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">657,940 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">267,001 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">879,131 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">726,051 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:48%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net change in cash and cash equivalents<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">229,510 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">137,850 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15,009 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">47,715 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Net Cash Used in Operating Activities</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Net cash used in operating activities was $428,430 for the six months ended June 30, 2021, primarily due to the net loss of $3,682,368 which was primarily offset by non-cash expenses of $2,863,230 related to stock-based compensation and partially decreased by an increase in accounts payable and accrued expenses of $229,751. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Net cash used in operating activities was $863,474 for the year ended December 31, 2020, as compared to $678,336 for the respective period in 2019, primarily due to the net loss of $3,403,486 and $5,021,190, respectively, which was primarily offset by a loss on extinguishment of debt of $3,452,366 in the year ended December 31, 2019 and non-cash expenses of $1,959,524 and $562,735, respectively, related to stock-based compensation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Net Cash Provided by Financing Activities</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Net cash provided by financing activities for the six months ended June 30, 2021 was $657,940, which was primarily due to the sale of common stock for cash. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Net cash provided by financing activities during the years ended December 31, 2020 and 2019 was $879,131 and $726,051, respectively, which was primarily due to the sale of common stock for cash. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Uses and Availability of Additional Funds</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our primary uses of capital are, and we expect will continue to be, compensation and related expenses, third-party clinical research and development services, laboratory and related supplies, manufacturing development costs, legal and other regulatory expenses and general administrative costs. The successful development of our products is highly uncertain. At this time, we cannot reasonably estimate or know the nature, timing and estimated costs of the efforts that will be necessary to complete the clinical development of our products and obtain regulatory approvals. We are also unable to predict when, if ever, net cash in&#xFB02;ows from revenues will enable us to be cash flow positive. This is due to the numerous risks and uncertainties associated with developing products, including, among others, the uncertainty of: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">successful enrollment in, and completion of clinical trials; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">performing preclinical studies and clinical trials in compliance with the FDA or any comparable regulatory authority requirements; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">the ability of collaborators to manufacture sufficient quantity of product for development, clinical trials or potential commercialization; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">obtaining and maintaining patent, trademark and trade secret protection for our products; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">making arrangements with third parties for manufacturing capabilities; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">scaling the commercial sales of products, if and when approved, whether alone or in collaboration with others; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:65pt; margin-top:-12pt; margin-bottom:0pt; ">acceptance of existing therapies, and future therapies, if and when approved, by healthcare providers, physicians, clinicians, patients and third-party payors; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">competing effectively with other therapies; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">obtaining and maintaining healthcare coverage and adequate reimbursement; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">protecting our rights in our intellectual property portfolio; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:44pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:65pt; margin-top:-12pt; margin-bottom:0pt; ">maintaining a continued acceptable safety profile of our products following approval. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">39</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We will not increase revenue from future product sales unless and until we or a collaborator successfully complete clinical development and obtain regulatory approval for such future products. If we obtain regulatory approval for any of our future products that we intend to commercialize on our own, we will incur significant expenses related to commercialization, including developing our internal commercialization capability to support product sales, marketing and distribution. As a result, we may need substantial additional funding to support our continuing operations and to pursue our growth strategy. Until such time, if ever, when we can generate substantial product revenue, we expect to finance our cash needs through this offering and, in the future and if needed, a combination of equity offerings, debt financings and potential collaboration, license and development agreements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, investors&#x2019; ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of stockholders. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our technologies, future revenue streams, research programs or products or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to a third party to develop and market products that we would otherwise prefer to develop and market ourselves. Our failure to raise capital as and when needed would compromise our ability to pursue our business strategy. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We will also incur costs as a public company that we have not previously incurred, including increased fees payable to the non-employee members of our board of directors, increased personnel costs, increased director and officer insurance premiums, audit and legal fees, investor relations fees and expenses for compliance with public-company reporting requirements under the Exchange Act and rules implemented by the SEC and Nasdaq. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Because of the numerous risks and uncertainties associated with product development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations. Our operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. Our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability to successfully commercialize our products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We believe that the net proceeds from this offering will enable us to fund our operating expenses and capital expenditure requirements until December 15, 2023. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. Without giving effect to the anticipated net proceeds from this offering, we expect that our existing cash will not be sufficient to fund our operating expenses and capital expenditure requirements through 2021. To finance our operations up to and beyond that point, we will need to raise additional capital, which cannot be assured. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our consolidated financial statements included elsewhere in this prospectus have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, which contemplate our continuation as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the outcome of this uncertainty. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Although no assurances can be given as to our ability to deliver on our revenue plans or that unforeseen expenses may arise, management believes that the revenue to be generated from operations, together with the potential closing of the Initial Public Offering in the near term, will provide the necessary funding for us to continue as a going concern. Management cannot guarantee any such Initial Public Offering will be available on favorable terms. As such, these matters raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of twelve months from the issue date of this filing. If adequate funds are not available on acceptable terms, or at all, we will need to curtail operations or cease operations.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Internal Controls</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. Prior to this offering, we were a private company and we are currently in the process of reviewing, documenting and testing our internal control over financial reporting. During our internal reviews, we have identified material weaknesses in our internal control over financial reporting.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have not performed an evaluation of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, nor have we engaged an independent registered accounting firm to perform an audit of our internal control over financial reporting as of any balance sheet date or for any period reported in our financial statements. Presently, we are not an accelerated filer, as such term is defined by Rule 12b-2 of the Exchange Act, and therefore, our management is not presently required to perform an annual assessment of the effectiveness of our internal control over financial reporting. This requirement will first apply to our second Annual Report on Form 10-K. Our independent public registered accounting firm will first be required to attest to the effectiveness of our internal control over financial reporting for our Annual Report on Form 10-K for the first year we are no longer an &#x201C;emerging growth company. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Critical Accounting Policies and Significant Judgments and Estimates</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">While our significant accounting policies are described in more detail in Note 3 to our consolidated financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Use of Estimates</font>
      </p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">40</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions, revenue and expenses and disclosure of contingent liabilities at the date of the financial statements. The Company bases its estimates and assumptions on historical experience, known or expected trends and various other assumptions that it believes to be reasonable. As future events and their effects cannot be determined with precision, actual results could differ from these estimates which may cause our future results to be affected. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">41</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Revenue Recognition</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We recognize revenue when our performance obligations with our customers have been satisfied. At contract inception, we determine if the contract is within the scope of ASC Topic 606 and then we evaluate the contract using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. We only recognize revenue to the extent that it is probable that a significant revenue reversal will not occur in a future period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We enter into licensing and treatment fee agreements with our customers for the use of our device in their practices. These agreements generally have terms of one year with automatic renewal if certain requirements are met and amounts due per these agreements are billed monthly. We also sell products related to the provision of services. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Revenue Streams</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We derive revenues from our license agreements by charging a monthly licensing fee for the duration of the agreement. We derive revenues from treatment fee agreements by collecting fees based on the number of treatments per month the customer performs. We derive revenues from equipment by selling additional individual nodes to customers for use with our device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Performance Obligations</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management identified that subsequent licensing revenue has one performance obligation. That performance obligation is satisfied as long as the licensing contract is remains valid and is not terminated. The licensing revenue is invoiced monthly and is recognized at a point in time in which the invoice is sent to the customer. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management identified that our equipment revenue has one performance obligation. That performance obligation is satisfied when the electrodes are delivered to the customer. We recognize revenue at a point in time in which the electrodes are delivered to the customer. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Practical Expedients</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As part of ASC 606, the Company has adopted several practical expedients including: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Significant Financing Component &#x2013; we do not adjust the promised amount of consideration for the effects of a significant financing component since we expect, at contract inception, that the period between when we transfer a promised goods or services to the customer and when the customer pays for that service will be one year or less. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Unsatisfied Performance Obligations &#x2013; all performance obligations related to contracts with a duration of less than one year, we have elected to apply the optional exemption provided in ASC Topic 606 and therefore, are not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Shipping and Handling Activities &#x2013; we elected to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Right to invoice &#x2013; we have the right to consideration from a customer in an amount that corresponds directly with the value to the customer of our performance completed to date we may recognize revenue in the amount to which the entity has a right to invoice. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Intangible Assets</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We record our intangible assets at cost in accordance with Accounting Standards Codification (&#x201C;ASC&#x201D;) 350, <font style="font-style:italic; ">Intangibles &#x2013; Goodwill </font><font style="font-style:italic; ">and Other</font>. Definite lived intangible assets are amortized over their estimated useful life using the straight-line method, which is determined by identifying the period over which the cash flows from the asset are expected to be generated.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Impairment of Long-Lived Assets</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We review long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is determined by comparing the forecasted undiscounted net cash flows of the operation to which the assets relate to the carrying amount. If the operation is determined to be unable to recover the carrying amount of its assets, then these assets are written down first, followed by other long-lived assets of the operation to fair value. Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Fair Value Measurements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As defined in ASC 820, <font style="font-style:italic; ">Fair Value Measurements and Disclosures</font>, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). We utilize market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">42</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:9%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 1: </p>

               </td>

               <td style="width:89%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:9%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:89%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:9%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 2: </p>

               </td>

               <td style="width:89%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:9%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:89%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:9%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 3: </p>

               </td>

               <td style="width:89%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#x2019;s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Fair Value of Financial Instruments</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The carrying value of cash, accounts receivable, inventory, accounts payable and accrued expenses, and other current liabilities approximate their fair values, based on the short-term maturity of these instruments. The carrying amount of the loans payable approximates the estimated fair value for this financial instrument as management believes that such debt and interest payable on the note approximates our incremental borrowing rate. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Stock&#x2010;based Compensation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We apply the provisions of ASC 718, <font style="font-style:italic; ">Compensation - Stock Compensation</font> (&#x201C;ASC 718&#x201D;), which requires the measurement and recognition of compensation expense for all stock&#x2010;based awards made to employees, including employee stock options, in the statements of operations.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For stock options issued to employees and members of the board of directors for their services, we estimate the grant date fair value of each option using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common stock consistent with the expected life of the option, risk-free interest rates and expected dividend yields of the common stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, we recognize stock-based compensation expense equal to the grant date fair value of stock options on a straight-line basis over the requisite service period, which is generally the vesting term. Forfeitures are recorded as they are incurred as opposed to being estimated at the time of grant and revised. Due to our limited history and lack of public market for our common stock, we used the average of historical share prices of similar companies within its industry to calculate volatility for use in the Black-Scholes option pricing model. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to ASU 2018-07 Compensation &#x2013; Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting, we account for stock options issued to non-employees for their services in accordance with ASC 718. We use valuation methods and assumptions to value the stock options that are in line with the process for valuing employee stock options noted above. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Research and Development</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All research and development costs are charged to operations as incurred. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Leases</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In accordance with ASC 842, <font style="font-style:italic; ">Leases</font>, we recognize a right-of-use (&#x201C;ROU&#x201D;) asset and corresponding lease liability on our balance sheets for our office space lease agreement. See Note 10 for further discussion, including the impact on our financial statements and related disclosures.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">ROU assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The lease terms may include options to extend or terminate the lease if it is reasonably certain that we will exercise that option. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Leases in which we are the lessee are comprised of office rental. All of the leases are classified as operating leases. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Income Taxes</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We utilize ASC 740, <font style="font-style:italic; ">Income Taxes</font>, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. We account for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is &#x201C;more likely-than-not&#x201D; that a deferred tax assets will not be realized.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For uncertain tax positions that meet a &#x201C;more likely than not&#x201D; threshold, we recognize the benefit of uncertain tax positions in the financial statements. Our practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the statements of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">43</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Recent Accounting Pronouncements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for us for interim and annual periods in fiscal years beginning after December 15, 2022. We believe the adoption will modify the way we analyze financial instruments, but we do not anticipate a material impact on results of operations. We are in the process of determining the effects adoption will have on its consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">See footnotes to our consolidated financial statements for the years ended December 31, 2020 and 2019 included elsewhere in this prospectus. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Off-Balance Sheet Arrangements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Factors That May Affect Future Results and Financial Condition</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The information contained under the caption &#x201C;Risk Factors&#x201D; beginning on page 12 of this prospectus provides examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. Readers should be aware that the occurrence of any of the events described in these risk factors could have a material adverse effect on our business, results of operations and financial condition. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Emerging Growth Company Status</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are an &#x201C;emerging growth company&#x201D; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and we intend to take advantage of some of the exemptions from reporting requirements that are applicable to other public companies that are not emerging growth companies. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our share price may be more volatile. We may take advantage of these exemptions until the last day of our fiscal year following the fifth anniversary of the completion of this offering. However, if any of the following events occur prior to the end of such five-year period, (i) our annual gross revenue exceeds $1.07 billion, (ii) we issue more than $1.0 billion of non-convertible debt in any three-year period or (iii) we become a &#x201C;large accelerated filer,&#x201D; (as defined in Rule 12b-2 under the Exchange Act), we will cease to be an emerging growth company prior to the end of such five-year period. We will be deemed to be a &#x201C;large accelerated filer&#x201D; at such time that we (a) have an aggregate worldwide market value of common equity securities held by non-affiliates of $700 million or more as of the last business day of our most recently completed second fiscal quarter, (b) have been required to file annual and quarterly reports under the Exchange Act, for a period of at least twelve months and (c) have filed at least one annual report pursuant to the Exchange Act. Even after we no longer qualify as an emerging growth company, we may still qualify as a &#x201C;smaller reporting company,&#x201D; which would allow us to take advantage of many of the same exemptions from disclosure requirements including reduced disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy statements. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are emerging growth companies. As a result, changes in rules of U.S. generally accepted accounting principles or their interpretation, the adoption of new guidance or the application of existing guidance to changes in our business could significantly affect our financial position and results of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Quantitative and Qualitative Disclosures about Market Risk</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our cash as of June 30, 2021 consisted of cash. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of interest rates. Because of the short-term nature of the instruments in our portfolio, we would not expect a sudden change in market interest rates to have a material impact on our financial position or results of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">44</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e8619_anchor"><font style="font-weight:bold; ">BUSINESS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Overview</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Through our existing &#x201C;Gen-1&#x201D; device, we provide an FDA-cleared, easy-to-administer treatment that utilizes bioelectronic medical technology to safely and successfully treat anxiety and insomnia, without the need for drugs or psychotherapy. Our Gen-1 device is classified by the FDA as a Class II device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All our products are non-invasive and undetectable and, critically, can provide relief to those afflicted with mental health issues without adverse side effects. Moreover, our proprietary design of varying voltages, currents, electromagnetic fields and various frequencies&#x2014;referred to collectively as waveform&#x2014;particularly our proprietary, patented symmetrical alternating current waveform, based on responses from our clinical providers, has proven to be highly effective in stimulating a positive response from the mid-brain structures associated with various mental health disorders and distinguishes our devices from all comparable neurostimulation technologies currently available. Our devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head. The features of this waveform make the application of the stimulation undetectable to the human body and this technique is proprietary to our devices, which enables the use of a higher current than all other devices in the market. Our design of an advanced waveform that is safely administered to the human brain is the basis of our treatment and our continuing evolution. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As aforementioned, we currently sell a medical device to medical professionals which is administered by them to patients in a clinical setting and which emits our original waveform at 4 milliamps during treatment&#x2014;referred to as Generation 1 or Gen-1. This device has been cleared in the United States to treat anxiety and insomnia, two prevalent and serious diseases. Prior to a regulatory change, our Gen-1 device was also used to treat depression. We have already begun designing and developing new advanced waveform technology to be emitted at 15 milliamps through our existing medical device improved with a modern enclosure&#x2014;referred to as Generation 2 or Gen-2&#x2014;which can penetrate deeper into the brain and the associated structures of mental illness, which we believe will generate enhanced patient response. Gen-2 is presently being tested in clinical trials, for anxiety, insomnia and depression in the United States and China, and preliminary data provided by the University of California San Diego supports the safety of utilizing our waveform technology at an increased power. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are also currently designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer&#x2019;s disease and dementia. In part due to increasing incidence attributed to the devastating impacts of the COVID-19 pandemic, mental health and cognitive disorders are widespread across the globe and cause substantial health, social and economic losses and hardships accordingly. Our focus is on the continued development of our innovative bioelectronic medical technologies and rapid regulatory approval to help reverse these losses and hardships by safely and effectively treating various mental health disorders. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We recognize that an additional barrier to treatment in today&#x2019;s mental health treatment landscape&#x2014;beyond the concerns about safety, efficacy and discomfort that have been associated with conventional mental health treatments such as drugs, psychotherapy and other forms of electrical stimulation&#x2014;is stigma. Therefore, we are developing a new headset design to emit our waveform technology which will offer medical professionals the opportunity to prescribe the headset device for use in a patient&#x2019;s home&#x2014;referred to as Generation 3 or Gen-3&#x2014;to increase access to mental health treatment. We believe that in order to preserve product safety and integrity in the United States, the headset device will require physician oversight including prescriptions for use, monthly authorization for continued patient use and monthly physician monitoring through our digital management platform. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">According to Infinium Global Research, the global neurostimulation devices market is projected to grow from approximately $4.7 billion in 2018 to approximately $9.8 billion for a CAGR of 10.9% from 2019-2025. There are several drivers of this growth. First, many mental health disorders are treated with psychotherapy or pharmaceutical intervention and have limited efficacy and, in the case of the latter increased awareness of the side effects of medication. Second, the rising number of geriatric patients, particularly with respect to Alzheimer&#x2019;s disease, will increase demand for mental health treatments. Third, increased diagnosis of cases of anxiety, depression and various other mental health disorders in all age populations will contribute to the market development. Doctors and patients will seek effective, safer and more cost-effective alternatives to current care standards. Advancements in neurostimulation techniques, such as those we are developing, will provide safe and effective treatment options that address irregularities in the brain&#x2019;s functional health. These functional brain health issues are believed to be the underlying cause of many mental health disorders and chronic diseases. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Overall, we believe that sustained growth in the sale and use of our existing Gen-1 device in combination with our advanced waveform, technological upgrades and the development of a modern headset monitored with our IT management platform, evidenced in our Gen-2 and Gen-3 devices, will position us to disrupt the traditional mental health treatment model. The stigma of expensive psychotherapy or pharmaceutical medication with side effects and dependency issues will be replaced with clinically proven, safe and cost-effective technology that is undetectable to the patient during treatment. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Market and Industry Background</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Historically, pharmaceutical solutions have been the first line of treatment for those who suffer from anxiety, insomnia, depression and other mental health disorders. Beginning in 1950, for patients that were not responding to medication, ECT, also called &#x201C;shock therapy,&#x201D; became available. Over time, researchers began to look at alternative ways to inject electricity into the human brain. One such method was via implantable neurostimulators that required invasive surgery procedures associated with high cost and high risk. Implantable devices became the potential solution for those who would not take or could no longer take pharmaceuticals. The interest in electricity continued with the creation of small handheld devices powered by a direct current (DC) battery that the consumer could buy without any medical supervision. Clinical versions of DC stimulators, known as transcranial direct current stimulation (tDCS), were developed by researchers; many of these devices are still in research settings without industry support. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In 1992, a new neurostimulation technique emerged called trans-cranial magnetic stimulation (TMS). This technique evolved into repetitive trans-cranial magnetic stimulation (rTMS), which utilized repetitive magnetic pulse energy to stimulate the brain of patients struggling with depression. The American pharmaceutical industry embraced and funded this technology. The FDA cleared rTMS only for patients who had failed to respond to anti-depressants. Side effects, high cost and moderate efficacy continue to burden this technology sector. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Both insurance companies and healthcare providers are looking for alternative ways to decrease costs while still providing safe and effective treatments. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">45</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Anxiety Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Anxiety disorders are considered the most prevalent of psychiatric disorders. Anxiety disorders include generalized anxiety disorder, social anxiety disorder, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder (PTSD) and phobias. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following anxiety facts and statistics support the demand for a safe, effective and low-cost solution for anxiety: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">According to the National Institute of Mental Health (NIMH), 40 million adults in the United States suffer from anxiety disorders, and such disorders are the most common mental illness in the United States&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Anxiety disorders cost the United State more than $42 billion a year, almost one-third of the country&#x2019;s $148 billion total mental health bill, according to &#x201C;The Economic Burden of Anxiety Disorders,&#x201D; a study commissioned by Anxiety and Depression Association of America (ADAA) (The Journal of Clinical Psychiatry, 60(7), July 1999)&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Relatedly, the National Institute on Drug Abuse (NIDA) has revealed that overdose deaths involving benzodiazepines to treat anxiety&#x2014;such as Xanax and Valium&#x2014; have quadrupled between 2002 and 2015&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">According to Fortune Business Insights, the global anxiety disorders and depression treatment market size was $8.50 billion in 2019 and is projected to reach $13.03 billion by 2027&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Insomnia Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Insomnia is a common sleep disorder considered to be responsible for at least $63 billion in direct and indirect healthcare costs each year, according to the Harvard American Insomnia Study. A frightening number of insomnia cases are undiagnosed and untreated, even as the condition becomes a mounting financial burden on America&#x2019;s employers and the healthcare system. Data surrounding sleep disorders demonstrate that insomnia is a growing problem that shows no signs of slowing down. Relatedly: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">According to a study in the Journal of Clinical Sleep Medicine, up to 48% of all adults over 60 experience insomnia&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Moreover, the Centers for Disease Control and Prevention (CDC) estimate that about 70 million Americans suffer from chronic sleep problems&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">40% of people with insomnia are believed to also be affected by a mental health disorder and around 75% of adults with depression suffer from insomnia, according to the Sleep Foundation&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Although people successfully treat short-term insomnia with sleeping pills, many become dependent on them&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">According to MarketsandMarkets, the United States insomnia treatment market is expected to be worth $4.24 billion by 2021&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">These current market conditions present an opportunity to introduce a technology that provides a safe, effective and drug-free alternative for those suffering from insomnia. We have the ability to decrease the number of potentially addictive insomnia prescriptions needed by patients and offer physicians a non-pharmaceutical option to provide their patients. Additionally, we are developing a solution for home-based treatment for chronic insomnia and to improve sleep hygiene for its user. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Depression Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Depression continues to be the leading cause of medical disability around the world. Poor efficacy, risk and adverse side effects of current anti-depressants are driving the preference for non-pharmacological therapies, which will limit growth for the pharmaceutical sector of the depression treatment market. This limitation will enhance the research and development of novel therapies that treat depression safely and effectively without adverse side effects. Historically, according to the CDC, only one-third of people with severe depression have taken anti-depressants. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Most patients with severe depression remain untreated and the potential market for a safe, effective and affordable solution is significant: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">According to the World Health Organization (WHO), globally, more than 264 million people of all ages suffer from depression&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">In 2017, around 17.3 million adults age 18 or older in the United States had experienced at least one major depressive episode in the last year, equaling 6.7% of adults in the United States, according the NIMH&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Depression is also associated with increased mortality and suicide&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Relatedly, according to Fortune Business Insights, the global anxiety disorders and depression treatment market size was $8.50 billion in 2019 and is projected to reach $13.03 billion by 2027&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Any decline in the depression medication market will indirectly accelerate the growth of the neurostimulator market. Based on the market data and current trends, the depression market&#x2014;like the anxiety and insomnia market&#x2014;has enormous potential our products. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As of 2019, our current medical device is considered a Class II device. Treatment of depression in the United States is limited to Class III devices only. Prior to 2019, our existing Gen-1 medical device had been used to successfully treat depression in the USA. The Gen-2 version of our device will be subject to approximately eighteen months of clinical study before our application for PMA from the FDA and classification as a Class III device. Following this classification, we can market our device as a treatment for depression. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Over recent years more clinical data has proven that medication approved for the treatment of depression does not provide adequate efficacy. In addition to efficacy challenges, side effects can be overwhelming for patients. Frequently, doctors will prescribe based on the least amount of side effects rather than efficacy. Because of the large number of patients struggling with major depressive disorders and treatment resistant depression, alternative treatments are currently experiencing renewed interest and growth. Specifically, neurostimulation related to electricity and magnetic pulse energy are leading the industry of medical technology for the treatment of mental health disorders.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Beginning in 2003, our device was cleared for anxiety, depression, insomnia. Over the last 17 years, providers in clinics of our technology have reported overwhelming success in their clinics from an anecdotal level with patients struggling with depression and had been resistant to medication.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">46</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Substance Use Disorders (Opioid Addiction) Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">According to the NIDA, substance use and substance use disorders cost the United States more than $740 billion a year in healthcare, crime and lost productivity costs; but dollars barely capture the devastating human cost of addiction to individuals, families and communities. According to the National Survey on Drug Use and Health, 19.7 million adults in the United States suffered from a substance use disorder in 2017. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Relatedly, drug overdose is now a leading cause of unintentional fatal injury in our nation, claiming more than 70,630 lives in the United States in 2019, as revealed by the CDC. Significantly, opioids were involved in 49,860 of these overdose deaths in 2019, accounting for 70.6% of all drug overdose deaths. According to the NIDA, between eight and twelve percent of people using an opioid for chronic pain develop an opioid use disorder. Opioid addiction also has broad implications for public health due to secondary complications of opioid use. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">According to Reports and Data, the global drug addiction treatment market is forecast to reach $31.17 billion by 2027. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The current success rate of the best drug and alcohol rehabilitation facilities is minimal. This represents a significant market opportunity for our company. The disease of addiction is brain-based in its nature. Currently brain-based treatments for the disease are only available to patients who can afford long-term expensive boutique treatment centers. We intend to demonstrate that a brain-based approach to addiction treatment will enhance a patient&#x2019;s success at long-term recovery. Our hypothesis is that the current pilot study design at the University California San Diego (see below) will provide a source of validation for this treatment modality in addiction. Initial anecdotal research from prior use in Europe with our products in the addiction treatment model will provide the basis of our test market. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Chronic Pain Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Originally, our waveform was designed as an electro-analgesic for pain. This refers to the ability to electrically interrupt the pain signalling process in the brain. By interrupting the pain signalling process in the brain, our products can reduce symptoms and discomfort associated with chronic pain. By reducing the symptoms and discomfort associated with chronic pain, physicians can reduce medications and avoid dependency issues related to opiate-based medications. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">According to Research and Markets, the global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate revenue of $151.7 billion in 2030. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Currently, we own an electrostimulation patent for a device that will apply electrodes to the brain, spine and the place of injury. The placement of these electrodes in conjunction with our various waveforms creates an opportunity for us to treat chronic pain without medication. Upon funding, we plan to immediately develop a prototype of our existing patented design and introduce it into clinical trials for the treatment of chronic pain. In previous pilot studies, our existing Gen-1 product reduced pain in patients suffering from injuries originating in industrial accidents. However, we plan to use the new advanced waveform emitted at 15 milliamps into the new prototype pain device for new clinical trials for the treatment of chronic pain. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Alzheimer&#x2019;s Disease and Dementia Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Alzheimer&#x2019;s disease is a degenerative brain disease and the most common form of dementia. Dementia is not a specific disease, but rather an overall term that describes a group of symptoms. According to the WHO, there are around 50 million people living with Alzheimer&#x2019;s disease and other dementias worldwide. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Additionally, according to the Alzheimer&#x2019;s Association: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">The number of Americans living with Alzheimer&#x2019;s is growing and growing fast&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">An estimated 6.2 million Americans age 65 and older are living with Alzheimer&#x2019;s dementia in 2021&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">12.7 million people age 65 and older are projected to have Alzheimer&#x2019;s dementia by 2050&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">$256.7 billion worth of care is provided by family members and other unpaid caregivers&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">In 2021, Alzheimer&#x2019;s and other dementias will cost the nation $355 billion, including $239 billion in Medicare and Medicaid payments combined. Unless a treatment to slow, stop, or prevent the disease is developed, in 2050, Alzheimer&#x2019;s is projected to cost more than $1.1 trillion (in 2021 dollars)&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">According to Reports and Data, the global Alzheimer&#x2019;s therapeutics market is projected to reach $13.57 billion by 2027 from $7.42 billion in 2019 with a substantial CAGR of 9.2% through the forecast period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We believe our products could be leveraged to extend the quality of life for millions of people. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Products and Services</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our existing Gen-1 treatment consists of an FDA classified Class II medical device that delivers a transcranial alternating current stimulation (tACS) via disposable headset electrodes that are placed in a specific pattern on the skull of the patient. The device and disposable headset electrodes transmit a non-invasive brain stimulation using a small, pulsed electric frequency to the patient. Essentially, our device utilizes a proprietary, patented symmetrical alternating current waveform that based on responses from our clinical providers has proven to be highly effective in stimulating a positive response from the mid-brain structures associated with various mental health disorders. The current proprietary waveform at 77.5 hertz and 4 milliamps stimulates these key mid-brain structures involved in regulating neuromodulators and neurotransmitters. These neurochemicals regulate moods, emotions, sleep and cognition. Our patented waveform and electrode placement distinguish our treatment modality from all comparable electrical stimulators currently available. Our device generates a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head. The features of this waveform make the application of the stimulation undetectable to the human body and this technique is proprietary to our device, which enables the use of a higher current than all other devices in the market. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our waveform stimulates the hypothalamic region of the brain and its correlating networks responsible for maintaining the functional health of the brain. A major function of the hypothalamus is to maintain homeostasis (balance) by constantly sensing and adapting to information received by the brain. When the body is faced with trauma that is associated with the &#x201C;fight or flight&#x201D; response, this region of the brain becomes unable to maintain normal levels of serotonin, dopamine, beta-endorphins and other neurotransmitters. The result of reduced levels of these important neurochemicals can be anxiety, insomnia, depression and other mental health disorders, the symptoms of which can increase in frequency and severity if not treated. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">47</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Clinical results indicate that 10 to 15 treatments with our existing technology, for 40 minutes per session, helps stabilize neurochemicals within the hypothalamic region of the brain, a process which has been referred to as &#x201C;resetting the brain.&#x201D; Early research involving cerebral spinal fluid has demonstrated that beta-endorphins increased by an average of 350% in healthy subjects following these treatments. Beta-endorphins are powerful neurohormones found in the central nervous system that help to relieve pain and stress and are also involved in other positive responses within the brain and body. The beta-endorphin response associated with the neurostimulation by our technology supports the hypothesis that our treatment is encouraging the brain&#x2019;s ability to normalize neurochemicals associated with major mood disorders and mental health challenges. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our existing treatment has been cleared in the United States for the treatment of anxiety and insomnia. Overall, Gen-1 is a safe, non-invasive, low-risk, drug-free therapy with a medical device that has proven to be effective in treating various mental health disorders. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Next Generations</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have already begun to design and develop a second Generation of our technology. Our waveform in the next Generation utilizes a new advanced waveform and increases the amperage that the device emits from 4 milliamps to 15 milliamps. Our hypothesis is that the new advanced waveform will allow us to increase the power of the device exponentially without creating any safety risks or patient discomfort. By increasing the power, our waveform can penetrate deeper into the brain and the associated structures of mental illness. This deeper penetration also enhances patient response, especially in the treatment-resistant population that normally does not respond to any current treatments for major mental health issues. Clinical providers have indicated to us a strong and positive response from treatment-resistance patients. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our Gen-2 device has been submitted for approval in China for the treatment of insomnia depression. Our new, Gen-2 device will continue full clinical testing for approximately eighteen months to achieve PMA from the FDA as a Class III device, which we will then market for the treatment of depression in the United States. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Gen-2 device has a fresh and modern appearance that meets the technology standards of the digital tech world of 2021. Early adopters of the Gen-1 device will be able to access additional firmware upgrades which are planned to enhance the previously purchased devices to the 15-milliamp waveform. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our Gen-2 device is equipped with Radio Frequency Identification (RFID) technology that exchanges electrode usage data with a reader in the main device. The purpose of RFID is to track and maintain control of the proprietary single use electrode. Our electrode chip is programmed to exchange data with the device and allow activation for a single treatment with a new electrode only. This upgrade in technology also ensures the proprietary nature of the electrodes that support treatment outcomes are sustained. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We will also be developing a new headset design for our products that will offer medical professionals the opportunity to prescribe the headset device&#x2014;Gen-3&#x2014;for use in a patient&#x2019;s home to increase access to mental health treatment. We believe that in order to preserve product safety and integrity, in the United States, the headset device will require physician oversight including prescriptions for use, monthly authorization for continued patient use and monthly physician monitoring through a Nexalin virtual clinic digital management platform. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Marketing and Growth Strategy</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Sales of our products will follow a three-phase process in the United States. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Phase 1</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Starting immediately in the United States, sales of the current, Gen-1 device, which is FDA cleared for anxiety and insomnia, will commence. Anxiety and insomnia are so common in our population that healthcare providers are currently actively searching for safe and effective treatment options without the negative side effects and addiction issues associated with pharmaceutical medication. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In the first year with the Gen-1 device, the sales team will employ an aggressive sales model that directly targets service providers such as licensed wellness centers and mental health clinics. The Phase 1 sales program will target specific geographic territories that will generate revenue and lay the foundation for a national marketing campaign promoting our company and products. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This initial phase will strengthen the clinical case for our treatment by organizing and structuring a portfolio of research and abstracts that originated during the research and development of the waveform. The portfolio will also include clinical summaries from current clinicals in the United States and China that are in the manuscript phase with pending applications for publication. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We will participate in virtual conventions and meetings, leverage remote sales techniques and promote our company and products in trade publication articles. As in-person events, such as trade shows, are scheduled by event organizers, we plan to fully participate. We will also utilize digital marketing services to promote our products via social media interactions. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Phase 1 Pricing</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Current clinical providers of our technology pay a license fee of $995 per month and pay $6 per single use electrode. The monthly license fee agreement allows for unlimited use of the device. The only charge for use is related to the single use electrode. During the calendar years of 2019 and 2020, some providers chose to buy the device at $15,000, rather than continue to pay the monthly usage fee.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">While our Phase 1 program has not officially started, we intend to rely heavily on a national sales effort which will require a sales manager and sales director. These positions will be filled after this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">48</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Phase 2</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The second phase of the sales plan will begin with regulatory approval of our Gen-2 device followed thereafter by manufacture of such device. All Phase 1 strategies and sales momentum will transition into the sales and marketing plan of Phase 2. Additional conventions, virtual meetings and marketing strategies will be added to the existing sales plan in Phase 1. In addition to the licensed medical professional community, our sales team will add the chiropractic community of 60,000 licensed chiropractors in the United States to the concept of targeted purchasers. Additional marketing will occur in the addiction treatment sector. All sales projections in this phase will include current sales from Phase 1, new sales from Phase 2 and a transition sales program for providers using the Gen-1 device. This is important to accurately project revenue from device sales and the recurring revenue generated from the sale of the microchipped disposable headset electrodes. The sales team has accounted for various market adjustments and attrition rates related to device sales and disposable headset electrodes sales. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Gen-2 device upgrades are in three primary areas&#x2014;the new waveform, new modern enclosure and the &#x201C;chipped&#x201D; single use electrodes for recurring revenue. The waveform in this Gen-2 device is powered at 15 milliamps. The enclosure for the Gen-2 device, currently in the design stage, will be released during this phase. The design will provide a fresh and modern appearance that is associated with technological standards in the digital tech world of 2022. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our Gen-2 devices will be equipped with RFID technology that exchanges electrode usage data with a reader in the main device. The purpose of RFID is to track and maintain control of the proprietary single use electrode. Our electrode chip will be programmed to exchange data with the device and allow activation for a single treatment with a new electrode only. This ensures a recurring revenue stream on the device and protects against any generic knockoffs designed to avoid treatment costs. This upgrade in technology also ensures the proprietary nature of the electrodes that support treatment outcomes are sustained. The revenue projections in Phase 2 are based on device sales and recurring disposable electrode sales. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Phase 2 sales will include the development and launch of a &#x201C;Patient Activation Program&#x201D; that encourages passive patients to become active healthcare consumers interested in our treatment. This program will provide a web-based patient recruitment and management platform. The Patient Activation Program is designed as a module that will eventually plug into the virtual clinic digital cloud computing platform&#x2014;to be developed as part of Gen-3&#x2014;that will manage all aspects of our business model including the outpatient headset device for outpatient consumer use in the home. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Phase 2 Pricing</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Gen-2 device and the per treatment charge associated with the disposable electrode will require additional market analysis supported with data from the Phase 1 sales plan. The current stimulator market is based on two distinct market price points. The high end of the market is dominated by the Neurostar and Brainsway rTMS systems that require large capital expenses between $100,000 and $300,000 per device. The Neurostar system also requires a single use disposable magnet priced at an average of $100 per treatment. The low end of the market is dominated by small plastic handheld devices that are powered with a DC battery and are sold over the internet direct to consumers for an average of $400. Our sales plan is designed to exploit the disparity in the pricing models and will target the mid-market entry point to maximize the sales and revenue volume. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Phase 3</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This phase of our sales plan provides a long-term scalable business model. Our team will have developed the foundation and marketing assets necessary to launch the new virtual clinic model that will complement the traditional clinic model. Our sales model is to have placed more than 1,000 devices on the global stage. The momentum and branding strategies of our existing providers will be leveraged to enhance the launch of the Phase 3 global sales plan. The Gen-2 device at 15 milliamps supported by the outpatient headset and our virtual clinic digital management platform is intended to disrupt the current mental healthcare model. The Gen-2 device at 15 milliamps will offer patients a cost effective and efficient treatment model for day-to-day mental health challenges. This device, with its advanced waveform, can treat existing mental health disorders associated with anxiety and insomnia. Additionally, new FDA treatment indications for depression, substance use issues associated with addiction, especially as related to opioids, and alcoholism and chronic pain will be incorporated into our treatment regimen. Additional research and treatment efficacy are being investigated in the Alzheimer&#x2019;s community for patient care and management. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Phase 3 sales plan is developed to triangulate and stimulate the physician, consumer and manufacturer relationship. Trends in healthcare indicate consumers are involved in treatment decisions that concern their mental health. Because of the advancement in healthcare technologies, home-based care with medical supervision provides patients with a cost-effective and efficient treatment option. Home-based care also avoids the stigma associated with treatment for mental health disorders. In the sales plan presented, we will have established a global &#x201C;provider&#x201D; network in excess of 1,000 physicians, with 800 such physicians located in the United States. We will leverage this community to immediately establish a network of physicians that prescribe our home-based devices in a virtual clinic setting. Our goal is that over 40,000 patients will have received a regiment of our treatments by the launch of the outpatient headset device and the IT management platform. Most of the patients treated would be part of a digital community that supports brand awareness and the sharing of anonymous outcomes in a social media setting. The Patient Activation Program will include a robust data gathering system on providers and patients (opt-in) that enhances all traditional marketing strategies. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">At this point in the sales plan, we would have developed an extensive patient activation program that is active and driving patients to our products. This patient recruitment system will provide the marketing vehicle to launch our outpatient, home-based headset treatment device. This new treatment option would exist in addition to the clinic-based service then available. We will continue to build the provider network with our virtual and convention models. In addition to existing providers becoming &#x201C;prescribers&#x201D; for our home-based unit, a sales team will recruit additional physicians to become &#x201C;prescribers&#x201D; of our home-based unit. This allows market penetration in areas without our existing providers. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our devices in Phase 3 will have modern aesthetics with advanced digital capabilities. In this phase, we will focus on the ability to record and transmit usage data. Advanced power management, network communication and patient-centric design will translate into improved device comfort, efficacy and consumer compliance. We will also gather data from user habits through cloud-based technology. In addition, real time patient conditions such as brain activity and biometrics will be tracked and recorded. This data will be available in our patient portal for physician monitoring. The data blueprints developed will increase our ability to penetrate the market and contribute to market valuation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">49</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Phase 3 Pricing</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A transition program for all our providers will be developed to upgrade their devices to our latest device with the advanced waveform. Depending on the final enclosure and internal hardware components, the target trade-in and transition price is $8,000 from Gen-1 providers to Gen-2 providers. Specific pricing of our Gen-2 devices at 15 milliamps will need further market analysis within six months of the launch. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Reimbursement</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Reimbursement strategies for this type of technology are complex and vary from one diagnosis to another. We utilize an RFID system that will track doses delivered. This will simplify comparing our devices to pharmaceutical interventions. Beginning in Phase 1, a complete reimbursement assessment will be conducted to develop a three-year strategy to acquire reimbursement. We will employ a two-prong approach. The first prong will evaluate the clinic-based product offered by physicians. The second prong will focus on tracking usage and response from the outpatient headset model that is tracked through the virtual platform. Frequently therapies that are used in the home are not classified as durable medical equipment and will fall into a reimbursement gap without coverage. We intend to work to successfully achieve a Level 2 code under the healthcare common procedure coding system. We will work to seek reimbursement for conditions in sequence with the home based and the clinic-based unit that will maximize value of treatment from a financial standpoint as well as monitoring the response by the patient community. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Specific strategies to ensure successful reimbursement will include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Payer relations&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Medical policy research with the Centers for Medicare &amp; Medicaid Services (CMS)&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">CPT code analysis and applications&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Health economics analysis&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Outcomes research&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Current payer mix of comparable technologies&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Variations of coverage in clinical indications&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Chinese Market</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In September 2018, we entered into an agreement with Wider, pursuant to which we and Wider shall form the Joint Venture. The Joint Venture will be formed following the completion of certain funding, clinical study, and publication milestones, which Wider has undertaken. Following its formation, the Joint Venture will design and implement a comprehensive business model and distribution plan for our devices in China, Hong Kong, Macau and Taiwan. The first phase of distribution in China includes implementation of a sales strategy by Wider for mainland China and other territories serviced by Wider. In September 2021, the China National Medical Products Administration (NMPA), the equivalent of the United States FDA, granted clearance for sale of the 15 milliamps power parameters in China. No other regulatory of governmental approvals are required for the sale of our devices by Wider in China, Hong Kong, Macau and Taiwan. When the Joint Venture is formed and Wider completes sales of our devices in China, there are no regulatory or other restrictions that would restrict either (i) the transfer from China of any proceeds resulting from such sales by Wider to the Joint Venture in Hong Kong, other than standard compliance with China&#x2019;s State Administration of Foreign Exchange policies, or (ii) our receipt of our share of such proceeds from Hong Kong to us in the United States. We expect to consummate the formation of the Joint Venture in the fourth quarter of 2021. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Research</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Summary of Current Clinical Trials in the United States</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In 2019, we began a research partnership with the University California San Diego (UCSD). Prior to the pandemic, two clinical studies were undertaken with UCSD, however, these trials were paused due to the shutdown of college campuses in California. In the summer of 2021, final contract preparations and clinical protocols began development. Contracts are expected to be signed in December of 2021 to perform special clinical trials for the treatment of anxiety and insomnia.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The first is studying the benefits of our Gen-2 device as a treatment for veterans suffering with opiate addiction. This pilot study was designed by UCSD and funded by the department of Veterans Affairs. For this opiate addiction study, the primary endpoint will be alleviating withdrawal symptoms. Secondary endpoints will include decreasing dosages of medication used in opiate addiction cessation, as well as MEG gamma band improvement.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The other study at UCSD is focused on veterans suffering from mild traumatic brain injury (mTBI) and is funded by the United States Department of Defense. One of the primary symptoms associated with mTBI is PTSD. or this mTBI study, the primary endpoint will be the assessment of reduction of post-concussion symptoms. A secondary endpoint for the study will be improvement and MEG slow-wave abnormalities. Additional studies are planned for patients and veterans with suicidal thoughts related to mTBI.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition to UCSD, we are in negotiations with other academics to initiate further trials to address new FDA guidelines on existing 4 milliamp and safety in our 15-milliamp Gen-2 device. These new trials will support new 510(k)s for anxiety and insomnia at 15 milliamps. These trials are supplementary to the special control trials required by the FDA. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">50</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Recently a pilot study was completed with the University of Pennsylvania (UPenn) at an inpatient psychiatric hospital in the Hackensack meridian healthcare system. The study began with 93 subject patients and was completed by 79 subject patients. The pilot data demonstrated that 73% of patients that received our treatment had a 50% reduction in depression symptoms in a 5-day treatment window. These patients were isolated and secluded in an adult treatment wing at the hospital and were possible candidates for electroconvulsive therapy (ECT). The patients in the study were not responding to medication treatment and needed to be hospitalized. The follow-up trials recommended by UPenn will build on the observations of this clinical study. In addition to the symptom reduction, other data will be researched and published on the economic savings by adding our treatment instead of continued hospitalization and possible ECT or other implant technology costs. Further trial strategies are in development to address safety with the 15-milliamp Gen-2 device. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A second clinical trial was performed at Xuanwu Hospital in Beijing, China studying our technology for the treatment of depression: &#x201C;The effect of transcranial alternating current stimulation intervention on depressed patients who have never taken medication.&#x201D; A total of 30 subjects were enrolled. After four weeks of tACS intervention, the remission ratio of the active group was also higher than that of the control group. In addition, the remission ratio in the fourth week was higher than that in the eighth week, indicating that the acute effect of tACS in reducing the degree of depression was obvious. With the cessation of tACS intervention, the patients&#x2019; depression levels rebounded to a certain extent at the end of the next four weeks of follow-up, that is, the eighth week, but the antidepressant effect still had a significant clinical effect and can last until the eighth week. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In conclusion, tACS has the effect of reducing depression with no obvious adverse reactions have been observed. The results of this clinical trial were recently published in the medical journal &#x201C;BRAIN.&#x201D; The article was accepted for publication in June of 2021. An additional insomnia trial performed in China was also accepted for publication in the medical journal &quot;Psychotherapy and Psychosomatics&#x201D; in December of 2019. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Other areas of research that will be designed and funded relate to the treatment of substance use disorders, chronic pain, Alzheimer&#x2019;s disease and dementia. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Summary of Current Clinical Trial Strategy for the Joint Venture</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Research and development are the fundamental core of any pharmaceutical or medical device company. Although small trials, with limited patients, can show promise for a treatment, they are generally not acceptable to the FDA for product approval. In order to commercialize a product for widespread use, multiple large-scale trials are required to demonstrate both efficacy and safety. In the past two decades, the cost of conducting such trials has more than doubled, with many small start-up companies unable to raise the necessary capital to complete these vital projects. The increase in cost reflects several variables which are required for successful clinical trial completion. The various costs can include patient recruitment and retention expenses, physician and nurse expenses, as well as the expenses of other healthcare providers. Various regulations, each more complex than the next, also have added significant cost to the process. Data collection, as well as data analysis, is also a significant portion of the study cost. Additionally, almost all studies are conducted through either a large university, with its underlying overhead for administrative costs and institutional review board approval, or through a contract research organization, which also adds significant overhead costs in addition to the hard cost of the study itself. Latest estimates for the cost per patient for an average trial is approximately $41,000 per patient. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The planned research for Joint Venture would include at least five major areas of research. These studies would be performed over approximately eighteen to twenty-four months, with the goal of publishing the findings in a peer reviewed journal. All research will be controlled by our team, with all trial designs requiring written final approval by our Chief Medical Officer. Clinical updates will be required every two weeks. Frequent in-person inspections will also be performed to ensure the integrity of the research efforts. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition to clinical trial work in China and current studies in the United States required by the FDA, further proposed studies will evaluate a large cohort of patients with depression. Clinical providers have indicated to us a strong and positive response from treatment-resistance patients. This trial would include a double-blind study design with active and sham group treatment. These patients would be selected for treatment for major depressive episodes. Patient selection screening will evaluate over 200 subjects in order to acquire the number of patients needed for a successful trial. Each patient, upon enrollment, will be evaluated extensively prior to initiation of therapy. Patients will be treated a minimum of 15 separate times, with each visit requiring pre- and post-test screening. Moreover, upon completion of therapy, post-test examination will be performed not only immediately thereafter but also over the course of three months to establish not only efficacy but durability of the treatment. Since recent regulatory changes by the FDA require submission of new clinical studies for continued approval of treatment of depression, the results would further bolster our FDA approval process demonstrating both safety and efficacy. We anticipate a large trial, with approximately 100 subjects, randomized to active and placebo treatment. In the United States, a trial of this magnitude would cost between $1.2 million and $1.8 million, if performed at a leading research hospital. Furthermore, for this particular trial, we will be seeking patients who are pharmaceutically na&#xEF;ve, i.e., patients who have never received antidepressant pharmaceuticals. In the United States, this is a difficult study to populate, as the prevalence of antidepressants in our society leads to very few patients who have not previously received such drugs. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">One of the areas of brain stimulation which shows promise is the area of improvement of memory and heightening of mental acuity. Learning can be improved when certain neural circuits are stimulated. Our aim is to demonstrate the effectiveness of our product in memory and learning skills. This study will be conducted in China and will be designed to demonstrate increased capacity for memory and learning with the addition of proper brain stimulation. The study will incorporate multiple patient tasks including both memorization tracking as well as evaluating improvement in physical dexterity. The goal of this research is to have a handheld, at-home device for students as well as adults. We anticipate 40-60 patients for the segments of the trial. Current plans are to have at least two different trials, one with memory assessment and the other with manual dexterity evaluation. The trials are difficult to perform, requiring significant hands-on proctorship for each patient. Wider will cover all costs associated with the research required for the consumer product for students in China. These trials will support an aggressive distribution model for the product directly to the consumer in China for the enhancement of memory and learning. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">51</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There are multiple transcranial stimulation devices on the market. Few have been studied in terms of their neurophysiology. One of the areas that we wish to explore is the activation of various areas of the brain following stimulation with our device. This evaluation would be performed with sophisticated fMRI equipment evaluating areas of neuronal stimulation, both within the deep and superficial regions of the brain. Blood flow activation models will demonstrate, using sophisticated fMRI mapping, the targeted areas for the brain, looking for both areas of stimulation and neural network changes. Additionally, we will utilize PET scanning to evaluate changes in brain function and activity. Measurements of GABA, an inhibitory neuron chemical, as well as glutamate, an excitatory transmitter, will be performed. Such trials are expensive by definition, as the cost of fMRI as well as PET scanning are quite high. The cost of one small 10-person trial would border on $40,000 or more per patient for the radiotracers and scanning times, as well as patient recruitment. We estimate the cost of this trial would be in excess of $800,000. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Transcranial stimulation as it affects neuronal function has been studied in multiple diseases. One of the most challenging today is Alzheimer&#x2019;s disease. As the population&#x2019;s longevity increases, the disease affects a greater number worldwide. Animal research has shown some promise with various wavelength stimulations of the brain in potentially slowing the progress of the disease. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">At the start of 2021, an Alzheimer&#x2019;s specific clinical trial was underway in China: &#x201C;Transcranial alternating current stimulation for patients with mild Alzheimer&#x2019;s disease.&#x201D; Extensive cognitive pre- and post-evaluations are being performed at the beginning and conclusion of the study, with less rigorous evaluations before and after each therapy session. To date, ten subjects have undergone radioisotope C-11PIB PET-MR examination, thirty-six subjects have undergone MR EEG examination, thirty-four subjects have completed treatment and twenty-one subjects have completed the follow-up. This clinical trial is in progress and expected to be completed in the fourth quarter of 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Given the nature of their illness, the patients in this study require skilled nursing assistance throughout the study, increasing costs considerably. Estimated cost for completion of this study is approximately $22,000 per patient. We estimate the cost of this trial to be $1.2 million, with such cost being borne solely by Wider as part of the Joint Venture. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A final area of study would include evaluation of chemical changes within the brain following transcranial stimulation. Chemicals, which are naturally formed in the brain, control many of our moods and thoughts, modulating feelings of pain, depression and generalized mood. These substances also drive cravings in substance use disorders. One of the areas of research would be to validate changes in cerebrospinal fluid demonstrating serotonin levels. Serotonin is a &#x201C;feel good&#x201D; chemical which has also been associated with learning. Other chemicals, such as dopamine, act in a reward center mechanism. Additionally, certain other neurons require specific chemicals to either fire or be inhibited from firing. These areas can be explored through both chemical testing of bodily fluids and utilizing specific radioactive markers in the brain for evaluation with PET MRI scans. Current research plans would allow us access to such sophisticated diagnostic equipment to conduct multiple clinical investigations accordingly. This study would require invasive testing, including blood sample drawings as well as lumbar punctures. These invasive tests will be repeated multiple times upon the same patient, making study recruitment challenging. Estimates for a 20-patient trial are approximately $21,000 per patient, and the total cost of this trial would be in excess of $400,000. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The estimated total investment value of the four clinical trials in China is in excess of $4.8 million, with such costs being borne solely by Wider as part of the Joint Venture. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Development</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Devices</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our engineering team is currently working on the design of new generations of the Nexalin clinical device, an outpatient device and a consumer device. These new Nexalin devices will include new enclosures, proprietary disposable headset electrodes for revenue control and modern consumer headsets. These new generations of devices will utilize a new advanced waveform with power increased to 15 milliamps. Our team projects an eight- to twelve-month timeline for design and manufacturing files to be completed and prototypes to be tested. A new regulatory and clearance filing with the FDA will require nine to twelve months. A transition plan will support the introduction of the Gen-2 device into the sales model that will be established during Phase 1. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The next stage for our business in China is to design and manufacture a consumer-based device that can be easily acquired at an affordable price point. The engineering team is designing the new device to market and distribute in the China market for memory enhancement. This consumer device and sales plan will add an additional scalable revenue track. Our engineering and design team will design the headset to administer the Nexalin waveform at the precise areas of the brain that have proven clinical efficacy. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The consumer headset will make use of our investment in the virtual clinic digital management platform. The users will be able to download an application to their mobile devices that will gather data associated with user habits and the initial response to the treatment by the client. The Nexalin app will then communicate with a cloud-based program created to support and modify future waveform and treatment recommendations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Virtual Clinic Digital Management Platform</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We look to capitalize on the post pandemic digital health model. Our team began researching IT digital development firms at the beginning of the pandemic. We have now completed our research and bidding process and have begun contract negotiations with a leading IT design team to begin work on an advanced, proprietary IT management platform that will eventually manage all aspects of the Nexalin clinic model. The vision is to implement a virtual clinic model that will enable providers and clinics to integrate remote outpatients into an overall treatment process. Our IT platform goes well beyond telehealth and is designed to support all aspects of the treatment model in conjunction with various data sets to support marketing, data collection and patient monitoring. Our digital management platform will manage the entire clinical and outpatient headset business model. The proprietary IT platform will manage all aspects of a new virtual health center related to safe and effective treatment for mental health. As the development of the new generations of our devices and the outpatient headset are developed, the digital platform will eventually manage and triangulate the relationship between the medical professional, the patient and the manufacturer. The digital platform will handle logistics, data collection and user experience data for clinical evaluation. Additionally, there will be an app that the patients will install on their phones that will communicate with the outpatient headset. The app will upload user information that is HIPAA compliant to the IT management platform. Modules will be designed and implemented in the platform to collect biometric data. The biometric data will be utilized to evaluate patient response. A symptom exam for additional clinical validation will also be offered in the app. All data and user information will be stored in a secure, HIPAA compliant cloud computing center and access to the information will be managed through a secure and compliant dashboard management system. The medical professional will have access to all data to monitor outpatient experience, client response and general health and wellness information. </p>

      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">52</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We will leverage our IT investment to create a lead management system for mental health clinics connecting prospective patients with providers. The medical professional will be able to engage in a telehealth virtual appointment with prospective patients to complete an evaluation and assess whether the patient is a candidate for the outpatient headset program. After the professional approves the device for the patient, we will automatically prepare shipment of the device directly to the outpatient consumer from the manufacturer. We will have an internal department to monitor shipment, and to answer questions through a help desk on how to set up and use the device. The medical professional can be reimbursed for the virtual appointment via the outpatient&#x2019;s insurance for telehealth care which is becoming part of the new normal in the post-pandemic, digital-health world. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Additional design and implementation of modules related to social media marketing, bio-metric data collection and user experience will eventually complete the design of the IT management platform. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Manufacturing</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In December 2021, we entered into a quality assurance agreement with Apical Instruments, an FDA-registered manufacturer, to ensure quality assurance of our products. We currently have enough design and manufacturing support to meet all projected company design and sales goals. Our regulatory team works closely with the Apical quality team to ensure all current compliance and testing standards are adhered to. All distribution channels will rely on a collaboration of the Apical and Nexalin teams. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Regulatory Strategy</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our Gen-1 device was originally cleared by the FDA for the treatment of anxiety, insomnia and depression through our 510(k) application. Section 510(k) of the Federal Food, Drug and Cosmetics Act or FFDCA, involves an application submitted to the FDA that demonstrates a medical device is safe and effective because it is substantially equivalent to another legally marketed device that has been cleared previously by the FDA for the same treatment indication. At the time of that original clearance, the 510(k) submission did not require specific clinical data related to the technology in the submission document. Nexalin is classified at the FDA as a CES device. The CES device category in general was classified as a high-risk Class III medical device. Historically a Class III medical device would require a PMA. A PMA is the FDA process of extreme scientific and regulatory review to evaluate the safety and effectiveness of any Class III medical device. The CES device category of medical devices was exempt from the PMA process and allowed the 510(k) application for treatment without scientific data. The PMA process for a Class III medical device requires twelve to eighteen months and a capital investment that frequently exceeds $1.5 million for each treatment indication. The process of amending a current 510(k) application with new clinical testing data that provides evidence of effectiveness can be completed in six to eight months and requires a capital investment of $300,000 to $500,000. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Beginning in 2016, the FDA began to hold public comment periods to support possible reclassification of CES devices to a Class II medical device. This decision would essentially lower the risk category of CES devices. On December 20, 2019, the FDA issued new rulings related to CES devices for the treatment of anxiety, depression and insomnia. Depression treatment with CES devices will remain a Class III medical device and will now require a full PMA that provides definitive clinical trial evidence of effectiveness and safety. We have made a strategic decision to file a new PMA for the treatment of depression with the Gen-2 device that administers a new advanced Nexalin waveform at 15 milliamps. The Gen-1 device currently is cleared by the FDA at 4 milliamps. We will not file a PMA on the Gen-1 4 milliamps device for depression. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For the treatment of insomnia and anxiety, the FDA will not require a PMA application; however, it will require our company to amend our current 510(k) application on the Gen-1 device with new clinical testing data that provides evidence of effectiveness. The deadline for submitting this clinical testing data was December 19, 2020. As a result of the pandemic, this deadline has been extended. The Nexalin regulatory team began communicating with the FDA in late 2020 to outline possible timelines for clinical trials that will begin as the country reopens so that patients can safely participate in our clinical trials. We will continue to market the Gen-1 device for the treatment of anxiety and insomnia until the amended 510(k) application is provided to the FDA and approved. We have engaged in &#x201C;pre-sub&#x201D; meetings and are in the FDA comment period related to the special control trials for existing treatment indications of anxiety and insomnia. All of our protocols and contracts are in final preparations with UCSD&#x2019;s legal and regulatory teams. A second meeting with the FDA has been scheduled to inform it of changes in the protocols. The FDA has not officially provided us with any deadline related to the amendment of our current 510(k) application. We anticipate a second meeting the FDA in early 2022 for the submission of final protocols for the FDA&#x2019;s review and approval. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Beginning in the third quarter of 2021, we will begin designing and implementing two new clinical trials on its Gen-2 15 milliamp device for the treatment of anxiety and insomnia. Additionally, we will design a new clinical trial strategy with its new Gen-2 device at 15 milliamps for the treatment of major depressive disorder (MDD). Our regulatory team has engaged in &#x201C;pre-sub&#x201D; meeting with the FDA to begin soliciting guidance on the new PMA for the treatment of depression. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Intellectual Property</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our commercial success depends in part on our ability to: obtain and maintain proprietary or intellectual property protection for our products, our core technologies and other know-how; operate without infringing on the proprietary rights of others; and prevent others from infringing on our proprietary or intellectual property rights. Our policy is to seek to protect our proprietary and intellectual property position by, among other methods, filing United States and foreign patent applications related to our proprietary technology, inventions and improvements that are important to the development and implementation of our business. We also rely on the skills, knowledge and experience of our scientific and technical personnel, as well as that of our advisors, consultants and other contractors. To help protect our proprietary know-how that is not patentable, we rely on trade secret protection and confidentiality agreements to protect our interests. We require our employees, consultants and advisors to enter into confidentiality agreements prohibiting the disclosure of confidential information and requiring disclosure and assignment to us of the ideas, developments, discoveries and inventions important to our business. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We file patent applications directed to our key products to establish intellectual property positions. These patent applications are intended to protect these products as well as their uses in the treatment of diseases. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">53</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The intellectual property portfolios for our most advanced products are summarized below. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Patents</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are the owner and inventor of one existing patent and five pending patents related to the electro-stimulation techniques related to our products and services. Our current patents cover a therapeutic electro-stimulation apparatus (the medical device) and the software used to create and administer the stimulation to the patient. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Recently, we developed a strategy to create a broad intellectual property estate focused on the stimulation techniques that our current technology is based on. Our legal team is currently working closely with our engineers on new claims and device improvements. These designs and claims will support a new portfolio of provisional patents related to non-invasive neurostimulation of the brain with specific arrays of frequencies and triangulating electrode placement. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">INTELLECTUAL PROPERTY MATRIX</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 15, 2020</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">









            <tr class="odd" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CASE</font></p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">TITLE / MARK</font> <font style="font-weight:bold; ">COUNTRY</font> <font style="font-weight:bold; ">/</font> <font style="font-weight:bold; ">TYPE</font></p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">IN</font> <font style="font-weight:bold; ">THE</font> <font style="font-weight:bold; ">NAME</font> <font style="font-weight:bold; ">OF</font>
                  </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">SERIAL </font><font style="font-weight:bold; ">NO.</font> <font style="font-weight:bold; ">FILING</font> <font style="font-weight:bold; ">DATE</font>
                  </p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">PAT. / REG. </font><font style="font-weight:bold; ">NO.</font> <font style="font-weight:bold; ">ISSUED</font> <font style="font-weight:bold; ">DATE</font></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">STATUS</font><font style="font-weight:bold; "></font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-001A </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ELECTROSTIMULATION APPARATUS AND METHOD </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Non-Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">10/075,675 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">02/15/2002</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">6,904,322 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">06/07/2005</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">ISSUED</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">all maintenance fees paid Expires 08/02/2023</p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-002A </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">MULTI-CHANNEL ELECTROSTIMULATION APPARATUS AND METHOD </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Non-Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">11/820,844 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">06/19/2007</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">7,769,463 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">08/03/2010</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">ISSUED</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">3<sup>rd</sup> Term Maintenance Fee Due 08/03/2022</p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-003T</p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXALIN TECHNOLOGY</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Trademark </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc. </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">86/741,415 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">08/29/2015</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">4,936,260 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">04/12/2016</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">REGISTERED</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Section 8 &amp; 15 Due 04/12/2022</p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td colspan="6" style="width:100%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">International</font><font style="font-weight:bold; "></font><font style="font-weight:bold; ">Class</font><font style="font-weight:bold; ">010:</font> Electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulation
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-004T</p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><img src="smallnexalin.jpg" alt="image provided by client" style="width:27px; height:30px; ">&#x2009;</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Trademark </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc. </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">86/741,418 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">08/29/2015</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">4,936,261 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">04/12/2016</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">REGISTERED</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Section 8 &amp; 15 Due 04/12/2022</p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td colspan="6" style="width:100%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">International</font><font style="font-weight:bold; "></font><font style="font-weight:bold; ">Class</font><font style="font-weight:bold; ">010: </font>Electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulation
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-005T</p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXALIN</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Trademark </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc. </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">87/610,810 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">09/15/2017</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">5,547,368 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">08/21/2018</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">PENDING</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Section 8 &amp; 15 Due 08/21/2024</p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td colspan="6" style="width:100%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">International</font> <font style="font-weight:bold; ">Class</font> <font style="font-weight:bold; ">010: </font>Electrotherapy and medical devices for providing transcutaneous and transcranial electrical stimulation
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CASE</font>
                  </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">TITLE / MARK</font> <font style="font-weight:bold; ">COUNTRY</font> <font style="font-weight:bold; ">/</font> <font style="font-weight:bold; ">TYPE</font>
                  </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">IN</font> <font style="font-weight:bold; ">THE</font> <font style="font-weight:bold; ">NAME</font> <font style="font-weight:bold; ">OF</font>
                  </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">SERIAL </font><font style="font-weight:bold; ">NO.</font> <font style="font-weight:bold; ">FILING</font> <font style="font-weight:bold; ">DATE</font></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">PAT. / REG. </font><font style="font-weight:bold; ">NO.</font> <font style="font-weight:bold; ">ISSUED</font> <font style="font-weight:bold; ">DATE</font></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">STATUS</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-008N </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DUAL FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ANXIETY, DEPRESSION, AND INSOMNIA (ADI)</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">63/054,955 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">07/22/2020</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">n/a</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-008A </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DUAL FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ANXIETY, DEPRESSION, AND INSOMNIA (ADI)</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Non-Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">In</font> <font style="font-weight:bold; ">process</font> <font style="font-weight:bold; ">to</font> <font style="font-weight:bold; ">be</font> <font style="font-weight:bold; ">prepared</font> <font style="font-weight:bold; ">and</font> <font style="font-weight:bold; "></font><font style="font-weight:bold; ">filed</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">priority deadline 07/22/2021</p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-009N </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">63/054,964 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">07/22/2020</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Non-provisional </font><font style="font-weight:bold; ">application filed, see</font> <font style="font-weight:bold; ">NEXAL-009A</font><font style="font-weight:bold; "></font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-009N2 </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">63/061,255 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">08/05/2020</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Non-provisional </font><font style="font-weight:bold; ">application filed, see</font> <font style="font-weight:bold; ">NEXAL-009A</font><font style="font-weight:bold; "></font></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-009A </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Non-Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">17/116,233 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">12/09/2020</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Pending;</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Expedited</font> <font style="font-weight:bold; ">Foreign</font> <font style="font-weight:bold; ">Filing</font> <font style="font-weight:bold; ">License</font> <font style="font-weight:bold; ">Granted</font><font style="font-weight:bold; "></font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-009RC </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Chinese Non-Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">In</font> <font style="font-weight:bold; ">process</font> <font style="font-weight:bold; ">to</font> <font style="font-weight:bold; ">be</font> <font style="font-weight:bold; ">prepared</font> <font style="font-weight:bold; ">and</font> <font style="font-weight:bold; "></font><font style="font-weight:bold; ">filed</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">priority deadline 07/22/2021 </p>

               </td>

            </tr>



         </table>
      </div>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">54</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">









            <tr class="odd" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CASE</font>
                  </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">TITLE / MARK</font> <font style="font-weight:bold; ">COUNTRY</font> <font style="font-weight:bold; ">/</font> <font style="font-weight:bold; ">TYPE</font>
                  </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">IN</font> <font style="font-weight:bold; ">THE</font> <font style="font-weight:bold; ">NAME</font> <font style="font-weight:bold; ">OF</font>
                  </p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">SERIAL </font><font style="font-weight:bold; ">NO.</font> <font style="font-weight:bold; ">FILING</font> <font style="font-weight:bold; ">DATE</font></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">PAT. / REG. </font><font style="font-weight:bold; ">NO.</font> <font style="font-weight:bold; ">ISSUED</font> <font style="font-weight:bold; ">DATE</font></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">STATUS</font><font style="font-weight:bold; "></font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-009PC </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">PCT Application</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">In</font> <font style="font-weight:bold; ">process</font> <font style="font-weight:bold; ">to</font> <font style="font-weight:bold; ">be</font> <font style="font-weight:bold; ">prepared</font> <font style="font-weight:bold; ">and</font> <font style="font-weight:bold; "></font><font style="font-weight:bold; ">filed</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">priority deadline 07/22/2021</p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-010N </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR OPIOID USE DISORDER (OUD) AND SUBSTANCE USE DISORDER (SUD)</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">63/054,973 </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">07/22/2020</p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:11%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">NEXAL-010A </p>

               </td>

               <td style="width:43%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR OPIOID USE DISORDER (OUD) AND SUBSTANCE USE DISORDER (SUD)</p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">U.S. Non-Provisional</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; ">Nexalin Technology, Inc.</p>

               </td>

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; text-indent:18pt; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">In</font> <font style="font-weight:bold; ">process</font> <font style="font-weight:bold; ">to</font> <font style="font-weight:bold; ">be</font> <font style="font-weight:bold; ">prepared</font> <font style="font-weight:bold; ">and</font> <font style="font-weight:bold; "></font><font style="font-weight:bold; ">filed</font><font style="font-weight:bold; "></font>
                  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our legal team will file additional provisional and non-provisional patent applications and copyright protection pertaining to future Generation technology, proprietary software and trademarks. The patent claims associated with the non-provisional patent applications will be defined and prepared in the filings. The intention is to build an intellectual property portfolio asset. Future research and development projects related to advancements in neurostimulation and neuromodulation technology will be identified and investigated for future patent filings. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Patent Term and Term Extensions</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The term of individual patents depends upon the legal term for patents in the countries in which they are obtained. In most countries, including the United States, the patent term is twenty years from the earliest effective filing date of a non-provisional patent application. In the United States, a patent&#x2019;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the United States Patent and Trademark Office, or the USPTO, in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier filed patent. The term of a patent that covers a product may also be eligible for patent term extension when FDA approval is granted, provided statutory and regulatory requirements are met. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Similar provisions are available in foreign jurisdictions to extend the term of a patent that covers an approved product. In the future, if and when our products receive approval by the FDA or foreign regulatory authorities, we expect to apply for patent term extensions on issued patents covering those products, depending upon the length of the clinical trials for each product and other factors. The expiration dates referred to above are without regard to a potential patent term extension or another market exclusivity that may be available to us. However, we cannot provide any assurances that any such patent term extension of a foreign patent will be obtained and, if obtained, the duration of such extension. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our patents and patent applications are subject to procedural or legal challenges by others. We may be unable to obtain, maintain and protect the intellectual property rights necessary to conduct our business, and we may be subject to claims that we infringe or otherwise violate the intellectual property rights of others, which could materially harm our business. For more information, see the section titled &#x201C;Risk Factors&#x2014;Risks Related to Our Intellectual Property.&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Trademarks, Trade Secrets and Know-How</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our trademark portfolio currently consists of registered trademark rights for the mark NEXALIN TECHNOLOGY in the United States. In connection with the ongoing development and advancement of our products and services in the United States and various international jurisdictions, we routinely seek to create protection for our marks and enhance their value by pursuing trademarks and service marks where available and when appropriate. In addition to patents and trademark protection, we rely upon unpatented trade secrets and know-how and continuing technological innovation to develop and maintain our competitive position. We seek to protect our proprietary information, in part, by using confidentiality agreements with our commercial partners, collaborators, employees and consultants, and invention assignment agreements with our employees. These agreements are designed to protect our proprietary information and, in the case of the invention assignment agreements, to grant us ownership of technologies that are developed through a relationship with a third party. These agreements may be breached, and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our commercial partners, collaborators, employees and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Competition</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We plan to be the leader in brain-based health. We compete with traditional pharmaceutical therapies. All of these have side effects, such as drug dependency as well as adverse health risks. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We also compete with several neurostimulators at the high and low end of the market as well as implanted devices. All have either a high-risk profile or uncomfortable side effects with moderate efficacy. Our products were designed as a cost-effective option to all current reimbursed treatments available to the patient. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We believe that existing neurostimulation products are either high risk, high cost and difficult to administer. In addition, they are invasive, frequently requiring surgery and multiple visits to a physician. Since many of the conditions requiring ongoing treatments, the difficulty and cost of administering them make them of limited utility for broad application. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">55</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our researchers and developers understood that specific electrical waveforms with specific frequencies that mimicked the natural electricity in the brain was the future of the treatment of mental health issues and health issues related to the nervous system. After successful research on rabbit brains and then human subjects, a new waveform was designed that utilized the alternating current and frequency patterns that evoked a specific chemical response associated with mental health. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">To ensure the integrity of the waveform and penetration into deep mid-brain structures, the waveform needed to be undetectable to the human body. This refers to the alternating current configuration of the patented waveform. This would eliminate the major downfall with other stimulators that are limited in power because of patient discomfort associated with the treatment. A triangulating electrode system was also designed to ensure the entire brain was stimulated rather than a targeted area that may not be associated with the mental disorder. The specifics of our waveform are covered in our patents. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Pharmaceuticals</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Drug-based therapies are sometimes associated with side effects, including drug dependency and additional adverse health risks. Pharmaceuticals include SSRIs, narcotics and benzodiazepines, all of which have issues with tolerance, dependence and withdrawal. Narcotics and benzodiazepines moreover have addictive properties. All these medications also raise significant issues when long-term use builds up tolerance in the body. This tolerance then requires more of the same medication or additional medications to achieve the same effect. With each medication stacked, a new set of side effects can occur. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Numerous reviews of clinical data have exposed lower overall effectiveness than the original data first published when the medication was introduced. In fact, most popular antidepressant studies with negative outcomes have never been published. According to a study in the New England Journal of Medicine, and then reported in the New York Times, based on the published literature, it appeared that 94% of the trials conducted on antidepressant agents were positive. The study in the New England Journal of Medicine found, however, that by contrast, the FDA analysis, which included studies that were not published, showed that 51% were positive. Many studies that have negative outcomes are never published and are removed from public access. This approach to publishing only positive clinical studies and then engaging in major media marketing campaigns has contributed to a prescription medication epidemic. In addition to patients that do not respond to psychiatric medications, there is another population of patients that report that side effects overwhelm any benefits the medications may offer. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">After decades of prescription abuse by certain industry professionals, patients are now seeking alternative treatments that are effective without the serious side effects. Consumer influence and awareness, accompanied with digital technology advancements, are driving many physicians to adopt new treatment modalities like neurostimulators supported with lifestyle changes. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Antidepressants such as Prozac, Paxil, Zoloft, Celexa, Lexapro, Effexor, Pristiq, Wellbutrin and Cymbalta are probably the most studied antidepressants, but the following observations apply to most or all antidepressants: these drugs produce long-term apathy and loss of quality of life; they frequently produce a generalized loss of motivation or interest in many or all aspects of life; they frequently cause irreversible dysfunction and loss of interest in sexuality, relationship and love; withdrawal from all antidepressants can cause a wide variety of distressing and dangerous emotional reactions from depression to mania and from suicide to violence; after withdrawal from antidepressants, individuals often experience persistent and distressing mental and neurological impairments; and some people find antidepressant withdrawal to be so distressing that they cannot fully stop taking the drugs. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Benzodiazepines (benzos) or anti-anxiety drugs such as Xanax, Klonopin, Ativan, Valium, Librium, Halcion and others are nicknamed &#x201C;benzos&#x201D;. Benzos have been found to deteriorate memory and other mental capacities. Human studies demonstrate that they frequently lead to dementia after longer-term exposure. After withdrawal, individuals exposed to these drugs may also experience multiple persisting problems, including memory and cognitive dysfunction, emotional instability, anxiety, insomnia and muscular and neurological discomforts. Mostly because of severely worsened anxiety and insomnia, many cannot stop taking them and become permanently dependent. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Sleep Aids, such as Ambien, Intermezzo, Lunesta and Sonata, pose similar problems to the benzos, including memory and other mental problems, dependence and painful withdrawal. They can cause abnormal mental states and behaviors, including sleepwalking. Insufficient data is available concerning brain shrinkage and dementia, but these are likely outcomes considering their similarity to benzos. Recent studies show that these drugs increase death rate, taking away years of life, even when used intermittently for sleep. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Psychiatric medication will always be a part of the global mental health treatment model. However, more consumers are aware of the risks and issues with these medications. From a global perspective, for various reasons, other societies are not as dependent on the pharmaceutical medication model. Subsequently, consumer and physician trends now demonstrate demand for effective treatments without the risk and adverse side effects typically associated with drugs. In addition, the long-term costs associated with medication will eventually find their way into the treatment strategy of the world&#x2019;s leading economies. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Neurostimulation Technology</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Electroconvulsive Therapy</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">ECT is a medical treatment most commonly used in patients with severe major depression who have not responded to medication. The procedure is done under general anesthesia in which electric currents are passed through the brain that intentionally trigger a seizure. During the recovery phase of the induced seizure, the brain experiences a normalizing response in dysregulated areas of the brain associated with the mental disorder. Some have referred to this response as a &#x201C;reset&#x201D; in the brain. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The procedure can be effective with chronic MDD and suicidal patients. Surveys in the medical community indicate that the use of ECT remains controversial. As of 2001, it was estimated that about one million people receive ECT annually and that number will continue to escalate as major pharmaceutical companies abandon the anti-depressant market due to high research and development costs and lack of efficacy. According to published studies, the overall remission rate for patients given a round of ECT treatment was 50.9%. All literature on ECT states that most patients will still need medication. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">56</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Side effects of ECT may include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Headache or muscle ache in the hours following treatment&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Confusion shortly after treatment&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Short- or long-term memory loss&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Cognitive impairment&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The cost of ECT is estimated at $3,000 per session with eight to twelve sessions normally required. Including the costs of the procedure room, nursing staff and anesthesiologist, the average cost for a complete ECT program is $25,000. ECT is usually administered three times a week, on alternate days, over a course of two to four weeks. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">ECT is for non-responders to medication who are diagnosed with severe mental disorders. It is the only real option for patients who have failed to find relief under the medication model and are still struggling. We believe that our opportunity comes from the fact that a majority of the population that is diagnosed with one of the major mood disorders either will not respond to medication or the side effects will overwhelm the benefits of the medications. Most of these patients will not have a mental disorder that is severe enough to warrant ECT, but some have decided to proceed with ECT anyways because, until recently, it was the only alternative treatment available. This population of patients that are looking for alternatives to medication is the primary focus of our marketing strategy. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Vagus Nerve Stimulation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The vagus nerve stimulation device consists of a generator the size of a matchbox that is surgically implanted under the skin below the person&#x2019;s collarbone. Lead wires from the generator are tunnelled up to the patient&#x2019;s neck and wrapped around the left vagus nerve under the skin. When activated, the device sends electrical current along the left vagus nerve to the brainstem, which then sends signals to certain areas in the brain. Follow-up surgeries are required to replace the battery for the stimulation device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Some of the side effects and health problems associated with implanted vagus nerve stimulation devices can include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Voice changes&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Hoarseness&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Throat pain&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Cough&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Headaches&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Shortness of breath&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Difficulty swallowing&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Tingling or prickling of the skin&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Insomnia&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Worsening of sleep apnea&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The cost of vagus nerve stimulation is estimated at $25,000 including implant and surgery expenses. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Deep Brain Stimulation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Deep brain stimulation (DBS) has primarily been used for treating Parkinson&#x2019;s disease. However, DBS is now offered to treatment resistant patients with severe depression and suicidal intentions. The DBS system consists of three components: the implanted pulse generator (IPG), the lead and an extension. The lead is connected to the IPG by an extension, an insulated wire that runs below the skin, from the head, down the side of the neck. All three components are surgically implanted inside the body. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A hole about 14 mm in diameter is drilled into the skull and the probe electrode is inserted into the brain. The exact mechanism of action of DBS is not known. Its direct effect on the physiology of brain cells and neurotransmitters is currently debated, but it operates by sending high-frequency electrical impulses into specific areas of the brain. Generally, DBS is associated with 30&#x2013;60% improvement in clinical evaluations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Cost of DBS is reported to be between $50,000 and $60,000 to implant. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Transcranial Direct Current Stimulation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">tDCS is a contemporary, portable, non-invasive neurostimulator technique that delivers a low electric current to the scalp. A fixed current between 1 and 2 milliamps is typically applied. tDCS works by placing a positive (anode) and negative (cathode) current via electrodes to an area of the scalp or clips to the earlobe. The positioning of the anode and cathode electrodes is used to influence the direction of the current. The placement of these electrodes sets up a targeting system to stimulate a specific area of the brain that the clinician feels is the cause of the reported symptoms. The current delivered by tDCS is not considered strong enough to trigger an action potential in a neuron. The power of tDCS is limited in treatment due to the patient threshold of discomfort and pain are primarily due to the voltage carried in the DC current that is very uncomfortable to the patient. This limited power also makes it difficult to effectively stimulate deep areas of the mid-brain associated with trauma and various mood disorders. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">57</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Over the last ten years, several new manufacturers have attempted to improve the tDCS technology with various types of electrode placement patterns. Additionally, academic researchers have started studying tDCS in a controlled setting to catch up with the evolving neurostimulation industry. These same academic communities have developed strategies to isolate the newer tDCS technology from the hand-held plastic battery devices sold on the internet. These internet devices have created a lot of negative impressions in various professional communities. These impressions are the result of small manufacturers selling portable pocket devices they claim will treat, and sometimes cure, major mental health disorders. They have no medical or clinical supervision. A patient can buy the device and inject electricity from a battery into the skull without clinical oversight. The low efficacy is usually at the same level as the &#x201C;placebo&#x201D; response. Placebo implies that some patients will have a positive response just by having an expectation of treatment. The manufacturers of these devices often place a medical professional&#x2019;s name on their website along with the results of a private study that states the device works and is safe to help build credibility among consumers. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The costs of the hand-held plastic battery devices sold on the internet usually range from $50 to $600 each. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Transcranial Magnetic Stimulation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">TMS is indicated for the treatment of MDD in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. The FDA requires that the patients&#x2019; eligibility for TMS is based on their failure to respond to medication before they qualify for TMS. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">TMS treatment emerged in the 1990s. Over the next decade, the venture capital and private equity investment community invested over $400 million into the validation and clinical strategy of TMS. A large percentage of these investors are closely tied to the pharmaceutical industry. The TMS clearance from the FDA supports the pharmaceutical treatment model first and then allows the TMS technology to step in when the medication model fails. The evolution of the TMS technology and marketing strategy has shifted the conversation and the acceptance of non-invasive stimulation of the brain for mental health disorders. The TMS industry business model requires an expensive investment and capital risk by the prescribing physician. The investment costs are then passed on to the patient and the payer community. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The TMS technology uses strong magnetic pulse energy that is induced by electrical current in a magnetic coil. The curved magnetic coil is positioned lightly on the head in the area of the brain associated with mood disorders. During the treatment the patient will hear a clicking sound and experience a tapping sensation on the head associated with the pulsed magnetic energy distributed from the coil. TMS therapy takes twenty to forty minutes and is administered five days a week for approximately four to six weeks. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The effectiveness of TMS is subject to debate. The accepted rate of response varies from 35% to 60% depending on the structure and site of the study. The data for rTMS is robust and supports a reimbursement co-pay from the insurance companies depending on the policy and the carrier. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Some of the side effects associated with TMS can include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Fainting (rare)&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Seizure&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">General discomfort&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Pain and headaches at treatment site on scalp&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Hypomania, meaning behavior that is noticeably different from the person&#x2019;s typical behavior&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Cognitive change&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Impaired working memory&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:24pt; margin-top:0pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:42pt; margin-top:-12pt; margin-bottom:0pt; ">Hearing loss (rare)&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Neurostar rTMS device cost ranges from $90,000 to $110,000. The disposable is a small single use magnet that attaches to the magnetic coil and is priced to the physician at approximately $100 each. The cost of rTMS devices without a disposable can range from $50,000 to $300,000. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The cost to the patient ranges from $6,000 to $12,000 for a complete round of TMS treatments. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Clearly the rTMS (Neurostar and Brainsway) community is the high end of the market for several reasons outlined in this document. Because of issues related to efficacy, safety, side effects and financial investment, we believe that this therapy will occupy a specialized niche of the market. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Psychotherapy</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Psychotherapy, or talk therapy, is another treatment modality that has traditionally been used to treat certain mental health disorders. The structure and frequency of psychotherapy implemented to treat any given mental health issue varies tremendously depending on the provider, patient and circumstances of the mental health issue. Barriers to the use of psychotherapy, however, include concerns related to stigma, accessibility, efficacy and costs. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Psychedelics</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The use of psychedelics, like psilocybin, to treat certain mental health disorders is emerging as a new treatment modality in this field. However, barriers to such therapeutic drug use include concerns related to stigma, efficacy, safety and regulatory complexities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">58</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Government Regulation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Government authorities in the United States, at the federal, state and local level, and other countries extensively regulate, among other things, the research, development, testing, manufacture, quality control, approval, labeling, packaging, storage, recordkeeping, promotion, advertising, distribution, marketing and export and import of products such as those that we have developed and are developing. The FDA previously regulated our Gen-1 device as a medical device through a 501(k) clearance, however, our Gen-2 device will require a PMA. We will work with FDA to update our 501(k) application and obtain a PMA, as needed. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We may also be subject to United States federal, state and local laws and regulations designed to prevent healthcare fraud and abuse, protect privacy, the environment and our domestic technology from unintended foreign exploitation and regulate certain business practices. We believe that our policies, practices and procedures are properly designed to prevent unreasonable risk related to these areas and consequential financial liability. Our operations may also be subject to various regulations under federal laws regarding the international transfer of technology, as well as to various federal and state laws related to business operations. In addition, we may be subject to federal contracting procedures, audit and oversight. Compliance with all of these laws, regulations and requirements has not had, and we believe will not have in the future, material effects on our capital expenditures, earnings or competitive position. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Medical Device Regulation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Medical devices commercially distributed in the United States require either FDA clearance of a 510(k) premarket notification submission, granting of a de novo request or PMA, unless an exemption exists. Under the FFDCA, as administered by the FDA, medical devices are classified into one of three classes&#x2014;Class I, Class II or Class III&#x2014;depending on the degree of risk associated with each medical device and the extent of manufacturer and regulatory control needed to ensure its safety and effectiveness. Regulatory control increases from Class I to Class III. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Relevantly, Class II devices are moderate risk devices and are subject to the FDA&#x2019;s general controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. Such special controls can include performance standards, post-market surveillance, patient registries and FDA guidance documents. Most manufacturers of Class II devices are required to submit to the FDA a premarket notification under Section 510(k) of the FFDCA requesting permission to commercially distribute the device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Class III devices are deemed the highest risk devices by the FDA and generally include life-sustaining, life-supporting or some implantable devices or devices that have a new intended use or use advanced technology that is not substantially equivalent to that of a legally marketed device. Class III devices require a PMA. For a device that is Class III by default (because it is a novel device that was not previously classified and has no predicate), the manufacturer may request that the FDA reclassify the device into Class II or Class I via a de novo request. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">To obtain 510(k) clearance, a premarket notification submission must be submitted to the FDA demonstrating that the proposed device is substantially equivalent to a predicate device. A predicate device is a legally marketed device that is not subject to premarket approval, i.e., a device that was legally marketed prior to May 28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been reclassified from Class III to Class II or I (e.g., via the de novo classification process), or a device that was previously cleared through the 510(k) process. The FDA&#x2019;s 510(k) review process usually takes from three to six months but can take longer. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">After a device receives 510(k) marketing clearance, any modification that could significantly affect its safety or effectiveness or that would constitute a major change or modification in its intended use, will require a new 510(k) marketing clearance or, depending on the modification, a de novo request or PMA approval. The FDA requires each manufacturer to determine whether the proposed change requires submission of a 510(k), de novo, or a PMA in the first instance. If the FDA disagrees with a manufacturer&#x2019;s determination, the FDA can require the manufacturer to cease marketing and/or request the recall of the modified device until FDA has cleared or approved a 510(k), de novo or PMA for the modification. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The PMA process is more demanding than the 510(k) premarket notification process. In a PMA, the manufacturer must demonstrate that the device is safe and effective, and the PMA must be supported by extensive data, including data from preclinical studies and human clinical trials. The PMA must also contain, among other things, a full description of the device and its components, a full description of the methods, facilities and controls used for manufacturing and proposed labeling. Following receipt of a PMA submission, the FDA determines whether the application is sufficiently complete to permit a substantive review. If the FDA accepts the application for review, it has 180 days under the FDCA to complete its review of a PMA, although in practice, the FDA&#x2019;s review often takes significantly longer, and can take up to several years. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The FDA will approve the new device for commercial distribution if it determines that the data and information in the PMA application constitute valid scientific evidence and that there is reasonable assurance that the device is safe and effective for its intended use(s). The FDA may approve a PMA application with post-approval conditions intended to ensure the safety and effectiveness of the device, including, among other things, restrictions on labeling, promotion, sale and distribution, and collection of long-term follow-up data from patients in the clinical study that supported PMA approval or requirements to conduct additional clinical studies post-approval. The FDA may condition PMA approval on some form of post-market surveillance when deemed necessary to protect the public health or to provide additional safety and efficacy data for the device in a larger population or for a longer period of use. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Like in the context of 501(k) clearances, certain changes to an approved device, such as changes in manufacturing facilities, methods or quality control procedures, or changes in the design performance specifications, which affect the safety or effectiveness of the device, require submission of a PMA supplement. PMA supplements often require submission of the same type of information as a PMA, except that the supplement is limited to information needed to support any changes from the device covered by the original PMA and may not require as extensive clinical data or the convening of an advisory panel. Certain other changes to an approved device require the submission of a new PMA, such as when the design change causes a different intended use, mode of operation and technical basis of operation, or when the design change is so significant that a new Generation of the device will be developed, and the data that were submitted with the original PMA are not applicable for the change in demonstrating a reasonable assurance of safety and effectiveness. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">59</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Clinical trials are almost always required to support a PMA and are sometimes required to support a 510(k) submission. All clinical evaluations of investigational devices to determine safety and effectiveness must be conducted, unless exempt, in accordance with the FDA&#x2019;s investigational device exemption (IDE) regulations. If the device presents a significant risk to human health, as defined by the FDA, the FDA requires the device sponsor to submit an IDE application to the FDA, which must become effective prior to commencing human clinical trials. A significant risk device is one that presents a potential for serious risk to the health, safety or welfare of a patient and either is implanted, used in supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating disease or otherwise preventing impairment of human health or otherwise presents a potential for serious risk to a subject. Clinical trials must further comply with the FDA&#x2019;s good clinical practice regulations for institutional review board approval and for informed consent and other human subject protections </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">After a device is cleared or approved for marketing, numerous and pervasive regulatory requirements continue to apply. Relatedly, the FDA has broad regulatory compliance and enforcement powers. If the FDA determines that we failed to comply with applicable regulatory requirements, it can take a variety of compliance or enforcement actions. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Other Healthcare Laws</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Medical device developers are often subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct their business. Such laws include, without limitation, United States federal anti-kickback, fraud and abuse, false claims, civil monetary penalties, consumer fraud, pricing reporting, data privacy and security and transparency laws and regulations as well as similar foreign laws in the jurisdictions outside the United States. Similar state and local laws and regulations may also restrict business practices in the medical device industry, such as: state anti-kickback and false claims laws, which may apply to business practices, including but not limited to, research, distribution, sales and marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers, or by patients themselves&#x37E; state laws that restrict payments that may be made to healthcare providers and other potential referral sources&#x37E; state and local laws which require tracking gifts and other remuneration and items of value provided to physicians, other healthcare providers and entities or that require the registration of medical device sales representatives&#x37E; state and local laws that require the registration of medical device sales representatives&#x37E; and state and local laws governing the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not pre-empted by HIPAA, thus complicating compliance efforts. Violation of any of such laws or any other governmental regulations that apply may result in penalties, including, without limitation, significant administrative, civil and criminal penalties, damages, fines, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, the curtailment or restructuring of operations, exclusion from participation in governmental healthcare programs and imprisonment. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Healthcare Reform Efforts</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The United States is considering, and has recently enacted, several legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to sell our products profitably. Among policymakers, providers, payors and consumers in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, promoting value-based care and coordination, improving quality and expanding access. Current and future legislative proposals to further reform healthcare or reduce healthcare costs may change potential coverage of or alter possible reimbursement for the services and treatments associated with the use of our products. The cost containment measures that payors and providers are instituting and the effect of any healthcare reform initiative implemented in the future could impact our revenue from the sale of our products. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Historically, for example, the implementation of the ACA changed healthcare financing and delivery by both governmental and private insurers substantially and affected medical device manufacturers significantly. The ACA imposed, among other things, a 2.3% federal excise tax, with limited exceptions, on any entity that manufactured or imported Class I, II and III medical devices offered for sale in the United States that began on January 1, 2013. Through a series of legislative amendments, the tax was suspended for 2016 through 2019 and ultimately repealed. As a result of the repeal and the prior moratorium, sales of taxable medical devices after December 31, 2015 are not subject to the tax. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Other legislative changes that have been proposed and adopted since the ACA was enacted have, among other things, included reductions to CMS payments to providers and impacted healthcare financing generally. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Chinese Laws and Regulations</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">To market and sell our products in China and any other jurisdictions, we must obtain separate marketing approvals and comply with numerous and varying regulatory requirements, such as the NMPA which is responsible for the registration of medical devices for the Chinese market. Under the NMPA, depending on the risk classification of our products, product tests and/or clinical trials may be required for approval. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Our Team</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our team is critical to helping us achieve our goal of designing and developing innovative, safe and effective, neurostimulation products to treat patients suffering from various mental health disorders. Our informal human capital policies are structured to identify, recruit, retain and incentivize our existing and new employees. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We currently have approximately four employees, three of whom are members of our leadership team. Three of our employees are engaged in research and development activities and one is focused on sales and marketing. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">None of our employees are represented by a labor union or covered by a collective bargaining agreement. We consider our relationship with our employees to be good. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have historically utilized contractors to perform many of our services. Through this process, we have reduced our burn rate by 75% over the last three years and have attracted highly quality professionals. Currently, we utilize six to ten paid professional consultants in various areas related to regulatory, engineering, legal, financial and other miscellaneous tasks necessary to run our business on day-to-day basis and to facilitate the development of new products. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">60</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Our Facilities</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our principle executive office is located at 1776 Yorktown, Suite 550, Houston, Texas 77056. We lease this office space under an operating lease, and our rent expense totalled approximately $50,000 in 2020. Management and supporting staff are hosted at this location. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We do not own or operate manufacturing facilities for the production of any of our products, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We currently rely on a limited number of third-party contract manufacturers for all our required manufacturing. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We believe our current premises are sufficient for our needs at this time. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Legal Proceedings</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There are no material pending legal proceedings in which the Company or any of its subsidiaries is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of its voting securities, or security holder is a party adverse to us or has a material interest adverse to the Company other than the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Sarah Veltz v. Nexalin Technology, Inc. et al.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Plaintiff, Sarah Veltz, filed a lawsuit in this matter on January 20, 2021 in Orange County Superior Court (Case No. 30-2021-01180164-CU-WT-CJC) (the &#x201C;Complaint&#x201D;) naming the Company and others as defendants. In her Complaint, Plaintiff contends that she was employed by defendants, including Nexalin, and has not been paid all wages, including overtime wages and other benefits allegedly due her. Plaintiff also contends that, during her employment, she was subjected to sexual harassment by the Company&#x2019;s then Chief Executive Officer. Plaintiff seeks both compensatory and punitive damages. On March 12, 2021, the Company filed its answer to the Complaint. The court has set a jury trial in this matter for April 24, 2023. Management&#x2019;s intent is to contest the allegations vigorously and, as of the date of this report, is unable to provide an evaluation of the potential outcome of the litigation within the probable or remote range or to provide an estimate of the amount of or a range of potential loss that might be incurred by the Company. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Employment Development Department</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Additionally, we are currently engaged in settlement discussions with the Employment Development Department (EDD) of the state of California. This matter involves issues related to our previous management&#x2019;s classification of certain work provided to or on behalf of our business as contract labor instead of employee labor. The EDD has subpoenaed six years&#x2019; worth of information from us and currently is considering levying a $286,000 tax charge against us. We have petitioned for reassessment and believe the hired workers at issue were indeed actual contractors and not employees. All our business in California has been closed and moved out of the state. A settlement with EDD is anticipated within twenty-four months. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e10895_anchor"><font style="font-weight:bold; ">MANAGEMENT</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Directors and Executive Officers</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table sets forth the name, age as of June 30, 2021, and position of the individuals who currently serve as our directors and executive officers. The following also includes certain information regarding the individual experience, qualifications, attributes and skills of our directors and executive officers as well as brief statements of those aspects of our directors&#x2019; backgrounds that led us to conclude that they are qualified to serve as directors. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">








            <tr class="odd" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Name</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Age</font>
                  </p>

               </td>

               <td style="width:2%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Position</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Executive Officers:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Mark White<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">President, Chief Executive Officer, Director </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">David Owens, M.D.<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Chief Medical Officer, Director </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;]<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Chief Financial Officer </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Non-Employee Directors:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Rick Morad<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Director </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Alan Kazden<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Director </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Ben Hu, M.D.<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Director </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Executive Officers</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Mark White, President and Chief Executive Officer, Board of Directors</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Mr. Mark White has been with Nexalin since 2012, first as an independent consultant from 2012 to 2018, and then as President and Chief Executive Officer from 2018 to present. Mr. White is a versatile health technology executive with over twenty-five years in leadership roles spanning medical device development, clinical operations and business development. Prior to joining Nexalin, he owned and operated his own clinics and addiction centers, where he has saw first-hand the positive results the technology achieves. Early in his career, Mr. White spent several years building companies and recruiting successful management teams to accelerate growth across several industries. Mr. White attended the University of Houston. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">61</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">David Owens M.D., Chief Medical Officer, Board of Directors</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. David Owens has been with Nexalin since 2017 when he was named Chief Medical Officer of the company. Dr. Owens has been involved in numerous medical and software ventures over the past decade. Prior to joining Nexalin, he served with Empiric Systems, LLC, a software company specializing in radiology information systems and PACS viewing systems. He received a degree in chemistry and physics from Furman University and later a M.D from the Medical University of South Carolina in Charleston. He completed his residency and fellowship at Emory University Hospital in Neuroradiology and Interventional Neuroradiology. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">[&#x2022;]<font style="text-decoration:underline #000000; font-style:italic; ">, Chief Financial Officer</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">[&#x2022;] </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Non-Employee Directors</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Rick Morad, Chairman of the Board</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Rick Morad is a founding investor and shareholder in Nexalin. He has served on our board of directors since 2018. Mr. Morad has been a successful business operator since 1987. Mr. Morad is also a licensed attorney. Mr. Morad received a B.S/B.A. in business administration, with a major in Finance and a minor in Accounting, from John Carroll University. He also received a J.D., and graduated with high honors, from John Marshall Law School. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Alan Kazden</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Mr. Alan Kazden was an original investor in Nexalin and has served as a Director since 2019. Mr. Kazden has over 30 years of diverse experience consulting with emerging growth companies in strategic business planning, partnering, raising capital, and acting as a virtual CFO. Prior to joining Nexalin, Mr. Kazden worked in various industries such as technology, manufacturing &amp; distribution, real estate, health care, entertainment, and emerging growth companies. He also previously served as a consultant to the Mayor&#x2019;s Office and Los Angeles City Council on local tax issues. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Ben V. Hu M.D.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. Ben V. Hu is a founding investor and shareholder in Nexalin Technology. Dr. Hu is currently in private practice in Ohio, focusing on Ophthalmology. Since 2018, he has advised the Nexalin executive team on market development strategies and clinical trial structures to support marketing and distribution at a global level. Dr. Hu is also an advisor and member of the Board of Directors to Med-logics Inc. a company developing a surgical technology for cataract surgery utilizing a new patented technology. Dr Hu was awarded his Doctor of Medicine in 1983 from Case Western University and his Chemical Engineering degree from MIT School of Chemical Engineering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Medical Board and Advisors</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our Medical Board advises our management team in planning, development and execution of scientific, clinical and research and development initiatives and strategies. Our Medical consists of experts across a range of key disciplines relevant to our initiatives. Each Medical Board member has entered into an agreement with us that includes confidentiality, non-disclosure and intellectual property terms, and receives modest compensation for services. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have entered into agreements with each member of the Medical Board, which set forth the terms and conditions relating to the individual&#x2019;s service on the Medical Board. The agreements outline each member&#x2019;s responsibilities to the Medical Board, which include providing the Company with guidance and scientific advice on matters before the Medical Board, assisting the Company in establishing strategic relationships with leading physicians, scientists and medical institutions, attending meetings and more. The agreements establish base compensation, either on a per meeting or hourly rate, up to a maximum cap per year, not including reimbursement for expenses incurred. They also include confidentiality and protection of Company intellectual property, and indemnification protection. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our current advisors are: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">David Owens, M.D., Chief Medical Officer</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Please see Dr. David Owens&#x2019; biography under &#x201C;Executive Officers&#x201D; above. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Abe Scheer, M.D.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. Abraham Scheer specializes in psychiatry. Dr. Scheer has over thirty-nine years of experience in the field of psychiatry. Dr. Scheer has lectured extensively throughout the United States on neuromodulation devices. Dr. Scheer was part of the Speakers&#x2019; Bureau for both Medtronic&#x2019;s Neuromodulating Division and Cyberonics Neuromodulator Division. His clinical expertise includes, Adult and Child Neurology, Brain Injury Medicine and Adult and Child Psychiatry. Dr. Scheer has trained and worked at the finest medical institutions in the United States, which include Columbia University College of Physicians and Surgeons, Cornell Medical College, University of Connecticut and the University of Pittsburgh. Dr. Scheer currently is Director of Neurology and Stroke Services for Beebe Healthcare in Delaware. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">62</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Irene Cergnul, M.D.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. Irene Cergnul completed her postgraduate training at Bronx Lebanon Hospital Center in New York and after her final year as Chief Resident was recruited as Assistant Professor/Faculty in the Depart of Family Medicine. She worked as the Medical Director in the in-patient service and taught residents in training for the next four years. She was a Research Coordinator involving multiple studies on HIV, depression, as well as neuropathy, and is a co-author on several publications. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. Cergnul has been involved in the field of addiction medicine, HIV care and mental health for the last seventeen years. She is committed to developing and integrating current and new modalities in the treatment of addictive disorders and has dedicated her working career to treating the underserved population in NY and NJ. Her private practice focuses on novel modalities used in treating addiction and dual diagnosis patients and has successfully incorporated Nexalin as an integral part of her treatment armamentarium. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-style:italic; ">Nancy White, Ph.D.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. Nancy White is the Clinical Director of Unique Mind Care in Houston, Texas. She is recognized as an industry leader in the development of a brain-based approach to support neurobehavioral wellness. Dr. White has specialized in the diagnosis and treatment of functional brain disorders for more than twenty years. She is a Fellow, past President and Board member of the International Society for Neurofeedback and Research (ISNR), a Certified EEG Fellow of the Biofeedback Certification International Alliance (BCN) and a QEEG Diplomate and member of the Quantitative EEG Certification Board. Dr. White is a licensed Clinical Psychologist in the State of Texas as well as an Advanced Addictions Counselor. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. White is a pioneer in the practical application of neuroscientific research to clinical practice, including the extension of advanced brain-based therapies to all psychiatric mood disorders including Post-Traumatic Stress, Autism and Addictions. She is a frequent presenter of her work at conferences, including the American Academy of Anti-Aging Medicine, the International Society for Neurofeedback and Research, the Association for Applied Psychophysiology and Biofeedback, Future Health and the National Academy of Neuropsychology. She also serves as a consulting editor of the Journal of Neurotherapy (Taylor and Francis). </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dr. White has dedicated seven years to the development of the clinical application of the Nexalin therapy. Her research and clinical data on the use of Nexalin therapy has been presented at international conferences. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Family Relationships</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There are no family relationships among any of our directors or executive officers. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Board Composition</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our board of directors currently consists of five members. There are no contractual obligations regarding the election of our directors. Our nominating and corporate governance committee and our board of directors may therefore consider a broad range of factors relating to the qualifications and background of nominees. Our nominating and corporate governance committee&#x2019;s and our board of directors&#x2019; priority in selecting board members is identification of persons who will further the interests of our stockholders through their established record of professional accomplishment, the ability to contribute positively to the collaborative culture among board members, knowledge of our business, understanding of the competitive landscape, professional and personal experiences and expertise relevant to our growth strategy. Our directors hold office until their successors have been elected and qualified or until the earlier of their resignation or removal. [Our amended and restated certificate of incorporation and amended and restated bylaws that will become effective immediately prior to the closing of this offering also provide that our directors may be removed only for cause by the affirmative vote of the holders of at least two-thirds of the votes that all our stockholders would be entitled to cast in an annual election of directors, and that any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office.] </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Director Independence</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our board of directors has undertaken a review of its composition, the composition of its committees and the independence of each director. Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, our board of directors has determined that all of our directors other than Mark White and Dr. Owens have no relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is &#x201C;independent&#x201D; as that term is defined under the applicable rules and regulations of the SEC and Nasdaq. In making this determination, our board of directors considered the current and prior relationships that each non-employee director has with our company and all other facts and circumstances our board of directors deemed relevant in determining his or her independence, including the beneficial ownership of our share capital held by each non-employee director. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Committees of the Board of Directors</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our board of directors has established an audit committee, a compensation committee and a nominating and corporate governance committee, each of which will have the composition and responsibilities described below upon completion of this offering. From time to time, the board may establish other committees to facilitate the oversight of our business. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">63</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Audit Committee</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Effective upon completion of this offering, our audit committee will be composed of three directors, [&#x2022;], and our board of directors has determined that each of them is independent within the meaning of applicable Nasdaq listing requirements and the independence requirements contemplated by Rule 10A-3 under the Securities Exchange Act of 1934, as amended, or the Exchange Act. [&#x2022;] is the chairman of the audit committee and our board of directors has determined that [&#x2022;] is an &#x201C;audit committee financial expert&#x201D; as defined by SEC rules and regulations. Our board of directors has determined that the composition of our audit committee meets the criteria for independence under, and the functioning of our audit committee complies with, the applicable requirements of the Sarbanes-Oxley Act, applicable Nasdaq listing requirements and SEC rules and regulations. We intend to continue to evaluate the requirements applicable to us and we intend to comply with the future requirements to the extent that they become applicable to our audit committee. The principal duties and responsibilities of our audit committee include: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">appointing and retaining an independent registered public accounting firm to serve as independent auditor to audit our financial statements, overseeing the independent auditor&#x2019;s work and determining the independent auditor&#x2019;s compensation;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">approving in advance all audit services and non-audit services to be provided to us by our independent auditor;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls, auditing or compliance matters, as well as for the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">reviewing and discussing with management and our independent auditor the results of the annual audit and the independent auditor&#x2019;s review of our quarterly financial statements;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">conferring with management and our independent auditor about the scope, adequacy and effectiveness of our internal accounting controls, the objectivity of our financial reporting and our accounting policies and practices; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transactions.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Compensation Committee</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Effective upon completion of this offering, our compensation committee will be composed of three directors, [&#x2022;], each of whom is a non-employee member of our board of directors as defined in Rule 16b-3 under the Exchange Act. [&#x2022;] is the chairman of the compensation committee. Our board of directors has determined that the composition of our compensation committee satisfies the applicable independence requirements under, and the functioning of our compensation committee complies with the applicable requirements of, Nasdaq listing rules and SEC rules and regulations. We intend to continue to evaluate and intend to comply with all future requirements applicable to our compensation committee. The principal duties and responsibilities of our compensation committee include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">establishing and approving, and making recommendations to the board of directors regarding, performance goals and objectives relevant to the compensation of our chief executive officer, evaluating the performance of our chief executive officer in light of those goals and objectives and setting, or recommending to the full board of directors for approval, the chief executive officer&#x2019;s compensation, including incentive-based and equity-based compensation, based on that evaluation;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">setting the compensation of our other executive officers, based in part on recommendations of the chief executive officer;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">exercising administrative authority under our stock plans and employee benefit plans;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">establishing policies and making recommendations to our board of directors regarding director compensation;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">reviewing and discussing with management the compensation discussion and analysis that we may be required from time to time to include in SEC filings; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">preparing a compensation committee report on executive compensation as may be required from time to time to be included in our annual proxy statements or annual reports on Form 10-K filed with the SEC.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Nominating and Corporate Governance Committee</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Effective upon completion of this offering, the nominating and corporate governance committee will be composed of three directors, [&#x2022;]. [&#x2022;] is the chairman of the nominating and corporate governance committee. Our board of directors has determined that the composition of our nominating and corporate governance committee satisfies the applicable independence requirements under, and the functioning of our nominating and corporate governance committee complies with the applicable requirements of, Nasdaq listing standards and SEC rules and regulations. We will continue to evaluate and will comply with all future requirements applicable to our nominating and corporate governance committee. The nominating and corporate governance committee&apos;s responsibilities include: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">assessing the need for new directors and identifying individuals qualified to become directors;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">recommending to the board of directors the persons to be nominated for election as directors and to each of the board&apos;s committees;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">assessing individual director performance, participation and qualifications;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">developing and recommending to the board corporate governance principles;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">monitoring the effectiveness of the board and the quality of the relationship between management and the board; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">overseeing an annual evaluation of the board&#x2019;s performance.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">64</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Board Leadership Structure</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our board has determined that upon completion of this offering our corporate governance guidelines will provide that, if the chairman of the board is a member of management or does not otherwise qualify as independent, the independent directors of the board may elect a lead director. The lead director&#x2019;s responsibilities would include, but would not be not limited to: presiding over all meetings of the board of directors at which the chairman is not present, including any executive sessions of the independent directors; approving board meeting schedules and agendas; and acting as the liaison between the independent directors and the chief executive officer and chairman of the board. Our corporate governance guidelines will further provide the flexibility for our board of directors to modify our leadership structure in the future as it deems appropriate. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Role of the Board in Risk Oversight</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">One of the key functions of our board of directors is informed oversight of our risk management process. Our board of directors will not have a standing risk management committee, but will rather administer this oversight function directly through our board of directors as a whole, as well as through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure and our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. Our audit committee will also monitor compliance with legal and regulatory requirements. Our nominating and corporate governance committee will monitor the effectiveness of our corporate governance practices, including whether they are successful in preventing illegal or improper liability-creating conduct. Our compensation committee will assess and monitor whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. While each committee will be responsible for evaluating certain risks and overseeing the management of such risks, our entire board of directors will be regularly informed through committee reports about such risks. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Code of Business Conduct and Ethics for Employees, Executive Officers and Directors</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Effective upon completion of this offering, we will adopt a Code of Business Conduct and Ethics, or the code of conduct, applicable to all our employees, executive officers and directors. Following the completion of this offering, the code of conduct will be available on our website at <font style="font-style:italic; ">www.nexalin.com</font>. The nominating and corporate governance committee of our board of directors will be responsible for overseeing the code of conduct and must approve any waivers of the code of conduct for employees, executive officers and directors. We expect that any amendments to the code of conduct, or any waivers of its requirements for any executive officer or director, will be disclosed on our website.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Compensation Committee Interlocks and Insider Participation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">None of our directors who currently serve as members of our compensation committee is or has at any time during the past year been, one of our officers or employees. None of our executive officers currently serves, or in the past year has served, as a member of the board of directors or compensation committee of any other entity that has one or more of its executive officers serving on our board of directors or compensation committee. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Limitation on Liability and Indemnification Matters</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our amended and restated certificate of incorporation, which will become effective immediately after the completion of this offering, and our amended and restated bylaws, which will become effective immediately prior to the completion of this offering, limits our directors&#x2019; liability, and may indemnify our directors and officers to the fullest extent permitted under Delaware General Corporation Law, or the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability for any: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">transaction from which the director derives an improper personal benefit;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">unlawful payment of dividends or redemption of shares; or&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">breach of a director&#x2019;s duty of loyalty to the corporation or its stockholders.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">These limitations of liability do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive relief or recession. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The DGCL and our amended and restated bylaws provide that we will, in certain situations, indemnify our directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment or reimbursement of reasonable expenses (including attorneys&#x2019; fees and disbursements) in advance of the final disposition of the proceeding. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">65</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, we have entered or will enter into indemnification agreements with our directors and officers. These indemnification agreements, among other things, require us to indemnify our directors and officers for certain expenses, including attorneys&#x2019; fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as a director or officer, or any other company or enterprise to which the person provides services at our request. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We also maintain a directors&#x2019; and officers&#x2019; insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors and officers. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We believe that these provisions in our amended and restated certificate of incorporation and amended and restated bylaws, these indemnification agreements and this insurance are necessary to attract and retain qualified persons as directors and officers. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Insofar as indemnification of liabilities arising under the Securities Act of 1933, as amended, or the Securities Act, may be permitted to our board of directors, executive officers or persons controlling us pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Board of Advisors. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Nexalin has also established a Board of Advisors. The members of the Board of Advisors serve at the request of the Board and advise and make recommendations with respect to the strategic direction of the company and similar matters. The members of the Board of Advisors do not have, or shall be deemed to have, a fiduciary relationship in respect of the company. The members of the Board of Advisors are set forth below. We have entered into agreements with each member of the Board of Advisors, which set forth the terms and conditions relating to the individual&#x2019;s service on the Board of Advisors. The agreements establish base compensation and also include confidentiality and protection of Company intellectual property, and indemnification protection.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Tucker Anderson</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Tucker Andersen spent twenty-seven years with the private investment partnership Cumberland Associates, including fifteen years as a co-managing partner of the firm. Subsequent to his retirement from that position, he founded Above All Advisors, a consulting and investment firm. He is on several advisory and private company boards, including, Questech Corporation, Value Insight Partners, and Artificial Cell Technologies. He received his B.A. in Quantitative Studies from Wesleyan University in 1963. Tucker is the recipient of both the Wesleyan Distinguished Alumnus Award and the Exeter Founder&apos;s Day Award. He is both a Chartered Financial Analyst and an Associate Member of the Society of Actuaries.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Leonard Osser</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Leonard Osser has been a Director of Milestone Scientific since December 2017. He served as Milestone Scientific&#x2019;s Chairman from 1991 until September 2009, and during that time, from 1991 until 2007, was also Chief Executive Officer of Milestone Scientific. In September 2009, he resigned as Chairman of Milestone Scientific, but remained director, and assumed the position of Chief Executive Officer.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Gian Domenic Trombetta</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Gian Domenico Trombetta has been the President and CEO of Innovest S.p.A. an Italian corporation specializing in private equity and distressed assets since 1992. He was previously with Booz Allen &amp; Hamilton Inc. focusing on strategy and acquisition services. Mr. Trombetta received B.A, from Luiss University in Rome in 1984.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">66</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e11508_anchor"><font style="font-weight:bold; ">EXECUTIVE AND DIRECTOR COMPENSATION</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our named executive officers for the year ended December 31, 2020, which consist of our principal executive officer and our other most highly compensated executive officers, are: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">Mark White, our President and Chief Executive Officer;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">David Owens, M.D., our Chief Medical Officer; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">[&#x2022;], our Chief Financial Officer.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Summary Compensation Table</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table presents the compensation awarded to, earned by, or paid to our named executive officers, during the years ended December 31, 2019 and 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:30%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Name and</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Principal</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Position</font>
                  </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year</font>
                  </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Salary ($)</font>
                  </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">All Other</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Compensation</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">($)</font>
                  </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total ($)</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Mark White, CEO<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2019 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">149,375 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">149,375 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2020 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">159,375 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">159,375 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">David Owens, M.D., CMO<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2019 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">197,118 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">197,118 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2020 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;], CFO<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2019 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2020 </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; ">





            <tr class="odd" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x200B;<sup>(1)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:95%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Represents the fair value of 788,471 shares of the Company&#x2019;s common stock valued at $0.25. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Narrative to Summary Compensation Table</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We review compensation annually for all employees, including our executives. In setting executive base salaries and bonuses and granting equity incentive awards, we consider compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders and a long-term commitment to our company. In addition, we have also engaged compensation consultants and take into consideration their assessments of our compensation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The compensation committee of our board of directors has historically reviewed and made recommendations to our board of directors regarding our executives&#x2019; compensation. Our compensation committee typically reviews and discusses management&#x2019;s proposed compensation with the chief executive officer for all executives other than the chief executive officer. Based on those discussions and its discretion, the compensation committee then recommends the compensation for each executive officer for approval by our board of directors. To date, our compensation committee has not adopted a peer group of companies for purposes of determining executive compensation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On February 15, 2021, the Company entered into an employment agreement with Mark White to serve as Chief Executive Officer of the Company for a three-year term. Pursuant to the agreement, Mr. White is entitled to receive $200,000 in annual compensation and is eligible to receive up to $200,000 in cash and stock-based compensation upon achieving certain performance metrics. Additionally, on February 15, 2021, pursuant to the agreement, the Company issued shares of the Company&#x2019;s common stock in an amount representing two (2%) percent of the Company&#x2019;s issued and outstanding shares as of the effective date of the agreement, or 1,616,526 shares of the Company&#x2019;s common stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On February 15, 2021, the Company entered into an employment agreement with David Owens, M.D. to serve as Chief Medical Officer of the Company for a three-year term. Pursuant to the agreement, Dr. Owens is entitled to receive $150,000 in annual compensation that is payable to him by the issuance of Company common stock and he is eligible to receive bonus compensation based upon achieving certain performance metrics. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Annual Base Salary</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Base salaries for our executives are initially established through arm&#x2019;s length negotiation at the time the executive is hired, taking into account such executive&#x2019;s qualifications, experience, prior salary, the scope of his or her responsibilities and competitive market compensation paid by other companies for similar positions within the industry. Base salaries are reviewed annually in January by our compensation committee and approved by our board of directors in connection with our annual performance review process. Salaries may be adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance and experience. In making decisions regarding salary increases, we may also confer with a compensation consultant or draw upon the experience of members of our board of directors with other companies. Any approved salary increases are typically effective in May of the same year. The 2019 and 2020 base salaries of our named executive officers are as follows: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:29%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Name</font>
                  </p>

               </td>

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019 </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Base </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Salaries</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:18%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020 </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Base </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Salaries</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; background-color:#CCEEFF; ">

               <td style="width:29%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Mark White<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:14%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">149,375 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:14%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">159,375 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:29%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">David Owens, M.D.<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:14%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:14%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:29%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;]<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:35%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:14%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:4%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:14%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">67</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Health and Welfare Benefits</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All of our current named executive officers are eligible to participate in our employee benefit plans, including our medical, dental and vision insurance plans, in each case on the same basis as all of our other employees. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">401(k) Plan</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We maintain a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees may defer eligible compensation on a pre-tax basis, up to the statutorily prescribed annual limits on contributions under the Internal Revenue Code of 1986, as amended, or the Code. Contributions are allocated to each participant&#x2019;s individual account and are then invested in selected investment alternatives according to the participants&#x2019; directions. Employees are immediately and fully vested in their contributions. The 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan&#x2019;s related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. Pursuant to our 401(k) plan, during 2016 and 2019, we made 50% matching contributions on up to 6% of an employee&#x2019;s eligible compensation. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Director Compensation Table</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">None of our non-employee directors received compensation for service on our board of directors during the during the years ended December 31, 2019 and 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Non-Employee Director Compensation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have not historically had a formal compensation policy with respect to service on our board of directors, but we have reimbursed our non-employee directors for direct expenses incurred in connection with attending meetings of our board of directors or its committees, and occasionally granted stock options. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In addition, under our non-employee director compensation policy, each non-employee director elected to our board of directors after the completion of this offering will receive shares of our common stock equal to $35,000 per annum. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This policy is intended to provide a total compensation package that enables us to attract and retain qualified and experienced individuals to serve as directors and to align our directors&#x2019; interests with those of our stockholders. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Rule 10b5-1 Sales Plans</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our directors and executive officers may adopt written plans, known as Rule 10b5-1 plans, in which they will contract with a broker to buy or sell shares of our common stock on a periodic basis. Under a Rule 10b5-1 plan, a broker executes trades pursuant to parameters established by the director or officer when entering into the plan, without further direction from them. The director or officer may amend a Rule 10b5-1 plan in some circumstances and may terminate a plan at any time. Our directors and executive officers also may buy or sell additional shares outside of a Rule 10b5-1 plan when they are not in possession of material non-public information subject to compliance with the terms of our insider trading policy. Prior to 180 days after the date of this offering, subject to early termination, the sale of any shares under such plan would be prohibited by the lock-up agreement that the director or officer has entered into with the underwriters for this offering. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">68</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e12000_anchor"><font style="font-weight:bold; ">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following is a description of transactions since our inception to which we have been a participant in which the amount involved exceeded or will exceed $120,000, and in which any of our directors, executive officers or holders of more than 5% of our share capital, or any members of their immediate family, had or will have a direct or indirect material interest, other than compensation arrangements which are described under the section titled &#x201C;Executive and Director Compensation.&#x201D; Pursuant to our corporate reorganization, all shares issued in connection with the transactions discussed below have been exchanged for the same number and classes of newly issued shares of common stock of Nexalin. See &#x201C;Corporate Reorganization.&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Joint Venture</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In September 2018, we entered into an agreement with Wider, pursuant to which we and Wider shall form the Joint Venture. Wider has an experienced medical technology team in China and when formed, the Joint Venture will design and implement a comprehensive business model and distribution plan for our devices in China, Hong Kong, Macau and Taiwan. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The first phase of distribution in China includes a sales strategy for mainland China and other territories serviced by Wider. Treatment clearance by the China National Medical Products Administration (NMPA), the equivalent of the United States FDA, for the 15 milliamps power parameters was granted on August 13, 2021 for the treatment of primary insomnia and moderate to severe depression in China. In March 2021, in anticipation of NMPA approval and the formation of the Joint Venture, Wider, through a wholly owned subsidiary, executed a $5 million purchase order for 1,000 devices from us. Further, also in March 2021 in anticipation of NMPA approval, Wider executed a purchase agreement with us for the purchase of 50 devices, which are expected to be delivered in September 2021. Advance deposits on this first order of 50 devices were received by us from Wider. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We will benefit financially by selling our devices to the Joint Venture when formed, in China because (i) we will have control of direct sales and profit flow and (ii) we will be entitled to receive 50% of net profits generated by the Joint Venture from sales in Asia. Moreover, all funding for our operations and research related to design and development of our products and services for sales in China will be funded solely by Wider. On behalf of, and in anticipation of the formation of, the Joint Venture, Wider is currently conducting four clinical studies in conjunction with Anding and Xuanwu Hospitals&#x2014;two major neurological centers in Beijing, China. The studies will focus on the use of the new 15 milliamps waveform therapy for existing and new treatment indications. Such studies would require an investment of approximately $5 million if performed in the United States. Publications will be prepared and submitted by key opinion leaders (KOLs) to international peer-reviewed journals for all four studies and approval applications made to the NMPA. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As noted, we will own 50% of the Joint Venture. Additionally, Wider will receive a one-eighth equity position in our company at a valuation of $40 million, one-third of which has been issued and the balance of which is to be issued upon completion of the four clinical trials. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">U.S. Asian Consulting Group, LLC</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On May 9, 2018, the Company entered into a five-year consulting agreement with U.S. Asian Consulting Group, LLC (&#x201C;U.S. Asian&#x201D;). The two members of U.S. Asian are shareholders in the Company. Pursuant to the consulting agreement, U.S. Asian will provide consulting services to the Company with regards to, among other things, corporate development and financing arrangements. The Company is to pay U.S. Asian $10,000 per month for services rendered and, on October 24, 2018, the Company issued 4,995,000 shares of the Company&#x2019;s common stock to U.S. Asian. The Company recorded consulting expenses related to the consulting agreement of $120,000 and $120,000 for the years ended December 31, 2020 and 2019, respectively, on the Company&#x2019;s statements of operations. For the years ended December 31, 2020 and 2019, U.S. Asian was owed $299,320 and $197,419, respectively, for accrued and unpaid services. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to the consulting agreement, U.S. Asian&#x2019;s shares in the Company consist of an anti-dilution provision whereas U.S. Asian&#x2019;s security holdings, during the term of the consulting agreement, shall remain at 10% of the Company&#x2019;s total number of issued and outstanding shares of the Company&#x2019;s common stock, on a fully diluted basis. As of December 31, 2020, the 10% anti-dilution provision, on a fully diluted basis, would result in a total of 7,954,765 shares of the Company&#x2019;s common stock. The Company recorded an additional $328,156 and $412,032 in additional paid in capital on the balance sheets for the years ended December 31, 2020 and 2019, respectively. As of December 31, 2020, the additional 2,959,765 shares of the Company&#x2019;s common stock had yet to be issued. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In March 2021, the consulting agreement was amended to provide for U.S. Asian to waive and relinquish its anti-dilution rights in exchange for the issuance of [*] shares immediately prior to this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Loan Payable - Officer</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 11, 2019, the company received $50,000 from the Company&#x2019;s Chief Executive Officer. The loan has a principal of $50,000, an interest rate of 16.5%, and a maturity date of October 11, 2020. The issuance of the loan resulted in an original issuance discount of $9,833. Total amortization on the debt discount was $6,750 and $1,500 for the years ended December 31, 2020 and 2019, respectively. The Company paid this loan in full during the year ended December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Promissory Notes</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 19, 2018, the Company issued an on demand promissory note payable with the Company&#x2019;s Chairman of the Board for $10,000 with interest to begin accruing on January 1, 2020 at 5% per annum. Total interest expense on this note was $281 and $506 for the years ended December 31, 2020 and 2019, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 25, 2018, the Company entered into a promissory note payable with an accredited investor for $20,000 with interest at 15% per annum, due October 25, 2019. Total interest expense on this note was $2,449 for the year ended December 31, 2019. On June 1, 2019, the outstanding principal and interest was converted into 100,000 shares of the Company&#x2019;s common stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">69</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 25, 2018, the Company entered in a promissory note payable with an accredited investor for $50,000 due on October 25, 2019. Pursuant to the note, the maturity date was extended to October 25, 2020. The bears interest at 100% per annum and the note holder was issued shares of the Company&#x2019;s common stock in lieu of interest. Total interest expense related to this note was $50,000 and $41,667 for the years ended December 31, 2020 and 2019, respectively. On October 7, 2020, the Company entered into a Letter of Agreement Addendum with the note holder, whereas, the Company agreed to make ten monthly principal payments beginning November 1, 2020 with the full principal amount to be paid in full by August 31, 2021. In addition, if the full principal amount is not paid in full by August 31, 2021 the Company will issue an additional 50,000 shares of common stock to the noteholder. During the years ended December 3, 2020 and 2019, the Company paid $9,200 and $4,000, respectively, in cash towards the outstanding principal. The amount outstanding at December 31, 2020 and 2019, was $36,800 and $46,000. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Corporate Reorganization</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As more fully described in the section of this prospectus titled &#x201C;Corporate Reorganization,&#x201D; We completed a corporate reorganization on [&#x2022;], 2021. As part of the corporate reorganization, we formed Nexalin Technology, Inc., a Delaware corporation, in [&#x2022;], 2021 with nominal assets and liabilities for the purpose of consummating the corporate reorganization described herein. In connection with the corporate reorganization, our existing shareholders of Nexalin Technology, Inc., a Nevada corporation, exchanged their shares for the same number and classes of newly issued shares in Nexalin Technology Inc, a Delaware corporation. As a result, Nexalin Nevada became a wholly owned subsidiary of Nexalin. Nexalin had nominal assets and liabilities and did not conduct any operations prior to the reorganization other than its incorporation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon this completion of the corporate reorganization on [&#x2022;], 2021, the historical consolidated financial statements of Nexalin Nevada became the historical consolidated financial statements of Nexalin, the entity whose shares of common stock are being sold in this offering, though such historical financial data do not give effect to the corporation reorganization. We expect that the corporate reorganization will not have a material effect on our financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Related Person Transaction Policy</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Prior to this offering, we have not had a formal policy regarding approval of transactions with related parties. Prior to the completion of this offering, we expect to adopt a written related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. The policy will become effective immediately upon the execution of the underwriting agreement for this offering. For purposes of this policy, a related person transaction is a transaction, arrangement or relationship or any series of similar transactions, arrangements or relationships, in which we and any related person are, were or will be participants in which the amount involved exceeds $120,000. Transactions involving compensation for services provided to us as an employee or director are not covered by this policy. A related person is any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our audit committee, or, if audit committee approval would be inappropriate, to another independent body of our board of directors, for review, consideration and approval or ratification. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable us to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under our code of business conduct that we expect to adopt prior to the completion of this offering, our employees and directors will have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a con&#xFB02;ict of interest. In considering related person transactions, our audit committee, or another independent body of our board of directors, will take into account the relevant available facts and circumstances including, but not limited to: </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the risks, costs and benefits to us;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the impact on a director&#x2019;s independence in the event that the related person is a director, immediate family member of a director or an entity with which a director is affiliated;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the availability of other sources for comparable services or products; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The policy requires that, in determining whether to approve, ratify or reject a related person transaction, our audit committee, or other independent body of our board of directors, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our shareholders, as our audit committee, or other independent body of our board of directors, determines in the good faith exercise of its discretion. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">70</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e12126_anchor"><font style="font-weight:bold; ">PRINCIPAL STOCKHOLDERS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table sets forth the beneficial ownership of our shares as of September 30, 2021 for: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:72pt; margin-top:-12pt; margin-bottom:0pt; ">each person, or group of affiliated persons, who is known by us to beneficially own more than 5% of our common stock;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:72pt; margin-top:-12pt; margin-bottom:0pt; ">each of our named executive officers;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:72pt; margin-top:-12pt; margin-bottom:0pt; ">each of our directors; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:72pt; margin-top:-12pt; margin-bottom:0pt; ">all of our current executive officers and directors as a group.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The percentage ownership information shown in the table is based upon 90,135,920 shares of our common stock outstanding as of September 30, 2021. The percentage ownership information under the column titled &#x201C;After Offering&#x201D; is based on the sale of [&#x2022;] shares of our common stock in this offering. The percentage ownership information assumes no exercise of the underwriters&#x2019; option to purchase additional shares. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Certain of our stockholders (or their affiliates), including those affiliated with certain of our directors, have indicated an interest in purchasing up to an aggregate of approximately [&#x2022;] shares of our common stock in this offering at the public offering price. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, fewer or no shares in this offering to these entities, or these entities may determine to purchase more, fewer or no shares of common stock in this offering. The following table does not re&#xFB02;ect any potential purchases by these potential purchasers. If any shares are purchased by our existing principal stockholders or their affiliated entities, the number and percentage of shares of our common stock beneficially owned by them after this offering will differ from those set forth in the following table. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The address for persons listed in the table is c/o Nexalin Technology, Inc., 1776 Yorktown, Suite 550, Houston, TX 77056. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Directors, Executive Officers and 5% Shareholders</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:22%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Name of Beneficial Owner</font>
                  </p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number of Shares </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Beneficially Owned</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Percentage of </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shares Beneficially</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Owned</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Before Offering)</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Percentage of </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shares Beneficially</font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Owned </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(After Offering)</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Marilyn Elson<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">6,654,337<sup>(2)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">7.38% </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Mark White<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">5,682,526<sup>(2)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">6.30% </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Len Osser<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">4,436,558<sup>(1)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">4.92% </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rick Morad<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">3,235,842<sup>(3)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">3.59% </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Benjamin Hu<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">3,124,384<sup>(3)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">3.47% </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">David Owens, MD<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2,773,471<sup>(3)</sup> <sup>(4)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">3.08% </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Alan Kazden<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">1,495,943<sup>(3)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">1.66% </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Dr. Nancy White<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">300,000<sup>(5)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:22%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Abraham Scheer<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">255,000<sup>(5)</sup> </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x200B;<sup>(1)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Mark White is Chief Executive Officer and a director of the Company. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x200B;<sup>(2)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Len Osser and Marilyn Elson are husband and wife and deemed to have beneficial ownership of each other&#x2019;s holdings. Len and Marilyn are both the members of U.S. Asian Consulting LLC and beneficially own its shares of the Company. An additional amount of shares will be issued to U.S. Asian Consulting, LLC that sustains their equity at 15% of issued and outstanding shares prior to our offering. </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x200B;<sup>(3)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Director </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x200B;<sup>(4)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">David Owens, MD is Chief Medical Officer and a director of the Company </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#x200B;<sup>(5)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Advisory Board Member </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">*<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:97%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less than 1% </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">71</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e12542_anchor"><font style="font-weight:bold; ">DESCRIPTION OF CAPITAL STOCK</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">The following description of our capital stock and certain provisions of our amended and restated certificate of incorporation and </font><font style="font-style:italic; ">amended and restated bylaws are summaries. You should also refer to the amended and restated certificate of incorporation, the </font><font style="font-style:italic; ">amended and restated bylaws and the registration rights agreement, which are filed as exhibits to the registration statement of which </font><font style="font-style:italic; ">this prospectus is part.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">General</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon the completion of this offering and filing of our amended and restated certificate of incorporation, our authorized capital will consist of shares of common stock, par value $0.001 per share. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Common Stock</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Outstanding Shares</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As of September 8, 2021, we had 88,530,701 shares of common stock outstanding, held of record by [&#x2022;] stockholders. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Voting Rights</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders. The affirmative vote of holders of at least 662/3% of the voting power of all of the then-outstanding shares of capital stock, voting as a single class, will be required to amend certain provisions of our amended and restated certificate of incorporation, including provisions relating to amending our amended and restated bylaws, the classified board, the size of our board, removal of directors, director liability, vacancies on our board, special meetings, stockholder notices, actions by written consent and exclusive forum. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Dividends</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Holders of our common stock are entitled to receive rateably any dividends that our board of directors may declare out of funds legally available for that purpose. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Liquidation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In the event of our liquidation, dissolution or winding up, holders of our common stock are entitled to share rateably in all assets remaining after payment of liabilities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Rights and Preferences</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Holders of our common stock have no pre-emptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate in the future. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Fully Paid and Nonassessable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All outstanding shares of our common stock are fully paid and non-assessable, and the shares of common stock to be issued upon completion of this offering will be fully paid and non-assessable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Anti-Takeover Provisions</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Certificate of Incorporation and Bylaws to be in Effect Immediately Prior to Completion of this Offering</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our amended and restated certificate of incorporation and amended and restated bylaws, each to become effective immediately prior to the completion of this offering, will: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">provide that the authorized number of directors may be changed only by resolution of our board of directors;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">provide that directors may only be removed for cause, which removal may be effected, subject to any limitation imposed by law, by the holders of at least 66&#x2154;% of the voting power of all of our then-outstanding shares of the capital stock entitled to vote generally at an election of directors;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent or electronic transmission; </p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">72</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:0pt; ">&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder&#x2019;s notice;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">provide that special meetings of our stockholders may be called only by the chairman of our board of directors, our chief executive officer or president or by our board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">not provide for cumulative voting rights, therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The amendment of any of these provisions would require approval by the holders of at least 66&#x2154;% of the voting power of all our then-outstanding common stock entitled to vote generally in the election of directors, voting together as a single class. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The combination of these provisions will make it more difficult for our existing stockholders to replace our board of directors as well as for another party to obtain control of us by replacing our board of directors. Because our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management. As a consequence, these provisions may also inhibit &#xFB02;uctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals, because negotiation of takeover proposals could result in an improvement of their terms. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Section 203 of the Delaware General Corporation Law</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in a business combination with any interested stockholder for a period of three years following the date the person became an interested stockholder, with the following exceptions: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested holder;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (a) by persons who are directors and also officers and (b) pursuant to employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66&#x2154;% of the outstanding voting stock that is not owned by the interested stockholder.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In general, Section 203 of the DGCL defines business combination to include the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">any merger or consolidation involving the corporation and the interested stockholder;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In general, Section 203 of the DGCL defines an &#x201C;interested stockholder&#x201D; as an entity or person who, together with the entity&#x2019;s or person&#x2019;s affiliates and associates, beneficially owns, or is an affiliate of the corporation and within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">73</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A Delaware corporation may &#x201C;opt out&#x201D; of these provisions with an express provision in its certificate of incorporation. We have not opted out of these provisions, which may as a result, discourage or prevent mergers or other takeover or change of control attempts of us. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Choice of Forum</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our amended and restated certificate of incorporation will provide that the Court of Chancery of the State of Delaware will be the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us or any of our directors, officers, employees or agents arising under the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws; any action or proceeding to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or our amended and restated bylaws; and any action asserting a claim against us that is governed by the internal affairs doctrine. Our amended and restated certificate of incorporation will further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. The enforceability of similar choice of forum provisions in other companies&#x2019; certificates of incorporation has been challenged in legal proceedings, and it is possible that, in connection with one or more actions or proceedings described above, a court could find the choice of forum provisions contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Transfer Agent and Registrar</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our transfer agent and registrar for our common stock is [&#x2022;]. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Nasdaq Capital Market Listing</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have applied to list our common stock on The Nasdaq Capital Market under the trading symbol &#x201C;[&#x2022;].&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">74</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e12796_anchor"><font style="font-weight:bold; ">SHARES ELIGIBLE FOR FUTURE SALE</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Prior to this offering, no public market existed for our common stock. Future sales of our common stock in the public market after this offering, or the perception that these sales could occur, could adversely affect prevailing market prices for our common stock and could impair our future ability to raise equity capital. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Based on the number of shares outstanding as of July 31, 2021, upon completion of this offering and assuming no exercise of the underwriters&#x2019; option to purchase additional shares, &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares of our common stock will be outstanding, after giving effect to the issuance of &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares offered by us in this offering. All of the shares of our common stock sold in this offering will be freely tradable without restrictions or further registration under the Securities Act, except for any shares sold to our &#x201C;affiliates,&#x201D; as that term is defined under Rule 144 under the Securities Act. The remaining shares of our common stock held by existing stockholders are &#x201C;restricted securities,&#x201D; as that term is defined in Rule 144 under the Securities Act. Restricted securities may be sold in the public market only if registered or if their resale qualifies for exemption from registration described below under Rule 144 promulgated under the Securities Act. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As a result of contractual restrictions described below and the provisions of Rules 144 and 701, the shares sold in this offering and the restricted securities will be available for sale in the public market as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares sold in this offering and &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; of the existing restricted shares will be eligible for immediate sale upon the completion of this offering;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">approximately &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; restricted shares will be eligible for sale in the public market 90 days after the date of this prospectus, subject to the volume, manner of sale and other limitations under Rule 144 and Rule 701; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">approximately &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; restricted shares will be eligible for sale in the public market upon expiration of lock-up agreements 180 days after the date of this prospectus, subject in certain circumstances to the volume, manner of sale and other limitations under Rule 144 and Rule 701.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Rule 144</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In general, persons who have beneficially owned restricted shares of our common stock for at least six months, and any affiliate of the company who owns either restricted or unrestricted shares of our common stock, are entitled to sell their securities without registration with the SEC under an exemption from registration provided by Rule 144 under the Securities Act. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Non-Affiliates</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Any person who is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale may sell an unlimited number of restricted securities under Rule 144 if: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the restricted securities have been held for at least six months, including the holding period of any prior owner other than one of our affiliates;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">we have been subject to the Securities Exchange Act of 1934, as amended, or the Exchange Act, periodic reporting requirements for at least 90 days before the sale; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">we are current in our Exchange Act reporting at the time of sale.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Any person who is not deemed to have been an affiliate of ours at the time of, or at any time during the three months preceding, a sale and has held the restricted securities for at least one year, including the holding period of any prior owner other than one of our affiliates, will be entitled to sell an unlimited number of restricted securities without regard to the length of time we have been subject to Exchange Act periodic reporting or whether we are current in our Exchange Act reporting. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Affiliates</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Persons seeking to sell restricted securities who are our affiliates at the time of, or any time during the three months preceding, a sale, would be subject to the restrictions described above. They are also subject to additional restrictions, by which such person would be required to comply with the manner of sale and notice provisions of Rule 144 and would be entitled to sell within any three-month period only that number of securities that does not exceed the greater of either of the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">1% of the number of shares of our common stock then outstanding, which will equal approximately &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares immediately after the completion of this offering based on the number of shares outstanding as of July 31, 2021; or&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the average weekly trading volume of our common stock on The Nasdaq Capital Market during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Additionally, persons who are our affiliates at the time of, or any time during the three months preceding, a sale may sell unrestricted securities under the requirements of Rule 144 described above, without regard to the six month holding period of Rule 144, which does not apply to sales of unrestricted securities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">75</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Rule 701</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Rule 701 under the Securities Act, as in effect on the date of this prospectus, permits resales of shares in reliance upon Rule 144 but without compliance with certain restrictions of Rule 144, including the holding period requirement. Most of our employees, executive officers or directors who purchased shares under a written compensatory plan or contract may be entitled to rely on the resale provisions of Rule 701, but all holders of Rule 701 shares are required to wait until 90 days after the date of this prospectus before selling their shares. However, substantially all Rule 701 shares are subject to lock-up agreements as described below and in the section of this prospectus titled &#x201C;Underwriting&#x201D; and will become eligible for sale upon the expiration of the restrictions set forth in those agreements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Lock-Up Agreements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We and the holders of substantially all of the shares of our common stock outstanding on the date of this prospectus, including each of our executive officers and directors, have entered into lock-up agreements with the underwriters or otherwise agreed, subject to certain exceptions, that we and they will not, directly or indirectly, offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of or hedge any of our shares of our common stock, any options or warrants to purchase shares of our common stock, or any securities convertible into, or exchangeable for or that represent the right to receive shares of our common stock, without the prior written consent of the representatives of the underwriters for a period of 180 days from the date of this prospectus. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Registration Rights</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon the completion of this offering, the holders of &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; shares of our common stock will be entitled to rights with respect to the registration of their shares under the Securities Act, subject to the lock-up agreements described under &#x201C;Lock-Up Agreements&#x201D; above. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares purchased by affiliates. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">76</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e13089_anchor"><font style="font-weight:bold; ">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">FOR NON-U.S. HOLDERS OF COMMON STOCK</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following discussion is a summary of material U.S. federal income tax considerations relating to ownership and disposition of our common stock by a non-U.S. holder. For purposes of this discussion, the term &quot;non-U.S. holder&quot; means a beneficial owner (other than a partnership or other pass-through entity) of our common stock that is not, for U.S. federal income tax purposes: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">an individual who is a citizen or resident of the United States;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or of any state thereof or the District of Columbia;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">an estate the income of which is subject to U.S. federal income taxation regardless of its source; or&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">a trust if (1) a U.S. court is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have authority to control all substantial decisions of the trust or (2) the trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This discussion does not address the tax treatment of partnerships or other entities that are pass-through (or disregarded) entities for U.S. federal income tax purposes or persons who hold their common stock through partnerships or such other pass-through or disregarded entities. The tax treatment of a partner in an entity or arrangement that is treated as a partnership for U.S. federal income tax purposes generally will depend upon the status of the partner and the activities of the partnership. A partner in a partnership or other pass-through entity that will hold our common stock should consult his, her or its own tax advisor regarding the tax consequences of acquiring, holding and disposing of our common stock through a partnership or other pass-through entity, as applicable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This discussion is based on current provisions of the Internal Revenue Code of 1986, as amended, or the Code, existing and proposed U.S. Treasury Regulations promulgated thereunder, and current administrative rulings and judicial decisions, all as in effect as of the date of this prospectus, and all of which are subject to change or to differing interpretation, possibly with retroactive effect. Any change could alter the tax consequences to non-U.S. holders described in this prospectus. There can be no assurance that the Internal Revenue Service, which we refer to as the IRS, will not challenge one or more of the tax consequences described in this prospectus. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We assume in this discussion that each non-U.S. holder holds shares of our common stock as a capital asset (generally, property held for investment) for U.S. federal income tax purposes. This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular non-U.S. holder in light of that non-U.S. holder&apos;s individual circumstances nor does it address any aspects of U.S. state, local or non-U.S. taxes, the alternative minimum tax, the estate or gift taxes or the Medicare tax on net investment income. This discussion also does not consider any specific facts or circumstances that may apply to a non-U.S. holder and does not address the special tax rules applicable to particular non-U.S. holders, such as: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">financial institutions;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">brokers or dealers in securities;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">tax-exempt organizations;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">pension plans;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">owners that hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or other integrated investment;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">traders in securities that have elected the mark-to-market method of accounting for their securities holdings;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">insurance companies;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">controlled foreign corporations;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">passive foreign investment companies;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">persons that have a functional currency other than the U.S. dollar;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">persons who have acquired our common stock pursuant to the exercise of an option or otherwise in a compensatory transaction;&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">non-U.S. governments; and&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">certain U.S. expatriates.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">77</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT, AND IS NOT INTENDED TO BE, </font><font style="font-weight:bold; ">LEGAL OR TAX ADVICE. PROSPECTIVE INVESTORS SHOULD CONSULT THEIR OWN TAX ADVISORS REGARDING </font><font style="font-weight:bold; ">THE U.S. FEDERAL, STATE, LOCAL AND NON-U.S. INCOME, ESTATE AND OTHER TAX CONSIDERATIONS OF </font><font style="font-weight:bold; ">ACQUIRING, HOLDING AND DISPOSING OF OUR COMMON STOCK. IN ADDITION, SIGNIFICANT CHANGES IN U.S. </font><font style="font-weight:bold; ">FEDERAL INCOME TAX LAWS WERE RECENTLY ENACTED. YOU SHOULD ALSO CONSULT WITH YOUR TAX </font><font style="font-weight:bold; ">ADVISOR WITH RESPECT TO SUCH CHANGES IN U.S. TAX LAW AS WELL AS POTENTIAL CONFORMING </font><font style="font-weight:bold; ">CHANGES IN STATE TAX LAWS.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Distributions on Our Common Stock</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As discussed under &quot;<font style="font-style:italic; ">Dividend Policy</font>&quot; above, we do not expect to make cash dividends to holders of our common stock in the foreseeable future. Distributions, if any, on our common stock generally will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a tax-free return of the non-U.S. holder&apos;s investment, up to the holder&apos;s tax basis in the common stock. Any remaining excess will be treated as capital gain, subject to the tax treatment described below under the heading &quot;<font style="font-style:italic; ">Gain on Sale, Exchange or Other Taxable Disposition of Our Common Stock</font>.&quot; Any such distributions will also be subject to the discussion below under the headings &quot;<font style="font-style:italic; ">Information Reporting and Backup Withholding</font>&quot; and &quot;<font style="font-style:italic; ">FATCA</font>.&quot;      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dividends paid to a non-U.S. holder generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&apos;s country of residence. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Dividends that are treated as effectively connected with a trade or business conducted by a non-U.S. holder within the United States, and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the non-U.S. holder within the United States, are generally exempt from the 30% withholding tax if the non-U.S. holder satisfies applicable certification and disclosure requirements (generally including provision of a valid IRS Form W-8ECI (or applicable successor form) certifying that the dividends are effectively connected with the non-U.S. holder&apos;s conduct of a trade or business within the United States or, if an applicable income tax treaty so provides, attributable to a permanent establishment or a fixed base maintained by the non-U.S. holder within the United States). However, such U.S. effectively connected income, net of specified deductions and credits, is taxed in the hands of the non-U.S. holder at the same corporate or graduated individual U.S. federal income tax rates applicable to United States persons (as defined in the Code). Any U.S. effectively connected income received by a non-U.S. holder that is classified as a corporation for U.S. federal income tax purposes may also be subject to an additional &quot;branch profits tax&quot; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&apos;s country of residence. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A non-U.S. holder of our common stock who claims the benefit of an applicable income tax treaty between the United States and such holder&apos;s country of residence generally will be required to provide a properly executed IRS Form W-8BEN or W-8BEN-E (or successor form) and satisfy applicable certification and other requirements. Non-U.S. holders are urged to consult their own tax advisors regarding their entitlement to benefits under a relevant income tax treaty and the specific methods available to them to satisfy these requirements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A non-U.S. holder that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim for a refund with the IRS. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Gain on Sale, Exchange or Other Taxable Disposition of Our Common Stock</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Subject to the discussion below under the headings &quot;<font style="font-style:italic; ">Information Reporting and Backup Withholding</font>&quot; and &quot;<font style="font-style:italic; ">FATCA</font>,&quot; a non-U.S. holder generally will not be subject to U.S. federal income tax or withholding tax on any gain realized upon such non-U.S. holder&apos;s sale, exchange or other taxable disposition of our common stock unless:
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the gain is effectively connected with the non-U.S. holder&apos;s conduct of a U.S. trade or business and, if an applicable income tax treaty so provides, the gain is attributable to a permanent establishment or fixed base maintained by the non-U.S. holder in the United States, in which case the non-U.S. holder generally will be taxed on a net income basis at the corporate or graduated individual U.S. federal income tax rates applicable to United States persons (as defined in the Code) and, if the non-U.S. holder is a foreign corporation, the branch profits tax described above in &quot;<font style="font-style:italic; ">Distributions on Our </font><font style="font-style:italic; ">Common Stock</font>&quot; also may apply;&#x2009;&#x2009;
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">the non-U.S. holder is a non-resident alien individual present in the United States for a period or periods aggregating 183 days or more in the taxable year of the disposition and certain other conditions are met, in which case the non-U.S. holder will be subject to a 30% tax (or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&apos;s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S.-source capital losses of the non- U.S. holder recognized in the taxable year of the disposition, if any; or&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">we are, or have been, at any time during the five-year period preceding such disposition (or the non-U.S. holder&apos;s holding period, if shorter) a &quot;U.S. real property holding corporation&quot; unless our common stock is regularly traded on an established securities market and the non-U.S. holder holds no more than 5% of our outstanding common stock, directly or indirectly, at any time during the shorter of the five-year period ending on the date of the disposition or the period that the non-U.S. holder held our common stock. Generally, a corporation is a &quot;U.S. real property holding corporation&quot; if the fair market value of its &quot;U.S. real property interests&quot; (as defined in the Code and applicable Treasury Regulations) equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be no assurance, we believe that we are not currently, and we do not anticipate becoming, a &quot;U.S. real property holding corporation&quot; for U.S. federal income tax purposes. If we are a U.S. real property holding corporation and either our common stock is not regularly traded on an established securities market or a non-U.S. holder holds more than 5% of our outstanding common stock, directly or indirectly, during the applicable testing period, such non-U.S. holder&apos;s gain on the disposition of shares of our common stock generally will be taxed in the same manner as gain that is effectively connected with the conduct of a U.S. trade or business, except that the branch profits tax generally will not apply. If we are a U.S. real property holding corporation and our common stock is not regularly traded on an established securities market, a non-U.S. holder&apos;s proceeds received on the disposition of shares will also generally be subject to withholding at a rate of 15%. Prospective investors are encouraged to consult their own tax advisors regarding the possible consequences to them if we are, or were to become, a U.S. real property holding corporation.&#x2009;&#x2009; </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">78</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Information Reporting and Backup Withholding</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We must report annually to the IRS and to each non-U.S. holder the gross amount of the distributions on our common stock paid to such holder and the tax withheld, if any, with respect to such distributions. Non-U.S. holders generally will have to comply with specific certification procedures to establish that the holder is not a United States person (as defined in the Code) in order to avoid backup withholding at the applicable rate with respect to dividends on our common stock. Generally, a non-U.S. holder will comply with such procedures if it provides a properly executed IRS Form W-8BEN or W-8BEN-E (or other applicable Form W-8), or otherwise meets the documentary evidence requirements for establishing that it is a non-U.S. holder, or otherwise establishes an exemption (and the payor does not have actual knowledge or reason to know that such holder is a United States person). Dividends paid to non-U.S. holders subject to withholding of U.S. federal income tax, as described above under &quot;<font style="font-style:italic; ">Distributions on Our Common Stock</font>,&quot; will generally be exempt from U.S. backup withholding.      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Information reporting and backup withholding, currently at a rate of 24%, generally will apply to the proceeds of a disposition of our common stock by a non-U.S. holder effected by or through the U.S. office of any broker, whether U.S. or non-U.S., unless the holder certifies its status as a non-U.S. holder and satisfies certain other requirements, or otherwise establishes an exemption from backup withholding. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a non-U.S. holder where the transaction is effected outside the United States through a non-U.S. office of a broker. However, for information reporting purposes, dispositions effected through a non-U.S. office of a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. Non-U.S. holders should consult their own tax advisors regarding the application of the information reporting and backup withholding rules to them. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Copies of information returns may be made available to the tax authorities of the country in which the non-U.S. holder resides or is incorporated under the provisions of a specific treaty or agreement. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a non-U.S. holder can be refunded or credited against the non-U.S. holder&apos;s U.S. federal income tax liability, if any, provided that an appropriate claim is timely filed with the IRS. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">FATCA</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Foreign Account Tax Compliance Act, or FATCA, generally imposes a 30% withholding tax on dividends on, and gross proceeds from the sale or disposition of, our common stock paid to a foreign entity unless (i) if the foreign entity is a &quot;foreign financial institution,&quot; the foreign entity undertakes certain due diligence, reporting, withholding, and certification obligations, (ii) if the foreign entity is not a &quot;foreign financial institution,&quot; the foreign entity identifies certain of its U.S. investors, if any, or (iii) the foreign entity is otherwise exempt from FATCA. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Withholding under FATCA generally applies (1) to payments of dividends on our common stock, and (2) to payments of gross proceeds from a sale or other disposition of our common stock. However, under proposed U.S. Treasury Regulations, withholding under FATCA will not apply to the gross proceeds from any sale or disposition of our common stock. An intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this section. Under certain circumstances, a non-U.S. holder may be eligible for refunds or credits of the tax. Non-U.S. holders should consult their own tax advisors regarding the possible implications of FATCA on their investment in our common stock and the entities through which they hold our common stock, including, without limitation, the process and deadlines for meeting the applicable requirements to prevent the imposition of the 30% withholding tax under FATCA. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">The preceding discussion of material U.S. federal tax considerations is for informational purposes only. It is not legal or tax </font><font style="font-weight:bold; ">advice. Prospective investors should consult their own tax advisors regarding the particular U.S. federal, state, local and </font><font style="font-weight:bold; ">non-U.S. tax consequences of purchasing, holding and disposing of our common stock, including the consequences of any </font><font style="font-weight:bold; ">proposed or recently enacted changes in applicable laws.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">79</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e13325_anchor"><font style="font-weight:bold; ">UNDERWRITING</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have entered into an underwriting agreement, dated &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;, 2021, with Maxim Group LLC, who we refer to as the underwriter, with respect to the shares of common stock sold in this Offering. Subject to certain conditions, we have agreed to sell to the underwriter, and the underwriter has agreed to purchase, at the public offering price per unit less the underwriting discounts set forth on the cover page of this prospectus, the number of shares of common stock listed next to its name in the following table: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" ">

               <td style="width:30%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Underwriter</font>
                  </p>

               </td>

               <td style="width:45%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:25%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number of Shares </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">of Common Stock</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Maxim Group LLC<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:45%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:25%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:40pt; margin-top:0pt; margin-bottom:0pt; ">Total:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:45%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:142%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The underwriting agreement provides that the underwriters are obligated to purchase all the shares of common stock in the offering if any are purchased, other than those shares covered by the option described below. The underwriting agreement also provides that if an underwriter defaults the purchase commitments of non-defaulting underwriters may be increased or the offering may be terminated. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Certain of our stockholders (or their affiliates), including those affiliated with certain of our directors, have indicated an interest in purchasing up to an aggregate of approximately $ &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; million of shares of our common stock in this offering at the public offering price. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, fewer or no shares in this offering to these entities, or these entities may determine to purchase more, fewer or no shares of common stock in this offering. The underwriters will receive the same underwriting discounts and commissions on any shares of common stock purchased by these entities as they will on any other shares of common stock sold to the public in this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Over-Allotment Option</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have granted to the underwriters a 30-day option to purchase on a pro rata basis up to &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; additional shares of common stock at the initial public offering price less the underwriting discounts and commissions. The option may be exercised only to cover any over-allotments of common stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Discount, Commissions and Expenses</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The underwriters propose to offer the shares of common stock initially at the public offering price on the cover page of this prospectus and to selling group members at that price less a selling concession of up to $&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; per share. After the initial public offering the underwriters may change the public offering price and selling concession. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table summarizes the compensation and estimated expenses we will pay: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">
















            <tr class="odd" style=" ">

               <td style="width:52%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:28%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:52%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Per </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Share</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">No </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercise</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Full </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercise</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:52%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Public offering price<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:52%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Underwriting discounts and commissions to be paid by us ([&#x2022;]%)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:52%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Proceeds, before expenses, to us<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have also agreed to reimburse the underwriters in an amount up to $25,000 for legal fees and expenses relating to clearance of this offering with the Financial Industry Regulatory Authority, or FINRA. In accordance with FINRA Rule 5110, these reimbursed fees and expenses are deemed underwriting compensation for this offering. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Lock-Up Agreements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have agreed, subject to certain exceptions, that we will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, or file with the SEC a registration statement under the Securities Act relating to, any shares of our common stock, or securities convertible into or exchangeable or exercisable for shares of our common stock, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, without the prior written consent of the representatives for a period of 180 days after the date of this prospectus. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our officers, directors and holders of substantially all of our common stock and securities exercisable for or convertible into our common stock outstanding immediately prior to this offering have agreed, subject to certain exceptions, that they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any shares of our common stock, or securities convertible into or exchangeable or exercisable for any shares of our common stock, enter into a transaction that would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of our common stock, whether any of these transactions are to be settled by delivery of our common stock or other securities, in cash or otherwise, or publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement, without, in each case, the prior written consent of the representatives for a period of 180 days after the date of this prospectus. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Indemnification</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have agreed to indemnify the underwriters and certain of their controlling persons against certain liabilities, including liabilities under the Securities Act, and liabilities arising from breaches of representations and warranties contained in the underwriting agreement, or to contribute to payments that the underwriters may be required to make in respect of those liabilities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">80</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Price Stabilization, Short Positions and Penalty Bids</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In connection with the offering the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate covering transactions and penalty bids in accordance with Regulation M under the Exchange Act. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">Over-allotment involves sales by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase, which creates a syndicate short position. The short position may be either a covered short position or a naked short position. In a covered short position, the number of shares over-allotted by the underwriters is not greater than the number of shares that they may purchase in the over-allotment option. In a naked short position, the number of shares involved is greater than the number of shares in the over-allotment option. The underwriters may close out any covered short position by either exercising their over-allotment option and/or purchasing shares in the open market.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">Syndicate covering transactions involve purchases of common stock in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of shares to close out the short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment option. If the underwriters sell more shares than could be covered by the over-allotment option, a naked short position, the position can only be closed out by buying shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering.&#x2009;&#x2009; </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:54pt; margin-top:-12pt; margin-bottom:0pt; ">Penalty bids permit the representatives to reclaim a selling concession from a syndicate member when the shares of common stock originally sold by the syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.&#x2009;&#x2009; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">These stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of the common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. These transactions may be effected on The Nasdaq Capital Market or otherwise and, if commenced, may be discontinued at any time. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A prospectus in electronic format may be made available on the web sites maintained by one or more of the underwriters, or selling group members, if any, participating in this offering and one or more of the underwriters participating in this offering may distribute prospectuses electronically. The representatives may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the underwriters and selling group members that will make internet distributions on the same basis as other allocations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Con&#xFB02;icts of Interest</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The underwriters and their respective affiliates are full-service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The underwriters do not expect to sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Nasdaq Listing</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have applied to list our common stock on The Nasdaq Capital Market. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Selling Restrictions</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">General</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">81</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Canada</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Shares of our common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the Securities legislation of the purchaser&#x2019;s province or territory. The purchaser should refer to any applicable provisions of the Securities legislation of the purchaser&#x2019;s province or territory for particulars of these rights or consult with a legal advisor. Pursuant to section 3A-3 of National Instrument 33-105 <font style="font-style:italic; ">Underwriting Con&#xFB02;icts </font>(NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriters con&#xFB02;icts of interest in connection with this offering.      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">United Kingdom</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This document is only being distributed to and is only directed at persons who are &#x201C;qualified investors&#x201D; (as defined in the Prospectus Directive) who are (i) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or the Order, (ii) high net worth entities, and (iii) other persons to whom it may lawfully be communicated, falling with Article 49(2)(a) to (d) of the Order (all such persons together being referred to as &#x201C;relevant persons&#x201D;). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. This document and its contents are confidential and should not be distributed, published or reproduced (in whole or in part) or disclosed by any recipients to any other person in the United Kingdom. Any person who is not a relevant person should not act or rely on this document or any of its contents. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">European Economic Area</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In relation to each Member State of the European Economic Area that has implemented the Prospectus Directive (each, a &#x201C;Relevant Member State&#x201D;), an offer to the public of any securities described in this prospectus may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any ordinary shares may be made at any time under the following exemptions under the Prospectus Directive if they have been implemented in that Relevant Member State: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:11pt; margin-bottom:0pt; ">(a)</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:72pt; margin-top:-12pt; margin-bottom:0pt; ">to any legal entity which is a qualified investor as defined in the Prospectus Directive; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:11pt; margin-bottom:0pt; ">(b)</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; padding-left:72pt; margin-top:-12pt; margin-bottom:0pt; ">to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive) per Relevant Member State, subject to obtaining the prior consent of the underwriters; or </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:11pt; margin-bottom:0pt; ">(c)</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:72pt; margin-top:-12pt; margin-bottom:0pt; ">in any other circumstances falling within Article 3(2) of the Prospectus Directive; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">provided that no such offer of securities described in this prospectus shall result in a requirement for the publication by us or any underwriter of a prospectus pursuant to Article 3 of the Prospectus Directive or a supplemental prospectus pursuant to Article 16, of the Prospectus Directive or any measure implementing the Prospectus Directive in a Relevant Member State and each person who initially acquires any securities or to whom any offer is made on the basis of (a) above will be deemed to have represented, acknowledged and agreed that it is a &#x201C;qualified investor&#x201D; within the meaning of Article 2(1)(e) of this Prospectus Directive. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For the purposes of this provision, the expression an &#x201C;offer of securities to the public&#x201D; in relation to any securities in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the securities to be offered so as to enable an investor to decide to purchase or subscribe for the securities, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Relevant Member State. The expression &#x201C;Prospectus Directive&#x201D; means Directive 2003/71/EC (as amended, including by Directive 2010/73/EU) and includes any relevant implementing measure in each Relevant Member State. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Switzerland</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or the SIX, or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this prospectus nor any other offering or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Neither this prospectus nor any other offering or marketing material relating to the offering, the Company, or the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or the CISA. The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of shares. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">82</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">China</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This prospectus does not constitute a public offer of the shares offered by this prospectus, whether by sale or subscription, in China. The shares are not being offered or sold directly or indirectly in China to or for the benefit of, legal or natural persons of the PRC. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Further, no legal or natural persons of China may directly or indirectly purchase any of the shares without obtaining all prior Chinese governmental approvals that are required, whether statutorily or otherwise. Persons who come into possession of this prospectus are required by the issuer and its representatives to observe these restrictions. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Hong Kong</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The shares may not be offered or sold by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.32, Laws of Hong Kong), or (ii) to &#x201C;professional investors&#x201D; within the meaning of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a &#x201C;prospectus&#x201D; within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.32, Laws of Hong Kong), and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#x201C;professional investors&#x201D; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Singapore</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the &#x201C;SFA&#x201D;), (ii) to a relevant person, or any person pursuant to Section 275(1A), and in accordance with the conditions, specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Where the shares are subscribed or purchased under Section 275 by a relevant person which is: (a) a corporation (which is not an accredited investor) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or (b) a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures and units of shares and debentures of that corporation or the beneficiaries&#x2019; rights and interest in that trust shall not be transferable for 6 months after that corporation or that trust has acquired the shares under Section 275 except: (1) to an institutional investor under Section 274 of the SFA or to a relevant person, or any person pursuant to Section 275(1A), and in accordance with the conditions, specified in Section 275 of the SFA; (2) where no consideration is given for the transfer; or (3) by operation of law. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Japan</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The securities have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (the Financial Instruments and Exchange Law) and each underwriter has agreed that it will not offer or sell any securities, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Law and any other applicable laws, regulations and ministerial guidelines of Japan. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">83</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e13916_anchor"><font style="font-weight:bold; ">LEGAL MATTERS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The validity of the shares being offered by this prospectus will be passed upon for us by Warshaw Burstein, LLP. Certain legal matters related to this offering will be passed upon for the underwriters by Nelson Mullins Riley &amp; Scarborough LLP. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e13931_anchor"><font style="font-weight:bold; ">EXPERTS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our consolidated financial statements as of December 31, 2019 and 2020, and for the years then ended, have been included herein and in the registration statement in reliance upon the report of Friedman, LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The audit report covering the December 31, 2020 consolidated financial statements contains an explanatory paragraph that states that the Company&#x2019;s recurring losses and negative cash &#xFB02;ows from operations raise substantial doubt about the entity&#x2019;s ability to continue as a going concern prior to this offering. The consolidated financial statements do not include any adjustments that might result from the outcome of that uncertainty. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e13949_anchor"><font style="font-weight:bold; ">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have filed with the SEC a registration statement on Form S-1 under the Securities Act, with respect to the shares of common stock being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all the information in the registration statement and its exhibits. For further information with respect to our company and the shares offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">You may read our SEC filings, including the registration statement, over the internet at the SEC&#x2019;s website at <font style="font-style:italic; ">www.sec.gov</font>. You may also read and copy any document we file with the SEC at its public reference room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. You may also obtain copies of these documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Upon completion of this offering, we will be subject to the information reporting requirements of the Exchange Act, and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for inspection and copying at the public reference room and website of the SEC referred to above. We also maintain a website at <font style="font-style:italic; ">www.nexalin.com</font>, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not part of, and is not incorporated into, this prospectus.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">84</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e13980_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">TABLE OF CONTENTS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div style="margin-left:0pt; ">
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">For the Years Ended December 31, 2020 and 2019</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-weight:bold; ">Page</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Report of Independent Registered Public Accounting Firm</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-2</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Consolidated Balance Sheets at December 31, 2020 and 2019</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-3</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Consolidated Statements of Operations For the Years Ended December 31, 2020 and 2019</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-4</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Consolidated Statements of Stockholders&#x2019; Deficit For the Years Ended December 31, 2020 and 2019</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-5</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Consolidated Statements of Cash Flows For the Years Ended December 31, 2020 and 2019</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-6</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Notes to Consolidated Financial Statements For the Years Ended December 31, 2020 and 2019</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-7</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;</p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">For the Six Months Ended June 30, 2021</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Condensed Consolidated Balance Sheets at June 30, 2021 (unaudited) and December 31, 2020</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-19</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Condensed Consolidated Statement of Operations for the six months ended June 30, 2021 and 2020 (unaudited)</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-20</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; "><font style>Condensed Consolidated Statement of Changes in Stockholders&#x2019; Equity for the six months ended June 30, 2021 and 2020 </font><font style>(unaudited)</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-21</font></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2021 and 2020 (unaudited)</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-22</font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style>Notes to Condensed Consolidated Financial Statements (unaudited)</font></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style>F-23</font></p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-1</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-10pt; margin-bottom:-10pt !important; margin-bottom:0pt; " id="d1e14009_anchor">&#xA0; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e14019_anchor"><font style="font-weight:bold; ">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; ">To the Board of Directors and Stockholders of Nexalin Technology, Inc. and Subsidiary </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Opinion on the Consolidated Financial Statements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:8pt; margin-bottom:0pt; ">We have audited the accompanying consolidated balance sheets of Nexalin Technology, Inc. and Subsidiary (the &#x201C;Company&#x201D;) as of December 31, 2020 and 2019 and the related consolidated statements of operations, stockholders&#x2019; deficit, and cash flows for the years ended December 31, 2020 and 2019, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2020 and 2019 and the results of its operations and its cash flows for the years ended December 31, 2020 and 2019, in conformity with accounting principles generally accepted in the United States of America. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Substantial Doubt about the Company&#x2019;s Ability to Continue as a Going Concern</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:8pt; margin-bottom:0pt; ">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, recurring losses since inception, which raise substantial doubt about its ability to continue as a going concern. Management&#x2019;s evaluation of the events and conditions and management&#x2019;s plans regarding those matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to that matter. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Basis for Opinion</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:8pt; margin-bottom:0pt; ">These consolidated financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on the Company&#x2019;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:8pt; margin-bottom:0pt; ">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:8pt; margin-bottom:0pt; ">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">/s/ Friedman LLP</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; ">We have served as the Company&#x2019;s auditor since 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; ">Marlton, New Jersey </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">September 9, 2021 </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-2</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e14081_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. </font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONSOLIDATED BALANCE SHEETS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">ASSETS</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Current Assets:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,436 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">63,427 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accounts receivable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,599 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,690 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Inventory<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">22,656 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">21,598 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Prepaid expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">9,194 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">20,434 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Current Assets</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">116,885 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">111,149 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Equipment, net of accumulated depreciation of $1,641,395 and $1,640,966, respectively<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,576 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,357 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Assets</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">118,461 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">112,506 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Current Liabilities:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:20pt !important; margin-top:0pt; margin-bottom:0pt; ">Accounts payable and accrued expenses (Includes related party of $199,320 and $197,419, respectively)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">982,779 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">465,111 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Lease liability<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,973 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">25,102 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loan payable - shareholder<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">46,800 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loan payable - officer<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">41,667 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Note payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">500,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">500,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Current Liabilities</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,566,552 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,041,880 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Long-term Liabilities:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Lease liability - net of current portion<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">89,934 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">95,181 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loan payable - shareholder, net of current portion<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">46,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">PPP Loan payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">22,916 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Device loan payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">92,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Convertible debt, net of discount of $611 and $2,684, respectively<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,389 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,816 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Liabilities</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,708,791 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,291,877 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Commitments and Contingencies</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Stockholders&apos; Deficit:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:20pt !important; margin-top:0pt; margin-bottom:0pt; ">Common stock, $0.001 par value; 100,000,000 shares authorized; 73,909,279 and 62,718,539 shares issued and outstanding, respectively<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">73,909 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,718 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Additional paid in capital<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,949,281 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">59,967,945 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accumulated deficit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(64,613,520 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(61,210,034 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Stockholders&apos; Deficit</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,590,330 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,179,371 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Liabilities and Stockholders&apos; Deficit</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">118,461 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">112,506 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying footnotes are an integral part of these consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-3</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e15223_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. </font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONSOLIDATED STATEMENTS OF OPERATIONS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:28%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Revenues, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">242,914 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">207,383 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cost of revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">29,039 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">61,813 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross profit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">213,875 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">145,570 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating expenses:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Professional fees<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">299,187 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,133 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Salaries and benefits<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">137,847 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">156,397 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Selling, general and administrative<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,035,248 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,377,204 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loss on impairment of right of use asst<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">37,047 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">21,671 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total operating expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,509,329 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,633,405 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss from operations<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,295,454 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,487,835 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expense:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Interest expense, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,681 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">80,989 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loss on extinguishment of debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">29,351 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,452,366 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total other expense<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">108,032 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,533,355 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,403,486 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,021,190 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss per Common Share - Basic and Diluted<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.05 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.08 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted Average Shares Outstanding - Basic and Diluted<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">71,665,615 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">60,909,306 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#xA0; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying footnotes are an integral part of these consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-4</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e15963_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. </font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; DEFICIT</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">























            <tr class="odd" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="4" style="width:26%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Common Stock</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Additional</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Paid-in</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Accumulated</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shareholders&apos;</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shares</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Amount</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Capital</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Deficit</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Deficit</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance at January 1, 2019</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">58,776,561 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">58,776 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">54,783,395 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(56,188,844 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,346,673 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock issued for cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,999,192 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,999 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">660,385 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">662,384 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Warrants issued to investors for inducement<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,377,366 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,377,366 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock compensation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">411,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">411 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">562,324 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">562,735 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Shares issued for conversion of debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,456,786 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,457 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">504,697 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">506,154 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Shares issued for inducement<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">75,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">75 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">74,925 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">75,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Beneficial conversion feature associated with convertible debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,853 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,853 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,021,190 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,021,190 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance as of December 31, 2019</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,718,539 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,718 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">59,967,945 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(61,210,034 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,179,371 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock issued for cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,256,996 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,257 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">877,825 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">884,082 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Warrants issued to investors<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,851 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,851 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock compensation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,325,471 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,326 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,955,198 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,959,524 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Shares issued for conversion of debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">233,273 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">233 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">57,587 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">57,820 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Shares issued for exercise of warrants<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">325,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">325 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">61,425 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">61,750 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Shares issued for inducement<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">12,450 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">12,500 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,403,486 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,403,486 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance as of December 31, 2020</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">73,909,279 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">73,909 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,949,281 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(64,613,520 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,590,330 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying footnotes are an integral part of these consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-5</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e17177_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. </font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONSOLIDATED STATEMENTS OF CASH FLOWS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:28%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Years Ended</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font></p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash flows from operating activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,403,486) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5,021,190) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Adjustments to reconcile net loss to net cash used in operating activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Stock compensation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,959,524 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">562,735 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Amortization of debt discount<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8,824 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,815 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loss on impairment of right of use asset<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">37,047 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">21,670 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loss on extinguishment debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">29,351 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,452,366 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Depreciation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">429 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">535 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Changes in operating assets and liabilities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accounts receivable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(909) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7,165 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Prepaid assets<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,240 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">18,281 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Inventory<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,058) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,902 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accounts payable and accrued expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">525,987 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,77,944 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Lease liability<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(30,423) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(20,559) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash used in operating activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(863,474) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(678,336) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash flows from investing activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Purchases of property and equipment<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(648) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash used in investing activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(648) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash flows from financing activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Sale of common stock for cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">884,082 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">662,384 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Proceeds from exercise of warrants<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">61,750 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Proceeds from convertible debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">27,500 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Proceeds from PPP loans<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">22,916 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Payments on loan payable - shareholder<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(9,200) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(4,000) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Payments on device loans<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(32,000) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Proceeds from notes payable - officer<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Payments on notes payable - officer<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(48,417) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(9,833) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash provided by financing activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">879,131 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">726,051 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net increase in cash and cash equivalents<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15,009 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">47,715 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents - beginning of year<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">63,427 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15,712 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents - end of year<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,436 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">63,427 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Supplemental cash flow information:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash paid for:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Interest<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Non-cash investing and financing activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Conversion of debt and accrued interest into common stock<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">57,820 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">506,154 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Right of use asset and lease liability recorded upon lease of additional space<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">37,047 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">21,671 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Beneficial conversion feature in connection with convertible debt issued<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,853 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying footnotes are an integral part of these consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-6</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e18408_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. AND SUBSIDIARY</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTES TO </font><font style="font-weight:bold; ">CONDENSED </font><font style="font-weight:bold; ">CONSOLIDATED FINANCIAL STATEMENTS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 1 &#x2013; ORGANIZATION AND BUSINESS OPERATIONS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Corporate History</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Nexalin Technology, Inc. (&#x201C;Nexalin,&#x201D; or the &#x201C;Company&#x201D;) was formed on October 19, 2010 as a Nevada corporation. The Company&#x2019;s principal offices are located at 1776 Yorktown, Suite 550, Houston, Texas 77056. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On September 6, 2019, Neuro-Health International, Inc. (&#x201C;Neuro-Health&#x201D;), a Nevada corporation, a wholly-owned subsidiary of the Company, was formed. Neuro-Health had no activity during the years ended December 31, 2019 and 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Business Overview</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company is a medical device company that designs and develops innovative neurostimulation products to help uniquely and effectively combat the ongoing global mental health epidemic. The Company currently licenses and markets a Federal Drug Administration approved non-invasive and drug-free therapy for the treatment of anxiety and insomnia (the &#x201C;Nexalin Device&#x201D; or &#x201C;Nexalin Therapy&#x201D; and, collectively, &#x201C;Nexalin&#x201D;). The Nexalin Device emits a patented, frequency-based waveform that has been proven to be highly effective in stimulating a positive response from the mid-brain structures associated with various mental health disorders. The Company&#x2019;s design of an advanced waveform that is safely administered to the human brain is the basis of the Company&#x2019;s treatment and the evolution of its business strategy. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 2 &#x2013; GOING CONCERN AND LIQUIDITY</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The accompanying consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. At December 31, 2020, the Company had a significant accumulated deficit of approximately $64,614,000 and working capital deficit of approximately $1,450,000. For the year ended December 31, 2020, the Company had a loss from operations of approximately $3,295,000 and negative cash flows from operations of approximately $863,000. The Company&#x2019;s operating activities consume the majority of its cash resources. The Company will continue to promote its services to existing and potential customers, but it anticipates that it will continue to incur operating losses as it executes its development plans through 2021, as well as other potential strategic and business development initiatives. In addition, the Company has had and expects to have negative cash flows from operations, at least into the near future. The Company previously funded these losses primarily through the sale of equity and issuance of convertible notes. The accompanying consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management believes that the actions presently being taken to further implement its business plan will enable the Company to continue as a going concern. While the Company believes in its viability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company&#x2019;s ability to further implement its business plan and raise additional funds through the Initial Public Offering or otherwise. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Although no assurances can be given as to the Company&#x2019;s ability to deliver on its revenue plans or that unforeseen expenses may arise, management believes that the revenue to be generated from operations, together with the potential closing of the Initial Public Offering in the near term, will provide the necessary funding for the Company to continue as a going concern. Management cannot guarantee any such Initial Public Offering will be available on favorable terms. As such, these matters raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of twelve months from the issue date of this report. If adequate funds are not available on acceptable terms, or at all, the Company will need to curtail operations or cease operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 3 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Basis of Presentation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;). The summary of significant accounting policies presented below is designed to assist in understanding the Company&#x2019;s financial statements. Such financial statements and accompanying notes are the representations of Company&#x2019;s management, who is responsible for their integrity and objectivity. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Principles of Consolidation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of Nexalin and its wholly-owned subsidiary Neuro-Health. Intercompany accounts and transactions have been eliminated in consolidation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Use of Estimates</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions, revenue and expenses and disclosure of contingent liabilities at the date of the financial statements. The Company bases its estimates and assumptions on historical experience, known or expected trends and various other assumptions that it believes to be reasonable. As future events and their effects cannot be determined with precision, actual results could differ from these estimates which may cause the Company&#x2019;s future results to be affected. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-7</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Revenue</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company recognizes revenue when its performance obligations with its customers have been satisfied. At contract inception, the Company determines if the contract is within the scope of ASC Topic 606 and then evaluates the contract using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only recognizes revenue to the extent that it is probable that a significant revenue reversal will not occur in a future period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company enters into licensing and treatment fee agreements with its customers for the use of the Nexalin Device in their practices. These agreements generally have terms of one year with automatic renewal if certain requirements are met and amounts due per these agreements are billed monthly. The Company also sells products related to the provision of services. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Revenue Streams</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The company derives revenues from its license agreements by charging a monthly licensing fee for the duration of the agreement. The Company derives revenues from treatment fee agreements by collecting fees based on the number of treatments per month the customer performs. The company derives revenues from equipment by selling additional individual nodes to customers for use with the Nexalin Device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Performance Obligations</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management identified that subsequent licensing revenue has one performance obligation. That performance obligation is satisfied as long as the licensing contract is remains valid and is not terminated. The licensing revenue is invoiced monthly and is recognized at a point in time in which the invoice is sent to the customer. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management identified that the Company&#x2019;s equipment revenue has one performance obligation. That performance obligation is satisfied when the electrodes are delivered to the customer. The Company recognizes revenue at a point in time in which the electrodes are delivered to the customer. The Company does not offer a warranty on the electrodes and there have been no returns of equipment during the years ended December 31, 2020 and 2019. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management identified that treatment fee revenue has one performance obligation. The performance obligation is satisfied upon the completion of individual treatments on patients by customers. (The Company phased out treatment fee contracts in 2019). </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Practical Expedients</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As part of ASC 606, the Company has adopted several practical expedients including: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:16pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Significant Financing Component - the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised goods or services to the customer and when the customer pays for that service will be one year or less. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Unsatisfied Performance Obligations &#x2013; all performance obligations related to contracts with a duration of less than one year, the Company has elected to apply the optional exemption provided in ASC Topic 606 and therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Shipping and Handling Activities &#x2013; the Company elected to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Right to invoice - the Company has a right to consideration from a customer in an amount that corresponds directly with the value to the customer of the Company&#x2019;s performance completed to date the Company may recognize revenue in the amount to which the entity has a right to invoice. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Disaggregated Revenues</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Revenue consists of the following by service offering for the year ended December 31, 2020: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">

















            <tr class="odd" style=" ">

               <td colspan="2" style="width:19%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Licensing Fee</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:19%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Treatment Fee</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Equipment</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Other</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">116,178 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:17%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">125,770 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:17%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">966 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:17%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">242,914 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Revenue consists of the following by service offering for the year ended December 31, 2019: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">

















            <tr class="odd" style=" ">

               <td colspan="2" style="width:19%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Licensing Fee</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:19%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Treatment Fee</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Equipment</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Other</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">181,335 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,875 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:17%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">18,278 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:17%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,895 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:17%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">207,383 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Contract Modifications</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There were no contract modifications during the years ended December 31, 2020 and 2019. Contract modifications are not routine in the performance of the Company&#x2019;s contracts. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Cash and Cash Equivalents</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-8</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Accounts Receivable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Accounts receivable are reported at their outstanding unpaid principal balances, net of allowances for doubtful accounts. The Company periodically assesses its accounts and other receivables for collectability on a specific identification basis. The Company provides for allowances for doubtful receivables based on management&#x2019;s estimate of uncollectible amounts considering age, collection history, and any other factors considered appropriate. Payments are generally due within 30 days of invoice. The Company writes off accounts receivable against the allowance for doubtful accounts when a balance is determined to be uncollectible. The Company did not record and allowance for doubtful accounts at December 31, 2020 and 2019, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Inventory</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Inventory consists of finished goods stated at the lower of costs or net realizable value with cost determined on a first-in first-out basis. The Company reviews the composition of inventory at each reporting period in order to identify obsolete, slow-moving, quantities in excess of demand, or otherwise non-saleable items. The Company did not record a reserve for obsolete inventory at December 31, 2020 and 2019. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Equipment</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Equipment are recorded at cost. Depreciation is computed using straight-line method over the estimated useful lives of the related assets, generally five years. Expenditures that enhance the useful lives of the assets are capitalized and depreciated. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Maintenance and repairs are charged to expense as incurred. At the time of retirement or other disposition of equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Intangible Assets</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company records its intangible assets at cost in accordance with Accounting Standards Codification (&#x201C;ASC&#x201D;) 350, <font style="font-style:italic; ">Intangibles &#x2013; </font><font style="font-style:italic; ">Goodwill and Other</font>. Definite lived intangible assets are amortized over their estimated useful life using the straight-line method, which is determined by identifying the period over which the cash flows from the asset are expected to be generated. During the years ended December 31, 2020 and 2019, the Company did not record an impairment on intangible assets.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Impairment of Long-Lived Assets</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company reviews long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is determined by comparing the forecasted undiscounted net cash flows of the operation to which the assets relate to the carrying amount. If the operation is determined to be unable to recover the carrying amount of its assets, then these assets are written down first, followed by other long-lived assets of the operation to fair value. Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Advertising and Marketing Costs</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company expenses advertising and marketing costs as they are incurred. Advertising and marketing expenses were $10,710 and $11,721 for the years ended December 31, 2020 and 2019, respectively, and are recorded in selling, general and administrative expenses on the statement of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Fair Value Measurements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As defined in ASC 820, <font style="font-style:italic; ">Fair Value Measurements and Disclosures</font>, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 1:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; ">Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 2:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; ">Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 3:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; ">Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#x2019;s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-9</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Fair Value of Financial Instruments</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The carrying value of cash, accounts receivable, inventory, accounts payable and accrued expenses, and other current liabilities approximate their fair values based on the short-term maturity of these instruments. The carrying amount of the loans payable approximates the estimated fair value for this financial instrument as management believes that such debt and interest payable on the note approximates the Company&#x2019;s incremental borrowing rate. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Net Loss per Common Share</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The dilutive effect, if any, of warrants is calculated using the treasury stock method. All outstanding convertible notes are considered common stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. Since the effect of common stock equivalents is anti-dilutive with respect to losses, the warrants and shares issuable upon conversion have been excluded from the Company&#x2019;s computation of net loss per common share for the years ended December 31, 2020 and 2019. At December 31, 2020 and 2019, the Company had approximately 3,798,494 and 2,194,140 shares of common stock, respectively, yet to be issued. These shares were included in the basic and diluted net loss per common share on the consolidated statements of operations. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table summarizes the securities that would be excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company&#x2019;s net loss position even though the exercise price could be less than the most recent fair value of the common shares: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="5" style="width:44%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended December 31,</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Warrants<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,341,416 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,634,856 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Convertible notes<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">28,235 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,209,945 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,712,856 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Stock-Based Compensation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company applies the provisions of ASC 718, <font style="font-style:italic; ">Compensation - Stock Compensation</font> (&#x201C;ASC 718&#x201D;), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, including employee stock options, in the statements of operations.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For stock options issued to employees and members of the board of directors for their services, the Company estimates the grant date fair value of each option using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common stock consistent with the expected life of the option, risk-free interest rates and expected dividend yields of the common stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, the Company recognizes stock-based compensation expense equal to the grant date fair value of stock options on a straight-line basis over the requisite service period, which is generally the vesting term. Forfeitures are recorded as they are incurred as opposed to being estimated at the time of grant and revised. Due to the Company&#x2019;s limited history and lack of public market for its common stock, the Company used the average of historical share prices of similar companies within its industry to calculate volatility for use in the Black-Scholes option pricing model. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to ASU 2018-07 Compensation &#x2013; Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting, the Company accounts for stock options issued to non-employees for their services in accordance with ASC 718. The Company uses valuation methods and assumptions to value the stock options that are in line with the process for valuing employee stock options noted above. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Research and Development</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All research and development costs are charged to operations as incurred. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Leases</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In accordance with ASC 842, <font style="font-style:italic; ">Leases</font>, the Company recognized a right-of-use (&#x201C;ROU&#x201D;) asset and corresponding lease liability on its balance sheets for its office space lease agreement. See Note 10 for further discussion, including the impact on the Company&#x2019;s financial statements and related disclosures.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">ROU assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The lease terms may include options to extend or terminate the lease if it is reasonably certain that the Company will exercise that option. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Leases in which the Company is the lessee are comprised of office rental. All of the leases are classified as operating leases. The Company has a lease agreement for office space with a remaining term of 3.08 years as of December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Income Taxes</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-10</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company utilizes ASC 740, <font style="font-style:italic; ">Income Taxes</font>, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. The Company accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is &#x201C;more likely-than-not&#x201D; that a deferred tax assets will not be realized.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For uncertain tax positions that meet a &#x201C;more likely than not&#x201D; threshold, the Company recognizes the benefit of uncertain tax positions in the financial statements. The Company&#x2019;s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the statements of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Recent Accounting Pronouncements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects adoption will have on its consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 4 &#x2013; EQUIPMENT</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Equipment consists of the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Computer equipment<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,640,936 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,640,288 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Furniture and fixtures<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,035 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,035 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,642,971 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,642,323 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Less: accumulated depreciation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,641,395) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,640,966) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Equipment, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,576 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,357 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Total depreciation expense for the years ended December 31, 2020 and 2019 was $429 and $535, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 5 &#x2013; ACCOUNTS PAYABLE AND ACCRUED EXPENSES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Accounts payable and accrued expenses consist of the following amounts: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accounts payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">461,161 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">324,470 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued interest<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">171,285 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">101,031 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued insurance<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">13,845 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Credit cards - management<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">14,333 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,460 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued settlement liabilities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">336,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15,305 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">982,779 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">465,111 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 6 &#x2013; NON-CONSOLIDATED JOINT VENURE AND RELATED PARTY TRANSACTIONS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Joint Venture</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On September 21, 2018, the Company entered into a joint venture agreement (the &#x201C;JV Agreement&#x201D;) with Wider Come Limited, a China company (&#x201C;Wider&#x201D;) for the purpose of marketing, sale and distribution of the Company&#x2019;s proprietary devices for the treatment of (i) anxiety, depression and insomnia (&#x201C;AD&amp;I&#x201D;) and (ii) Alzheimer&#x2019;s and dementia (&#x201C;A&amp;D&#x201D;) in the applicable territories. Each of the parties to the joint venture will hold a 50% interest in the equity, profits and losses, shareholder voting, management control and rights to use production capacity of the facility. The Company will provide a global exclusive technology license for A&amp;D treatment to the JV and Wider will contribute $5,000,000 in funding for the design and execution of Company approved clinical studies. In addition, Wider will receive a one-eighth equity position in the company. The Company will also provide the Joint Venture (the &#x201C;JV&#x201D;) with a license for exclusive distribution of its technology for the treatment of AD&amp;I in the applicable territories. The JV will be controlled by an equally represented Board of Directors in which neither entity has sole decision-making ability over day-to-day or significant operational decisions. As of the date of this report the $5,000,000 has not been funded. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On May 22, 2019, the Company entered into a supplementary agreement for the JV Agreement (the &quot;Supplementary Agreement&quot;). Pursuant to the Supplementary Agreement, Wider was to fund the JV within thirty days of execution of the JV Agreement with $600,000 in cash to be used for clinical trials in China. Within thirty days of the funding the Company is to issue 5% of the Company in non-diluted common stock to Wider&#x2019;s shareholders. As of the date of this report the $600,000 has not been funded. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-11</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On April 6, 2020, the Company entered into a three-year service agreement with Wider, pursuant to which Wider will perform clinical trials associated with the formation of the JV. In consideration, the Company and certain designated Wider shareholders have entered into stock issuance agreements for the issuance of 9,000,000 shares of the Company&#x2019;s common stock, as a result of the Supplementary Agreement, and simultaneously with the execution of this service agreement, Wider shall contribute $200,000 to the Company. As of December 31, 2020, the Company has issued 3,000,000 shares to the designated shareholders. The fair value of the 3,000,000 shares issued (less the contributed $200,000 in cash) resulted in a charge to stock-based compensation of $550,000 and is recorded in selling, general and administrative expenses on the statement of operations. The remaining 6,000,000 shares will be issued in the following schedule upon Wider&#x2019;s successful completion of the following milestones (i) 50% upon successful completion of the fourth of four clinical trials pursuant to the terms and conditions of the service agreements and (ii) 50% upon all four trials being published in international medical journals satisfactory to the Company. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">U.S. Asian Consulting Group, LLC</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On May 9, 2018, the Company entered into a five-year consulting agreement with U.S. Asian Consulting Group, LLC (&#x201C;U.S. Asian&#x201D;). The two members of U.S. Asian are shareholders in the Company. Pursuant to the consulting agreement, U.S. Asian will provide consulting services to the Company with regards to, among other things, corporate development and financing arrangements. The Company is to pay U.S. Asian $10,000 per month for services rendered and, on October 24, 2018, the Company issued 4,995,000 shares of the Company&#x2019;s common stock to U.S. Asian. The Company recorded consulting expenses related to the consulting agreement of $120,000 and $120,000 for the years ended December 31, 2020 and 2019, respectively, on the Company&#x2019;s statements of operations. For the years ended December 31, 2020 and 2019, U.S. Asian was owed $299,320 and $197,419, respectively, for accrued and unpaid services. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to the consulting agreement, U.S Asian&#x2019;s shares in the Company consist of an anti-dilution provision whereas U.S. Asian&#x2019;s security holdings, during the term of the consulting agreement, shall remain at 10% of the Company&#x2019;s total number of issued and outstanding shares of the Company&#x2019;s common stock, on a fully diluted basis. As of December 31, 2020, the 10% anti-dilution provision, on a fully diluted basis, would result in a total of 7,954,765 shares of the Company&#x2019;s common stock. The Company recorded an additional $328,156 and $412,032 in additional paid in capital on the balance sheets for the years ended December 31, 2020 and 2019, respectively. As of December 31, 2020, the additional 2,959,765 shares of the Company&#x2019;s common stock had yet to be issued. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Loan Payable - Officer</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 11, 2019, the company received $50,000 from the Company&#x2019;s Chief Executive Officer. The loan has a principal of $50,000, an interest rate of 16.5%, and a maturity date of October 11, 2020. The issuance of the loan resulted in an original issuance discount of $9,833. Total amortization on the debt discount was $6,750 and $1,500 for the years ended December 31, 2020 and 2019, respectively. The Company paid this loan in full during the year ended December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Promissory Notes</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 19, 2018, the Company issued an on demand promissory note payable with the Company&#x2019;s Chairman of the Board for $10,000 with interest to begin accruing on January 1, 2020 at 5% per annum. Total interest expense on this note was $281 and $506 for the years ended December 31, 2020 and 2019, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 25, 2018, the Company entered into a promissory note payable with an accredited investor for $20,000 with interest at 15% per annum, due October 25, 2019. Total interest expense on this note was $2,449 for the year ended December 31, 2019. On June 1, 2019, the outstanding principal and interest was converted into 100,000 shares of the Company&#x2019;s common stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 25, 2018, the Company entered in a promissory note payable with an accredited investor for $50,000 due on October 25, 2019. Pursuant to the note, the maturity date was extended to October 25, 2020. The bears interest at 100% per annum and the note holder was issued shares of the Company&#x2019;s common stock in lieu of interest. Total interest expense related to this note was $50,000 and $41,667 for the years ended December 31, 2020 and 2019, respectively. On October 7, 2020, the Company entered into a Letter of Agreement Addendum with the note holder, whereas, the Company agreed to make ten monthly principal payments beginning November 1, 2020 with the full principal amount to be paid in full by August 31, 2021. In addition, if the full principal amount is not paid in full by August 31, 2021 the Company will issue an additional 50,000 shares of common stock to the noteholder. During the years ended December 3, 2020 and 2019, the Company paid $9,200 and $4,000, respectively, in cash towards the outstanding principal. The amount outstanding at December 31, 2020 and 2019, was $36,800 and $46,000. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 7 &#x2013; CONVERTIBLE NOTES AND LOANS PAYABLE</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Convertible Notes Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As of December 31, 2020 and 2019, convertible notes consist of the following amounts: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, due October 30, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,500 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, due November 3, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, due November 28, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, due January 13, 2024<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, due February 4, 2024<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total convertible notes payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">19,500 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Debt discounts, unamortized<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(611) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,684) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total convertible notes payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,389 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,816 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-12</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Total amortization expense was $2,074 and $15,134 for the years ended December 31, 2020 and 2019, respectively. Holders of the above convertible notes may convert at maturity date at a conversion price is 85% of the latest sale price per share. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the following convertible notes were converted into shares of the Company&#x2019;s common stock: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">







            <tr class="odd" style=" ">

               <td style="width:77%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:77%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, issued on October 31, 2018<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:77%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, issued on November 29, 2018<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,500 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:77%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, issued on January 14, 2019<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:77%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">13,500 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The above convertible notes, prior to conversion, included gross debt discounts totaling $2,382 as of December 31, 2020. Total amortization expense related to these debt discounts was $1,862 and $46 for the years ended December 31, 2020 and 2019, respectively. The above convertible notes, principal and accrued interest, were converted into an aggregate of 64,440 shares of the Company&#x2019;s common stock. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company entered into five convertible notes payable for an aggregate of $27,500 with interest at 12% per annum, with maturity dates ranging from January 10, 2024 to February 4, 2024, convertible at any time at 85% of the latest share sale price. The issuance of the convertible notes resulted in a discount from the beneficial conversion feature of $4,853. At various dates of conversion during the year ended December 31, 2019, the Company and the convertible debt holders amended the conversion terms to reflect a price of $0.50 per share. Total interest expense on these convertible notes was approximately $1,300 for the years ended December 31, 2020 and 2019. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Subsequent to December 31, 2020, the Company issued an aggregate of 40,000 shares of common stock to various investors for the conversion of $6,000 and $1,740 in principal and accrued interest, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Device Loans Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As of December 31, 2020, device loans payable consist of the following amounts: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Notes payable, due March 27, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Notes payable, due March 28, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Notes payable, due April 16, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Notes payable, due April 22, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Note payable, due April 23, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Notes payable, due April 30, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">32,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total device notes payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">92,000 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">At various dates during the years ended December 31, 2020 and 2019, the Company and the note holders settled the individual device notes in shares of the Company&#x2019;s common stock at a price range of $0.25 to $0.50 per share, resulting in $36,000 and $285,375 in outstanding principal and approximately $948 and $25,000 in accrued interest being converted into an aggregate of 147,200 and 1,078,436 shares of the Company&#x2019;s common stock, respectively. Total interest expense for the above notes was approximately $1,925 and $40,144 for the years ended December 31, 2020 and 2019, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The device notes contain an operational bonus provisions, pursuant to which, until the individual device note is paid in full, the noteholder will receive 10% of the income from the noteholders device location that is paid to the Company for the usage of that specific device. For the years ended December 31, 2020 and 2019, the Company did not pay out or record operational bonuses related to the above device notes payable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Subsequent to December 31, 2020, the Company issued an aggregate of 102,080 shares of common stock to various investors for the conversion of $16,000 and $4,416 in principal and accrued interest, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Loans Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On May 4, 2020, under the U.S. Small Business Administration&#x2019;s Paycheck Protection Program, the Company entered into a note payable with a financial institution for $22,916 at an interest rate of 1% per annum and a maturity date of June 22, 2022. Pursuant to the note, principal and interest payments are deferred for six months, which, at that time the Company may apply for loan forgiveness. If the Company does not apply for loan forgiveness the Company will be required to make monthly payments of $1,299 starting on December 1, 2020. As of December 31, 2020, the Company has not applied for loan forgiveness. All remaining unpaid principal and interest is due and payable at the maturity date. At any time during the term of the note, the note holder may call all remaining amounts owed in full. At December 31, 2020, $22,916 was outstanding. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Legacy Ventures International, Inc.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On September 11, 2017, the Company issued a promissory note (the &#x201C;Promissory Note&#x201D;) in favor of Legacy Ventures International, Inc. (&#x201C;Legacy&#x201D;) as part of a commercial transaction with Legacy that was never consummated. The Promissory Note was issued in the original principal amount of $500,000, with interest at 4% per annum and a maturity date of December 31, 2017. As of December 31, 2020, this promissory note is in default. The Company recorded $20,000 of interest expense for the years ended December 31, 2020 and 2019. The amount outstanding at December 31, 2020 and 2019, was $500,000. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-13</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 8 - STOCKHOLDERS&#x2019; EQUITY</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Equity Transactions During the Period</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued an aggregate of 1,999,192 shares of common stock for a range of $0.20 - $1.25 per share to various investors for cash proceeds of $533,498. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued an aggregate of 411,000 shares of common stock with a range of fair values of $0.25 - $0.80 per share to various consultants for services rendered in lieu of cash for a compensation charge of $562,735. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the company issued an aggregate of 1,456,786 shares of common stock to various note holders for the conversion of debt. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued an aggregate of 75,000 shares of common stock with a fair value of $1.00 per share to a note holder as inducement. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 3,470,996 shares of common stock to various investors for cash proceeds of $684,296. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 3,000,000 shares of common stock to various investors in the Company&#x2019;s JV for cash proceeds of $200,000 pursuant to a certain services agreement. The Company recorded the excess fair value of $550,000 as stock compensation expense. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 4,325,471 shares of common stock with a fair value of $0.25 per share to various consultants for services rendered in lieu of cash for a compensation charge of $1,556,956. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the company issued an aggregate of 233,273 shares of common stock to various note holders for the conversion of debt. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 325,000 shares of common stock as a result of the exercise of warrants to various investors for cash proceeds of $61,750. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued an aggregate of 50,000 shares of common stock with a fair value of $0.25 per share to a note holder as inducement. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Warrants</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The issuance of warrants to purchase shares of the Company&#x2019;s common stock including those attributed to debt issuances are summarized as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">











            <tr class="odd" style=" ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shares</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Weighted</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Average</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercise Price</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at January 1, 2019<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,514 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Granted<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,929,004 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercised<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expired or cancelled<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(305,698 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at December 31, 2019<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,633,820 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Granted<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">639,240 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercised<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(325,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expired or cancelled<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,606,644 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:69%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at December 31, 2020<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,341,416 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table summarizes information about options to purchase shares of the Company&#x2019;s common stock outstanding and exercisable at December 31, 2020: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">

















            <tr class="odd" style=" ">

               <td colspan="2" style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Range of</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">exercise prices</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Outstanding</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Warrants</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:19%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Weighted-</font> <font style="font-weight:bold; ">Average</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Remaining Life</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">In Years</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:19%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Weighted-</font> <font style="font-weight:bold; ">Average</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercise</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Price</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercisable</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,341,416 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.2 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,341,416 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:17%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,341,416 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.2 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:16%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,341,416 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The compensation expense attributed to the issuance of the warrants, if required to be recognized on the nature of the transaction, was recognized as they vested/earned. These warrants are exercisable up to one year from the date of grant. All are currently exercisable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-14</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Issuances of warrants to purchase shares of the Company&#x2019;s common stock were as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued various warrants for 3,348,710 shares of the Company&#x2019;s common stock with a range of terms of up to two years and an exercise price of $0.50 per share in connection with exchange agreements with noteholders and cash investors. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued various warrants for 380,000 shares of the Company&#x2019;s common stock to two convertible note holders with a term of twenty-four months after the Company issues a series of private funding and an exercise price of $0.50 per share with exchange agreements with noteholders. As of December 31, 2020, these private placements have not taken place. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued various warrants for 200,294 shares of the Company&#x2019;s common stock with no expiration term and an exercise price of $0.50 per share with exchange agreements with noteholders. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued various warrants for 639,240 shares of the Company&#x2019;s common stock with a range of terms up to seven months and an exercise price of $0.50 per share in connection with exchange agreements with noteholders and cash investors. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As a result of the issuance of these warrants the Company recognized $62,637 and $3,377,366 of stock compensation expense for the years ended December 31, 2020 and 2019, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Shares To Be Issued</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On December 4, 2019, a convertible note holder converted outstanding $4,000 and $760 in principal and interest, respectively, into 19,040 shares of the Company&#x2019;s common stock. As of December 31, 2019, these shares were not issued. As a result, at December 31, 2019, the Company recorded $4,760 as additional paid in capital on the balance sheets. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company received cash in the aggregate amount of $124,126 from investors for an aggregate amount of 510,000 shares of the Company&#x2019;s common stock. As of December 31, 2019, these shares were not issued. As of December 31, 2020, 262,000 (not including the 2,954,365 shares to be issued to U.S. Asian as noted in Note 6) of these shares were not issued. As a result, at December 31, 2019, the Company recorded $124,126 as additional paid in capital on the balance sheets. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 9 &#x2013; COMMITMENTS AND CONTINGENCIES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Legal Claims</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There are no material pending legal proceedings in which the Company or any of its subsidiaries is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of its voting securities, or security holder is a party adverse to us or has a material interest adverse to the Company other than the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Sarah Veltz v. Nexalin Technology, Inc. et al.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Plaintiff, Sarah Veltz, filed a lawsuit in this matter on January 20, 2021 in Orange County Superior Court (Case No. 30-2021-01180164-CU-WT-CJC) (the &#x201C;Complaint&#x201D;) naming the Company and others as defendants. In her Complaint, Plaintiff contends that she was employed by defendants, including Nexalin, and has not been paid all wages, including overtime wages and other benefits allegedly due her. Plaintiff also contends that, during her employment, she was subjected to sexual harassment by the Company&#x2019;s then Chief Executive Officer. Plaintiff seeks both compensatory and punitive damages. On March 12, 2021, the Company filed its answer to the Complaint. The court has set a jury trial in this matter for April 24, 2023. Management&#x2019;s intent is to contest the allegations vigorously and, as of the date of this report, is unable to provide an evaluation of the potential outcome of the litigation within the probable or remote range or to provide an estimate of the amount of or a range of potential loss that might be incurred by the Company. The Company believes its potential exposure to be approximately $50,000 and, as such, has accrued this amount on the consolidated balance sheet at December 31, 2020. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Employment Development Department</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company is currently engaged in settlement discussions with the Employment Development Department (EDD) of the state of California. This matter involves issues related to our previous management&#x2019;s classification of certain work provided to or on behalf of our business as contract labor instead of employee labor. The EDD has subpoenaed six years&#x2019; worth of information from us and currently is considering levying a $286,000 tax charge against us. We have petitioned for reassessment and believe the hired workers at issue were indeed actual contractors and not employees. All our business in California has been closed and moved out of the state. A settlement with EDD is anticipated within twenty-four months. The Company believes its potential exposure to be approximately $286,000 and, as such, has accrued this amount on the consolidated balance sheet at December 31, 2020. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 10 &#x2013; LEASES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as ROU assets and corresponding lease liabilities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On June 1, 2018, the Company recognized ROU assets and lease liabilities of $129,376. The Company elected to not recognize ROU assets and lease liabilities arising from short-term office leases, leases with initial terms of twelve months or less (deemed immaterial) on the balance sheets. On August 1, 2019, the Company exercised its right to lease an additional 500 square feet of office space. As a result, the Company recorded an additional ROU asset and lease liability of $21,671. During the year ended December 31, 2020, the Company exercised its right to lease an additional 1,000 square feet of office space. As a result, the Company recorded an additional lease liability of $37,047. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">When measuring lease liabilities for leases that were classified as operating leases, the Company discounted lease payments using its estimated incremental borrowing rate at June 1, 2018. The weighted average incremental borrowing rate applied was 10%. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-15</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table presents net lease cost and other supplemental lease information: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, 2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, 2019</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Lease cost<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:20pt; margin-top:0pt; margin-bottom:0pt; ">Operating lease cost (cost resulting from lease payments)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">43,500 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">32,500 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:20pt; margin-top:0pt; margin-bottom:0pt; ">Short term lease cost<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:20pt; margin-top:0pt; margin-bottom:0pt; ">Sublease income<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net lease cost<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">43,500 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">32,500 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating lease &#x2013; operating cash flows (fixed payments)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating lease &#x2013; operating cash flows (liability reduction)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">30,422 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">20,559 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Non-current leases &#x2013; right of use assets&#x200B;<sup>(1)</sup><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Current liabilities &#x2013; operating lease liabilities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,973 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">25,102 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Non-current liabilities &#x2013; operating lease liabilities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">89,934 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">95,181 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:36pt; margin-top:8pt; margin-bottom:0pt; ">(1)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;During the years ended December 31, 2020 and 2019 the Company performed impairment analyses on the right of use assets recorded as a result of the office space expansion. The Company concluded that the carrying amount of the right of use asset would not be recoverable due to the Company forecasting that the future undiscounted net cash flow of the Company would not exceed the carrying amount of the right of use asset. As a result, the Company recorded a loss on impairment of right of use asset of $37,047 and $21,670 on its consolidated statement of operations during the years ended December 31, 2020 and 2019. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Future minimum payments under non-cancellable leases for operating leases for the remaining terms of the leases following the year ended December 31, 2020: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">







            <tr class="odd" style=" ">

               <td style="width:67%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Fiscal Year</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:31%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Operating Leases</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:67%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2021<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">48,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:67%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2022<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">48,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:67%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">48,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:67%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2024<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:30%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:67%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Total future minimum lease payments<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">148,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:67%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount representing interest<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:30%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(21,093) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:67%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Present value of net future minimum lease payments<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:30%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">126,907 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 11 &#x2013; CONCENTRATION OF CREDIT RISK</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Cash Deposits</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (&quot;FDIC&quot;) up to $250,000. As of December 31, 2020 and 2019, the Company did not have any amounts in excess of the FDIC insured limit. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Revenues</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">One customer accounted for 41% of revenue for the year ended December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Two customers accounted for 25% of revenue for the year ended December 31, 2019, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">15% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">10% </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Accounts Receivable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Four customers accounted for 78% of the accounts receivable as of December 31, 2020, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">30% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">18% </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer C<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">15% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer D<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">15% </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Three customers accounted for 67% of the accounts receivable as of December 31, 2019, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">30% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">22% </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Customer C<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">15% </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Accounts Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Two vendors accounted for 65% of accounts payable as of December 31, 2020, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Vendor A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">55% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Vendor B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:50%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">10% </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">One vendor accounted for 64% of the accounts payable as of December 31, 2019. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-16</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 12 &#x2013; INCOME TAXES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company identified their federal and Nevada state tax returns as their &#x201C;major&#x201D; tax jurisdictions. The periods for income tax returns that are subject to examination for these jurisdictions is 2016 through 2020. The Company believes their income tax filing positions and deductions will be sustained on audit, and they do not anticipate any adjustments that would result in a material change to their financial position. Therefore, no liabilities for uncertain tax positions have been recorded. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">At December 31, 2020, the Company had approximately $17,191,410 in net operating loss carry-forwards for federal and state income tax reporting (tax effected) purposes. As a result of the Tax Cuts Job Act 2017 (the &#x201C;Act&#x201D;), certain future carry-forwards do not expire. The Company has not performed a formal analysis, but believes its ability to use such net operating losses and tax credit carry-forwards in the future is subject to annual limitations due to change of control provisions under Sections 382 and 383 of the Internal Revenue Code, which will significantly impact its ability to realize these deferred tax assets. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company&#x2019;s net deferred tax assets, liabilities and valuation allowance as of December 31, 2020 and 2019 are summarized as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:34%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Year Ended December 31,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Deferred tax assets:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Net operating loss carry forwards<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">17,990,052 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">17,191,410 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Valuation allowance<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(17,990,052 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(17,191,410 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:64%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Net deferred tax assets<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We recorded a valuation allowance in the full amount of our net deferred tax assets since realization of such tax benefits has been determined by our management to be less likely than not. The valuation allowance increased $798,642 during the year ended December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">A reconciliation of the statutory federal income tax benefit to actual tax benefit for the years ended December 31, 2020 and 2019 is as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2019</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Federal statutory blended income tax rates<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(21 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">)% </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(21 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">)% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">State statutory income tax rate, net of federal benefit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Change in valuation allowance<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">26 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">27 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(5 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(6 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Effective tax rate<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">% </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">%  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As of the date of this filing, the Company has not filed its 2020 federal and state corporate income tax returns. The Company expects to file these documents as soon as practicable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Act was enacted on December 22, 2017. The Act reduces the U.S. federal corporate tax rate from 35% to 21% and will require the Company to re-measure certain deferred tax assets and liabilities based on the rates at which they are anticipated to reverse in the future, which is generally 21%. The Company adopted the new rate as it relates to the calculations of deferred tax amounts as of December 22, 2017. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 13 &#x2013; SUBSEQUENT EVENTS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Commitments</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On February 15, 2021, the Company entered into an employment agreement with Mark White to serve as Chief Executive Officer of the Company for a three-year term. Pursuant to the agreement, Mr. White is entitled to receive $200,000 in annual compensation and is eligible to receive up to $200,000 in cash and stock-based compensation upon achieving certain performance metrics. Should Mr. White receive stock-based bonus compensation he shall be entitled to receive options to purchase up to 20% of the number of shares issued as stock-based bonus compensation. Additionally, pursuant to the agreement, the Company shall issue shares of the Company&#x2019;s common stock in an amount sufficient for Mr. White to own an aggregate amount of two (2%) percent of the Company&#x2019;s issued and outstanding shares as of the date effective date of the agreement, or 1,616,526 shares of the Company&#x2019;s common stock. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On February 15, 2021, the Company entered into an employment agreement with David Owens, MD to serve as Chief Medical Officer of the Company for a three-year term. Pursuant to the agreement, Dr. Owens is entitled to receive $150,000 in annual compensation that is payable to him by the issuance of Company common stock and he is eligible to receive bonus compensation based upon achieving certain performance metrics. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On February 22, 2021, the Company entered into an engagement letter with Maxim Group LLC (&#x201C;Maxim&#x201D;), pursuant to which Maxim will act as the exclusive lead managing underwriter and book runner in connection with the Initial Public Offering on a &#x201C;firm commitment&#x201D; basis. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In March 2021, the Company entered into an agreement with U.S. Asian pursuant to which U.S. Asian waived and relinquished any rights of protection against dilution afforded to it, provided such dilution results from a transaction that (i) imputes a pre-money valuation to the Company of not less than $7 million, (ii) raises not less than $7 million, and (iii) imputes a post-money valuation to the Company of not less than $25 million. In exchange for the waiver and relinquishment of such rights, the Company will issue shares of the Company&#x2019;s common stock in an amount sufficient for U.S. Asian (together with its owners) to own an aggregate amount of fifteen (15%) percent of the Company&#x2019;s issued and outstanding shares of common stock as of the date of issuance. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-17</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Issuance of Common Stock</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During 2021, the Company issued an aggregate of 210,140 shares of common stock to various note holders for the conversion of $30,000 and $8,625 in principal and accrued interest, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During 2021, the Company issued an aggregate of 2,763,529 shares of common stock to various investors for cash proceeds of $605,156. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During 2021, the company issued an aggregate of 11,477,921 shares of common stock to various consultants for services provided in lieu of cash for a total of $2,615,154. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During 2021, the Company issued an aggregate of 169,832 shares of common stock to various investors for the exercise of warrants for cash proceeds of $35,966. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Loans Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On February 4, 20201, under the U.S. Small Business Administration&#x2019;s Paycheck Protection Program, the Company entered into a note payable with a financial institution for $22,916 at an interest rate of 1% per annum and a maturity date of February 4, 2026. Pursuant to the note, principal and interest payments are deferred for ten months, which, at any time during the ten months the Company may apply for loan forgiveness. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management has evaluated subsequent events through to the date these financial statements were issued. Based on their evaluation, no material events, other than what has been disclosed above, have occurred that require disclosure. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-18</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:48pt; margin-bottom:0pt; " id="d1e22024_anchor d1e22045_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. AND SUBSIDIARY</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONDENSED CONSOLIDATED BALANCE SHEETS</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2021</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Unaudited)</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">ASSETS</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Current Assets:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,07,946 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,436 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accounts receivable, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">14,295 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,599 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Inventory<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">18,227 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">22,656 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Prepaid expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">17,271 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">9,194 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Current Assets</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">357,739 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">116,885 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Equipment, net of accumulated depreciation of $1,641,644 and $1,641,395, respectively<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,307 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,576 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Assets</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">359,046 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">118,461 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Current Liabilities:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:20pt !important; margin-top:0pt; margin-bottom:0pt; ">Accounts payable and accrued expenses (Includes related party of $359,320 and $299,320, respectively)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,263,352 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">982,779 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Lease liability<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">38,861 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,973 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Loan payable - shareholder<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">42,200 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">46,800 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Note payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">500,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">500,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Deferred revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">130,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Current Liabilities</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,974,413 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,566,552 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Long-term Liabilities:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Lease liability - net of current portion<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">70,020 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">89,934 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">PPP Loan payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">45,832 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">22,916 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Device loan payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Convertible debt, net of discount of $- and $611, respectively<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,389 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Liabilities</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,090,265 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,708,791 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Commitments and Contingencies</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Stockholders&apos; Deficit:</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:20pt !important; margin-top:0pt; margin-bottom:0pt; ">Common stock, $0.001 par value; 100,000,000 shares authorized; 88,124,701 and 73,909,279 shares issued and outstanding, respectively<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">88,125 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">73,909 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Additional paid in capital<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">66,476,544 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,949,281 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accumulated deficit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(68,295,888 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(64,613,520 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Stockholders&apos; Deficit</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,731,219 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,590,330 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total Liabilities and Stockholders&apos; Deficit</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">359,046 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">118,461 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying notes are an integral part of these condensed consolidated financial statements.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-19</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e23255_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. AND SUBSIDIARY</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Unaudited)</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:24%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">For the Six Months Ended</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, 2021</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, 2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Revenues, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">64,096 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">173,505 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cost of revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">13,142 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10,748 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross profit<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">50,954 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">162,758 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating expenses:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Professional fees<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">302,362 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">99,886 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Salaries and benefits<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">96,525 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">37,596 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Selling, general and administrative<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,297,730 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,174,418 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total operating expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,696,617 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,311,901 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss from operations<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,645,663 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,149,143 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Other expense:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Interest expense, net<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,705 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">39,652 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total other expense<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">36,705 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">39,652 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,682,368 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,188,795 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Loss per Common Share - Basic and Diluted<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.05 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(0.03 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Weighted Average Shares Outstanding - Basic and Diluted<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">79,151,987 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">65,875,892 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying notes are an integral part of these condensed consolidated financial statements.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-20</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e23976_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. AND SUBSIDIARY</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&apos; DEFICIT</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Unaudited)</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">
























            <tr class="odd" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:28%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Common Stock</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Additional </font><font style="font-weight:bold; ">Paid-in</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Accumulated</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total </font><font style="font-weight:bold; ">Shareholders&apos;</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shares</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Amount</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Capital</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Deficit</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:13%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Deficit</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance at January 1, 2020</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,718,539 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,718 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">59,967,945 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(61,210,034) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,179,371) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock issued for cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,672,800 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,673 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">298,329 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">302,002 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Warrants issued to investors<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">12,901 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">12,901 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock compensation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,760,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,760 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,959,262 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,962,022 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Shares issued for conversion of debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">198,960 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">199 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">49,541 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">49,740 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Shares issued for exercise of warrants<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">111,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">111 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15,639 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15,750 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,188,795) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,188,795) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance as of June 30, 2020</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">69,461,299 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">69,461 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,303,617 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(63,398,829) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,025,752) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance at January 1, 2021</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">73,909,279 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">73,909 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">62,949,281 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(64,613,520) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,590,330) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock issued for cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,757,529 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,758 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">600,899 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">603,657 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Stock compensation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,077,921 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,078 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,852,152 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,863,230 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Shares issued for conversion of debt<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">210,140 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">210 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">38,415 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">38,625 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:-10pt !important; padding-left:10pt !important; margin-top:0pt; margin-bottom:0pt; ">Shares issued for exercise of warrants<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">169,832 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">170 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">35,797 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">35,967 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,682,368) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,682,368) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:26%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Balance as of June 30, 2021</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">88,124,701 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">88,125 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">66,476,544 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(68,295,888) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(1,731,219) </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying footnotes are an integral part of these condensed consolidated financial statements.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-21</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e25202_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. AND SUBSIDIARY</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">(Unaudited)</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="6" style="width:24%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Six Months Ended</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, 2021</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30, 2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash flows from operating activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Loss<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(3,682,368) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(2,188,795) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Adjustments to reconcile net loss to net cash used in operating activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Stock compensation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,863,230 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,962,022 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Warrants issued to investors<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">12,901 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Issuance of common stock for inducement of loan payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Amortization of debt discount<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">58 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,037 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Depreciation<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">269 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">203 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Changes in operating assets and liabilities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accounts receivable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(7,696) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">2,395 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Prepaid assets<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(8,077) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(4,503) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Inventory<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,429 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,434 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accounts payable and accrued expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">229,751 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(31,743) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Accounts payable - related party<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">60,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">101,901 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Deferred revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">130,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Lease liability<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(18,026) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11,997 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash used in operating activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(428,430) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(129,151) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash flows from financing activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Sale of common stock for cash<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">603,657 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">302,002 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Proceeds from exercise of warrants<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">35,967 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15,750 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Proceeds from PPP loans<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">22,916 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">22,916 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Payments on loan payable - shareholder<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(4,600) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(32,000) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Payments on notes payable - officer<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(41,667) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net cash provided by financing activities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">657,940 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">267,001 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net increase in cash and cash equivalents<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">229,510 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">137,850 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents - beginning of year<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">78,436 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">63,427 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash and cash equivalents - end of year<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">307,946 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">201,277 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Supplemental cash flow information:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash paid for:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Interest<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Non-cash investing and financing activities:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Conversion of debt and accrued interest into common stock<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">38,625 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">49,740 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">The accompanying footnotes are an integral part of these condensed consolidated financial statements.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-22</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; " id="d1e26264_anchor"><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC. AND SUBSIDIARY</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:21pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 1 &#x2013; ORGANIZATION AND BUSINESS OPERATIONS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Corporate History</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Nexalin Technology, Inc. (&#x201C;Nexalin,&#x201D; or the &#x201C;Company&#x201D;) was formed on October 19, 2010 as a Nevada corporation. The Company&#x2019;s principal offices are located at 1776 Yorktown, Suite 550, Houston, Texas 77056. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On September 6, 2019, Neuro-Health International, Inc. (&#x201C;Neuro-Health&#x201D;), a Nevada corporation, a wholly-owned subsidiary of the Company, was formed. Neuro-Health had no activity during the years ended December 31, 2019 and 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Business Overview</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company is a medical device company that licenses and markets a Federal Drug Administration approved non-invasive and drug-free therapy for the treatment of anxiety, depression, and insomnia (the &#x201C;Nexalin Device&#x201D; or &#x201C;Nexalin Therapy&#x201D; and, collectively, &#x201C;Nexalin&#x201D;). The Nexalin Device emits a patented, frequency-based waveform that interacts with the structures of the mid-brain that help to regulate and stabilize neurochemicals. The hypothesis is that Nexalin stimulates the hypothalamus and areas of the brain associated with mood control. The Nexalin device transmits a gentle, undetectable frequency-based waveform that is administered via electrode pads that are placed on the forehead and behind each ear of the patient. The Nexalin Therapy sessions last approximately forty minutes. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 2 &#x2013; GOING CONCERN AND LIQUIDITY</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The accompanying unaudited condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. At June 30, 2021, the Company had a significant accumulated deficit of approximately $68,048,000 and working capital deficit of approximately $1,617,000. For the six months ended June 30, 2021, the Company had a loss from operations of approximately $3,398,000 and negative cash flows from operations of approximately $429,000. The Company&#x2019;s operating activities consume the majority of its cash resources. The Company will continue to promote its services to existing and potential customers, but it anticipates that it will continue to incur operating losses as it executes its development plans through 2021, as well as other potential strategic and business development initiatives. In addition, the Company has had and expects to have negative cash flows from operations, at least into the near future. The Company previously funded these losses primarily through the sale of equity and issuance of convertible notes. The accompanying unaudited consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management intends to raise significant funds through the Initial Public Offering and contemplates the filing of a Form S-1 with the Securities and Exchange Commission on or about @@, 2021. Management believes that the actions presently being taken to further implement its business plan will enable the Company to continue as a going concern. While the Company believes in its viability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company&#x2019;s ability to further implement its business plan and raise additional funds through the Initial Public Offering or otherwise. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Although no assurances can be given as to the Company&#x2019;s ability to deliver on its revenue plans or that unforeseen expenses may arise, management believes that the revenue to be generated from operations, together with the potential closing of the Initial Public Offering in the near term, will provide the necessary funding for the Company to continue as a going concern. Management cannot guarantee any such Initial Public Offering will be available on favorable terms. As such, these matters raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of twelve months from the issue date of this report. If adequate funds are not available on acceptable terms, or at all, the Company will need to curtail operations or cease operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-23</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 3 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Basis of Presentation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The accompanying unaudited condensed consolidated financial information as of and for the six months ended June 30, 2021 and 2020 has been prepared in accordance with GAAP for interim financial information. In the opinion of management, such financial information includes all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the Company&#x2019;s financial position at such dates and the operating results and cash flows for such periods. Operating results for the six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the entire year or for any other subsequent interim period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (the &#x201C;SEC&#x201D;). These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company&#x2019;s audited financial statements for the year ended December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Principles of Consolidation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The unaudited condensed consolidated financial statements include the accounts of Nexalin and its wholly-owned subsidiary Neuro-Health. Intercompany accounts and transactions have been eliminated in consolidation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Use of Estimates</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions, revenue and expenses and disclosure of contingent liabilities at the date of the financial statements. The Company bases its estimates and assumptions on historical experience, known or expected trends and various other assumptions that it believes to be reasonable. As future events and their effects cannot be determined with precision, actual results could differ from these estimates which may cause the Company&#x2019;s future results to be affected. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Revenue</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company recognizes revenue when its performance obligations with its customers have been satisfied. At contract inception, the Company determines if the contract is within the scope of ASC Topic 606 and then evaluates the contract using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only recognizes revenue to the extent that it is probable that a significant revenue reversal will not occur in a future period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company enters into licensing and treatment fee agreements with its customers for the use of the Nexalin Device in their practices. These agreements generally have terms of one year with automatic renewal if certain requirements are met and amounts due per these agreements are billed monthly. The Company also sells products related to the provision of services. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Revenue Streams</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The company derives revenues from its license agreements by charging a monthly licensing fee for the duration of the agreement. The company derives revenues from equipment by selling additional individual nodes to customers for use with the Nexalin Device. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-24</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Performance Obligations</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management identified that subsequent licensing revenue has one performance obligation. That performance obligation is satisfied as long as the licensing contract is remains valid and is not terminated. The licensing revenue is invoiced monthly and is recognized at a point in time in which the invoice is sent to the customer. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Management identified that the Company&#x2019;s equipment revenue has one performance obligation. That performance obligation is satisfied when the electrodes are delivered to the customer. The Company recognizes revenue at a point in time in which the electrodes are delivered to the customer. The Company does not offer a warranty on the electrodes and there have been no returns of equipment during the six months ended June 30, 2021 and 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Practical Expedients</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As part of ASC 606, the Company has adopted several practical expedients including: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:16pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Significant Financing Component - the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised goods or services to the customer and when the customer pays for that service will be one year or less. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Unsatisfied Performance Obligations &#x2013; all performance obligations related to contracts with a duration of less than one year, the Company has elected to apply the optional exemption provided in ASC Topic 606 and therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Shipping and Handling Activities &#x2013; the Company elected to account for shipping and handling activities as a fulfillment cost rather than as a separate performance obligation. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:57pt; margin-top:-12pt; margin-bottom:0pt; ">Right to invoice - the Company has a right to consideration from a customer in an amount that corresponds directly with the value to the customer of the Company&#x2019;s performance completed to date the Company may recognize revenue in the amount to which the entity has a right to invoice. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Disaggregated Revenues</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Revenue consists of the following by service offering for the six months ended June 30, 2021: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">














            <tr class="odd" style=" ">

               <td colspan="2" style="width:24%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Licensing Fee</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Equipment</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Other</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:22%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:22%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:22%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">55,938 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:22%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">7,980 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:22%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">178 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:22%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">64,096 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Revenue consists of the following by service offering for the six months ended June 30, 2020: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">














            <tr class="odd" style=" ">

               <td colspan="2" style="width:24%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Licensing Fee</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Equipment</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Other</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Total</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:23%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:22%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:22%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:22%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:23%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">55,613 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:22%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">117,892 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:22%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:22%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">173,505 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; ">Contract Modifications</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">There were no contract modifications during the six months ended June 30, 2021 and 2020. Contract modifications are not routine in the performance of the Company&#x2019;s contracts. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Deferred Revenue</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company receives payment for equipment and devices in advance of shipping. The Company recognizes the revenue as being earned upon delivery. Deferred revenue of $130,000 and $- was recognized as of June 30, 2021 and December 31, 2020, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-25</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Deferred revenue activity as of June 30, 2021, is summarized below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">








            <tr class="odd" style=" ">

               <td style="width:75%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Deferred</font>
                  </p>

               </td>

               <td style="width:2%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:75%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Revenue</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:75%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:75%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at January 1, 2021<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:75%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Recognized<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">130,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:75%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Transferred to revenue<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:75%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at June 30, 2021<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">130,000 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Cash and Cash Equivalents</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Accounts Receivable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Accounts receivable are reported at their outstanding unpaid principal balances, net of allowances for doubtful accounts. The Company periodically assesses its accounts and other receivables for collectability on a specific identification basis. The Company provides for allowances for doubtful receivables based on management&#x2019;s estimate of uncollectible amounts considering age, collection history, and any other factors considered appropriate. Payments are generally due within 30 days of invoice. The Company writes off accounts receivable against the allowance for doubtful accounts when a balance is determined to be uncollectible. The Company did not record and allowance for doubtful accounts at June 30, 2021 or December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Inventory</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Inventory consists of finished goods stated at the lower of costs or net realizable value with cost determined on a first-in first-out basis. The Company reviews the composition of inventory at each reporting period in order to identify obsolete, slow-moving, quantities in excess of demand, or otherwise non-saleable items. The Company did not record a reserve for obsolete inventory at June 30, 2021 or December 31, 2020. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Equipment</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Equipment are recorded at cost. Depreciation is computed using straight-line method over the estimated useful lives of the related assets, generally five years. Expenditures that enhance the useful lives of the assets are capitalized and depreciated. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Maintenance and repairs are charged to expense as incurred. At the time of retirement or other disposition of equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Impairment of Long-Lived Assets</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company reviews long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is determined by comparing the forecasted undiscounted net cash flows of the operation to which the assets relate to the carrying amount. If the operation is determined to be unable to recover the carrying amount of its assets, then these assets are written down first, followed by other long-lived assets of the operation to fair value. Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-26</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Advertising and Marketing Costs</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company expenses advertising and marketing costs as they are incurred. Advertising and marketing expenses were $27,878 and $4,675 for the six months ended June 30, 2021 and 2020, respectively, and are recorded in selling, general and administrative expenses on the unaudited condensed statement of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Fair Value Measurements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As defined in ASC 820, <font style="font-style:italic; ">Fair Value Measurements and Disclosures</font>, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 1:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; ">Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 2:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; ">Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:10%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Level 3:<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:90%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; margin-bottom:0pt; ">Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#x2019;s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Fair Value of Financial Instruments</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The carrying value of cash, accounts receivable, inventory, accounts payable and accrued expenses, and other current liabilities approximate their fair values using level 3 inputs, based on the short-term maturity of these instruments. The carrying amount of the loans payable approximates the estimated fair value for this financial instrument as management believes that such debt and interest payable on the note approximates the Company&#x2019;s incremental borrowing rate. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Net Loss per Common Share</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The dilutive effect, if any, of warrants is calculated using the treasury stock method. All outstanding convertible notes are considered common stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. Since the effect of common stock equivalents is anti-dilutive with respect to losses, the warrants and shares issuable upon conversion have been excluded from the Company&#x2019;s computation of net loss per common share for the six months ended June 30, 2021 and 2020. These shares were included in the basic and diluted net loss per common share on the unaudited condensed consolidated statements of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-27</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table summarizes the securities that would be excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company&#x2019;s net loss position even though the exercise price could be less than the most recent fair value of the common shares: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="5" style="width:44%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Six Months Ended June 30,</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2021</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Warrants<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">816,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,855,074 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Convertible notes<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">34,000 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">816,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3,889,074 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Stock-Based Compensation</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company applies the provisions of ASC 718, <font style="font-style:italic; ">Compensation - Stock Compensation</font> (&#x201C;ASC 718&#x201D;), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, including employee stock options, in the statements of operations.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For stock options issued to employees and members of the board of directors for their services, the Company estimates the grant date fair value of each option using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common stock consistent with the expected life of the option, risk-free interest rates and expected dividend yields of the common stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, the Company recognizes stock-based compensation expense equal to the grant date fair value of stock options on a straight-line basis over the requisite service period, which is generally the vesting term. Forfeitures are recorded as they are incurred as opposed to being estimated at the time of grant and revised. Due to the Company&#x2019;s limited history and lack of public market for its common stock, the Company used the average of historical share prices of similar companies within its industry to calculate volatility for use in the Black-Scholes option pricing model. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to ASU 2018-07 Compensation &#x2013; Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting, the Company accounts for stock options issued to non-employees for their services in accordance with ASC 718. The Company uses valuation methods and assumptions to value the stock options that are in line with the process for valuing employee stock options noted above. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Research and Development</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All research and development costs are charged to operations as incurred. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Leases</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In accordance with ASC 842, <font style="font-style:italic; ">Leases</font>, the Company recognized a right-of-use (&#x201C;ROU&#x201D;) asset and corresponding lease liability on its balance sheets for its office space lease agreement. See Note 10 for further discussion, including the impact on the Company&#x2019;s unaudited condensed consolidated financial statements and related disclosures.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">ROU assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The lease terms may include options to extend or terminate the lease if it is reasonably certain that the Company will exercise that option. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Leases in which the Company is the lessee are comprised of office rental. All of the leases are classified as operating leases. The Company has a lease agreement for office space with a remaining term of 2.58 years as of June 30, 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-28</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Income Taxes</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The Company utilizes ASC 740, <font style="font-style:italic; ">Income Taxes</font>, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. The Company accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is &#x201C;more likely-than-not&#x201D; that a deferred tax assets will not be realized.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">For uncertain tax positions that meet a &#x201C;more likely than not&#x201D; threshold, the Company recognizes the benefit of uncertain tax positions in the financial statements. The Company&#x2019;s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the statements of operations. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Recent Accounting Pronouncements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects adoption will have on its consolidated financial statements. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In March 2021, the FASB issued ASU 2021-03, Intangibles &#x2013; Goodwill and Other (Topic 350) (&#x201C;ASU 2021-03&#x201D;) which requires an entity to identify and evaluate goodwill impairment triggering events when they occur to determine whether it is more likely than not that the fair value of a reporting unit (or entity, if the entity has elected the accounting alternative for amortizing goodwill and chosen that option) is less than its carrying amount. If an entity determines that it is more likely than not that the goodwill is impaired, it must test goodwill for impairment using the triggering event date as the measurement date. An entity is required to disclose the amount assigned to goodwill in total and by major business combination, or by reorganization event resulting in fresh-start-start reporting. Also, the weighted average amortization period in total and the amortization period by major business combination, or by reorganization event resulting in fresh-start reporting. ASU 2021-03 was effective for the Company on January 1, 2021 and did not have a significant impact on its unaudited condensed consolidated financial statement. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">In May 2021, the FASB issued ASU 2021-04 &#x201C;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014; Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815- 40) Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#x201D; which clarifies and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. An entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as follows: i) for a modification or an exchange that is a part of or directly related to a modification or an exchange of an existing debt instrument or line-of-credit or revolving-debt arrangements (hereinafter, referred to as a &#x201C;debt&#x201D; or &#x201C;debt instrument&#x201D;), as the difference between the fair value of the modified or exchanged written call option and the fair value of that written call option immediately before it is modified or exchanged; ii) for all other modifications or exchanges, as the excess, if any, of the fair value of the modified or exchanged written call option over the fair value of that written call option immediately before it is modified or exchanged. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-29</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; ">modifications or exchanges occurring on or after the effective date of the amendments. The Company is currently evaluating the impact of this standard on its unaudited condensed consolidated financial statements </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 4 &#x2013; ACCOUNTS PAYABLE AND ACCRUED EXPENSES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Accounts payable and accrued expenses consist of the following amounts: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">










            <tr class="odd" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">June 30,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2021</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31,</font>
                  </p>

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accounts payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">713,153 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">461,161 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued interest<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">192,537 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">171,285 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued settlements<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">336,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">336,000 </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">21,664 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">14,333 </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:54%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,263,354 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">982,779 </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 5 &#x2013; NON-CONSOLIDATED JOINT VENURE AND RELATED PARTY TRANSACTIONS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Joint Venture</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On September 21, 2018, the Company entered into a joint venture agreement (the &#x201C;JV Agreement&#x201D;) with Wider Come Limited, a China company (&#x201C;Wider&#x201D;) for the purpose of marketing, sale and distribution of the Company&#x2019;s proprietary devices for the treatment of (i) anxiety, depression and insomnia (&#x201C;AD&amp;I&#x201D;) and (ii) Alzheimer&#x2019;s and dementia (&#x201C;A&amp;D&#x201D;) in the applicable territories. Each of the parties to the joint venture holds a 50% interest in the equity, profits and losses, shareholder voting, management control and rights to use production capacity of the facility. The Company will provide a global exclusive technology license for A&amp;D treatment to the JV and Wider will contribute $5,000,000 in funding for the design and execution of Company approved clinical studies. In addition, Wider will receive a one-eighth equity position in the company. The Company will also provide the Joint Venture (the &#x201C;JV&#x201D;) with a license for exclusive distribution of its technology for the treatment of AD&amp;I in the applicable territories. The JV is controlled by an equally represented Board of Directors in which neither entity has sole decision-making ability over day-to-day or significant operational decisions. As of the issuance date of these unaudited condensed consolidated financial statements the $5,000,000 has not been funded. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On May 22, 2019, the Company entered into a supplementary agreement for the JV Agreement (the &quot;Supplementary Agreement&quot;). Pursuant to the Supplementary Agreement, Wider was to fund the JV within thirty days of execution of the JV Agreement with $600,000 in cash to be used for clinical trials in China. Within thirty days of the funding the Company is to issue 5% of the Company in non-diluted common stock to Wider&#x2019;s shareholders. As of the issuance date of these unaudited condensed consolidated financial statements the $600,000 has not been funded. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On April 6, 2020, the Company entered into a three-year service agreement with Wider, pursuant to which Wider will perform clinical trials associated with the formation of the JV. In consideration, the Company and certain designated Wider shareholders have entered into stock issuance agreements for the issuance of 9,000,000 shares of the Company&#x2019;s common stock, as a result of the Supplementary Agreement, and simultaneously with the execution of this service agreement, Wider shall contribute $200,000 to the Company. As of December 31, 2020, the Company has issued 3,000,000 shares to the designated shareholders. The fair value of the 3,000,000 shares issued (less the contributed $200,000 in cash) resulted in a charge to stock-based compensation of $550,000 and is recorded in selling, general and administrative expenses on the statement of operations. The remaining 6,000,000 shares, which are being held in escrow, will be issued in the following schedule upon Wider&#x2019;s successful completion of the following milestones (i) 50% upon successful completion of the fourth of four clinical trials pursuant to the terms and conditions of the service agreements and (ii) 50% upon all four trials being published in international medical journals satisfactory to the Company. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-30</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">U.S. Asian Consulting Group, LLC</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On May 9, 2018, the Company entered into a five-year consulting agreement with U.S. Asian Consulting Group, LLC (&#x201C;U.S. Asian&#x201D;). The two members of U.S. Asian are shareholders in the Company. Pursuant to the consulting agreement, U.S. Asian will provide consulting services to the Company with regards to, among other things, corporate development and financing arrangements. The Company is to pay U.S. Asian $10,000 per month for services rendered and, on October 24, 2018, the Company issued 4,995,000 shares of the Company&#x2019;s common stock to U.S. Asian. The Company recorded consulting expenses related to the consulting agreement of $60,000 for the six months ended June 30, 2021 and 2020, respectively, on the Company&#x2019;s unaudited condensed consolidated statements of operations. At June 30, 2021 and December 31, 2020, U.S. Asian was owed $359,320 and $299,320, respectively, for accrued and unpaid services. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to the consulting agreement, U.S Asian&#x2019;s shares in the Company consist of an anti-dilution provision whereas U.S. Asian&#x2019;s security holdings, during the term of the consulting agreement, shall remain at 10% of the Company&#x2019;s total number of issued and outstanding shares of the Company&#x2019;s common stock, on a fully diluted basis. In March 2021, the Company entered into an agreement with U.S. Asian pursuant to which U.S. Asian waived and relinquished any rights of protection against dilution afforded to it, provided such dilution results from a transaction that (i) imputes a pre-money valuation to the Company of not less than $7 million, (ii) raises not less than $7 million, and (iii) imputes a post-money valuation to the Company of not less than $25 million. In exchange for the waiver and relinquishment of such rights, the Company will issue shares of the Company&#x2019;s common stock in an amount sufficient for U.S. Asian (together with its owners) to own an aggregate amount of fifteen (15%) percent of the Company&#x2019;s issued and outstanding shares of common stock as of the date of issuance. On June 22, 2021, the Company issued 6,091,395 shares of common stock in satisfaction of the waiver (See Note 7). </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Common Stock Issuances</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On February 15, 2021, pursuant to his employment agreement the Company issued 1,616,526 shares of common stock to Mark White at a fair value of $0.20 per share (see Note 8). </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Promissory Notes</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 19, 2018, the Company issued an on demand promissory note payable with the Company&#x2019;s Chairman of the Board for $10,000 with interest to begin accruing on January 1, 2020 at 5% per annum. Total interest expense on this note was $370 for the six months ended June 30, 2021 and 2020, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">On October 25, 2018, the Company entered in a promissory note payable with an accredited investor for $50,000 due on October 25, 2019. Pursuant to the note, the maturity date was extended to October 25, 2020. The bears interest at 100% per annum and the note holder was issued shares of the Company&#x2019;s common stock in lieu of interest. Total interest expense related to this note was $25,000 for the six months ended June 30, 2021 and 2020, respectively. On October 7, 2020, the Company entered into a Letter of Agreement Addendum with the note holder, whereas the Company agreed to make ten monthly principal payments beginning November 1, 2020 with the full principal amount to be paid in full by August 31, 2021. In addition, if the full principal amount is not paid in full by August 31, 2021 the Company will issue an additional 50,000 shares of common stock to the noteholder. During the six months ended June 30, 2021, the Company paid $4,600, in cash towards the outstanding principal. The amount outstanding at June 30, 2021 and December 31, 2020, was $32,200 and $36,800, respectively. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-31</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 6 &#x2013; CONVERTIBLE NOTES AND LOANS PAYABLE</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Convertible Notes Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">As of December 31, 2020, convertible notes consist of the following amounts: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">








            <tr class="odd" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:14%; border-bottom:0.7pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, due November 3, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">12% Convertible note payable, due February 4, 2024<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total convertible notes payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">6,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Debt discounts, unamortized<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(611 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:0.7pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total convertible notes payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5,389 </p>

               </td>

               <td style="width:142%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-32</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Total amortization expense was $81 and $674 for the six months ended June 30, 2021 and 2020, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2021, the Company issued an aggregate of 40,000 shares of common stock to various investors for the conversion of $6,000 and $2,000 in principal and accrued interest, respectively. There are no convertible notes outstanding at June 30, 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Device Loans Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">As of December 31, 2020, device loans payable consist of the following amounts: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">








            <tr class="odd" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:14%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">December 31, </font><font style="font-weight:bold; ">2020</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Notes payable, due April 22, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">16,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">8% Note payable, due April 23, 2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">8,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total device notes payable<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:13pt; margin-bottom:0pt; ">At various dates during the six months ended June 30, 2021, the Company and the note holders settled the individual device notes in shares of the Company&#x2019;s common stock at a price range of $0.15 to $0.25 per share, resulting in $24,000 in outstanding principal and $6,625 in accrued interest being converted into an aggregate of 170,140 shares of the Company&#x2019;s common stock. Total interest expense for the above notes was approximately $7,527 and $15,054 for the six months ended June 30, 2021 and 2020, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">The device notes contain an operational bonus provisions, pursuant to which, until the individual device note is paid in full, the noteholder will receive 10% of the income from the noteholders device location that is paid to the Company for the usage of that specific device. For the six months ended June 30, 2021 and 2020, the Company did not pay out or record operational bonuses related to the above device notes payable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2021, the Company issued 170,140 shares of common stock to a note holder for the conversion of $24,000 and $6,625 in principal and accrued interest, respectively. There are no device loans outstanding at June 30, 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Loans Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">On May 4, 2020, under the U.S. Small Business Administration&#x2019;s Paycheck Protection Program, the Company entered into a note payable with a financial institution for $22,916 at an interest rate of 1% per annum and a maturity date of June 22, 2022. Pursuant to the note, principal and interest payments are deferred for six months, which, at that time the Company may apply for loan forgiveness. If the Company does not apply for loan forgiveness the Company will be required to make monthly payments of $1,299 starting on December 1, 2020. On June 9, 2021, the Company applied for loan forgiveness. As of the issuance date of these unaudited condensed consolidated financial statements the Company has not received a response regarding its loan forgiveness application. At June 30, 2021, $22,916 was outstanding. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">On February 4, 2021, under the U.S. Small Business Administration&#x2019;s Paycheck Protection Program, the Company entered into a note payable with a financial institution for $22,916 at an interest rate of 1% per annum and a maturity date of February 4, 2026. Pursuant to the note, principal and interest payments are deferred for ten months, which, at any time during the ten months the Company may apply for loan forgiveness. If the Company does not apply for loan forgiveness the Company will be required to make monthly payments of $458 starting on December 1, 2021. On June 9, 2021, the Company applied for loan forgiveness. As of the issuance date of these unaudited condensed consolidated financial statements the Company has not received a response regarding its loan forgiveness application. At June 30, 2021, $22,916 was outstanding. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-33</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Legacy Ventures International, Inc.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">On September 11, 2017, the Company issued a promissory note (the &#x201C;Promissory Note&#x201D;) in favor of Legacy Ventures International, Inc. (&#x201C;Legacy&#x201D;) as part of a commercial transaction with Legacy that was never consummated. The Promissory Note was issued in the original principal amount of $500,000, with interest at 4% per annum and a maturity date of December 31, 2017. As of June 30, 2021, this promissory note is in default. The Company recorded $3,334 of interest expense for the six months ended June 30, 2021 and 2020. The amount outstanding at June 30, 2021 and December 31, 2020, was $500,000, respectively. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 7 - STOCKHOLDERS&#x2019; DEFICIT</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Issuance of Common Stock</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2020, the Company issued an aggregate of 3,672,800 shares of common stock to various investors for cash proceeds of $302,002. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2020, the Company issued an aggregate of 2,760,000 shares of common stock with a fair value of $0.25 per share to various consultants for services rendered in lieu of cash for a compensation charge of $1,962,022. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2020, the company issued an aggregate of 198,960 shares of common stock to various note holders for the conversion of debt. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2020, the company issued an aggregate of 111,000 shares of common stock to various investors for the conversion of warrants. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2021, the Company issued an aggregate of 2,757,529 shares of common stock to various investors for cash proceeds of $603,657. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2021, the Company issued an aggregate of 11,077,921 shares of common stock with a fair value of $0.25 per share to various consultants for services rendered in lieu of cash for a compensation charge of $2,863,230. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2021, the company issued an aggregate of 210,140 shares of common stock to various note holders for the conversion of debt. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">During the six months ended June 30, 2021, the company issued an aggregate of 169,832 shares of common stock to various investors for the conversion of warrants. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Warrants</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">The issuance of warrants to purchase shares of the Company&#x2019;s common stock including those attributed to debt issuances are summarized as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Weighted</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Average</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Shares</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercise Price</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at January 1, 2021<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1,341,416 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Exercised<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(169,832 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Expired or cancelled<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(355,584 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Outstanding at June 30, 2021<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">816,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-34</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">The following table summarizes information about options to purchase shares of the Company&#x2019;s common stock outstanding and exercisable at June 30, 2021: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">


















            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td colspan="2" style="width:16%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Weighted-</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Weighted-</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:16%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Average</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Average</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td colspan="2" style="width:16%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Range of</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Outstanding</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Remaining Life</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercise</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:16%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">exercise prices</font><font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:16%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Warrants</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">In Years</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Price</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:21%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exercisable</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">816,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.15 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">816,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:15%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">816,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.15 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">0.50 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:20%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">816,000 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:13pt; margin-bottom:0pt; ">The compensation expense attributed to the issuance of the warrants, if required to be recognized on the nature of the transaction, was recognized as they vested/earned. These warrants are exercisable up to one year from the date of grant. All are currently exercisable. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Issuances of warrants to purchase shares of the Company&#x2019;s common stock were as follows: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">The Company did not issue any warrants during the six months ended June 30, 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 8 &#x2013; COMMITMENTS AND CONTINGENCIES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Employment Agreements</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">On February 15, 2021, the Company entered into an employment agreement with Mark White to serve as Chief Executive Officer of the Company for a three-year term. Pursuant to the agreement, Mr. White is entitled to receive $200,000 in annual compensation and is eligible to receive up to $200,000 in cash and stock-based compensation upon achieving certain performance metrics. Should Mr. White receive stock-based bonus compensation he shall be entitled to receive options to purchase up to 20% of the number of shares issued as stock-based bonus compensation. Additionally, pursuant to the agreement, on February 15, 2021, the Company issued shares of the Company&#x2019;s common stock in an amount sufficient for Mr. White to own an aggregate amount of two (2%) percent of the Company&#x2019;s issued and outstanding shares as of the date effective date of the agreement, or 1,616,526 shares of the Company&#x2019;s common stock. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">On February 15, 2021, the Company entered into an employment agreement with David Owens, MD to serve as Chief Medical Officer of the Company for a three-year term. Pursuant to the agreement, Dr. Owens is entitled to receive $150,000 in annual compensation that is payable to him by the issuance of Company common stock and he is eligible to receive bonus compensation based upon achieving certain performance metrics. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Legal Claims</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">There are no material pending legal proceedings in which the Company or any of its subsidiaries is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of its voting securities, or security holder is a party adverse to us or has a material interest adverse to the Company other than the following: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Sarah Veltz v. Nexalin Technology, Inc. et al.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Plaintiff, Sarah Veltz, filed a lawsuit in this matter on January 20, 2021 in Orange County Superior Court (Case No. 30-2021-01180164-CU-WT-CJC) (the &#x201C;Complaint&#x201D;) naming the Company and others as defendants. In her Complaint, Plaintiff contends that she was employed by defendants, including Nexalin, and has not been paid all wages, including overtime wages and other benefits allegedly due her. Plaintiff also contends that, during her employment, she was subjected to sexual harassment by the Company&#x2019;s then Chief Executive Officer. Plaintiff seeks both compensatory and punitive damages. On March 12, 2021, the Company filed its answer to the Complaint. The court has set a jury trial in this matter for April 24, 2023. Management&#x2019;s intent is to contest the allegations vigorously and, as of the date of this report, is unable to provide an evaluation of the potential outcome of the litigation within the probable or remote range or to provide an estimate of the amount of or a range of potential loss that might be incurred by the Company. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-35</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Employment Development Department</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">The Company is currently engaged in settlement discussions with the Employment Development Department (EDD) of the state of California. This matter involves issues related to our previous management&#x2019;s classification of certain work provided to or on behalf of our business as contract labor instead of employee labor. The EDD has subpoenaed six years&#x2019; worth of information from us and currently is considering levying a $286,000 tax charge against us. We have petitioned for reassessment and believe the hired workers at issue were indeed actual contractors and not employees. All our business in California has been closed and moved out of the state. A settlement with EDD is anticipated within eighteen months. The Company believes its potential exposure to be approximately $286,000 and, as such, has accrued this amount on the unaudited consolidated balance sheet at June 30, 2021. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 9 &#x2013; LEASES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as ROU assets and corresponding lease liabilities. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">The Company is party to a lease for 3,500 square feet of space in Houston, Texas (the &#x201C;Houston Lease&#x201D;) with respect to its corporate operations. The Houston Lease is scheduled to expire on January 1, 2024 and provides for an annual base rental of $48,000. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">When measuring lease liabilities for leases that were classified as operating leases, the Company discounted lease payments using its estimated incremental borrowing rate at June 1, 2018. The weighted average incremental borrowing rate applied was 10%. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">The following table presents net lease cost and other supplemental lease information: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">












            <tr class="odd" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Six Months </font><font style="font-weight:bold; ">Ended </font><font style="font-weight:bold; ">June 30, 2021</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:11%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Six Months </font><font style="font-weight:bold; ">Ended </font><font style="font-weight:bold; ">June 30, 2020</font>
                  </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Lease cost<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">&#xA0;Operating lease cost (cost resulting from lease payments)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">19,500 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net lease cost<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">19,500 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0;<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating lease &#x2013; operating cash flows (fixed payments)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">19,500 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Operating lease &#x2013; operating cash flows (liability reduction)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">18,027 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">13,270 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Current liabilities &#x2013; operating lease liabilities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">38,861 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">35,177 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:74%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Non-current liabilities &#x2013; operating lease liabilities<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">70,020 </p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:10%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">108,881 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:13pt; margin-bottom:0pt; ">Future minimum payments under non-cancelable leases for operating leases for the remaining terms of the leases following the six months ended June 30, 2021: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">








            <tr class="odd" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="text-decoration:underline #000000; font-weight:bold; ">Fiscal Year</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:14%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Operating Leases</font>
                  </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2021 (excluding the six months ended June 30, 2021)<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2022<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">48,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2023<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">48,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">2024<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Total future minimum lease payments<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">124,000 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Amount representing interest<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(15,119 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; margin-bottom:3px; margin-bottom:1pt; ">) </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:82%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Present value of net future minimum lease payments<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">108,881 </p>

               </td>

               <td style="width:100%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 10 &#x2013; CONCENTRATION OF CREDIT RISK</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Cash Deposits</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (&quot;FDIC&quot;) up to $250,000. As of June 30, 2021 and December 31, 2020, the Company had $57,946 and $- in excess of the FDIC insured limit. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-36</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-style:italic; ">Revenues</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Six customers accounted for 65% of revenue for the six months ended June 30, 2021, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">13 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer C<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">11 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer D<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer E<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer F<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">%  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:13pt; margin-bottom:0pt; ">Two customers accounted for 67% of revenue for the six months ended June 30, 2020, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">57 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">%  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Accounts Receivable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Two customers accounted for 63% of the accounts receivable as of June 30, 2021, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">42 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">21 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">%  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:13pt; margin-bottom:0pt; ">Four customers accounted for 78% of the accounts receivable as of December 31, 2020, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">30 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">18 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer C<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Customer D<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">%  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; "><font style="font-style:italic; ">Accounts Payable</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Four vendors accounted for 86% of accounts payable as of June 30, 2021, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Vendor A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">31 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Vendor B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">29 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Vendor C<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">15 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Vendor D<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">%  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:13pt; margin-bottom:0pt; ">Three vendors accounted for 74% of the accounts payable as of December 31, 2020, as set forth below: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="70.2127659574468%" cellpadding="0" style="border-spacing:0; margin:auto; ">






            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Vendor A<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">55 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">% </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:78%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Vendor B<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:20%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10 </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">%  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:14pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NOTE 11 &#x2013; SUBSEQUENT EVENTS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Subsequent to June 30, 2021, the Company issued 376,000 shares of common stock for cash proceeds of $93,750. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:36pt; margin-top:8pt; margin-bottom:0pt; ">Subsequent to June 30, 2021, the Company issued 1,629,219 shares of common stock, with a fair value of $0.25 per share, to various consultants for services rendered to the Company in lieu of cash paid. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">F-37</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">NEXALIN TECHNOLOGY, INC.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; ">[*] </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">PART II</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">INFORMATION NOT REQUIRED IN PROSPECTUS</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Item 13. </font><font style="font-weight:bold; font-style:italic; ">Other Expenses of Issuance and Distribution.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following table sets forth all costs and expenses, other than underwriting discounts and commissions, payable by us in connection with the sale of the shares of common stock being registered. All amounts shown are estimates except for the SEC registration fee, the Financial Industry Regulatory Authority, or FINRA, filing fee and The Nasdaq Capital Market, or Nasdaq, initial listing fee. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" class="fin" cellpadding="0" style="border-spacing:0; margin:auto; ">









            <tr class="odd" style=" ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td colspan="3" style="width:14%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Amount to be </font><font style="font-weight:bold; ">Paid</font>
                  </p>

               </td>

            </tr>



            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">SEC registration fee<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">FINRA filing fee<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">The Nasdaq listing fee<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Printing and engraving expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Legal fees and expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accounting fees and expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Transfer agent and registrar fees and expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Miscellaneous fees and expenses<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:1pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

            </tr>

            <tr class="odd" style=" background-color:#CCEEFF; ">

               <td style="width:80%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:10pt; margin-top:0pt; margin-bottom:0pt; ">Total<font style="padding-left:2pt; " class="swap"> </font></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:5%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p>

               </td>

               <td style="width:12%; vertical-align:bottom; border-bottom:3px double #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p>

               </td>

               <td style="width:1%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:13pt; margin-bottom:0pt; ">_______________________________ </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:5pt; margin-bottom:0pt; ">* To be filed by amendment. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Item 14. </font><font style="font-weight:bold; font-style:italic; ">Indemnification of Directors and Officers.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As permitted by Section 102 of the Delaware General Corporation Law, we have adopted provisions in our amended and restated certificate of incorporation and amended and restated bylaws that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a director. The duty of care generally requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except for liability for: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:39pt; margin-top:-12pt; margin-bottom:0pt; ">any breach of the director&#x2019;s duty of loyalty to us or our stockholders; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:39pt; margin-top:-12pt; margin-bottom:0pt; ">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:39pt; margin-top:-12pt; margin-bottom:0pt; ">any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends; or </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:39pt; margin-top:-12pt; margin-bottom:0pt; ">any transaction from which the director derived an improper personal benefit. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our amended and restated certificate of incorporation also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">As permitted by Section 145 of the Delaware General Corporation Law, our amended and restated bylaws provide that: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:39pt; margin-top:-12pt; margin-bottom:0pt; ">we may indemnify our directors, officers and employees to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; padding-left:39pt; margin-top:-12pt; margin-bottom:0pt; ">we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions; and </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#x2022;</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:39pt; margin-top:-12pt; margin-bottom:0pt; ">the rights provided in our bylaws are not exclusive. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Our amended and restated certificate of incorporation, to be attached as Exhibit 3.2, and our amended and restated bylaws, to be attached as Exhibit 3.3, provide for the indemnification provisions described above and elsewhere herein. We have entered or will enter into, and intend to continue to enter, into separate indemnification agreements with our directors and officers that may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. These indemnification agreements generally require us, among other things, to indemnify our officers and directors against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also generally require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended, or the Securities Act. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">We have purchased and currently intend to maintain insurance on behalf of each and every person who is or was a director or officer of our company against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">II-1</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The form of Underwriting Agreement, to be attached as Exhibit 1.1 hereto, provides for indemnification by the underwriters of us and our officers and directors who sign this Registration Statement for specified liabilities, including matters arising under the Securities Act. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Item 15. </font><font style="font-weight:bold; font-style:italic; ">Recent Sales of Unregistered Securities.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "><font style="font-weight:bold; font-style:italic; ">Issuances of Share Capital</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The following list sets forth information regarding all unregistered securities sold by us for the years ended December 31 2019 and 2020 and through the date of the prospectus that forms a part of this registration statement. Pursuant to our corporate reorganization, all shares issued in connection with the transactions discussed below have been exchanged for the same number and classes of newly issued shares of common stock of Nexalin Technology, Inc. See &#x201C;Corporate Reorganization.&#x201D; </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The offers, sales and issuances of the securities described in the paragraphs above were exempt from registration under Section 4(a)(2) of the Securities Act and Regulation D promulgated under the Securities Act. The recipients represented to us that they acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. The recipients also represented to us that they were accredited investors as defined in Rule 501 promulgated under the Securities Act.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued an aggregate of 1,999,192 shares of common stock for a range of $0.20 - $1.25 per share to various investors for cash proceeds of $662,384. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued an aggregate of 411,000 shares of common stock with a range of fair values of $0.25 - $0.80 per share to various consultants for services rendered in lieu of cash for a compensation charge of $562,735. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the company issued an aggregate of 1,456,786 shares of common stock to various note holders for the conversion of debt.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2019, the Company issued an aggregate of 75,000 shares of common stock with a fair value of $1.00 per share to a note holder as inducement.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 3,256,996 shares of common stock to various investors for cash proceeds of $684,082. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 3,000,000 shares of common stock to various investors in the Company&#x2019;s JV for cash proceeds of $200,000 pursuant to a certain services agreement. The Company recorded the excess fair value of $550,000 as stock compensation expense.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 4,325,471 shares of common stock with a fair value of $0.25 per share to various consultants for services rendered in lieu of cash for a compensation charge of $1,409,524.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the company issued an aggregate of 233,273 shares of common stock to various note holders for the conversion of debt.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 325,000 shares of common stock as a result of the exercise of warrants to various investors for cash proceeds of $61,750. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued an aggregate of 50,000 shares of common stock with a fair value of $0.25 per share to a note holder as inducement.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the nine months ended September 30, 2021, the Company issued an aggregate of 3,133,529 shares of common stock to various investors for cash proceeds of $697,407.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the nine months ended September 30, 2021, the Company issued an aggregate of 12,707,140 shares of common stock with a fair value of $0.25 per share to various consultants for services rendered in lieu of cash for a compensation charge of $3,270,535.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the nine months ended September 30, 2021, the Company issued an aggregate of 210,140 shares of common stock with a fair value of $0.25 per share to various note holders for the conversion of debt.</p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">During the nine months ended September 30, 2021, the Company issued an aggregate of 169,832 shares of common stock as a result of the exercise of warrants to various investors for cash proceeds of $35,967. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Item 16. </font><font style="font-weight:bold; font-style:italic; ">Exhibits and Financial Statement Schedules.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">(a) Exhibits. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">







            <tr class="odd" style=" ">

               <td colspan="2" style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exhibit</font>
                  </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:5%; border-bottom:1pt solid #000000; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number</font>
                  </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Description of Document</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">1.1 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Form of Underwriting Agreement. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3.1 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Amended and Restated Certificate of Incorporation, as currently in effect. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3.2 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Form of Amended and Restated Certificate of Incorporation, to be in effect upon the completion of this offering </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3.3 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Amended and Restated Bylaws, currently in effect. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">3.4 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Form of Amended and Restated Bylaws, to be in effect upon the completion of this offering. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>



         </table>
      </div>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">II-2</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">







            <tr class="odd" style=" ">

               <td colspan="2" style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exhibit</font>
                  </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:5%; border-bottom:1pt solid #000000; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number</font>
                  </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Description of Document</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4.1 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Form of Specimen stock certificate evidencing shares of common stock. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">4.2 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Registration Rights Agreement, to be in effect upon the completion of this offering. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">5.1 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Opinion of Warshaw Burstein, LLP as to legality. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>



         </table>
      </div>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">II-3</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">







            <tr class="odd" style=" ">

               <td colspan="2" style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Exhibit</font>
                  </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td colspan="2" style="width:5%; border-bottom:1pt solid #000000; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Number</font>
                  </p>

               </td>

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; border-bottom:1pt solid #000000; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Description of Document</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>



            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10.1 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="e14459ex10-1.htm">Joint Venture Agreement between the Company and Wider Limited, and Supplement thereto.</a></font><font style></font><font style> </font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10.2 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="e14459ex10-2.htm">Employment Agreement between the Company and Mark White.</a></font><font style> </font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10.3 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="e14459ex10-3.htm">Agreement between the Company and David Owens, M.D.</a></font><font style> </font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">10.4 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><font style><a href="e14459ex10-4.htm">Quality Assurance Agreement between the Company and Apical Instruments.</a></font><font style> </font></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">23.1 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Consent of Friedman LLP, independent registered public accounting firm. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">23.2 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Consent of Warshaw Burstein, LLP (included in Exhibit 5.1). </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:right; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">24.1 </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:3%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:91%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Power of Attorney (included on signature page to this registration statement). </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; ">





            <tr class="odd" style=" ">

               <td colspan="2" style="width:100%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">_______________________________ </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">* </p>

               </td>

               <td style="width:93%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">To be submitted by amendment. </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:93%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:5%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">+ </p>

               </td>

               <td style="width:93%; vertical-align:top; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Indicates management contract or compensatory plan. </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">(b) Financial Statement Schedules. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">No financial statement schedules have been submitted because they are not required or are not applicable or because the information required is included in the consolidated financial statements or the notes thereto. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">II-4</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><font style="font-weight:bold; ">Item 17. </font><font style="font-weight:bold; font-style:italic; ">Undertakings.</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">The undersigned Registrant hereby undertakes that: </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this Registration Statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this Registration Statement as of the time it was declared effective. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">(2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="font-style:italic; ">bona fide </font>offering thereof.
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">If we fail to develop and successfully commercialize other current and future products, our business and future prospects may be harmed and our business will be more vulnerable to any problems that we encounter in developing and commercializing our products. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">II-5</p>

         </div><hr style="border-top:1.5pt solid #000000;"><div style="page-break-after:always;"></div>
      </div>


      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><font style="font-weight:bold; ">SIGNATURES</font>
      </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to the requirements of the Securities Act, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized on the 1st day of November, 2021. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto;  margin-left:auto; ">






            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:30%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; ">NEXALIN TECHNOLOGY, INC. </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">By: </p>

               </td>

               <td style="width:28%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">/s/ MARK WHITE </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Mark White</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">President and Chief Executive Officer</font>
                  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">KNOWN ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints ___________________________, and each of them, his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto and any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, together with all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration statement or any such amendment or any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and (iv) take any and all actions which may be necessary or appropriate to be done, as fully for all intents and purposes as he or she might or could do in person, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his substitutes may lawfully do or cause to be done by virtue thereof. </p>
      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. </p>

      <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

      <div>
         <table width="100%" cellpadding="0" style="border-spacing:0; margin:auto;  margin-left:auto; ">







            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; ">By: </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:18pt; margin-bottom:0pt; ">/s/ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; ">Mark White </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Mark White</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">President and Chief Executive Officer</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">By: </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">/s/ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">David Owens </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">David Owens</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Chief Medical Officer</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">By: </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">/s/ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">[&#x2022;] </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Chief Financial Officer</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">By: </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">/s/ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Alan Kazden </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Alan Kazden</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">By: </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">/s/ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Ben V. Hu </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Ben V. Hu</font>
                  </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">&#xA0; </p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">By: </p>

               </td>

               <td style="width:10%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">/s/ </p>

               </td>

               <td style="width:18%; vertical-align:bottom; border-bottom:0.5pt solid #000000; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Rick Morad </p>

               </td>

            </tr>

            <tr class="even" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Rick Morad</font>
                  </p>

               </td>

            </tr>

            <tr class="odd" style=" ">

               <td style="width:70%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td style="width:2%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:left; margin-bottom:0pt; "></p>

               </td>

               <td colspan="2" style="width:28%; vertical-align:bottom; ">

                  <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><font style="font-style:italic; ">Chairman of the Board</font>
                  </p>

               </td>

            </tr>



         </table>
      </div>

      <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; text-indent:18pt; margin-top:8pt; margin-bottom:0pt; ">&#xA0;</p>


      <div>
         <div style="width:100%; clear:both;">

            <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">II-6</p>

         </div><hr style="border-top:1.5pt solid #000000;">
      </div>
















































   </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>filename2.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="text-align: right; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 4.65pt; margin-bottom: 0; text-align: center">JOINT VENTURE AGREEMENT</P>

<P STYLE="font: bold 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 4.65pt; margin-bottom: 0; text-align: center"><IMG SRC="image_079.gif"></P>

<P STYLE="font: 13.5pt Courier New, Courier, Monospace; margin-top: 7.55pt; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 21pt Courier New, Courier, Monospace; margin: 0.1pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt; text-indent: 36.05pt">JOINT VENTURE AGREEMENT, dated as of
September <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">21, 2018 </FONT>(this <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Agreement&rsquo;),
</I></B></FONT>is by and between Nexalin Technology, Inc., a Nevada corporation <FONT STYLE="font-size: 11.5pt"><B><I>(&ldquo;Nexalin&rdquo;),</I></B></FONT>
and [Wider come Limited], a company formed under the laws of [Hong Kong] (&lsquo;Wider&rsquo;&rsquo;,and together with Nexalin, collectively, the <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;parties&rdquo;</I></B></FONT>
and each, a <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;party&rdquo;).</I></B></FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt; text-indent: 36.05pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><IMG SRC="image_080.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt"></P>

<P STYLE="font: 17pt Arial, Helvetica, Sans-Serif; margin: 0.55pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><U>RECITALS</U>:</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="image_081.gif"></P>

<P STYLE="font: 17pt Arial, Helvetica, Sans-Serif; margin: 0.3pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 10.95pt 0 0pt; text-indent: 35.2pt">WHEREAS, the parties desire to establish
a <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt">50/50</FONT> joint venture for the purposes of conducting
clinical trials of Nexalin&rsquo;s proprietary medical devices and ultimately managing the commercialization and distribution of the Nexalin
products in the Territories (as defined below).</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 10.95pt 0 0pt; text-indent: 35.2pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.95pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_082.gif">&nbsp;</P>


<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 9.25pt 10.95pt 0 0pt; text-indent: 35.2pt">NOW, THEREFORE, in consideration
of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties to this Agreement hereby agree as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 7pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_083.gif"></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 10.9pt; margin-bottom: 0; text-align: center"><I>[Signature page to Joint
Venture Agreement]</I></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><I></I></P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0">ARTICLE 1</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0">CERTAIN DEFINITIONS</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><IMG SRC="image_084.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 6.05pt 9.35pt 0pt 0pt; text-indent: 34.95pt">Section 1.1. <U>Certain Definitions:For</U>
purposes of this Agreement, the following terms shall have the following meanings:</P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 7.4pt 0pt 0pt 34.95pt"><FONT STYLE="font: 19pt Courier New, Courier, Monospace"><IMG SRC="image_085.gif"></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.8pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 7.4pt 0pt 0pt 34.95pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;A&amp;D&rdquo;</I></B></FONT>
<FONT STYLE="font-size: 11.5pt">has the meaning set forth in Section</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">2.1.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 7.4pt 0pt 0pt 34.95pt"><IMG SRC="image_086.gif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 9.35pt 0 0pt; text-indent: 33.4pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;A&amp;D&rdquo;</I></B></FONT>
<FONT STYLE="font-size: 11.5pt">means, </FONT><FONT STYLE="font-size: 11.5pt"><B>Alzheimer&rsquo;s disease,</B></FONT> <FONT STYLE="font-size: 11.5pt">also
referred to simply as </FONT><FONT STYLE="font-size: 11.5pt"><B>Alzheimer&rsquo;s,</B></FONT> <FONT STYLE="font-size: 11.5pt">is a chronic neurodegenerative
disease that usually starts slowly and worsens over time</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 3.2pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 3.2pt 0 0 0pt"><IMG SRC="image_087.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 14pt 6.65pt 0 0pt; text-indent: 34.05pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;A&amp;D
Distribution Agreement&rdquo;</I></B></FONT> means, collectively, one or more distribution agreements to be entered into between the JV and
other appointed distributors at such time that the distributor obtains all necessary Permits in any of the applicable Territories, pursuant
to which Nexalin will provide the Nexalin Products for the treatment of A&amp;D to the JV for sale and distribution in any such applicable
Territories.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 14pt 6.65pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_088.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 15.55pt 9.35pt 0 0pt; text-indent: 33.85pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;A&amp;D
Clinical Trials&rdquo;</I></B></FONT> means the clinical trials of Nexalin Products for the treatment of A&amp;D in the Territory to be sponsored
by the JV. Now, the A&amp;D clinical trials experimenting in China have been authorized by Nexalin and funded by Wider, and the final
results of the experiments will be the capital contribution of Wider to the JV.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><IMG SRC="image_089.gif"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> / 26&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><FONT STYLE="font-size: 10pt"><IMG SRC="image_003.gif" ALT="" STYLE="height: 15px; width: 208px"></FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 0pt 0pt 33.85pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;AD&amp;I&rdquo;</I></B></FONT>
has the meaning set forth in Section 2.1.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0pt 0pt 33.85pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 11pt; width: 151.95pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0pt 0pt 33.85pt">&nbsp;</P>

<P STYLE="font: 15.5pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0pt 0pt 33.85pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;AD&amp;I&rdquo;</I></B></FONT>
means, Anxiety, Depression and Insomnia</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0pt 0pt 33.85pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0 0pt"></P>

<P STYLE="margin: 0pt 0pt 0pt 33.85pt"><IMG SRC="image_005.gif" ALT="" STYLE="width: 270px; height: 16px"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 10.95pt 0 0pt; text-indent: 33.75pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;AD&amp;I
Distribution Agreement&rdquo;</I></B></FONT> means, collectively, one or more distribution agreements to be entered into between the
JV and Nexalin at such time that the JV obtains all necessary Permits in any of the applicable Territories, pursuant to which
Nexalin will provide the Nexalin Products for the treatment of AD&amp;I to the JV for sale and distribution in any such applicable
Territories.</P>

<P STYLE="font: 5.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.55pt 0 0 0pt"><IMG SRC="image_090.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 11.25pt 7.25pt 0 0pt; text-indent: 33.65pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Affiliate&rdquo;</I></B></FONT>
means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or
is Controlled by or is under common Control with the Person specified. Notwithstanding the foregoing, for purposes of this Agreement,
(a) any Person which owns directly or indirectly 15% or more of the Equity Interests having ordinary voting power for the election of
the board of directors or equivalent governing body of a Person or 10% or more of the partnership or other ownership interests of a Person
(other than as a limited partner of such Person) shall be deemed an Affiliate of such Person, and (b) each director (or comparable manager)
of a Person shall be deemed to be an Affiliate of such Person.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 7.95pt 6pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_091.gif"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> / 26&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.5pt 17.4pt 0 0pt; text-indent: 33.9pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Control&rdquo;
</I></B></FONT>means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies
of a Person, whether through the ability to exercise voting power, by contract or otherwise. <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Controlling&rdquo;</I></B></FONT>
and <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Controlled&rsquo;</I></B></FONT> have meanings correlative thereto.</P>

<P STYLE="font: 15.5pt Arial, Helvetica, Sans-Serif; margin: 9.6pt 0 0 0pt"><IMG SRC="image_092.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 15.9pt 7.15pt 0 0pt; text-indent: 33.55pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Distributions
Agreements&rdquo;</I></B></FONT> <FONT STYLE="font-size: 11.5pt">means, collectively, each A&amp;D Distribution Agreement and each AD&amp;I
Distribution Agreement.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 15.9pt 7.15pt 0 0pt; text-indent: 33.55pt"><IMG SRC="image_006.jpg" ALT="" STYLE="height: 11pt; width: 327.2pt">&nbsp;</P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 17.4pt 0 0pt; text-indent: 33.9pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Equity
Interests&rdquo;</I></B></FONT> means, with respect to any Person, all of the shares of capital stock of (or other ownership, limited liability
company or other similar membership, or profit interests in) such Person.</P>

<P STYLE="font: 22.5pt Courier New, Courier, Monospace; margin: 5.05pt 0 0 0pt; text-align: left"><IMG SRC="image_093.gif"></P>

<P STYLE="font: 14.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 17.4pt 0 0pt; text-indent: 33.9pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Formation Date&rdquo;</I></B></FONT>
<FONT STYLE="font-size: 11.5pt">means the effective date of the Shareholders&rsquo; Agreement.</FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 17.4pt 0 0pt; text-indent: 33.9pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 17.4pt 0 0pt; text-indent: 33.9pt"><IMG SRC="image_007.jpg" ALT="" STYLE="height: 12.25pt; width: 175.55pt"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 15.5pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 7.15pt 0 0pt; text-indent: 33.7pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Governmental
Authority&rdquo;</I></B></FONT> means the government of any other nation, or of any political subdivision thereof, whether state or
local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive,
legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 7.15pt 0 0pt; text-indent: 33.7pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 7.15pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_094.gif">&nbsp;</P>

<P STYLE="font: 22.5pt Courier New, Courier, Monospace; margin: 4.25pt 5.1pt 0 0pt; text-align: center"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 7.15pt 0 0pt; text-indent: 33.7pt"><FONT STYLE="font: 13pt Arial, Helvetica, Sans-Serif"><B><I>&ldquo;JV&rdquo;
</I></B></FONT>has the meaning set forth in Section 2.1.</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> / 26&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0.05pt 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 8pt 0 0pt; text-indent: 33.85pt"><FONT STYLE="font-size: 10pt"><IMG SRC="image_010.gif" ALT="" STYLE="height: 15px; width: 179px"></FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.1pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 8pt 0 0pt; text-indent: 33.85pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;JV
Documents&rdquo;</I></B></FONT> means, collectively, this Agreement, the Organizational Documents of the JV, the Distribution Agreements, the
Services Agreements and any agreed executed and delivered by the JV and/or the Shareholders in connection with any of the foregoing or
this Agreement.</P>

<P STYLE="font: 17pt Courier New, Courier, Monospace; margin: 9.3pt 0 0 0pt"><IMG SRC="image_095.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 14.05pt 7.15pt 0 0pt; text-indent: 33.85pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Nexalin
Products&rdquo;</I></B></FONT> means Nexalin&rsquo;s existing transcranial alternating current stimulation devises and related disposables for the
treatment of AD&amp;I and/or A&amp;D.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 8.4pt 0 0 0pt"><IMG SRC="image_096.gif"></P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 8pt 0 0pt; text-indent: 34.15pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Organization
Documents&rdquo;</I></B> </FONT>means, (a) with respect to any corporation, the certificate or articles of incorporation and the
bylaws (or equivalent or comparable constitutive documents with respect to any non-U.S. jurisdiction); (b) with respect to any
limited liability company, the certificate or articles of formation or organization and operating agreement; and (c) with respect to
any partnership, joint venture, trust or other form of business entity, the partnership, joint venture or other applicable agreement
of formation or organization and any agreement, instrument, filing or notice with respect thereto filed in connection with its
formation or organization with the applicable Governmental Authority in the jurisdiction of its formation or organization and, if
applicable, any certificate or articles of formation or organization of such entity.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 8pt 0 0pt; text-indent: 34.15pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 8pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_097.gif"></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> / 26&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 10.5pt Courier New, Courier, Monospace; margin: 0.4pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 31.65pt 0 0pt; text-indent: 33.75pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Permit&rsquo;
</I></B></FONT>means, collectively, all licenses, leases, powers, permits, franchises, certificates, authorizations, approvals and clearances
issued by a Governmental Authority.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 11.6pt 15.95pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_098.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 15.6pt 10.7pt 0 0pt; text-indent: 33.9pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Person&rdquo;</I></B></FONT>
means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental
Authority or other entity.</P>

<P STYLE="font: 17pt Courier New, Courier, Monospace; margin: 9.05pt 0 0 0pt; text-align: left"><IMG SRC="image_099.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 14.1pt 31.65pt 0 0pt; text-indent: 33.5pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Restrictive
Period&rdquo;</I></B></FONT> means the last day of the calendar year in which the 2nd anniversary of the Formation Date occurs.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 14.1pt 31.65pt 0 0pt; text-indent: 33.5pt"><IMG SRC="image_008.jpg" ALT="" STYLE="height: 11pt; width: 304.15pt">&nbsp;</P>

<P STYLE="font: 16.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 12.4pt 0 0pt; text-indent: 34.05pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Shareholders&rdquo;</I></B></FONT>
shall mean each of Nexalin and WIDER and/or any of their respective Affiliates designated by them to be the owner of record of the Equity
Interests of the JV.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 12.4pt 0 0pt; text-indent: 34.05pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 12.4pt 0 0pt; text-indent: 33.9pt"><IMG SRC="image_018.gif" ALT="" STYLE="width: 565px; height: 15px"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 12.4pt 0 0pt; text-indent: 33.9pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Shareholders&rsquo;
Agreement&rdquo;</I></B></FONT> has the meaning set forth in Section 3.3.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 12.4pt 0 0pt; text-indent: 33.9pt"><IMG SRC="image_010.jpg" ALT="" STYLE="height: 11.15pt; width: 191.25pt"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 12.4pt 0 0pt; text-indent: 33.9pt"><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Territories&rdquo;
</I></B></FONT>means, collectively, (i) with respect to AD&amp;I, China, Hong Kong, Taiwan and Macau and such other countries and territories
agreed by the parties at any time, and (ii) with respect to A&amp;D, the world. The term <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Territory&rdquo;
</I></B></FONT>means each geographical area or nation designated as a distinct territory in the applicable Distribution Agreement and,
in the context of Permits, the geographical area for which a Governmental Authority has jurisdiction over any such Permits.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 12.4pt 0 0pt; text-indent: 33.9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 12.4pt 0 0pt; text-indent: 33.9pt"><IMG SRC="image_011.jpg" ALT="" STYLE="height: 12.95pt; width: 413.05pt"></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> / 26&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 5pt 0 0pt; text-align: justify; text-indent: -0.1pt"><IMG SRC="image_100.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 12.3pt; margin-bottom: 0; text-align: center">ARTICLE
2</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 12.3pt; margin-bottom: 0; text-align: center">JOINT VENTURE</P>

<P STYLE="font: 24.5pt Courier New, Courier, Monospace; margin: 4.75pt 0 0 0pt; text-align: center"><IMG SRC="image_101.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.05pt 10.95pt 0 0pt; text-indent: 35pt">Section 2.1. <FONT STYLE="font-size: 11.5pt"><B><U>Scope.</U></B></FONT>
Nexalin will provides a global exclusive technology license for A&amp;D treatment in exchange for WIDER designing and funding a world-class
study in China that is approved by Nexalin. Such study shall take place at a major university and/or hospital in China and meet international
peer review standards. Nexalin will also provide the JV with a license for exclusive distribution of its technology for the treatment
AD&amp;I in the Territory.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 10.45pt 13.85pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_102.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 10.45pt 13.85pt 0 0pt; text-indent: 38.45pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.95pt 18.45pt 0 0pt; text-indent: 35.05pt">Section 2.2. <FONT STYLE="font-size: 11.5pt"><B><U>Formation
of Joint Venture.</U></B> Nexalin</FONT> and WIDER shall form a Hong Kong company (the <B><I>&ldquo;JV&rdquo;) </I></B>the purpose of which will
be the marketing, sale and distribution of Nexalin&rsquo;s proprietary medical devises for the treatment of (i)Anxiety, Depression and Insomnia
<FONT STYLE="font-size: 11.5pt"><B><I>(&ldquo;AD&amp;I&rdquo;</I></B></FONT> and (ii) Alzheimer&rsquo;s and Dementia <FONT STYLE="font-size: 11.5pt"><B><I>(&ldquo;A&amp;D&rdquo;</I></B></FONT>
in the applicable Territories.Nexalin and WIDER will be the only Shareholders of the JV, with each party owning fifty percent (50%) of
the JV&rsquo;s Equity Interests.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 8.7pt 7.9pt 0 0pt; text-align: justify; text-indent: 0.35pt"><IMG SRC="image_103.gif"></P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 7.4pt 0 0pt; text-align: justify; text-indent: 0.05pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.95pt 18.45pt 0 0pt; text-indent: 35.05pt">Section
2.3. <FONT STYLE="font-size: 11.5pt"><B><U>Funding of the JV.</U></B></FONT> No later than December 21, 2018, WIDER will establish
a capital plan for the JV (the <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Initial Operating Budget&rsquo;), </I></B></FONT>which will set
out the JV&rsquo;s anticipated capital needs for A&amp;D Clinical Trials in China. After the completion of the</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 11.65pt 9.35pt 0 0pt; text-indent: 0.1pt">A&amp;D clinical trials, Nexalin
and WIDER will be responsible for contributing capital to the JV to fund operating budget. JV will establish an operating budget. After
the A&amp;D study is completed, statistical analysis is completed and is in the form of acceptance for publication and regulatory approval,
then all future expenses will be paid by the shareholders of both parties in proportion to the shares of the JV. After the initial funding
for clinical trial for A&amp;D in China by WIDER, WIDER and Nexalin will oversee third party fundraising efforts for JV operations as
necessary. All the parties will work together to support JV&rsquo;s financing activities to the greatest extent possible.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.75pt 0pt 0pt; text-align: left"><IMG SRC="image_104.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.75pt 0pt 0pt; text-align: left"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.95pt 18.45pt 0 0pt; text-indent: 35.05pt"><U>A&amp;D Clinical Trials
&amp; Permits.</U></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.95pt 18.45pt 0 0pt; text-indent: 35.05pt">&nbsp;<IMG SRC="image_105.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.55pt 5.35pt 0 0pt; text-indent: 71.15pt"><FONT STYLE="font-size: 11.5pt">(a)</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 11.5pt">Authorized
by Nexalin, WIDER agrees to fund and execute the A&amp;D Clinical Trials in China; it being understood and agreed that the JV will
be the clinical trial sponsor of record. JV shall be responsible for the prosecution of any and all necessary Permits for the
marketing, sale and distribution of Nexalin Products in the applicable <I><U>Territories; provided, however,</U></I> that Nexalin
shall reasonably cooperate with any and all such efforts including, without limitation, (i) the granting the JV a license to exploit
the Nexalin Products in connection with the prosecution of any Permits, (ii) timely responding to document and/or information
requests which would include documents from internal document control system.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.55pt 5.35pt 0 0pt; text-indent: 71.15pt"><FONT STYLE="font-size: 11.5pt"></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.55pt 5.35pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_106.gif">&nbsp;</P>



<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">(b)<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The protocol of the A&amp;D Clinical Trials must be approved by Nexalin and WIDER, the final result should be related to the global
business promotion of Nexalin products. The amount of patients enrolled must consider the drop off rate that will ensue given nature
of the patient pool. The amount of sessions and timing of those sessions must be strictly adhered to in order to maximize success for
the enrolled group. Time of completion of the study, statistical analysis and submission for publication will be the responsibility of
WIDER. Financial and management of the study in China by WIDER are principal inducements for Nexalin entering the JV. A double or triple
blind study that includes EEG and PET-MRI will be preferred.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.45pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_107.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 14.95pt 0 0pt; text-align: right; text-indent: 65.4pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.8pt 15.2pt 0 0pt; text-align: right; text-indent: 33.9pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Based
on any invention patents obtained by A&amp;D clinical trials, the JV has the right to register, authorize, produce, sell the intellectual
property worldwide that pertains to products established by JV and covered in this contract.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.45pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_108.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Nexalin will have a cost-free
license from JV to utilize patents created and owned by JV for the products and treatment indications not covered in this contract.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.45pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_109.gif">&nbsp;</P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 5pt; margin-bottom: 0">ARTICLE 3</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 5pt; margin-bottom: 0">OTHER AGREEMENTS</P>

<P STYLE="font: 19.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 38.45pt 0 0pt; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.35pt 225.95pt 0 0pt; text-align: center">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">3.1.</FONT>
<U>Distribution Agreements.</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.35pt 225.95pt 0 0pt; text-align: center"><U></U></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0 0pt"><IMG SRC="image_012.jpg" ALT="" STYLE="height: 11.5pt; width: 105.15pt"></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">(a)<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Under each Distribution Agreement, Nexalin will grant the JV a license to exploit the Nexalin Products solely in connection with
the marketing, sale and distribution of the Nexalin Products in the applicable Territories. Nexalin further agrees that it will charge
the JV US$5200.00 per unit FOB factory for existing Nexalin&rsquo;s products (to be adjusted annually with CPl).Electrodes will be charged at
cost plus 20% per unit.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt"><IMG SRC="image_110.gif"></P>

<P STYLE="font: 17.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">(b)<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Each
AD&amp;I Distribution Agreement will provide that the JV would be the sole and exclusive distributor of Nexalin Products for AD&amp;I
in the applicable Territory covered thereby; <FONT STYLE="font-size: 11.5pt"><I><U>provided</U>, <U>however</U>,</I></FONT> that if the
JV fails to meet certain minimum sales thresholds in any applicable Territory following the eighteen (18) month anniversary when obtaining
Registration License of Nexalin Products from CFDA, the JV would no longer retain such exclusivity in respect of such Territory and Nexalin
(through the JV) would be permitted to develop and exploit new distributions partnerships (on an exclusive or non-exclusive basis) with
third parties in any such Territory; it being understood and agreed that the AD&amp;I Distribution Agreement will not have any minimum
sales thresholds during the first eighteen months of the term thereof.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 13.45pt 0 0pt; text-indent: 70.3pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.45pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_111.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.9pt 0 0 0pt; text-indent: 35.15pt">Section 3.2. <U>Service Agreements.</U>
The Board, as part of the development of the initial Annual Plan (defined below), will determine the personnel other resources required</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 9.35pt 0 0pt">by the JV including, but limited to, distributor services,
clinical trial services, finance services (accounting, cash collections etc.) and IT services. Such resources may be provided to the
JV by the Shareholders under the one or more services agreements to be entered into by the JV and such Shareholder (<B>&ldquo;Services
Agreements&rdquo;</B>) or acquired directly by the JV, with cost implications as follows:</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 9.35pt 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 9.35pt 0 0pt"><IMG SRC="image_112.gif"></P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.65pt 8.65pt 0 0pt; text-align: right"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.55pt 6.95pt 0 0pt; text-indent: 70.1pt"><FONT STYLE="font-size: 11.5pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Costs
for resources directly engaged by the JV will be borne directly by the JV;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.55pt 6.95pt 0 0pt; text-indent: 70.1pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.55pt 6.95pt 0 0pt; text-indent: 70.1pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_113.gif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.55pt 6.95pt 0 0pt; text-indent: 70.1pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.55pt 6.95pt 0 0pt; text-indent: 70.1pt"><FONT STYLE="font-size: 11.5pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Costs for discrete resources seconded from a Shareholder to the JV (e.g., an Nexalin brand manager seconded to the JV) will be recharged
from the Shareholder to the JV under the Services Agreement with such Shareholder; and</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.55pt 6.95pt 0 0pt; text-indent: 70.1pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.55pt 6.95pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_114.gif">&nbsp;</FONT></P>

<P STYLE="font: 6pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0 0pt"><FONT STYLE="font-size: 13.5pt"></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.6pt 21.1pt 0 0pt; text-indent: 69.95pt"><FONT STYLE="font-size: 10.5pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Costs
of the Shareholders managing their interest in the JV (e.g., attending board meetings) will be borne by the Shareholders and not recharged.</FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><IMG SRC="image_116.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.85pt 9.35pt 0 0pt; text-indent: 35.15pt">Section 3.3. <U>Organizational
Documents.</U> No later than December 21, 2018, the parties shall cause all necessary Organizational Documents to be executed and
delivered by the Shareholders including, without limitation, a shareholders&rsquo; or similar agreement (the <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Shareholders&rsquo;
Agreement&rdquo;)</I></B></FONT> setting forth various matters relating to the operation and governance of the JV, in all cases,
consistent with terms set forth in this Agreement.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.85pt 9.35pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_115.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 11.55pt 6.2pt 0 0pt; text-indent: 0.45in"></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><FONT STYLE="font-size: 10pt"><IMG SRC="image_027.gif" ALT="" STYLE="height: 15px; width: 378px"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.85pt 9.35pt 0 0pt; text-indent: 35.15pt">Section 3.4. <U>Restrictive Covenants.</U></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.85pt 9.35pt 0 0pt; text-indent: 35.15pt"><IMG SRC="image_117.gif">&nbsp;</P>

<P STYLE="font: 15.5pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6.05pt 17.1pt 0 0pt; text-indent: 70.25pt"><FONT STYLE="font-size: 11.5pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except as otherwise provided in this Agreement or any of the other JV Documents, Nexalin may not
sell the Nexalin Products in the Territory other than through the JV and JV may not sell the Nexalin Products outside of the Territory.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6.05pt 17.1pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_118.gif"></FONT></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 10.6pt 0 0pt; text-align: justify; text-indent: 72.6pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 20pt 0 0pt; text-indent: 70.3pt"><FONT STYLE="font-size: 11.5pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;WIDER, either directly or indirectly through any WIDER Affiliate, may not distribute, market or
sell any other line of neurostimulators for the treatment of AD&amp;I and/or A&amp;D.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 20pt 0 0pt; text-indent: 70.3pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 20pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_119.gif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.15pt 13.05pt 0 0pt; text-indent: 35.15pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">3.5.
</FONT><U>A&amp;D Device</U>. Nexalin shall have the first right to design, produce and manufacture the device for the treatment of A&amp;D
(the <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;A&amp;D Device&rdquo;);</I></B></FONT><I> <U>provided, however,</U></I> that if Nexalin chooses
not to exercise any such rights, it shall assign such rights to the JV. Notwithstanding the foregoing, if any new patented inventions
for the treatment of A&amp;D are developed in connection with any A&amp;D Device, the JV shall be the record owner of any such invention
described in such patent.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.15pt 13.05pt 0 0pt; text-indent: 35.15pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.15pt 13.05pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_120.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">ARTICLE 4</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 6.25pt; margin-bottom: 0; text-align: center">GOVERNANCE</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0.35pt; margin-bottom: 0"><IMG SRC="image_016.jpg" ALT="" STYLE="height: 30.25pt; width: 29pt"></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.15pt 13.05pt 0 0pt; text-indent: 35.15pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">4.1.</FONT>
<U>Board of Directors</U>.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 11.65pt 0 0 0pt"><IMG SRC="image_121.gif">&nbsp;</P>

<P STYLE="font: 14.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 13.2pt 0 0pt; text-indent: 70.3pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The JV will be managed by a Board of Directors (the <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Board&rdquo;)</I></B></FONT> consisting
of five (5) members. Each of Nexalin and WIDER will have the right to nominate and appoint two (2) representatives to the Board and the
fifth director shall be mutually agreed upon by the Shareholders.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 13.2pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_122.gif"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0.55pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 13.2pt 0 0pt; text-indent: 70.3pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Board will meet in person or via video conference at least four (4) times per year; provided that the Board may meet less frequently
until such time that the A&amp;D Clinical Trials have been completed and the JV obtains all necessary Permits for the marketing, sale
and distribution of Nexalin Products in one or more Territories. A quorum for Board meetings will require a majority of the directors
then in office, which must include at least one (1) representative of Nexalin and WIDER. Unless otherwise provided herein, the affirmative
vote of a majority of the Board <FONT STYLE="font-size: 11.5pt"><I>(i.e.,</I></FONT> three (3) of the five (5) directors) will be required
for all decisions, subject to Reserved Matters described below. The Board may also act by written consent, approved by a majority of
the directors.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 13.2pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_123.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"></P>


<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 2.65pt 10.45pt 0 0pt; text-indent: 70.15pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The Board will be responsible
for setting and monitoring achievement of the strategic objectives of the JV and,at such time that the JV obtains all necessary Permits
for the marketing, sale and distribution of Nexalin Products in any of the Territories, will delegate implementation of those objectives
to a general manager.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 2.65pt 10.45pt 0 0pt; text-indent: 70.15pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 2.65pt 10.45pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_124.gif"></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 9.75pt 0 0pt; text-indent: 65pt"></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.4pt 4.65pt 0 0pt; text-indent: 35.05pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">4.2.</FONT>
<U>General Manager.</U> At such time that the JV obtains all necessary Permits for the marketing, sale and distribution of Nexalin Products
in any of the Territories, the Board will appoint a general manager of the JV who will have responsibility for the operations of the JV,
selection of the JV&rsquo;s management team, execution of the strategic/business plan and who will have authority for all matters which are
not specifically reserved for the Board.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.4pt 4.65pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_125.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 8.5pt 5.1pt 0 0pt; text-align: right"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 9.6pt 0 0pt; text-align: justify; text-indent: 35pt">Section 4.3.
<U>Reserved Matters - Nexalin and WIDER Approval.</U> Certain matters <FONT STYLE="font-size: 11.5pt"><B><I>(&ldquo;Reserved Matters&rdquo;) </I></B></FONT>will
require the approval of Nexalin and WIDER in their respective capacities as Shareholders of the JV. Reserved Matters will include the
following:</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 9.6pt 0pt 0pt; text-align: justify; text-indent: 0pt"><IMG SRC="image_126.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 9.25pt 8.55pt 0 0pt; text-align: justify; text-indent: 5.5pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-size: 11.5pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;A&amp;D Clinical Trial protocols.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_127.gif">&nbsp;</FONT></P>



<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0.1pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"><FONT STYLE="font-size: 11.5pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any merger, consolidation, conversion or reorganization of the JV or adoption of any plan or agreement
to do any of the foregoing;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_128.gif"></FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0 0pt"></P>

<P STYLE="margin: 0 0 0 0pt"></P>

<P STYLE="font: 5.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"> <FONT STYLE="font-size: 11.5pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any voluntary filing for bankruptcy or receivership;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"></P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt">&nbsp;<IMG SRC="image_129.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"> <FONT STYLE="font-size: 11.5pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the creation of any subsidiary of the JV;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"><IMG SRC="image_130.gif">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.55pt 0 0 0pt"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.1pt 5.75pt 0 0pt; text-indent: 69.95pt"><FONT STYLE="font-size: 11.5pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any sale, lease, transfer, pledge or other disposition of all or substantially all of the properties
or assets of the JV, other than sales, leases, transfers, pledges or other dispositions of assets in the ordinary course of business;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.05pt 45.6pt 0pt 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif"><IMG SRC="image_131.gif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.05pt 45.6pt 0 0pt; text-align: justify; text-indent: 70.45pt"><FONT STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any sale, lease, transfer or license relating to any intellectual property licensed from Nexalin,
except in the ordinary course of business and as contemplated under this Agreement;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.05pt 45.6pt 0 0pt; text-align: justify; text-indent: 70.45pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.05pt 45.6pt 0pt 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif"><IMG SRC="image_132.gif">&nbsp;</FONT></P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.2pt 7.75pt 0 0pt; text-indent: 70.3pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the lending of money by the
JV to, or the guarantee by the JV of any obligation of, any Person or the granting of any lien upon the JV&rsquo;s assets;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.2pt 7.75pt 0 0pt; text-indent: 70.3pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.2pt 7.75pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_133.gif">&nbsp;</P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.2pt 11.8pt 0 0pt; text-indent: 70.1pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any material amendment to
the Shareholders&rsquo; Agreement of the JV or any Distribution Agreement with Nexalin to the extent such amendment negatively and disproportionately
affects any party&rsquo;s economic interests or governance rights,</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.2pt 11.8pt 0 0pt; text-indent: 70.1pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.2pt 11.8pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_134.gif"></P>

<P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 0 0 0pt"></P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 29.65pt 0 0pt; text-indent: 69.9pt"><FONT STYLE="font-size: 11.5pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any
transaction with any Affiliate of WIDER or Nexalin that is on terms less favorable than an arm&rsquo;s length transaction;</FONT>&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 29.65pt 0 0pt; text-indent: 69.9pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_135.gif"></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 8.95pt 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.15pt 17.4pt 0 0pt; text-indent: 70.25pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>any
investment in any joint venture or similar arrangement with, or equity issued by, a third party;&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.15pt 17.4pt 0 0pt; text-indent: 70.25pt"><IMG SRC="image_136.gif"></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 24.4pt 0 0pt; text-indent: 70pt"><FONT STYLE="font-size: 11.5pt">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any issuance of equity securities (or securities convertible into or exchangeable for equity securities);
and</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.7pt 24.4pt 0 0pt; text-indent: 70pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_137.gif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 8.8pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5pt 54.1pt 0 0pt; text-indent: 69.9pt"><FONT STYLE="font-size: 11.5pt">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;such other matters as may be mutually agreed upon by the Shareholders in the Shareholders&rsquo; Agreement.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5pt 54.1pt 0 0pt; text-indent: 69.9pt"><IMG SRC="image_018.jpg" ALT="" STYLE="height: 13.7pt; width: 247.95pt"></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 11.4pt 0 0pt; text-indent: 35.15pt">Section 4.4. <U>Annual Planning.</U>
Following the completion of the A&amp;D Clinical Trials and/or successful prosecution of necessary Permits for the marketing, sale and
distribution of Nexalin Products in the applicable Territories, the JV shall prepare, in consultation with the shareholders, an annual
plan(an <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Annual Plan&rdquo;)</I></B></FONT> for marketing and distribution of the Nexalin Products
in any such Territory.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 11.4pt 0 0pt; text-indent: 35.15pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.4pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_138.gif">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 4.9pt; margin-bottom: 0; text-align: center">ARTICLE 5</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 6.7pt; margin-bottom: 0; text-align: center">DISTRIBUTIONS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 6.7pt; margin-bottom: 0; text-align: center"><IMG SRC="image_139.gif">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 0 0 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.45pt 6.65pt 0 0pt; text-indent: 35.15pt">Section 5.1. <U>Distribution
of Cash from Operations.</U> The Board will have the authority to determine the timing and amount of any distributions of cash from operations
to be made to the Shareholders. Subject to there being available cash and reasonable required reserves, available cash from operations
will be distributed to the Shareholders on a [quarterly] basis and in accordance with their respective ownership percentages.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.45pt 6.65pt 0 0pt; text-indent: 35.15pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.45pt 6.65pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_140.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 22.35pt 6.65pt 0 0pt; text-indent: 35.15pt">Section 5.2. <U>Distributions
upon Termination and Liquidation.</U> Upon any termination of the JV as described in the Section 7.1 below, the Board will first
distribute all intangible assets to the Shareholders who initially contributed such assets and thereafter liquidate the tangible
assets of the JV and apply and distribute the proceeds of such liquidation as follows:</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 22.35pt 6.65pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_141.gif"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 7.9pt 5.4pt 0 0pt; text-indent: 20.6pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.7pt 14.55pt 0 0pt; text-indent: 69.95pt"><FONT STYLE="font-size: 11.5pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;First, to the payment of the debts and liabilities of the JV, including debts owed to any Shareholder;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05in 5.3pt 0 0pt; text-indent: 70.1pt"><IMG SRC="image_142.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05in 5.3pt 0 0pt; text-indent: 70.1pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Second, to the setting up of such reserves as the Board may deem reasonably necessary for any contingent or unforeseen liabilities
or obligations of the JV; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05in 5.3pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_143.gif"></P>

<P STYLE="font: 16pt Courier New, Courier, Monospace; margin: 9.35pt 26.45pt 0 0pt; text-indent: 69.5pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 2.4pt 12.35pt 0 0pt; text-indent: 70.3pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Thereafter, to the Shareholders in accordance with their respective ownership percentages.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 2.4pt 12.35pt 0 0pt; text-indent: 70.3pt"><IMG SRC="image_144.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.2pt 0 0 0pt"></P>


<P STYLE="margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">ARTICLE 6</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">TRANSFERABILITY</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 17.5pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.55pt 7.75pt 0 0pt; text-indent: 35.15pt">Section 6.1. <U>General Restriction
on Transferability.</U> No Shareholder will be allowed to transfer its ownership interest in the JV without the prior written consent
of the other Shareholder; <FONT STYLE="font-size: 11.5pt"><I>provided, that </I></FONT>no such consent will be required for (x) any transfers
to any affiliate of any Shareholder (a <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Permitted Transfer&rdquo;) </I></B></FONT>or (y) as part
of any divestiture required by any court or other regulatory authority (a <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Required Divestiture&rdquo;)
</I></B></FONT>Notwithstanding anything herein to the contrary, in no event would Nexalin, WIDER or the JV be obligated to partner with
a proposed transferee who is wholly or partially owned, directly or indirectly, by a competitor of Nexalin or who does not pass Nexalin&rsquo;s
background and anti-bribery and foreign corrupt practices act checks.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.55pt 7.75pt 0 0pt; text-indent: 35.15pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.55pt 7.75pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_145.gif">&nbsp;</P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 3.05pt 6.15pt 0 0pt; text-align: justify; text-indent: 0.55pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.55pt 7.75pt 0 0pt; text-indent: 35.15pt">Section 6.2. <U>Sale by a Shareholder
of Equity Interests in the JV.</U></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.55pt 7.75pt 0 0pt; text-indent: 35.15pt">&nbsp;<IMG SRC="image_146.gif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.15pt 14pt 0 0pt; text-indent: 70.5pt"><FONT STYLE="font-size: 11.5pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of a proposed sale of its Equity Interests in the JV by either Shareholder (the </FONT><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Selling
Shareholder&rdquo;)</I></B></FONT> <FONT STYLE="font-size: 11.5pt">as part of a Required Divestiture (which shall not include any
Permitted Transfer), the Selling Shareholder must offer to sell its Equity lnterests in the JV (an </FONT><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Offer
to Sell&rdquo;)</I></B></FONT> <FONT STYLE="font-size: 11.5pt">the other Shareholder (the </FONT><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Remaining
Shareholder&rdquo;)</I></B></FONT> <FONT STYLE="font-size: 11.5pt">for a price equal to the fair market value of such interest </FONT><FONT STYLE="font-size: 11.5pt"><B><I>(&ldquo;FMV&rdquo;), </I></B></FONT><FONT STYLE="font-size: 11.5pt">as
determined by a mutually approved third-party appraiser or valuation firm.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.15pt 14pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_147.gif">&nbsp;</FONT></P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.95pt 6.5pt 0 0pt; text-align: justify; text-indent: 70.3pt"><FONT STYLE="font-size: 11.5pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If WIDER is the Remaining Shareholder, then Nexalin must continue to provide the Nexalin Products
under the Distributions Agreements for up to 7 years.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 5.95pt 6.5pt 0pt 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_148.gif"></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 7.4pt 6.3pt 0 0pt; text-align: justify; text-indent: 70.3pt"><FONT STYLE="font-size: 11.5pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If Nexalin is the Remaining Shareholder, then WIDER must continue to provide the services under
the Services Agreement for up to 7 years (excluding clinical trials).</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 7.4pt 6.3pt 0pt 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_149.gif"></FONT></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 0.2pt 0 0 0pt">&nbsp;</P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6.75pt 18.9pt 0 0pt; text-indent: 70.3pt"><FONT STYLE="font-size: 11.5pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any third party purchaser of the Selling Shareholder&rsquo;s interest will be bound by all of the terms
of the Shareholders&rsquo; Agreement in lieu of such Selling Shareholder.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6.75pt 18.9pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_150.gif"></FONT></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 0 0 0pt">&nbsp;</P>


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">ARTICLE 7</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 6.2pt; margin-bottom: 0; text-align: center">TERMINATION; EVENTS OF DEFAULT</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 6.2pt; margin-bottom: 0; text-align: center"><IMG SRC="image_151.gif">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.55pt 7.75pt 0 0pt; text-indent: 35.15pt">Section 7.1. <U>Termination of JV</U>. The JV may be terminated
as follows:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 1.55pt 7.75pt 0 0pt; text-indent: 35.15pt"><IMG SRC="image_152.gif">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;after
the Restrictive Period by Nexalin [if certain performance metrics are not met]; provided that any termination pursuant to this section
will only be effective upon no less than 2 years with advance written notice to WIDER;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt"><IMG SRC="image_153.gif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;by the mutual written agreement
of the Shareholders;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt"><IMG SRC="image_154.gif">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt"> <FONT STYLE="font-size: 11.5pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;by WIDER upon one year&rsquo;s advance notice to Nexalin; or</FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_155.gif">&nbsp;</FONT></P>



<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt">&nbsp;</P>


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;upon the entry of a decree
of judicial dissolution or as otherwise required under applicable law.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 5.25pt 0 0pt; text-align: justify; text-indent: 34.45pt"><IMG SRC="image_156.gif">&nbsp;</P>

<P STYLE="font: 4.5pt Arial, Helvetica, Sans-Serif; margin: 0.2pt 0 0 0pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60.4pt"></TD><TD STYLE="width: 25.4pt"><FONT STYLE="font-size: 11.5pt">a)</FONT></TD><TD STYLE="padding-right: 18.55pt"><FONT STYLE="font-size: 11.5pt"><U>Extension Periods</U>. If neither Shareholder timely provides a
termination notice, the JV shall automatically renew for an additional 2 years period beginning at the end of the Restrictive Period (the
</FONT><FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Extension Period&rdquo;)</I></B></FONT> <FONT STYLE="font-size: 11.5pt">Extension Periods
shall continue every five (5) years until one Shareholder provides a termination notice.</FONT></TD></TR></TABLE>

<IMG SRC="image_157.gif">

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60.4pt"></TD><TD STYLE="width: 25.4pt"><FONT STYLE="font-size: 11.5pt">b)</FONT></TD><TD STYLE="padding-right: 6.2pt"><FONT STYLE="font-size: 11.5pt"><U>Events of Default</U>. The following events (and such other events
as may be mutually agreed upon by the Shareholders under any other JV Documents) will constitute an</FONT> <FONT STYLE="font-size: 11.5pt"><B>&ldquo;Event
of Default&rdquo;:</B></FONT></TD></TR></TABLE>

<p><IMG SRC="image_158.gif"></p>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60.4pt"></TD><TD STYLE="width: 25.4pt">( a )&nbsp;</TD><TD STYLE="padding-right: 6.2pt">a breach by a Shareholder of any material provision of the Shareholders&rsquo; Agreement, any Distributions
Agreement or any</TD></TR></TABLE>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 85.8pt">Services Agreement;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 85.8pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 85.8pt"></P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0 0pt">&nbsp;<IMG SRC="image_159.gif"></P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0 0pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60.4pt"></TD><TD STYLE="width: 25.4pt">( b )</TD><TD STYLE="padding-right: 0.3in">any act or omission by a Shareholder that constitutes fraud, willful misconduct
or gross negligence related to the operation of the JV or the willful misapplication or misappropriation of the JV&rsquo;s funds;</TD></TR></TABLE>

<P STYLE="padding-top: 9pt; padding-bottom: 9pt"><IMG SRC="image_160.gif"></p>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60.4pt"></TD><TD STYLE="width: 25.4pt; text-align: left">(c)</TD><TD STYLE="text-align: justify">the bankruptcy of a Shareholder;</TD>
</TR></TABLE>


<p></P>

<P STYLE="margin-left: 60.4pt"><IMG SRC="image_161.gif"></p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60.4pt"></TD><TD STYLE="width: 25.4pt">( d )</TD><TD STYLE="padding-right: 0.3in">a Shareholder becoming convicted of a criminal indictment which has had or would reasonably be expected
to have, directly or indirectly, a material adverse effect on the business, condition or results of operations of such Shareholder.</TD></TR></TABLE>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 11.2pt 0 0pt; text-indent: 46.85pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 11.2pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_162.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 11.2pt 0 0pt; text-indent: 46.85pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 11.2pt 0 0pt; text-indent: 46.85pt">Section 7.4 <U>Rights upon Event
of Default</U>. Upon the occurrence of an Event of Default with respect to a Shareholder (a <B>&ldquo;Defaulting Shareholder&rdquo;</B>),
the other Shareholder (the <FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;Non-Defaulting Shareholder&rdquo;)</I></B></FONT> will have the right
to purchase or require that the JV purchase the ownership interest of the Defaulting Shareholder at a [to be determined] discount to
FMV.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 11.2pt 0 0pt; text-indent: 46.85pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 11.2pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_163.gif">&nbsp;</P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 6.25pt; margin-bottom: 0; text-align: center">ARTICLE 8</P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 8pt; margin-bottom: 0; text-align: center">CONFIDENTIAL INFORMATION</P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 8pt; margin-bottom: 0; text-align: center"><IMG SRC="image_164.gif"></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 8pt; margin-bottom: 0; text-align: center">&nbsp;</P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.75pt 9.75pt 0 0pt; text-indent: 34.85pt">Section 8.1 <U>Definition.</U> By
virtue of this Agreement and the other JV Documents, each party may have access to information that is confidential to the other party
or to the</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 11pt 2.35pt 0 0pt; text-indent: 0.05pt">JV <FONT STYLE="font-size: 11.5pt"><B><I>(&ldquo;Confidential
Information&rdquo;).</I></B></FONT> Confidential Information shall include the intellectual property of a party and its technical information,
client lists, business plans, organization policies, software, in both source code and object code forms, concepts, design architectures,
specifications, processes, techniques, algorithms, know-how, source materials, training materials, maintenance information and materials,
and other information that is labeled or otherwise designated as confidential or that by its nature would reasonably be expected to be
kept confidential.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 11pt 2.35pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_165.gif">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.85pt 6.7pt 0 0pt; text-indent: 35.15pt">Section 8.2 <U>Nondisclosure</U>.
The parties agree, both during the term of the JV and thereafter, to hold each other&rsquo;s (and the JV&rsquo;s) Confidential Information in strict
confidence. The parties agree not to make each other&rsquo;s Confidential Information available in any form to any third party or to use each
other&rsquo;s Confidential Information for any purpose other than the implementation of this Agreement and/or in connection with such party&rsquo;s
performance of its obligations and/or enjoyment of its rights under this Agreement. Each party agrees to use the same degree of care
that it uses to protect its own confidential information of a similar nature and value, but in no event less than a reasonable standard
of care, to ensure that Confidential Information is not disclosed or distributed by its employees or agents in violation of the provisions
of this Agreement. The parties represent that each has, with each of its employees who may have access to any Confidential Information,
an appropriate agreement sufficient to enable it to comply with all of the terms of this Section.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.85pt 6.7pt 0 0pt; text-indent: 35.15pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.85pt 6.7pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_166.gif">&nbsp;</P>



<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"><FONT STYLE="font-family: Courier New, Courier, Monospace; font-size: 10pt"><IMG SRC="image_041.gif" ALT="" STYLE="height: 17px; width: 255px"></FONT></P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 6.8pt; margin-bottom: 0">ARTICLE 9</P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 6.8pt; margin-bottom: 0">MISCELLANEOUS PROVISIONS</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 6.8pt; margin-bottom: 0"><IMG SRC="image_167.gif">&nbsp;</P>


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.85pt 0 0 0pt; text-indent: 35.15pt">Section 9.1 <U>Amendments.</U>
The Agreement may only be amended or waived by an instrument in writing signed by the party to be charged.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.85pt 0 0 0pt; text-indent: 35.15pt"><IMG SRC="image_168.gif">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 6.4pt 0 0pt; text-indent: 35.15pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">9.2</FONT>
<U>Governing Law</U>. This Agreement, The Distribution Agreements and all other Organizational Documents of the JV shall be governed by,
and construed in accordance with, the internal laws of Hong Kong without regard to conflicts of laws principles. Disputes among the parties
with respect to the JV will be subject to the exclusive jurisdiction of Hong Kong courts.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4pt 6.4pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_169.gif">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5pt 6.4pt 0 0pt; text-indent: 34.95pt">Section 9.3 <U>Statement.</U> All
the Parties hereby declare that no one shall violate any prohibitive provisions of local law in different regions where this Agreement
is performed. If the provisions of this Agreement conflict with the laws of that region, the Parties shall promptly amend or repeal the
provisions in conflict.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5pt 6.4pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_170.gif">&nbsp;</P>




<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.15pt 11.5pt 0 0pt; text-indent: 34.8pt">Section 9.4 <U>Notices.</U>
All written communications hereunder shall in writing and shall be mailed, emailed or delivered to the respective addresses
specified on the signature pages hereto, or as to each party, to such other address as shall be designated by such party in a
written notice to the other party. Written communications shall be effective upon receipt unless such communication is mailed in
which case it shall be effective three Business Days after deposit in first class mail.</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.1pt 7.7pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_171.gif">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.1pt 7.7pt 0 0pt; text-indent: 35pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">9.5</FONT>
<U>Costs and Expenses.</U> All costs and expenses (including legal expenses) incurred by either party in connection with the formation
of the JV and/or the negotiation of this Agreement or any of the other JV Documents will be borne by such party.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.1pt 7.7pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_172.gif">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.85pt 0 0 0pt; text-indent: 35pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">9.6</FONT>
<U>Rights of Access.</U> Each Shareholder will have the right to reasonably inspect the books and records of the JV.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.85pt 0 0 0pt; text-indent: 35pt"><IMG SRC="image_173.gif">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.25pt 7.7pt 0 0pt; text-indent: 35pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">9.7
<U>JV</U></FONT><U> Documents.</U> All <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">JV</FONT> Documents shall
be drafted in both English and Chinese. The controlling language of this document is English.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2.25pt 7.7pt 0 0pt; text-indent: 35pt">&nbsp;<IMG SRC="image_176.gif"></P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 3.2pt 7.7pt 0 0pt; text-indent: 35pt">Section 9.8 <U>Severability of Provisions.</U>
If one or more of the provisions of this Agreement shall be for any reason whatever held invalid, such provisions shall be deemed severable
from the remaining covenants and provisions of this Agreement, and shall in no way affect the validity or enforceability of such remaining
provisions, the rights of any parties hereto. To the extent permitted by law, the parties hereto waive any provision of law which renders
any provision of this Agreement prohibited or unenforceable in any respect.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 3.2pt 7.7pt 0pt 0pt; text-indent: 0pt"><IMG SRC="image_175.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 3.2pt 7.7pt 0 0pt; text-indent: 35pt">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 1.8pt 0 0 0pt; text-indent: 34.8pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">9.9</FONT>
<U>Binding Effect</U>. All provisions of this Agreement shall be binding upon and inure to the benefit of the respective successors and
assigns of the parties hereto.</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05in 0pt 0pt; text-indent: 0pt"><IMG SRC="image_177.gif">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05in 0 0 0pt; text-indent: 35.15pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">9.10
</FONT><U>Assignment.</U> Neither this Agreement nor any of the rights, interest or obligations hereunder may be assigned by any party
hereto without the prior written consent of the other party, which shall not be unreasonably withheld or delayed. Notwithstanding the
foregoing, (i) WIDER may assign this Agreement in whole to an Affiliate of WIDER or to a successor of WIDER in the event of a sale of
its business, a merger, an acquisition or another change in control of WIDER, provided that WIDER shall not assign this Agreement without
the prior written consent of Nexalin to any entity that, in Nexalin&rsquo;s reasonable judgment, is not financially or otherwise capable of
performing WIDER&rsquo; obligations hereunder. and (ii) Based on reciprocity principle , after obtain the written consent of WIDER, Nexalin
may assign this Agreement in whole to an Affiliate of Nexalin or to a successor of Nexalin in the event of a sale of its business, a
merger, an acquisition or another change in control of Nexalin. This Agreement shall bind and inure to the benefit of the parties and
their respective successors and permitted assigns.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05in 0 0 0pt; text-indent: 35.15pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05in 0pt 0pt; text-indent: 0pt"><IMG SRC="image_178.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05in 0 0 0pt; text-indent: 35.15pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05in 0 0 0pt; text-indent: 35.15pt"></P>


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.1pt 9.35pt 0 0pt; text-indent: 35.15pt">Section <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">9.11</FONT>
<U>Counterparts.</U> This Agreement may be executed in any number of counterparts, each of which so executed shall be deemed to be an
original, but all such counterparts shall together constitute but one and the same instrument. Each of the parties hereto respectively
agrees that faxed or electronically transmitted copies of the signature pages of this Agreement, whether sent to any other party hereto
or to such other party&rsquo;s respective counsel, shall be deemed definitively executed and delivered, and with the same force and effect as
if manually signed and delivered, and for all</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 0 0 0pt; text-align: justify">purposes whatsoever.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 0 0 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 0 0 0pt; text-align: justify"><IMG SRC="image_179.gif"></P>



<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 7.65pt 9.15pt 0 0pt; text-align: center"><I>[signature page follows]</I></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 7.65pt 9.15pt 0 0pt; text-align: center"><I><IMG SRC="image_180.gif">&nbsp;</I></P>


<P STYLE="font: 22pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 13.35pt 0 0pt; text-align: justify; text-indent: -0.1pt">IN WITNESS
WHEREOF, Nexalin and WIDER have caused this Agreement to be duly executed by their respective officers thereunto duly authorized as of
the date and year first above written.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 13.35pt 0 0pt; text-align: justify; text-indent: -0.1pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 13.35pt 0 0pt; text-align: justify; text-indent: -0.1pt"><IMG SRC="image_181.gif"></P>


<P STYLE="font: 20pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt; text-align: justify">WIDER COM LIMITED</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom">&nbsp;<IMG SRC="image_182.gif"></TD>
  <TD STYLE="text-align: left; vertical-align: bottom"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 7%; vertical-align: bottom">Name:</TD>
  <TD STYLE="text-align: left; width: 33%; vertical-align: bottom">&nbsp;<IMG SRC="image_183.gif"></TD>
  <TD STYLE="text-align: left; width: 60%; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">Title:</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 11.2pt 0 0 0pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 11.1pt 0 0 0pt">Address for Notices:</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.4pt 0 0 0pt">WIDER COM LIMITED</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.85pt 147.25pt 0 0pt; text-indent: 0.15pt">FLAT/RM E BLK 1 8/F KWUM TONG
INDUSTRIAL</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.85pt 147.25pt 0 0pt; text-indent: 0.15pt">CENTRE 472-484 KWUN TONG ROAD</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.85pt 147.25pt 0 0pt; text-indent: 0.15pt">KWUN TONG</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.85pt 147.25pt 0 0pt; text-indent: 0.15pt">Attn:ZHU YUN President
and CEO</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 5.85pt 147.25pt 0 0pt; text-indent: 0.15pt">Tel: +86 17710536623</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 0 0 0pt">Email: patrick-777@vip.163.com</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">NEXALIN
TECHNOLOGY, INC.</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom">&nbsp;<IMG SRC="image_184.gif"></TD>
  <TD STYLE="text-align: left; vertical-align: bottom"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 7%; vertical-align: bottom">Name:</TD>
  <TD STYLE="text-align: left; width: 33%; vertical-align: bottom">&nbsp;<IMG SRC="image_185.gif"></TD>
  <TD STYLE="text-align: left; width: 60%; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">Title:</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;<IMG SRC="image_186.gif"></TD>
  <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0 0pt"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 21.05pt 0 0 0pt">Address for Notices:</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.95pt 284.1pt 0 0pt; text-indent: 0.35pt">Nexalin Technology, Inc.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2pt 284.1pt 0pt 0pt; text-indent: 0.35pt">1776 Yorktown, Suite 550</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2pt 284.1pt 0pt 0pt; text-indent: 0.35pt">Houston, TX 77056</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2pt 284.1pt 0pt 0pt; text-indent: 0.35pt">Attn: Mark White, President
and CEO</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2pt 284.1pt 0pt 0pt; text-indent: 0.35pt">Email: Mark@nexalin-usa.com</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 2pt 284.1pt 0pt 0pt; text-indent: 0.35pt">Tel.:
(281) 830-890 Y6</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;/ 26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.6pt 0.55pt 0 3.65pt; text-align: center">Supplementary agreement for the
JOINT VENTURE AGREEMENT</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0">&nbsp;</P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0.35pt; margin-bottom: 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_048.gif" ALT="" STYLE="width: 122px; height: 16px"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 8.7pt 0 5.85pt; text-indent: -0.2pt">In view of the joint venture agreement
between NEXALIN and WIDER on 2018-9-21, the two parties agreed to supplement the contents of the original agreement :</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 8.7pt 0 5.85pt; text-indent: -0.2pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 8.7pt 0 5.85pt; text-indent: -0.2pt"><IMG SRC="image_061.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 15pt 0.55pt 0 21.55pt; text-align: center">Article 1 certain definitions</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_049.gif" ALT="" STYLE="width: 73px; height: 15px"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 16.5pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 11.5pt">1.1</FONT></TD><TD STYLE="text-align: left; width: 94%"><FONT STYLE="font-size: 11.5pt">Pain is an unpleasant feeling and emotional experience
caused by tissue damage or potential damage</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
                                                            <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2"><IMG SRC="image_022.jpg" ALT="" STYLE="height: 12.25pt; width: 337.8pt"></TD></TR>
                                                            </TABLE>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.1pt 0 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 11.5pt">1.2</FONT></TD><TD STYLE="text-align: left; width: 94%"><FONT STYLE="font-size: 11.5pt">&ldquo;PM&rdquo; has the meaning of pain management.</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
                                                                                                                                                                                                                                      <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2"><IMG SRC="image_023.jpg" ALT="" STYLE="height: 12.25pt; width: 164.95pt">&nbsp;</TD></TR>
                                                                                                                                                                                                                                      </TABLE>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 0 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 8.8pt 0pt 0pt; text-align: left; text-indent: 17.55pt"><FONT STYLE="font-size: 11.5pt">1.3</FONT>
<FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;PM Distribution Agreement&rdquo;</I></B></FONT> <FONT STYLE="font-size: 11.5pt">means, collectively,
one or more distribution agreements to be entered into between the JV and other appointed distributors at such time that the distributor
obtains all necessary Permits in any of the applicable Territories.</FONT></P>



<P STYLE="font: bold 16.5pt Courier New, Courier, Monospace; text-indent: 40pt; margin: 3.2pt 0 0 12.95pt"></P>

<P STYLE="font: bold 16.5pt Courier New, Courier, Monospace; margin: 3.2pt 0pt 0pt"><IMG SRC="image_062.gif"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 14.45pt 4.95pt 0 5.1pt; text-align: left; text-indent: 17.65pt"><FONT STYLE="font-size: 11.5pt">1.4</FONT>
<FONT STYLE="font-size: 11.5pt"><B><I>&ldquo;PM Clinical Trials&rdquo;</I></B></FONT> <FONT STYLE="font-size: 11.5pt">means the clinical trials
of Nexalin Products for the treatment of PM in the Territory to be sponsored by the JV.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 14.45pt 4.95pt 0 5.1pt; text-align: left; text-indent: 17.65pt"><IMG SRC="image_024.jpg" ALT="" STYLE="height: 11.35pt; width: 400.3pt"></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Article 2 joint venture</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 11.5pt Arial, Helvetica, Sans-Serif; margin-top: 0.15pt; margin-bottom: 0"><IMG SRC="image_025.jpg" ALT="" STYLE="height: 11pt; width: 78.35pt"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 16.5pt Arial, Helvetica, Sans-Serif; margin: 0.3pt 0 0">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.85pt 0pt 0pt; text-indent: 29.3pt">2.1 Within days of JV signing this
agreement and JV has already opened a Bank A/C, Wider is to inject a capital of US$600,000.00 into the JV by depositing into the JV Bank
A/C. The funding is for the PM clinical trials in China. The protocol of the clinical trials must be approved by Nexalin and the JV. Such
study should take place at a major university and/or hospital in China and meet international peer review standards. The funding is also
to be used for the application to the NMPA for license to market, sales and distribution of the PM products in the territory.</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 9.65pt 0pt 0pt"><IMG SRC="image_063.gif"></P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.45pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 10.95pt 0pt 0pt; text-align: left; text-indent: 23.7pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">2.2</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 11.5pt">In consideration of this funding, Nexalin will grant the JV the exclusive distribution rights for
the PM products in the territory.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 10.95pt 0pt 0pt; text-align: left; text-indent: 23.7pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 10.95pt 0 5.1pt; text-align: left; text-indent: 23.7pt"><FONT STYLE="font-size: 11.5pt"></FONT></P>

<P STYLE="text-indent: 23.7pt; font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.35pt 0pt 0pt"><IMG SRC="image_026.jpg" ALT="" STYLE="height: 11.7pt; width: 371.85pt"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0.2pt 0 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.5pt 0pt 0pt; text-align: justify; text-indent: 17.55pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11.5pt">2.3</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11.5pt">Nexalin will support the JV in the registration of the PM products to NMPA with timely response
on information, permits and documents as requested.</FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="text-indent: 23.7pt; margin: 0pt"><IMG SRC="image_055.gif" ALT="" STYLE="width: 587px; height: 17px"></P>

<P STYLE="text-indent: 23.7pt; margin: 0pt"></P>

<P STYLE="font: 14.5pt Arial, Helvetica, Sans-Serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 10.05pt 0pt 0pt; text-align: justify; text-indent: 17.5pt"><FONT STYLE="font-size: 11.5pt">2.4</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 11.5pt">Nexalin will grant Wider a global exclusive technology license(except in the USA) to manufacture
the PM products and sell exclusively to Nexalin and the JV. Wider has no rights at any time under any circumstances to sell the PM products
for the treatment of PM to anyone else except Nexalin and JV for the sale and distribution in any such applicable territories. Wider is
to add 10% above factory cost before selling to Nexalin and JV. All purchase orders from Nexalin and JV of the PM products should be issued
to</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 6.1pt 0 6.35pt; text-align: justify; text-indent: -0.1pt">Wider for
processing. Nexalin will also have to manufacture PM device in USA manufacturer that is registered with FDA to sustain all necessary regulatory
and compliance standards in USA.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 6.1pt 0pt 0pt; text-align: justify; text-indent: 0pt">&nbsp;<IMG SRC="image_064.gif">&nbsp;</P>


<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0"><I>&nbsp;</I></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 5.35pt 0pt 0pt; text-align: justify; text-indent: 17.7pt"><FONT STYLE="font-size: 11.5pt">2.5</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 11.5pt">Nexalin will provide Wider with all necessary information for the manufacturing of the PM products,
including but not limited to the Engineering design, specifications, drawings, 8.0.M, testing protocols, documents and final manufacturing
sample.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 5.35pt 0 6pt; text-align: justify; text-indent: 17.7pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 5.35pt 0pt 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_065.gif"></FONT></P>





<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 11.45pt 6pt 0pt 0pt; text-align: justify; text-indent: 17.6pt"><FONT STYLE="font-size: 11.5pt">2.6</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 11.5pt">Any new patented inventions for the treatment of PM that are developed in connection with any PM
clinical trials in China, the JV shall be the record owner of any such inventions described in such patent. Based on any invention patents
obtained by PM clinical trials, the JV has the right to register, authorize, produce, sell the intellectual property worldwide that pertains
to products established by JV and covered in this contract.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 11.45pt 6pt 0pt 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_066.gif">&nbsp;</FONT></P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 9.5pt 6.1pt 0pt 0pt; text-align: justify; text-indent: 17.55pt"><FONT STYLE="font-size: 11.5pt">2.7</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 11.5pt">Except as otherwise provided in this Agreement or any of the other JV Documents, Nexalin may not
sell the PM Products in any Territory other than through the JV. It is understood that Nexalin has sold the Nexalin device in the USA
and under the CE Mark in Europe for pain. Nexalin may continue to sell the Nexalin device in these territories</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt">directly from Nexalin Technology.</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt"><IMG SRC="image_067.gif"></P>



<P STYLE="font: 8.5pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 9.95pt 0pt 0pt; text-align: justify; text-indent: 17.35pt"><FONT STYLE="font-size: 11.5pt">2.8</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 11.5pt">Within <U>30 days</U> after Wider injected a capital of US$600,000.00 into the JV bank account,
Nexalin is to issue 5% of its company non diluted Common Stock to Wider&rsquo;s shareholders as specified by Wider.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 9.95pt 0pt 0pt; text-align: justify; text-indent: 17.35pt"><FONT STYLE="font-size: 11.5pt">&nbsp;<IMG SRC="image_068.gif"></FONT>&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 4.65pt 9.95pt 0 5.7pt; text-align: justify; text-indent: 17.35pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>



<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.55pt 0pt 0pt; text-align: center">Article 3 MISCELLANEOUS
PROVISIONS</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 10.55pt 0pt 0pt; text-align: center"></P>

<P STYLE="text-align: center; font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 0.25pt; margin-bottom: 0">&nbsp;<IMG SRC="image_069.gif"></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.4pt 0pt 0pt; text-align: justify; text-indent: 17.55pt"><FONT STYLE="font-size: 10.5pt">3.1</FONT>
<FONT STYLE="font-size: 11.5pt">After the entry into force of this agreement, it becomes an integral part of the original contract and
has the same legal effect as the original contract.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.4pt 0pt 0pt; text-align: justify; text-indent: 17.55pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.15pt 0pt 0pt 17.55pt"><IMG SRC="image_028.jpg" ALT="" STYLE="height: 12.95pt; width: 441.5pt"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 14.5pt Arial, Helvetica, Sans-Serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.4pt 0pt 0pt; text-align: justify; text-indent: 17.55pt"><FONT STYLE="font-size: 10.5pt">3.2</FONT>
<FONT STYLE="font-size: 11.5pt">Counterpart Execution. This Agreement may be executed in multiple counterparts and by facsimile and/or
by e-mail, and all executed counterparts together shall constitute the original instrument.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.4pt 0pt 0pt; text-align: justify; text-indent: 17.55pt"><FONT STYLE="font-size: 11.5pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.4pt 0pt 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-size: 11.5pt"><IMG SRC="image_070.gif">&nbsp;</FONT></P>


<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0.4pt 0 0">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.25pt 0pt 0pt; text-align: justify; text-indent: 17.35pt">IN WITNESS
WHEREOF, the Parties have executed this Agreement on the date(s) as set forth below:</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0 11.25pt 0 5.35pt; text-align: justify; text-indent: 17.35pt">&nbsp;</P>

<P STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif; margin: 0.2pt 0pt 0pt 17.35pt"><IMG SRC="image_029.jpg" ALT="" STYLE="height: 12.25pt; width: 216.45pt"></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 11.5pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 14%">NEXALIN</TD>
    <TD COLSPAN="1" ROWSPAN="3" STYLE="border-bottom: Black 1pt solid; width: 33%">&nbsp;<IMG SRC="image_071.gif"></TD>
  <TD STYLE="width: 6%">&nbsp;</TD>
  <TD STYLE="width: 14%">WIDER</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
      <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
      <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
      <P STYLE="margin-top: 0; margin-bottom: 0">Signed:</P></TD>
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">Signed:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;<IMG SRC="image_072.gif"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">Print name:</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom">&nbsp;<IMG SRC="image_073.gif"></TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">Print name:</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom">&nbsp;<IMG SRC="image_076.gif"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">Print
title:</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom">&nbsp;<IMG SRC="image_074.gif"></TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">Print
title:</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom">&nbsp;<IMG SRC="image_077.gif"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; vertical-align: bottom">Date
(m/d/y):</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom">&nbsp;<IMG SRC="image_075.gif"></TD>
  <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
  <TD STYLE="text-align: left; vertical-align: bottom">Date
(m/d/y):</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;<IMG SRC="image_078.gif"></TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font: 11.5pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>filename3.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 4.3pt 0pt 0pt; text-align: right">Exhibit 10.2</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 4.3pt 0pt 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 4.3pt; margin-bottom: 0; text-align: center">EMPLOYMENT AGREEMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 10.15pt 0 0 47pt"><B>EMPLOYMENT AGREEMENT</B> (this &#8220;Agreement&#8221;)
dated as of February 15, 2021 between</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 11pt"><B>MARK WHITE</B> (the &#8220;<B>Executive</B>&#8221;) and <B>NEXALIN
TECHNOLOGY INC.</B> (the &#8220;<B>Company</B>&#8221;).</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.6pt 0 0 47pt"><B>WHEREAS</B>, the Company would like to employ the Executive
as its Chief Executive Officer;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 11pt">and</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.55pt 0 0 11pt; text-indent: 35.95pt"><B>WHEREAS</B>, the Company and the
Executive desire to provide for the terms and conditions of the future employment of the Executive by the Company.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 11pt; text-indent: 35.95pt"><B>NOW</B>, <B>THEREFORE</B>, in consideration
of the premises and covenants herein contained, the parties hereto agree as follows:</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.65pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Employment Term.</B> Subject to the terms and conditions hereof, the Company employs the Executive and the Executive accepts such
employment for the three (3) year period commencing on February 15, 2021 and ending on February 14, 2024 (the &#8220;<B>Employment Term</B>&#8221;),
unless the Employment Term is extended or terminated as provided in Sections 2 and 7, respectively.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 5.65pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Renewal.</B> The Employment Term shall be extended for successive one-year periods unless prior to January 1 of any year, either
party notifies the other that he or it chooses not to extend the Employment Term. By way of example, if neither party makes an election
prior to January 1, 2024 then the Employment Term shall automatically be extended by one additional year to February 14, 2025.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.8pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties and Responsibilities. </B>During the Employment Term, the Executive shall serve as the Chief Executive Officer of the Company
and as the holder of such other senior executive positions consistent therewith as the Board may determine. He shall report to, and be
subject to, the direction of the Company&#8217;s Board of Directors with such duties and responsibilities as are commensurate with his
title and position. The Executive shall work on a full-time basis and shall devote his time, energy and attention to the business of the
Company; it being understood that Executive&#8217;s employment hereunder shall not preclude his working on other non-competitive business
matters that do not interfere with his duties hereunder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.3pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.8pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&nbsp;&nbsp;&nbsp;
</FONT>Compensation.</B></P>



<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.2pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 15.45pt 0 11pt; text-align: left; text-indent: 0in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT><B>Basic Compensation</B>. In payment for services to be rendered by the Executive hereunder, the Executive shall be entitled to
annual Basic Compensation in cash, less any withholding required by law; of $200,000 per annum, payable monthly or on such more frequent
schedule as the Company may elect.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 9.65pt 0 11pt; text-align: left; text-indent: 0in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><B>Bonus.</B> The Executive shall be entitled to an aggregate bonus of $200,000 each year during his employment on achieving targets
set for each year by the Compensation Committee of the Board of Directors of the Company. The aggregate bonus earned by Executive in
any year will be payable (i) one- half (1/2) in cash (payable as soon as practicable following the determination of the bonus amount)
and (ii) one-half (1/2) by an allotment of Shares (the &#8220;Bonus Shares&#8221;) issuable within 15 days after the expiration of the
Employment Term, or any extension thereof. The Bonus Shares for each year shall be such number of Shares which, when valued as set forth
below, shall equal one-half (<SUP>1</SUP>/<FONT STYLE="font-size: 7pt">2</FONT>) of the aggregate bonus amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.05pt 0.25pt 0 11pt">The Executive acknowledges that the Bonus Shares issuable
under this Section 4(b) will be taken by him for investment and not for distribution thereof and will not be sold or otherwise disposed
of in violation of the Securities Act of 1933 as amended and the rules and regulations promulgated thereunder (the &#8220;<B>Securities
Act</B>&#8221;) and shall contain restrictions as are customary in grants of this kind and taxable to the Executive in accordance with
applicable federal and state tax laws.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 22.75pt 0 11pt; text-indent: 35.95pt">The value of such Bonus Shares shall
be determined as follows: (i) if the Company is publicly traded, the average daily trading price of the Company&#8217;s shares over the
prior 30 days, or (ii) if the Company is not publicly traded, a per share value based upon the most recent value of the shares in private
sales transactions over the prior ninety (90) days.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT><B>Options.</B> If in any year the Executive receives an allotment of Bonus Shares under Section 4(b) above, he shall also be entitled
to receive options to purchase 20% of the number of Bonus Shares included in the allotment. The options shall be issued at the same time
that the Bonus Shares are allotted and shall be exercisable at a per share purchase price equal to 100% of fair market value on the date
of grant or 110% of fair market value if the Executive is the owner of 10% or more of the Company&#8217;s outstanding shares. Such options
shall have a five (5) year duration and shall vest and become exercisable to the extent of one-third (1/3) of the options granted at the
expiration of each of the first three (3) years from the date of grant. The vested options shall be exercisable only while Executive is
employed by the Company or within thirty (30) days after any termination of employment. The options shall not contain anti-dilution protections.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt"> (d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT><B>Additional Bonus</B>. [TBD]</P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 6pt 0 11pt; text-align: justify; text-indent: 35.95pt">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; </FONT><B>Stock
Issuance.</B> Promptly following the execution and delivery of this Agreement by both parties, the Company shall issue to the
Executive shares of common stock of the Company equal to _________________ shares (i.e., representing two (2%) percent of the issued
and outstanding shares of common stock of the Company as of the date hereof). The newly issued shares shall have a fair market value
per share equal to $0.01. The Executive acknowledges that the shares issuable under this Section 4(e) will be taken by him for
investment and not for distribution thereof and will not be sold or otherwise disposed of in violation of the Securities Act.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&nbsp;
</FONT><B>Specified Employee.</B> If the Executive is a &#8220;specified employee&#8221; of the Company within the meaning of Section
409A(a)(2)(B)(i) of the Internal Revenue Code (the &#8220;Code&#8221;) (or any successor provision), no payment under this Section 4 in
connection with the Executive&#8217;s termination of employment (other than a payment of salary through the date of such termination,
and payments on account of termination of employment by reason of death) shall be made until the date which is six (6) months after the
date of the termination of the employment of the Executive (or, if earlier, the date of death of the Executive); provided further, if
the Company determines based upon written advice of counsel that any such payment if made during the calendar year that includes the termination
date would not be deductible in whole or in part by reason of Code &sect; 162(m), such payment shall be made on January 2 of the following
calendar year (or such later date as may be required under the preceding proviso if the Executive is a &#8220;specified employee&#8221;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.8pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Expenses.</B> During the Employment Term, the Executive shall be entitled to receive prompt reimbursement for all reasonable expenses
incurred by him (in accordance with the policies and procedures established from time to time by the Board of Directors of the Company)
in performing services hereunder, provided that such expenses are incurred and accounted for in accordance with the policies and procedures
established by the Company.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.8pt 0 11pt; text-align: justify; text-indent: 35.95pt"> <B>6.</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT><B>Other Benefits</B>. The Executive shall be entitled to the following additional benefits:</P>




<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.05pt 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT> four (4) weeks of paid vacation during each year of the term; it being understood and agreed that Executive shall be entitled
to take such additional paid vacation time as does not interfere with the performance of his duties hereunder and as are not reasonably
objected to by the Company&#8217;s Board of Directors.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.6pt 0 11pt; text-align: justify; text-indent: 35.95pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Paid holidays in accordance with the Company&#8217;s usual holiday schedule plus eight additional paid holiday, or personal days,
to be taken at such time as the Executive determines; it being understood and agreed that Executive shall be entitled to take such additional
paid holidays or paid personal days as do not interfere with the performance of his duties hereunder and as are not reasonably objected
to by the Company&#8217;s Board of Directors.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.9pt 0 11pt; text-align: justify; text-indent: 35.95pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Such major medical, health and dental coverage benefits and long-term disability group plan coverage generally available to the
Company's officers. To the extent the Executive qualifies, the Executive may participate in, or benefit under, any employee benefit plan,
arrangement or perquisite made available by the Company to its key executives. Family medical, health and dental coverage benefits and
long-term disability group plan coverage may be obtained for the Executive&#8217;s family at his sole cost and expense.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.6pt 0 11pt; text-align: justify; text-indent: 35.95pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>The Company shall reimburse the Executive for such ordinary and necessary business- related expenses as shall be incurred by the
Executive in the course of the performance of his duties under this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 5.75pt 0 11pt; text-align: justify; text-indent: 35.95pt">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>A monthly car allowance in the amount of the monthly rental cost of a luxury sedan or its equivalent plus expenses for business
use.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 5.95pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Termination.</B> The Executive's employment hereunder may be terminated under the following circumstances:</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 31.55pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>The Company shall have the right to terminate the employment of the Executive under this Agreement for disability in the event
the Executive suffers an injury, or physical or mental illness or incapacity of such character as to substantially disable him from performing
his duties hereunder for a period of more than one hundred eighty (180) consecutive days upon the Company giving at last thirty (30)
days written notice of termination; provided, however, that if the Executive is eligible to receive disability payments pursuant to a
disability insurance policy or policies paid for by the Company, the Executive shall assign such benefits to the Company for all periods
as to which he is receiving payment under this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.75pt 0 11pt; text-align: justify; text-indent: 35.95pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>This Agreement shall terminate upon the death of Executive.</P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.75pt 0 11pt; text-align: justify; text-indent: 35.95pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>The Company may terminate this Agreement at any time for &#8220;Cause&#8221; because of (i) his being convicted of criminal charges
or violating such rules and regulations of the Securities and Exchange Commission as may result in criminal action or material fines against
the Company; (ii) Executive&#8217;s material breach of any term of this Agreement; or (iii) the willful engaging by the Executive in misconduct
which is materially injurious to the Company, monetarily or otherwise; provided, in the case or (ii) or (iii), however, that the Company
shall not terminate this Agreement pursuant to this Section 7(c) unless the Company shall first have delivered to the Executive a notice
which specifically identifies such breach or misconduct, specifies reasonable corrective action and the Executive shall not have cured
the breach or corrected the misconduct within fifteen (15) days after receipt of such notice.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 47pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: left; padding-right: 6pt">The Executive may terminate his employment for &#8220;Good Reason&#8221; on five days
written notice if:</TD></TR></TABLE>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 4.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83pt"></TD><TD STYLE="width: 36pt">(i)</TD><TD STYLE="text-align: justify; padding-right: 5.7pt">he is assigned, without his express written consent, any duties inconsistent with
his positions, duties, responsibilities, authority and status with the Company as of the date hereof, or a change in his reporting responsibilities
or titles as in effect as of the date hereof, except in connection with the termination of his employment by him without Good Reason;</TD></TR></TABLE>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 82.95pt"></TD><TD STYLE="width: 36.05pt">(ii)</TD><TD STYLE="text-align: left">his compensation is reduced; or</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83pt"></TD><TD STYLE="width: 36pt">(iii)</TD><TD STYLE="text-align: justify; padding-right: 6pt">any purchaser or purchasers of substantially all of the business or assets of the
Company do not agree, at or prior to the closing of any such transaction, by agreement in form and substance satisfactory to the Executive
to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no sale was consummated.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.6pt 0 11pt; text-align: justify; text-indent: 35.95pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Upon termination
of Executive&#8217;s employment by Executive or by the Company, for any reason or for no reason, Executive shall deliver promptly to the
Company all records, manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, data, tables, and calculations,
and copies thereof, in whatever medium, which are the property of the Company or its affiliates or which relate in any relevant, meaningful
way to the business, products, practices, techniques, customers, suppliers, functions or operations of the Company or its affiliates,
and all other property and Confidential Information of the Company or its affiliates, including, but not limited to, all documents which
in whole or in part contain any Confidential Information of the Company or its affiliates, which in any of these cases are in his possession
or under his control.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.6pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>8.</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><B>Nondisclosure; Noncompetition.</B></P>



<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.35pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>The Executive agrees not to use or disclose, either while in the Company's employ or at any time thereafter, except with the prior
written consent of the Board of Directors, any trade secrets, proprietary information, or other information that the Company considers
confidential relating to processes, suppliers (including but not limited to a list or lists of suppliers), customers (including but not
limited to a list or lists of customers), compositions, improvements, inventions, operations, processing, marketing, distributing, selling,
cost and pricing data, or master files utilized by the Company, not presently generally known to the public, and which is, obtained or
acquired by the Executive while in the employ of the Company.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.9pt 0 11pt; text-align: justify; text-indent: 35.95pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>During his employment and for a period of two years thereafter, the Executive shall not, directly or indirectly; (i) in any manner,
engage in any business which competes with any business conducted by the Company (including any subsidiary) and will not directly or indirectly
own, manage, operate, join, control or participate in the ownership, management, operation or control of, or be employed by or connected
in any manner with any corporation, firm or business that is so engaged (provided, however, that nothing herein shall prohibit the Executive
from owning not more than three percent (3%) of the outstanding stock of any publicly held corporation), (ii) persuade or attempt to persuade
any employee of the Company to leave the employ of the Company or to become employed by any other entity, or (iii) persuade or attempt
to persuade any current client or former client with leaving, or to reduce the amount of business it does or intends or anticipates doing
with the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.75pt 0 11pt; text-align: justify; text-indent: 35.95pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>During his employment with the Company, and for two years thereafter, the Executive shall not take any action which might divert
from the Company any opportunity learned about by him during his employment with the Company (including without limitation during the
Employment Term) which would be within the scope of any of the businesses then engaged in or planned to be engaged in by the Company.</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.05pt 6pt 0 11pt; text-align: justify; text-indent: 35.95pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&nbsp;
</FONT> In the event that this Agreement shall be terminated, then notwithstanding such termination, the obligations of the Executive
pursuant to this Section 8 of this Agreement shall survive such termination.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.3pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 6.05pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Inventions.</B></P>



<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.25pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.6pt 0 11pt; text-align: justify; text-indent: 35.95pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>The Executive acknowledges and agrees that all ideas, methods, inventions, discoveries, improvements, work products, developments,
software, know-how, processes, techniques, methods, works of authorship and other work product, whether patentable or unpatentable, (A)
that are reduced to practice, created, invented, designed, developed, contributed to, or improved with the use of any Company resources
and/or within the scope of the Executive&#8217;s work with the Company or that relate to the business, operations or actual or demonstrably
anticipated research or development of the Company, and that are made or conceived by the Executive, solely or jointly with others, during
his employment with Company, or (B) suggested by any work that the Executive performs in connection with the Company, either while performing
the Executive&#8217;s duties with the Company or on the Executive&#8217;s own time, but only insofar as the Inventions are related to
the Executive&#8217;s work as an employee or other service provider to the Company, shall belong exclusively to the Company (or its designee),
whether or not patent or other applications for intellectual property protection are filed thereon (the &#8220;Inventions&#8221;). The
Executive will keep full and complete written records (the &#8220;Records&#8221;), in the manner prescribed by the Company, of all Inventions,
and will promptly disclose all Inventions completely and in writing to the Company. The Records shall be the sole and exclusive property
of the Company, and the Executive will surrender them upon the termination of his employment or upon the Company&#8217;s request. The
Executive irrevocably conveys, transfers and assigns to the Company the Inventions and all patents or other intellectual property rights
that may issue thereon in any and all countries, whether during or subsequent to his term of employment, together with the right to file,
in the Executive&#8217;s name or in the name of the Company (or its designee), applications for patents and equivalent rights (the &#8220;Applications&#8221;).
The Executive will, at any time during and subsequent to his term of employment, make such applications, sign such papers, take all rightful
oaths, and perform all other acts as may be requested from time to time by the Company to perfect, record, enforce, protect, patent or
register the Company&#8217;s rights in the Inventions, all without additional compensation to the Executive from the Company. The Executive
will also execute assignments to the Company (or its designee) of the Applications, and give the Company and its attorneys all reasonable
assistance (including the giving of testimony) to obtain the Inventions for the Company&#8217;s benefit, all without additional compensation
to the Executive from the Company, but entirely at the Company&#8217;s expense.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>In addition, the Inventions will be deemed Work for Hire, as such term is defined under the copyright laws of the United States,
on behalf of the Company and the Executive agrees that the Company will be the sole owner of the Inventions, and all underlying rights
therein, in all media now known or hereinafter devised, throughout the universe and in perpetuity without any further obligations to the
Executive. If the Inventions, or any portion thereof, are deemed not to be Work for Hire, or the rights in such Inventions do not otherwise
automatically vest in the Company, the Executive hereby irrevocably conveys, transfers and assigns to the Company, all rights, in all
media now known or hereinafter devised, throughout the universe and in perpetuity, in and to the Inventions, including, without limitation,
all of the Executive&#8217;s right, title and interest in the copyrights (and all renewals, revivals and extensions thereof) to the Inventions,
including, without limitation, all rights of any kind or any nature now or hereafter recognized, including, without limitation, the unrestricted
right to make modifications, adaptations and revisions to the Inventions, to exploit and allow others to exploit the Inventions and all
rights to sue at law or in equity for any infringement, or other unauthorized use or conduct in derogation of the Inventions, known or
unknown, prior to the date hereof, including, without limitation, the right to receive all proceeds and damages therefrom. In addition,
the Executive hereby waives any so-called &#8220;moral rights&#8221; with respect to the Inventions. To the extent that the Executive
has any rights in the results and proceeds of the Executive&#8217;s service to the Company that cannot be assigned in the manner described
herein, the Executive</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.05pt 5.8pt 0 11pt; text-align: justify">agrees to unconditionally waive
the enforcement of such rights. The Executive hereby waives any and all currently existing and future monetary rights in and to the Inventions
and all patents and other registrations for intellectual property that may issue thereon, including, without limitation, any rights that
would otherwise accrue to the Executive&#8217;s benefit by virtue of the Executive being an employee of or other service provider to the
Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 6.05pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Successors;
Binding Agreement.</B></P>



<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.35pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.75pt 0 11pt; text-align: justify; text-indent: 35.95pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>The Company shall require any purchaser or purchasers of the Company or any purchaser or purchasers of substantially all of the
business or assets of the Company, by agreement in form and substance satisfactory to the Executive, to assume and agree to perform this
Agreement in the same manner and to the same extent that the Company would be required to perform it if no such purchase had taken place.
As used in this Agreement, &#8220;Company&#8221; shall mean the Company as hereinbefore defined and any successor to its business or assets
which executes and delivers the agreement provided for in this Section 9(a) or which otherwise becomes bound by all the terms and provisions
of this Agreement by operation of law.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>This agreement shall inure to the benefit of and be enforceable by the Executive's personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees. If the Executive should die while any amount would still be payable
hereunder if the Executive had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with
the terms of this Agreement to the Executive&#8217;s devisee, legatee or other designee or, if there be no such designee, to the Executive's
estate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 5.65pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Amendment; Waiver</B>. No provisions of this Agreement may be modified, supplemented, waived or discharged unless such waiver,
modification or discharge is agreed to in a writing signed by the Executive and the Company. No waiver by either party hereto at any time
of any breach by the other party hereto of, or in compliance with, any condition or provision of this Agreement to be performed by such
other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either
party which are not set forth expressly in this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.8pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Applicable Law.</B> The validity, interpretation, construction, and performance of this Agreement shall be governed by the laws
of the State of Nevada without regard to its conflict of laws principles.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.8pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Severability of Covenants</B>. In the event that any provision of this Agreement, including any sentence, clause or part hereof,
shall be deemed contrary to law or invalid or unenforceable in any respect by a court of competent jurisdiction, the remaining provisions
shall not be affected, but shall remain in full force and effect and any invalid and enforceable provisions shall be deemed, without further
action on the part of the undersigned, modified, amended and limited solely to the extent necessary to render the same valid and enforceable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 6.05pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>14.</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><B>Remedies.</B></P>



<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.3pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 6.05pt 0 11pt; text-align: justify; text-indent: 35.95pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>In the event of a breach or threatened breach of any of the Executive's covenants under Section 8, the Executive acknowledges that
the Company will not have an adequate remedy at law. Accordingly, in the event of any such breach or threatened breach, the Company will
be entitled to such equitable and injunctive relief as may be available to restrain the Executive from the violation of the provisions
thereof.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.6pt 5.95pt 0 11pt; text-align: justify; text-indent: 35.95pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT> Nothing herein shall be construed as prohibiting the Company, on the one hand, and the Executive, on the other hand, from pursuing
any remedies available at law or in equity for any breach or threatened breach of the provisions of this Agreement by the other party,
including the recovery of damages.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.8pt 0 11pt; text-align: justify; text-indent: 35.95pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>If the Company terminates this Agreement at any time without Cause (as defined above in Section 7(c)) or the Executive terminates
his employment for a Good Reason (as defined above in Section 7(d)), after the first anniversary of the date hereof, the Executive shall
be entitled under this Section 14(c) to receive an amount equal to the amount of the compensation payments that, but for his termination
of employment, would have been payable to the Executive under Section 4(a) as follows:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 36%">Termination under Section 13(c)</TD>
    <TD STYLE="width: 13%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 51%">Compensation under Section 4(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Within the first full calendar year of the Executive&#8217;s employment</TD>
    <TD>&nbsp;</TD>
    <TD>an amount equal to the amount of compensation payments for 6 months</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Within the second full calendar year of &nbsp;the Executive&#8217;s employment</TD>
    <TD>&nbsp;</TD>
    <TD>an amount equal to the amount of compensation payments for 12 months</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Within or after the third full calendar year of the Executive&#8217;s employment</TD>
    <TD>&nbsp;</TD>
    <TD>an amount equal to the amount of compensation payments for one 18 month period</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">The Executive shall also be entitled to the amounts of any bonus payments under &sect;4(b) for the year of termination to the extent that targets were achieved prior to the date of termination. </TD></TR>
  </TABLE>
<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>The above amounts shall be deemed liquidated damages, and not a penalty. The Executive shall not be required to mitigate the amount
of any payment received pursuant to this paragraph nor shall the amount payable under this paragraph be reduced by any compensation earned
by the Executive after the date of his termination of employment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 6pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Notices.</B> Any notice, request, instruction or other document to be given hereunder by any party to the other party shall be
in writing and shall be deemed to have been duly given when delivered personally or five (5) days after dispatch by registered or certified
mail, postage prepaid, return receipt requested, to the party to whom the same is so given or made:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%">&nbsp;</TD>
    <TD STYLE="width: 45%">If to the Company</TD>
    <TD STYLE="width: 42%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20pt">addressed to:</TD>
    <TD>Nexalin Technology Inc.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>1776 Yorktown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Suite 550</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Houston, TX 77056</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;Attention:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-left: 20pt">with a copy to:</TD>
    <TD>Warhsaw Burstein LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>575 Lexington Avenue</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>New York, New York 10022</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Attention: Martin Siegel, Esq.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>If to the Executive</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20pt">addressed to:</TD>
    <TD>Mr. Mark White</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 42%">8605 Cedardale</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Houston, TX 77055</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 191.05pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 11pt">or to such other address as the one party shall specify to
the other party in writing.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 11pt; text-align: justify; text-indent: 35.95pt"><B>16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>
</FONT>Entire Agreement</B>. This Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained
herein and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether
oral or written, by any officer, employee or representative of any party hereto; and any prior agreement of the parties hereto in respect
of the subject matter contained herein is hereby terminated and canceled.</P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 11pt"><B>IN WITNESS WHEREOF</B>, the parties have executed this Agreement
on the date and year first above written.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.35pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: left">NEXALIN TECHNOLOGY INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 36%; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 5%; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 35%; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 24%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">By:&#8239;<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Lucida Console, Monospace; font-size: 8.5pt">Mark
    White</FONT></U><U><FONT STYLE="font-size: 8.5pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Lucida Console, Monospace">CEO</FONT></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.3pt 0 0 60pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 32.4pt; width: 70.95pt"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left"><B>MARK WHITE</B></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1pt 161.1pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1pt 161.1pt 0 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1pt 161.1pt 0 0; text-align: center"><B>&nbsp;</B></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>filename4.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 4.3pt 0pt 0pt; text-align: right">Exhibit 10.3</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 4.3pt 0pt 0pt; text-align: right">&nbsp;</P>
<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">EMPLOYMENT AGREEMENT&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>EMPLOYMENT AGREEMENT</B> (this
&#8220;Agreement&#8221;) dated as of February 15, 2021 between <B>DAVID OWENS, MD </B>(the &#8220;<B>Executive</B>&#8221;) and <B>NEXALIN
TECHNOLOGY INC.</B> (the &#8220;<B>Company</B>&#8221;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company would
like to employ the Executive as its Chief Medical Officer; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company and
the Executive desire to provide for the terms and conditions of the future employment of the Executive by the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOW</B>, <B>THEREFORE</B>,
in consideration of the premises and covenants herein contained, the parties hereto agree as follows:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Employment
Term.</B> Subject to the terms and conditions hereof, the Company employs the Executive and the Executive accepts such employment for
the three (3) year period commencing on February 15, 2021 and ending on February 14, 2024 (the &#8220;<B>Employment Term</B>&#8221;),
with an option for the Company and the Executive to extend the term for an additional two (2) year period no later than sixty (60) days
prior to the expiration of the initial Employment Term.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Duties
and Responsibilities.</B> During the Employment Term, the Executive shall serve as the Chief Medical Officer of the Company and as the
holder of such other senior executive positions consistent therewith as the Board may determine. He shall report to, and be subject to,
the direction of the Company&#8217;s Board of Directors with such duties and responsibilities as are commensurate with his title and position.
The Executive shall work on a full-time basis and shall devote his time, energy and attention to the business of the Company; it being
understood that Executive&#8217;s employment hereunder shall not preclude his working on other non-competitive business matters that do
not interfere with his duties hereunder. Due to the fact that the current amount of time required for the Executive to perform his services
is unknown as of the date hereof and may likely fluctuate during the Employment Term, a semi-annual written evaluation of this Agreement
will be performed jointly by the Company and the Executive and any modifications hereto may be mutually agreed to by the parties (including
approval by the Company&#8217;s Board of Directors).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Compensation.
</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Basic
Compensation</B>. In payment for services to be rendered by the Executive hereunder, the Executive shall be entitled to annual compensation
of $150,000, which shall be payable on January 15th of each calendar year during the Employment Term and shall be payable by the issuance
to the Executive of shares of common stock of the Company based upon the value of such shares as follows: (i) if the Company is publicly
traded, the average daily trading price of the Company&#8217;s shares over the prior 30 days, or (ii) if the Company is not publicly traded,
$0.20 per share based upon the most recent value of the Company&#8217;s shares in private sales transactions prior to the date hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Bonus.</B>
The Executive may be entitled to receive additional compensation based upon the successful achievement of certain mutually agreed upon
research and development &#8220;milestones.&#8221; Two milestones will be agreed upon each year by the parties (including approval by
the Company&#8217;s Board of Directors). The milestones for the year of 2021 include:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Evaluation
of new 15 mA digital waveform for safety; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Evaluation
of efficacy of the Company&#8217;s neurostimulation stimulation device in opioid use disorder management.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The total compensation for each milestone achieved
will be equal to $50,000 and shall be payable by the issuance to the Executive of shares of common stock of the Company based upon the
same valuation procedure as set forth above.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Additional milestones may be agreed upon at any time
between the Parties with compensation to be paid in an amount commensurate to the proposed Services for such milestones and will be compensated
in the award of Company stock as agreed by the Parties. There will be no limit to the number of milestones that can be proposed within
a twelve-month period.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Specified
Employee. </B>If the Executive is a &#8220;specified employee&#8221; of the Company within the meaning of Section 409A(a)(2)(B)(i) of
the Internal Revenue Code (the &#8220;Code&#8221;) (or any successor provision), no payment under this Section 4 in connection with the
Executive&#8217;s termination of employment (other than a payment of salary through the date of such termination, and payments on account
of termination of employment by reason of death) shall be made until the date which is six (6) months after the date of the termination
of the employment of the Executive (or, if earlier, the date of death of the Executive); provided further, if the Company determines based
upon written advice of counsel that any such payment if made during the calendar year that includes the termination date would not be
deductible in whole or in part by reason of Code &sect; 162(m), such payment shall be made on January 2 of the following calendar year
(or such later date as may be required under the preceding proviso if the Executive is a &#8220;specified employee&#8221;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Expenses.
</B>During the Employment Term, the Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by
him (in accordance with the policies and procedures established from time to time by the Board of Directors of the Company) in performing
services hereunder, provided that such expenses are incurred and accounted for in accordance with the policies and procedures established
by the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Other
Benefits</B>. The Executive shall be entitled to the following additional benefits:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;two
(2) weeks of paid vacation during each year of the term; it being understood and agreed that Executive shall be entitled to take such
additional paid vacation time as does not interfere with the performance of his duties hereunder and as are not reasonably objected to
by the Company&#8217;s Board of Directors.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Paid
holidays in accordance with the Company&#8217;s usual holiday schedule.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Such
major medical and dental coverage benefits and long-term disability group plan coverage generally available to the Company's officers.
To the extent the Executive qualifies, the Executive may participate in, or benefit under, any employee benefit plan, arrangement or perquisite
made available by the Company to its key executives.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall reimburse the Executive for such ordinary and necessary business-related expenses as shall be incurred by the Executive
in the course of the performance of his duties under this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Termination.</B>
The Executive's employment hereunder may be terminated under the following circumstances:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have the right to terminate the employment of the Executive under this Agreement for disability in the event the Executive
suffers an injury, or physical or mental illness or incapacity of such character as to substantially disable him from performing his duties
hereunder for a period of more than one hundred eighty (180) consecutive days upon the Company giving at last thirty (30) days written
notice of termination; provided, however, that if the Executive is eligible to receive disability payments pursuant to a disability insurance
policy or policies paid for by the Company, the Executive shall assign such benefits to the Company for all periods as to which he is
receiving payment under this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall terminate upon the death of Executive.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company may terminate this Agreement at any time for &#8220;Cause&#8221; because of (i) his being convicted of criminal charges or violating
such rules and regulations of the Securities and Exchange Commission as may result in criminal action or material fines against the Company;
(ii) Executive&#8217;s material breach of any term of this Agreement; or (iii) the willful engaging by the Executive in misconduct which
is materially injurious to the Company, monetarily or otherwise; provided, in the case or (ii) or (iii), however, that the Company shall
not terminate this Agreement pursuant to this Section 7(c) unless the Company shall first have delivered to the Executive a notice which
specifically identifies such breach or misconduct, specifies reasonable corrective action and the Executive shall not have cured the breach
or corrected the misconduct within fifteen (15) days after receipt of such notice.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The Executive may terminate his employment for &#8220;Good Reason&#8221; on five days written notice if:</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 11pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">he is assigned, without his express written consent, any duties inconsistent
with his positions, duties, responsibilities, authority and status with the Company as of the date hereof, or a change in his reporting
responsibilities or titles as in effect as of the date hereof, except in connection with the termination of his employment by him without
Good Reason; or</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 11pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">his compensation is reduced.</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
termination of Executive&#8217;s employment by Executive or by the Company, for any reason or for no reason, Executive shall deliver promptly
to the Company all records, manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, data, tables, and calculations,
and copies thereof, in whatever medium, which are the property of the Company or its affiliates or which relate in any relevant, meaningful
way to the business, products, practices, techniques, customers, suppliers, functions or operations of the Company or its affiliates,
and all other property and Confidential Information of the Company or its affiliates, including, but not limited to, all documents which
in whole or in part contain any Confidential Information of the Company or its affiliates, which in any of these cases are in his possession
or under his control.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Nondisclosure;
Noncompetition.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Executive agrees not to use or disclose, either while in the Company's employ or at any time thereafter, except with the prior written
consent of the Board of Directors, any trade secrets, proprietary information, or other information that the Company considers confidential
relating to processes, suppliers (including but not limited to a list or lists of suppliers), customers (including but not limited to
a list or lists of customers), compositions, improvements, inventions, operations, processing, marketing, distributing, selling, cost
and pricing data, or master files utilized by the Company, not</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">presently generally known to the public, and which
is, obtained or acquired by the Executive while in the employ of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;During
his employment and for a period of two years thereafter, the Executive shall not, directly or indirectly; (i) in any manner, engage in
any business which competes with any business conducted by the Company (including any subsidiary) and will not directly or indirectly
own, manage, operate, join, control or participate in the ownership, management, operation or control of, or be employed by or connected
in any manner with any corporation, firm or business that is so engaged (provided, however, that nothing herein shall prohibit the Executive
from owning not more than three percent (3%) of the outstanding stock of any publicly held corporation), (ii) persuade or attempt to persuade
any employee of the Company to leave the employ of the Company or to become employed by any other entity, or (iii) persuade or attempt
to persuade any current client or former client with leaving, or to reduce the amount of business it does or intends or anticipates doing
with the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; During his employment with
the Company, and for two years thereafter, the Executive shall not take any action which might divert from the Company any opportunity
learned about by him during his employment with the Company (including without limitation during the Employment Term) which would be within
the scope of any of the businesses then engaged in or planned to be engaged in by the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In the event that this Agreement shall be terminated, then notwithstanding such termination, the obligations of the Executive pursuant
to this Section 8 of this Agreement shall survive such termination.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Inventions.
</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Executive acknowledges and agrees that all ideas, methods, inventions, discoveries, improvements, work products, developments, software,
know-how, processes, techniques, methods, works of authorship and other work product, whether patentable or unpatentable, (A) that are
reduced to practice, created, invented, designed, developed, contributed to, or improved with the use of any Company resources and/or
within the scope of the Executive&#8217;s work with the Company or that relate to the business, operations or actual or demonstrably anticipated
research or development of the Company, and that are made or conceived by the Executive, solely or jointly with others, during his employment
with Company, or (B) suggested by any work that the Executive performs in connection with the Company, either while performing the Executive&#8217;s
duties with the Company or on the Executive&#8217;s own time, but only insofar as the Inventions are related to the Executive&#8217;s
work as an employee or other service provider to the Company, shall belong exclusively to the Company (or its designee), whether or not
patent or other applications for intellectual property protection are filed thereon (the &#8220;Inventions&#8221;). The Executive will
keep full and complete written records (the &#8220;Records&#8221;), in the manner prescribed by the Company, of all Inventions, and will
promptly disclose all Inventions completely and in writing to the Company. The Records shall be the sole and exclusive property of the
Company, and the Executive will surrender them upon the termination of his employment or upon the Company&#8217;s request. The Executive
irrevocably conveys, transfers and assigns to the Company the Inventions and all patents or other intellectual property rights that may
issue thereon in any and all countries, whether during or subsequent to his term of employment, together with the right to file, in the
Executive&#8217;s name or in the name of the Company (or its designee), applications for patents and equivalent rights (the &#8220;Applications&#8221;).
The Executive will, at any time during and subsequent to his term of employment, make such applications, sign such papers, take all rightful
oaths, and perform all other acts as may be requested from time to time by the Company to perfect, record, enforce, protect, patent or
register the Company&#8217;s rights in the Inventions, all without additional compensation to the Executive from the Company. The Executive
will also execute assignments to the Company (or its designee) of the Applications, and give the Company and its attorneys all reasonable
assistance (including the giving of testimony) to obtain the Inventions for the</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Company&#8217;s benefit, all without additional compensation
to the Executive from the Company, but entirely at the Company&#8217;s expense.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
addition, the Inventions will be deemed Work for Hire, as such term is defined under the copyright laws of the United States, on behalf
of the Company and the Executive agrees that the Company will be the sole owner of the Inventions, and all underlying rights therein,
in all media now known or hereinafter devised, throughout the universe and in perpetuity without any further obligations to the Executive.
If the Inventions, or any portion thereof, are deemed not to be Work for Hire, or the rights in such Inventions do not otherwise automatically
vest in the Company, the Executive hereby irrevocably conveys, transfers and assigns to the Company, all rights, in all media now known
or hereinafter devised, throughout the universe and in perpetuity, in and to the Inventions, including, without limitation, all of the
Executive&#8217;s right, title and interest in the copyrights (and all renewals, revivals and extensions thereof) to the Inventions, including,
without limitation, all rights of any kind or any nature now or hereafter recognized, including, without limitation, the unrestricted
right to make modifications, adaptations and revisions to the Inventions, to exploit and allow others to exploit the Inventions and all
rights to sue at law or in equity for any infringement, or other unauthorized use or conduct in derogation of the Inventions, known or
unknown, prior to the date hereof, including, without limitation, the right to receive all proceeds and damages therefrom. In addition,
the Executive hereby waives any so-called &#8220;moral rights&#8221; with respect to the Inventions. To the extent that the Executive
has any rights in the results and proceeds of the Executive&#8217;s service to the Company that cannot be assigned in the manner described
herein, the Executive agrees to unconditionally waive the enforcement of such rights. The Executive hereby waives any and all currently
existing and future monetary rights in and to the Inventions and all patents and other registrations for intellectual property that may
issue thereon, including, without limitation, any rights that would otherwise accrue to the Executive&#8217;s benefit by virtue of the
Executive being an employee of or other service provider to the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Successors.</B>
This agreement shall inure to the benefit of and be enforceable by the Executive's personal or legal representatives, executors, administrators,
successors, heirs, distributees, devisees and legatees. If the Executive should die while any amount would still be payable hereunder
if the Executive had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms
of this Agreement to the Executive&#8217;s devisee, legatee or other designee or, if there be no such designee, to the Executive's estate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Amendment; Waiver</B>.
No provisions of this Agreement may be modified, supplemented, waived or discharged unless such waiver, modification or discharge is agreed
to in a writing signed by the Executive and the Company. No waiver by either party hereto at any time of any breach by the other party
hereto of, or in compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver
of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No agreements or representations, oral
or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly
in this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Applicable Law.</B> The
validity, interpretation, construction, and performance of this Agreement shall be governed by the laws of the State of Nevada without
regard to its conflict of laws principles.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Severability of Covenants</B>.
In the event that any provision of this Agreement, including any sentence, clause or part hereof, shall be deemed contrary to law or invalid
or unenforceable in any respect by a court of competent jurisdiction, the remaining provisions shall not be affected, but shall remain
in full force and effect and any invalid and enforceable provisions shall be deemed, without further action on</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">the part of the undersigned, modified, amended and
limited solely to the extent necessary to render the same valid and enforceable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Remedies.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of a breach or threatened breach of any of the Executive's covenants under Section 8, the Executive acknowledges that the Company
will not have an adequate remedy at law. Accordingly, in the event of any such breach or threatened breach, the Company will be entitled
to such equitable and injunctive relief as may be available to restrain the Executive from the violation of the provisions thereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Nothing
herein shall be construed as prohibiting the Company, on the one hand, and the Executive, on the other hand, from pursuing any remedies
available at law or in equity for any breach or threatened breach of the provisions of this Agreement by the other party, including the
recovery of damages.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)<B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>If
the Company terminates this Agreement at any time without Cause (as defined above in Section 7(c)) or the Executive terminates his employment
for a Good Reason (as defined above in Section 7(d)), after the second anniversary of this Agreement, the Executive shall be entitled
under this Section 14(c) to receive an amount equal to the amount of the compensation payments that, but for his termination of employment,
would have been payable to the Executive under Section 4(a) for the remaining period of the Employment Term.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
above amounts shall be deemed liquidated damages, and not a penalty. The Executive shall not be required to mitigate the amount of any
payment received pursuant to this paragraph nor shall the amount payable under this paragraph be reduced by any compensation earned by
the Executive after the date of his termination of employment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notices.</B> Any notice,
request, instruction or other document to be given hereunder by any party to the other party shall be in writing and shall be deemed to
have been duly given when delivered personally or five (5) days after dispatch by registered or certified mail, postage prepaid, return
receipt requested, to the party to whom the same is so given or made:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">If to the Company</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: justify"><FONT STYLE="font-size: 11pt">addressed to:</FONT></TD>
    <TD STYLE="width: 57%; text-align: justify"><FONT STYLE="font-size: 11pt">Nexalin Technology Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">1776 Yorktown </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Suite 550 </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Houston, TX 77056</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Attention: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">with a copy to:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Warhsaw Burstein LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">575 Lexington Avenue</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">New York, New York 10022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Attention: Martin Siegel, Esq.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">If to the Executive </FONT></TD>
    <TD STYLE="font: normal 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">addressed to:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">David Owens, MD</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">4545 Harris Trail</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Atlanta, Georgia 30327</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">or to such other address as the one party shall specify
to the other party in writing.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Entire Agreement</B>. This
Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes all prior
agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer,
employee or representative of any party hereto; and any prior agreement of the parties hereto in respect of the subject matter contained
herein is hereby terminated and canceled.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>IN WITNESS WHEREOF</B>, the parties have executed
this Agreement on the date and year first above written.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 67%; text-align: justify"><FONT STYLE="font-size: 11pt"><B>NEXALIN TECHNOLOGY INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">By: ___________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: bold 11pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: bold 11pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Title:</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">_______________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: bold 10.5pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: bold 10.5pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">DAVID OWENS, MD </FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>filename5.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 11pt"><B>Exhibit 10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 1pt; color: #2F2F2F">NEX-CNT-00016</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.2pt 0 0 1.4pt; color: #2F2F2F"><FONT STYLE="font-size: 10pt">Revision</FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: bold 14.5pt Times New Roman, Times, Serif; margin: 11.35pt 145.9pt 0 146.25pt; text-align: center; text-indent: 0in">Apical
Quality Agreement</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 11.6pt 13.6pt 0 9.25pt; text-indent: -0.05pt">This Quality Agreement (&ldquo;Agreement&rdquo;)
is made on <U>12/21/2020</U>&#9;by and between Nexalin and Apical Instruments (&ldquo;Apical&rdquo;).</P>

<P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0.3pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 14.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9.3pt"></TD><TD STYLE="width: 20.65pt">1</TD><TD>Introduction</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12.05pt 0 0 9pt">The objectives of this Quality Assurance Agreement are to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.8pt"></TD><TD STYLE="width: 17.3pt">&#8226;</TD><TD>establish a collaborative partnership</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.8pt"></TD><TD STYLE="width: 17.1pt">&#8226;</TD><TD>define responsibilities</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.8pt"></TD><TD STYLE="width: 17.05pt">&#8226;</TD><TD>assure that all quality requirements concerning the Nexalin Products are met</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 6.8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.8pt"></TD><TD STYLE="width: 17.05pt">&#8226;</TD><TD>ensure that operations between Apical and Nexalin run smoothly.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 6.1pt 0 0 8.95pt; text-indent: -0.2pt">This Quality Assurance Agreement defines
the Quality relationship only and is supplementary to existing and future Agreements which describe the business Terms and Conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 14.5pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.7pt"></TD><TD STYLE="width: 20.55pt">2</TD><TD>Scope</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12.05pt 0 0 8.75pt">This Quality Assurance Agreement applies to all Nexalin
products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 14.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 8.6pt"></TD><TD STYLE="width: 20.6pt">3</TD><TD>Quality Agreement</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 11.55pt 0 0 8.55pt; text-indent: 0.2pt">Nexalin is responsible for overall
compliance to applicable regulations. Apical will maintain the Nexalin Quality System, Design History File (DHF) and the Device Master
Record (DMR) for Nexalin.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 10.7pt 26.95pt 0 8.25pt; text-indent: 0.05pt">Apical agrees to notify Nexalin&rsquo;s
Quality prior to implementation of any changes to the purchased product such as materials used or configuration or site of manufacture.
This will allow Nexalin to determine the overall impact, if any, of the changes to Nexalin&rsquo;s product.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.2pt 0 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 10.7pt 26.95pt 0 8.25pt; text-indent: 0.05pt">Nexalin will qualify and approve Apical by use of one of the
following activities:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.05pt"></TD><TD STYLE="width: 17.1pt">&#8226;</TD><TD>Questionnaire</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.5pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.05pt"></TD><TD STYLE="width: 17.15pt">&#8226;</TD><TD>Audit</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 5.85pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.85pt"></TD><TD STYLE="width: 17.3pt">&#8226;</TD><TD>Oversight of first articles inspection</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.55pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.85pt"></TD><TD STYLE="width: 17.25pt">&#8226;</TD><TD>Design Verification</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 6.8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.85pt"></TD><TD STYLE="width: 17.25pt">&#8226;</TD><TD>Process Validation</TD></TR></TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 1pt; color: #2F2F2F">NEX-CNT-00016</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.2pt 0 0 1.4pt; color: #2F2F2F"><FONT STYLE="font-size: 10pt">Revision</FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 26.95pt 0 9.45pt"><FONT STYLE="color: #3F3F41">Ongoing Apical</FONT> <FONT STYLE="color: #2F2F2F">qualification
and approval will be based upon the following sources of feedback:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.15pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 43.55pt"></TD><TD STYLE="width: 17.25pt"><FONT STYLE="font-size: 10pt; color: #3F3F41">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 10pt; color: #3F3F41">Periodic Apical</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">audits</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 8.4pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 43.3pt"></TD><TD STYLE="width: 17.5pt"><FONT STYLE="font-size: 10pt; color: #3F3F41">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 10pt; color: #3F3F41">Periodic</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">inspections of received
product</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.95pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 43.3pt"></TD><TD STYLE="width: 17.05pt"><FONT STYLE="font-size: 10pt; color: #3F3F41">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 10pt; color: #3F3F41">Customer</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">feedback investigations</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 43.3pt"></TD><TD STYLE="width: 17.1pt"><FONT STYLE="font-size: 10pt; color: #3F3F41">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 10pt; color: #3F3F41">Ability</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">of</FONT> <FONT STYLE="font-size: 10pt; color: #3F3F41">Apical</FONT>
<FONT STYLE="font-size: 10pt; color: #2F2F2F">to meet delivery expectations</FONT></TD></TR></TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9.05pt"><FONT STYLE="color: #2F2F2F">The attached table details the
QSR</FONT> <FONT STYLE="color: #3F3F41">responsibilities</FONT> <FONT STYLE="color: #2F2F2F">and authorities under this agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; width: 37%; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #3F3F41"><B>QSRarea</B></FONT></TD>
    <TD STYLE="padding-left: 8pt; border-top: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; width: 11%; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2F2F2F"><B>Nexalin</B></FONT></TD>
    <TD STYLE="padding-left: 8pt; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; font: 11pt Times New Roman, Times, Serif; width: 12%; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #3F3F41"><B>Apical</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; width: 40%; text-align: center"><FONT STYLE="font-size: 10pt; color: #3F3F41"><B>Plan</B></FONT><B><FONT STYLE="font-size: 10pt; color: #161616">/</FONT></B><B><FONT STYLE="font-size: 10pt; color: #2F2F2F">Notes</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt"><FONT STYLE="color: #2F2F2F">Subpart</FONT> <FONT STYLE="color: #3F3F41">A</FONT>
    <FONT STYLE="color: #161616">-</FONT> <FONT STYLE="color: #2F2F2F">General Provisions</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2F2F2F">&sect; 820.1</FONT> <FONT STYLE="font-size: 10pt; color: #161616">-</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">Scope</FONT></TD>
    <TD STYLE="padding-left: 8pt; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 9.5pt; color: #2F2F2F"><B>X</B></FONT></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 9.5pt; color: #2F2F2F"><B>X</B></FONT></TD>
    <TD ROWSPAN="3" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.75pt 0pt 0pt auto; text-indent: 0pt"><FONT STYLE="color: #2F2F2F">Both Nexalin
    and Apical shall have independent</FONT> <FONT STYLE="color: #3F3F41">Quality Systems.</fONT> <FONT STYLE="color: #161616"></FONT></P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0.25pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt"><FONT STYLE="color: #3F3F41">Apical</FONT>
    <FONT STYLE="color: #2F2F2F">shall be ISO 13485 certified prior to re</FONT><FONT STYLE="color: #161616">l</FONT><FONT STYLE="color: #2F2F2F">ease
    of </FONT><FONT STYLE="color: #3F3F41">any</FONT> <FONT STYLE="color: #2F2F2F">product for commercial distribution to the European market.
    If Nexa </FONT><FONT STYLE="color: #161616">l</FONT><FONT STYLE="color: #2F2F2F">in is classified as a Class II device in the</FONT> <FONT STYLE="color: #3F3F41">European</FONT>
    <FONT STYLE="color: #2F2F2F">market, they shall be certified to ISO 13485 prior to</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #2F2F2F">release to that market.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2F2F2F">&sect; 820.3</FONT> <FONT STYLE="font-size: 10pt; color: #161616">-</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">Definitions</FONT></TD>
    <TD STYLE="padding-left: 8pt; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 9.5pt; color: #3F3F41"><B>X</B></FONT></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 9.5pt; color: #2F2F2F"><B>X</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0.45pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; text-align: left; color: #2F2F2F">&sect; 820.5 - Quality system</P></TD>
    <TD STYLE="padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #2F2F2F"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #3F3F41"><B>X</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0.1pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt"><FONT STYLE="color: #2F2F2F">Subpart B</FONT> <FONT STYLE="color: #161616">-</FONT>
    <FONT STYLE="color: #2F2F2F">Quality System Requirements</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2F2F2F">&sect; 820.20</FONT> <FONT STYLE="font-size: 10pt; color: #3F3F41">- Management</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">responsibility</FONT></TD>
    <TD STYLE="padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 12.5pt Times New Roman, Times, Serif; margin: 0.5pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #3F3F41"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 12.5pt Times New Roman, Times, Serif; margin: 0.45pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #3F3F41"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2F2F2F">Both parties are expected to have a management responsibility process</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.1pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; text-align: left"><FONT STYLE="color: #2F2F2F">&sect; 820</FONT><FONT STYLE="color: #161616">.</FONT><FONT STYLE="color: #2F2F2F">22
    - Quality audit</FONT></P></TD>
    <TD STYLE="padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.2pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #2F2F2F"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.55pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #2F2F2F"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2F2F2F">Both parties are expected to have an internal audit process.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #2F2F2F">&sect;</FONT>
    <FONT STYLE="font-size: 10pt; color: #2F2F2F">820</FONT><FONT STYLE="font-size: 10pt; color: #595959">.</FONT><FONT STYLE="font-size: 10pt; color: #2F2F2F">25</FONT>
    <FONT STYLE="font-size: 10pt; color: #161616">-</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">Personnel</FONT></P></TD>
    <TD STYLE="padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.5pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #3F3F41"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.5pt 0pt 0pt auto; text-indent: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin: 0 0pt 0pt auto; text-indent: 0pt; color: #3F3F41"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10pt; color: #2F2F2F">Apical shall be able to demonstrate compliance for manufacturing and quality staff.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-left: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2F2F2F">Subpart C</FONT> <FONT STYLE="font-size: 10pt; color: #161616">-</FONT> <FONT STYLE="font-size: 10pt; color: #2F2F2F">Design Controls</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 1pt; color: #2F2F2F">NEX-CNT-00016</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.2pt 0 0 1.4pt; color: #2F2F2F"><FONT STYLE="font-size: 10pt">Revision</FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 8.5pt Times New Roman, Times, Serif; margin: 0.2pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; width: 37%; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt"><FONT STYLE="font-size: 10pt; color: #2A2B2D"><B>QSRarea</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; width: 12%; padding-left: 8pt"><FONT STYLE="font-size: 10pt; color: #2A2B2D"><B>Nexalin</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; width: 12%; padding-left: 8pt"><FONT STYLE="font-size: 10pt; color: #2A2B2D"><B>&#9;Apical</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; width: 39%; padding-left: 8pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #2A2B2D"><B>Plan/Notes</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">
    </P><P STYLE="text-indent: 0pt; font: 15.5pt Times New Roman, Times, Serif; margin: 0.3pt 0pt 0pt">&nbsp;</P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D">&sect; 820.30 - Design controls</P></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; padding-left: 8pt; vertical-align: bottom">
    </P><P STYLE="text-indent: 0pt; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt">&nbsp;</P>
    <P STYLE="text-indent: 0pt; font: 16pt Times New Roman, Times, Serif; margin: 0.2pt 0pt 0pt">&nbsp;</P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D"><B>X&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D"><B>&nbsp;&nbsp;&nbsp;X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.45pt 0pt 0pt; text-indent: 0pt; color: #2A2B2D"><FONT STYLE="font-size: 10pt">All
design control for the product is managed by Apical. </FONT><FONT STYLE="font-size: 9.5pt">If </FONT><FONT STYLE="font-size: 10pt">Apical
believes design changes are <FONT STYLE="color: #2A2B2D">needed </FONT><FONT STYLE="color: #4F4F4F">, </FONT><FONT STYLE="color: #2A2B2D">they
will discuss with Nexalin and await formal notification of design ECO approval before implementation.</FONT></FONT></P>
    <P STYLE="text-indent: 0pt; font: 10.5pt Times New Roman, Times, Serif; margin: 0.15pt 0pt 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; text-indent: 0pt"><FONT STYLE="color: #2A2B2D">Manufacturing
changes shall be documented in the Apical Quality system. Nexalin must be a signatory for all manufacturing changes.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">
    <P STYLE="text-indent: 0pt; font: 13pt Times New Roman, Times, Serif; margin: 0.45pt 0pt 0pt">&nbsp;</P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0pt; color: #2A2B2D">Subpart D - Document Controls</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="text-indent: 0pt; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt"></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt"><FONT STYLE="color: #2A2B2D">&sect; 820.40</FONT> <FONT STYLE="color: #4F4F4F">-</FONT>
    <FONT STYLE="color: #2A2B2D">Document controls</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 8pt">
    <P STYLE="text-indent: 0pt; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt"></P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.75pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="color: #2A2B2D">Apical
    is responsible for controls on documents associated with manufacturing (e.g. OHR</FONT><FONT STYLE="color: #4F4F4F">,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; text-indent: 0pt"><FONT STYLE="color: #2A2B2D">component
    specifications</FONT><FONT STYLE="color: #4F4F4F">,</FONT> <FONT STYLE="color: #2A2B2D">DMR documents).</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">
    <P STYLE="text-indent: 0pt; font: 13.5pt Times New Roman, Times, Serif; margin: 0.35pt 0pt 0pt">&nbsp;</P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D">Subpart E - Purchasing Controls</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="text-indent: 0pt; font: 11pt Times New Roman, Times, Serif; margin: 0 0pt 0pt"></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 7.4pt 0pt 0pt; color: #2A2B2D">&sect; 820.50 - Purchasing controls<BR>
&nbsp;</P></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; padding-left: 8pt; vertical-align: bottom">
    </P><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 7.4pt 0pt 0pt; color: #2A2B2D"><B>X</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.95pt 0pt 0pt; text-indent: 0pt; color: #2A2B2D">Nexalin will use
    a purchase order or equivalent to request parts manufacture. Apical will maintain purchasing control records for materials and parts purchased
    for the manufacture of the parts.</P>
    <P STYLE="text-indent: 0pt; font: 9.5pt Times New Roman, Times, Serif; margin: 0.45pt 0pt 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; text-indent: 0pt; color: #2A2B2D">Apical is responsible
    for Apical approvals of all purchased parts/services for the product.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-left: 8pt; border-right: black 1pt solid; font: 11pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt"><FONT STYLE="font-size: 10pt; color: #2A2B2D">Subpart F</FONT> <FONT STYLE="font-size: 10pt; color: #111111">-</FONT> <FONT STYLE="font-size: 10pt; color: #2A2B2D">Identification and Traceability</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    </P><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt"><FONT STYLE="color: #2A2B2D">&sect; 820.60</FONT> <FONT STYLE="color: #111111">-
    </FONT><FONT STYLE="color: #2A2B2D">Identification</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 8pt">
    </P><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; text-align: center; color: #2A2B2D"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2A2B2D">Apical shall be compliant with identification requirements during product manufacturing, including assignment of serial numbers.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-left: black 1pt solid">
    <P STYLE="text-indent: 0pt; font: 9.5pt Times New Roman, Times, Serif; margin: 0.1pt 0pt 0pt">&nbsp;</P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0pt"><FONT STYLE="color: #2A2B2D">&sect; 820</FONT><FONT STYLE="color: #4F4F4F">.</FONT><FONT STYLE="color: #2A2B2D">65
    - Traceability</FONT></P></TD>
    <TD COLSPAN="2" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt; color: #2A2B2D"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>N/A</I>
    -</FONT> Traceability requirements are</P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0pt 0pt; color: #2A2B2D">only required for surgical implants.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-left: 8pt; border-right: black 1pt solid; font: 11pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt"><FONT STYLE="font-size: 10pt; color: #2A2B2D">Subpart G</FONT> <FONT STYLE="font-size: 10pt; color: #111111">-</FONT> <FONT STYLE="font-size: 10pt; color: #2A2B2D">Production and Process Controls</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 1pt; color: #2F2F2F">NEX-CNT-00016</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.2pt 0 0 1.4pt; color: #2F2F2F"><FONT STYLE="font-size: 10pt">Revision</FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 8.5pt Times New Roman, Times, Serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434"><B>QSRarea</B></FONT></TD>
    <TD STYLE="text-align: left; border-top: black 1pt solid; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434"><B>Nexalin</B></FONT></TD>
    <TD STYLE="text-align: left; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434"><B>&#9;Apical</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: bottom; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #343434"><B>Plan/Notes</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; padding-left: 8pt; vertical-align: bottom; width: 37%"><FONT STYLE="font-size: 10pt; color: #232323">&sect;
    </FONT><FONT STYLE="font-size: 10pt; color: #343434">820.</FONT><FONT STYLE="font-size: 10pt; color: #232323">70 - Production</FONT>
    <FONT STYLE="font-size: 10pt; color: #343434">and process</FONT> <FONT STYLE="font-size: 10pt; color: #232323">controls</FONT></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; width: 12%; vertical-align: bottom"><P STYLE="font: 14.5pt Times New Roman, Times, Serif; margin-top: 0.15pt; margin-bottom: 0"></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; width: 11%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #2A2B2D"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; width: 40%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 6.5pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">Apical
    will</FONT> <FONT STYLE="font-size: 10pt; color: #232323">have</FONT> <FONT STYLE="font-size: 10pt; color: #343434">full responsibility.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434">&sect;
    820.72 </FONT><FONT STYLE="font-size: 10pt; color: #232323">- </FONT><FONT STYLE="font-size: 10pt; color: #343434">Inspection</FONT><FONT STYLE="font-size: 10pt; color: #525252">,
    </FONT><FONT STYLE="font-size: 10pt; color: #343434">measuring</FONT> <FONT STYLE="font-size: 10pt; color: #525252">,</FONT> <FONT STYLE="font-size: 10pt; color: #343434">and
    test equipment</FONT></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 15pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: #343434"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #2A2B2D"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 6.5pt; margin-bottom: 0; color: #343434"><FONT STYLE="font-size: 10pt">Apical
    will have full responsibility.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.3pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt; color: #343434">&sect;
    820.75</FONT> <FONT STYLE="font-size: 10pt; color: #525252">-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Process validation</FONT></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: #343434"></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #2A2B2D"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 1.65pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">Apical
                                            will </FONT><FONT STYLE="font-size: 10pt; color: #232323">have </FONT><FONT STYLE="font-size: 10pt; color: #343434">full
                                            responsibility. The only anticipated process validation is the overall assembly</FONT> <FONT STYLE="font-size: 10pt">process
                                            validation.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom"><P STYLE="font: 14.5pt Times New Roman, Times, Serif; margin-top: 0.1pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">Subpart
    H</FONT> <FONT STYLE="font-size: 10pt; color: #232323">-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Acceptance Activities</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0.2pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">&sect;
    820.80</FONT> <FONT STYLE="font-size: 10pt; color: #232323">-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Receiving, in-process,
    </FONT><FONT STYLE="font-size: 10pt; color: #232323">and</FONT> <FONT STYLE="font-size: 10pt; color: #343434">finished device acceptance</FONT></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.3pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: #343434"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #2A2B2D"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 1.2pt; margin-bottom: 0; color: #343434"><FONT STYLE="font-size: 10pt">Apical
                                            will have full responsibility. Apical will generate a certificate of conformance (CoC) for
                                            each device that will be provided to Nexalin.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9.5pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 5.85pt; text-align: left; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434">&sect;
    820.86</FONT> <FONT STYLE="font-size: 10pt; color: #232323">-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Acceptance status</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.6pt; padding-left: 8pt; color: #2A2B2D; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434"><B>X</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 8pt; text-align: left"><FONT STYLE="font-size: 10pt; color: #343434">Apical
    will</FONT> <FONT STYLE="font-size: 10pt; color: #232323">have</FONT> <FONT STYLE="font-size: 10pt; color: #343434">full responsibility.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: left; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434">Subpart
    I</FONT> <FONT STYLE="font-size: 10pt; color: #232323">-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Nonconforming Product</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 13pt Times New Roman, Times, Serif; margin-top: 0.35pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">&sect;
    820.90 </FONT><FONT STYLE="font-size: 10pt; color: #232323">-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Nonconforming product</FONT></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 7.15pt; margin-bottom: 0; text-align: center; color: #343434"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 7.15pt; margin-bottom: 0pt; color: #343434"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 1.45pt; margin-bottom: 0; color: #343434"><FONT STYLE="font-size: 10pt">Non-conforming
                                            product reports will be generated by Apical.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.25pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">Apical
    will provide periodic summaries of nonconforming product</FONT> <FONT STYLE="font-size: 10pt; color: #232323">reports</FONT> <FONT STYLE="font-size: 10pt; color: #343434">as
    feedback to Nexalin.</FONT></P>
    <P STYLE="font: 8.5pt Times New Roman, Times, Serif; margin-top: 0.55pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">Apical
    shall also</FONT> <FONT STYLE="font-size: 10pt; color: #232323">maintain</FONT> <FONT STYLE="font-size: 10pt; color: #343434">a</FONT>
    <FONT STYLE="font-size: 10pt; color: #232323">nonconforming</FONT> <FONT STYLE="font-size: 10pt; color: #343434">product process.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom"><P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0.4pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">Subpart
    </FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #232323">J-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Corrective
    and Preventive Action</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="border-right: black 1pt solid; text-align: left; padding-left: 8pt; border-left: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.3pt; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #343434"><FONT STYLE="font-size: 10pt">&sect;
    820.100 - Corrective and preventive action<BR>
&nbsp;<BR>
</FONT></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 9.3pt; margin-bottom: 0; color: #343434"><FONT STYLE="font-size: 10pt"><B>X</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 9.3pt; margin-bottom: 0pt; color: #343434"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="text-align: left; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434">Apical
    and Nexalin will each maintain a CAPA process.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: left; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-left: 8pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #343434">Subpart
    K</FONT> <FONT STYLE="font-size: 10pt; color: #232323">-</FONT> <FONT STYLE="font-size: 10pt; color: #343434">Labeling and Packa.2:in
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">2;</FONT> Control</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #343434">&amp;
    </FONT><FONT STYLE="font-size: 10pt; color: #343434">820.120 - Device</FONT> <FONT STYLE="font-size: 10pt; color: #232323">labeling</FONT></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; vertical-align: bottom"></FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 9.85pt; margin-bottom: 0; color: #343434"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; text-align: left; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 9.85pt; margin-bottom: 0pt; color: #343434"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #343434">Nexalin
is responsible for</FONT> <FONT STYLE="font-size: 10pt; color: #232323">designing </FONT><FONT STYLE="font-size: 10pt; color: #343434">the
labeling, but may enlist Apical&rsquo;s help. Apical is responsible for all other elements of</FONT> <FONT STYLE="font-size: 10pt; color: #232323">this
</FONT><FONT STYLE="font-size: 10pt; color: #343434">clause.</FONT></P></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 1pt; color: #2F2F2F">NEX-CNT-00016</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.2pt 0 0 1.4pt; color: #2F2F2F"><FONT STYLE="font-size: 10pt">Revision</FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 8.5pt Times New Roman, Times, Serif; margin: 0.2pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D"><B>QSR area</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; text-align: left; padding-left: 8pt; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D"><B>Nexalin&#9;</B></FONT></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D"><B>Apical</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: bottom; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt; color: #2D2D2D"><B>Plan/Notes</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; width: 37%; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 9.25pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect;</FONT>
    <FONT STYLE="font-size: 10pt; color: #2D2D2D">820.130</FONT> <FONT STYLE="font-size: 10pt; color: #1D1D1F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Device
    packa&pound;.ing</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; width: 12%; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 9.7pt; margin-bottom: 0pt; color: #2D2D2D"><B>X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; width: 12%; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 9.7pt; margin-bottom: 0pt; color: #2D2D2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; width: 39%; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 1.2pt; margin-bottom: 0pt"><FONT STYLE="color: #1D1D1F">Nexalin</FONT>
    <FONT STYLE="color: #2D2D2D">is responsib </FONT><FONT STYLE="color: #0F0F0F">l</FONT><FONT STYLE="color: #2D2D2D">e for design and verifying
    packaging design but may enlist Apical&rsquo;s</FONT> <FONT STYLE="color: #1D1D1F">help.</FONT></P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.25pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">Apical
    is responsible for all other packaging operations</FONT><FONT STYLE="color: #464646">.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0.25pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">Subpart L</FONT> <FONT STYLE="color: #1D1D1F">-</FONT>
    <FONT STYLE="color: #2D2D2D">Handling</FONT><FONT STYLE="color: #464646">,</FONT> <FONT STYLE="color: #2D2D2D">Storage</FONT><FONT STYLE="color: #464646">,</FONT>
    <FONT STYLE="color: #2D2D2D">Distribution</FONT> <FONT STYLE="color: #464646">,</FONT> <FONT STYLE="color: #2D2D2D">and Installation</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect;</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">820.140</FONT> <FONT STYLE="font-size: 10pt; color: #1D1D1F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Handling</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; padding-left: 8pt; font: 11pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D"><B>X</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt; color: #2D2D2D">Apical
will have full responsibility.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D">820.150</FONT> <FONT STYLE="font-size: 10pt; color: #1D1D1F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Storage</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; padding-left: 8pt; font: 11pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D"><B>X</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt; color: #2D2D2D">Apical will have full responsibility.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    </P><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 7.8pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect; </FONT><FONT STYLE="font-size: 10pt; color: #2D2D2D">820.160</FONT>
    <FONT STYLE="font-size: 10pt; color: #1D1D1F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Distribution</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; vertical-align: bottom">
    </P><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 7.8pt; margin-bottom: 0pt; color: #2D2D2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 7.8pt; margin-bottom: 0pt; color: #2D2D2D"><B>&nbsp;</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2D2D2D">Nexalin has full responsibility
    for distribution.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.35pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2D2D2D">Apical will provide a copy
of the packing slip and CoC for each unit <FONT STYLE="color: #2D2D2D">distributed</FONT> <FONT STYLE="color: #1D1D1F">to</FONT> <FONT STYLE="color: #2D2D2D">Nexalin</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0.2pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2D2D2D"><FONT STYLE="font-size: 10.5pt">&sect;</FONT>
    <FONT STYLE="font-size: 10pt">820.170 - Installation</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; vertical-align: bottom">
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0.45pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2D2D2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2D2D2D"><B>&nbsp;</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D">Nexalin</FONT> <FONT STYLE="font-size: 10pt; color: #1D1D1F">has </FONT><FONT STYLE="font-size: 10pt; color: #2D2D2D">full responsibility for installation</FONT><FONT STYLE="font-size: 10pt; color: #464646">.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">Subpart M</FONT> <FONT STYLE="color: #0F0F0F">-</FONT>
    <FONT STYLE="color: #2D2D2D">Records</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect;</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">820.180</FONT> <FONT STYLE="font-size: 10pt; color: #1D1D1F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">General requirements</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; vertical-align: bottom">
    <P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin-top: 0.25pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2D2D2D"><B>X&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 10.5pt; margin-bottom: 0pt; color: #2D2D2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D">Each company is required to maintain records per this clause</FONT><FONT STYLE="font-size: 10pt; color: #464646">.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 8.5pt Times New Roman, Times, Serif; margin-top: 0.45pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect;</FONT>
    <FONT STYLE="font-size: 10pt; color: #2D2D2D">820.181</FONT> <FONT STYLE="font-size: 10pt; color: #0F0F0F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Device
    master record</FONT><FONT STYLE="font-size: 10pt; color: #464646">.</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; vertical-align: bottom">
    </P><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; color: #2D2D2D">&nbsp;</P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 10.5pt; margin-bottom: 0pt; color: #2D2D2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 1.2pt; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">Apical will
finalize </FONT><FONT STYLE="color: #464646">, </FONT><FONT STYLE="color: #2D2D2D">release, and maintain the DMR. Nexalin representative
must be a signatory on </FONT><FONT STYLE="color: #1D1D1F">the </FONT><FONT STYLE="color: #2D2D2D">DMR and associated documents</FONT><FONT STYLE="color: #464646">.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.25pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect;</FONT>
    <FONT STYLE="font-size: 10pt; color: #2D2D2D">820.184</FONT> <FONT STYLE="font-size: 10pt; color: #464646">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Device
    history record</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.4pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; color: #2D2D2D"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 10.5pt; margin-bottom: 0pt; color: #2D2D2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D">Apical will maintain the original records for</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #2D2D2D"><B>OHR.</B></FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">A copy will be provided to Nexalin.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect;</FONT>
    <FONT STYLE="font-size: 10pt; color: #2D2D2D">820</FONT><FONT STYLE="font-size: 10pt; color: #464646">.</FONT><FONT STYLE="font-size: 10pt; color: #2D2D2D">186
    - Quality system record</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; vertical-align: bottom">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 10.5pt; margin-bottom: 0pt; color: #2D2D2D"><B>X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 10.5pt; margin-bottom: 0pt; color: #2D2D2D"><B>X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.5pt; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">Apical shall
maintain</FONT> <FONT STYLE="color: #1D1D1F">Nexalin&rsquo;</FONT><FONT STYLE="color: #2D2D2D">s</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D"><B>QSR</B></FONT>
    <FONT STYLE="font-size: 10pt; color: #2D2D2D">per the requirements of this clause</FONT><FONT STYLE="font-size: 10pt; color: #464646">.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-left: black 1pt solid; vertical-align: bottom">
    </P><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 8.35pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2D2D2D">&sect;</FONT>
    <FONT STYLE="font-size: 10pt; color: #2D2D2D">820.198</FONT> <FONT STYLE="font-size: 10pt; color: #1D1D1F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Complaint
    files<BR>
&nbsp;</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-left: 8pt; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"></P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 8.35pt; margin-bottom: 0pt; color: #2D2D2D"><B>X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 8.35pt; margin-bottom: 0pt; color: #2D2D2D"><B>&nbsp;X</B></P></TD>
    <TD STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.5pt; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">Nexalin will
</FONT><FONT STYLE="color: #1D1D1F">have </FONT><FONT STYLE="color: #2D2D2D">full</FONT> <FONT STYLE="color: #1D1D1F">responsibility</FONT>
<FONT STYLE="color: #2D2D2D">for complaint</FONT> <FONT STYLE="color: #1D1D1F">handling</FONT><FONT STYLE="color: #464646">.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.5pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">Apical may
    be asked to</FONT> <FONT STYLE="color: #1D1D1F">participate</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="color: #2D2D2D">in investigations
and/or corrective actions</FONT><FONT STYLE="color: #464646">.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: left; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2D2D2D">Subpart N</FONT> <FONT STYLE="font-size: 10pt; color: #0F0F0F">-</FONT> <FONT STYLE="font-size: 10pt; color: #2D2D2D">Servicing</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 1pt; color: #2F2F2F">NEX-CNT-00016</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.2pt 0 0 1.4pt; color: #2F2F2F"><FONT STYLE="font-size: 10pt">Revision</FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 8.5pt Times New Roman, Times, Serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border: black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2A2A2B"><B>QSRarea</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding-left: 8pt; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2A2A2B"><B>Nexalin&#9;</B></FONT></TD>
    <TD STYLE="padding-left: 8pt; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-size: 10pt; color: #2A2A2B"><B>Apical</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt; color: #2A2A2B"><B>Plan/Notes</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; width: 37%; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.1pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10.5pt; color: #2A2A2B">&sect;</FONT>
    <FONT STYLE="font-size: 10pt; color: #2A2A2B">820</FONT><FONT STYLE="font-size: 10pt; color: #484648">.</FONT><FONT STYLE="font-size: 10pt; color: #2A2A2B">200
    - Servicing</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 8pt; text-align: left; width: 12%; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.35pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; color: #2A2A2B"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: black 1pt solid; padding-left: 8pt; border-bottom: black 1pt solid; text-align: left; width: 12%; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; width: 39%; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 1.2pt; margin-bottom: 0pt; color: #2A2A2B">The servicing of returned devices</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B">shall follow Apical&rsquo;s
    Servicing Process.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin-top: 0.35pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="color: #2A2A2B">Subpart O</FONT> <FONT STYLE="color: #131313">-</FONT>
    <FONT STYLE="color: #2A2A2B">Statistical Techniques</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.1pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><FONT STYLE="font-size: 10.5pt">&sect;
    </FONT><FONT STYLE="font-size: 10pt">820.250 - Statistical techniques</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 8pt; text-align: left; vertical-align: bottom">
    </P><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><B>X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 1.2pt; margin-bottom: 0pt; color: #2A2A2B">Nexalin and Apical
    will comply with this clause as appropriate in their operation (e.g. sampling</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B">plans)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 8.55pt; margin-bottom: 0pt; color: #2A2A2B">&sect; <FONT STYLE="font-size: 10pt">830
    - Unique Device Identification</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 8pt; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 8.5pt Times New Roman, Times, Serif; margin-top: 0.35pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><B>X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.75pt; margin-bottom: 0pt; color: #2A2A2B">Nexalin is responsible
    for obtaining the UDI prefix and registering with FDA. Apical is responsible for generation and application of UDI</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B">labels.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    </P><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0.1pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><FONT STYLE="color: #2A2A2B">ISO 14971</FONT> <FONT STYLE="color: #131313">-</FONT>
    <FONT STYLE="color: #2A2A2B">Risk Management</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 8pt; text-align: left; vertical-align: bottom">
    </P><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 9.4pt; margin-bottom: 0pt; color: #2A2A2B"><B>X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 9.4pt; margin-bottom: 0pt; color: #2A2A2B"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.3pt; margin-bottom: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0pt; color: #2A2A2B">Nexalin will have a Risk</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B">Management File. Apical
    will maintain the file for Nexalin.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left; vertical-align: bottom">
    </P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.45pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B">IEC 62304 and 62366</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 8pt; text-align: left; vertical-align: bottom">
    </P><P STYLE="font: 9.5pt Times New Roman, Times, Serif; margin-top: 0.3pt; margin-bottom: 0pt">&nbsp;</P>
    <P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><B>X</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 10.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B"><B>&nbsp;</B></P></TD>
    <TD STYLE="padding-left: 8pt; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: left; vertical-align: bottom">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.3pt; margin-bottom: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0pt; color: #2A2A2B">Nexalin will have full</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; color: #2A2A2B">responsibility for
    compliance to these standards.</P></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 1pt; color: #2F2F2F">NEX-CNT-00016</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 1.2pt 0 0 1.4pt; color: #2F2F2F"><FONT STYLE="font-size: 10pt">Revision</FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 143.2pt 0 146.25pt; text-align: center; color: #343638"><B>SIGNATURE PAGE</B></P>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0.1pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.55pt 0pt 0pt; color: #343638"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AGREED
TOBY:</B></FONT></P>

<P STYLE="font: 7.5pt Times New Roman, Times, Serif; margin: 0.35pt 0pt 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.55pt 0pt 0pt; color: #343638"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Apical Instruments</TD>
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font: 11pt Times New Roman, Times, Serif"><B>Nexalin</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 36%">&nbsp;</TD>
    <TD STYLE="width: 29%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 0pt 0pt; color: #343638"><FONT STYLE="font: 11pt Times New Roman, Times, Serif">2971 Spring St</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0.55pt 0pt 0pt; color: #343638"><FONT STYLE="font: 11pt Times New Roman, Times, Serif">Redwood City, CA 94063</FONT></P>

</TD>
    <TD>&nbsp;</TD>
  <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><FONT STYLE="font: 11pt Times New Roman, Times, Serif; color: #343638">1776 Yorktown,</FONT> <FONT STYLE="font: 11pt Times New Roman, Times, Serif; color: #262628">Ste 550</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0pt 0pt"><FONT STYLE="font: 11pt Times New Roman, Times, Serif; color: #262628">Houston, TX.,</FONT> <FONT STYLE="font: 11pt Times New Roman, Times, Serif; color: #343638">77056</FONT></P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Kim Khoe</FONT></TD>
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">John P. Claude</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Name</B></TD>
    <TD>&nbsp;</TD>
  <TD><B>Name</B></TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="font: 11pt Arial, Helvetica, Sans-Serif; border-bottom: Black 1pt solid">/s/ Kim Khoe</TD>
  <TD>&nbsp;</TD>
    <TD STYLE="font: 11pt Arial, Helvetica, Sans-Serif; border-bottom: Black 1pt solid">/s/ John P. Claude</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Signature</B></TD>
    <TD>&nbsp;</TD>
  <TD><B>Signature</B></TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Director RAQA</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Consulting Engineer</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Title</B></TD>
    <TD>&nbsp;</TD>
  <TD><B>Title</B></TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">12/12/2020</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">12/12/2020</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Date</B></TD>
    <TD>&nbsp;</TD>
  <TD><B>Date</B></TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="font: 11pt Arial, Helvetica, Sans-Serif; border-bottom: Black 1pt solid; text-align: center">N/A</TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">N/A</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Tax ID</FONT> <B>Number (if available)</TD>
    <TD>&nbsp;</TD>
  <TD>Tax ID</FONT> <B>Number (if available)</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.55pt 0pt 0pt; color: #343638"><FONT STYLE="font: 11pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.55pt 0pt 0pt; color: #343638"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.55pt 0pt 0pt; color: #343638"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #8 =D# 2(  A$! Q$!_\0
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MA63(CF8#[LL1)&<9P03QR"#T]O\ @[G_ (51H.?^>;_^C&K*^/D,<GPMN7<
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M!^$$/COPG:ZYXCUG4?GC\BQA@*@0Q1DJ =P.02,@ #N<G/$QNTWV*=DTNY]
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M(M*759-5L4TYL;;MKA!"<G P^<=>.M>"?':_G\1^/M$\(63%FCVAE!R/-E(
MR!Z* ?\ @1KUKQ%X!@UKX=)X/M;O[#!''#&DWE>9@1E3RN5R3M]>^:A7<.;S
M+>DN7R.ET[5=.U>V-SIE_:WL 8J9;:99%R.V5)&:MUR?P\\$_P#"!>&WTC^T
M/MVZX:?S?)\K&0!C;N;T]:ZRJ=KZ$J]M0HHHI#"BBB@ HHHH **** "BBB@
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MPOXHL]?ADF,PD\R3>Q_TA"WS@GN#@C/J/45]N6UQ'=VL-S"VZ*5!(C>H(R*
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M_B;6_%*7FAQW%_K4#_;?,.)7#*P_>-OR#\Q')[F@#[;@A2WMXX(AB.-0BCT
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MSCU_A_2O9O'LOD_#SQ(^2#_9ER 1U!,; 5Y%^S,C"/Q/(1\K&U /N/-S_,4
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MZDH00>'1AU'<,*TK7QSJ;>.+/Q7K(75[RV=6"3_(IVC"8"@ 8.&&!U&3G)R
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M ]J;<^+_ !1XA\.Z5X'.Z2&VF$4,**1+*<X1'YY"] ,#MGH,?3O@+P':^%/
MBZ'<(DLUTC-J!ZAW=<,O^Z!\H]<9QR: //?V<?$B2Z9J?AN:0>;#)]KMP3R4
M;"N![ A3_P #->X75U!96LMU=31PV\*%Y)9&"JBCDDD]!7QTXU;X2_$LND<F
MZQN&\OS,J+F \=?1E/X'W%;?B;QOXK^,6K0Z+I&G2Q6G#"P@DWC(QEY7PHP#
MZX X[\T ;_COXZZIJ>K1Z?X)DDM[9)-HN1"&ENF/ "JP.%]!C<>.G2N*\'3W
M.G?&K3I-7@%O=_VJ4N(CTCD=BI'?@%O_ *_>O>/AI\(-/\%+'J>H%+W72O\
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M=V"QZY161X=\4:+XKT\WNB:A'=P@[7V@JR'T92 5_$<]JUG=8T9W8*JC)8G
M H>FX+786BO,]<^._@G1KO[-%/=ZFP)5WL(@R(1_M,RAL]BN16CX2^+WA/QA
M=BRM+F:SOG8B.VO4$;2=/ND$J>O3.>#Q0M=@>FYW=%(S*BEF(50,DDX %>7Z
MO\??!>E:B]I$;_40G#3V4*M'G)! +.N>G4 @YX)HOT';J>HT5@>%/&>A>-+!
MKO1;P3>7M$T+*5DA)&0&4_CR,@X."<5S_C/XNZ!X'UM=)U.SU.6=H5F#6T4;
M)M)('+.#GY3VH>CLQ+571W]%>/\ _#1W@_\ Z!NN?]^(?_CM=EX&^(FD>/X[
MU]*MKZ$6902?:D1<[LXQM9O[IZXII-B;L==117*6/Q"T34O'5UX1M!<RW]JC
M/+,J+Y*E<;EW;LY!.#QC/&:76P^ESJZ*9++'!$\LKK'&BEG=C@*!U)/85Y9J
M'[0G@NROI+>&/5+U$P!/;0+Y;<=M[JWMT^F12NKV';2YZM161X<\3Z1XLTI=
M2T6\6YMRVUN"K(PZJRGD'_\ 6.*UZIJVC$G<**YF7QUHT?CJW\'JTTVJ2Q&1
MO+"F.+"EL.<Y!(&< 'J.E=-2Z7#K8**** "BBB@ KRCXF?#635)9-<T.$&Z(
M+75LHQYO'++CJQ'4=\ @$YSZO16E*K*E+FB9U*<:D>61\X^#/B3J7A!S87B/
M=Z>I*F!V*O"V<$KGISDE3QZ8YKV_0/&>@^)(D:PU"+SF_P"7>5@DH_X">?RS
M6?XJ^'.A^*2\[Q_8[\C_ (^H% +'L77HW\_>O)-8^$/BC3"\EK'%J$*G*FW?
M#@9_NM@Y^F>OOQVOZOB-;\LCD7MZ&EN9'T517S"NI>.M"C\EI]<M4C&-DGFA
M5'L&X&<CGZ^F:0>,_&J@?\3?4\ <')Y'Y?C[^^34_4)=)(KZZNL6?3]%?,/_
M  F7C;I_:NI\<=^OY?YQWSRO_"9^->?^)KJ@&<9(/'3';Z?7\>3^SY_S(/KT
M?Y6?3M%?,7_"9^-AUU75!M('?@^G3G^N/?E/^$S\; '_ (FNIC'7KP?R_P ^
M^>3^SY_S(/KL?Y6?3U%?,7_"9^-LG_B:ZH,''0G'IV__ %X]^4_X3/QKC_D*
M:H "/4X]NG_Z\>_)]0G_ #(/KT?Y6?3U>*_'1I]5UWP?X7,K16>HWG[XJ>I+
MH@/X!V_.M;X1:WKFKW>JKK%W=SB-(_+$_13E@<?D!^'OSJ?%?P)=^,=&M+G2
M)$CUK2Y3/:%C@/T)3/0$E5()XR,< DUQU:?LJB4M;-7.NE/VD&UI=,ZZW\/:
M/:Z"-#ATZV72Q'Y?V7RP4*GKD=R3R2>2>>M>5_"*1=!^('C'P=;L[6%M,;BU
M4N6\L!MI'7T91G_9YI^G_$;XE7$*Z0WPZN#K&&C^W2EXK;>,_,<KMQQVDP>W
M4"L?X3:-=Z7\:/$\5]>_;KR"U/VFY085I9&1V'_?61^!X%3'X[]T_GM^02LH
M6[-?+I^)Z)I?PWM+/XAZIXPOKP:A=71'V:.6 #[+T'!R<G  !P,#/K7%?M"2
MZ--I.G6L1AD\2_:D^SI#@W C(;KCD*3C [GIT->R:A9IJ.G75E)))&EQ$T3/
M&1N4,""1D$9Y[@UX5XG^$S?#BR'C#P=JEPUUI@,DD5]'%+E#P64[0!@$]B?0
M@CF'I9/1*WY_UJ:+JUJW_D>O:IHM]K_@671KB^:SO;NR6&>X1-^UBH#\9&0>
M1U[]:C\&^$M.\#>&8=,M3&3&NZYNB@0S-U+MR?PR3@<5/X-\0?\ "5>$-,UL
MQ>4]U"&D0=%<$JV.3QN!Q[5G^./A]I7C^"S@U6ZOH8[1F=!:NB[BP YW*WIV
MQUJYW4I6ZD0LXKR/-_!9LKC]H;6+CPJ83HHM#]I>V \DL57[N..7&??#$5[A
M//';6\D\SA(HU+NQZ* ,DUX;X?34_A!\1]/\)FY2]\.ZW(6A<P*LJR-\HR1R
M2"$!SP0<@ \5U?QR\2C0?A[/:12!;K5&^RH.^SJY_+C_ ($*B3M37+Z?._Z7
M^XJ*O4=_Z5O^!]YYUI7AV;XD>&_'_BR:%S<7DF-/7'($6'VCZ@(N?K7K/PF\
M3_\ "4_#[3[B5PUW;#[+<<@G<G )^J[3^->;^"OC3X+\(^$-.T5-.UEGMXOW
MSI!%AY#RYYESC)./;%4O@OXML+?XDZQI5B98M(U=WFLXYPJ,C@E@N 2,[21P
M?X16B24G!;67WK_/4B3NN=[W_!_Y:'8?M%?\D[M>O_(2C_\ 0)*]2TS_ )!5
MGQC]PG'_  $5Y9^T5_R3NT_["4?_ *+DKU/3?^059_\ 7!.O^Z*F'PR]?T+G
MO'T?YGGOQD\#6&O^$[S6H8$AUC38C<1W,:X=T099&(ZC R,]"..IRFA^-+W4
M/@-/X@$I;4K:PF1Y">?-C!4,??@-^-=AXUN([7P+KT\P!C73Y\@]_D(Q7!_!
M'2H[[X.RV5[&3:W\UPC#)&Z-AL/TZ'I4VO&<5V7WZ_F#:3A)]VOEN+\!?#=A
M9^"(O$!A634]1>0O<.,NJ*Y78#V!*Y/J3ST&,KXMVUIX0\;>%_&&G1+;WDMX
M8[SRSM^T)\N=P!&3@L">^1GI5+1)O'_PADGT)?#$_B716D>2TFLE;<,XR255
MBONK#KG!(Z\_\5(O%7B.'1M;\16BZ5#/=+;:?HZMOE57&YI'/&&R%&" 1QD#
M'.C:E4C*.UU_E8FUHR4NS_SO^IZ9\>;XVWPRFMDR7O;F&!5'4_-OZ?\  *FT
MOXF^ _#.DZ=H-QXA@\^RM88'\F*25 0@'WT4K]>>.];OC7P!I?CRPL[35;F^
MABM7,B"UD5=Q(Q\VY6_R:!\,_!(TO^S_ /A&--\GR_+WF >;CU\W[^??.?>H
M5U?U_0;UY?3\SI+.]M=1M([NRN8;FVE&8YH7#HPZ<$<&O(-+_P"3I=9X_P"8
M<.3_ -<XJK_"D3^$OBEXF\"I<O/IL2&XM_,))0@J1[9*R#)QR5%8VN^'M0\2
M_M$ZS8:9KUSHMQ]D20W5L&W[1%'E?E93@Y'?M37QQDNJ?Y#^S-/I;\T?0]%>
M/_\ "H/&'_16=<_*;_X_7I7AO2;K1/#MKIM[JDVJ7,*D/>3[M\I))R<LQ[XZ
MGI0]FR>IXSH%@GQ:^+FKZIK*^?HFB/Y-M:MGRW^8A<CN#M+GUX!XXKW5+*UB
ML5L8[:%+18_*$"Q@1A,8V[>F,<8KQ?\ 9]"65WXMTJ1A]I@NTW#&. 77/YBO
M;Z++DBEV7XC;O.3[-K[CS'3_ (:W_ACXH?V_X8ELK;0KI-M]8.[)R<Y\M0I7
M .& R,<@8%9GQRUK4)SHG@O2Y#'-K4P6=AUV;@JK]"22?9?3->I7NN:5IMY;
M6E_J-K:W%UQ!'/*J&4Y PN3R<D<#GFO'OB>$L/CCX(U*X8+;OY<>2,X*RG_X
ML4)7<(O:_P#F[ W92DM[?\ ]1\)^#M&\&Z5'8Z5:1QML59KC:/,G8?Q.W4\D
MG'09P,"N=^)GPT@\:6"W6FK;V?B&!U>"].4W $95V4$D #(ZD$#& 37H-0WE
MW;V%G-=W<R0V\*%Y)'.%11U)]J):ZL(Z:(P+O0]7UOX?2:'JFHQVVJ7-I]GN
M+NU!D7=T9@"%)##J..I^M.\&^$M.\#>&8=,M3&3&NZYNB@0S-U+MR?PR3@<5
MM6.H66J6BW>GWEO=VSDA9K>59$;!P<,"1UKG/''P^TKQ_!9P:K=7T,=HS.@M
M71=Q8 <[E;T[8ZT2;NVNH)*R3Z'F_@O[%<_M"ZS<^%?*.B"TQ=/; >06*K]W
M''+C/OAB*]TKPGP^FI_"#XCZ?X4-PE[X>UN0F%S BRJY^49(Y)!V@YX(.0 >
M*]U)"@DG ')-/10C;9?YZ_<+7G=]_P#@'E_Q?\5WUM!9>#M 9CKFML(P4.#%
M$3@G/;/(SV 8UV?@[PI8^#?#5MH]BH^0;II<<S2D#<Y^N/P  [5YE\-(_P#A
M-?BGXC\<38>WM7-I8@G.WC:"../D'_CYKV#5-2MM'TJZU*]?9;6L32RL!G"J
M,GBI3Y8<SZZ_+HOU]6-J\[+II\^O^7R.2^)WC27PIH,5MIBF77M4?[-I\*C+
M;C@%\=\9&/<CMFO+?AAX<F\*_'*?2+JX\^ZBTS?,_7,CI&[ $]0"QYZG%:7@
M+6]&\2>,KWQ]XJU[2[6=&:WTNPN;V-&MX_[Q4MQP2!ZDL?2FZ=XCT-/VD=6U
M1]:TY=.>P")=FZ01,WEQ# ?."<@\9[>U."M)-[N_RTT7ZOS] EK%I=+??=7?
M^7WG>_&:.^D^%>LBQWE@J-*$ZF(."_X8Y/L#3_A=_P (Y_PK2P_LC[-]E\C_
M $[.W/G;1YGF^_U[8[8IGQ0\=R>$_!<6H:2(;JZU"18+1_\ 61_,"V_CAA@<
M=B2.HKC],_9ZTV^L%N_$6IW:ZK/^\E33EAA@C)'W54)CCVP/84E>TE;_ (?L
M#M>/S_X<9\(([7_A:/C*3P^N/#HPL9C.8R^_Y=O;'^LQ[?KWGQ N_&?EV&F>
M#+2(W%Z7%Q?3?=M$!4;LGC)W'LQPIPI[<A\/-1U+P3XZE^&VK-:SVQA\_3[J
M&V6$R?+GY@O7(5LDY.5/)[>QTVDXQMM;[]Q)M2E??_AK'SMX6\*OX.^/^E:=
M/?R7]U+927%Q<2=7D9)"Q&>>W4DD\GO@?1->-:@?^,H],&!SII[=?DDKV6FG
M>$7Z_FQ6M.7R_(****104444 %%%% !1110 4444 %%%% !1110 4444 %<#
M\5].\47/A^UO_"=S>)?:?<":2VMIF3[1'CE2H(WD$#Y>XR!DX%%%)H:.6/[0
M5M/:BRLO"^K2^(S^[^P[ 4$HX89!+G'/&P'C''6NB^$W@_4=!L-1UK7U UW6
MIS<7"]XUR2%.#C)))('J!VHHIP=X*IUDO\G^I,OC<.B_X)QUU_:OP:^(&KZV
M-*GOO">KOYLTMLN3;DMG![*0SD $@,&&#D'$7B;XCZA\5-,D\+^"- OV2Z*K
M>7=TBJL*9)P=I95!V_>)SP0 2:**F"YKP>T?ZL.<N7WEN_ZN=_J7PYBN?A&/
M!<,R^=%;*(IV! ,ZG=N[D MGZ UPOASXNR> ='M_#/C;0=4M[ZP00PO!&I$L
M2DJ#\S*"!C 920<444Y3:E_B_3^K HKEMV)_#MEKWQ/^)%AXSU/2I-+T#34#
M6,4P.Z<XW*0< L"2&W8VX  SR:76MWCW]H.PTM2)-,\.()I@5X\P$,?KEC&O
M/]T_B455N6HHKI=_/N3?F@Y/K9?(]NKQ?X\Z9<Z>^A>-M.&VYTR=8Y6'!VEM
MR9/H&!'_  .BBLYMQ2DMTU^:_P S2*3NGU3_ "&?''5(-;^$&CZI;,##=W<$
MR8.?O1.<?4=/PJ6S_:)\(V]E;PMINM[HXU0[8(L9 QQ^\HHJ]I22VO\ H2M8
M0D][?J9.O^+?$7QDA3P_X4T.[L]#FE NM3NUPK!=I*DC*K@G.T,S-@=.17LF
MD>';?1/"=OX?LI98X8+;R%F5L/D@Y<'LV23]:**<HI)P[_Y?\$49-VEV_P _
M^ >0:%\2]7^&27'A_P"(-AJ]W,DK/:WZ-YQG4XZ,[#<!D'()(S@@$5:TR/6/
MB[X\TKQ!>Z1-IWA;2"9;1;D<W39!##IG.%)QE1MQDYHHI4WS)S>\7;]+A/1J
M"V?_  ]C=^,O@[5=>L-,US04,NJZ+*9DA7EI$R&.T=V!4$#OSCG ..O[0VGQ
MV9M;GPWJJZ^N8FL@JA/.!QMR3O'/;9D=.:**4-9JGT?^:0Y/W>?JO^":WPG\
M):Q;WVJ^,O$T7DZQK!RMN5VF&,G.".JDX7CJ HSSTR]+_P"3I=9X_P"8<.3_
M -<XJ**:?OQ79/\ (&OW<WZ?^E(]FHHHH \8\8^&/$O@SQX_CKP;8M?PW?RZ
MAIT2%BQ. Q"KR03ALC)#9)R,TH_:.\.I:$3:)J\=^J'=!MC*"3^[O+ XSQG;
MGV[444H:R5/I^6J_S*>OO]0\*>'O$OCGQ_%XW\6V#Z996(*Z=ITH(<8)QD$
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%Y7NC_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !F &8# 2(  A$! Q$!_\0
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M@/?,5WB:W(C&,XE'*-^&30BX-7L]F:OB.&WU+2V@TV,%]#F6S!7K+&P"[O\
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MP[@TOB.;39?#NE?V2Q6$SSNT#'+0,VTE#[>A]*YFBE<7M'R\H4444$!1110
M4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.gif
M1TE&.#=AT  / '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M!L"(^'9G&0$ <00)  A)E!A PM"=OB43B P>P015(V$LP4'7&"PU04$%="U
M@1-Q )"*>LDP)8 !3U3XA'YJO.3) A9<   W/[UC@00D4*#,1N2H@L GVY0
M  8 7."A"1N= , R D$!P"\3K7)$%$9(86$23]C(BD\HB+!&&W+,08>+CC"T
M3@8IP/.(/M$A0@P &8"S4#P A*&/@,31M8A AP  "3.M ,!$,\X0,,5"J!S
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MYB%=#5SQ+$OL2(-%O0 $(HU(X\R @!( O " "VK0!4-P M6S 0UY '"E/MP
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M+1??B,,/PO %2 "5%D!H !ON\ -DL&0% BC"!:S*DF><YZOQV(@U-."".I#
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M5[##03Z9@0Y>8HNQ"&1@T'@# +9@9RP+I%(3^(0^!F:JB<2B A)XF#[4 0$
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="[$-!UB# E$+'P /2S%Q * #Z.<+[G, ]1 0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] TP# 2(  A$! Q$!_\0
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M7Q-?Q3'=7=W9QW$H@L;B4H@MG./+VJ=JG:J'(R-R*QW$<^]_\+M^'G_0P_\
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M<X7 !]#T5\T>"_&GBF?X+^+K.UNYVFT:*V%G-$I::&&1R)!N_NJBL0>J#."
MJ[>;^!T\T/Q;TA(I9$29)TE56(#KY+MAO4;E4X/< ]J /KNL/QAXEA\'^$[_
M %Z>WDN$M$4B%" 79F"*,GH-S#)YP,\'I6Y7G_QM_P"20Z[_ -N__I1'0!Y_
M_P --?\ 4H_^5+_[51_PTU_U*/\ Y4O_ +57FGPYUGP;H.J7-_XMTJ[U,J@6
MT@CBCEB!.0[.CL 3C&WJ.2<9 (]+_P"%I_"#_H0O_*/:?_%T '_#37_4H_\
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M/LNSSOW,D>W=G;]]1G.UNGI0!P?QA^*U]X(O;'1]'MXS?RHEW+/.NY!%O(V
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M_9E_YFG_ +=/_:U?0% &'JO@WPSKCW$NIZ!IMS/<)LEG>V7S6&W;_K,;@0,
M$'(P,8Q7R9\2O!'_  @7BUM*CNOM-K+$+FV=AAQ&S,H5^,;@5(R.#P>,X'V?
M7C?[2$$+>!=,N&BC,Z:FJ)(5&Y5:*0L >H!*J2.^T>E '6?"+7+CQ!\,]*N[
MV_\ MM\GF0W$C.&<%78*'Q_%LV'GDY!.<Y/<5\__ +,O_,T_]NG_ +6KZ H
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MXMCTC1KR>YC%HDL_GRH[QR,S?*=JC'RA#@C/S9Z$4 ?0_P $O^20Z%_V\?\
MI1)7H%>?_!+_ ))#H7_;Q_Z425Z!0 5AP>"_"MK<17%OX:T:&>)P\<D=A$K(
MP.000N00><UN5X/\;/BJEO%/X3\/W6ZX;?%J<Z!60(596@&0<MSR1C;C&<Y"
M@'D'Q$UA-;\?:S=0I8K;K=RQPM91*J2H';$A*_?9OO%R3G/I@#U3P#\;/"OA
M/P1IFAW&G:R9[5'$AC6*12S.S$@EE."6SC''3)QD^!U]'ZWX ^$&MZQ/J/\
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M9/!7@K4O'FLS:7I<]I#/%;M<,UT[*I4,JX&U6.<N.WK7TW\;?^20Z[_V[_\
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M'_0UZY_X,9O_ (J@#L/B1\&]4\(SRW^D0SW^A=0X/FS0!4!9I0J@!<A\,,@
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MK!2&#;'=MV^/AAM*@X(RQP2?8* /AC4-"\2:)IQ_M+2M5L+&:5<_:;>2*-Y
M&V_> !8 OCO@M[U3TW2=2UFX:WTO3[N^G5"[1VL+2L%R!DA03C) S[BOI/\
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M_J4?_*E_]JKPS5KR'4=9OKVWM([."XN))8[:/&V%68D(, # !QT'3H*^D_\
MAG'P?_T$M<_[_P /_P :KB/BK\']'\$^$H]7T:;5;F07:13^>R.D<;*WS':@
MQ\P09)Q\V.I% 'K_ ,(M<N/$'PSTJ[O;_P"VWR>9#<2,X9P5=@H?'\6S8>>3
MD$YSD\O^T=_R3S3_ /L*Q_\ HJ6O//V??$LVE^-WT);>.2#6$P\A)#1-$DCJ
M1V((W CW!SQ@^A_M'?\ )/-/_P"PK'_Z*EH Y_\ 9E_YFG_MT_\ :U?0%?/_
M .S+_P S3_VZ?^UJ^@* "O&_VD)X5\"Z9;M+&)WU-72,L-S*L4@8@=2 64$]
MMP]:]@GGAM;>6XN)8X8(D+R22,%5% R22>  .<U\B?%[QU;^.?%J3:<9_P"S
M+*+R+?S&($AW$M*$/W=W ]2$7..@ .__ &9?^9I_[=/_ &M7T!7F?P*\/0Z-
M\-[6]-M)%>:H[7$[2H%8J&*Q@< [-H##.?ODC@UZ90!Y'\;_ (C3>%M+BT+1
M[F2#6+Y-[RHAS#;G<I*MGAV88!&2 &/RG::\,^'_ ,.]4^(.HSPV,T%M:VFP
MW5Q,<[ Q( 51RS8#$#@?+R1D5V'[1W_)0]/_ .P5'_Z-EKT_X"7VES_#.VM+
M*2#[=;2R&^C1=KAV=BC-ZY0* W/W<9^4@ 'CGQ6^%+> 7@U#3[B2YT6X<0JT
M[+YL4NTG:V  P(5B"!V((& 6Z#X,_%F'0+<>&O$#QQ:7&DLMK=X \C :1D8=
M6#'=MQEMQVX.1M^A]5TJQUS2[C3-3MH[FSN$V2Q/T8?S!!P01R" 1@BOC3X@
M>$?^$)\6W.D"\@N8QF6+RY=[QQLQV++\HQ)M"D@#'S C@T >@6OQ]\2OXYGE
MM[3^T=(N)6BM-*$2QR8)Q'AE#-YAXR,L"68 #C'TO7RA\!-/M[OXF6UU+J,%
MO-9Q220VS@[[HLC(0O;Y0Q8\YXX!&XK]7T %>/\ [1W_ "3S3_\ L*Q_^BI:
M]@KQ_P#:._Y)YI__ &%8_P#T5+0!SG[,T$+7'B6X:*,SHELB2%1N56,I8 ]0
M"54D=]H]*^@Z^>/V:+&WDU'Q%?M'FZAB@AC?<?E1RY88Z<F-/R]S7T/0 444
M4 %<?\2O!'_">^$FTJ.Z^S744HN;9V&4,BJRA7XSM(8C(Y'!YQ@^=_'_ ,/>
M+]9N-+?2[:[O]%1,-:6B-(R7&6^=D49(*X /(&&'R[OF\4_X03QA_P!"IKG_
M (+IO_B: /7_  Q^SC_Q]?\ "5ZE_<^S?V5/]=V_S(O]W&/>N@_X9Q\'_P#0
M2US_ +_P_P#QJO'+^R^(/@CPGI%[+JNLZ;I]X\J16D=Q<0FV96/#IP$+_,R@
M=0":CL;_ .*>IV<=Y87?C*[M9,[)H)+J1&P2#AAP<$$?A0!Z/XG_ &<?^/7_
M (134O[_ -I_M6?Z;=GEQ?[V<^U8'_#./C#_ *"6A_\ ?^;_ .-5R]]?_%/3
M+.2\O[OQE:6L>-\T\EU&BY( RQX&20/QJ3PUX=\5?%FXGMV\21W$^GH'2/5K
MZ5VVN<,8QAC@%5#'CJOK0!]-_#OPW>>$? FFZ'?R0275KYN]X&)0[I7<8) /
M1AVKJ*^,-;^%_C#1-8GT[^P[Z_\ )V_Z386DTL+Y4-\K;!G&<'W!KT_X ^'/
M%FCZYJLM[9SZ9IC1()X;ZS='N'^;88RP&-OS9.3]X#'(90#8^.GQ(U'PU]E\
M/:+-/:7US%]HGNTV\0MO0(N02&)!.X8*[1@G)QY9\)OAS-XX\0)<7MM(?#]H
M_P#I<F\IYC8R(E.,DDX+8QA>X)7/U7J>A:/K?E?VMI5C?^3GR_M=NDNS.,XW
M XS@=/058L;"STRSCL["T@M+6/.R&",1HN22<*.!DDG\: /B3QI!#:^.O$-O
M;Q1PP1:G<I''&H5442L  !P !QBO1/\ AG'QA_T$M#_[_P W_P :KS_QW_R4
M/Q+_ -A6Z_\ 1K5L3>*OB9/X<MKU]3\1C2+?=LOD,J(=SX.Z88W_ #?*-S''
M08Z4 =1_PSCXP_Z"6A_]_P";_P"-53U;X!>*M&T:^U2XU#1F@LK>2XD6.:4L
M512Q S&!G ]17%_\)WXP_P"AKUS_ ,&,W_Q57+KQ)X^?PTTMYJGB!]%OG\OS
MYY96BF(#J4$C<$$;P5!P<<@[1@ [3]G'_DH>H?\ 8*D_]&Q5]/U\P?LX_P#)
M0]0_[!4G_HV*OI^@#S_XV_\ )(==_P"W?_THCKY@\'>#M4\<:Y_9.D^0LRQ-
M-)).^U(T&!DX!)Y*C@'KZ9(^C_C]J?V#X7SVWD^9_:%W#;;MV/+P3+NQCG_5
M8QQ][/;!\P_9Q_Y*'J'_ &"I/_1L5 &'XM^#'B;P=X?EUJ]GTVXM(759?LLS
M%D#':&(95R-Q XR>1QC)&Y^SF$D\?7L<D$$FS3WFC=X59XW#HF5<C<ORR.#@
MC.><X%>O_&W_ ))#KO\ V[_^E$=>0?LX_P#)0]0_[!4G_HV*@#UOXR^"YO&'
M@IC8I&=0TYS=0CR2[RJ%.^)".06X( SDJH/J/#/@MXT_X1/QHEM=W<%MI&I8
MBNWF7A64-Y;;OX?F."3\N&)/0$?6]>!^+O@!J6M>-;O4],U>TCT^_N#<3_:=
MWFQ,[$R!55<.!DD9*]<'IN(!SG[1W_)0]/\ ^P5'_P"C9:^A_"=C<:9X-T.P
MO(_+NK73[>&9-P.UUC4,,C@X(/2ODCXI:S>:W\2M=EO'S]FNY+.% 3M2.)BB
M@ DXS@L<<;F8X&:^SZ "HYYX;6WEN+B6.&")"\DDC!510,DDG@ #G-25Y?\
M'Y[=/A?.)[R>"1[N$01Q$A;A\DE'P.5"AGYQ\R+SG (!S_Q'^-NG?\(];_\
M"#^(?^)G]K7S?]";_4['S_K8]OWMG3G]:\4U_P ?^*_%"-%K&N7<\#($:!2(
MHG ;<-T: *3GG)&>!Z"I/!'@+6/'VHW-GI)@B^S1>;)-<EUC&2 %W*K?,>2
M>H5O2NX_X9Q\8?\ 02T/_O\ S?\ QJ@#S_PQX5_X2;[5_P 3[0]*^S[/^0K>
M>1YN[/W.#G&WGTR/6O0-+\#_  QT&SM)?&'C6"]OGE9S#H\QG@V*1\C%$9^1
MU.4ZD#[NZC_AG'QA_P!!+0_^_P#-_P#&JIZM\ O%6C:-?:I<:AHS065O)<2+
M'-*6*HI8@9C S@>HH ]S\'>-?A[?WG]B>%+JQ@FDW3"U@LVMA(0!N(!10S8
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M$O+.[@R&9-P 8<.I4LW (YZYZ5]IUCWWA/PWJ=Y)>7_A_2KNZDQOFGLHY';
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_005.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.gif
M1TE&.#=A#@$0 '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MR)"A0P 0^/8=3>(\ "3^N5,#   B::E4P15H"$"Y@:E*)#!QA-[ =HF&G_\
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M0A!"@(0QE$$.9G!#)!Y D&P0('&!>H5 ,D6!>1#$!((3"!L < #:H*!3Q9
M O^T,  /OL "$[B#0,X! "7^PQR D!2&)) A(BS"+'$ @#0&,H,)M*@@E@
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M"W=NCC;6,*T6X;<YA_B'& #0 7\L:!_D& '/_A$X3TB %03_:6Q2*,MGVX#
MT *YC (0L,6#K&$" F'! M(0!BP8(1<$R4.:IBP!#TPL4Z^H1 \H@(<*;.(?
MD>!$7$@1# 5 @AH V$<&W: )3=3\(?+HA"<J@(=].\$5LBH'5&4HD"=@X![[
MZ 8$3I$$#/Q#M+.HAR!"X0432/L1Z"!T(_3 B,V,JS4GR$(Y:+0!@11 #0>1
M 0%V6*>"\" Y'_ #-+,1#@! :R"R@$8C(. ,P_W#"P9 A![(H X%_,-##'!&
M.<H1#QH 8 CBF&6P[:&.,0-@:(%4@D#2;0&!V!X,_[  :/]! X/_0Q^2^ 0
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M!B0%*Q6P"%Y .J!P.C$P UJ@#P,Q!0B@"I& !P 0"WN (0; 95IF",4  )+
M&DL@BCC1"E-@#O*P9P*!)A@"!P11"RL  #WU#0 P ?:!5++2'(Z00>,@#P)W
M#U80 AR""P" !1OX!.40 C4@BOT0 ;(EC0313PYP56&2 8IP%^+@"1ER 5+0
M')D 30BP#O^@)P&@6AW #G.0!(:0 2@P,<Z0 0T0#-+5' \P B80 2/@ :U
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AE8<0_I")"6$/NA0A$+]P",@ IK(0";A%#H&H$ $0$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ]!QD# 2(  A$! Q$!_\0
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M@YC\;?'[1]8\):AI6B:9??:KZ)K9WO414CC=2K,-KDEL' ' YSSC!X#X)?\
M)7M"_P"WC_TGDH ^OZ**KW]];Z9IUS?WDGEVMK$\TS[2=J*"6.!R< 'I0!8K
MY0^#GB+Q!<?%>SC_ +8GD;4]RWS73--YZ1QLP#9;.X!<*V?ESW&5/L=Y\>?
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M%:E? D$$UU<16]O%)-/*X2..-2S.Q.  !R23QBMS_A!/&'_0J:Y_X+IO_B:
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MJ%$9@K-DC:H5>G&  .,#% '8?#;XM+\/=&N[ :')?O<W'G&0W[1JHV@ !-K
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MX/S#(]Q7M?PL^-NHW^N1Z'XLF^TM?2K':7B0JI21L 1LJ  J3C#8R"><@Y4
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MXECA@B0O))(P544#)))X  YS7C_A']H"Q\1^);31[_1)-.%VXAAG6Y\\>:Q
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M"M;M8[D.YWSX 9HU"\C(*@L2,;\C)!%?6<$$-K;Q6]O%'#!$@2..-0JHH&
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M'!)(P37RQX1GU+X<_%ZTM;R6.U>"]%E>M*S)$T+L%9SG;E-I$BD\<*V*^PZ
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M\ '7_P#"T_A!_P!"%_Y1[3_XNC_A:?P@_P"A"_\ */:?_%T?\+3^$'_0A?\
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MP,S*6="1DX ;Y,JI+$\'FOK>O&_B-\#--UFWN-4\+0QV.J*BD6486.WGV@Y
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M4P3C(WHP9<X/*G .0>0<@\YH ^YZ*S]"U/\ MOP]IFK>3Y/VZTBN?*W;MF]
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M2!R2'YVD8JY\=/!;^)=#L=4&K6.GPZ1YK3M>EE0H^SD%0QW910%"G=NXYP"
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MW@3@S2D$A<XPHPI))Z ' )P#S?PA^)'_  G.AO;:E- -=L^)D3Y3/'QB8+C
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M1[:TNX+G2--S%:/"O#,P7S&W?Q?,, CY<*".I)L?#CXP?\*_\/7&D_V%]O\
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M<[MNW'G$R[<9/3?C/?&>.E=A7S)\#/B--HVLP^%M4N9&TN]?99@H7\BX9A@
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M\'Q-\%W7B"+0[?Q!:37\KA(UCW-&[$9 $H&PD],;NO'7BNLH **** "BBB@
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MV[74F2$7( SC+'N0H8@'&* /#/V@O$LVJ>-TT)K>..#1TPD@)+2M*D;L3V
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M<<^JLP]L\<U\J>#M7L= \8Z5J^I6<EW:6=PLSQ1OM;(^ZP]2K8;!(!VX) -
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M@,00#CO@X]#7VOX%U_0/$/A6UE\-M(-/M$2T6*16#0%47]V=W4JI49!(/J:
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M <;8D0Y )'53WH ZCP9\$=8\8>'(]<CU2QM;6XBE-LC!W=I$<H%<8 525/S
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M7^ ;.YD2<75EBQN7F?>99$1<R;NIW!@3GG)(YQD^;_M-?\RM_P!O?_M&N<^
M7BYM'\8G0[N]D33]30K%$S*(Q<\;6Y/!904XY8E!@X&.C_::_P"96_[>_P#V
MC0 ?LR_\S3_VZ?\ M:OH"OG_ /9E_P"9I_[=/_:U?0% !7S_ /M-?\RM_P!O
M?_M&O=-5U6QT/2[C4]3N8[:SMTWRROT4?S))P !R20!DFOC3XA>+/^$U\:7V
MLQI/':OMCMH9GW&.-0 /9<G+%1P"QY/4@'M?[-FFPQ>%=9U16D\^XO1;NI(V
MA8T#*1QG.96SSV'3O[97#_";PG_PB'@&SMI'G-U>XOKE)DV&*1T7,>WJ-H4
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M@X((Y! (P17Q9XXT&S\,>--4T:PO?MMK:2[$F)!/(!*MCC<I)4].5/ Z  ]
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M_P#2>2OK^OD#X)?\E>T+_MX_])Y*^OZ /G_]IK_F5O\ M[_]HU<^"FKMX?\
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M0'A"2N\Y Y(*]<#IN(!P&L?'7Q5<7B#P^8-"TR&)(H+&&&*4(%&/O,GX
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M8]MYTB$3QKC'?(D())0!@ I.XT =!\0O%G_"%>"[[68T@DNDVQVT,S[1)(Q
M'NV!EBHY(4\CJ/CBQT:\U#3-4U&%/]%TV));B0@X&^18U4$#&XEL@'&0K>E?
M1?QO^'_BCQC<:5=Z'Y=Y!:H\1LBR1M&S')D#L0&!"JI&>-H(!R<4_$?@C_A
MOV=-:TJ2Z^TW4LL-S<NHP@D::%2J<9V@*!D\GD\9P #SSX7:';>--$\3>$_)
MM$U26WCO+"]FM48PE'4.IDQO ;,:\9 &XX[-U&@>%=:^"FDZWXQU6;39+LVY
ML+&R$I/G.\R_.3QD!4WA1R5SG80:R_@#XGM_#^K>(1J,\%MIG]GB[N)Y,Y4Q
MR!5 QUSYQ&,$D[0/0\?XY\::I\2/%$5QY$ZQG;#8Z<C^;Y9( (7"C<S-STR>
M!R * -#X3:#>>+_B=9W$E[B2RE&JW,TQ+O+LD4D>[,S#))[D\D8.IK^I0ZK^
MTO%<0+(J)KMI;D. #NB>.)CP3QN0D>V.G2O<_A9X%3P+X2CMY1G4[S;/>L57
M*N5'[H%<Y5.0.3DEB,;L#YX_YN%_[FO_ -NZ -CXV^$_^$.\:6FLZ2\%G:W^
M)+6&S3R#:R0A <;>!DE6##!R3QQD^W_"SQTGCKPE'<2G&IV>V"]4LN6<*/WH
M"XPK\D<#!# 9VY-SXD^%V\7^ ]2TJ".-KS8)K3<BD^:AW *20%+ %-V1@.>V
M17SQ\#/%"^'OB##:7$D@M-63[&0';:)208F*@'<=WR#ICS"<@9R ?6=%<'\6
M?'+>!_!SSV<L:ZM>/Y%F&"MM/5I-I/(5>^"-S)D$&OG3P_X0\6?%?7+Z_$OF
M3/NDGU"]#K"SC:/+#*I 8!EP@QA1Q@ 4 ?8]%?)'@CQOKOPD\47.DZM:S_8?
M-VW^GL1N1L#]Y'SC=C!SG:ZXY^ZP^E_^$[\'_P#0UZ'_ .#&'_XJ@#H****
M(YYX;6WEN+B6.&")"\DDC!510,DDG@ #G-?/FN?M(W%Q9WMMHFA?99GW);7D
M]P'*#/#F+;C=CMN(!_O 8/T/7F>F_ CP1IVLMJ!MKN[3>7CL[J8-!&=P88
M+ 8QARP()SGK0!X!H?A3Q?\ %3Q!<WJ"2>2=V:YU*[W+ K #Y2P!&<%0$4<
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MJ6)/&!SP .*^TZ^4/B%H]OJ/[0DVD2O.+>^U"SBD82EG E2+=M+9QC<<#H.
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M^8(."".00",$4 ?(GC_Q_JGQ-URR L/)AA_=65C#^]?>^T-\P +LQ"@  =
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M)\P.6Y &,8&[KG@ X?\ X7;\0_\ H8?_ "2M_P#XW5?Q-\6O%WBO1SI.HWD
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M0@L510H)P ,X'H*KZ;X:T'1KAKC2]$TVQG9"C26MJD3%<@X)4 XR <>PK4H
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M(&W[I))KI/\ A -"_P"%?_\ "%^7/_9/E>7GS3YF[=OW[O[V_P";IMSQC'%
M'RA=7WB#XH>.8!<2>?J5_*L,2A6\N!,] !DK&HRQZ\!F.3DGW_7?$>E_ GPE
MH>D66D?;YKG?O9'\@2NBKYDK$[SN8LN!S@<9 4 ]1X(^&OA_P%]IDTI)YKJX
MX>ZNV5Y G'R A0 N1G@<G&2<#%SQGX&T7QUI:6.L12 Q/OAN("%EA/&=I((P
M0,$$$'@]0" #YL^)7Q;N/B%IUC8+IG]G6MO*TTB>>)O-?&%.=BE=H+_7=["O
M0_V;-$A31M9UYO+:>:X%FF8QNC5%#MANN&,BY''W!U[:G_#./@__ *"6N?\
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M->)O&%NM\5CTS3RZ8FO%96E1@"7B3'S@*0025!S@'KCZ;_X03P?_ -"IH?\
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MM73='+ SCS=P(P<$1#!/(8\'MZOX3^#?A/PCJ+7]O#/?W7RF)]0*2^05.=R
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MECMSO#*T>5W!EV@!BQ.,\D\UZ!10!XO^T9X>N-0\+Z=KD#9CTN5DG3 X24H
M^2>S*HP <[\\ &N<^"?Q(\+^$_"M_I>NWTEG.UZ;B-C \BNK(BX&P$@@H<Y
MZC&><?0=]86>IV<EG?VD%W:R8WPSQB1&P01E3P<$ _A7B^L_LW:7=ZB\VD:[
M/I]J^3]GFM_M&PDDX5MRG:!@ ')XY)S0!Y)X]U*'QW\5+VXT%9)TU"XAM[0.
M!&96")$#R> S#(SC@C..0.L_X9Q\8?\ 02T/_O\ S?\ QJO5_ OP9\/^#91>
@W!_M;4Q@K<7,2A(B&W!HTYVMPOS$D_+P1DBO2* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ \\# 2(  A$! Q$!_\0
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M^-'A_P &:Y)HLUI?7E]#Y1F$**$C#8)&YB,L$.X #!R!D<XQ_P#AH[P?_P!
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MZ'/ ![Y17D_P1\?Z[XVL]6@UR2":33_)V3I$$>3S#(3N ^7C: , >^3S7K%
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M.:^9/@E_R5[0O^WC_P!)Y* /K^BBB@ HHK#\8>)8?!_A._UZ>WDN$M$4B%"
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MM:Y;^((-6U2[OTMGMWA-U*9&0N) V&;)Q\B\9P.<=3D ]LHHHH *^8/VCO\
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MY<-WJ+R'[4RAS$L>S(56!!+;P,G. #QD@C4^#.C:[H/PZM;+74\F0RO+;6[
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MO/SG/'2O2_'GP;\%^&_AO?WT$EW;WEBGFK>RR-*TS%L+&Z#"X8LJ@JHQP22
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MU/XE:*)O$E](MUJ"">&>[Q"R,WSJ$8[!E2P50.N HSB@#8_X9Q\8?]!+0_\
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MAN="6/<GU)P , 2:-\>_&VGZBDVHW4&J6O >WF@CBR,@DJT:@AL @$Y ST-
M'6>';;5_@9\/M5UW5[6-]4U:XBM;:R#!EA91*5>1U.""-QVKZ*,C<=O5_"CQ
MO>?$[P]K>D^([6"3[/%';S2PDQ_:(Y4=6W 'Y6^1B2I ^;@+CGJ/BEHUGK?P
MUUV*\3/V:TDO(7 &Y)(E+J02#C."IQSM9AD9KQC]G/Q#;Z?XHU'0YUQ)JD2O
M ^3R\0<E, =U9CDD8V8Y)% 'G_Q \'7'@?Q;<Z3+\UNV9K.0N&,D!8A"V ,-
MP0>!R#CC!/T'\6/$?B/PC\*+!DOHQK%R\-E>7D(P=QB8R/&0!M)9.#@8!. #
M@CU2OFC]H_6?M?BW3-(1X'CL+0RML.7225N5;GCY4C(& ?FSR"* .S_9_P#%
MVM>(]+UBPUB]DO1I[Q-#/.Q>7$GF$JSDY8 IQGD9(SC 'LE>7_ 31K/3_AG;
M:C"G^E:E+)+<2$#)V.T:J"!G: N0#G!9O6O4* /%_C1\4M=\'ZM;:'H:P6\D
M]HMR]XZ"1US(0%53\H^X<DAL[N,$9/SYK_B/5_%.J-J6M7TEW=E F]@%"J.@
M55 "CJ< #DD]2:],_:._Y*'I_P#V"H__ $;+7I?P6\-Z+-\)+1Y]+M)SJ;R/
M>^?$)!.4F=4W!LC"A1@= <GJ22 >,>'/C/XF\+>&+/0=-@TT6]JY9)9(6:1@
M9#(RD[L8.2O !P>"#S7K^I?$-;[]GZ77M=2.*[UBWN;&**TC;:96,L:@ DX&
MU2Q)/8XYP#YA\?=)TW1O'5C;Z7I]I8P-ID;M':PK$I;S91DA0!G  S["N/U+
MQG?:AX(T;PF(XXM/TUY)CCEII6=V#$XX 60J /<DG@* 8=C?WFF7D=Y87<]I
M=1YV302&-UR"#AAR,@D?C707WQ'\:ZA>274WBC54D?&1!<M"@P .$0A1T[#G
MKUKW_P" ?A/^PO!;:S*\XNM:VR-#(FP1QH7$>.YW!BV[H0RX'&3ZQ0!\D?#O
MXB>+(/'VC0S:[?7MO>7<5I-!>W#S(4D=5) 8\,,Y!'IW!(/UO7QII,UC<_&R
MQGTL1C3Y/$<;VHCCV*(C<@IA<#:-N.,#%?9= !7A_P"TCK-FGA[2=#W[KZ6[
M^V;%(.R-$=,L,Y&2_'&#M;GBO9-5U6QT/2[C4]3N8[:SMTWRROT4?S))P !R
M20!DFOCSQCXDU'XE^/O/ACWM<2K9:; 56,B,N1&K'.-Q+9))QECR!@  Z#X/
M_$?1_A__ &S_ &M;7TWV[R/+^R(C8V>9G.YE_OCIGO1\8/B/H_Q _L;^R;:^
MA^P^?YGVM$7._P O&-K-_</7':NO_P"&9?\ J;O_ "F__;:X#XF_#+_A7/\
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M_O#CN/INO)_V?O#UOIGP_P#[85M]UJTK/(<$;4C9HU3K@X(=LX'W\<X%>L4
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M2^*KE+C2]8UO694#[)[2[NI6 96Z,C'J&'0C@BO3/@K\3K/PQIVJZ3K]]/\
M9(XC=6$1 *AE#-)&I)&&?Y2JDA2P/1F^;@],TV;XE?$U[>!H[!]8O9[@ER9!
M"I+2L. -Q"@@=,G'3.0 ?4_PRGU>Z^&^AW&N2R37\MOO,DC!F>,L3$21U)CV
M')Y]><UUE%% ''_%3^T?^%7^(?[+_P"/C[(=_P!W_4Y'G?>X_P!7O]_3G%?&
M%??]>7_%+XO6_@?;IFE)!>ZZVUGCDR8[9#SF3!!+$=%!'!W'C 8 ^</^$[\8
M?]#7KG_@QF_^*K#@GFM;B*XMY9(9XG#QR1L59&!R"".00><U]-_ [QYXE\9?
MVQ#KD\%W'9^6ZW&Q8Y 7W )M10I7Y"<\$'^\#\OF'P]U/^U_VA(=5L(<QWNH
M7EPB3ML*QNDK'. WS!23CH2,9 .0 <_K?B#X@>'-8GTG5O$>N6]]!M\R+^U)
M'V[E##E7(/!!X-9__"=^,/\ H:]<_P#!C-_\57IGC?XH^/\ PE\3;U)VCBM(
M'D%I8S0_N)K=CA'.T@L3M!SNR&W+P-RUZ7\-_B]I?CGRM-N4^PZZ(MSPG_5S
MD9W&(YR< ;BIY )QN"EJ ,_X#:SXIUGPO>2:^\]S8I*!87ER2TDO+>8-Q.65
M3MP3W+#)VX7UBBB@#Q_]H[_DGFG_ /85C_\ 14M<_P#LR_\ ,T_]NG_M:N@_
M:._Y)YI__85C_P#14M<A\ O[1_X1[QW_ &1_R$_LD/V/[O\ KMD^S[WR_>QU
MX]: ,/X^^(8=9^((LK6YDE@TNW%NZ[PT8F)+.5P2,X**W0Y3!Z"MCQKI5]HO
M[-OA6PU*VDM;M-3WO#)PRA_M#KD=CM8<'D=#@\5R_P .O >I>,_'BC7=.U*7
M3XKB4ZI<2[D/FJ,E'=N=Y<J& ^?#$\=1J?M ZY;ZKX^@M+._^TPZ?:"&6-')
M2*?>Q<#MNQL!Q_=P>5P #K_V:+&XCT[Q%?M'BUFE@AC?</F= Y88Z\"1/S]C
M7$?'[4_M_P 4)[;R?+_L^TAMMV[/F9!EW8QQ_K<8Y^[GO@>W_!;1/[$^%^E[
M[?R;B^W7LOS[M^\_(W4@9C$? Q[C.:^</BIJ?]K_ !0\0W/D^5LNS;;=V[/D
M@1;LX'79G';..>M $?P\\:3>"/%EKJ+/=OI^_%Y:P3%1,NUE!*]&*[RP![CJ
M,YK[3KY@^.7@;^RO%NGW6A:#Y%AJ$20*+.+Y'NMS#8$7[K%=F  -V"1D[J]W
M^'6CZIH'P_T?2]:???V\1$@\WS-@+,53=_LJ57C@;< D8H N3^"_"MU<2W%Q
MX:T::>5R\DDEA$S.Q.222N22><U\:>++&WTSQEKEA9Q^7:VNH7$,*;B=J+(P
M49/)P .M?<]?$'CO_DH?B7_L*W7_ *-:@#[?KXXUVZU'X>?&'4[S3K>"TN++
M4)9;>'8IC$,F2J[1P%,;@8&" >Q''V/7@_Q\^'EQ?;O&.FIYC0Q)%>V\, W;
M%WDSLV<M@;%(P<*,YPO ![A]OL_[._M'[7!]A\KS_M/F#R_+QNW[NFW'.>F*
M^+/$>I7?CSX@WEW:K)-/JEZ([2.0)&Q4D)"AP=H(78N<]LDGK6IIOQ2UW2_A
MU=^#85@-K-NC2<H-\4+[C+&!T.XMPQY&6]5*]I^SKX76^\07WB2XCDV:<@AM
M248*99 0Q#9P2J<%<'_6@\8&0#Z+L+&WTS3K:PLX_+M;6)(84W$[44 *,GDX
M '6K%%% 'S!^T=_R4/3_ /L%1_\ HV6J_@/XXWG@SPY#H<VAP7]K;[OL[I.8
M7&YV=MQ(8-RW& N,=ZL?M'?\E#T__L%1_P#HV6NK^%/PI\'^(/AYI^L:QILE
MY>7;RLSM<R(%"R,@50C*,83/.3DGG&  #QSQ[XWO/'WB$:M>6L%KY<7V>&*$
MDXC#LR[B3\S?.02  <=!78> _@=>>,_#D.N3:Y!86MQN^SHD!F<[79&W E0O
M*\8+9SVK/^-?A;1O"/C*SL-#L_LEK)IZ3,GFO)ES)("<N2>BC\J]W^"7_)(=
M"_[>/_2B2@#Y\U^^\9> /B,TE_JNI3W]DX$-Q=3R$7=L)-R@_.28F(R4W8!R
M#R#7U'X9\9:/XI\+CQ#9S>18KYGG?:616@V$[O,PQ"\ -R?ND'O7G?Q]\#+K
M'A\>*+.*1M0TU DX4L=]MDD_* >59MV> %WDYP,>8?";7[F.'Q#X7G:1=%U/
M3+F2[N0KR"P"POF?8."",*1P2=@SP 0#+^#]C;ZA\5] ANH_,C65Y@-Q&'CC
M>1#QZ,JGWQSQ7V/7R!\$O^2O:%_V\?\ I/)7U_0!\_\ [2-UKH_LFS^SX\/'
M][YRH#NNAO&UF[80Y XSN;KM^7,\$V&@?":W@\1^-A(/$%P@FTW3(58W$$1#
M(S.NX("P<\/C 0X.[*CZ3KS/XD_""'X@ZS::HNLR:?/#;_9W4VXF5U#%E(^9
M2#EFSR<\=,<@&7_PT=X/_P"@;KG_ 'XA_P#CM>8?&#XCZ/\ $#^QO[)MKZ'[
M#Y_F?:T1<[_+QC:S?W#UQVKK_P#AF7_J;O\ RF__ &VO//B9\,YOAU<:<K:I
M'J$%\DA1Q"8F5D*[@5RPQAUP<^O QR =Y\._C7X;\(^!--T._LM5DNK7S=[P
M11E#NE=Q@F0'HP[5T_\ PT=X/_Z!NN?]^(?_ ([7GG@3X&S>,_"=MKTNOQV*
M7+N(H5M3,=JL4RQWK@[E;@9XQSS@='_PS+_U-W_E-_\ MM 'J'@CXE>'_'OV
MF/2GGANK?E[6[54D*<?. &(*Y..#P<9 R,]A7E?P_P#@G8^"?$']M7&JR:E=
MQ(5M<0>2L18%68C<VXE3@=AD\$X(]4H X?XE?#BW^(FG6,+7OV&ZLY6>.X\H
MR_(PPR;=RCDA#GMM]S7F%GKWA;X%:X=$BLI]<U=]O]J:C@0F"-L,L<2'.?E(
M8C< 3MRW9/H>N+\<_#'0/'223WT<D.J"W$%O?([$P@,6'R9VL,L<Y&2"<$<$
M %<_%/0;[X?7_B33;^TAGBMY3%:7TR+()@)/+1T5\Y<QD@ Y8=*\ \):R?%_
MBRYF\<PZEXBT^WLKN\D7[3(!:;5\QG15("@[ @7*KEU] *XO7-'N/#^N7ND7
M;P27%G*T4C02B1"1Z$?R.".A (('M_[-$UFO_"10?:?].D\A_(8 9C7>-RG.
M6Y?!X &5Y.[  /$-$T34?$>L0:3I-O\ :+Z?=Y<6]4W;5+'EB . 3R:[3X/Z
MJWA?XJ6R:C<QZ9 R3VM]]KVQ! $9MC%_NGS$3T.1COBOIO0? _AKPQJ-Y?Z-
MI$%G=7?$KH6/&<[5!)"+G^%<#@<<#'RY\8/#4WAKXC:B);B.=-2=M1B*@@JL
MLC_*P]0P8<=1@\9P #'\2PMKOQ+U>#2S'=/?ZQ,EJ8Y%VREYB$PV<8.1SG'-
M?;=?+'P#\)_V[XT;697@-KHNV1H9$WF21PXCQV&TJ6W=057 YR/J>@ KS_XV
M_P#)(==_[=__ $HCKT"O/_C;_P DAUW_ +=__2B.@#Y8\-^%M9\7:C)8:'9_
M:[J.(S,GFI'A 0"<N0.K#\ZZC_A27Q#_ .A>_P#)VW_^.5<^ TU]%\5+-+02
M&"6WF2\VQ[@(MA8;CCY1YBQ\\<X'?!^LZ /D#_A27Q#_ .A>_P#)VW_^.5C^
M)/AWXJ\(Z='?ZYI7V2UDE$*O]HBDRY!(&$8GHI_*OM>O'_VCO^2>:?\ ]A6/
M_P!%2T <_P#LR_\ ,T_]NG_M:OH"OG_]F7_F:?\ MT_]K5] 4 %?+G[14;)\
M1K5FFDD#Z9$RJP7$8\R0;5P <9!/.3ECSC 'L?QB\3:[X4\##4= /EW!NXXI
M9_)$GD1D,=V""HRP5<L"/FQU(-?)FI:MJ6LW"W&J:A=WTZH$62ZF:5@N2< L
M2<9)./<T =98?"#QWJ>G6U_9Z%YEK=1)-"_VN ;D8 J<%\C((ZUG^)/AWXJ\
M(Z='?ZYI7V2UDE$*O]HBDRY!(&$8GHI_*MC_ (7;\0_^AA_\DK?_ .-UA^)?
M'WBCQ?;P6^NZM)=00.7CC$:1KN(QDA% )QD G.,G'4T >]^#?^37KG_L%:E_
MZ%-7A'P[\26?A'QWINN7\<\EK:^;O2!07.Z)T& 2!U8=ZKZ;XX\2Z1H=WHEE
MJ\Z:9=1-#):N%D0(V[<%# [,[VSMQG.>PH\$^&/^$Q\7V.@?;/L?VKS/W_E>
M9MVQL_W<C.=N.O>@#T3XL_%G0?'GA6UTO2[34H9XKU+AFNHT52H1UP-KL<Y<
M=O6MO]F7_F:?^W3_ -K5R'Q'^#__  K_ ,/6^K?V[]O\Z[6V\K[)Y6,H[;L[
MV_N8QCO77_LR_P#,T_\ ;I_[6H ^@***XOQG\4O#/@=T@U"XDN;QGVM9V6V2
M6,;0VYP6 48*XR<G/ (!( .TKY@_:._Y*'I__8*C_P#1LM>IZ!\=?!NO:HM@
MTEWIA9"RSZBL<41(YV[PY .,XS@<8SD@'RS]H[_DH>G_ /8*C_\ 1LM 'T_1
M110 5\J?M :K8ZG\1D2QN8YS9626MQLY"2B21BF>A(##..AR#R"!]#^//%2^
M#/!U_K)ADEEC39 JQ,Z^:W";\8VINQDDCT') /R9X9T#5/B1XY%IY^+J^EDN
M;R[,65C!)9Y"%&!DG ' +,HR,T =9KNB?$/P;X!\/ZE%J&LV&GBW9+BVANFB
M^R.TTC+O1,8#*Z\MDAB5.WY5KAX8O$?C?5"K7%WJEW#;L[S7=SD0PIEB6DD;
M"(,GDD#)]37W'7B?[0<_B^VTNU?399(O#90I>M:LRN9&RN)<?\LBI  Z$DAN
M=E '.:IXXL_AK\.K/P=X;O['4-7GB>2\U*Q(:%?-\P-MD1PWG)A K$?=53@<
M >-C2KYM&?6!;2?V>EPMJ;@\+YK*6"#U.U23CIQG&1GU3X7_  6N/$ODZSXC
MCGM-(.R6"' #7J'=GD-NC7A3G'S*WRD<-7T'/X1T6;P=+X52RC@TE[<VZQ1J
M#L!_B&X'YPWS;CD[N3DT >5_L_>.K>ZT?_A#KPP075INDLOF(:Y1F9W&#QN4
MDG@\J>GRDU8\9_&Z\\(_$R30Y-+@FTBT\H7+J29WWH'+(<A1C>/E(.=I^89^
M7QCQ)H.N_"GQS'%%>^7=V^+BRO("!YD9) 8KSC.&5E.1U'S*<FGI=A??$/X@
MK;J(XKO6+UYI6C7Y8@Q+R, S<A5W'&<G&,YH ^VZ**^;/CCXB\9:1X\VP7^I
M:9I;6Z+9-:7,D23@#+L=K8+AF(/0X"<<@D ^DZ^;/VD-*OE\5:9K!MI/[/>R
M6U%P.5\U7D8H?0[6!&>O.,X./,_^$[\8?]#7KG_@QF_^*H_X3OQA_P!#7KG_
M (,9O_BJ /I?X777_"/? O3]1O[>=([2TN;QXPF':,222 J#C.5P1V.1SBOG
M#1=,O/B1\11:F:"TNM7NY;B60*2D>=TC[5SDX ; )YX!(ZUGWWBSQ)J=G)9W
M_B#5;NUDQOAGO9)$;!!&5)P<$ _A5/3=6U+1KAKC2]0N[&=D*-):S-$Q7(."
M5(.,@''L* /N^""&UMXK>WBCA@B0)''&H544#   X  XQ4E?$'_"=^,/^AKU
MS_P8S?\ Q520>-/&UU<16]OXE\033RN$CCCOYF9V)P  &R23QB@#[;HJGI,E
M]-HUC+JD,<&H/;QM=11G*I*5&]1R> V1U/U-7* /D#XV_P#)7M=_[=__ $GC
MJQX6^-?B3PCX<M-#L++2I+6UW['GBD+G<[.<D2 =6/:CXZ_;/^%KZE]I\_R?
M*@^R^;G;Y?EKG9G^'?OZ<;MW?->E_#3X3>$M:^'FD:EKN@R/J%RDCN[SSQEE
M\QMAVA@,%-I! Y&#WH XS_AH[QA_T#=#_P"_$W_QVC_AH[QA_P! W0_^_$W_
M ,=KU_\ X4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QR@#Y,U;4IM9UF
M^U2X6-9[VXDN)%C!"AG8L0,DG&3ZFOO.OASQEI2Z'XUUO3(K:2V@M[V5((GW
M96+<?+^]R05VD$]00><U]QT %%%?/GQW^(>M6FJ7'@^Q22SL)+>-KB<QE7N
MV251\X,1&%. "2KJ3C((!E_&OXIV_B//AC0I?,TV&4/=7:.=MRZYPBX.&C!Y
MR<[F (X4%NKUC5?'FK_L_:=K%K<W<>K,[W5_<1[+:3[(AE8.,;<#:L1^3EAZ
M@G/*?!SX2?V_]C\5:UY#Z2LK&"R=-_VK;N4EL$;5#@<$'=M((P1GZ7H ^4/A
MO\9-4\(SQ6&KS3W^A="A'FS0!4(58BS !<A,J<@ ' !)R?'C7-+U[Q];RZ3?
MP7L,&GQPR2P/O3?OD; 8<-PZ]"?3J"*]'^+'P>TO4XM4\66%U_9UQ!:375U
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MA4;E5C*6 /4 E5)'?:/2@#H_VCO^2>:?_P!A6/\ ]%2UY!\,OAE_PL;^U/\
MB;_V?]@\K_EV\W?OW_[:XQL]^M>O_M'?\D\T_P#["L?_ **EKYPTS7=8T3S?
M[)U6^L/.QYGV2X>+?C.,[2,XR>OJ: /;_P#AF7_J;O\ RF__ &VN0^(_P?\
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M&_"_@J'4_#VBR03K>QI/*LTTH2(J_P![<Q &[8,^I [T /\ V9?^9I_[=/\
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*_P#T;+110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ]!ID# 2(  A$! Q$!_\0
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M!=TC CD,<=.?>@#K_P#AIK_J4?\ RI?_ &JC_AIK_J4?_*E_]JH_X6G\(/\
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M//\ H8?_ "2N/_C=>0?\,X^,/^@EH?\ W_F_^-4?\,X^,/\ H):'_P!_YO\
MXU0!Z_\ \+M^'G_0P_\ DE<?_&ZW/#7C[POXON)[?0M6CNIX$#R1F-XVVDXR
M Z@D9P"1G&1GJ*\ G_9U\90V\LJ7>C3NB%EBCN) SD#[HW1@9/3D@>I%</\
M#Z>:V^(WAMX)9(G.IVZ%D8J2K2!6''8J2".X)% 'VW1110!P?Q,^)D/PZM].
M9M+DU">^>0(@F$2JJ!=Q+88YRZX&/7D8Y\[_ .&FO^I1_P#*E_\ :J/VFO\
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M4J=&'\P0<@@\@@@X(JOXCU^Q\+>'[S6M2:06EJ@9_+7<S$D*J@>I8@<X'/)
MYKYT_9\\0ZI:>-&T*)9Y],O8I))HP<I;NHR)CP<9P$/(SO7.<**]?^-O_)(=
M=_[=_P#THCH \_\ ^&FO^I1_\J7_ -JH_P"&FO\ J4?_ "I?_:J\\^$W@K3?
M'GBJZTO5)[N&"*R>X5K5U5BP=%P=RL,8<]O2NT^)GPB\)^!_!<^K6VHZJU\T
ML<-K'/(C)(Y.2#MC&/D#GJ.GX$ ]C^'GCB'Q_P"&FU:*QDLGCN'MY86D#@,
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M@'';)QZFO?*^%/#3PQ^*M(>XLI+Z!;V$R6D<0E:==XR@0\,6'&.^<4 >U_\
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MGDA2@!..V1GU%?1^DZ;#HVC6.EV[2-!96\=O&TA!8JBA03@ 9P/04 7****
M"BBB@#XL^&>JWVD_$;07L+F2 W%[#:S;>DD3R*K(PZ$$?D0",$ UL?&:>:U^
M,^L7%O+)#/$]L\<D;%61A!&001R"#SFOJ/\ X1/PW_:/]H_\(_I7V[S?/^T_
M8H_,\S.[?NQG=GG/7-1ZEX-\,ZQ?K?ZCH&FW5V'#F:6V5F<A"@WG'S@*> V0
M, ]0" #/^&FOWWBCX>:1K&IM&UY.DBRNB[0Y21DW8Z D*"<8&2< #BOGSX#?
MV/\ \+#;^U_L/_'H?L?VO9_Q\>;%L\O=_P M.N,<]<5]5P00VMO%;V\4<,$2
M!(XXU"JB@8  '  '&*^)/ G_ "4/PU_V%;7_ -&K0!H:UK-GX\^*IU&_?[%I
MNHZA%$\A(C,5N"L89B2P5@@!)Y&<]J]K_:'@AM?AII=O;Q1PP1:G$D<<:A51
M1#*  !P !QBN0^/7P^;3=4/BW3()&L[U_P#3E2-0EO+P _'.'.<DC[V<G+@5
MGZCXEFUK]F^WBU6WCN);/6(].LIE)C,*I#O5F X<A"\?;@@G)&2 <_X*^$VO
M>/-&FU32[O388(KAK=ENI'5BP56R-J,,8<=_6ND_X9Q\8?\ 02T/_O\ S?\
MQJN'\-_$3Q5X1TZ2PT/5?LEK)*9F3[/%)ER "<NI/11^5;'_  NWXA_]##_Y
M)6__ ,;H S_'7PXUCX?_ &#^UKFQF^W>9Y?V1W;&S;G.Y5_OCIGO7T?\$O\
MDD.A?]O'_I1)7S!XG\;>(O&/V7^W]0^V?9=_D_N8X]N[&[[BC.=J]?2OH_X
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M/B+QC'XFO1=_:P\3RP*ZM!.8\ ;T93D%5"D @$#U))^?/C;_ ,E>UW_MW_\
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M_AH[P?\ ] W7/^_$/_QVN?\ ^&9?^IN_\IO_ -MH_P"&9?\ J;O_ "F__;:
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M""&$95$4D$#KL+#&0593GFO4* "J>JZK8Z'I=QJ>IW,=M9VZ;Y97Z*/YDDX
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M+(I8X')P >E?<]?"&A:9_;?B'3-)\[R?MUW%;>;MW;-[A=V,C.,YQD4 >_\
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M49AO"[,@ Y&>"".O%>>? Z*\UO4?$7AG^T9X;&^T2Y7R]Q:-)',<?F>7D L
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MD\9:38-)FUAT_P Z--H^5WD<,<]>1&GY>YKZ7KY ^-O_ "5[7?\ MW_])XZ
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M]E_\2C^S_L'F_P#+SYN_?L_V%QC9[]:]?_X9Q\'_ /02US_O_#_\:KRSXO\
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M_P#E2_\ M5=!_P ,X^#_ /H):Y_W_A_^-4?\,X^#_P#H):Y_W_A_^-4 <_\
M\--?]2C_ .5+_P"U5)!^TS"UQ$MQX4DC@+@2/'?AV5<\D*8P"<=LC/J*W/\
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MCH<VKZO/Y5O'PJKR\KGHB#NQP?R)) !(YOX>?%32/'Z-;Q0R66K1H\DMDV7
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MJ@@@\$$<8KZ/U7]G_P &ZGJEQ?))J5B)WW_9[26-8D/?:&0D#/.,X&<# P
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M1/OBLIAMEE='4CS(W0CRB X(.">.Q!/T?!!#:V\5O;Q1PP1($CCC4*J*!@
M<  <8H (((;6WBM[>*.&") D<<:A510,  #@ #C%2444 %%%% 'S!XR_Y.AM
MO^PKIO\ Z##7I?QL^(&K^"=+TRWT7RX;O47D/VIE#F)8]F0JL""6W@9.< 'C
M)!'SYX3OKC4_BGH=_>2>9=76MV\TS[0-SM.I8X' R2>E>K_M-?\ ,K?]O?\
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MG^T)?LOFYV^7M3.S/\._?TXW;N^:]8K+\-Z)#X<\-:;HT'EE+.W2(ND8C$C
M?,^T="S98\GDGDUJ4 </\8+ZXT_X4:_-:R>7(T20D[0<I)(D;CGU5F'MGCFO
M&/V<?^2AZA_V"I/_ $;%7I_QXUO3K'X<7>DW-QLOM2V?9(MC'S/+FB9^0,#
M.>2,]JXS]F_PU-]HU/Q4UQ&( C:<D !+%LQR,Q/0 #:!USD],<@'E_C*&^US
MXKZW9Q&2YO+C6);6!7DY8^:4C3+'  &U1DX  Z 5VG_#./C#_H):'_W_ )O_
M (U7/_\ -PO_ '-?_MW7U_0!\@?\*2^(?_0O?^3MO_\ '*S_ !#\+_%WA;0Q
MJ^KZ7Y-KYOE2;)4E,73:S;"0%8D@'/48.,KG[/KRO]H*&^E^&1>T,@@BO8GO
M-LFT&+#*-PS\P\QH^.><'MD %/\ 9Q_Y)YJ'_85D_P#145>P5X_^SC_R3S4/
M^PK)_P"BHJ]@H R_$>@6/BGP_>:+J2R&TND"OY;;64@AE8'U# 'G(XY!'%>;
MP?LZ^#8;B*5[O69T1PS127$85P#]T[8P<'IP0?0BO7** /'_ /AG'P?_ -!+
M7/\ O_#_ /&J/^&<?!__ $$M<_[_ ,/_ ,:KV"B@#Q__ (9Q\'_]!+7/^_\
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M\W"_]S7_ .W=?7]?,DWAJ%OVI!IT%Q(B?VFNHEW 8[O+%TR\8X+94>@(ZXY
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M=NT:SWMQ';QM(2%#.P4$X!.,GT-?>=>1VGP"T73?&MAKNGZI=P6=I<+<BQ9
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M@L& ! 4@! ,!>57@5[_\2/B]I?@;S=-MD^W:Z8MR0C_5P$XVF4YR,@[@HY(
MSM#!JC^#O@.Q\)Z3?W8:.ZU"6]N;4W9BV,(H9FB"#DX!:,N<8^\ <[0:K_&;
MX<V/B?1KCQ&+J2UU#2K*5RP7>L\2*SB,C(VG=G##U.0>, 'SYHVF:[\3/'*0
MR33W5]?2B2[NRH;R8\@-(1D *HP N0/NJ.H%?7]C9Z7X+\)1V\9\C3-*M"7<
MID[$4EG8*.6."QP.23QS67X!\ Z;\/\ 1I+*REDN)[AUDN;F5%#.P4# P,A
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M))E"02,.".JC\J^Q_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB: /F#_A=OQ#_P"AA_\ )*W_ /C='_"[?B'_ -##_P"25O\ _&Z^G_\ A!/!
M_P#T*FA_^"Z'_P")H_X03P?_ -"IH?\ X+H?_B: /F2#XX_$&&XBE?6HYT1P
MS126<(5P#]T[4!P>G!!]"*^L["Z^W:=;7GV>>W\^))?)N$V21[@#M=>S#.".
MQK+@\%^%;6XBN+?PUHT,\3AXY([")61@<@@A<@@\YK<H *^*/%E]<:9\4]<O
M[.3R[JUUNXFA?:#M=9V*G!X."!UK[7KXD@\-0K\2XO"UQ<220#6!ITD\8",R
M^=Y98 Y ..>^/>@#O!^T9XLCBACCL-*DV1(CR3Q.SR.% 9SM95&YLG 48SCG
M&:/^&CO&'_0-T/\ [\3?_':]?'P4\ M%"LVA^=)'$D1E-Q)&9-JA=S!&5=QQ
MDD 9))ZFC_A27P\_Z%[_ ,G;C_XY0!Y)!^TAXJ6XB:XTK1I( X,B1QRHS+GD
M!BY ..^#CT->9^*?$EYXN\1W>N7\<$=U=;-Z0*0@VHJ# ))Z*.]?4_\ PI+X
M>?\ 0O?^3MQ_\<KYL^)>@6/A?XAZOH^F+(MG \;1([;B@>-7VYZD L0,Y. ,
MDGF@#ZS\"?\ )//#7_8*M?\ T4M=!6?H6F?V)X>TS2?.\[[#:16WF[=N_8@7
M=C)QG&<9-:% '%^-?BCX<\!W$-IJC7<UY*BR+;6L.YA&2PWDL57&4(QG/3C'
M->;^,/CEX-\2^$[_ $=]$UFX%TBKY;M' ,A@0V]6<@J1N'RD$@ C!-;'Q_\
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ML1CG(S_A_P#!#PS)HV@>(=2EN[^XFMX[Q[:0J+=BZ[E4IMR0N1U;#$<C!VT
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M>"[635@')F!WVY)P,R2.\>6=CC@+C Q\H"@['[07AJ'5/!":ZUQ)'/H[Y2,
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M0!]=^!/^2>>&O^P5:_\ HI:Z"J]A8V^F:=;6%G'Y=K:Q)#"FXG:B@!1D\G
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MC(XP,!1CC"CJ<D\'\+/@]I>D7[^(+^Z_M*XMKNX@M8WAV)$\,\D7FD;CN8[
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>W]E>O!;QN08D(2-A)MQDN"QP2<#@@9 (^@Z /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_010.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.gif
M1TE&.#=ALP / '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MP -4 #'$.P>=@\@! %2AS#(S * "*PV5 $$^C !02C< 1''1&E% T40!$="
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ML0"L&@*/.FAE (UH2 YX, L5Z. !6C'! D$@@&DL   1L$4^V*$9 .0@'VD
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,W"P?H[B#(/(1$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ^!"8# 2(  A$! Q$!_\0
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MY!\0?@=9^$?"%QK]GKD\WV.*$3030#][(TBHS*P(V+\P(4ACQ]XYXK_LX_\
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MWWPL\;:;H<FLW>@3Q6,<0FD8R1ET0X.6C#;Q@')R/EP<XP: /J__ (3OP?\
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MC((ZT 6**** "BBO(_B-\;['PM<7&CZ%%'?ZQ"ZK+)(,V\)R=RDA@6<8 P,
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M;EHLJ.A;81N;GEFRQ[DUCZGKNL:WY7]K:K?7_DY\O[7</+LSC.-Q.,X'3T%
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M8**P_"GBW2/&>C#5-&FDD@#^7(LD91HY-JL4.>"0&'()'H36Y0 445X_X_\
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MU7H'AS2/"VEKINBV,=I:!R^Q26+,>I9F)+'H,DG@ = *^5/C;_R5[7?^W?\
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MSJ2#CAE0AA[@D'M7:7]K]NTZYL_M$]OY\3Q>=;OLDCW C<C=F&<@]C7S9/\
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M%GAJ&QN?%6D0:H8QI\E["ET9)-BB(N ^6R-HVYYR,5]E^._^2>>)?^P5=?\
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MYE )!R!R<<G (R >,?'+P)H'@RXT270;62U2\2998C,TBY0IAAN)()WD'G'
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M-OF2_:H7V[F"CA7)/) X% 'U7!XT\$VMO%;V_B7P_#!$@2..._A544#   ;
M '&*\4_:'UW1];_X1S^R=5L;_P G[3YGV2X279GRL9VDXS@]?0UY/X;\+:SX
MNU&2PT.S^UW4<1F9/-2/" @$Y<@=6'YUU'_"DOB'_P!"]_Y.V_\ \<H ]+^
M7B70=&\"WUOJFMZ;8SMJ<CK'=721,5\J(9 8@XR",^QKVRQO[/4[..\L+N"[
MM9,[)H)!(C8)!PPX.""/PKXP\2?#OQ5X1TZ._P!<TK[):R2B%7^T129<@D#"
M,3T4_E7N?[-\;#P+J<IFD*-J;*(B%VJ1%'EAQG)R <DCY1@#G(![)7/^._\
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M>+7]G_Q)?>?]CUSPY<>1*T$WDW<C^7(OWD;$?##(R#R* /9_^%V_#S_H8?\
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ML[:SJ>G23:YJ/]BW2RE%M_(2YW)@$/N27 R21CV]ZU_^&9?^IN_\IO\ ]MK
M_P"$-^.?_/UKG_@]7_X]5SPO\&]?T;2[G6M8\5R>#9T<PLZR+@Q'9@M*DR@
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MQR3G=T&*^GZ\K^/7A==<\!G58HY&O-'?SDV(SEHF(608!P !M<L0<",] 2:
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M$E]SRX." ,>_M7H?P3^'^K^"=+U.XUKRX;O47C'V56#F)8]^"S*2"6WDX&<
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MPV_V$1^:X!*IN,N%R<#)Z9KR?P)_R4/PU_V%;7_T:M;D_P 9_B#<V\L#^(I
MDB%&,=M"C $8X94!4^X(([5A^!/^2A^&O^PK:_\ HU: /M^BBB@#P_\ :4U/
MRO#VAZ3Y.?M-V]SYN[[OE)MVXQSGSLYSQM[YXX3X1^'/ &K6^H7?C'5;1)XW
M$4-E=77V90I /F!]RER2"N ?EP20=RXZO]H'POXDUCQ#I%YIMC?:C8BT:(0V
MD4DWDR!R68JH(7<&09ZG8?05@6/P(EMM#CU'Q=XGL?#<DDIC6&<)(!UQF3S%
M7<<,=HSP.N<@ '9IX ^":V]W$==TUWG=VCE;6TW6X8<*F&P0O4;PQ]2:^?+"
M'2Y/$-M#>74Z:0UVB37'E[9%@W@,^T;L-MR<#=SZUGU8L+&XU/4;:PLX_,NK
MJ5(84W ;G8@*,G@9)'6@#Z'NM&^ 5GIT%]++8M#-MVK#?W,L@R,C=&CEUX'.
MX#!X.#Q69)'^SV[PLLTD81]S*HOL2#:1M;()QD@\8.5'.,@X\W[-_BI7 @U7
M1G38I)>253NVC<,!#P&R >X .!G Y_QK\(]2\!^%8=7U34K2:>6]6U6WM59E
M"E&;>7;:<Y0C;M]#GM0!])^!=;\(ZIH8L_!]Q ]AI^(?)C1T,>>02K@,<\G<
M?O'=R3FNHKYT_9LT29]9UG7F\Q8(;<6:9C.V1G8.V&Z941KD<_?'3O[_ *MJ
M4.C:-?:I<+(T%E;R7$BQ@%BJ*6(&2!G ]10!<KQ?QY\#KSQAX[FUR'7(+:UO
M-OVA'@+/#LB5%V@'#Y*\Y*X_VJYC0_VC-;DURRCUNPTJ/3'E5+F2"*57C0\%
MQ\S9V]<;3G&.,YKZ/H ^2/'GP:UWP39S:FEQ!J.D1;=]RF(WCR54;HR>[-@;
M2W3)Q7:? SXGS?:(?"&NW<9@*;=-N)F(8-D 09Z$$9VY(QC:,Y4#UOXC_8_^
M%:^(_MWD>3_9\VWS\;?,VGR\9_BW[=O?=C'.*^2/ G_)0_#7_85M?_1JT ?;
M]%%% !17-^/O$LWA#P1J>NV]O'<3VR((XY"0NYW5 3CD@%LXXSC&1G->9_#?
MXZ7GB7Q1%HOB&SL;;[9\EK/;9C59,$[7#N<[N@QSNP,'=D &?-^S1NU&X\CQ
M/Y5CP8-]GOD&2V5;#J.!M^8=23\JX&?+/%O@CQ'\.=4M&U!HXG=R]G>6D^0S
M)M)*GAU*EEY('/3/6OM.O-_CK]C_ .%4:E]I\CSO-@^R^;C=YGF+G9G^+9OZ
M<[=W;- %/X._%&;QO;W&EZPT?]M6J"0-%"56:$!5+GDC?N/( 4?,,#KCU2OF
M#]G'_DH>H?\ 8*D_]&Q5]/T %>?_ !M_Y)#KO_;O_P"E$=>@5Y_\;?\ DD.N
M_P#;O_Z41T >4?LW7UQ'XRU:P63%K-I_G2)M'S.DB!3GKP)'_/V%?2]?/'[-
M%C;R:CXBOVCS=0Q00QON/RHY<L,=.3&GY>YKT/XF?%-?AW<:= -'DU![Q)')
M,K0J@4J!AMC!B<G(!R,#/WA0!P_[3,\RV_AJW6600.]R[QACM9E$04D="0&8
M ]MQ]:W/V<?^2>:A_P!A63_T5%7EGQ?^).F_$&XTE=+L[N""Q24L]UM5G9RO
M 520  @YSSD\#'/L?P#T:\TCX:K+>)Y?]H7;WD*$$,(RJ(I(('786&,@JRG/
M- 'J%<_X[_Y)YXE_[!5U_P"BFKH*IZMIL.LZ-?:7<-(L%[;R6\C1D!@KJ5)&
M01G!]#0!\*6-_>:9>1WEA=SVEU'G9-!(8W7((.&'(R"1^-;'_"=^,/\ H:]<
M_P#!C-_\57L?@/X"ZKH?C&PU?7KW39K2R?STBM9)&9Y5^YG*K@!L-U.=H&,$
MX]\H ^$-3UW6-;\K^UM5OK_R<^7]KN'EV9QG&XG&<#IZ"K&D^*_$&@V<]II.
MM7UE;S\R1P3L@SE3N&#\K?(HW#!QQG!(KV?]IK_F5O\ M[_]HUN?LWP0KX%U
M.X6*,3OJ;(\@4;F58HRH)ZD LQ [;CZT >"?\)WXP_Z&O7/_  8S?_%5ASSS
M75Q+<7$LDT\KEY))&+,[$Y))/))/.:^^Z\3U7]G33=0\2W&H0:Y)::?/<>:;
M**S7,:DY9$<, HZA?D.T8X..0#VB">&ZMXKBWECF@E0/')&P974C(((X((YS
M6/XE\'Z!XPMX(->TV.\2!R\1+LC(2,'#*0<'C(S@X'H*V(((;6WBM[>*.&")
M D<<:A510,  #@ #C%24 >!_%SP%\/O!_@B>>RL([/6)W1+$&ZF=G(=2^%9R
M,!,Y)&!D=R*\P^&P\#_VS=MXZDD%F+?%N@24J9-PY+1'<"!G P0<G)! SU'[
M0'BN'7/&,&C6IC>#1T9'D7!W3/M+C()&%"HN, A@X/:J]S\(YH?@U!XM,D@U
M!4:\>V2$R%[=S&$Y#D*%0-*3MSAR#C;F@#L_B?\ ##P3I7PSN_$'A^R\F:'R
M)8)X;N25)4=U7^)F!4A\@C'0<XR#YII7C73;'X-:YX/E@NSJ%_>K<12*B^4%
M!A.&.[.?W;= >H_#<^%7]J>-M%UOX=2ZGY&F36@NX7>+S3;ND\1(4;A\K9.1
MGKR,9;/F>K6<.G:S?65O=QWD%O<211W,>-LRJQ <8)&"!GJ>O4T >L?L[W>B
MV7BK4I=0U&.UU"6W2VLXI7"+,'<;@,CE]RQ@ ')W'@]N;^-O_)7M=_[=_P#T
MGCKF[73=7T#QCI]I,T>DZI%<6\B27A"K;,VUT>3((4 ,K$$<<@C@BO8_BI\'
M_$OB/X@/K&C+!<VNH^6)2\BQ_92JK'ELG++@;LJ">HQP-P![!X$_Y)YX:_[!
M5K_Z*6N@JGI.FPZ-HUCI=NTC065O';QM(06*HH4$X &<#T%7* .7^(VL_P!@
M?#K7M1#SQR+:-%%) <.DDG[M&!R,89U.1R,<<UX9^S?/,OCK4[=99! ^F,[Q
MACM9EEC"DCH2 S 'MN/K7I?Q[UFST_X9W.G3/_I6I2QQ6\8(R=CK(S$$YV@+
M@D9P67UKQCX(^)]+\+^/C-J\_P!GM[RT:T6=ON1NSHP+G^%?D(SVR,X&2 #Z
M7\=_\D\\2_\ 8*NO_135\H?#7QO_ ,(%XM759+7[3:RQ&VN44X<1LRL63G&X
M%0<'@\CC.1];^++&XU/P;KEA9Q^9=76GW$,*;@-SM&P49/ R2.M?(GPY\*6/
MC3QC;Z+?ZE)8I*C.GEQ;VF*X9HP>B$H'.XY V]#G% 'K=]^TO9QWDBV'AB>>
MU&-DD]X(G;@9RH1@.<_Q'UXZ57_X::_ZE'_RI?\ VJN@_P"&<?!__02US_O_
M  __ !JC_AG'P?\ ]!+7/^_\/_QJ@#TSPYK]CXI\/V>M::TAM+I"R>8NUE()
M5E(]0P(XR.."1S6I5/2M*L=#TNWTS3+:.VL[=-D42=%'\R2<DD\DDDY)JY0!
M\"00375Q%;V\4DT\KA(XXU+,[$X  '))/&*[S_A27Q#_ .A>_P#)VW_^.5R_
MA.Y^Q^,M#NMT"^3J%O)FXE\J,8D4_.^#M7CEL' YP:^YZ /B#P)_R4/PU_V%
M;7_T:M?6_CKP+I?CS0S87X\JXCRUK=HN7MW/<>JG RO?'8@$?)'@3_DH?AK_
M +"MK_Z-6OM^@#XH\,:SJ/P^\?0W$KSVTEC=_9]0AA*L7C5\2Q]=K=#CG&0"
M"" :]0_:+OK?4].\&W]G)YEK=17$T+[2-R,(2IP>1D$=:U_B[\']4\4>*+?7
M/#RP-)=[(;Y)9-FP@8$V2>5"A0549^4$!B3CC/C99P^';#P?X16[N[V?2[*6
M1[FXQ\ZR. H7DD &)@%_A7:,F@#T/]G'_DGFH?\ 85D_]%15[!7G?P0TI=,^
M%>F/]FD@GO7ENIM^X%R7*H^#T!C6/&.",'OD^B4 %>=^/OB9I6E>"-3O/#OB
M+1KC5D1%MXX[J.9LLZJ6"!N2JDMT(XY!&17HE?!%A8W&IZC;6%G'YEU=2I#"
MFX#<[$!1D\#)(ZT =8GQ:\>1V]W /$MV4NW=Y"RH64L,'8Q7,8] A 7MBJ>G
MVGC'XD:B+""YOM:NK6)IE2[O<^6F5#$&5L#)*].O'I6Y-\#OB#$X5-%CF!16
MW)>0@ E02OS.#D$X/;(."1@F/_A27Q#_ .A>_P#)VW_^.4 =!8_!WPW;2QQ^
M(/B3H=M=12E+NS@FC)7:Q!4.[@AL#NG![''/L?AJ[^&'@^WG@T'6?#]FD[AY
M2-31V<@8&69R<#G S@9/J:\$L?@5X^N[R.";2X+*-LYGGNXRB8!/(1F;GIP#
MU].:X?6]$U'PYK$^DZM;_9[Z#;YD6]7V[E##E20>"#P: /N^BL/P7/-=>!?#
MUQ<2R33RZ9;/))(Q9G8Q*223R23SFMR@ J.>"&ZMY;>XBCF@E0I)'(H974C!
M!!X((XQ4E% 'Q1XFT#5/AOXY-IY^;JQECN;.[$6%D (9) &&#@C!'(#*PR<5
M[GJGQML9OA,VKZ=J%I!XF=$M_L;IEDG./,94)/R!=S*Q)7[H.3E:D_:!/AJ3
MPAC4)X#K\.TZ=#YS>8H>1?,;8#]TK&PW,,9& <FOF"@#O/A)X+F\8^-;8,D?
M]GZ>Z75X9H3(CJK#$1'0E\$8/8,><8/V'7E_P.O_  M_P@UMIVB7?_$PYGU"
MVGD'G>=A5=PO_//[@4CC&,_-NKU"@ HHHH **\#^./Q/U+3=4_X170;N2T>)
M$EO;J!F24,?F6-6XVC;M8E2<[@,C# ^81^'_ !_I&B3>.(O[2LK2Y3?+J*WO
MERRK(X&6&\2,&8J<D<\-TYH ^RZ*\;^"'Q,OO%*2^'-8$D]_96_G17I.3+$&
M5<2=RX++\W\0Z\C+% 'LE%%% &'XP\2P^#_"=_KT]O)<):(I$*$ NS,$49/0
M;F&3S@9X/2OE3X1^'KCQ#\2M)2!MD=A*M_.^ =J1,"."1G+;5XSC=G! -?5?
MC#PU#XP\)W^@SW$ENEVB@3( 2C*P=3@]1N49'&1GD=:Y?X;?":Q^'MQ=WQU"
M34-0N$\D3&/RECBR"5";CDEE!))[  #G(!R_QL^(WAR3PQJOA&UN9+K5)'1)
M/)3,<#))&Y#L2!G (PN[!!!Q7GGP*US2_#WC+4K_ %>_@LK5=*E&^9\;B)(C
MM4=6; .%&2<<"NO\3_L\7E_XMFN]$U&QM=(NI?->*52'M]S998T5=K*/X1E>
MR]MQ+G]FC;IS?9?$^^^7>1YMGMC?@;%X<E>0V6^;@C"\<@%#QU^T#<:I9FP\
M)P3V$,T16>[N5"SJ2>D>UB%X!^;D_-QM(!/F^C_#KQ=K^AOK6EZ)/<V"[\2*
MR OM^]L4D,_<?*#D@@<C%>Y^"_V?](T6X6]\1W$>L3A$9+81E((I 06SSF49
M&!N !&<J<\>R4 ?''PY^)6J> M1\N-_.TBXE0W=JR[\#(W/&-PQ)M!'7!XR#
M@8^B_"GQ?\(>+;@6EO>26-XS[8[:_58FEY4#:02I)+8"YW'!XQS1XY^$WASQ
MP\EY.DEEJS(%%[;GEL*0N]#PX&1Z-A0-P KS#2OV<M5A\2V[:GJ>FSZ+'<;I
M0AD$LT0.=NW "E@ #A_ER2"<<@'T'?S7%OIUS-9VOVNZCB=X;?S!'YK@$JFX
M\+DX&3TS7Q9K_B[Q-XYU1EO[V[NC<W :'3X68Q*Y^55CBR1G!P.I.3DDDD_;
M=5X;"SM[RYO(;2".ZNMOVB9(P'EVC"[F'+8' STH \3^&?P*ALT.J>-;..:[
MWCR-.,@9(MK9W2%3AR<?=R5P><DX7V34]=T?1/*_M;5;&P\[/E_:[A(M^,9Q
MN(SC(Z>HK0KY<_:"\-3:7XW376N(Y(-83*1@$-$T21HP/8@C:0?<C'&2 <O/
M#8Z[\;)8',=UI]_XC*,8Y/EEB>YQPRGH5/4'OQ7V77RA\$/!'_"4^+?[5ENO
M)M=$EAN61!\\LFXM&HXP%RA)/7L.N1]7T >5_%GX30^,K=]8T=(X?$$2<C(5
M;Q0.%8] X'"L?]T\8*^0?!J3Q7IWQ&6PT>&0 .%U>TG(0+ L@1V96(.]"W&/
MF!R,$%@?K.B@ KY__::_YE;_ +>__:-?0%>-_M$>&IM3\)VFO17$:)H[L)86
M!S(LS1IE3ZA@O!Z@GGC! #]GB>&U^&FJ7%Q+'#!%J<KR22,%5%$,1))/  '.
M:\X^+/Q9F\97#Z/H[R0^'XGY."K7C \,PZA >54_[QYP%]?^$?@Q=.^% L-3
MDCNH-=1KN6)-RA8IHE79NR#G:!DC&"2!TR>;\)_L]V^D>*&O==OX-4TVWVM:
MP"(IYSXY,JG("@]%!.[C.!E2 4_@CX+A\/:-=>/_ ! DEN$MY&M5EA!\NW"A
MFG'5LD!@, ';G[P<5L3_ +2'A5;>5K?2M9DG"$QI)'$BLV. 6#D@9[X./0UZ
MIKFC6?B'0[W2+]-]K=Q-$^ "5ST9<@@,#@@XX(!KPC_AFB\_M'9_PD\'V'RL
M^=]C/F>9G[NS?C;CG=NSGC;WH \W^%NC7FM_$K0HK-,_9KN.\F<@[4CB8.Q)
M .,X"C/&YE&1FOL^O._AM\)K'X>W%W?'4)-0U"X3R1,8_*6.+()4)N.264$D
MGL  .<^B4 %%%% 'P9JNE7VAZI<:9J=M);7EN^R6)^JG^1!&"".""",@UZ);
M>&/A_P"$XM-U/Q/X@_M]KB+]YH^DF-S#(5!/F2I-C:I.."I8X(R PKV_XR>&
M+?Q%\.M2F,$#7VFQ-=VT\F08PF&D (_O(K#!X)VYZ CYH\!>"+SQ]XA.DV=U
M!:^7%]HFEF!.(PZJVT ?,WS@@$@''44 7/&?Q,UKQ>B6($>F:+"GE0Z99$I%
ML# J''1R J@< #;D*N376>&_V?M=UKP])?ZC>?V1?-DV]G<0!O,78"I=@^8\
MDD$%2RXZ=J]C\#?";PYX'>.\@22]U94*F]N#RN5 ;8@X0'!]6PQ&X@UWE 'Q
M19WGB7X7>-"0/L6K6>T3P,ZR(Z, VQ]I(92"IX/'!!! (]_\%_'?P_X@^RV.
ML_\ $IU)HB99IBJVA<=E<ME<CD!@,?=R3C/>>)?!^@>,+>"#7M-CO$@<O$2[
M(R$C!PRD'!XR,X.!Z"OESXI_#7_A7FHV?D:A]LL;_P TP;TVR1[",JV.&X=?
MF&,G/RCC(!]=P3PW5O%<6\L<T$J!XY(V#*ZD9!!'!!'.:DKQ_P#9YT&\T[P7
M<:M->^9:ZI+OM[4$XA\LLC,<\;F(P<#HB\GH/8* "J]]?V>F6<EY?W<%I:QX
MWS3R"-%R0!ECP,D@?C5BN3^(W@Q?'7@ZXTA9(XKM76>TEDW;4E7.,X/0J67H
M<;LX) H X_5?VA_"%D]Q%86VI:@Z)F*1(ECBE;;D#+D.HSP3L[' /&?&/%OQ
M/\5?$-+32YXXXD+E!:::)5%TS,NT.A=MY#*-HQU)KN-$_9LU)[C=KVN6D,"N
MAV6"M*TBY^8;G"A#C&#ANO3CGVOPWX'\->$?,.AZ1!:229#39:20@XRN]R6V
M_*#MSC(SC- 'F?P*^'.K^&KB]\0:Y;26<]Q;K!:V[.-WEL5=F=<94Y5  2",
M-D#BO5/%>DW&O>$M6TFTN?L]Q>6DD,<AQC+*1ALJWRGH<#."<8.#6Q10!\B3
M_!SXB:-<2W=OI,C&R<R1W-G=1ECL.0\8#!\\9 P&Z<9XJOX:^,'C+PU<3RC4
MY-429 IBU222=5(/#+\P*GJ.#@YY!P,?8=<OXL^'OAKQKMDUFP\RZCB:**ZB
MD:.2,'W!PV#R P(!)XY.0#'\"_%[P_XYO!IT*3V.I^4)/L]SMQ(<9<1L#\VW
MW"DCG'!QZ!7C_@/X'?\ "&^-(=<FUS[;':Q-]G1(/*)D<,C;@2WRA3Q@Y)/8
M+\WL% !7S!^T=_R4/3_^P5'_ .C9:^GZ^?\ ]I'PW_R"?%"2?]0^6-F_WY$*
MC'_73))_NX'6@#H/V<?^2>:A_P!A63_T5%7L%<7\+O!4W@/P<-+NYXYKR6X>
MXN&B<M&&.% 3*J<;43.1USVQ7:4 >/\ _#1W@_\ Z!NN?]^(?_CM> >!/^2A
M^&O^PK:_^C5KVO5?V;+&ZU2XGTSQ#)8V<C[HK9[3SC$/[N_S 2,YQD9QC))Y
M/0>!O@;HOA+5(]5OKR35[^!RUN7A$<41XPVS+$N"#@EL#((&0#0!ZI7/^-O$
M_P#PAWA"^U_[']L^R^7^X\WR]VZ14^]@XQNST[5T%5[^QM]3TZYL+R/S+6ZB
M>&9-Q&Y&!##(Y&03TH ^9)_VBO&4UO+$EIHT#NA598[>0LA(^\-TA&1UY!'J
M#7#V<7B_XAZI!IL5QJ6MW<:.\:7%RSB)>-QW.V$!PHR2,G:.N*^F['X*> ;&
M6.4:'Y\D<IE4SW$CC[Q8*5W;64<+@@Y YR<D]Y!!#:V\5O;Q1PP1($CCC4*J
M*!@  <  <8H \O\ A-\)H?!MNFL:PD<WB"5.!D,MFI'*J>A<CAF'^Z.,EOG3
MP)_R4/PU_P!A6U_]&K7V_7R)I/@2^TKXX6/A1-1C%Q:7L<RWD8Q\BJ)]P#*P
M#[!T((W<$D<T =9\<]3\:^'_ !HES#KM]::1>1 6*6=VT0&P+Y@95(^;<V<G
M.0RC/&!Y/KWBK7?$_P!C_MK4Y[W['%Y,'FD?*O<\=6.!ECEC@9)P*^YZ* //
M_@WX3O/"/@&*WOW_ -*OI3?/"4*F#>B 1MGG< HSP,$D<XR>\G@ANK>6WN(H
MYH)4*21R*&5U(P00>"".,5)10!\:?$GX?W?@'Q T!\R32[AV-A<R,FZ50%+
MA3D%2X7) SC( Z#<T/X\>+-!T.RTF*VTJXALXEACDG@??L7A0=KJ.!@=.W.3
MDU]3WUA9ZG9R6=_:07=K)C?#/&)$;!!&5/!P0#^%>?W7P*\ W'D>5I<]KY<J
MR-Y-W(?-4=4;>S?*>^W#<<$4 >">,_BYXF\;Z6FF7YM+6S#[Y(K)&03$8V[]
MS,2 1D#@9Y.2!CT?X!?#Z^LK@^,-4@CBBFMS'812QYD(8C,PS]P%05'=@Q/
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M"F*UN0RDY/S'S%<YYQUQP..N0#EY_P!IF%;B5;?PI)) '(C>2_",RYX)41D
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M6^US5+C4]3N9+F\N'WRROU8_R  P !P  !@"OM/_ (03P?\ ]"IH?_@NA_\
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CI'@C1ELM-MXQ.Z)]KN0#NN)%4 L<DD#.2%!P-QQU-% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !("/8# 2(  A$! Q$!_\0
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M#$@LPW!1C.>1C:6 !]3T5C^)_$^E^$=#FU?5Y_*MX^%5>7E<]$0=V.#^1)(
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M.H(&Y0 4444 %%>7Z'\>/">O:Y9:3%;:K;S7DJPQR3P)LWMPH.UV/)P.G?G
MR:]0H **** "BN'\7?%7P_X)\0VFC:O%?"2XB2;SX8E>.-&=ERWS;N-I)PIX
MZ9/%=A8W]GJ=G'>6%W!=VLF=DT$@D1L$@X8<'!!'X4 6**** "BBB@ K#'C+
MPRVLOHXU_3?[01UC-N;E0V]F*A!SR^Y2"HY'&0,C.Y7R9\6? U]X&\8OK&FQ
M26^DW5QY]E<6YV_9Y?O&,;0-A# E /X0,$E6P ?6=%>;_"'XD?\ "<Z&]MJ4
MT UVSXF1/E,\?&)@N,#)."%R >?E#**ZSQAXEA\'^$[_ %Z>WDN$M$4B%" 7
M9F"*,GH-S#)YP,\'I0!'_P )SX6_X2'^P/[>L?[3Z>1YH^]OV>7N^[YF[C9G
M=[5T%?&GPIT"^\0?$;2%L5CQ8W$=]<,[;0L4<BDGU))P !W(S@9(^RZ "BBB
M@ HKQO\ : U7Q-I6EZ/+H5SJ5K9AY7O9[+<@0CRUCWR+RH)=@ 2 3ZD#'@G_
M  G?C#_H:]<_\&,W_P 50!]OT5\0?\)WXP_Z&O7/_!C-_P#%4?\ "=^,/^AK
MUS_P8S?_ !5 'V_17Q!_PG?C#_H:]<_\&,W_ ,54D'C3QM=7$5O;^)?$$T\K
MA(XX[^9F=B<  !LDD\8H ^VZ*R_#4U]<^%=(GU02#4)+*%[H21[&$I0%\K@;
M3NSQ@8K4H ***R_$>OV/A;P_>:UJ32"TM4#/Y:[F8DA54#U+$#G YY('- &I
M17D]A^T)X/OM1MK/[+JMOY\J1>=<1PI''N(&YV\SA1G)/85ZQ0 445A^+?%>
MF^#/#\NLZH9# CJBQQ;?,D9CC"!B 3C+$9Z*3VH W**\?_X:.\'_ /0-US_O
MQ#_\=H_X:.\'_P#0-US_ +\0_P#QV@#V"BO(X/VBO!LUQ%$]IK,".X5I9+>,
MJ@)^\=LA.!UX!/H#7IFC:YI?B'3DO](OX+VU; WPOG:2 =K#JK8(RIP1GD4
M:%%%% !116?K.N:7X>TY[_5[^"RM5R-\SXW$ G:HZLV <*,DXX% &A17C_\
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M-;)(A=6QRP8[1MY!)&> 2 #[#K/UG7-+\/:<]_J]_!96JY&^9\;B 3M4=6;
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MZ[2Q.!VE?-'A/]GG6=1W3>)KK^R(TE4"WBV323)U8[E8JGH#\W.<C &?I>@
MHHHH *X/QG\7/#/@C5$TR_-W=7A3?)%9(KF$'&W?N90"0<@<G')P",]Y7R!\
M;?\ DKVN_P#;O_Z3QT ?6>E:K8ZYI=OJ>F7,=S9W";XI4Z,/Y@@Y!!Y!!!P1
M5RN/^%>F?V1\+_#UMYWF[[07.[;MQYQ,NW&3TWXSWQGCI784 %%%% !7/_\
M"=^#_P#H:]#_ /!C#_\ %53^)T=]+\,O$2Z=-'#.+)V9G&08@,RKT/)C#@>Y
M'(ZCY<^''@7_ (6!XAN-)_M'[!Y-HUSYOD>;G#HNW&Y?[^<Y[4 ?5_\ PG?@
M_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5X__P ,R_\ 4W?^4W_[
M;1_PS+_U-W_E-_\ MM 'L'_"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\
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M0WVNZS% ADNM0O[@(IDD^:65VQRS'J6/4GOS0!]YU'#/#<H7@ECE0.R%D8,
MRL58<=PP(([$$5\8:_\ #7Q;X6TMM2UK3([2T#A-[7D#%F/0*JN2QZG !X!/
M0&NP^ &KVVC>*M4GU+5[2PT][+8PNKQ(5DEWJ4PK,-Q"B3D XR>F[D ^HZ\[
M@^-7A"Z\8Q>'+>6[FDEN!;1WD<2M;O(>  P;<06^7=MQGG.WYJZ3_A._!_\
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M-@@'T?17S!\./C?>>'/M%GXHEOM4L7W2I-N,]RLAV +NDD $> QQUR?>N_\
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MOZ*\/^"GQ,\2^+O$-YHVN7$%W'':/=+/Y"QR AXU"_)A=OS$_=SD]<<5[A0
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MW#3H]K,Q25R7D7*QX(#,P&,\ <GK72?\+M^'G_0P_P#DE<?_ !N@#P#XV_\
M)7M=_P"W?_TGCHK/^*6MZ=XC^(^K:MI-Q]HL9_)\N78R;ML**>& (Y!'(HH
MW/ M_#XY^--KK'B?4X[.YDN$N81&@59IHROE0@GA1A0.<EMNW.Y@:/COJM]>
M_$^_L+BYDDM+!(DM83]V(/$CM@>I8\GKP!T  N>&?A%XVTCXAZ7)<:/NM;#4
M+>>6Z2>/RVB$OWE)()X0G;C< 1D#(SN?%;X4^,/$'Q#U#6-'TV.\L[M(F5UN
M8T*E8U0JP=E.<IGC(P1SG( ![GX4TRST;PEI.G6$T$]K!:1JD\"A4G^4$R
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MSD<GC."-CX6:3#J7CJRN[O4[33K/2734;BXNG"KMCE0!020,LS(O)'4GDX!
M.?TWQ+KVC6[6^EZWJ5C SEVCM;IXE+8 R0I S@ 9]A5S_A._&'_0UZY_X,9O
M_BJ^VX)X;JWBN+>6.:"5 \<D;!E=2,@@C@@CG->!_M-?\RM_V]_^T: .P^ ^
MN:IKW@&XEU:_GO9H-0DACEG?>^S9&V"QY;EVZD^G0 5Z)J6K:;HUNMQJFH6E
MC SA%DNIEB4M@G +$#. 3CV->5_LX_\ )/-0_P"PK)_Z*BK0^,WP[U3QWIVF
MS:1-!]JT[SC]GF.WS@X4X5N@;*  ' .[DC'(!S_B[]HG3K/=;>%+/^T)N/\
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M HKP>^_:7LX[R1;#PQ//:C&R2>\$3MP,Y4(P'.?XCZ\=*K_\--?]2C_Y4O\
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M/)M&N?-\CS<X=%VXW+_?SG/:O3_^&9?^IN_\IO\ ]MK _9Q_Y*'J'_8*D_\
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M'>6\-QL\T1R O"S+D%24P>H^M>J>'OC_  Z-\/H-+?2)'UJQMUM;5EQ]G=5
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M5MKJ2OIGUJG!\&/B#<V\4Z>'9 DB!U$ES"C $9Y5G!4^Q ([T >A_P##,O\
MU-W_ )3?_MM'_#,O_4W?^4W_ .VUQFF_"CXJZ-<-<:7IUW8SLA1I+74X8F*Y
M!P2L@.,@''L*N3>#/C5:?:+]GUSS!$!(\6L!Y'1-Q"X64LV-S849Y8X&30!T
M_P#PS+_U-W_E-_\ MM,G_9FF6WE:W\5QR3A"8TDL"BLV. 6$A(&>^#CT->=^
M"O%GB2X^(>@^?X@U67[3J%I!/OO9&\V,2C"-D_,OSMP>/F/J:^H_B!JJZ+\/
MM?OVN9+5TLI$BFCW!EE<;(\%>0=[+SVZ\=: /D3P)_R4/PU_V%;7_P!&K7V_
M7QQ\'[&WU#XKZ!#=1^9&LKS ;B,/'&\B'CT95/OCGBOL>@#YP^,GQ"\8Z-\0
M)-+L;^?3K"T\B>U$,>SSSMR69B/WB[BRE?N'9@@D&O(]?\1ZOXIU1M2UJ^DN
M[LH$WL H51T"JH 4=3@ <DGJ37W77RY^T5!##\1K5XHHT>;3(GE95 +MYDBY
M;U.U5&3V ':@##\*?$+699=)\*ZW?P77A:66.TN;:^C0HL#, 3YF Z[ =RG<
M-NU>PQ7O]G\._ACH-F=;&E:4MB\2G[5>W!G@V.1M8&5F3D[<,/7 /-</XV\!
MZSXS^%G@&;0X/M-U9:?"C6^]$RDD$9+[G8#@Q@8YSN]J\X_X4E\0_P#H7O\
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M>'-7\4ZHNFZ+8R7=V4+[%(4*HZEF8@*.@R2.2!U(KK/^%)?$/_H7O_)VW_\
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M. *C\-7D.H_%S2+VWM([."XUV&6.VCQMA5IP0@P , ''0=.@H ^TZ\_^-O\
MR2'7?^W?_P!*(Z] KS_XV_\ )(==_P"W?_THCH \D_9OGF7QUJ=NLL@@?3&=
MXPQVLRRQA21T) 9@#VW'UKV?PK\*_"G@_5)=3TRRD:\9W,4MQ(9# C8^1.P
M&1N.6P2"Q!KQ3]G'_DH>H?\ 8*D_]&Q5]/T %%%% !7R1>WUQJ'[1BS74GF2
M+XECA!V@82.=8T''HJJ/?'/-?6]?('_-PO\ W-?_ +=T ?7]%%% 'R!\;?\
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M3=3E'D$1;BETVU5R1SM8 *>#@A>@W&OI^@ HHHH *Y_QW_R3SQ+_ -@JZ_\
M135T%<_X[_Y)YXE_[!5U_P"BFH ^-/#FOWWA;Q!9ZUIK1B[M7+)YB[E8$%64
MCT*DCC!YX(/->B7_ .T)XPOM.N;/[+I5OY\3Q>=;QS))'N!&Y&\SAAG(/8UR
M?PTT"Q\4?$/2-'U-9&LYWD:5$;:7"1L^W/4 E0#C!P3@@\U[WXL^$'@33/!N
MN7]GH7EW5KI]Q-"_VN<[76-BIP7P<$#K0!\\>"?#'_"8^+['0/MGV/[5YG[_
M ,KS-NV-G^[D9SMQU[UZA\2?@Y9^$_AU!J.FWOG2:?+OO9)XP'G\WRH_D*CA
M59<A&SC>WS9Z\?\ !+_DKVA?]O'_ *3R5]=SP0W5O+;W$4<T$J%)(Y%#*ZD8
M((/!!'&* /GCX!?$%;&X/@_5)XTMYW,EA++(W$I(S",\ -RPZ?-D<EQBW^TU
M_P RM_V]_P#M&O+/%^D-\/?B1=6.EWDCOIEQ%/:SR(I93M65,CH2N0.F#C.!
MG%=9\:_%G_"21>$8I$@^U)I27UR87R$DN%1C'MY*X"!ADDD./J0#U?X Z9]@
M^%\%SYWF?VA=S7.W;CR\$1;<YY_U6<\?>QVR?4*X?X/V-QI_PHT"&ZC\N1HG
MF W Y221Y$/'JK*?;//-=Q0!A^)?!^@>,+>"#7M-CO$@<O$2[(R$C!PRD'!X
MR,X.!Z"O._%G@;X/^"M.6\UK2O*\W<((4N[AY)F49(51)]!DX4$C)&17<?$3
MQ)>>$? FI:Y81P275KY6Q)U)0[I40Y (/1CWKY8\=?$?6/B!]@_M:VL8?L/F
M>7]D1USOVYSN9O[@Z8[T >G^&_B%\(/"/F:SH>BZK:7\F;5H/GDD,1PQ;YY3
M'MRH'WMV1TQS7$>/_C!?^/-.?2Y]&L;:P$J30?/(\T3J,$[PRJV<L.4Z-Z@&
MO-ZZSPKXGT#P]92M?>#[36-4#NUO=7=RQBC!0*%:#!5P#D\X//!& : ,OP]X
M5UWQ7>&UT/3)[V1?OE  D>02-SG"KG:<9(SC YKZ#^&'P2A\-W%KKWB)H[G5
M$0/#9A08[23).2V2'<#&#T4YQNPK#A/^&CO&'_0-T/\ [\3?_':Z/P'\>M5U
MSQC8:1KUEIL-I>OY"2VL<BLDK?<SEFR"V%Z#&X'. <@'OE%%% !7C_[0WAO^
MT_!=OKB2;9-(E^9"V T<I5#@8Y8,(\<@8W=3BO8*CG@ANK>6WN(HYH)4*21R
M*&5U(P00>"".,4 > ?LY>*X87U#PI<&-'F<WMJQP"[;0LB<GD[55@ .@<D\"
MO6_B%XL_X0KP7?:S&D$ETFV.VAF?:))&( ]VP,L5')"GD=1\R>.O!FI_"[QC
M;W%I))]D%QY^E7DGELS&/8W*@GE68#D -C.,'%4_&/CSQ!\2M1TZ.^MX#)#F
M*UM;&%OF=R,X!+,S-A1C/88&2<@%CX1^'KCQ#\2M)2!MD=A*M_.^ =J1,"."
M1G+;5XSC=G! -?8]>=_"#X?S>!/#4QU#R_[6U!UEN0C$B)5'R1YS@E<L21W8
MC) !/HE !1110 4444 >!_M,SS+;^&K=99! [W+O&&.UF41!21T) 9@#VW'U
MKSS1_%WBGPQ\+!%HK?9+&]U6XCGOH@3(&\B+$>2N(\@E@P.XE3C;M.ZY\=?$
M,VL_$BZLA<QRV>EHMO L3EE#%0TA/)&_<2IQC[@!Y%?0>A>"=._X5?IGA35]
M/_T?[)%]LM?.;_79$C_.K9_UF3P<=AQ0!S?P=^*,WC>WN-+UAH_[:M4$@:*$
MJLT("J7/)&_<>0 H^88'7'FG[1W_ "4/3_\ L%1_^C9:X^]M;SX6?%!8OM'V
MJ;2+N.7? YB\^,A7VD\[=R-M8<CDCYAUV/CK#;Q_%?4G@NO.DEB@>=/+*^2_
MEJ F3][Y0K9']_'4&@#Z3^'T$-M\.?#:011Q(=,MW*HH4%FC#,>.Y8DD]R2:
MZ2N?\"?\D\\-?]@JU_\ 12UT% !1110!\P?M#>)/[3\:6^AI'MCTB+YG*X+2
M2A7.#GE0HCQP#G=U&*[_ /9Q_P"2>:A_V%9/_145>0?&W_DKVN_]N_\ Z3QU
M[7^S[9PVWPR$T5W'.]U>RRRQKC,# *FQN3SM17YQPXX[D ]4HHHH **** /B
M#P)_R4/PU_V%;7_T:M?;]?$'@3_DH?AK_L*VO_HU:^WZ "BBB@ KY0^/VF?8
M/BA/<^=YG]H6D-SMVX\O ,6W.>?]5G/'WL=LGZOKYP_:4NK-_$.AV:6^V^BM
M'EEFV ;XW?"+NZG!20X/ W<=30!Z'\"-;FUCX96\,_F%].N)+,2/(7+J '7K
MT 60(!S@*/H/3*\?_9Q_Y)YJ'_85D_\ 145>P4 %<WX^\2S>$/!&IZ[;V\=Q
M/;(@CCD)"[G=4!..2 6SCC.,9&<UTE4]5TJQUS2[C3-3MH[FSN$V2Q/T8?S!
M!P01R" 1@B@#YL_X:.\8?] W0_\ OQ-_\=H_X:.\8?\ 0-T/_OQ-_P#':]?_
M .%)?#S_ *%[_P G;C_XY4<_P9^&UK;RW%QHD<,$2%Y))+^=510,DDF3  '.
M: /!/&/Q@\2>-M#_ +(OX;&VM3*LK_8UD0R;<X5LN05R0<8ZJI[5'X*^+.O>
M ]&FTO2[339H);AKAFNHW9@Q55P-KJ,80=O6L?Q:=#U+QC+;^#=-DCTTNL%I
M&@E>2X;INP[,V68D #'&W@'-;GQ#^&5QX%TG0[]Y)Y/M\0%S$\8(M9Q&A9#(
MI*MEC)CIPG5L$T =!_PT=XP_Z!NA_P#?B;_X[1_PT=XP_P"@;H?_ 'XF_P#C
MM;'PA\-?#SQSH;VVI:) -=L^)D2]N%,\?&)@N_ R3@A<@'GY0RBO1_\ A27P
M\_Z%[_R=N/\ XY0!R_PJ^+^M^-_%LFD:M9V,4/V1Y8VL[>7.]67[Q+,%7!;D
MXYVC.2 ?:*YOPUX!\+^$+B>XT+28[6>= DDAD>1MH.< NQ(&<$@8S@9Z"NDH
M \CG_9U\&S7$LJ7>LP([EEBCN(RJ G[HW1DX'3DD^I-1_P##./@__H):Y_W_
M (?_ (U7L%% 'E=G^S[X(MK>ZBF&I7;S)MCEFN0&@.#\R;%4$\@_,&' XZY^
M:/#6FPZSXJTC2[AI%@O;V&WD:,@,%=PI(R",X/H:^ZZ^(/ G_)0_#7_85M?_
M $:M 'T7J7[/O@B^N%EMQJ6GH$"F*UN0RDY/S'S%<YYQUQP..N:?_#./@_\
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M/_"0^$M)U<O \EW:1RR^0<HLA4;U')QAMPP3D8P>:\W_ &CO^2>:?_V%8_\
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M>I8]2>_- 'LG[0^NZ/K?_".?V3JMC?\ D_:?,^R7"2[,^5C.TG&<'KZ&M?X
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M:^WZ^4/AY\,_%/\ PLK3!J.CWUA;Z==BYGN9H#Y?[IMP56)"ON8!05)X.X9
M-?5] '%_%K4IM*^%?B"X@6-G>W%N0X)&V5UB8\$<[7)'OCKTKQ3]G'_DH>H?
M]@J3_P!&Q5Z_\;?^20Z[_P!N_P#Z41U\Z?##QQ#X!\5/JEQ8R7<$]N;618Y
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M "2M_P#XW7U_10!\B0?''X@PW$4KZU'.B.&:*2SA"N ?NG:@.#TX(/H17O\
MI'@?P?XB?2_&[^'XX-4O4@U/<EQ( DI57!PI"DYY)V_,<DCDU\^?&W_DKVN_
M]N__ *3QU]/^!/\ DGGAK_L%6O\ Z*6@#H**** .;NM5\&^$=49+FYT;2+_4
MG\R7/EPO.?G;?(>#C(?YFXR<9R<'YX\??!T>#;B.Z37K232Y79MDTD<=VL8)
M+;$=E68JNW[K LS ;1UK#\9:S_PLSXH++ICSQPZA+;V=FE\<>3D*F"%+;5WE
MFXS]XG&35CXP6G]E^+[/1O[4^W_V7I5I9?\ 'OY7D[(_N]]V<^9G)QYFW/RT
M >MZ3\/_ (/'PK8ZC<7&FW,&R."34)-2D@66;8&(*F4!'(^;9U&>G%8\_P"S
ME8ZE<2W^E^*HXM/N7,UK''9^<JQ,<H _F_. I'S=^M8'A&Z^"EUX:M#XCT^2
MRU:-!%<!I;MQ*P S(IC. &ZXXP<C& "=O_C'C_/]H4 <Q\7/ASH7@K3M*ET[
M5(/MWE0P7%CD^9,V)-UU@N2JDJ%V@;0>]=)^S-&QN/$LHFD"*ELIB 7:Q)EP
MQXSD8(&"!\QR#QC'\5V7P4O=&*^']7DTR\B?S2\=I=W#3*%;]V%D95!)*\DC
MIU )K;^!WB?P5H=Y<:%;7E\=2U.4%;N]ME@23:,)" LK@-EG(/&=V.NT$ ^@
M***\;^,/Q9AT"WO_  MHSW::XR1K)=1@(MLK#<<,>2Y7'0<;\A@RXH P_P!H
M'Q__ ,R7ITG]V34RT7^Z\2*Q_!C@?W1G[PKPBPL;C4]1MK"SC\RZNI4AA3<!
MN=B HR>!DD=:] ^%_P /;SXB^(9M1U-YSID$HEN[F4%_M4A=6:+=N#;F4L2P
MR1QG[PKF_!<BS?$OP]*D,<"/K%LRQ1EBJ S+\HW$G Z<DGU)H W/#7B7Q+\)
M/&BZ?J#3PV\,JG4--$BRHR.%)90&V^9LVD,".@!.,BJ_Q>OK?4_B=J=_9R>9
M:W45K-"^TC<C6T14X/(R".M>I_&?X4ZGXB\06NM>&--DNKNY1EU#-S&B@H$6
M-@'8<E<@XX^4< Y)\0U/1;[3?%B:/XHGDL9XG@AN97/V@V\6U=I^4G<%C*X4
M'H .* /N.OD#_FX7_N:__;NOI_\ X3OP?_T->A_^#&'_ .*KY<@GANOC[%<6
M\L<T$OB@/')&P974W6001P01SF@#[#HHK/US6;/P]H=[J]^^RUM(FE?! +8Z
M*N2 6)P ,\D@4 >=Z)\=_#FL^,?["6UNXX)[A+>QO<96=CQEDX9 6P%ZYW9;
M9S7S1X:U*'1O%6D:I<+(T%E>PW$BQ@%BJ.&(&2!G ]16AX%UW2/#?BJUU36=
M)DU&"!T>-8YS&T,BNK"48X<@*?D) .>374>'/&6FZ=\5]9\3P:W=Z;I]P\MT
M5?3UEENE:59&M=H9@A;D"3</N@\9P #/^*WCNQ\?>)8+_3].DMH+>W$"RSG]
M[*,EOF4,54 LV,<\DDG("\/!!-=7$5O;Q233RN$CCC4LSL3@  <DD\8KW"'X
MA_!^#Q*?$*>$]9.J&X:Z\YP''FL22^QIRN<G(XX.",8%>?\ B#QQ#JOQ9_X3
M*WL9!!'>V]Q';22 ,ZP[  2 0I8)GOC/?&2 6/AAXM7X>>.GGU2RD"2(;"Z$
MA9&M094+N5VDDKL/RX!J.POK?4_CK;7]G)YEK=>)4FA?:1N1KD%3@\C((ZUZ
M/<_$SX2ZWXML]=O_  ]JL>IQ2Q%;YD"!"C J[K'+\VWC^%C@ 8. *\TU37]%
MA^,;>(].:[GTE-82^W.H$C@2!Y"H.."V[:#@XVYP<T ?9=>?_&W_ ))#KO\
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M%^^Q';&.>E=QXV^!?_"'>$+[7_\ A(_MGV7R_P!Q]A\O=ND5/O>8<8W9Z=J
M.;^$WC73? ?BJZU35(+N:"6R>W5;5%9@Q=&R=S*,80]_2NT^)7Q7\'^/?"3:
M5';ZY;744HN;9V@A*&1590K_ +S.TAB,CD<'G&#Y_P##CP+_ ,+ \0W&D_VC
M]@\FT:Y\WR/-SAT7;C<O]_.<]JK^/_!=QX#\4/H\\_VF,Q)-!<; GFHPP3M#
M-MPP9>3_  YZ$4 ?2?P4\-3>&_AS:F>XCF?4W&H@("!&LD:;5R>IVJ">G)(Y
MQD]QJNE6.N:7<:9J=M'<V=PFR6)^C#^8(."".00",$5E^!/^2>>&O^P5:_\
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M'/3YD4\>GIFN$\=_!#7[OQY<R>&=*M(]%NW1T9;A42W) #[E)W !MS80$ $
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M)K6XY>UNU9XP_'S@!@0V!C@\C&0<#'8?\-'>,/\ H&Z'_P!^)O\ X[0!Z?\
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M_MWCN;6.,G=N5L,0,_,?+:0;><YX!.*\8_9\\1PZ1XUNM-N[Z.WM]3MPD:.
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M96\^6GM+EF1(G]8]JM\IY^7C;VX("^J>!O!ECX%\-1Z/8R23$N9KB=^#-*0
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M@;H?_?B;_P".T?\ #1WC#_H&Z'_WXF_^.UZ__P *2^'G_0O?^3MQ_P#'*/\
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M1IWNFZR:D J1\C^%&)?(W?Q+C@\]*\P\0_%SQKXAO!.^LSZ?&GW(--=K=%R
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MNBBB@ HHHH **** ,.?P7X5NKB6XN/#6C33RN7DDDL(F9V)R225R23SFH_\
MA!/!_P#T*FA_^"Z'_P")HHH /^$$\'_]"IH?_@NA_P#B:V+&PL],LX[.PM(+
M2UCSLA@C$:+DDG"C@9))_&BB@"Q6?J>A:/K?E?VMI5C?^3GR_M=NDNS.,XW
MXS@=/0444 :%%%% !1110 4444 %%%% !1110 4444 %%%% %>^L+/4[.2SO
M[2"[M9,;X9XQ(C8((RIX." ?PJQ110 4444 1SP0W5O+;W$4<T$J%)(Y%#*Z
MD8((/!!'&*KZ;I.FZ-;M;Z7I]I8P,Y=H[6%8E+8 R0H S@ 9]A110!<HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML?+NQNV_+G'%;%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% $<\$-U;RV]Q%'-!*A22.10R
MNI&""#P01QBB""&UMXK>WBCA@B0)''&H544#   X  XQ110!)1110 5'/!#=
M6\MO<11S02H4DCD4,KJ1@@@\$$<8HHH CL;"STRSCL["T@M+6/.R&",1HN22
M<*.!DDG\:L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!7L;"STRSCL["T@M+6/.R&",1HN22<*.
M!DDG\:L444 %%%% !1110 4444 %%%% 'R!\;?\ DKVN_P#;O_Z3QT444 ?_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  D@# 2(  A$! Q$!_\0
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M*YGCRK8) 8'((SP017&?LS1L;CQ+*)I BI;*8@%VL29<,>,Y&"!@@?,<@\8
M/H.BOF3XP_%'4KSQ8-.\.:Q);Z?8( +K3+YL73.JL260X(7[H'."&YYP/?\
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M;_\ ;:X#XF_#+_A7/]E_\3?^T/M_F_\ +MY6S9L_VVSG?[=*Z#_AH[QA_P!
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M4J;E=JHI4LVQ2@7IQD$\Y !\(G^(/C*YN)9W\5:R'D<NPCO9$4$G/"J0%'L
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MS#([$CO7U'7-^!O!ECX%\-1Z/8R23$N9KB=^#-*0 6QG"C"@ #H ,DG)/24
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M^BQP([A6EDO(2J G[QVN3@=> 3Z U]+^!O!ECX%\-1Z/8R23$N9KB=^#-*0
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M_P#;O_Z3QT =AH7[/']M^'M,U;_A*?)^W6D5SY7]G[MF] VW/F#.,XS@5?\
M^&9?^IN_\IO_ -MKV#P)_P D\\-?]@JU_P#12U\R>/\ Q=XZT[QYK-K>Z[J5
MA*EP2MM::@XBCC(!C"[=H(V%>=H)ZL 2: ,?PU9PZ=\7-(LK>[CO(+?788H[
MF/&V95G #C!(P0,]3UZFOM.OCCX3^&-4\1>/M+FL(-UOIMW#=W4[\)&B.&P3
M_>;:0!W^@)'V/0!X_P#M'?\ )/-/_P"PK'_Z*EH_9Q_Y)YJ'_85D_P#1455_
MVC[/5)_"6F7%L=VF6]V3=H$R0Y7$;DXX49=3R.77@\8L?LX_\D\U#_L*R?\
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893%=3-DW#H1YC9/+<N,MW.1G(."@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "H *$# 2(  A$! Q$!_\0
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M)<17'VAP J;5\P$-@!<#.<#@')(!H?\ #1W@_P#Z!NN?]^(?_CM'_#1W@_\
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M6+2_O!;[X]*M9V1OOD H RO(3@ '"J/FSD#< #J_^&CO!_\ T#=<_P"_$/\
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MC'!&N059\&8LV5.!N P"<C.-OJ<'[17@V:XBB>TUF!'<*TLEO&50$_>.V0G
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MQT8CO7F=]^S=X;DLY%L-9U6"Z.-DDYCE1>1G*A5)XS_$/7GI7M%% 'S_ /\
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M3:7I=IILT$MPUPS74;LP8JJX&UU&,(.WK0!S=]9:[X)\1R6LSSZ9J]IC)@G
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M>BZO"F^UL)98KC )*>;LVL<# 7*8))'+*.<T44 <9X&^!5]XM\-1ZQ?:I)I
MG<FWB>S\PRQ8&)/OJ0"2< CD $<$5T?_  S+_P!3=_Y3?_MM%% !_P ,R_\
M4W?^4W_[;7.>.?@5?>$O#4FL6.J2:N('!N(DL_+,46#F3[[$@$#( X!)/ -%
M% ';_LWZ)-:>&M7UF7S%2_N$BB1HRH*Q _.K?Q M(R\#@H>?3VRBB@ HHHH
M\S^(WP=L?'FJ6VIP7T>EWBH4N95M?--P.-F[YU&5 (SR2"!T45Q?_#,O_4W?
M^4W_ .VT44 '_#,O_4W?^4W_ .VT?\,R_P#4W?\ E-_^VT44 '_#,O\ U-W_
M )3?_MM=I\-OA!#\/M9N]4;69-0GFM_LZ*+<0JBE@S$_,Q)RJXY&.>N>"B@#
+TRBBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_018.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_018.gif
M1TE&.#=A-0(/ '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MG)R1D9&:FIJ2DI*4E)25E967EY>,C(R0D)"3DY.&AH:6EI:!@8&(B(B+BXN
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M@,A 8^!8!#&TX&A!/@/5<L5;%"GR+2( Z,!7+2[L , !#Q2-  0&/H#-0,$
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MB'#(X3G_@,$/BA"#'\3@!B?HP0],5 !:360-(: & /C@CFY6*DI6 ("T @$
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M42 0A/\;'Q"![/YABLHZ#P!7>&_^J@" !1C !/TX0!=5 0!>H( 3_Q#0C0@
M" -T0R"L4I- 7M& "$   YB01(8=@ %3#.0:C^A$%2G299O^XQXST$$,:U ,
M \"H)+D P"+0X8U:>^,Q-PU&,+QQ#WU$(!*A"  -X)$,W\BC  "X 0SXLP<(
MW& +,P! ;@6BQP!0YQ_S($#@ I3L?QBB" CXP1*L(8 ;# 0/LH% "F1C AZ(
MJ !'$@@-;E0#$D1@V0> 00.N,%%78",:M",%-:0AC6UP(QK]J,BZ00<H0@
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M#]@E!2,@$& 0!J\P#*80!9(P4=%5![SA$L:0<_,$  E@>SN@#,Z0  "P"__
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M 5ME 0N !T+P!A6C983Y#_3A8O^P#_/F$@+Q5S_@J"8B"/^@!09P#0(12&:
M C+PHBY#$/2P.\?%"T%6"W @5QNG@V9  PR 2T2Y 17 "<BV(P*1"0;@$+1S
M 3BP;@"0/$&V">@P!ZP' D;P#QA@3@+1,@SP)W00L71 !0!0#0\Q#Y4  K)!
M!7E !YO060)A#P-P &P0![>3!AV@ /W@)UUB#T! "7\@&Q3@+#<RLQ+_H ^Y
M6 1!< 3_L !^IPKK)045T"*TT =&&P9[X  <  9V$ 9&2P< -&]%$GG.^G<
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M J$+K"(;(E $6P %38!L\?</]F B-[("_\ Z>M / )"Z Z$$S[<$79 $$*
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M(0YO07=_563B\&,#$0(:\ [+=RIA\ $. )84D391_U@BTS80N" 'KU 13'
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M"&L  /GY$"6P7@[@4/Z0QR7Q AF0A3::>0^A!I7%&%M  :;6!*SG PHP$5Z
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M"(!W!<]]N")1XAT4[=B(^L=M#K ,/F3R C"AWS]A #P0DYB( !8S'EC\:P1
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MOT0/ $)DRD6._?[IYXUAM&$B 7@.!,"3:'BH@)M- /@ @ H8V4>B6@#HQ28
M=+ G-A#_E"DH&R...&,, +H@ H("ZB#B"%\DRD(N!FZ,1!M/64! '78VB,&@
M=F:P )]_"IB#L+:H*:@<:R*1(!S"* *A"B64^**'#3KZQYX'OFS!'5&Z\2<&
M%\11R8!Z?"D$E0!6$*406&PU: TL9-IGF@UP\&@8*0#8P1B#" 2@#B[_^D>
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:]X];Z (:'OU,5Y*!"L+8@Y<R004C?A00 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !,!6$# 2(  A$! Q$!_\0
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MXY@%"X;;$RCDDG#X.,80\YX /?**\3^#VIKX-^%9UWQ-K\<6BW5P18V[*S&
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M^AA_\DKC_P"-UJ:!\2_!_BC5%TS1]:CGO&0NL30R1%P.NW>H!..<#G )Z T
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M)/H%!P!C[QSGC'I_P8GFN?A)H+SRR2N$E0,[%B%69U4<]@H  [  4 =Y6/\
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MY&>M %BBBO-_B?\ %BW^'\MG8V]G]MU.?;,T3DHB0;B"2V/O-M91C..IZ ,
M>D45\_\ _#37_4H_^5+_ .U4?\--?]2C_P"5+_[50!] 45\__P##37_4H_\
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M#A2Q+8Z9.>M>(>._^2A^)?\ L*W7_HUJL>)/AWXJ\(Z='?ZYI7V2UDE$*O\
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M#\T>'K/4O'WQ-A6"[CT_4-2O9+LW$6X"!LM*S)@YR,':,]<<CK7VG0!\@?\
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MOAGO8XW7,\A&5)R,@@_C7@GBOX;^*/!EN;O6;&..S-Q]GCN8YT=9&PQ! !W
M$*3R![X/%7/#?PE\7>*M'MM6TZS@^PW$HCCEEN$7*[F5GQG.U2N#QN.1M#<X
M /7]3_:/\/VVHQ0Z=I-]>VHE*3W#,L6$! #QJ<E\C)PVSMG&3CA/BS\7--\>
M:-:Z1I>FW<,$5PETUQ=,JL6"NNP(NX8PX.[=ZC'>O2_#'P$\*Z?H<,7B"U_M
M34S\\\RSRQHI/\"!67Y1ZD9/)XR%'(?&OX=^%?"/@VSO]#TK[)=2:@D+/]HE
MDRACD)&'8CJH_*@#/^%OQET?P9X7;1=6TF?]W*TD<]A&A:;<<GS0S+\PX 89
MRH P-N3T<W[2VFKJ@C@\-W;Z?O4&=[E5EV\;CY8!&1S@;^<#D9XR/@G\-_"_
MBSPK?ZIKMC)>3K>FWC4SO&J*J(V1L())+G.2>@QCG/E_C_1;'P]X\UG2M,GC
MFL[>X(BV'(C! ;R\Y))0DH23G*G.#Q0!]IV%];ZGIUM?V<GF6MU$DT+[2-R,
M 5.#R,@CK5BLOPUILVC>%=(TNX:-I[*RAMY&C)*ED0*2,@'&1Z"J?C'QCI?@
M?0_[6U;SVA:588XX$W/(YR<#) ' 8\D=/7 (!<U_PYI'BG2VTW6K&.[M"X?8
MQ*E6'0JRD%3U&01P2.A-?+'CWX9ZUX \2VKZ8;NYL[BX4:;=P ^:)<Y6,[>1
M*#T(^]C(Y!"^EZ9^TIH\OF_VMX?OK7&/+^R3)<;NN<[MF.W3.<GICGK/"7QG
M\,^,?$$6BV4&I6]W,C-%]JA4*Y4;BH*LV#M!/.!P><X! ,O4OBU+X"TS2-,\
M96$]SXCEM([BY-D$$05I&4Y.[_6!5)(4;2W (!R-SQIH&B_%#X?-=6"QW\OV
M=[C2KB%@K"7!PN6Z!F 5E;&,<X*@CSO]I'PW_P @GQ0DG_4/EC9O]^1"HQ_U
MTR2?[N!UKM/@1JMC>_#"PL+>YCDN[!Y4NH1]Z(O*[KD>A4\'IP1U!  /GCPE
MJ^M> ?B#$]O9R3:A;7#6<]@CD^>2=C1?)G<=W3[PW!3@XKW_ .+GQ6N? 5QI
M^G:3;VEQJ%PAGF^U*Y6.+)5<!2N2S!OXN-AR/F!KM+7P/X:L?%$_B6VTB"/5
MYMQ>X!;JPPS!<[58]V !.6R?F.?FCXX^(;?7_B5<I:K^[TV(6!?)^=T9B_!
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MMREOXB,C@U]9Z5XF\ Z'I=OIFF>(?#]M9VZ;(HDU"+"C_OK)).22>222<DT
M>">%_@E>W%G)JGC.]_X1O3(O)D#3F,&5'/S DO\ N6'RCYUZMTXQ7T?X6LM"
MT_PY:6OAIX'TA-_V<P3F9#EV+8<DY^8MWXZ5XO\ '[QMX?UCP]IVB:5J4%_=
M?:UNW>TD66.-%1TP7!QN);H,\ DXR,['[.>CZI8^%]1U*Z?&FZA*ILXO-SRA
M=9'V]%R=J^IV<C 4D ]HKY\\7_'_ %[2?%6HZ7I>D::D%C<26K-=;Y6D9'9=
MXVL@4$ ?+@XYY-?0=</?_"#P)J>HW-_>:%YEU=2O-,_VN<;G8DL<!\#))Z4
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MYSM=8V*G!?!P0.M>$?"W1-.\1_$?2=)U:W^T6,_G>9%O9-VV%V'*D$<@'@T
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M]X[7)P.O )] : #XRZ7X<TWQ?:/X72T&GWED+DM:2^9$TAFE5BN"0!\N-JX
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M2(V"",J3@X(!_"J^B:WJ/AS6(-6TFX^SWT&[RY=BOMW*5/# @\$CD4 >W_\
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M%(7.YV<Y(D ZL>U>?W]]<:GJ-S?WDGF75U*\TS[0-SL26.!P,DGI0!]AZ_\
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MY)X['A<>++D^#Y)&T<HAC#(ZA6VC<%+DNPSSEL<D@# !/>>"?^%-?\(A8_\
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M-US_ +\0_P#QVO(/AE\,O^%C?VI_Q-_[/^P>5_R[>;OW[_\ ;7&-GOUKO_\
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M \5]GT >3^+/A!X$TSP;KE_9Z%Y=U:Z?<30O]KG.UUC8J<%\'! ZUXQ\$O\
MDKVA?]O'_I/)7T_X[_Y)YXE_[!5U_P"BFKY@^"7_ "5[0O\ MX_])Y* /HOX
MJ^%U\6?#[4;18Y'N[9#>6@C1G8RQ@D*%!&XLI9._WLX) KQC]G?Q+#IGBR[T
M&6WD=]813%,I&(VA61\,/0J6Y'0@<<Y'TW7R1\7O"?\ P@GCY+G27G@M;S_3
MK5XT\H6\F\YCC9<#Y"%(Q@J&4>Y /JO5M2AT;1K[5+A9&@LK>2XD6, L512Q
M R0,X'J*^0/#^FP_$KXL^1<-)8P:O>W%U((R':-?GE* D 9P-N['?.#TKJ/B
M!\8H?''P^L](%M=V>J&X22^$9 MY%4-P#NW$%MC;6'!'4X!/7_LZ^$IK.POO
M%5W#&!>H+>R<2$MY:N?-)4< %E0#//R'H#R >Z4444 >/_M'?\D\T_\ ["L?
M_HJ6N0_9XUW1]$_X23^UM5L;#SOLWE_:[A(M^/-SC<1G&1T]177_ +1W_)/-
M/_["L?\ Z*EKP#PQX)\1>,?M7]@:?]L^R[/._?1Q[=V=OWV&<[6Z>E 'U_\
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M8X#Y. #TH L?!+_DKVA?]O'_ *3R5]?U\@?!+_DKVA?]O'_I/)7U_0 5X_\
MM'?\D\T__L*Q_P#HJ6O8*\?_ &CO^2>:?_V%8_\ T5+0!7_9NFN&\&ZM"UKM
MM4U#?'<>8#YCF- R;>HVA4.>^_V->D>._P#DGGB7_L%77_HIJ^4/ OQ'UCX?
M_;_[)MK&;[=Y?F?:T=L;-V,;67^^>N>U=)JWQ]\5:SHU]I=QI^C+!>V\EO(T
M<,H8*ZE21F0C.#Z&@#+^"7_)7M"_[>/_ $GDKU_]H[_DGFG_ /85C_\ 14M>
M0?!+_DKVA?\ ;Q_Z3R5Z_P#M'?\ )/-/_P"PK'_Z*EH Y_\ 9E_YFG_MT_\
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M^.E '23SPVMO+<7$L<,$2%Y))&"JB@9))/  '.:P_P#A._!__0UZ'_X,8?\
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M/_2>2@#H/VCO^2AZ?_V"H_\ T;+7K_P2_P"20Z%_V\?^E$E>0?M'?\E#T_\
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M-&B:WJ/AS6(-6TFX^SWT&[RY=BOMW*5/# @\$CD5V'_"[?B'_P!##_Y)6_\
M\;H ]_\ "/P=\+>#=875K(WUU?1Y\F6[G!\K*LK8"!0<AB/F!Z#&*] KX\F^
M,_Q!G0(_B*0 .K_);0H<JP8<J@.,CD=",@Y!(KZ7^&FOWWBCX>:1K&IM&UY.
MDBRNB[0Y21DW8Z D*"<8&2< #B@#K*^(/'?_ "4/Q+_V%;K_ -&M7V_7Q!X[
M_P"2A^)?^PK=?^C6H ]__P"&CO!__0-US_OQ#_\ ':^=/$NI0ZSXJU?5+=9%
M@O;V:XC60 ,%=RP!P2,X/J:]K_X9E_ZF[_RF_P#VVO$-=TS^Q/$.IZ3YWG?8
M;N6V\W;MW['*[L9.,XSC)H ],T7X>>-_AW93>.WL[1+S27)6PFS.9(F1D>0^
M4V %#YQGH&)P%&[I_A-\9]3U?Q F@>*9X[A[U\6E[MCBV/CB-@ H(;&%(&=Q
MQSN&WWROD3XR^"X?!_C5C8I(-/U%#=0CR0B1,6.^)"."%X( Q@,H/J0#V/\
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MHNZ52_SON5F&=S@D<??X&!QXA\3/BBOQ%M].B.@QV#V3R,)3=-*Q#!<J/E4
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MD\GG)))R <F)YEMWMUED$#NKO&&.UF4$*2.A(#, >VX^M?4?[/VCZ79_#_\
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M/RG(!R.,XR,]?\-M:7P[^SY::P\$DXLK>ZF\I Q+D32X'R@D#/5L849)X!H
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M_,QMW[<8W8XSUQ7H'P7^'GBFT\=V.OW^DSV%A9><':\4Q.[-$4 5#\Q^^#G
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M>?RK>/A57EY7/1$'=C@_D22 "1\B>,_&>M?$?Q*D\\<A!?R;#3X,N(@Q "J
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M%8X[,LA Y W>I->">-?%^I?$CQ5#>OI\<<Y1;2UMK56=BN]BBGNSY?&0!GC
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MN'TK[7O[&WU/3KFPO(_,M;J)X9DW$;D8$,,CD9!/2O"Y_P!F:%KB5K?Q7)'
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M2AI-B]7D<]22>!DC+, 2,YH ^L_AWXDO/%W@33=<OXX([JZ\W>D"D(-LKH,
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M_P#'*] HH X_1OA9X)T#44O].T"!+I,%'FDDFV$$$,HD9@K @88<CUKL***
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?G XKWBO'_P!H[_DGFG_]A6/_ -%2T ?,%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_022.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$!U0# 2(  A$! Q$!_\0
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M]QUZ\4:9KNCZWYO]DZK8W_DX\S[)<)+LSG&=I.,X/7T->'_\,R_]3=_Y3?\
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MF?9]0V1R_:,. O[L2;EW+EN>F,5YOXJ\/7'A3Q1J.AW3;Y+24H'P!YB$91\
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M5>Z%%)?016[Q26QF2-8&W9WC>X!+@@' _P"68R>F/+/^%)?$/_H7O_)VW_\
MCE 'T_\ \)WX/_Z&O0__  8P_P#Q5'_"=^#_ /H:]#_\&,/_ ,57S!_PI+XA
M_P#0O?\ D[;_ /QRN3U_PYJ_A;5&TW6K&2TNP@?8Q#!E/0JRDAAU&03R".H-
M 'W77G?Q9^),WP]TNQ%C9QW&H7[N(3/GRHU3;O+ $$GY@ !CJ23Q@V/@Q/-<
M_"307GEDE<)*@9V+$*LSJHY[!0 !V  KSO\ ::_YE;_M[_\ :- 'J'PU\;_\
M)[X2759+7[-=12FVN44Y0R*JL63G.TA@<'D<CG&3V%>/_LX_\D\U#_L*R?\
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MX:O/$-CILD^EV3E+B9'4E" I/R9W$ ,"2!@#)/0X]4^#WQA_LK[/X9\37/\
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M&ZY (RI.1D$'\:^C_@CXGU3Q1X!,VKS_ &BXL[MK19V^_(BHC N?XF^<C/?
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M@7Q9X/TSP#X?LSX@T.TDCT^#S83>PQE9"@+[ESPQ8L3GG).>: /0*^>/AO\
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M7_5[<,0$)&3C)&00,&Y\$_ MQXF\6P:Q,)X=,TF5)_/11B6=65DB!/\ WT<
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MC@T_5SDHZN$@GRRJJ)N;=YAW8V\YVDYYP/./^&CO&'_0-T/_ +\3?_':-8^
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MU+' X&23TK[7H ***P_%'B[1?!VEO?ZQ>QP@(S10!@99R,#;&F<L<LOL,Y)
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M*1EMR?* 208R67JN 2!D4 ?/'P^^,NM>#WAL-0:34]%WJ&BE8M+ @7;B%B<
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M=7AT^QO;B#F%;U&=(W[. K+\P[9SCKC(!'KD/[14.G:6;+1_!5I8(B,($2[
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M,JHI)),3!B,9.WG/'&0*\S_X3OQA_P!#7KG_ (,9O_BJ] _X:.\8?] W0_\
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MK,_F7OBV[@T/3;?+S#S4DD*+@L=P)1%V[OF)."O*D4 <_P#&W_DKVN_]N_\
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M8[BXAMP+B_FG: NJ+R\GEE$S@<G P !P  //_"&A_!GQOK-]I>D:!=^?:H9
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MQIJ7AGP_8:;I;R6\^J.Y:\BF:.2%8BAPA7!RQ8 G/0$8.<CSS]G'_DH>H?\
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M=]R'^)?GVY_O*P[5[WX9U6QT/X4:%J>IW,=M9V^CVKRROT4>4GXDDX  Y)(
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MA\N,[FR2,X('&!A1QG)(!U'A3X<Z1H7P^'A:]MH[N.Z3?J(=RRRS,%W%3@$
M%1M( (VJ?O9->9_&#P-X!\&>"VEL-*^SZO=RI%9D7<CD8(9V*O)RH4%2<'!=
M>F<U] 5\V?M&Z_8ZAX@TO1;=I&N]+21KK*X53*(V50>YVKD]OF'.<@ %SX*?
M#OPKXN\&WE_KFE?:[J/4'A5_M$L>$$<9 PC =6/YUI_%;X:^!_"WP\U#4M.T
MR.TU /$EL[7DK%F,B[@JLY#'9O.,'@$]J[#X*>&IO#?PYM3/<1S/J;C40$!
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MLB!21D XR/05\4>)!I"^)=2&@R2/I/VAS:%T*GR\\#!).!T!/) !(!) ^ZZ
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MRX0,[!06:,JHY[EB !W) KI*R_$>@6/BGP_>:+J2R&TND"OY;;64@AE8'U#
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M I][ SGH*Y_X@?!.Q\;>(/[:M]5DTV[E0+=9@\Y92H"JP&Y=I"C![' X!R2
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M_:?,^R7"2[,^5C.TG&<'KZ&NC^!?B7PKHWP^>WN];M+&\:]E>XCOKJ*++84
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MJP8*&(QC&<"O7_!?[/=OI6HVNI>)K^#4&BRQT^&(F$N#\I9VP77')7:,G@Y
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M+=)O#>5("$"X'W?D1&P>?FST(KC/VEH-2:XT"X:*,Z6B2HDBJVY9F*E@Y^Z
M552HZG:_I7=_!'PQJGA?P"8=7@^SW%Y=M=K WWXT9$4!Q_"WR$X[9&<'( !T
MGC;QIIO@CP_/J5Z\<DX0FVL_.5)+ALJ,*#R0"P+$ X'.#TKY8TR#5_BO\38W
MO(I)I;ZX1[UK50@@MU*JQ&<A0J  $Y).!\Q//H'Q6^&OCCQ3\0]0U+3M,DN]
M/*1);.UY$H51&NX*K."HW[SC Y)/>O3_ (9_#.Q\ :67<QW.M7" 75V!P!U\
MN//(0'OU8C)Z * =98'2],^S>'[.>".2UM$,-GYV9%@7"*V"=Q48 W'OWS7@
MG[2>JV-UJFA:9!<QR7EDD[W,2\F(2>7LW=@2%)QUQ@]",Y_Q9^&WC"^\;ZUK
MUGI5WJ&GRO&T<T9C>0C8B[1&GSD*?E^[G"Y)/+'E_#WP?\::[<0%]$N[&S:X
M6*:>Z58FB7(W.(W968 '/'7! .: /:_V>;&XM/AK)-/'LCN]0EF@.X'>@5(R
M>.GS(PY]/3%>L5GZ%IG]B>'M,TGSO.^PVD5MYNW;OV(%W8R<9QG&36?XXM==
MOO!>J6WAJX\C5Y(L6[APAZC<%8_=8KN /&"0<CJ #YD^,_BY?%7CR9;.]CN=
M+L$%O:M"S%&. 9&&3@DMD;AP0B]< GZ#^$?AZW\/?#724@;?)?Q+?SO@C<\J
M@C@DXPNU>,9VYP"37@GPP^%^M>(?%5K=:AILEKI-A<"2Y:]MSMF*.0T(5L;B
M65E;LN#GG"GZSH *^?/VBO%S&XL?"ME>R!%0W&H11LNUB2/*5L'.1@MM.!\R
M'GC'T'7Q9H7ACQ'X^\:OIL[W<NH!Q]OGNWW2P1JRQNS"1@6*9 VYSQB@#VO]
MG/0[>W\)7NMR6&R^N;MX8[IT.7@54X4G^'?OSCJ5P<[1CRCXV_\ )7M=_P"W
M?_TGCKZSTG38=&T:QTNW:1H+*WCMXVD(+%44*"< #.!Z"OE#XS0377QGUBWM
MXI)IY7MDCCC4LSL8(P  .22>,4 ?3?@3_DGGAK_L%6O_ **6N@K'\)V-QIG@
MW0["\C\NZM=/MX9DW [76-0PR.#@@]*V* "N;\2^/O"_A"X@M]=U:.UGG0O'
M&(WD;:#C)"*2!G(!.,X..AKI*\+^,GPCU?Q'X@C\0^&[>.YGN$6*\MC*$;<H
MPL@+L%QM"J0,8V@X.20 >J?\)WX/_P"AKT/_ ,&,/_Q5?+'Q?O[/4_BEK-Y8
M7<%W:R>1LF@D$B-B",'##@X((_"K'_"DOB'_ -"]_P"3MO\ _'*[#X;?!+Q%
M;^+;35?$D/\ 9MKITL=S&B31R//(K;E4;2P500"2>3T'4E0#W/P7!-:^!?#U
MO<120SQ:9;))'(I5D81*""#R"#QBO&_VFO\ F5O^WO\ ]HU] 5XG^T3X<U?5
M]+TG4M/L9+BTTQ+A[QT()B5O*P=N<D?*Q) . "3@4 7/V<?^2>:A_P!A63_T
M5%7L%>7_  'T/5-!\ W$6K6$]E-/J$DT<4Z;'V;(UR5/*\HW4#UZ$&N@^*=C
MJFI?#/6[31HYY;Z2)0L<#8=T#J9%'KE PVC[V<8.<4 ?+GB_5V^(7Q(NK[2[
M.1'U.XB@M8)'4,QVK$F3T!; /7 SC)QFJ?B'PMXE\%2BUUFSGL/MT6,"5629
M P)4LA*G#*I*D\?*<=*]0^!/P\O)?$,WB'6])V6ECOBM1=J5<72N 6"'KLPX
MR>C8Q\RG;]%SP0W5O+;W$4<T$J%)(Y%#*ZD8((/!!'&* /E3X2_%5/ 7VVPU
M6*>?2)\S(EM$K2)/\HSDLORE1SG/*KC'.?2Y_P!H?P3=6\MO<:1K,T$J%)(Y
M+:%E=2,$$&3!!'&*W+[X%> ;NSD@ATN>RD;&)X+N0NF"#P'9EYZ<@]?7FN'_
M .&9?^IN_P#*;_\ ;: )/!7C[X/>']9FN]+TS4M$G>W:-KFZ$DJLI93L 620
MY) .<#[IY[$\:^/O@]X@UF&[U33-2UN=+=8UN;421*JAF.PAI(SD$DYP?O#G
ML(_^&9?^IN_\IO\ ]MH_X9E_ZF[_ ,IO_P!MH U-*^//@'0]+M],TS1-9MK.
MW39%$D$6%'_?W)).22>222<DU[)87UOJ>G6U_9R>9:W4230OM(W(P!4X/(R"
M.M>)Z5^S98VNJ6\^I^(9+ZSC?=+;):>291_=W^82!G&<#.,X(/(]P@@AM;>*
MWMXHX8(D"1QQJ%5% P  .  .,4 >!_M-?\RM_P!O?_M&O-/"'Q1\1^"-&OM+
MTAK3R+IS(&FAW-#(5VETY S@+PP8?*..N?;_ (Y>!-?\9V^B2Z#:QW3V;S++
M$9EC;#A,,-Q (&P@\YY'!YQT'PC\&7W@CP4+#4Y(S>7-PUW+$G(A+*J[-V<,
M0$&2.,D@9 R0#Y8\2^,-?\87$$^O:E)>/ A2(%%14!.3A5 &3QDXR<#T%?0?
M[./_ "3S4/\ L*R?^BHJZ3XF?#.'XBV^G*VJ2:?/8O(4<0B565PNX%<J<Y1<
M'/KP<\:'P\\#P^ /#3:3%?27KR7#W$LS1A 6(5<*N3@;57J3SD]\  KW/Q2\
M,Z?XWN?"FHW$EA=P(&-S=;4MV)17"A]W!VM_$ ,@C.2,\_\ %GQIH-U\,-:M
M])\2Z;->2I&BQVE^C2.IE0. %;)!7<"/3.>*YOQ[\!+_ %SQ1=ZQH&H6,4=]
M*TTUO=F1?+<@%B& ?=N;>W1<9 &1T\\@^!WQ!FN(HGT6.!'<*TLEY"50$_>.
MUR<#KP"?0&@#J/V;]*OF\5:GK MI/[/2R:U-P>%\UGC8(/4[5)..G&<9&?I.
MN/\ AKX(_P"$"\)+I4EU]INI93<W+J,()&55*IQG: H&3R>3QG ["@ HHHH
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M,?958.8ECWX+,I();>3@9P .<D@ '8:EX_\ "FC^(%T+4=<M+74"@<QRDJJ
M@D;WQL0D#(#$$Y'J,V-5\7:+I/A.X\3/>QW.EPIN\ZT83"0[M@52IP26^7K@
M'J1@FO(_C!\']9U_Q&WB/PXOVV:\V)=6CR)&8RJ!0ZEB 5(4 @G(/(R#\O ?
M\*A^)_\ 9W]G?V3/]A\WS_LW]HP^7YF-N_;YF-V.,]<4 9_PC\/7'B'XE:2D
M#;(["5;^=\ [4B8$<$C.6VKQG&[." :^QZ\K^#'PWF\':7-J.M6,<&O3O)'E
M9RY2W.S",%)3.Y"V1DX(YZ@>J4 >?^.OB]X?\#7ATZ9)[[4_*,GV>VVXC.,H
M)&)^7=[!B!SCD9^<->\2>*?BMXHLXI8_M-V_[FTL;52L<?'S%02<9QN9F/0<
MD*HQ[GX[^!L/C/Q9<Z]%K\EB]RB"6%K43#<JA,J=ZX&U5X.><\\X':>!? NE
M^ ]#%A8#S;B3#75VZX>X<=SZ*,G"]L]R22 ?(GB_PU-X0\3W6A7%Q'<3VR1&
M22,$+N>-7(&>2 6QGC.,X&<5[_-#X!\9?"CP_H^L>)-&M;^VTRW$,YO8A+:R
MB)0006!QD89#C..Q (/BS\&YO%=^_B'P_)&NJ.F+JVFD(6XVIA2AZ*^%5<'"
MG@Y7!+>2?\*2^(?_ $+W_D[;_P#QR@#K/@]I-OX0\:WVHZQXI\/VUI';O;H8
M=6MG%WEA@@9)"?+NYV-G;VW"N/A\8^(_'GB^'2]8UB[_ +/UR]@MKFTA?$4<
M;3)@1HV0A&U<-C/!R3ELR?\ "DOB'_T+W_D[;_\ QRO9_A;\'/\ A"-1;6M6
MO8+S4S$T4<<,>8[?)Y968;BQ4 9 7 9QSG- 'AGCKP+J_P -?$%N#<R- S[[
M#4(R(FD9 C,0JL60JS 9..F17T/\(/B!-X[\-3#4/+_M;3W6*Y**0)58?))C
M& 6PP('=2< $ =1XP\-0^,/"=_H,]Q);I=HH$R $HRL'4X/4;E&1QD9Y'6N7
M^&WPFL?A[<7=\=0DU#4+A/)$QC\I8XL@E0FXY)9022>P  YR =9?>+/#>F7D
MEG?^(-*M+J/&^&>]CC=<@$94G(R"#^-<WXP\4?#S6?"=_I^L>)M-DL)T59!:
M7BR2@[@5953<Q(8*>A''(QFO,/BM\*?&'B#XAZAK&CZ;'>6=VD3*ZW,:%2L:
MH58.RG.4SQD8(YSD#CX/@=\09KB*)]%C@1W"M+)>0E4!/WCM<G Z\ GT!H /
M#OCK2O &EZC_ ,(O'=WNM7Z>5_:.H6T<(M$&,"-%:0L22Q.6 RJ?*<'-SX5?
M#BX^(.N2:QK9GET:.5VN9S*"]S.-K&-CNWC(?<6QS@C()R._\,?LYZ=8WD-U
MXCU/^THQ%^\LH8VB3S"/^>@;<RCG& I/!.!D'V32M*L=#TNWTS3+:.VL[=-D
M42=%'\R2<DD\DDDY)H ^3/@_XQTOP3XREO\ 5_/%K<6AM=\*;_++21G<PSG:
M ISC)] :Z"P\5_#/2/B5JOBB6+7-5:2[>XM$:TB$<4C,6:09D!;DY3<JE0>0
M6 ([?Q/^SQI>L:Y-?Z1JW]D6\WS-:+:>:B/W*?.NU3Q\O..<8& ,?_AF7_J;
MO_*;_P#;: .0^,'Q'T?X@?V-_9-M?0_8?/\ ,^UHBYW^7C&UF_N'KCM7K?[/
M^E7VF?#EWOK:2 7MZ]U;[^"\1CC4/CJ 2IQGJ,$<$$\_I7[-EC:ZI;SZGXAD
MOK.-]TMLEIY)E']W?YA(&<9P,XS@@\CVRPL;?3-.MK"SC\NUM8DAA3<3M10
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M<8)D8I)"S#!*L/P.#E20,@X%2>%/"6D>#-&&EZ-#)' 7\R1I)"[22;54N<\
MD*.  /0"@#Y8^)GPSF^'5QIRMJD>H07R2%'$)B960KN!7+#&'7!SZ\#'/L?[
M./\ R3S4/^PK)_Z*BKN/&G@#0O'EG!!K$<XDM]WV>>"4H\6XJ6P#E3G8!\P/
MM@\UJ:!X<TCPMI:Z;HMC':6@<OL4EBS'J69B2QZ#))X '0"@#4KY_P#VFO\
MF5O^WO\ ]HU] 5X_\=/!/B+QC_8/]@:?]L^R_:/._?1Q[=WE[?OL,YVMT]*
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M?A_X,LWT73=8T/3HX97\R!M0CWB3.&WEFW%AC'S<C '0 5V%?,GCSX(>)/\
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MU')$?K]T]._O?@KXLZ#X\UF;2]+M-2AGBMVN&:ZC15*AE7 VNQSEQV]:I_\
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M/L*** +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GVNA:/8ZC/J-GI5C;
MWT^[SKF&W1))-QW-N8#)R0"<]3110!H4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
(? %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_023.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ Y0# 2(  A$! Q$!_\0
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MR<Q0ZA(BC)+.[$L%&6;))/+-ZGG8OOA#\3]3O)+R_P!)GN[J3&^:?489';
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ME0KJ 2" 3WVKZ4 ?9=%?,'_#1WC#_H&Z'_WXF_\ CM20?M(>*EN(FN-*T:2
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M?3]&:"RMX[>-I(92Q5%"@G$@&<#T%7/^&CO&'_0-T/\ [\3?_': /I^BN?\
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M1712"RE%8Y!5=H4# R!P.@!]'Z3IL.C:-8Z7;M(T%E;QV\;2$%BJ*%!. !G
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MEP1]T^V:KI5CKFEW&F:G;1W-G<)LEB?HP_F"#@@CD$ C!%?'GPX\=?\ "O\
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MDW [76=0PR.#@@]*^UZ .;\?:YJ7AKP1J>LZ3:QW-Y:(CK')&SKMWJ')"D'
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MJ+7]I36$U&=[SP_8RV)W>3##,\<B<_+N<[@V!D'"KD\\=*S_ -G'_DH>H?\
M8*D_]&Q5V^I?$3X/#7-4BNM"L;J:'?(UZNE12I=R]2J/R68DGYF 4X)W8()
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M2&9<8V Y!.<GICGB_B1XHL?&/C>\UK3K22WMYDC4>:,2.50*6<;F /&!MP,
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MMU72_#=I;3[P6>ZN6G4K@\!5"$'..<]CQSQY?XS\<ZUXZU1+[6)8P(DV0V\
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MG2,L=JLP 8@= 2%4$]]H]*N7NDW&CZPNGZU#/92+Y;3IY8:2-'57!V$CYMK
M[21SP<'./7+6R^#7C.POM/TI9/"VH*B/#>ZI,VW&\;MH:<HQQQ@D'YLC.#@
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M2: +E%>)R?M)Z"-4ACBT/4FT\IF6=F195;GA8\D,/N\EQU/''/>>"/B5X?\
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MM8 A,/)D!,[![*, # H [^/P-\$IDF>*71G2%-\K+K;D(NX+EOWO W,HR>Y
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97:%L@Y0D94Y4'(]!Z5<HHH ^ **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_024.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _"*\# 2(  A$! Q$!_\0
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MC)]37RI\;?\ DKVN_P#;O_Z3QU]/^!/^2>>&O^P5:_\ HI: .@HHHH ****
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MHH((W9'/4#.1D'T_XV?$#5_!.EZ9;Z+Y<-WJ+R'[4RAS$L>S(56!!+;P,G.
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MX8UR2ZNI7FF?^S91N=B2QP%P,DGI70:-=_&'0-@TZV\5I&D0A2&:REFC1!C
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M2-R=VS\QXX%<G^TO?_\ (NZ<EW_SWGEMED_W%1V7_OX 3_M8[UB?"#XF^&?
MOAK4K75+6[-_+<>>)+>!6,R815CW%@<@F1L'  W8.3@@'TW17C__  T=X/\
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M;?\ DKVN_P#;O_Z3QU['X-^#G@>^\%:)>W^DR75W=645Q+,]U*I+.H<C",
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M2,_/YH50R*.C'(QGJ#6)-^S?J2^)0(-5M'T'[0I)>1ENO)R-PP$*;P,@'H2
M<#.!U?\ PSCX/_Z"6N?]_P"'_P"-4 =1:ZY\+_#WGW^G7_A2RD6)@[V+P"1D
M')4"/YFZ#Y1G) XS7@GQG^(%IXW\06L&E^7)I>G(P@N0KJTS2!"Y(8 @ J%
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M=_)!)=6NS>\#$H=R*XP2 >C#M7:6WP+\7WWAJUUNP?3;I+JWBN(K9+AEE*N
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MDLV1QD^C_LX_\D\U#_L*R?\ HJ*KGQZ\+KKG@,ZK%'(UYH[^<FQ&<M$Q"R#
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M7S_^TU_S*W_;W_[1H Q/"/[0%]X<\-6FCW^B1ZB;1!##.MSY!\I0 JL-C D
M8SQD8R,Y)X?XA^.)O'_B5=6EL8[)([=+>*%9"Y"@LV6; R=S-T XP.V3[GX4
M^"_@G5/ .DW-WI\[WU[I\<TEV+J0.KR(&RH!V?*6XRIZ#.><^.?%GP5IO@/Q
M5:Z7I<]W-!+9)<,UTZLP8NZX&U5&,(.WK0!W'Q%UGXGZ9\2F;29=9:!$B@M?
MLEF_V6=_(W2;8R&5SGS3SN("]?E&/(_%-[KNH>([NZ\2I.FKOL^T"> 0N,(H
M7* #'RA>W/6ON>OD#XV_\E>UW_MW_P#2>.@#4TGQ9\9;;1K&#2[;63I\=O&E
MJ8]%5U,04!,-Y1W#;CG)S1X1^+/CC4?'6C6]WKTDL%[>VUM/&8(@K1F7!  7
M"DAR"PP3QSP,?3?_ !+O#/A[_GVTS3+3_:?RH8T_%CA5]R<=Z^1/A+IL.J_%
M3P_;SM(J)<&X!0@'=$C2J.0>-R 'VSTZT ?9=?!FDZ;-K.LV.EV[1K/>W$=O
M&TA(4,[!03@$XR?0U]YU\0>!/^2A^&O^PK:_^C5H ] _X9Q\8?\ 02T/_O\
MS?\ QJO/_ G_ "4/PU_V%;7_ -&K7V_7P)!/-:W$5Q;RR0SQ.'CDC8JR,#D$
M$<@@\YH ](^,/BV;QMX\&G:9-'?Z?9.+>P%K&6,LCA=Y!ZN2XVC'!"C'7)[N
MP_9PL+CPO;->:M?6FNR1(\WRQR0Q.2"R;!RV!E<A^2,].*\P\!6UOH5T?&&O
MZ5?2:;81?:-.(S%'=W:RJL:"0C#8.YB%).(V."%*GZ#^&WQ9L?B%<7=B=/DT
M_4+=/.$)D\U9(L@%@^T8(9@"".X()YP ><?$CX)Z#X3\$7FNZ7J.I-/:/&6C
MNF1U=6<)@;54@Y8'//0C'.1;_9E_YFG_ +=/_:U=9^T%J4UC\,C;Q+&4O[V*
MWE+ Y"@-+E>>NZ-1SG@GZCD_V9?^9I_[=/\ VM0!] 5\R3_LW^*EN)5M]5T:
M2 .1&\DDJ,RYX)4(0#CMDX]37TW10!\(:'HUYXAURRTBP3?=7<JQ)D$A<]6;
M )"@9).. ":](UOX-:QX,\$Z]K6K:M!^[BACC@L)'*S;IXP?-+*ORC@A1G+
M'(VX/G_A.^M],\9:'?WDGEVMKJ%O-,^TG:BR*6.!R< 'I7M?Q.^+WA3Q-X,U
MOP]I<UW)/(D+0W#0%8IB)8V*KGY@0-WWE ^4\],@'.?LX_\ )0]0_P"P5)_Z
M-BKG_C;_ ,E>UW_MW_\ 2>.K'P4\4Z-X1\97E_KEY]DM9-/>%7\IY,N9(R!A
M 3T4_E6/\4M;T[Q'\1]6U;2;C[18S^3Y<NQDW;844\, 1R".10!]1^&H[Z;X
M1Z1%I<T<&H/H4*VLL@RJ2F ;&/!X#8/0_0UX9^SC_P E#U#_ +!4G_HV*N[T
MCXT^#_#_ ,.=+@2\DO-4LM,@A^PI!(A:58U4KO9=H /4Y/ . > > _9UGAA^
M(UTDLL:/-IDJ1*S %V\R-L+ZG:K' [ GM0!]1U\@?&W_ )*]KO\ V[_^D\=?
M7]?('QM_Y*]KO_;O_P"D\= '-V<FM>"/$&E:H(9+6[1(;ZVWDA9HG&Y3E2-R
M,I*D _WE.#D5]C^$?%%CXQ\-6FL6$D9$J 31*^XP2X&Z-N <@GK@9&"."*\K
M\9^!;CQ=\%/"E]IPGFU+2M*@DBM8E#>>CQ1;QCKN 4,,9S@C!)&///@U\06\
M'^)5T^_GD_L747$<BF152"4D!9CNX  X;D<<G.T"@#ZSKX@\"?\ )0_#7_85
MM?\ T:M?;]?$'@3_ )*'X:_["MK_ .C5H ^WZCGGAM;>6XN)8X8(D+R22,%5
M% R22>  .<U)7QQ\0O'.H_$CQ0@MXIS8I*8],LO+5I%WA%/W1EF<J#MRV"<
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MF#P<@<9[@'((!'VW!/#=6\5Q;RQS02H'CDC8,KJ1D$$<$$<YH Y?7_AIX/\
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M!(Q:)=S;P-P8Y)W YSSG-?(D$S6UQ%.@C+QN'421JZD@YY5@0P]B"#WKO/\
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M@T*2%E)RS;FCCC<YYP6Z<*/3)H'P3^'/BG2UU+1=?UF[M"Y3>LT:E6'4,K1
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MV/Q#N?MEW!;^?I[00^=($\R1I8MJ+GJQP< <F@#ZGK/U/0M'UORO[6TJQO\
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MG\M=S,20JJ!ZEB!S@<\D#FOG#XJ?%S3?'OAJSTJPTV[MWBO3</).RXVJ'5
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M#Z&OHO\ 9Q_Y)YJ'_85D_P#145> >!/^2A^&O^PK:_\ HU: .T^+_P --%\
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M_;Q_Z3R4 ?7]%%?-EY^T/J\WC&UGM;:.W\.PW&)+;R@\\\)P"6). X&64*0
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M-M!VC."<9/4_6?@+PY#X6\%:7IJ6,=I<"WC>\12&+7!4>868$[CNXSDC  '
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MP.E=QINDZ;HUNUOI>GVEC SEVCM85B4M@#)"@#. !GV%<7\$O^20Z%_V\?\
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M1_#7P4\&^&[B><VDFJO*@0#5!',L8SD[5V 9/')!/'&,G(!\R>!/^2A^&O\
ML*VO_HU:^WZ^%/#5Y-IWBK2+VWM)+R>WO898[:/.Z9E<$(, G)(QT/7H:^ZZ
M /B#P)_R4/PU_P!A6U_]&K7N_P"TC=;/!NDV?V>=O-U#S?.5,QILC<;6;LQW
MY [A6]*\(\"?\E#\-?\ 85M?_1JU[G^TGJ4,7A71M+99//N+TW", -H6-"K
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MV*@#W_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\
MX03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Q['PGX;TR\CO
M+#P_I5I=1YV3064<;KD$'# 9&02/QK8HHH ^?_VFO^96_P"WO_VC7GG@KX3:
M]X\T:;5-+N]-A@BN&MV6ZD=6+!5;(VHPQAQW]:]#_::_YE;_ +>__:-=!^SC
M_P D\U#_ +"LG_HJ*@#QSQK\)M>\!Z-#JFJ7>FS02W"VZK:R.S!BK-D[D48P
MA[^E>Q_LX_\ )/-0_P"PK)_Z*BH_:._Y)YI__85C_P#14M'[./\ R3S4/^PK
M)_Z*BH ^?/!_AJ;QAXLL-!@N([=[MV!F<$A%52[' ZG:IP.,G'(ZUZQ/^S3J
M2V$KV_B2TDO Y$<4ELR1LN_ )<$D';SC:<'C)'S5Q?P2_P"2O:%_V\?^D\E?
M7] 'Q9X:TV;1OBYI&EW#1M/9:[#;R-&25+).%)&0#C(]!7VG7R)-!-;?M$A)
MXI(G/BA7"NI4E6N0RGGL5((/<$&OKN@ KXH\67UQIGQ3UR_LY/+NK76[B:%]
MH.UUG8J<'@X('6OL^_OK?3-.N;^\D\NUM8GFF?:3M102QP.3@ ]*^+/A_I3:
MU\0= L%MH[I'O8WEADVE6B0[Y,AN"-BMQWZ<]* -S_A=OQ#_ .AA_P#)*W_^
M-US_ (G\;>(O&/V7^W]0^V?9=_D_N8X]N[&[[BC.=J]?2OMN""&UMXK>WBCA
M@B0)''&H544#   X  XQ7@?[37_,K?\ ;W_[1H \X\(^)_B%H'AZ[/A<7R:0
MDKS7$L.GK-&CA%W%G*-MPH4GG@<U8N?BC\1];T/4HY=2GN=,\KR;UTL(MB))
ME,,ZQ_+NY Y'M7K_ .SC_P D\U#_ +"LG_HJ*O0/'03_ (0'Q!))!!-Y.GSS
M(D\*RIO1"ZDHP*G#*#R#TH ^:/@5?7%I\5]-A@DV1W<4\,XV@[T$;2 <]/F1
M3QZ>F:^MZ^0/@E_R5[0O^WC_ -)Y*^OZ "BBB@ KY_\ VFO^96_[>_\ VC7T
M!7SA^TIJ?F^(=#TGR<?9K1[GS=WWO-?;MQCC'DYSGG=VQR >K_!^^N-0^%&@
M374GF2+$\(.T#"1R/&@X]%51[XYYKN*\O^ -U>7'PO@BN;?RH;:[FBM7V%?-
MC)#ELG[WSNZY''RXZ@UZA0 4444 %4]5U6QT/2[C4]3N8[:SMTWRROT4?S))
MP !R20!DFKE?/_[0/C__ )DO3I/[LFIEHO\ =>)%8_@QP/[HS]X4 9'@GXG_
M !'\7>/M/LH;WS;22[66ZMX;2()%;!P9/F*[@H4X!+9Y R6(SY'!#?:[K,4"
M&2ZU"_N BF23YI97;'+,>I8]2>_-?1?[/W@O^RM#G\37UI/#?W^8K8R-@&U^
M5@P7_:8=3U"J1@'+>$>!/^2A^&O^PK:_^C5H Z#_ (4E\0_^A>_\G;?_ ..5
M3;X2^/%>]0^&KO-D@>7#(0P*EOW9W8E.!T3<0>.O%?9=% 'P1?6%YIEY)9W]
MI/:74>-\,\9C=<@$94\C((/XU]M^"YYKKP+X>N+B62:>73+9Y))&+,[&)222
M>22><U\N?&W_ )*]KO\ V[_^D\=?3_@3_DGGAK_L%6O_ **6@#QCXX7/CW4/
M$;Z!;6-])X>G\K[+'9VQ<73A"YW,H)+ JYV9'$:MMXW'A]0^$/B#1O EQXJU
M=X+.&.*.1;-MQGR\J( XP G#%NI(P 0#G'U_7S9^T5XH6^\06/ANWDDV:<AF
MN@'8*99 "H*XP2J<ALG_ %I'&#D V_V:+&XCT[Q%?M'BUFE@AC?</F= Y88Z
M\"1/S]C7O%>9_ K0+[0?ARC7ZQJ=1N#?0JK;B(GC0*6[ D+G'/!&<'('IE '
M%_%G5;[1?AAK5_IMS):W:)&B31\,H>5$;![':QY'(ZC!YKYT^#_@[2_&WC*6
MPU?SS:V]H;K9"^SS"LD8VL<9VD,<XP?0BO?_ (V_\DAUW_MW_P#2B.O(/V<?
M^2AZA_V"I/\ T;%0!]-P00VMO%;V\4<,$2!(XXU"JB@8  '  '&*DHHH \_^
M-O\ R2'7?^W?_P!*(Z^7/"GA+5_&>LC2]&ACDG">9(TD@18X]RJ7.>2 6' !
M/H#7U'\;?^20Z[_V[_\ I1'7D'[./_)0]0_[!4G_ *-BH Y__A27Q#_Z%[_R
M=M__ (Y5S3?@-X\OKAHKBQM-/0(6$MU=HRDY'RCR]YSSGIC@\],_6=% 'C?P
MS^""^%M4.L>(Y;2^OX'!LXH"S11'_GH=R@E\]!C"XSR<;?9*** /B#P)_P E
M#\-?]A6U_P#1JU[O^T9X>N-0\+Z=KD#9CTN5DG3 X24H ^2>S*HP <[\\ &O
MFBONOQ'H%CXI\/WFBZDLAM+I K^6VUE((96!]0P!YR..01Q0!XA^S?XEF^T:
MGX5:WC,!1M12<$A@V8XV4CH01M(Z8P>N>.?_ &@O$LVJ>-TT)K>..#1TPD@)
M+2M*D;L3V  V@#V)SS@<7\/_ !C<>!_%MMJT7S6[8AO(P@8R0%@7"Y(PW (Y
M'(&>,@W/#<E]X\^+VFW-]#'>3WVII<7,+G<AB5M[KAR?D6-2 I)X  STH ]C
M\2V-OI_[*\$-K'Y<;:?93$;B<O)+%(YY]69C[9XXKB/V<?\ DH>H?]@J3_T;
M%7K_ ,;?^20Z[_V[_P#I1'7D'[./_)0]0_[!4G_HV*@#Z'\4^&[/Q=X<N]#O
MY)X[6ZV;W@8!QM=7&"01U4=J\OA_9_\  =Q>7-G#KFJR75KM^T0I=P%XMPRN
MY1'E<CD9ZU[17R!XL^%GBSP)J*W5O%/>6L6ZXBU'3T<^2$.=SX&8F  ;.<#L
MQP< '4?$_P"%_@KP'X<,\.K:J=7N/^/&"=E=)=KH),E8QC"OGDC\>E<?X0\!
MIK?A+Q'XGU.X^RZ9IEI*+=Q,J&6["@HA!!RO(!Z$EU"D\XRVO]7^(?C73DUK
M4Y);N_N(;/[0R#$2LP4;47  &XG QDDGJ2:^G_%_@9IO@_=>$/#L4>^*WB2W
M20JGF&.17.2 !O;:3G@%FR<9)H \<_9Q_P"2AZA_V"I/_1L5<_\ \W"_]S7_
M .W==A\'-%O_  +=:QXP\56L^D:1!:?9&:[@D61G>6,@B,+N*C &<=6&,X;'
M!_#C3K[Q!\1K&_>YCQ8W"ZKJ%W=S[0L4<BO([,>22>_J<G R0 >E_M-?\RM_
MV]_^T:Z#]G'_ ))YJ'_85D_]%15Y)\5/B9#\1+C3UM]+DLX-/><1O),':57*
M8)4#"G"=,MUZ\<_0?PJ\$7G@+PE)IE_=07%U-=O<N8 =B955"@D GA <X'7'
M;) .XKQ_]H[_ ))YI_\ V%8__14M>P5\^?'KQYX<US0;30=(U&._NXKU;B5[
M?YXD41L,;^C$^8/NYQM;.",$ Z/]G'_DGFH?]A63_P!%15Y!\;?^2O:[_P!N
M_P#Z3QUAZ'X^\4>&M&N=)T;5I+.SN'9Y%CC3=N90I(<KN4X4<@C&,C!KUCPI
M\-_"7ASX?#6_B;8QVT\]QF+S)YUD2-@H1#'&0=^0[8 ) /.,$  X_P")/Q?F
M^(.C6FEKHT>GP0W'VAV-P9F=@I50/E4 89L\'/'3'/87E[J6M?LQ7CZYI4=N
M^G/:PZ>S6[(6A4P*DR[\Y+*[C<N 02!WKG_$NM_!S3+B"+0?",FMHR%I93J%
MU;+&<\*-V2QZD\ #CD\XT-$^(B^+/ ?B;PIJUA:6^EZ=H326$AF97!A*+"LC
M9 =RQBY 4$C&T[L  \O@\6ZO:^#KCPM!-''I=S<&XN$$8+2M^[P"QR0 8E(V
MXZG.>,?1?[/VAW&E> 9[N\L/LTVH79FBD= 'E@V*$)[[<[R,_P![(X;)^;/#
M6FPZSXJTC2[AI%@O;V&WD:,@,%=PI(R",X/H:^O]6\8>#_A[;Z?H^HZE'8(E
MNJ6UN$DF98D 5<[0Q XP"W7!ZX- '65\&:3ILVLZS8Z7;M&L][<1V\;2$A0S
ML%!. 3C)]#7W?!/#=6\5Q;RQS02H'CDC8,KJ1D$$<$$<YKXD\"?\E#\-?]A6
MU_\ 1JT >@?\,X^,/^@EH?\ W_F_^-5Y_P"!/^2A^&O^PK:_^C5K[?KX@\"?
M\E#\-?\ 85M?_1JT ?:>JZ58ZYI=QIFIVT=S9W";)8GZ,/Y@@X((Y! (P17Q
MYK&F:Q\*/B*B1S;[K3Y4N+:<*Z)<1GD<9!*D91@#C[RY/6OL^O-_BQ\+_P#A
M8%G:W-A/!:ZO:91'F7"31DC*NP!88Y*]0,L,?-D 'G'Q]U/^V_#W@35O)\G[
M=:37/E;MVS>D#;<X&<9QG KK_P!G'_DGFH?]A63_ -%15YY\9/#=CX,\/^$/
M#EI?R74MLEU-,99,MES'\P3)\M"RO@#C@\D[B?4_@#IGV#X7P7/G>9_:%W-<
M[=N/+P1%MSGG_59SQ][';) /4*^2+V^N-0_:,6:ZD\R1?$L<(.T#"1SK&@X]
M%51[XYYKZWKY,U-YI/VD$,]E'9N/$< $:1&,,HF4*^#U+J Y/\18GO0!J?M'
M?\E#T_\ [!4?_HV6NK^(^I36/[-_ANWB6,I?V]A;RE@<A1#YN5YZ[HU'.>"?
MJ.4_:._Y*'I__8*C_P#1LM=WXV@AF_9BL7EBC=X=,TYXF902C9B7*^AVLPR.
MQ([T 9?P!\*>']7\&ZC?ZGHMC?71U!H0]W LNU%C0@ ,"!R[=.O&<X&/+/BS
MI5CHOQ/UJPTVVCM;1'C=(8^%4O$CM@=AN8\#@=!@<5[7^SC_ ,D\U#_L*R?^
MBHJ\@^-O_)7M=_[=_P#TGCH ]7^(7A[PFGP+FUG1/#UC9^9:6<MM,;5!.B/)
M%C<_+%MIP3N.<GDUQ'[./_)0]0_[!4G_ *-BKO\ QE_R:];?]@K3?_0H:X#]
MG'_DH>H?]@J3_P!&Q4 ?3]>-_M(3PKX%TRW:6,3OJ:ND98;F58I Q ZD LH)
M[;AZU[)7SY^TS/"UQX:MUEC,Z)<N\88;E5C$%)'4 E6 /?:?2@#H_P!G'_DG
MFH?]A63_ -%15H?&[QU<>$?"\5CIQGAU+5=\<5U$P7R$0KO.>NXA@HQC&2<@
M@9XCX8>/-&^'WPEN+J^G^TWEWJ%P]K90HX9W5(5*,Y7:O56)R?E;C+ K7#Z-
M:Z[\9_B4AU&XW[L2W3*X1;:U5@"L0.<8W848.6;+=6:@"GIO@&:Y^&&L^-;N
M62*"V>.*SA"$><QE1&<DC!0!B!CJP/(VX;0TOP7#K?P1U'Q% DG]H:3J<A(B
MA#&:%D@W!B.0$R7!Z ;^.<CT_P"/&FPZ-\(]!TNW:1H+*]M[>-I""Q5()5!.
M !G ]!4G[-U];R>#=6L%DS=0ZAYTB;3\J/&@4YZ<F-_R]Q0!@? /XAV]CM\'
M:D_EK-*\ME<33G;O;8! JXPN3O8'(RQQC+<_0]?)'Q;^&K^!M8^VV*9T*]E8
M6HW,[0$*I*.Q7 R2VWDDJIR<@UZ/\'OC#_:OV?PSXFN?^)AQ'97TC?\ 'SZ1
MR'_GIZ-_%T/S?? /<*\_^-O_ "2'7?\ MW_]*(Z] KS_ .-O_)(==_[=_P#T
MHCH \L_9LU*:+Q5K.EJL?D7%D+AV(.X-&X50.<8Q*V>.PZ=_H/4]"T?6_*_M
M;2K&_P#)SY?VNW279G&<;@<9P.GH*^?/V;--FE\5:SJBM'Y%O9"W=23N+2.&
M4CC&,1-GGN.O;T?QM\;?#GA*XGT^U635M4A<I)!"VR.)@5R'D((S@GA0V"I!
MVT >0>+-)TVV_:-M]+@T^TBT\ZG8(;1(56(JRP[AL Q@Y.1CG)KZ?TW2=-T:
MW:WTO3[2Q@9R[1VL*Q*6P!DA0!G  S["OC3Q1XTN->^($OBZS@_L^Z,L,T*;
MQ+Y3Q*@4Y*@'E >1[<UZ!X4\<_%_7M6TEXYKZ73+F[CC>Z.C(\&SS K%F5%^
M4<YPR]#R.M '#_"W6;S1/B5H4MF^/M-W'9S(2=KQRL$8$ C.,AAGC<JG!Q7V
M?7QIK^FP_#7XJ16\#27Z:/<6EP2Y$9F8)'*PX!V@L2!UP,=<9/K?B7X]OHGC
MN*RM]/@NO#PB@E>90PGE26)9 Z9("X#K\K#G:>1GY0#W"N+\0^&_AYI%Q/XF
M\0:7HT#NC))-=1*5E8DR'$9X>4X8Y"ESR.>E2>-K[5-3^%]]?^#Y)Y+RZM(Y
MK1[=<2-$Q4L4!Y#&,MC'S9Z?-BOES2_ 7C+Q3K*HND:D9;JX=9;V\AD6-7#$
M2-)(PZA@V>IR",$\4 =A\2/'?@6_L+S1/"WA/3<2I&4UB*U2W9&#AF"+Y8;&
M!M))7J>".3J?!SP[H_C7X=>*/#TL7V;4FE0MJ"0H76-MK1H&ZE0\!)7@<\')
MR*_C/X-:/X*^&<FL7NK3R:ZGE($61%@DD9QN5%*[FPFX]<G:6P!P.G_9KTSR
MO#VN:MYV?M-VEMY6W[OE)NW9SSGSL8QQM[YX /,/@WKUGHOCZ*VO[+[7:ZQ$
M=*=" 0/-=,%E/#+D $>A)YQ@TY;.;X7?%F"&XNY)AI-[#))-:95I83M<@ D<
MM&V"N<<D9(YK<^,6AZII7Q<FN["PGMO[0EBFTZ2T3!EEVH&*;.?,\S)/\66!
M_B!/L]]\)]'\8Q:)J_BF">/78[2$:C]FD2,74@5=PDVC!P01E"#@X!P%P <!
M^T7?6^IZ=X-O[.3S+6ZBN)H7VD;D80E3@\C((ZUW_P #O#UQH'PUMGNF_>:E
M*;\)@?(CJH3D$YRJ*W;&[!&17B'Q9\W7/BY+HNE^1-';_9],T^"#8B1_*H\H
M$8 Q([CGITX P/J/PUILVC>%=(TNX:-I[*RAMY&C)*ED0*2,@'&1Z"@#4HHK
MQOX\>/-7\+V^F:7H>HQVL]ZDS731X,Z1@!5QW0$L_P P .4X(P: /6)-6TV'
M5(=+EU"T34)DWQ6C3*)77GE4SDCY6Y ['TJY7RAH?P'\6:]H=EJT5SI5O#>1
M+-''/.^_8W*D[48<C!Z]^<'(J/X9?$N[^'&J7.EZQ!=MI)>3S[-(D66&X^4;
ML, 21LVE2P R3U&" ?6=?('QM_Y*]KO_ &[_ /I/'7U_7'^-_AKX?\>_9I-5
M2>&ZM^$NK1E20IS\A)4@KDYY'!S@C)R <G^SJ83\.;H11R*XU.42EG#!F\N/
ME1@;1MVC!SR"<\X'KE4]*TJQT/2[?3-,MH[:SMTV11)T4?S))R23R223DFKE
M 'C_ ,=/&WB+P=_8/]@:A]C^U?:/._<QR;MOE[?OJ<8W-T]:N?!#QWJ?C/1M
M5BUNZDNM0L[A&\TPQQKY3K\JC8!DAD<G([CD]NH\<?#S1?']O9Q:L]W$]F[-
M#+:R!6 8#<IW @@[5/3/RC!'.;G@[P=I?@?0_P"R=)\]H6E::22=]SR.<#)P
M !P%' '3UR2 =!1110!\_P#[37_,K?\ ;W_[1KH/V<?^2>:A_P!A63_T5%7:
M>./AYHOC^WLXM6>[B>S=FAEM9 K ,!N4[@00=JGIGY1@CG.IX8\,:7X1T.'2
M-(@\JWCY9FY>5SU=SW8X'Y      &Q1110 4444 %%%% !1110!\@?&W_DKV
MN_\ ;O\ ^D\=?3_@3_DGGAK_ +!5K_Z*6L?Q7\)_"WC'7+?5]2@GCNH\";[-
M((Q=*,8$G&3@#&5(;!QGA<=I!!#:V\5O;Q1PP1($CCC4*J*!@  <  <8H DH
MHHH *^?_ -IK_F5O^WO_ -HU] 5A^*_"6D>,]&.EZS#)) '\R-HY"C1R;64.
M,<$@,>""/4&@#QO]F7_F:?\ MT_]K5V'Q[T:SU#X9W.HS)_I6FRQRV\@ R-[
MK&RDD9VD-D@8R57TKL/!W@[2_ ^A_P!DZ3Y[0M*TTDD[[GD<X&3@ #@*. .G
MKDG<G@ANK>6WN(HYH)4*21R*&5U(P00>"".,4 ?!EA8W&IZC;6%G'YEU=2I#
M"FX#<[$!1D\#)(ZU]SZ%IG]B>'M,TGSO.^PVD5MYNW;OV(%W8R<9QG&37/V/
MPL\$Z;KD>LVF@017T<IFC822%$<Y.5C+;!@G(P/EP,8P*["@#Y ^-O\ R5[7
M?^W?_P!)XZ^G_ G_ "3SPU_V"K7_ -%+6?XD^%_A'Q7K$>JZMI?F78P)'BE>
M/SU"E0'VD9QD'(PWRJ,[1BNL@@AM;>*WMXHX8(D"1QQJ%5% P  .  .,4 <O
MXX^'FB^/[>SBU9[N)[-V:&6UD"L P&Y3N!!!VJ>F?E&".<\O\2M L?"WP!U'
M1=-606EJD"IYC;F8FY1F8GU+$GC YX '%>J5P_Q@L;C4/A1K\-K'YDBQ),1N
M PD<B2.>?158^^..: .7_9Q_Y)YJ'_85D_\ 145?-FDZE-HVLV.J6ZQM/97$
M=Q&L@)4LC!@#@@XR/45]-_L\V-Q:?#62:>/9'=ZA+- =P.] J1D\=/F1ASZ>
MF*Y?PQ^SQ>6'BV&[UO4;&ZTBUE\U(HE)>XVME5D1EVJI_B&6[KWW  X#XB?%
MC5/B!%%926<%CID,HFCMT/F.7V[<LY SC+XP%^]SG -5_"/Q5\0>"?#UWHVD
M16(CN)7F\^:)GDC=D5<K\VWC:",J>>N1Q7U/_P ()X/_ .A4T/\ \%T/_P 3
M1_P@G@__ *%30_\ P70__$T ?)'A.^N-3^*>AW]Y)YEU=:W;S3/M W.TZEC@
M<#))Z5]KUX7;? 6YT[XFVNL:9>VEOX?M;V*[BA>1Y)U"$/LQM QN!4$L2%P3
MDC!]TH ^</VC/$]O?:QIWARUGG,FG[I;R/D1[W5#'_O,%W'.. ^ <E@/*TTG
MQ59Z6B)I^LP:?JSQ(JB&58KUC\T0'&)#W4<^HKW/Q1\$M3\0?%"77FN+&31+
MB[AEG@GNIC,T8""10=IQG#!0&  P!M  'MD$$-K;Q6]O%'#!$@2..-0JHH&
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M<CK@&NHL?V;O$DEY&M_K.E06ISOD@,DKKP<84JH/./XAZ\]*]O\ !WP_\/\
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M\6W$=A;065N\IGNI8HML%FC,3A5S]0J9YQU !(][@^(OP\^'5_%X.@>2)+5
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MC\%5\&ZI'KNL7T=WJD:,L,5ON$4!;<I;<<%R5..0 ,MP>"/7* /C#X<>.O\
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MU7.&&0>": /G3XX_$BS\57EOH&C3>=IMA*9)KA<%)YL;1L.,[5!8;@<-N/!
M4GN_V?/"+:3X:NM?OK*2&\U%PMNTJKDVP (9>-P#,23DX8(A Q@GG/#'[.=_
M%KD,OB>_L9=,C^=X;*60O,1T0DJNU3W(.>,#&=P^@X((;6WBM[>*.&") D<<
M:A510,  #@ #C% $E%%% !1110 4444 ?/\ ^TU_S*W_ &]_^T:\H\-_$3Q5
MX1TZ2PT/5?LEK)*9F3[/%)ER "<NI/11^5?2?Q9^&TWQ"TNQ-C>1V^H6#N81
M/GRI%?;O#$ D'Y001GH01SD6/A3X!F\ >&I[2^EM)]0NK@RS2VZ' 4 *B;B
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MALK53D!UW!I'Y'(W*J@@]0X(X%'C#X$:]XC\>7^K0:Q:#3[RX60O=2O)/&I
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MI&D0>5;Q\LS<O*YZNY[L<#\@     #4@@AM;>*WMXHX8(D"1QQJ%5% P  .
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MWW#G(;ZCKB](^%7A#1/$MWKMKI<9N)G5XHI0K16K [LPKCY"6 .>=N,+M'%
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M1;AVP21P1M7KCY0,X&<D9KM(((;6WBM[>*.&") D<<:A510,  #@ #C%244
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M57!C+$#Y2S2L.3S@8[Y^@ZKWUA9ZG9R6=_:07=K)C?#/&)$;!!&5/!P0#^%
M'@_A?]H'1]'\&V>FWFBWQOK"T2VA$+HT<VR-55F8X*9(.0%; ]>E>:6&F^(_
MC#X\O)(VM!J%RAN)I'/EQ11J%4# !.!\BC )Z$]S7M\_[.O@V:XEE2[UF!'<
MLL4=Q&50$_=&Z,G Z<DGU)KT#POX1T7P=I:6&CV4<("*LLY4&6<C)W2/C+'+
)-[#.  .* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_025.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] ;,# 2(  A$! Q$!_\0
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MA/7OB+#I,QU6VT2]E^SVLC3(9U<\1E\1E3N;C  V[Q\Q"DD ]O\ ^&CO!_\
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M)H ^WZ\_^)OPOL_B!9QW$<_V35[6)DMIMHV29((67C<5&#C!^7>QP>A^8/\
MA!/&'_0J:Y_X+IO_ (FC_A!/&'_0J:Y_X+IO_B: +FD:_P"*_A=XENX+=I+&
M\C=8[RSG4,DH4[@&'0@CHRG.&.UL-FOI/P!\6]"\=;+/_D'ZRV\_8)7+;E7G
M*/@!N#G'###<8&3Y!\,O@Q>>(9=0E\5:;?:=8+%Y4!?,$_G;D;<JLO*A0RDL
M,?/QD@E>?\:_"#Q)X-Q/Y?\ :=BWFOY]E#(WE1I@[IAMQ'D'/4CAN>,T ?7]
M<_XL\::%X*TY;S6KORO-W""%%+R3,HR0JC\!DX4$C)&16'\(--\1Z5\/K2V\
M2-()PY-K#*<R06^%V(_&00=Q .2H('&-H\@^,'@[Q?KGQ4N9+/1]2O;2=($L
MY41GB1=BJ1N^[&-^\D,1C)8\') .3T7^W?B;\5;:\D\_[9<W<<]S-8XB-K"A
M4%U;^'8H 4G)R%ZL>?1]2^"O@[PAJ,VL^)/$$Z>&H_*$,+_ZZ24GYD8HN67
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M"X^Y>6R!MTVP!<JK ,L@4+\A W+@CG[Y^TU_S*W_ &]_^T:Z#]G'_DGFH?\
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MJ"00.ZNLD6WS(V4YRA8$ XRI..C$=Z\[_P"&<?!__02US_O_  __ !JO8**
M/'_^&<?!_P#T$M<_[_P__&JKW_[._@^WTZYG_MO5;7RXG?S[B:$QQ8!.YQL7
MY1U/(X'4=:]HJO?V-OJ>G7-A>1^9:W43PS)N(W(P(89'(R">E 'Q1X'T&S\3
M^--+T:_O?L5K=R['F! / )"KGC<Q 4=>6'!Z'W__ (9Q\'_]!+7/^_\ #_\
M&JL>#/@=9^#_ !I'K\>N3W4=OYOV:V: (5W@J-[Y.["L>BKDX/ X/K% 'C__
M  SCX/\ ^@EKG_?^'_XU4D'[.O@V&XBE>[UF=$<,T4EQ&%< _=.V,'!Z<$'T
M(KURB@".""&UMXK>WBCA@B0)''&H544#   X  XQ4E%% !1110!\>?&>>&Y^
M+>O/!+'*@>)"R,& 9845AQW# @CL014=A\7_ !WIFG6UA9Z[Y=K:Q)#"GV2
M[44 *,E,G  ZU'\6M-ATKXJ>(+>!I&1[@7!+D$[I465AP!QN<@>V.O6OJ.P^
M'7@^QTZVL_\ A'-*N/(B2+SKBQA>23: -SMMY8XR3W- 'S1_PNWXA_\ 0P_^
M25O_ /&Z/^%V_$/_ *&'_P DK?\ ^-U]/_\ "">#_P#H5-#_ /!=#_\ $T?\
M()X/_P"A4T/_ ,%T/_Q- 'QAK>MZCXCUB?5M6N/M%]/M\R78J;MJA1PH '
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M@_X5_P"'KC2?["^W^==M<^;]K\K&41=N-C?W,YSWKT__ (9Q\'_]!+7/^_\
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M>#_^A4T/_P %T/\ \35>^^''@K4+.2UF\+Z4D;XR8+987&"#PZ ,.G8\].E
M'DD'[3,RV\2W'A2.2<(!(\=^45FQR0IC) SVR<>IHKV/_A!/!_\ T*FA_P#@
(NA_^)HH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_026.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !!"!$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BN/^(7Q
M"T[X?Z.ES<I]HOI\_9+/+)Y^UD#_ #A6"[0^>>O05\^:K\=_'%[JEQ<6&HQZ
M?:.^8K5+>*01+V&YT)8]R?4G  P  ?6=%?*&C?'OQMI^HI-J-U!JEKP'MYH(
MXLC()*M&H(; (!.0,]#7T7X&\9V/CKPU'K%C')"0YAN('Y,,H )7.,,,,"".
MH(R <@ '24444 %%%>-_$_XVP^&[BZT'PZL=SJB(4FO"P,=I)D# 7!#N!G(Z
M*<9W890 >R45\@?\+M^(?_0P_P#DE;__ !NND\*?M"Z_IUP(O$D,>K6COEI8
MT6&>,$KTV@(P #':0"2?O 4 ?3=%4]*U6QUS2[?4],N8[FSN$WQ2IT8?S!!R
M"#R""#@BKE !1110 45\X?%#XM>,M$^(&HZ3I5Y_9MI9[(TB-O#(SY4-O)(?
M[V[(P1\NW(#9KC_^%V_$/_H8?_)*W_\ C= '?_&#XM>(M!\:-H?AV\^Q1V42
M?:'-O&YED<!^"P;Y0I7' .2V<C%>V>&M2FUGPKI&J7"QK/>V4-Q(L8(4,Z!B
M!DDXR?4U\2:WK>H^(]8GU;5KC[1?3[?,EV*F[:H4<* !P .!786'Q1^(^F>'
MK8V>I3QZ1:[+*&7[!$8U*H-L>\Q\L% ."<XYH ^OZX_Q)\4/"/A36(]*U;5/
M+NS@R)%$\GD*5+ OM!QG &!EOF4XVG-> 6OQ^\<V^G3VTMQ8W4TF[;=S6H$D
M61@;0A5.#R-RGD\Y'%<WX,\&:U\1_$KP022$%_.O]0GRXB#$DLQ)RSL<X&<L
M<\@ D 'V787UOJ>G6U_9R>9:W4230OM(W(P!4X/(R".M6*IZ3IL.C:-8Z7;M
M(T%E;QV\;2$%BJ*%!. !G ]!5R@ HKS/XD_%^'X?:S::6NC2:A/-;_:'8W A
M5%+%5 ^5B3E6SP,<=<\<7_PTU_U*/_E2_P#M5 '2?'+QWK_@RWT2+0;J.U>\
M>9I93"LC80)A1N! !WDGC/ Y'.<_X>?''3'\-,OC;6HX]42X=49;.3,D6%(9
MO+0KG)8<8X4<=SY9\3?B;_PL;^R_^)1_9_V#S?\ EY\W?OV?["XQL]^M>?T
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M%V_#S_H8?_)*X_\ C=>,?&"]\">)[QO$?AS7_,U9]B75H]M.HG  4.I9 %8
M $$@$#(P1\P!]/V%];ZGIUM?V<GF6MU$DT+[2-R, 5.#R,@CK5BOG#X*?%#2
M?#&AZAI'B75/LUK'*LMCF*64_-GS%&T,%4$*0,#EV/.>/3_^%V_#S_H8?_)*
MX_\ C= 'H%%<OX;^(GA7Q=J,EAH>J_:[J.(S,GV>6/" @$Y=0.K#\ZZB@ KQ
M/0?V@H=:\:VND_V#)%I][<):V\WG RJS,5#NN,8.8\J#\N&.7X%=!\9_'D/A
M7PG-IUEJ,EOKU^@%L(,;XX]PWN3_   J&4'KD_+]TD?+FAZQ<>']<LM7M$@D
MN+.598UGB$B$CU!_F,$=000" #[OHKY$G^./Q!FN)94UJ.!'<LL4=G"50$_=
M&Y"<#IR2?4FN[OOC<^K?"/4))+V#2_%,LIM[>.SW$N@:,LXSGR_D=@"6ZJ2I
MR,  Z3P5\;X?&'CP:"NCR6UI<HXLYC(&<L@=R9!T 9 .!G:1U8-E?7*^(/!W
MC'5/ ^N?VMI/D-,T30R1SIN21#@X."".0IX(Z>F0>XOOVAO&MW9R00Q:592-
MC$\%NQ=,$'@.[+STY!Z^O- 'U/17SQ\*OC!XJUCQI;Z)K3?VK#?Y1&2.*)[<
MJ"Q<8"AEP#D'GC*\C:WT/0!\\?$_XM>+O#7Q,N],TN\@BL+'R,6[6Z,)LHLC
M;V(W<[B/E*\ 8P>3Z?\ #OXFZ7\0;.411_8M3@R9K%Y-Y"9P'5L#<O(!X&#P
M1RI.AXT\":/XUT>ZM;RW@BOI8A'#J MT>:':VY<,1G;G.5!&06&1G-<'\*?@
M]JO@GQ+/K&L:A:2$6YAABLI9"&+$9+Y"@@ <*0P).>"HH ]DKYHT;]H'77\<
MI<ZKY$?AZXE$;V8C!^RQD@;PX7>S*.3G(;Y@ N1MD^,_Q9AUY)O"N@/'+I@<
M?;+P ,+AE8$+&?[@8 [A]XCCY>6X_P ,?#&YUWP=?^*K_5K31])MDD$<MU&Y
M\UUQC&!]PL2NY=QW @*30!]!_P#"[?AY_P!##_Y)7'_QNC_A=OP\_P"AA_\
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M:'S+^3/RDKUVYQM3J3@GG 74T_\ 9_OKGX?3:A-)(/$DB+/:68EV1A"$;RY
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M1R*]CTS6?AOX]\%>'?!NIZI&-4%E;VL;BW*2PRJJ;DCE>,JI8H%X/S=!G(H
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M_FW%ODO!)&T;[ Q4. 1RIP#QTW+N"DXKYH^-O_)7M=_[=_\ TGCH ^OZ***
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MJ,GAEIQJ7R*%MH&EF9&8*PCVG*M@YW8. #C!PP^</^%V_$/_ *&'_P DK?\
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M#0!]UP2--;Q2O#) [H&:*0J60D?=.TD9'3@D>A-25\__ /#37_4H_P#E2_\
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M^@EH?_?^;_XU0 ?M >*O[7\46>DV.I_:-,MK2.=HHC^[,S@L'R.'S&T9!R0
MQQC+5ZO\//B%X?F\#:8FK>,K&?4HH@ER]]*MO)OQG:0Y!?:"%WC.XJ3G.:\H
M_P"&<?&'_02T/_O_ #?_ !JC_AG'QA_T$M#_ ._\W_QJ@#W_ /X3OP?_ -#7
MH?\ X,8?_BJIP?$WP7=>((M#M_$%I-?RN$C6/<T;L1D 2@;"3TQNZ\=>*\,_
MX9Q\8?\ 02T/_O\ S?\ QJO-_%/AN\\(^([O0[^2"2ZM=F]X&)0[D5Q@D ]&
M':@#[GHK#\%SS77@7P]<7$LDT\NF6SR22,69V,2DDD\DD\YK<H X?XJ^-/\
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MCX.TOQQH?]DZMYZPK*LT<D#[7C<9&1D$'@L.0>OK@@ \GOOC%\+-3O)+R_\
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MN@:MXCDM/ME_;PWJ-JE\(U+%$9D5,JK(">C!OO8)(KC/VCO^2AZ?_P!@J/\
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MV;M9O+O0]:TB9]]K82Q2V^224\W?N49. N4R  .68\YH X#6?@;K?A[3GO\
M5_$/ARRM5R-\US*-Q )VJ/*RS8!PHR3C@5<@_9X\575O%<6^K^'YH)4#QR1W
M,K*ZD9!!$>"".<UZ7\8_AAJGCC[)J6D7V;JSB:/[!/)MC<<MF,]%D)PIS@$;
M<E=O/BG@+XC:U\--4NK5[62>S9V6ZTV=C$5E'&X$@E'!&#QR!@C(! !L:K\!
MO$.AZ7<:GJ>M^'[:SMTWRRO/-A1_WZR23@ #DD@#)-8?A3X9W7C26XAT7Q#H
M<MQ;Y+P2//&^P,5#@&+E3@'CIN7<%)Q76?&3XJ6/B_2]+TSP]>W8LW0SW\3Q
M^6"_R[(V[DJ0Q(&5R5(+$<=/^SEX76#2]0\43QR">Y<V=MN1E'E+AG93G#!F
MP.G!B//)% %CX8_!/4O"7BR/7M:U&TD>U1A;0V3,P9G5D8N648 5C@#J3U&,
M'I/C#\1+CP'H=M%IT.[4]2\Q+>9P"D 3;N<@_>;YQ@8QW/3:WI%4]2TG3=9M
MUM]4T^TOH%<.L=U"LJAL$9 8$9P2,^YH ^0/#7AKQ'\6/&,[O<22R2.);_49
MAE85/ X&!G PJ#'3 PH)'M_C/X):+<^ TL/#>GQQZQ8)NMIV<*]T<@NLKXPQ
M89QG 4X *KD5XPGCSQ[X#N+O08[F/29(KAWGMDT^V7$C')/"8((Q@CC;MV_*
M!706WB+XT>*4M;)9=9BM-0>()>)IWD(JLP(?SHXP53H20>F>HH Z#X$:'I5[
M;ZKIFN^%I+J[BN')GO\ 3(W@A*!%,7F,N\2Y8DH> %R #G/C\.GZ1_PFIL+^
M>[TW1TO625[N,BXAA5CD,J*V)=HQC;C=UP,UJ>-_"/B3P#]FT/5KSS;&Y_TR
M-+:61K8R#*$X95'F 8S@9 9>>:V/#'P1\6>*-#AU>%K&RMY^85O9'1Y$[. J
M-\I[9QGKC!!(!T'BOQE\+K/0[?0-$\+P:S&;012ZDD:V<Z,N K"0Q;FDXW$X
M"G/\0) \K\/6>I76LP/I>CR:M/:NMPUHMLTZNJL.'1>2A. ?KCO7LEC\'O!7
MA>SCD\?>*8(]2CS<O9P7:QH\()PH4KYKYVMRN#S@<C)[O3?BO\*M&MVM]+U&
MTL8&<NT=KIDT2EL 9(6,#. !GV% '::-X>T33-E[IWAZQTJZEB <0VL4<B@X
M)1FCX."!G!(R.IK8J.">&ZMXKBWECF@E0/')&P974C(((X((YS4E '+^.O'6
ME^ ]#-_?GS;B3*VMHC8>X<=AZ*,C+=L]R0#\X>#;CQC\2/B5%*=>OH[IH@+V
M[M[C[,\=HK+N5-@P,DC"@8+')'4U'K_AKXC>-/&K2:UHFI+=SW MO-:UD^RV
MR[MH"LH8")<D[@3D9;)))/H^OWD/P)^'UAIFCVD;>(M70^??G#JLB!=[<@%@
MI?"*0!R2<G(8 S-/^ ^G>');_5_&^N0'0K+#Q_9F9#*H;_EID97(P-B$L2V
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M4TOP:UC'?F)PI^S2)-(F=S+YDJAG]=NX\+TPO&/XR_Y->MO^P5IO_H4->4?
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M75]4M]0UEI[*RFN(UDFB*ED0L <1@XR/45RG[./_ "4/4/\ L%2?^C8J]?\
MC;_R2'7?^W?_ -*(Z\@_9Q_Y*'J'_8*D_P#1L5 'T_7R!\;?^2O:[_V[_P#I
M/'7U_7R!\;?^2O:[_P!N_P#Z3QT ?3_@3_DGGAK_ +!5K_Z*6N@KR?PG\7_
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MM 6/B/Q+::/?Z))IPNW$,,ZW/GCS6("JPV*0"3C/.#C(QD@ ]DKY_P#VFO\
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MF0)@E0,L,OTRO3KSQZ)7/^+/!>A>-=.6SUJT\WRMQ@F1BDD+,,$JP_ X.5)
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M\J+2K7RY5D;R;=CYJCJC;W;Y3WVX;C@BK'_#1WC#_H&Z'_WXF_\ CM &'/\
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M8/&:ZCXM^,+SPO:Z!X(T#7+Z"XT:TCCOYK;,'F,(D$?S [ON[F*@[?G7DD<
M$G[07CB&^NCX,BL9 ]A<174MTT@P6,3?(JXZ;9%.XD<@C'<^5Z[X6&@WFG6\
MVNZ5<?;HHY]]LTS"WB< HT@,8895MVT MCMR,GB^#5$U.SN]9U.#4+Z_T^VN
MFDCDWNB-&!&LO Q)L"DYSG(.3G->O^-OAO>>*OACX2U_1H?.U*PT2VCFMUR7
MGA\M6&P9QN4ECM RVX\DA00#G(/V>/%5U;Q7%OJ_A^:"5 \<D=S*RNI&001'
M@@CG-=_\,_@@OA;5#K'B.6TOK^!P;.* LT41_P">AW*"7ST&,+C/)QMP_P!G
M/6/$$LM[I,J3R^'HXGDAF>)BD,X9,QJ_09#EBGMD8RV>8^,$WBGPW\7&UTW,
M\+'8^EW<8(01JH!102PX)8,IX;<25 <"@#ZGHKB_AGX^A\?^&C>-%';ZA;.(
MKRW1P0&QD.HSD(W.,]PPR=N3VE ')Z_\2_!_A?5&TS6-:C@O%0.T2PR2E >F
M[8I ..<'G!!Z$5Q?CGXR^#;SP-K5EI.I_;;Z[M'MHX/(FBSY@V%MS)CY0Q;!
MZ[<=ZR_B1\$]>\6>-[S7=+U'35@NTC+1W3.C(RH$P-JL",*#GCJ1CC)X37/@
M/XLT'0[W5I;G2KB&SB::2."=]^Q>6(W(HX&3U[<9.!0!7^"GBG1O"/C*\O\
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M(5MK96WE"V-[,^ 6)*CL  !QG),EA\7_ !WIFG6UA9Z[Y=K:Q)#"GV2 [44
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M'AO58=#\2Z;JT]M)=)97"7 A241%V0[E&XJV!N SQR,CCJ/:_P#AIK_J4?\
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MA7WC35+GPU;^1I$DN;= A0=!N*J?NJ6W$#C (&!T !]?^!/^2>>&O^P5:_\
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M( +F@:!XE^+_ (TFFFG\R9]C7^H/$JI"@ 4$JH +$+@*,9QV 9A<^*GPPF\
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M:9J=M'<V=QJ<B2Q/T8>5#^((."".00",$5QG[1W_ "4/3_\ L%1_^C9:[_\
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M^RX"[L9.,XSC)K[/KXL\-:;-HWQ<TC2[AHVGLM=AMY&C)*EDG"DC(!QD>@H
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M!JQXG\;>(O&/V7^W]0^V?9=_D_N8X]N[&[[BC.=J]?2OL>^\)^&]3O)+R_\
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M4>=#^)).  .22 ,DT 6-7^#VJ^"? WB36-8U"TD(MX(88K*60ABUS%DOD*"
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M/A]X-MK>*!/"NC%(T"*9+*-V( QRS EC[DDGO0!\R?\ "[?B'_T,/_DE;_\
MQNC_ (7;\0_^AA_\DK?_ .-U]/\ _"">#_\ H5-#_P#!=#_\34<_P^\&W-O+
M _A71@DB%&,=E&C $8X90"I]P01VH \_^#'Q4U?QC>S:#K4,<]W!;R77V]<(
M74.BA&C50,_.?F&. .,Y)]DK'\/>%="\*69M=#TR"RC;[Y0$O)@DC<YRS8W'
M&2<9P.*V* "BBB@ KQ_PI\!=+\/^+;C4+^>#6-,$1%K:W=ODJ[,>7&=K;4P
M<<EB<+M&?8** /._&:_#7P+I:7VL>&=&)E?9#;P:; TLQXSM! & #DDD <#J
M0#S\'C;X'S6\4KZ?HT#N@9HI-")9"1]T[8B,CIP2/0FNT^)'@6W\>>%Y;'$$
M>I1?O+&ZE4GRGR,C(YVL!M/7L<$J*\0_X9Q\8?\ 02T/_O\ S?\ QJ@#H_BY
MJ/PUM?!$]GH-MX?EU:\=%@DTN"!FB"NK,S.GW 5!7KD[NA&2*G[-WAZX;4=6
M\2LVVU2+[!&, ^8Y*2-WR-H5.W._KP:Y^']GGQK)>7,#RZ5%'%MV3O<,4FR,
MG: A88Z'<%]LCFOH/P-X,L? OAJ/1[&228ES-<3OP9I2 "V,X484  = !DDY
M) .DKE_'7CK2_ >AF_OSYMQ)E;6T1L/<..P]%&1ENV>Y(!ZBO/\ XJ_#C_A8
M&CV_V:Y\G4['=]D\Q]L)WLF_S,*S?=3C&.>M 'S!X0T;7=5U:6Y\.)YFI:5$
M-1C10&=O+D3[BD$,P+ [3UP0,G /6?"/P7-XY\:C4=82[FT^V=KJ>XEA,B74
MRLI\IW;();?N8')(SZY'O_PS\ P^ /#1LVECN-0N7$MY<(@ +8P$4XR47G&>
MY8X&[ ["&"&V0I!%'$A=G*HH4%F8LQX[EB23W))H ^3/CK8W%I\5]2FGCV1W
M<4$T!W [T$:QD\=/F1ASZ>F*]#\-?'WPKHWA72-+N-/UEI[*RAMY&CAB*ED0
M*2,R XR/05Z1XX^'FB^/[>SBU9[N)[-V:&6UD"L P&Y3N!!!VJ>F?E&".<\7
M_P ,X^#_ /H):Y_W_A_^-4 <1XX^.-GKGAS5/#VA:'/8VMYTNS.(G^9P\NZ-
M 1\Y+@_/SN)/4BNK^&&A-\0?@L^C^)GNWM$O2EC.5421Q1A"OENRG@-YB9YP
M-RC &!<_X9Q\'_\ 02US_O\ P_\ QJO6+"QM],TZVL+./R[6UB2&%-Q.U% "
MC)Y. !UH ^:/A/X4\>^'OB5"8]%GLH5W0ZA->P$0M &&\(^,,V0"NPG) /W=
MU?3<\\-K;RW%Q+'#!$A>221@JHH&223P !SFI*S]<T>W\0:'>Z1=O/';WD31
M2-!*8W /H1_(Y!Z$$$@@''_\+M^'G_0P_P#DE<?_ !NN;\>_&GP?<^"M4L-'
MO)-1O+ZWDM%B6"2(()%*EV9U P >@R2<#@9(X3_AG'QA_P!!+0_^_P#-_P#&
MJZ/2OV:85>WDUCQ)(Z;,SP6EL%.[;T61B> W<IR!T&> #RSX<>.O^%?^(;C5
MO[.^W^=:-;>5Y_E8RZ-NSM;^YC&.]=1K/[0?C'4-Z:<MCI<?FET:&'S9 G.$
M8R94]1DA1DCL.*]'_P"&<?!__02US_O_  __ !JNHT;X0^!M$V-%H,%U,(A$
MTE\3<;^F6*OE Q(ZJHZD# .* ,?X2^(KWXB^!KU/%5I!J"Q79A:6:WC,=P %
M<!D'&Y21_"!C9C)#&O1--TG3=&MVM]+T^TL8&<NT=K"L2EL 9(4 9P ,^PHT
MW2=-T:W:WTO3[2Q@9R[1VL*Q*6P!DA0!G  S["OC"?X?>,K:XE@?PKK)>-RC
M&.RD=20<<,H(8>X)![4 6/ACILVJ_$WP[;P-&KI>I<$N2!MB/FL. >=J$#WQ
MTZU]AZWK>G>'-'GU;5KC[/8P;?,EV,^W<P4<*"3R0.!7A_P/^&.L:9KB>*=<
ML?LD<<4L=K!.7CG60X7>4QPI4R+\W/.<8P:]<\<^#+'QUX:DT>^DDA(<36\Z
M<F&4 @-C.&&&((/4$X(." #YH^)GQ#F^)VLZ=;V&E20P6KR16D8)DGG:1E R
M!P"0J *,X.>3D8Q],U'Q7\+/$L=RMM)IU_);HS0W4 (E@<J^T@\@$J <$,""
M,@@@>]_"KX/_ /"$WDFKZS-!<ZN-\4'D-OACC8+\PW(&$G#C(.-K8[FO1-;\
M-Z+XCM_(UG2[2^0(Z(9H@S1AAAMC=4)P.5(/ ]* /D#PO:^"-2\2W*^(;S4M
M'T7[.6@*R">7S<H-K,L.""-Y^X.@&?7W?POX_P#A#X.TM+#1]4CA 15EG-C.
M99R,G=(_EY8Y9O89P !Q6?J7[-F@RVZKI>N:E;3[P6>Z5)U*X/ 50A!SCG/8
M\<\9?_#,O_4W?^4W_P"VT >@?\+M^'G_ $,/_DE<?_&Z\L\>O\+?&?BRUUN+
MQ?)9F5U74E%E<,945<*T>8\*^%5>>,?-C((<TW]FS7I;AEU37--MH-A*O:J\
M[%LC@JP0 8SSGL..>-/_ (9E_P"IN_\ *;_]MH [#P]\6O UM>:%X1TF\OKN
M,Q0V5O=M;D(& V(KY"MN.%Y";?F'(&<=YXCT"Q\4^'[S1=260VET@5_+;:RD
M$,K ^H8 \Y''((XKS/P?\ =+\.:Y;ZMJ&L3ZE-:2I-;1I#Y"*ZY(+?,Q;!VD
M8(^[SD'%>P4 >/\ _#./@_\ Z"6N?]_X?_C5=!8?!3P#8_9F_L/[1-!L/F7%
MQ(_F,N.77=L.2.1MVGIC'%>@44 ?.'[0^A:/HG_".?V3I5C8>=]I\S[);I%O
MQY6,[0,XR>OJ:Z?X>?&+P3IO@;3--U&?^R;JRB$#PBVD=9"!S*#&A'SDECG!
MW%NOWCZ)XS\#:+XZTM+'6(I 8GWPW$!"RPGC.TD$8(&"""#P>H!'D?\ PS+_
M -3=_P"4W_[;0!Z!_P +M^'G_0P_^25Q_P#&ZIZK\=_ ]EI=Q<6&HR:A=HF8
MK5+>6,RMV&YT 4=R?0' )P#Q?_#,O_4W?^4W_P"VU<TW]FG38KAFU3Q)=W,&
MPA4M;98&#9')9BX(QGC'<<\<@' ? C15U;XFV\SSR1#3K>2\VH64R$$(%RI!
M S)D]00"I!!-?6=<GX*^'>@^ [>9-+CDFGE=BUW=*C3A2%^0.JJ=F4!QZY-=
M90!Q>J_%GP/HNJ7&FW^O1I=VS[)42"60*W<;D4C(Z$9X.0>0:\H^+GQ#\ >+
M+?3[>&#4M5GM7+I<6LGV145@0ZDR(Q)RJ'[GIAAR#O\ Q.^">I>+?%DFO:+J
M-I&]TBBYAO690K(JHI0JIR"JC(/0CJ<X$>F?LUZ/%YO]K>(+ZZSCR_LD*6^W
MKG.[?GMTQC!ZYX /+/%/Q&UKQC;VGAS2[62PT-$@MK72+9C,SE %0,^-\ASC
M Z<+P6&X[C? /Q3)X2L]2M5@DU*7][)8M*8W6-ECV+AU4+(I,F\%L<#&3FO?
M_#'P\\+>$8H?[+TF 747(O9E$DY8KM8[SRN1G(7"\G &:ZB@#X@N-/\ %GAK
M1[R&\T[5=-TW4=D-P+FU>..8JWF(/F&-P*DC'.-W8G/0?#7XCV?P\^W3_P#"
M/_VC?7>U//:Z$7EQCG:H\MCR>3S@[5XXR?K>^L+/4[.2SO[2"[M9,;X9XQ(C
M8((RIX." ?PKS?QU\$_#_B:S,VCV\&CZG%$5A^S1K'!*<Y D11]1N7D9YW8
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MVZ;(HDU+A1_WZR23DDGDDDG)-=7_ ,,X^#_^@EKG_?\ A_\ C5'_  SCX/\
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M3Q21.4E<*ZE25:9V4\]BI!![@@UU&I>&M!UFX6XU31--OIU0(LEU:I*P7).
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M@ C)R3P,%O2-$^&7@OP]<?:-.\/VBS[T=9)MT[1LIRI0R%BA!.<KCH/05UE
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MXU"JB@8  '  '&* *^DZ;#HVC6.EV[2-!96\=O&TA!8JBA03@ 9P/05<HHH
MCG@ANK>6WN(HYH)4*21R*&5U(P00>"".,5\.>)_#&J>$=<FTC5X/*N(^59>4
ME0]'0]U.#^1! (('W/10!XO\!/ 5YH%G?:_K%E/:7]U_HUO#.A1TA!!9BI/\
M3 <,H(\O(X:O:*** "BBB@#Y ^-O_)7M=_[=_P#TGCKI(_C_ *EI&@Z-I.A:
M1:!+&RAMY9K[<YE98T4E51EV@,&ZDY&#\O(KH_B)\%/$GB[QWJ6N6%[I4=K=
M>5L2>60.-L2(<@1D=5/>O4-/\ >&[?2;"UO]%TK4;JUM(;9[N>PC+R^7&J!C
MD$]%'&3CI0!X8W[1OB:32[V!],TV.\E0+;7, 91 >=S%&+!SCIR ".0PXKS_
M ,#>,[[P+XECUBQCCF!0PW$#\":(D$KG&5.5!!'0@9!&0?J^3X8^")=4AU%O
M#&FB>)-BHL(6(CG[T0^1C\QY*D]/08CU/X5^!M7\K[3X9L8_*SM^R*;;.<9S
MY17=T[YQSCJ: /(-3_:4UB7RO[)\/V-KC/F?:YGN-W3&-NS'?KG.1TQS8\._
MM'W[ZC'#XATFQ%K++&AN+1I(_LZ$X=RIWE\ YP,=#USQZ/\ \*2^'G_0O?\
MD[<?_'*N:5\)O ^BZI;ZE8:#&EW;/OB=YY9 K=CM=B,CJ#C@X(Y H [2O/\
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M$FC^)(W??F""[MBHV[NC2*3R%[A.2.@SQA_\,X^,/^@EH?\ W_F_^-4 >O\
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MJD+P,DC/4UA^ O@UIO@;Q+=:RNH27[E&CLTF@53;JQY);G<^W"[@%X+<?-P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S!XR_
MY.AMO^PKIO\ Z##110!]/T444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_027.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_027.gif
M1TE&.#=A>@$/ '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MPT!\XX8T$* 06'! +&B!BP0,82 LR,'? #")?T # P; E$!@<1D/(& "#;
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M2O<!SW*] 0@$  .N\ ( 2@$/ '@(1\>P&P#,T(X S,#8A1@(.0#@@3>L9C5
M", &5B208?0W[(48N2<6 N5RW..94&AQ+V<F$'2D @"#^,?H;C;PFPT$$0"H
MQ37T\:UB9*,<.C" ;3:!@1903 03Z, T5! $?A1@U@+1AQSV @T 2)LB"$M!
M',@3@@KU8+L  ,8_B"$"BK' #LK(PQJ*884*/& %AP#'.JYP"96OPA ^@ 3D
MN:&06B#S,JLHR1TT\0D"."(6/[ ,_RJLCPR2P"</<Q! /DP  WT4@ @*F0(
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M"WM0!IQ0;$;D*(!""K/P P70!__02Z4D$"V  N.@"Q;)#^P "]#H#@1P!C2
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M-&"Y!]<K3+ 6A"8CY__S#[H) /U)$D+U>@H!(GEP"RLP C4@A#4P S.  C%
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KH0Z:, DW PTE,*8XE@A>W13V4 KS4(;A, +G^M5_<+'@  MH, GY$!  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_028.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !("90# 2(  A$! Q$!_\0
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M!!(()V* "BBB@ HHKB]1^*/AS3/'EOX/N&N_[0F>.,R+#F*.2091&.<Y.5Y
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M8?\ 0UZY_P"#&;_XJ@#[?HKX@_X3OQA_T->N?^#&;_XJC_A._&'_ $->N?\
M@QF_^*H ^WZ*^(/^$[\8?]#7KG_@QF_^*KV/X >+O$VM:SJFF:G>W>H:?';_
M &CS[IFE:*7<JA1(3P&7<=I_N$C'S9 /?***^2/B'X^\<?\ "<ZG;W.J7VDM
M:RF!+2QN98HU0'Y2/NE]P.[>0-P(P ,  'UO17Q!_P )WXP_Z&O7/_!C-_\
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M _<C^;(!QEB"N<%"#@F@#VRBN'^$_BO5/&/@:'4M7MO+NDE:#S@NU;H*!^]
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M503^)., L6.!G% 'UWX&\9V/CKPU'K%C')"0YAN('Y,,H )7.,,,,"".H(R
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MMF@4+@\AE+DG..,=SSQR >[Z!XCTCQ3I:ZEHM]'=VA<IO4%2K#J&5@"IZ'!
MX(/0BM2O._A-\-IOA[I=\;Z\CN-0OW0S"#/E1JF[8%) )/S$DG'4 #C)]$H
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MH4#&-V\E2<Y5QU7(]=3_ (0WX&?\_6A_^#UO_CU>0?\ "DOB'_T+W_D[;_\
MQRC_ (4E\0_^A>_\G;?_ ..4 ?3>A7/@W0_#3RZ'>:-;:+;N$EGM[B/RE?"K
M\\F<%R-@RQR<C.<U)_PG?@__ *&O0_\ P8P__%5\P?\ "DOB'_T+W_D[;_\
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M9[X./0UCZ'\6_&7ACQ5<WFJ75WJ#EVBNK"_ED54.\%PJ9 C<;2H^7"Y(V]J
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M((,F"".,4 9_P*^(]M+I:>%-9U"07D3G[#)<NBH8OD5(%8G<S[F;"X/' .
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M@@98,ZD DD ]]K>E 'S1\3O S>!?%DEC!%=G2Y45[*XN"K&8;5W\J ,AB1C
M(&T]P3Z_\./A_P##;QGX*L=171));N)%M[XO<SH?M"JN\X#XP<AACC##H<@<
MQ\3OBMX-\=>$Y+&#2-2&J1.KV5Q<0QJ(3N7?RLA."H(Q@@G:>P(X?X=>/IO
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M#K5SQ+X"^,?C"X@GUZPDO'@0I$#=6J*@)R<*K@9/&3C)P/05R?PX\=?\*_\
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M2_\ A=^F^#/"^A:)%H]W?:A;:99"7=(L,6UK9'RK?,2?F48*COSQSYI\;?\
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M[L=1UJ3]GW38;[XFBXE:0/864MQ$%(P6)6+#<=-LC'C'('T(!]5T444 >?\
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M]X[E'('&?\1O&4.B_#?2?AW;+'/>?8H!J<ANA/\ 9I$8%H00QPXD0Y!.%4
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M0LQX[EB23W))KI_VD-?OH$TC08&NX;.X1[BY(7$5P0P"+NZDJ06*]!N0\G&
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M< ##!@<8&"2.0 3L>)?!^@>,+>"#7M-CO$@<O$2[(R$C!PRD'!XR,X.!Z"O
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MDD^L/A) 0%B6)XW8GN23M 'N3GC!Q_V;] L1HVI^(RLAU!KAK$,6^58@L;D
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M^LML'V^)"VY5XPZ9 ;@XSPPPO.!@^0?LX_\ )0]0_P"P5)_Z-BKZ?H ^,/\
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M%R3@%B3C))Q[FOL_X?3PW/PY\-O!+'*@TRW0LC!@&6,*PX[A@01V((H ^1/
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M-0_["LG_ **BK0^.WABWUKX?SZIY$\E_I/[VW,.3A&9!+N7NH4;B>VS.0,Y
M.P\$^)[?Q=X2T_5X9X)9I(E%TL.0(IPH\Q,'D8)XSV(.2""?D#P)_P E#\-?
M]A6U_P#1JUZ9^S?JM\OBK4]'%S)_9[V371MSROFJ\:AQZ':Q!QUXSG QR_P0
MTIM3^*FF/]FCG@LDENIM^TA $*H^#U(D:/&.0<'MD 'UW7SI\;/ASINGW&J^
M+AKMI;3W;H\&D^0J-,V8TD*G?ECEB[$+WYZYKZ+KX\^,&MZEJWQ(U>&]^UPP
M6=P8K:UFD9EC4*J[T4X"B0*'X'.X<GK0!E_#_P '7'CCQ;;:3%\MNN)KR0.%
M,< 8!RN0<MR .#R1GC)'U_HVH>'X]GA_2-1L9)-.B$/V.&Z622%(\)AADL,<
M Y[]>:^0/!VB^,=?_M&P\*+?/&\0%\D%SY,;H<@+(2RJV<MA3U&[C&:],^&'
MP9\4:=XQM=8UT2:1!I[B6,0W"/)<-S\F48@)C(;/4':!R2H!P\\\-K\?9;BX
MECA@B\4%Y))&"JBBZR22>  .<U]AU\>?$O0&7XRZOH^F+)-/>WL;1([*"TLX
M5]N> !ND(&>@QD]ZN77PA^)]]Y'VS29[CR(E@A\[487\N-?NHN9.%&3@#@4
M:'[0SH_Q*C"7GGLFGQ!X\J?LYW.=G R,@A_FR?GZXP!]#^!/^2>>&O\ L%6O
M_HI:^//%7A[7_#6J16?B."2&\>W1T5YUE/E#*)RK$  )M SP%';%?8?@3_DG
MGAK_ +!5K_Z*6@#H**** /@S2=-FUG6;'2[=HUGO;B.WC:0D*&=@H)P"<9/H
M:]<'[-WB3[9"IUG2A:G9YL@,F]<@;]J[<-@[L98;L G;G \W\"?\E#\-?]A6
MU_\ 1JU]EMXET%4O7;6]-"6#A+QC=)BW8L5 DY^0E@1@XY&* /CB7P9?6/Q!
M@\'ZE)';W;WL-H\L?[Q0)"NUQR,C:P;!P><'!Z=9\>]&O-/^)ESJ,R?Z+J44
M<MO( <'8BQLI)&-P*Y(&<!E]:P](UN;Q'\9]+UF?S ]YKL$H1Y#(8U,R[4W'
MJ%7"C@< <"O3_P!ID0_9_#3-)()P]R$0("I7$6XELY!!VX&#G)Y&.0#(^(OC
M>V_X4YX2\-Z7?6EP]U96XOQ#.DC0B*.,B-U&2I+D'.0?W9'.36O^S?X:A^SZ
MGXJ:XD,Y=M.2  !0N(Y&8GJ23M Z8P>N>/&/!V@-XI\8Z5HJK(4NKA5E\ME5
MEB'S2,"W&0@8]^G0]*^V["QM],TZVL+./R[6UB2&%-Q.U% "C)Y. !UH L5Y
MO\2OA);_ !"U&QOUU/\ LZZMXFAD?R#-YJ9RHQO4+M)?Z[O85Z110!\_Z3\(
MO 7AG7)XO%?C'2K_ &Q;#83S"S>)SM97)$V[[N>".=V:Z#_A#?@9_P _6A_^
M#UO_ (]7S9!#?:[K,4"&2ZU"_N BF23YI97;'+,>I8]2>_-=I_PI+XA_]"]_
MY.V__P <H ]'\2?#SX2ZGIT<.A^*-#T6Z64.UQ_:0N=R8(*;7FP,D@Y]O>H]
M*_9OTV9[>[G\6R7NGR)O'V2U5#(I7*E9"[C'(.<'(^N:\<\3^"?$7@[[+_;^
MG_8_M6_R?WT<F[;C=]QCC&Y>OK7T'^SK/--\.;I)99'2'4Y4B5F)"+Y<;87T
M&YF.!W)/>@#P3X<7UQI_Q*\.36LGER-J$,).T'*2,(W'/JK,/;/'->H?'OX=
MW$=Y<^.+*;S;>3RTOH7(!B("QHZ^JG"@CJ"<\@G;Y/X$_P"2A^&O^PK:_P#H
MU:^K_BIIG]K_  O\0VWG>5LM#<[MN[/DD2[<9'79C/;.>>E '#_L_>-/[5T.
M?PS?7<\U_89EMA(N0+7Y5"AO]ECT/0,H&0,+Z1XL\%Z%XUTY;/6K3S?*W&"9
M&*20LPP2K#\#@Y4D#(.!7@'[./\ R4/4/^P5)_Z-BKZ?H X]?A?X1@\+ZGX>
ML]+^RV.I;3<&*5S(64@H=[$GY2 0#E<YXY.?+_\ AF7_ *F[_P IO_VVOH"L
M/QAXEA\'^$[_ %Z>WDN$M$4B%" 79F"*,GH-S#)YP,\'I0!\:?V#]H\9?\(]
MIU[!=>9J'V&WN\XCES)L63C=\IX/&>#WKV?_ (9E_P"IN_\ *;_]MKSSX/\
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MBK6O&'@H:GKD,:SK<-!%*D1C$Z*J_O/0DMO!*X&00 ,4 1_&W_DD.N_]N_\
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M%!<[EC08!('5AWKS30_BC\*/#6LW.K:-X8UFSO+A&21HT7;M9@Q 0S;5&5'
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MH,<8ZYY''7'=_"WQUX"OMWAKPM93Z2R[IH[>[4!K@GEB&WL78 #J<[0,<*<
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MP/(P ?0]%?(FA_&WQOHMQ<ROJ$>I).[2-%?H7578CE=I4J!C 4':,G"U]/\
MA'Q18^,?#5IK%A)&1*@$T2ON,$N!NC;@'()ZX&1@C@B@#X<HHHH ](\<>-/'
MNB_$75$N=;OK*X@N_,2U@O"\$:<-& HPK+L*_>4;OXADD5]+^"?$]OXN\):?
MJ\,\$LTD2BZ6'($4X4>8F#R,$\9[$')!!/F_Q@^#]QXGO&\1^'%\S5GV)=6C
MR!1.  H=2Q 5@  02 0,C!'S>$:/XJ\4^#+QX--U.^TZ2&5_,M6)V"3&QM\3
M?*6&,?,,C [@4 ?:]]?V>F6<EY?W<%I:QXWS3R"-%R0!ECP,D@?C7Q!?S7'B
M[QE<S6=KMNM7U!WAM_,!P\LA*IN.!U8#)Q^%:&L>./&/C*5+*_U>^O?/V0K9
MPC8DIW94>5& K-N(QP3T]!7L?PC^#=WHNJ#7_%5K&EW;.RVMD^R0*WRE9]Z.
M1D?. I'!PW4"@#V30K6\L?#VF6>HW'VB^@M(HKB;>7\R14 9MQY.2"<GDU3G
M\:>%;6XEM[CQ+HT,\3E)(Y+^)61@<$$%L@@\8K<KX8_X177?^$H_X1K^S)_[
M9\WR?LF!NW8SG/3;CYMV=NWYLXYH ^YZ*Q_"=C<:9X-T.PO(_+NK73[>&9-P
M.UUC4,,C@X(/2MB@#S_XV_\ )(==_P"W?_THCKP#X)?\E>T+_MX_])Y*^B_B
MSI5]K7PPUJPTVVDNKMTC=(8^68)*CM@=SM4\#D]!D\5X)\$-#U1_BO:S?8)U
MCTOSA?%TV_9R8WC"MGHQ8XV]>#Q@' !]7UXW^T-/XCMO#6GOI4MW%I)>5-2:
MW;:#N"K&'QSL.9!C[I) /.VO9** /E3X3?":;QE<)K&L))#X?B?@9*M>,#RJ
MGJ$!X9A_NCG)7O\ QU\!YO$GB=]6TO5K2S@G>")K1K8JMO"D:Q_(5.&("#"X
M4<XR,<^V44 ?+GCOX&S>#/"=SKT6OQWR6SH)86M3"=K,$RIWMD[F7@XXSSQ@
MT_AQ\'_^%@>'KC5O[=^P>3=M;>5]D\W.$1MV=Z_W\8QVKV?XZWUO:?"C4H9Y
M-DEW+!# -I.]Q(LA''3Y48\^GKBL?]G'_DGFH?\ 85D_]%14 9^A?L\?V)XA
MTS5O^$I\[[#=Q7/E?V?MW['#;<^8<9QC.#1\4O@BFJ;=7\&V4$%X-J3Z='MB
MCE'0.F<*C#N. 1SPV=WN%% 'SQ^S_%XLC\0WD5PM\-"LHI+66&YG=([><N&V
MI&1@R @Y&!@,23D@-]#T44 ?+GBR-HOVG;=7FDF)UBP;<X4$ B$A?E & #@=
M\ 9).2?I/6=#TOQ#ISV&KV$%[:MD[)DSM)!&Y3U5L$X88(SP:^:/$M];ZA^T
MU!-:R>9&NMV4).TC#QF*-QSZ,K#WQQQ7I_QT\=:IX1T.QL-(/D7&J^:K7:MA
MX439D)Z,=X^;M@XY(( .7^.OCRWL;,^ -(MX%A6*,7H\DJ( #')$D6" . ,\
M$8*@'.<:'[.?ABW@T.]\3RP3K?7$KVD+OD(8!L)*COEP03S]S Q\V?+/A]X$
MUKQ]XEAOYK62ZTM;U6U.[N)BH<$[W7=G<SL,_=R064DC.:]K^*7CJ_\ A9IW
MARP\/65BUK)%)"$NUDD\M(A&$ (<'HW?/04 '[0/B&WTSX?_ -CLN^ZU:54C
M&2-J1LLC/TP<$(N,C[^><&L_]FZQMX_!NK7ZQXNIM0\F1]Q^9$C0J,=.#(_Y
M^PKQCQU\1]8^('V#^UK:QA^P^9Y?V1'7._;G.YF_N#ICO7O?[/\ I5]IGPY=
M[ZVD@%[>O=6^_@O$8XU#XZ@$J<9ZC!'!!(!Z)H^AZ7X?LWM-(L(+*W>5YFCA
M3:"[')/\@/0  8  &A110!YW\<9X8?A)JZ2RQH\SP)$K, 7;SD;"^IVJQP.P
M)[5XI\./BK9^ /"6L64>C^?J]Q*);:XXV-\H4+*>&VI@L ,YW,/EZU[O\6/!
MUQXV\#36%CS?V\JW5JA<(LCJ""I)'=6;'3YMN2!FOFBST31/"_B,V7CR/58[
MBSE4W&G6444@D0H&4&83#&=PR #QT()X /5_@KXT\4^+_'VN7&JW<\UA):>:
MT*J?(MY-ZB-4Z[/EW\9RVTD[B,U0^.?CCP=KMFFDV4?]J:M;8,%_!-^XMPY5
MG *G$C$(HQ@@;NH((K@Y_BIJMMX?ET#PW96GAW3&N#,IL&D^T$9SAIF8EC]T
M%@ 2% X7Y:W/AM\%M4\32VFKZU']BT0^7.BR#+WB;N5 #!D4J#\YQ]Y2H(.0
M >=^&M2AT;Q5I&J7"R-!97L-Q(L8!8JCAB!D@9P/45]I^'?%&C^*=.CO-)OH
M)]T4<LD*RHTD&\9"R*I.UN",'N#Z5P?CWX):1XGLK5]&:/2]0L[=;>-BI=)X
MT3;&DG.<C"C?R<<$-@8^>)H?%?PU\2A'-WH^J(BO\D@Q(A(8<J2LB$KR.1E2
M#T(H ^VZ*\'\)_M&6\VZ'Q;8?9Y&E41W&GQ$QJAX)=68L,=<KNR#TR.?>* "
MBOE3XK^./%\'Q(U:S35=2TN"U=8H;:UO65?+V@JYV$ EP=_.2-P4GY:XO_A.
M_&'_ $->N?\ @QF_^*H ^WZ^//@P9E^+>@F".-WWR@AW*C;Y+[CD \A<D#N0
M!D9R,/\ X3OQA_T->N?^#&;_ .*K+TK5;[0]4M]3TRYDMKRW??%*G53_ "((
MR"#P02#D&@#[SHKX@_X3OQA_T->N?^#&;_XJC_A._&'_ $->N?\ @QF_^*H
M^WZ*^,-"\<>.)/$.F1V>OZK>W37<0AM;B_E,<SEQM1P7 *DX!R1P>M?9] %>
M^O[/3+.2\O[N"TM8\;YIY!&BY( RQX&20/QKY0^)_P 5KSQS>&SL&GM-"C^Y
M"28WGR$)\Y0Y5MKJ2OIGUK+\=Z[XR\1>++G3->2[BO/M"(-(A:0Q)*%"+Y<9
M9AE@<@C.[>2.#7K_ ,)O@PV@W":_XI@C.IQOFTLMRNMN0>)&()#/W4 D+U^]
MC: >0:U\*_%>@>$X?$>H64<=FZ!YHS(!+; LJIYB'!RQ8<#)'\6T\5ZW^S]X
MZN-4LY_"=^9YYK*(SVL[L"%@!5?*/?Y2PQUX.. H!]DU72K'7-+N-,U.VCN;
M.X39+$_1A_,$'!!'((!&"*^:/B#J]S\-M4U'P=X3LY-%LYGCN9-01W^U70.6
M 64X(B4G8 .<HV6)9P0#I_CK\3+&6PNO!6EB.ZE=U%_<9RL)1PPC7'5]RC<>
MB].3G;XIX5\0W'A3Q1IVN6J[Y+24.4R!YB$8=,D'&Y2PSCC.1S7>?";X33>,
MKA-8UA)(?#\3\#)5KQ@>54]0@/#,/]T<Y*^M_%CX6)XPT.UET2*"VU/3(C';
M0JBHDT7&(<X&W&/DYVC)'&[< #O/#WB'3?$^C0:II=S'-!*BEE5U9HF*AMC[
M20K@,,C/%:E?%'@7QUJG@/7!?V!\VWDPMU:.V$N$'8^C#)PW;/<$@_4_BCQO
M_9'POE\8Z=:^;OM(;BWAN#MQYQ0+OP3TW@D \XQD=: /-_VAO&GDV=OX2L+N
M!FG_ 'NI1!=SHH*M$I/1<G+$?>^5>@/S=!^SS8W%I\-9)IX]D=WJ$LT!W [T
M"I&3QT^9&'/IZ8KP3P]INK_$KX@P1WC7=]/>W"R7]PA :.'(#ODC:H5> ,8^
MZH'05]EV%C;Z9IUM86<?EVMK$D,*;B=J* %&3R< #K0!\2>"YX;7QUX>N+B6
M.&"+4[9Y))&"JBB5222>  .<U]A_\)WX/_Z&O0__  8P_P#Q5?%FDZ;-K.LV
M.EV[1K/>W$=O&TA(4,[!03@$XR?0UZI_PSCXP_Z"6A_]_P";_P"-4 >__P#"
M=^#_ /H:]#_\&,/_ ,57B'[0^NZ/K?\ PCG]DZK8W_D_:?,^R7"2[,^5C.TG
M&<'KZ&L__AG'QA_T$M#_ ._\W_QJN3^('PVU+X>OIXO[RTNDOD8H8-V59%3>
M""!QN? /<#)"]* /:_V<?^2>:A_V%9/_ $5%7L%>/_LX_P#)/-0_["LG_HJ*
MO8* "BBB@ KB[#XK^"]3\2_V#:ZS&]VSB.)]C"*63+#8CXP3\HP>C;UVEB<#
MM*^'-4\):OI/C%O"TT,;ZH+A+=$CD!61GQL(8X&&#*><8SSCF@#[CHHHH **
M** //_C;_P DAUW_ +=__2B.N'^!7BOP_P"'OAYJ0U?6K&RD74)9O)FG42,@
MBBY5,[FZ$# .2,#FN8^-Y\6)\0+K3O/U5M(U3R18VB3.T-P0J JL8."PD'W<
M9R0<<@GG[#X*>/K[[,W]A_9X9]A\RXN(T\M6QRZ[MXP#R-NX=,9XH ZCXG_%
M#P5X\\.&"'2=5&KV_P#QXSSJJ)%N=#)D+(<Y5,<@_AUK+^!WCEO#7BH:/=RW
M<FGZJZ016\05E6Y=T59#DC:-N02.3QP<#'9Z'^S=;V]Y97.MZ[]JA3:]S9P6
MY0.<<H)=V=N>^T$C^Z3D<!\4?!<_@SXBV\7A^TGM[6[\J72Q:M*[B0;5*JQY
M,@<;L DC>G3(% &A\0;ZWTS]I W]Y)Y=K:ZA833/M)VHL<)8X')P >E=O\:/
MB/XQ\(ZY;:=I(@L;&:)9HKT1>:\I&0Z$NNP8)7*@$_=.X;MH\<^)$U]<^-99
M]4$@U"2RL7NA)'L82FTA+Y7 VG=GC Q7UW''H_C'P]I]Y>:;!>6-U%'>0PWT
M"2;=R94E3D!@&(X]3S0!\B>"Y]2USXI>'KBXEN]0O'U.V>221FED94=222<G
M"JN<]@OH*^TZIZ;I.FZ-;M;Z7I]I8P,Y=H[6%8E+8 R0H S@ 9]A5R@#S_XU
MW_V'X4:QMN_L\T_E01XDV-)ND7<@]<H'R.Z[NV:\,^#.D:UJ^I>(X=#O)-/N
MWT=X8[X(2L3M+$0I8?=+*C@$<CE@"5JQ\=O&:^)/&(TBWCC^R:(\D E&[=)*
MVWS<Y P%9-HX_A)R01CU_P"!6@7V@_#E&OUC4ZC<&^A56W$1/&@4MV!(7..>
M",X.0 #YPG\:>-K6XEM[CQ+X@AGB<I)')?S*R,#@@@MD$'C%=IX'T*#X=ZL_
MB;QW901+:VD=Q8:<]Q$;R21Y%"R+ 7!^0!\[\%3R!E>/I?7)M4M]#O9=$M8+
MK4TB8VT,\FQ'?L"?Z9&>F5SN'QIIN@>)O&_C%M,*W=UK#N5N9+UF+0A,*S2L
MV2H7 '//0 $X% %C6M=\3?%'Q9"KI)<WEPX2VL;=F\J([5#;%9B$!";F.<<$
MG %7/AKXK?X>^/EN+^V\N%\V-^LRLKP(77<V ,[E*@D8.<$<$Y'TO\._A_9_
M#[0Y;&&X^V75Q*9;B[,(C+]E4 9(4#H"3RS'C.*\S^/7PYFN7/C'1[:25PG_
M !-$5RQ"JH"2A<= HPV#P IQ]XT >F?$3Q/<:#\,]2\0:)/ \PBB-M.,2)B1
MT4.O9N'R.HZ<$<57^%7C>\\>^$I-3O[6"WNH;M[9Q 3L?"JP8 DD<.!C)Z9[
MX'RQJ'C37=5\)6'AF]N_.TVPE,L =07'R[54MUVJ"V!VW8Y 4+]'_ /1KS2/
MAJLMXGE_VA=O>0H00PC*HBD@@==A88R"K*<\T >H53U75;'0]+N-3U.YCMK.
MW3?+*_11_,DG  ')) &2:Q_'/C.Q\"^&I-8OHY)B7$-O G!FE()"YQA1A223
MT . 3@'Y8\5>-/$?Q-\2Q6[/((KFX2*QTQ)L1(Q)5.N 7^8@N<=3T&  "3Q;
MXBO/BA\18TM99X;6\NX[;3[>[F+)!NV1[L#(3<0&8*#_ ,"QD_5?A'PO8^#O
M#5IH]A'&!$@,TJIM,\N!ND;DG)(Z9.!@#@"N'^$WPFA\&VZ:QK"1S>()4X&0
MRV:D<JIZ%R.&8?[HXR6]4H Y?QUX%TOQYH9L+\>5<1Y:UNT7+V[GN/53@97O
MCL0"/%/C9H%CX(\*^'/#FB+)%I\]Q/=W"R-O::=$B02$GH=K-PN%YZ=*W_'O
MQLU[P?\ $.]T2#3M-N-/M'A)WJXE=6C1V&X-@'YB =IQQP:\P^)WQ)F^(=_9
M,+..UL[)"8$Y,@9TC\P,V<, R':0%XZC/0 ]C_9Q_P"2>:A_V%9/_145>P5Q
M_P +=&L]$^&NA16:8^TVD=Y,Y W/)*H=B2 ,XR%&>=JJ,G%=A0!C^*?$EGX1
M\.7>N7\<\EK:[-Z0*"YW.J# ) ZL.]?*GP@T.'6?B#:7%W=1VUGI"'5+B1Y
MF%B*D<D$8W%"<X^4-R#BNP^/_C/6I?$#^$Q')::3"D<QQD?;20&#$XY16RH
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MOD>5C*(NW&YO[F<Y[T =A7S_ /M-?\RM_P!O?_M&OH"OG_\ ::_YE;_M[_\
M:- '0?LX_P#)/-0_["LG_HJ*O8*^+/"'A#QIXAM[ZX\+6EVT&PVMS)%<+ LB
ML,M&2S*'! !*\]1GJ*U/^%)?$/\ Z%[_ ,G;?_XY0!]7_P!NZ/\ V/\ VO\
MVK8_V9_S^_:$\G[VW[^=OWN.O7BO/_C+KNCW?PAU#[-JMC-]N\O[)Y=PC?:-
MEQ'OV8/S;>^,X[UXA_PI+XA_]"]_Y.V__P <K#\2^ ?%'A"W@N-=TF2U@G<I
M'()$D7<!G!*,0#C) .,X..AH [S]G'_DH>H?]@J3_P!&Q5]/U\R?LWP3-XZU
M.X6*0P)IC(\@4[59I8RH)Z D*Q [[3Z5]-T >?\ QM_Y)#KO_;O_ .E$=>0?
MLX_\E#U#_L%2?^C8J]?^-O\ R2'7?^W?_P!*(Z\@_9Q_Y*'J'_8*D_\ 1L5
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MM&\*Z1I=PT;3V5E#;R-&25+(@4D9 .,CT% &I1110 5Y_P#&W_DD.N_]N_\
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M"$4XVG:0P!!Y85A^![GQQ\1_$.HV47C?5;*Z6TEO%/VF41NX=0$VHP"*2_\
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M.KD(.2 &4GD,H...?FD\3?&+QX&2&-[^X15VH6$%K$H +?,6*("<GU9C@$L
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M ,%4 (R ?FS6O$FM>(GA?6-4N[XP($B\^4L$&U5X'0$A5R>K$9.3S0![_P#
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M )*'X:_["MK_ .C5KT!_V<_%D5G=2F_TJ6:.(O!##*Y,S@CY,LJA<C=@D]0
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M["\C\NZM=/MX9DW [76-0PR.#@@]*V* /D#XF_#+_A7/]E_\3?\ M#[?YO\
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MN1G.W'7O7E_@O]GNWTK4;74O$U_!J#198Z?#$3"7!^4L[8+KCDKM&3P<@$,
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MQN!QG Z>@K0HHH *Y/7_ (:>#_%&J-J>L:+'/>,@1I5FDB+@=-VQ@"<<9/.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
('P!1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_029.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$!+(# 2(  A$! Q$!_\0
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M?^2>:A_V%9/_ $5%7IFI>)=!T:X6WU36]-L9V0.L=U=)$Q7)&0&(.,@C/L:
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MO> ]&FTO2[339H);AKAFNHW9@Q55P-KJ,80=O6ND_P"&CO&'_0-T/_OQ-_\
M': /I^BOF#_AH[QA_P! W0_^_$W_ ,=KV?X5>-[SQ[X2DU._M8+>ZANWMG$!
M.Q\*K!@"21PX&,GIGO@ '<45R_CWQO9^ ?#PU:\M9[KS)?L\,4) S(49EW$G
MY5^0@D D9Z&O)_\ AIK_ *E'_P J7_VJ@#Z HKP,_M,P_9T9?"DAG+L'0WX"
MA<#:0WEY))W9&!C Y.>.D\7?$"W\2_!#6?$7AJZOK*2&6*$MDPS0N)HLC*GN
MK \$\-CKD  ]8HKX<\->#]?\87$\&@Z;)>/ @>4AU14!.!EF(&3S@9R<'T-=
M)_PI+XA_]"]_Y.V__P <H ^MX;^SN+RYLX;N"2ZM=OVB%) 7BW#*[E'*Y'(S
MUJQ7Q1X%^V:9\3O#\1\^TNH]5@@E0YC=<R!'1AU&064@^I!K[7H **** "BB
MB@ HHHH **** "BO,_C+IWC>]T:QE\'7-VB6[R27D5E.8IW&T;2N,%@,.-H.
M267Y3CCRS_A#?CG_ ,_6N?\ @]7_ ./4 ?3]%?+D_A/XX6UO+.]SX@*1H781
MZT'8@#/"K*2Q]@"3VKF_#>I?$GQ=J,EAH>OZY=W4<1F9/[5>/" @$Y=P.K#\
MZ /L>BOBC_A+/'G]H_V=_P )!XC^W>;Y'V;[;/YGF9V[-N<[L\8ZYK<C^#/Q
M)A29(M$D1)DV2JM_  Z[@V&_><C<JG![@'M0!]=T5\2?#Z>:V^(WAMX)9(G.
MIVZ%D8J2K2!6''8J2".X)%?;= !14<\\-K;RW%Q+'#!$A>221@JHH&223P !
MSFL/_A._!_\ T->A_P#@QA_^*H Z"N?\8^,=+\#Z'_:VK>>T+2K#'' FYY'.
M3@9( X#'DCIZX!/^$[\'_P#0UZ'_ .#&'_XJO-_CAK/AOQ%\.G2P\3:5/=6=
MW%<I;P74<KS=8RH ;/ D+9P?N_B #T#P1X]T?Q]IUS>:2)XOLTOE20W(19!D
M AMJLWRGD GJ5;TKJ*\'^ .N^&]$\&ZC_:6JZ587TVH-G[3<1Q2/&(TV_>()
M4$OCMDM[UZQ_PG?@_P#Z&O0__!C#_P#%4 =!17/_ /"=^#_^AKT/_P &,/\
M\55S3?$N@ZS<-;Z7K>FWTZH7:.UNDE8+D#)"DG&2!GW% &I117R9\2?''CJ#
MQYJ5I>:K=Z4]LXC2TTZ]=8DCQN0Y4C>2K!BQ /.,+@* #ZSHKX@_X3OQA_T-
M>N?^#&;_ .*H_P"$[\8?]#7KG_@QF_\ BJ /M^BOB#_A._&'_0UZY_X,9O\
MXJC_ (3OQA_T->N?^#&;_P"*H ^WZ*^:/@EX^\07'Q BT?4]4OM2M=1BD0"[
MN6D\IT4R!QNR>BLN 1G<"<[17TO0 445Y/\ &[POXN\56>DV?AJ&>>U'G?;H
M4NTB1^8S'N5F ;!5B.N/:@#U2>>&UMY;BXECA@B0O))(P544#)))X  YS6?I
MOB70=9N&M]+UO3;Z=4+M':W22L%R!DA23C) S[BOE3_A27Q#_P"A>_\ )VW_
M /CE'_"DOB'_ -"]_P"3MO\ _'* /K./5M-FU2;2XM0M'U"%-\MHLRF5%XY9
M,Y ^9>2.X]:R_P#A._!__0UZ'_X,8?\ XJOBBPL;C4]1MK"SC\RZNI4AA3<!
MN=B HR>!DD=:[C_A27Q#_P"A>_\ )VW_ /CE 'U/8^+/#>IWD=G8>(-*N[J3
M.R&"]CD=L DX4')P 3^%;%?('_"DOB'_ -"]_P"3MO\ _'*^K]"M;RQ\/:99
MZC<?:+Z"TBBN)MY?S)%0!FW'DY()R>30!H445\@77@GXHWWBB!+S3]<N-6@V
M^3>33,ZQ[1YB[;@ML&"21AN&XZ\4 ?7]%?,'_"&_'/\ Y^M<_P#!ZO\ \>K+
MU_3OC!X7TMM3UC4?$$%FKA&E75S*$)Z;MDA(&>,GC) ZD4 ?6=%?''AO4OB3
MXNU&2PT/7]<N[J.(S,G]JO'A 0"<NX'5A^==)/X&^-MU;RV]Q+K,T$J%)(Y-
M;1E=2,$$&7!!'&* /J.BOER?P-\;;JWEM[B769H)4*21R:VC*ZD8((,N"".,
M4>!_AK\1/#_CK3;@:9=V4$5Q;M>R17D:JUN9064E7PXPA)09/3(Y&0#ZCJGJ
M6K:;HUNMQJFH6EC SA%DNIEB4M@G +$#. 3CV-7*\'^,OPX\;>*O%$%]I1_M
M/31%MAM?-CB^QG W##, VX_-N'/8X"KD ]DTWQ+H.LW#6^EZWIM].J%VCM;I
M)6"Y R0I)QD@9]Q6I7Q!XG\$^(O!WV7^W]/^Q_:M_D_OHY-VW&[[C'&-R]?6
MK'AOX=^*O%VG27^AZ5]KM8Y3"S_:(H\. "1AV!Z,/SH ^M_^$[\'_P#0UZ'_
M .#&'_XJMR">&ZMXKBWECF@E0/')&P974C(((X((YS7R)_PI+XA_]"]_Y.V_
M_P <KL/!=]JWP0WOXSCOHK'5-XM]-M/*G_>)LW3$^8 G#!< DMSNQM7(!]'U
MY7I/Q]\*ZSK-CI=OI^LK/>W$=O&TD,04,[!03B0G&3Z&NT\'>,=+\<:'_:VD
M^>L*RM#)'.FUXW&#@X)!X*G@GKZY ^0/ G_)0_#7_85M?_1JT ?;]%%% !17
MS9\;/B+XCM?&]SH&EZE=Z=9V*1;OLLNQI9&3?N+* P&) NW)'R@]>GF?_"=^
M,/\ H:]<_P#!C-_\50!]OT5\0?\ "=^,/^AKUS_P8S?_ !5'_"=^,/\ H:]<
M_P#!C-_\50!]OT5\6:5\3/&6DZI;WZ>(M2N3"^[R+NZDFBD'0JR,V""/Q'4$
M$ U]IT %8?C#Q+#X/\)W^O3V\EPEHBD0H0"[,P11D]!N89/.!G@]*W*^7/B;
M\8=5U\ZYX733[2#23<>2K212+<8BD!R=Q&TEDSM*9 .#R,T >E_"7XM7GCS4
M;W2=6L((+Z&(W,<MH"(VC!52I#,2&!8'(."">F/F]8KXD\%>-=2\!ZS-JFEP
M6DT\MNUNRW2,RA2RMD;64YR@[^M=Y_PT=XP_Z!NA_P#?B;_X[0!U_@#XY7_B
MCQRFCZGIL$%G>;UM!:0R22(^<J)&W<J%#98*.<$[5SCV#4]=T?1/*_M;5;&P
M\[/E_:[A(M^,9QN(SC(Z>HKXD\.:_?>%O$%GK6FM&+NU<LGF+N5@0592/0J2
M.,'G@@\UJ>-_'NL>/M1MKS5A!%]FB\J.&V#K&,DDMM9F^8\ D=0J^E 'UO\
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M5++1+R"\TQ9=]M+!)O0(P#! VYMVW=MSGG;^% 'V_17/^!/^2>>&O^P5:_\
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M7T$<DIB6^GB5(.^&)W;E4\<E1C/.!G !ZA5/5M2AT;1K[5+A9&@LK>2XD6,
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M?%6GZHWB6.6"QN(+I%%D5:1D?<R'Y\*,*N&R>IX&.?=*^8/^&CO&'_0-T/\
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M8D[@"NS+$ 8!'S<[0,U]!Z!X<TCPMI:Z;HMC':6@<OL4EBS'J69B2QZ#))X
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M>#_^@;KG_?B'_P".T >P5S_CO_DGGB7_ +!5U_Z*:O/_ /AH[P?_ - W7/\
MOQ#_ /':Q_%?Q^\-ZOX2U;3+#3-5-U>VDELAG2-$7>I4L2'8\ DXQSC'&<@
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MA7<"N6&,.N#GUX&.??\ X'1LGPDTAFFDD#O.RJP7$8\YQM7 !QD$\Y.6/.,
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M-D[D8YRY[^E=W_PSCX/_ .@EKG_?^'_XU1^SC_R3S4/^PK)_Z*BKV"@#Q_\
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MC:2&4L510H)Q(!G ]!7+^&=5OM<^*^A:GJ=S)<WEQK%J\LK]6/FI^  &  .
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MD-*=Q)&,C  P,$DG'T/\#IEE^$FD(HD!B>=&W1LH)\YV^4D8888<C(SD=00
M ^&WPFL?A[<7=\=0DU#4+A/)$QC\I8XL@E0FXY)9022>P  YSZ)17S9\3/CG
M-K*#2O"$UW96@<F:_!,4LV&X$>#E$. <\,<X(4 A@#7^.'Q25$N/!^A7$<A=
M&BU.=-V8SN4^4CA@,X#*X((PVWKN @^!GPPF^T0^+]=M(Q $W:;;S*2Q;((G
MQT  SMR#G.X8PI/!^"?A)KOC30[_ %>'_1K6*)_L>] 3>S+T1<D +D8+DX!X
MYPVWFX/&GBJUMXK>W\2ZS#!$@2..._E544#   ;  '&* /8_VFO^96_[>_\
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M2%&2Y41$+M4@Q98<9R<@')(^48 YSZ'\$O\ DD.A?]O'_I1)7G_[37_,K?\
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M 4444 %>?_&W_DD.N_\ ;O\ ^E$=>@5Y_P#&W_DD.N_]N_\ Z41T ?(%%%%
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MX??!3Q5;^,K"_P!<MO[+M;"6.[5]\4_FO'(A$>$DRN1GYN<8Z<U]+T %%%%
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M?_ZGG_R;JQ8V7QDU"\CM87\9)(^<&>>XA08!/+N0HZ=SSTZU];T4 ? %??\
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MP?H(NUM(+>*"^EN[=$:81!-FW:[[064L>_"C.,YZO_AF7_J;O_*;_P#;:/\
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MA<G)P.F:G_XQX_S_ &A723?LZ^#97#)=ZS" BKM2XC()"@%OFC)R2,GMDG
MP!'_ ,,X^#_^@EKG_?\ A_\ C5 'BGQ)'@?^V;1O LDALS;XN$*2A1)N/(:4
M[B2,9& !@8))./?_ (#:E#??"NSMXED#V%Q-;RE@,%BYERO/3;(HYQR#]3YY
M\0/@'+I&G07G@];[4MF\W<,\J-(% !4QJ%7=T8$#+$E< \UZ?\'?".H^#? Q
MLM67RKZYNY+F2#*MY60J!=RL0V0@;(_O8[4 >@5YO>? SP->:X-2-A/%&=QD
ML89RD#L<\X'S+U& K*HVCC&<^D44 1P00VMO%;V\4<,$2!(XXU"JB@8  '
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F%% !1110 4444 %>?_&W_DD.N_\ ;O\ ^E$=%% 'R!1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_041.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_041.gif
M1TE&.#=A_P 1 '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M\D8EE#C!'@QH)",0.!(<H,%Z  C@;  ::'# ,0,Y(P  ,A@1PPP ;-"00-0
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MQ :!?(, >1C(P J1# 9,(1ED8AT BB 08W0  #EH@:6R,9!W5.,=^]## @
M 02L(2P$:<8>B(&/='#"%#DP0"5V,0,0'$DT^)@" /K!#A?(0"!&:$"N;-(R
M]F1C!D*HQBI>4PTK0* ? ]'B$0!AB$1P@@!.(X@( &#_C'FHB!G6R ![ O"4
M5D1!?T)H!A!,<*6<98,8:'/&&9@  ' < 0%ZJ(,9#F$>2O@C'PJX&9:8=HB"
MR* !L2A (5[  +1E90UMV$,5#M2&,[PA S[(C#]B<(!N7.,! #" #*3@CVP
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ML Z L%CC2^4Z!#X*,Q!S<&( UF0.'A!4;>!S L%3_J .TJ!C0K "\; .QN
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M, WXL&G_,1#&X'SE, T7D1+]L WMX ])$P(:PVF;YGF>Z)F>ZKF>ZJD3 0$
!.P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_048.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_048.gif
M1TE&.#=A>@ 0 '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MEI:*BHJ>GIZ2DI*#@X.+BXN-C8V:FIJ7EY>?GY^9F9F<G)R4E)2,C(R)B8F
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MCYNF;@.S>>,H$)< +@AS ?%#<N"W('](@AM 0)? < 5"7..8;1=";BT';@(
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M 4 #$JX"@ !1 "71+Q-PL(H]!Q" R$"LV E !TS<0@P)%#@3 P#_N3." 1/
M-0, HYSC2RL  "'0G1E&,@Q1&=! E /+E$$4!RMH8D\O,"3 BS-"M$) #?:\
M , 1]KSCP65<B .  ?+8 PD )W0VT#LA@,:!)*1<%D5T"3^S"@, K  -&!@0
M-<5 O^ ES#PV].% #/9D+(,]NF#FS!\ W"#0$ #$L2X<+:1 Q=%42.& (#4
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M _^R!PB$R.M.>4(("R!@#QTH8!V. , /$GBI3VP %@M3QB]*IH0=@,0>+0
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AAC$XL@MD(&,<'21')Q[S#3-IMR6[@,3Q)"(,2! C(  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_049.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_049.gif
M1TE&.#=A20 / '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M022#_$%%+A41 L FU"A0@D(+<3(#&DZ-1(,8:0#_(Y ND?P11 J%L%"(-EL
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%\! 0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image_055.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_055.gif
M1TE&.#=A2P(1 '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MHTV9!)UCR%<$31*+1O&0X<H_V[AA#T,&6+" !G=6 ,,3BMPC4#[\E,P/-QN
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MD$<QVD&0?E0 &@-9U  N4($*= L BR#(+ !@A"18X8)6H$#_!G(, %R!#(:
M!2M8(8I67&(.KQA(E]* B6)  Q=C ( =*G*F]\P  (#:  8VD V!( ,6W=#&
M-?^FH8UFB"(6 (B"*&P3#!P<P0D8&(ZG$N $&CB@+J8P0QCN\(8S . &>+A#
M'O00!FP,! L ^,<F%)<%#ERB#(G(V4"$LH<\-6%+!%F# NX4 DX1)!IWTLQ
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MH!<"*<<00"H!#P"@ #K8P@  T >"$(@/ TE #0JR#AXP0%E^4 8O4'$-451
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MZ8%]B./)ZXC'!(HP$&ATP1*BP],%\J2#@;28'_T @#:\T(%_5 ( /"$($1P
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M$A!0 U%P_S #!_4/&6 %!M$""_4) " /J0  R% , # & \$*%T %WO /P@
MOR 0LA "K#40QU1/_X!\&O !*S!?_^ , , )_^ "7# .NT +J8!]>W -:@4
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M_[ $Z4D0_( !C] +H1 *O9 *$Y &IZ @S1,$P$(*?Z8"XH!SDX ' "!=:Q
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M0 +DB %(@ ,#\"/9^,?_P /R] ]:X % .#2=> ^LH'TKL (WX KJT,>Q54<
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MF\1W/[U5_R"HBILO'OL/5/_0 @;QS%:=#0"P#2\ 6\"9U?] #:E@"G=P ;6
M"ZLH 43@3A.S!0"PD"[H:H,&B (R!") ! OP#XM"K;IP$#&T!K90ZZD0 PS@
MM1+A#QQ  P/! 3) $.@0!-!@" !@#]Z  8EF7&?PR]I[#1%0!Q?0=;B@ILHU
M$*Y 38<0#+]  @(@B#XD!]14!>FP5OB@"_CSC@,A@"_U#RH>A 5A@E6 "@X
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M"KA_@P" NBMNH\!P_]H!2#/0GKM_K !L^L<,@ ]#-QX*1'?,C@( 4>8=6P"
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M 8090*AA_H%G%3+T2$,  %P (@H, /@@CP?_L;">9>K  !J!R D$#7)H\:
M9@SY 8 %3.FE!V?CL.8?;@#0@YD)8A@('5H F&6@7 #(@0MSS]4B!P ^^2<=
M-M((@XXI;K4H S"R ,,,=@0: H9PHA,* +#4B0$"P#BP:(#L%/FG%;3D\@,
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BXO'*B'C#I1*-B!A@D$]6EN.6A41'4._B.*R652X$" @ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image_061.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_061.gif
M1TE&.#EAK (X /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     K (X   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3FERQ H"50%8$6HD:L:G2A"NL6$7*=.M
MIE<;9MT*]N!4KR,#!4+[56M;M@.ML/*J%NY)NQ[=)JQ+$.I#O2*G@@2\,&O%
ML@2[*E[LE?!8K!:?9KT6", *5JRF.E;+N3-GO @9(X8+6F2@:U2-9O7,.G58
MA('F"ES!M^!ERDPUZSX;E]6UW\"#RX9];;C!T\-]0]5,%_57S'9CIZ;M&N/E
MM4\[ Y:+N7OL[IBK)_]FM38T].>5#Z*5F]XRXHC9/4?U79HAV^L.Y=:';=PR
M:\_A#43>>.W9!A59A&$EG16XG59<=V1UYEMQWY4WVX&)^>74?P<^Y=IJ']9V
M88)2Z269;82=MMQNO%%'D(<(:L7;AMH!MMI_5GG(8H3@_09>9HGIAE966I%V
MWUF@$?F>>LR%MIYOF*D%I7<Y^O;4A,'Y6&666?;7%W 6VF:E4UB"N=5IKIUW
MD(-47>:E16C&QF5J#G*999A=S::F06Z211Y;5TKXH)0!5E6FF?1%IB%ZH>VF
MW&Y6$:E;0:<U]F"//Z:V)W[J*6>5BO71EAEW*JHXXVR*2:?8B\6YQAY3R''_
MN19RJ7'G&ILO[OE5;$W15AQ=0 [DX(\_3F:AK\$"8.J8MST(W'#-$AN5KY>:
MV=99H#ZVJW"U8AFF5'_F^JQ=S;;::)GBL2>NCX=JV1MVFEFY)'%O"H3<9/6.
M9:MTL86)IGMN-EF0K4UQIV1DT$DZU9BH%FEE>+YV^^.EX+G5IV4+C[I=E%!R
MUK%T$\6K,5,)[]<ID)K1>JJR$[-+)<N9*B9O7)3%IYQ:IY:,;Y%\RDLR:MJJ
MMR"5#-;;E]'#;O6JKRLV>5MY3$?X6Y@&\PDRM?XF>QMY $:9E9K-THF:7,X]
M/964N%D6Y8[^D:<;KFLZ9];:_18<I9Q4>]H;A7J+_TF96K_.S?6]XK9']L*
M5\;@MWL9[3?2@2MKKD%DCPW=OVWS;2?C3I'=%'V5P@GTHJ#F.M\U$4NN=(\4
M@[<6UM]-V-V'N4$<\:H4L7<BV5R+YU"?WST;)4&/[M99X/')V7*R:+)78;]Q
M(4>H[(5FJ*[NE"DX:N]M<WYT=-:2^3KF@FM%>&^SHW_?U</2J;7MHO5:*'?A
MWJ85L]63">3%0O>7>MR^DUQ[_H6YJI%I:DH+'/^^-!SR?4EL;:J3X<+%G>PI
MZUCQ00NO&)*T3D7.7I,3UM\6YJ.-"0<J-TL;  &F*_C\247@\I+]0(>;1'VE
M=G.)WP'!]!3-%>A&-U.>B/\F8B5U#6MJ%6D>VKAF08'X3#1%B]2G_N:Q$,9I
M;"F+G)Q<-B6& 0PLB9*1W/J7L0"M)D:Z69N00)@^\<%JC'$C3_Y8UD,+&3!#
M^^N.%M^G,4@=C2K].H_!4A>P@65O@0;R$@PQAB1/+09<9P+:GD!&JG!))6V(
M!*'$V+)!3;)1.7MQU\"\12G'Z4F%HYP:BR9DQX0Y"'"H-)O\YO*J4_Z*?]<Q
MV9J8*!O>W8>5))-CO6IY+J#9;59PY)V=@!- ^[QR0F1#H2D+8[&OO2Y9&R+6
MC]0BK/+H[#;-Z6&1<A.YG15I<;XZ$V>B0K[0806'%<K3WI;Y+$#63)!_0A;;
M+A3_/CUEII#Z6Y]L E8ZD(&K=2\#5WGXA3+<V$]MV QHP"#5*U5UY7!J$]Z4
M@L.YB4ZR;-?,VS_K=IPQWM$\<I.,NJRFQS>1L#J=Q$H+#[I%+F'F5X=KWQL1
MZ$20&LQ6%X)24SK)H&8RI'*MNM*S&!=-B"Z2<G?KC%<N%B]V?E!WM H/1F?#
MHJY.T::_R9@NU4,@M55'5'J\U+>6A1VKV%"3TJNB<?!#G<4!H&_!8X53FOC6
M8F9&IT%RE-O6*+G[96]IP\J4N!3IT-*=-*BS_!J0#+K7P1UOK@G[DUW_]5"
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M:U<UB"07I]-2Q'=D1=,OE>-TC%1;O01* J1!)61Z/"9EF-$7/Q0>PX-^:,6
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-XCN^Y%N^Y@N= 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image_062.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_062.gif
M1TE&.#EAK0(T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MF%7_112A*'V4PM6:/I5"1*$P9IVZHY_HV17;".EWNZ05.!N6.3P),(Z/4R2
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H';X;IVT*H.D)I^5>GM<I[]EQG.3>[?J^[_S>[_[^[P ?\/X>$   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image_063.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_063.gif
M1TE&.#EAO *! /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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,^ODGH($*6E%    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image_064.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_064.gif
M1TE&.#EAN@+) /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     N@+)   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRCRY8B:
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ME".V:[GN:5?#&EA>DK.XM29^(ULD[A#BH%FF)B&SZTM6TG<0N]SD-[SQFJ^
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M#"9$\Y][A*@'.;?:Z+@N#K'D\6 H&RL%NS0,7)Y,O%)9>D&K)<KZN1?)RY[
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M1702<\L]J9J4,L6D)58BS5C?>#T!9Y1@@$V'ID0YVA59F$"!!958!G)VIV1
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M+.DRJD-VI++K]I?-5TY5GD<KL(DF!3VPZY.Y!XJ2SFI9X>(>46TY3%DW9W3
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MH!)9/'+=,6Q7.XU4.,B@/>K[B8:<,$:.P#52KM]AI_;X?%UB>]H]3K6+,9^
M@*5S[DQ)#!)FHZK*V<BE/0G4M0=<HP7E)/,H :SVP5CJWN8TJ39S\TK:_0G.
M&K()4Z)A$#)5;LR!$6@T/?*32G'I,6RRP*3.D#"?O(ROT<LE;FASKS>_H&0C
M&K6H:*W@+FOI6N0,!Z-I,0H6PP7O "Y>(DZTJ2C8O(F<.2K\4%N$4"P*LS>#
MNXXT"L:L+8Y]FP^<S,U9=-J$<P5:81CS[,[0;$KKXEQ[(U/L-KB)GSB*I[B*
*KSB+MW@G!P0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image_065.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_065.gif
M1TE&.#EAN0([ /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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KT_2/-V&K)EX3$RR-+Q[D*3K;)4'D,]'C0I[D2K[D3-[D3O[D4&Z< 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>image_066.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_066.gif
M1TE&.#EAN@)3 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M4U[^(9*6ZEBH-H\&>+J[9&O:-Y+<]Q@8=RU"2LZ4UI--\L<@1#AP!586E'?
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-)=1"-=1#152H"0@ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>image_067.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_067.gif
M1TE&.#EAP@)5 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MO<>CBZ(]ME16&&I-NE1U'OJ5(69M'8-,QI-I!9,X)#(UG8-'?*8C9W%/NS)
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M.67ZL,S.PN@P[X4K"ZU;O1NMX< 1[_JVK60_?D"B-L-;OL&V5XXIA.=;5<#
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0 4QKI41B[=9Q)5<_"0@ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>image_068.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_068.gif
M1TE&.#EALP(V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M!]M4/6\M,#%!))34&B6LQ5 '-:S)%O0^:;986G)6[CH1GQ25N0TR<THRDQ(
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K0I 2=?2"G#[$SL.R*^=\T1W1G-.1F2.)T1[]T2 =TB(]TB1=THL9$   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>image_069.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_069.gif
M1TE&.#EA?  8 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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KU21&*R2\V\<)42D1E3L!QIQ+B&WD\LLPQRSSS#37;//-..>L\\X"!00 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>image_070.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_070.gif
M1TE&.#EAN0(\ /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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>LJG)E((&LS1;LS80>[,XF[,ZN[,\V[,^.Y4! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>image_071.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_071.gif
M1TE&.#EAJ@!; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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=VG%2G!"55;A8OT)VSD*3S.0F._G)4(YR4P(" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>image_072.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_072.gif
M1TE&.#EA,@ ] /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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$%!  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>image_073.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_073.gif
M1TE&.#EAR0 A /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MAFF52R0S75]J%'/2=48^][C?JM.=UB!!>*AR>[J#_^L$%7Z\Y:X3)4PX$,D
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-FJYZ]:M@#6M8 P( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>image_074.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_074.gif
M1TE&.#EA/0 ; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     /0 ;   (_P !"!Q(L*#!@P@3*EP88&"
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<$9P5452G4W_$R!!/F$X$(I"9MK2IIIT.%!  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>image_075.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_075.gif
M1TE&.#EAK  > /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M<7*V5Z0!_N8H3S>-MMP%61';2$']X3&U#<&*.$%5/./,*&*KDN5KPT%V7M!
M&:3X1"H \N!"3U!>$-,&P8WW*$@<M,*,=S)6+.9X'_/Y0 YBE0<5,[=>T;H2
MG5C%M"N(4F!=Q!-$!=$8M<R9YJ.D(HKU-E-]/$JLKW0 ]'0!IE]0!G5R][UN
M&^<T0G79&[@*&95_4-[',YA*#- )QS'L-A%: 54 ,;_'M6HXQVD30FKG/X'4
MA7O825!$\F"\GV@P(;KKBVRRPBJLA,I$F)H/5J:6/[K\864/,0!%[A/ IS1)
M(B70T1R>T#P!EF %(M(7?"U(MT%1<&TSFR$!('J%Q+D]HX8">8(5*MC$DJQ
3#U#TR8RR2((C5O&+8.1(0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>image_076.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_076.gif
M1TE&.#EA0  B /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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4EX@.E7B3DFNQ)->34$995D   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>image_077.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_077.gif
M1TE&.#EA/@ < /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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9ZN7W)::2>3O=!&" "":HX((,-IA@0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>image_078.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_078.gif
M1TE&.#EAEP D /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     EP D   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L6/"%5:LK/#XD:3)DPJML&)U+1!*@BM8C7Q)TZ1*
MD2IKK@@DLR;"F#XEJIR9DV:@:U:"'ARJM.'.G@)9N7P9<VK3@3&37EW(<R8
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;M.Y)2R9F[L<56J<P:2BGK/+*++?L,DH! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>image_079.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_079.gif
M1TE&.#EA30 9 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     30 9   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C,F05*.$**P17L%IAD17&@58V2AS)ZMJUCP9-B@10\EJ@EX&L<!08Z!HK
M@B5O'EP1:*9 F2-KFJQX4.@U "M,*E5*%$#-IBQM(FSY42C4AD95(GR:="FK
MEDV?"N18\BI(I1RMH.6)56M+G0:_JM1XM.O,D"[5+EWJ<^Q2*WH#E55(5ZK
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A6D%JCL1F4&NR&:>;=-9IYYUXYJGGGGSVZ>>?@#H4$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>image_080.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_080.gif
M1TE&.#EAO )9 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MV3B8@TX#")T(Y1F3MZ"BI6A_AD'AEKE8ZTC^X:S2 :R$6G!32CK* 1N7I33
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M;L4.0._BK\9%;W=,5C;[V0*-LX\<^^MYBBLLC\T=J'G%X?P;JS+; O'.LM(
MT*\N\CCS;SC,#L3/-X3\JHNSU<8;R*^VJ/,K*\X0%''$OU:C3K>J()1(O[^\
M\RNPSC3B#+RM2B3O0 I[(Q'!\O@ZT: 3'4SK.]*:VT^^'Q.*JRW.1"-,(/:Z
M^ZLQNN)S+D?A%/3LOZ$28R6VOXRKS\<$/Y2H-8307.P:QO[",D2Q#C,3LQV_
MU+%.@7:DD$46*PK1P!:K--"L%]?_[/&B!<W#,DT]"ST2RLX2TQ,O SFS4U&O
MQ"3K0PP9K2P[-O.TT\O8'-.Q5"L/6G1#-A^5R%+XV(MQHO>HG!(^TNID$[CH
M+@43.['T\Y6L$WE%*$2S^!SRTAD/,M \O"3=K+0Y)174LBHE9/10OP"PSD?P
MA"*QLA')$A),7Z$<;#"]9CTH,R"_!(Q45G,4<LX7!;,,-FS7-:M?&$/E,\F'
M0M1S7X&\"R[1CA(U=B'_9G20U!,GZPLP@.%5M]YR?23PH$2Q5/8P2<T--.-#
ML^.VU00A*OFC@TF,5JXP]\4PL<<RQAA+26,^\;"+7S3PR=]>8TS1TT(5J"]L
M&Z-31#L7_V08,NN:1)HOQFRS$+<'E50:2,6(+&C.I&S^[COCR%;0U807]9DN
M=PMJ5M6P.^MV:3>9C1'?K]=6^ENZ#874O'0AFEA,Q-5KV]6I-V*82P7#FM%L
MN&&3.$92QZ1Z1$L90QQ2GV/LDVU)O?U2;((L- [MN%IF:U6\O7)]K-!G[TK,
MSA-7'+*OZ"(5P[M!.RUQ"WW<[N!I0]_26\46/'=S$5D<$<G5]PI1T:OE]AD\
M-=?$5#C8B:+0P1S)5E9!4(.];?VJ.@T<H7V_"QXXZJSC^S%Z 0=;M_VD#K^A
MN2T$,,^;VEU\!Z+@&&@\0Q/0VNJR),A$;("@.MBG\$8SN<#I?/]/BY]T<*8]
M%V%+A *3SJ,*Y)\2S693NV*:6H)WK/ I\'\*X="+FM88MOFI;Z\[& ;CQ;[G
M&01C <P5MG#C&_-MIWUE2A"O%O2PNWGI>@3!D,0*IZAI46J'8XM;ZA0#F IU
ML2CC0U!]JB4V]U&-:% :6F"TZ)F'L24]Z:'0?IHEK+9EA4/[8UZ*;G.JHD5K
M:1;)U\X"(Y8:*HUA/3.BHF(T1482*5&6<N3TV(C#2.&P3Y!2F'<8<R"PH?!"
M,_P>I,RB'L5)+V9RNY9V  6Q/2VF*N$23XV^9+"OL(U]N_0,A]C'E^/=BH&K
MBAEOR+?)>"VM,J-LB[:>YRIC(<A7=]O_35\H!2.,"08[EG)3-U%'M]$(2'-%
MHZ5/PL2T5MEI3@C+4]RF>*>.I9&*I/21G>SH&V/=;W^J[!CSHO1-P\0,D;NR
M#L.^=:Y]O>Q\A9JD;][YS1"=1B_".J@T(PFU>7Y'BPV$H>+D:9!8P8=M>A$3
MZ[)&0X(YCCJ\8EOMQ(@C$3DKH:.D9%X&99P4K0VG8!-6$'OSI9XZ%'#+;&=O
M]A)-$>(EI8L3*#!)@Y>[+(2=%%EJ4,:EJ+K,#S9XE!MV;+05,WVTG>74D>P8
MM)\]TDF/6^P?\MI)(K(^Y*NW4=L>B]?0X$111,F"%Q[QBD56,2BBV!06O104
M5IS=QFE(ZJ8!_[F9,AC=QW8.85R@7+2SE/4,<A)IE,PDLZYUH:60V00FP#1J
MMUE=M%%<#$N)]"<JJN&P=]@*9!ZI)I:+VK(J,^2EUN(VF(SE$$ST5(APAV*C
M;TD'C.^:%7Y4E=='BK&/$.'4WU"[UK6BIJW2;2=N"N6X3.W2EZSZ"HM$64E+
M.C)=GY2F [$*6$B-LGAY0N$M2S,BFM4EA_G:S92TLT4']NE9E EI,%%U&^F0
M9TJ]?(UQ+S*T%LG/D"DSC;NXRLG25+$S4VOM@SYT&\W=%6BO+=&'S.1?KA@K
M9-CQTLY USB0\;*4"IHH6%]SQ,F*,*Y\1 J%YD2^'M&+1;S1:+NBZ_^9U\*R
M=/'UT*S2.ER_F2A!  602WVL-&0)=4>YFB:)@"I49CYU:5($5'UOBU[_L+1E
M#AHPAX1$L&8!9\!>\QD\0U<>2L[7(Q_JV0.)RY X7GC,KI1.IU[(50NQ)TY-
M4YC!XI0T_3;/OVUY&#?=4\?[MHK"S&NJ>H.9+1Z!U+7<=0V Y;-CEY"1*^WJ
M$=D,&YT=+1')IEX6=1[+JNQJ[ZRDAF:2)Q(TT%XVUZ #,U^RPLA3ANF"[A52
M )]G,!X)ZV/ \:.:!\D\T[VWV2]U\B<94F!,BF9W=!(>:I8\Y(]4R\U_EFK?
MXLC8Z,WH8O6L"DQGQ;2=P15U)*-:>0\3'&K_^_NU2 73NX48;.\<>X#<$2:V
M\!>:FG*6NQ'=;*JKI#\8._(NP>R1!U=W9)ENFG^HTRRN;;NTA$>Y.FMF][BI
M^]NO2<_/I=ED0JMFKQ'3%+[OC>]/^;F8SL7HGK.L=](N(Z0/SC-G5Y1K@OB)
MIS5][640X=(- 95-D<,R74\&4Y&@G4 $,2UR8S)66+SD%>K]M*QK*UR++Q-V
MP6';8SK$+>)4]W'P?4W/$$DI< Q>D]Q"9HG:B]D5G1O![H8\(BF_DQ?7NJ-D
MK5+NZ:,=J<7S(Z[_J6T7%ZJ=*$EF%S%;J,W$^;7J.RCY& QN;_]BW/X-(A^+
M)>++%@^XP^VD ;*(_UV$9_%4 >U@Z$E3=HVD")PBZ!^U(8GAE0D,F: =EO5=
M.SOI>O1AL;PJ:WW\14<ED?:H#B%Y0DU/45_8=_G.=$,S?2;2;B&GD[3P!_EV
ML]&#WV33I#'"6>]);70C(H.-%_PCG*Q3JX)YC;TC'',YC2+R,:)1H$HZC6ZQ
MIMA"0,E@$M,RLWD:'N-SOW19*8PQ-_/##-E2"&@[&)!9O<LKD2OQ-1Z"&*ZX
MB^&K.%%3P>"[HMSZ*.-#IU@#F:HZ#(2A/_Z1$A)2-C5RL:!2/[_Q&?6!P:WY
M(Y2C,D>**R(*I$KAB09".^NS/+9 0B[ZG^2+"K%*"&B30?2XG>.HB(>Y,</L
MXZ07W)I>H2#:\+VGX4+>T1VS,ZY02X@ Y NN(T'[RSLH+$#JDPTXRK#.P,$N
MF@]<X4$D5$-UHJWZH\$DI", _#*XHR';\[688A12>S4!(K4#(4/HH)T![+%2
M7)K#NPI4<P@5$0U1%(Y7!(F,8XA61(E@D3['44 ER2E75(B38HNMTHQ8C VF
M(T3*H,7E("4L'$6/L!JK&$9FC,:-6$5IK$:2  QHM,:)X"AM[$9O_$9PQ(HU
0"D=R+$=S/$=T3$>4" @ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>image_081.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_081.gif
M1TE&.#EA*  5 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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9MZ75(AR*MG9M@T=5;MS-N[?OW\ ?!@0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>image_082.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_082.gif
M1TE&.#EAN0)8 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M!M1[_<[I%1NLN3(F9SK:P;!@XENE),3B,LTGG452#5BX-'ZP]1<[G'5>5*G
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F;\=]QPESY[UW(;WS/7CA=VQ]>../1SYYY9=GOGGGGX<>^8   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>image_083.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_083.gif
M1TE&.#EAN (U /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     N (U   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSAS@@ST<845@E9^ZAP*= 5,HT23/A1*$*E2DE8"29U*52I"*TZ99HQ:< 4K
MK1FM0EQ!MJQ3AH' =@UT-N.U:QNCMO7:MB&K:SP7YA4H-N%;I"O>'HR:UJSA
MP=?4)LR:>"+;C'<+6FE\D-7>R7O]PL6<D*GE@8H'!KI6=S K@I^O4@80.+-!
MK5P93@Y]<'1IC8%IC]9J&^$*U[0'_G;:=VC@M\B3(W<M4#  SABCOJTZVO+9
MR<JS*]SMFY5W[U*SG_\&BO?@M?$(1S.7G!TY>H+. WW__IAO>Y[2WX+M_=#K
M\NVK.:>9<.>]UEYV>_TFWWE2W:5<00*JUUEY75$(VH'Z(109>>NU=N%Z$,(E
M86T44GC7;0"<:!=< F&7D(/SO45?0=PU]]Z$3!V7T&C:;>1A>JNER")BI WT
M%X!.64C4>4%)EU90(X;8HI(488<A<DTEYV!X2CIXI7/'N;<;E 42I)Y/$-Y(
M(Y4&\7A@92QZF=Q>;F*(585X42=57<>Q)>. 4X(XT(8V&OADDXA&:>67'(J&
M%Z+LL54?:U2&>1^>7]XXV6^G0?=:4#J>"6I!=Z5UWF\""F3IE9D%-IY_;#;_
MERFI119ZT*I:3M<4HG(BAV)#34[Y%:2.\C8DB4-.-IYB939WZ*\Q61@E +$Z
MYZE%^;%GG4*QRNJ=C#!^6RNE0LD'@%7-VL?E7NFVV:VC=:7*J8S!*:1L:'5>
M"M1=K)"%W5=-B>L=JN=]EY7 WX'+%&=E5<C<M:.E^)Z*LBJ7&68\"O6C0:FF
MJNJ<5'EYXU^"8>83P +U*F)V1BUZI<;*?;N@>^0)56J[@;+&FHIMS6P=C_,Y
MA2N75.;;GIH/&:VO?Y(BG-J:*1IUEW1:B4R:T="ZE)O.T!EEX=;64C@I11@B
MG:6@\26V,7_-E0M7@>U*^*^M0 JJKF$N$CAG0_(%_UVC0:[Z1B'!\O5=';]I
M45HPR7DN*/2Z4TTW*69E?XU@RJ<U:W*_ZE&E)&?8X1<D?)1=&R+>;)I<8+Z7
M>;ZR95.I.W:+X3'G,: 2!DZKXI<;J9P5_(HK-'ED'7G6F:@:]BY#"C8(LE0_
MX7H>N#@3R--O0IXE>:FE.I]U2ZZJ/)V%G$E^9JD7>:PL0^^259A^Z1)775KF
MEA>WA9&9OB;L4_5\I7F;T=.>!O4[S" *9@RJBE%^Q"_=_$EW-Z/3N @('S5A
M3(#H4Y7S+/.3\J'G1"<Z4LX^I"KOG&MTOLL+XF9'K0/9#B^XDAE"!#,M^YSP
M4E027X;,5"!^.:I?%X++UO](Z+N6):99_'%9V>!EJL:9JEX.:<WTU+*@IT5,
M=Y@32\>.U4)U-8M0.,E3P@IF&?+9+V9_2A\9$P:<-8:+9J1[8O56U2!J]>M^
MK3KAKY2V'R=&CHLWY-(;5S,U_V"E/60)WK<<%#WRA6D^PH/9>+Q$G G*2F^&
M6@R;U".7(Y6I3M^ZD[H:)9P3A@9+JXH7:<Q20Z"YQX=1:AZ/3L@_P/#D5&99
MW]@>"<GXM<=MNCK.:<(7H\P<R4I,26(O7SDC^\3,.U#2R-2."$A3LH8MD7%5
MDGREQX^Y)FT[%)).AGA#(C[GC/Z2D=T>\A=6M@MXRX2D:U#52! 5[S'R4=V-
M:IC_/0"QQ2SN4J5!O'2]$^J,5D;9S6ZTF=!--N9O?/E*60B:I7[YIXR3K*:
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/LC ;LS([LS3KJP$! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>image_084.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_084.gif
M1TE&.#EA,  V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     ,  V   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ A7F/U\%H@@JRL1"P8Z)K'CQX+6@E$<B))C18W#K3BD55+EQ0Q@@3)\F)"
M*QH/LFRY L *ESD'K@BT8D7*0#@GLEH:5.!.@S\]KMC9\5K3@22KGMSY,:;
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C5UF% H<0C?OAY%I69^+56E</28H09PKII>&HI)8*84   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>image_085.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_085.gif
M1TE&.#EAU0$7 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     U0$7   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3BERADN"*0 6MP!PI<^#+
MCRNLM(QY3:? %==F+K3B\R!0H0" LMSY,I#3IU!#$NT8J.C&%5BS9ET8U&*@
MI1>MUFP8J&M#L!M9]22J4VU5HFC37EMJY=I'M0^OL?I85RC0:W,5'DT(=._
MNE8)EK5JUN!?P) C0[9:5K+DBT 3)]5;T+)GP E9[=4;%T @PY4M(Q7XF7-"
MUPKKEBZ+= 4KJ+BABNTY$'!I@W5]-X2MT;):R:N3_G:,5J93M\^#/EW.T/E3
MZ-<3UU3K<ZI%T:(!@_\_"EIA8\?$$2,,+A1P<@#!6T/VBQ5ASOH4^R9U21R
M_,L(B6::<(IQ=IQJ!KF'6WDV.2534-8]915W^ E$&T'Q_8=466 QF%!9M[F7
MD!6LO&366!6YQ5UEITD75V$,_673?Y&]-QR-_>'U%TMX6:37:;>!6-B%/X$'
MGGA&%@6C:4Y!Z!1Z<^FT(XG4^1?801G^5]%1(/JTY&MV/20@?+P5="&/@2VG
M(%0>#HAC47BYM121-H&EWWH@/OF7D7&1")@5.8GWFUHL"5>65V6N%:9_FNVY
MT&,!7@E41FT6]*6%@2WFGXT0U:?59B6R4E26G\W48E '2E;:2YF1.:!F!%7_
MVF!5>#Y)T6#'P73I0;(*%&&3TM%&JV)8>?;>FM$M>EB@)>8D)5P$Z0@92W0:
M=5Y!J?:4VK31:@@<;_J->>NVGU$&F6$(;9NNI,I6U.M/_:D'0(EW"D;=8S7F
M.>Q/69T;U%:L(??@5X36Z:EK:!H$9'C2@:==5;@!BN*M)_JV:X+M%HBCC:>&
M=VR[,AZD5I"Z&=2C;5U5BQZG%!Y*&E8%S^N>;5HYF"M_IA;*Z4-.944HS(W5
M56)__(G:)HVP/E2L?( FB.Z 50:<]*99@6@9ED'-):Y-0K-$+6\QX]L6NKON
MB>39JRULI)&8-5:?RACG9)_/>HT'L,P,#C88QI\=_U39VL?%U:.%:$Y-YE>1
MLB1TF5#[^IQHS^'VDE67:BH8@4:QY2=;=,KMW]/ ;=9NMI89[I#FW#FGIK+O
MQGHEKV\]2.9>29,FW>LS[L4EV Q69>B5]<)KEZ;2)K=<A10GQQU7>A'=&<FX
M8^H;4;0]*"K&FA-5:7QQ63[0X*XO1-N?)@>6H:FX;RMJANN"!;Y]F//=&JS.
M6_HNA[%&W=!8=9%5\<YU(HQGR'2M@2SF*!>#45^()Z+O7<DL,<O=JV16K+1I
M"5$S.5CTXM:E=9%H:!SKB7Q6@RQ@V>]<@&.<0 ;7M(OQ!%BK&5EX1+4\_#DF
M*7XB'T(J!CJ*= 5-6U%3#_^A]*'7*04CI\$4]7JVPS"U#B)?60RM_N8WSNA'
M93 "3<'8YL YS26!G&'@9E8CD]_L*S\]0=E>X(8Q7^FP://:2P0+Q"2T-"4Q
M/UK0T]B#G>M$3T=NF:!"SB2>;M5(=(T[X7Q,QT#3.61-)3S6$$]81+#8T"NH
M01#60@3 AY216S-4F'NLIST5#NE?KKD=G-@5GE6%D7=C5%CL-(<X1)UK:25B
MWF$*N#P!":V*/\G-:O1GP*[,,9$./ [M&C@BL^RHBX?#5),4=B"(/46 S9MD
M1(26*F7*JG[\R5@QO89,Z3FR-X9!#%2H0\7BS$6$[P02?(I4M\^,;"F%814A
MH]C_+4!]K8"@FF#Q%&FLBU0S8,<QG(>0-Z"9C ENAW*3>#S4S;4!:"DR--(;
MX:-,*4U4F[$,9K<4UQA1);$S\HE-(37R%7S%:HC@G)$X,86F^&VKDZ+SVDRK
M2)J,T$8IJ?G@IMR$E:?HI8Q6\A)LA+.W;EV(1=9:(RR;"B]Z90^@#GE,"T44
M'.J\"V6+$E<@Z>@J!VHL:Q-MV+5(QRWIE8D],N,45;%EOO-<3%9;$V7\MI1#
M/S$I>.A4S/7"64F.GE%F 65(-?M7G5QM]$.Y1 ^]NE+(HYJEEO"JC5]<8SG
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0ATWL8AO[V,A.MK(O$A  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>image_086.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_086.gif
M1TE&.#EAZ  ; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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*BEC,HA:A&!  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>image_087.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_087.gif
M1TE&.#EAM@(V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MM,0AST*O<&(Q)%O!Q3MR410C*BM[7$FG7$E(]^.+5R2UO0M-!X(] $R$N"1
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$$   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>image_088.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_088.gif
M1TE&.#EAO0)3 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     O0)3   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZCRX8J?/GS%7]'0XU&71@4(/6K%2<"G0IU A6CD*8&K.0%056HT:B"G!
MK@E9>040Z-K8IH$$@H6X=F/:@BO>+K0BMR%=AG4;BOV:5>#=B$?_QKQVC2Q#
M5M?RIK1B5N!0Q&J+0B;(BE7"ME7/7@S$N3/3SIRCBEYQ;>C0LCVW F!5E[1E
MA$X):I[;&#7!N K+*O9[[34 UT*%SG9<%ZM2PLB3)X>;&&+O@H01ZAXX_6#9
MW\\'TMT],/O"%6-Q'_]GNH)5ZM)DWV8-Y+MA=(6NU;+NO/=V<][#5S<O7[DR
MY\J!W:=?7Q;QUU]EO1$H$&%E-28=@YTMI%QRNZU%&G?330?9A0--UF%[T E8
MW46D*=>5<@H^E2)(K'6(GD&3E669;95]:!^(!#%(G8"RI594AB_211B!#;YH
M4(,+3LAC=X5UMYN!!Q[X'E)+(A27C* UR!E5B,4V8D'7Q1<7<G(QEAQBO2%7
MXY$.EC6<;IP-R9A0SY6HI)()37G9<VA26%"?O0&JHXM+21EH?6HU*=":FT4I
MY8$I1E=B5F9.6)QR_IG9WVPCZDG9A.45UJ6+?^*(%&)RC:J:1!<*5UBKI*W_
M.%.L['TU9$)VFKKHA.;QY-VH!BDYYIBIMA>?E8,"0!AYIBT[)9#L)9>?F27F
M!Q:JC'6%6%8E?CJ1A[S=B=R.XI(9(H?5K1HFK^"16^ZRS+7GW:=D]C8GL)8B
MAN:^>2IJW6?^=G@IFIJBN:5]7!KI%\%I53HN18!:!K!!=K[;GA4&+R6DPD76
M655C!.K)V&PERNA:9]Z%NM2=BI&6[<?F5?F0RU5=][*RLLI48XLN.GB0OLG^
M>6=6VVHW+V^L >B?6"FS!EZ@A&U*<6*A=9M=M=%AK&^T9'ZFF,G8*8S4QF,R
MQ>BG9]U,F:,'(DEON4C%.=^6$![E)KI4C\I?U :'_X;=6U\:-+)]'/O,6\-F
MFZ6XJ6XZYFFXY9[5(GC!);6:7#)^S-AK@8<E-J@=WUI1K60IJ5[4*-]IM)KG
MR7Q=V";":/B 8(*\*&B^.:PFWS(G&9G:K$[X]X(Y#Y:6@*X=3>5K1<L>((BH
MUJY9T4FQA_&<B8IKL.>1'5OZ]Z'#2V7 8#M>):II%;D4I<H#RZ2X;I/JW-QQ
M!APVG6()2E[]<E>.\7W9FDKE*M<XQ[C/?)*CVI;F4QK#L0=!4.-;:QP%&O'=
MKG3*,5N9>D46-/4D+D6IV/3L]QXW30E[HV->WN1VFQ .ZS=4L8JF@F8KI.'.
M6 =$X.K4)",&>4=+8ZD1S?_D4QF C<4V%+D0RDKW%K'EQ(>*@M/L'*?"OC2/
M4"XR5?3,IZ;-H<II-8,0%3]6)L]\3#8.XI#/@ 1!<QE0=#E*T(Z8\C_61"V&
M<!Q?1#P%+O>HKG:%"=V,##<9044-D"PKDP4)!SA>">M]O.(:48[6(BS%28/]
M4AYVMN>M$&5/0"BD".FVY3+O89"'S4%B4WB'H2:]C$^^*1'];G@?H"6F8(G1
MTV3N4LE?F4MMCX-(K!S'1.(!)31^TP_,$/+%WET1:;M28):*E*1]-4A?!!.8
M7Z;R'+7UR3(<VE4(_6(KP%%P=8;<77,VIZQ!A4IT9O+*%<M'G6EZQ5/O0DB"
M*N?_*=TM"TA'\=#Z*D<Q^O -0'$,'YE&!2#V"*5+G%E94>3TS_T$<VIBZ^5$
MF2*SS8V)@VP:8;":5"2_A=*?IOM*%743SD3UIS?3F=>8NK:O0^[H<,JR#*/*
M4S\\\2PT[YG7ZWRW&LNDTJ8PO$]V@!>\"L:IB<6[B9F2U)=*Z8IVGLPI2BNZ
M*$RV$XV2><V0NFG!E3'O-:9\T%LT8SDRGM)/TV',6RG4/'?F,7X?P]-7=_C'
MD>).3Q6S8_J:P\?2/-6I,!K*16&HGY1Z)2Y:*]0MEZ+*(47/GPRI%HP&FT%E
MY<5.7?G?%$LW0JI82F7?<U>YVC-*PR:FI47M#M..=ZEE_\U4>#=U*RR5\C^-
M]5%WZ?27I.QU5#B&TS8%3**EJN/$IP!KB[+IDX*>253M1,N@@8&@'0^%)LJD
MY4*#DVZ..-<8IEHG3>+"2 ]C]Y6QF)=GAPO._ZKKUI'JLZ]=7==@L4+)=WU6
MJ:4A*+(:V9IW(6>B:B)7=^%#PPO*"&@<Q5QP>6BWV?6QG<GYX)"&ZIBH=I N
MVV+IO #T-*/F,H9O!.F7="/8G,:6F8HZVUSW):4XDG9PUD/>?=1H/\"\EG+%
MQ)EH$ @>O.:U?G'!$77W*K33* RX#/*/+G5:FJ(1]RQ7&VN/;R/:I])E*A=^
M(-MVLZ%U]FY7U)D6CR8SI0&Z>?](63E:,/5;.@1)6$>D<Q)SFFBI!WDE</]A
M36^%$\I_(J@_]'4,N?+3RQQ%V$4.Y4]PMGNIA-FW=$Z.4T6>MCMBF5)0)M8D
MU^SETK'U*:9ID;'1Y-*[H)HG.!R.SG-*6.7PB @Y^9E9;78-U2'/%=>?>@N@
MG+=*''4+S3_C,QJ]Z]D7CQ7+N4L3=WIFYM!*5G;I99-;81LO\U45IB@3*TD-
M_+#T:,F@B3D;G3LV%(>YE+T[4JPTI_VLT:YI:_\QTG#G,ZK')<B#8=DORAY]
MKJ*]S#CQ%MJE*VMD7:-N0/N6382V%$^RA%!'\=17'#%.-?2H6IPX/4A0]5I=
M=BISS^7_V=55=?V80"JPN3_!YJ/BV*P&4S>Y.V*UKGB&7R'65U+0F5$T5[0=
M,Y.<4&_N<=8L.FWWF7R5O"(JE-CV\"3Q+DW:K2'>L/+"AXX[2DO2.)-S<VLK
MJA!43/J;4!K73PJEJ)>=K5( $W11VP21A.,>IR8=<K!$F>D_BBDZ3.'%H[86
M"436HY*FV%,A4+;:+->LL?ST<T]C)[A2TXX;@5RVL:?JR\,SF:K0QF)!+1%[
M1SBBUAA%CI7(OW1MYEO]C9;>X/,VS"P$M-^2Y\Q?"(UVIEE:9'R#DYW%9G4\
M=6[\\'[#) 0G"CIUV1P4\:*GBTJY2[#6]ZOZ7-@\,G.P @PO_YEU>DD89P[9
M&S\P&C,/&'W5\4=G8AK6 W>E+C:D09UGDWFZ\D*11TVHPO4J&F=6&+4R_R9\
M0F,J[_1_N<1UOD9:LN,;,D)9?O(V* )UA-8Y5E=N9V0C[?1=G5,R&_-^"Q%7
MDV6 V(9?OT&!Z<8ZB'0GIK(JEF-\$Q6#ZK> >;$N,&ACOW9KA;%5ZI=7^W<F
M]_5_'_0_SI<9&C,5HH<TUI0ES<,S1R$<\#5AG45M=#1?(9)A124D[&<7&Q-%
M4^)^&E9<:<0KN>88HO4BLM0SKZ8<GA,S9Q> ^B$Q;O2"$AB$@J-)(G@>T.5K
MWI=7%@AYW7<F:0-P%_@S]A(C"[8H5/\V2 A85%SS9PQB+:JB@HV%7X'E%6$X
MA?X!&E:Q9+["@3#R4IK!-0BG'9^76RB%<)*4B?]W.FG44T386+(8B/*1.#U1
M)$DX4CQR*PH5A/ %2)C#76SS3 5T>)>&/1V3$=*R2M8B(&)W2IBA$*<&%]13
M5IVA(.WB8K;H+0[U&_X1AVSUA_:1AG Q. ^H:%8"%Q&%%-\RC-N8$+%!:VN6
M/FLUC@\R.S-5A([#=5YW>IU43]7H%U]X&P?Y&XR7AIA7BJEX)&F#CD;#07FF
M%D<DD0AI$;9Q)1%I)<EDD2WD9D6Q*DT!>O=7D(S%$R9I);FVD@62AB[)6Z$'
M<^M8D_28D(#_,1'=2$YP03$Q:9- &91".91$691&>91(F91*N91,V91.^910
M&952.9546956>958F95:N95<V95>^95@&99B.99D699F>99HF99JN99LV99N
M^99P&9=R.9=T69=V>9=XF9=ZN9=\V9=^^9> &9B".9B$69B&>9B(F9B*N9AY
M^9/?03&&^9 ]V4(DD2(H"1]<QT$8XYA'R9DU@Y%1T58[J10;T5;G&!1<QI*V
M IH-X9FPH2B!81W@M(1+>!2&8U[/QX,J.9E+*5>R(5KT2)-LTG0[9B^UR1-U
M,8Q\M8,YPF>8HH@G(FS"*4KJH4W,ARPYLYEVT5S?!I BV2%T1!\O_^4I(CE
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M""8K)R'IRH &RYP^22T[6:68$HF[R#FT%3R+!*C?>BM]&E)R]1PV\XL!)I*
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HB7$2.;FT06%*D01+8Y&OL"3+LC1+:^G*LU3+M63+MG3+MPR6@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>image_089.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_089.gif
M1TE&.#EAO (V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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7L4477X0Q1AEGI+%&&V_$,4<=50P( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>image_090.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_090.gif
M1TE&.#EAN )3 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MBU;WJJZLPB^IE5W*C2/0SN4(+9LZ CMSG' :.[D!(9KH<^,RV[PMR_C:V=Q
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MK"LY6)E<MR2Y+\8-,7G.U&E;W,.96>)HEN-K&Q%'6LX<LA2HCNF9?A1)K+$
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%E8   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>image_091.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_091.gif
M1TE&.#EAN@*1 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     N@*1   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HSQ7K$!J,-!2D$X?!F*HE"G%J@2M3'RJ<*I(
M*T^C,K3BU:%8B5:T)EQQ5J#:AH%8 >!:$*M#L 730J2;L&Q:LH$"!R:XXFU3
MN1Q77#/,,-!BO JM7"L+]QK$:X@3DH5HA17?M9/=7ON<=31ASYH!7+-<-_1
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M]%8AUD:*60C -FHGUSE"F]8WCY5.9F- WOL81:(=*[0Z1A1[4;@@BAG%$8=
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M)"YR 7"/(AS1#FVX,P<Q!$I"A&8'%;3_'[O9L&7& TXH7V<I,.6(D0<A%,X
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3E$:IE$XIE5:IE5XIEDYI0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>image_092.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_092.gif
M1TE&.#EAM@(V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     M@(V   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*@T:*%#!%586KKCF].FU%0H#85U1%2'4
M@5;"BA5+< 56A&'17GO(M>S5AH%810ST%F%3E*RZ0CR;5:[(O NU/HUJEZ^5
MN@L)[U7\D:]7@XX9FDT:66/EI0=7L+HLE!5B '0Y-YVJ5R!=Q@7I.CT]$.IF
MTU1!7YM-F[9BSZ@'SD8X.RRKW\!?$U0]D#A#W%XK>^8\U:_)V7%+ [ B??JU
MW 0/?RX;O'MP[ 1G>_^NWKS@[,NL88-W6STKU=$>8WN5K[O]0>C"L[,B;+;_
MY()6Y&<=9YFUYY]_ I7WU(']/73-9E:@YQ2#_Z6FUV\:4=?4AHQ1%QA]/GEX
MET#+!0C<@[^5]B!I_NTW582_:2;<8:M=YYIM ^'&%7%3G=>:CP;M9M!XLM76
MFWDH_B9><&=I9Z1GM#F77H[;A2=77-X)F%&,GCE'XG4 .&;<04YZ.9R1:-*V
M4%Z:/0@@79OYUUMEH9TU94*D1708=4=21%=M4"8)9)BQ]7=8G!4BE"*1;MF8
M9FFAA6F6:@BV%EFD *:Y%J&E.8FF?>8IJ24 XFE:V7G]+=<@1<UM^&>3;IK_
M%IVDVA&($U5Y0G4>G&GR]>>3-+[88ZT"T5AD;:@=FJ"1N1W*E89-]<;8F)*)
MMV&7T=:EW8;6QA4KH6!JV*UT;@9JI*T*[>AJMF'U^24 R,%F8&]P'E3O?%6I
MNZZT[OZJ*71N;1;;G<6N"^6Z@:QG78V@?ABEMWG]RI>P_U9)D&<""=FHOM&:
M&9J_3UZ\:7$6(RQDGMD]:'+#NEVI<;'OO7?M=IYJRO)\^XD%9)\][O:OPC*]
MN">I:.[X+*8]=MQ4NUJ!^?%5("^I%5:83H>5N:5ZC'717\KU%4.4DLQ?9!&:
MI2-49)_WKZ\'1\O?RW-5;*3(159%[8]@RF:FWAPO_ZT=;'*+UUK'_FGW6X?7
M&:M:@'5%;3/@FBH)(JMF[8EV64K_&5;"#Q+FN*;+KE8=A@EZV]3!)^YWL5\B
M6ASDIBB#A6N#L</\K^1ZG497:MMUZ6*/DZH^48_!H<HHH5Q=M63Q-[^4M)MF
M7W?:BC&?E2M]+(*Y',8RJCP>M'\6G#"IF\&IZ\AE,8AJCEY#A_"(&4O_<\H5
M&W1:JC8NQ[ZU*-<N$85M.I#(/+>;NQ5I6BLZ4^!&!D!5K>I'$>-6E4J$*ZQ-
M;%*S8Q!8L@2E[["J*H"2W,28I2!JO>]/KGJ;7$P4L==\"VOPDD^\V >;Y#4)
M<ZXZV>1J5IN$&8:#RP.,;O_6@K$S.:9'TRF;JM+"JA7A#TJ,F8IL2$6NYKT$
M5_0I(N.:MI^Z;,U(38O*:_)CK)Z!,7X^RUFLA/0KUH4'?6_\7*S,!R>(,2Y9
M.J.*6"[#&/U5C5"O*6'>*A*@TUVGB+L;8'&B0JTVZ7$L?*(/G" )R6_!*X*'
M? OI&M6K3$'M4_K+E!61E!'6S"E,LD%-[.YGR01!LDW%4DQYHA:5;]U(,$A4
M5FL"=3J]J8ED: I=IG+V2B&6I36IE-29Y/+%S[RJ?A71%'6P<IBMK&5W>HP2
M%8LR'HB!BU'@4QFWPI@0XW#%>N,KV&Z:N2E_Z4HX<(/-"G,8,=NYC)H#&^32
M\%?_MLK9RH]P_!4C-0G'B3P*3'";X1!'B*+("4YODA+@WX;80V/%LSD,C4P'
M:>,M,58I6 )<$(-":1%3RHQ;JJR@Y#IHS(,Z16.SO$I_8M/*CZUT>50#%*\
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MCSL9NR<5CZ=#=&VIAB.C9.+'F%@F7IHL$L3>'"E"R,.FD%\*6)G B,*78?/
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MD8:F81-NF1*;!!FC)%5,Q!%SN33>^!C),19N&6'4 9=)Z$K2N)/T*!B#$46
M%9*F,7>$J9:2.9F469D>,9>6F9F:N9F<V9F>^9F@&9JB.9JD69JF>9JHF9JJ
MN9JLV9JN^9JP&9NR.9NT69NV>9NXF9NZN9N\V9N^^9O &9S".9S$69S&>9S(
MF9S*N9S,V9S.^9S0&9W2.9W469W6>9W8F9W:F9UB%A)\QQ8$DDZ#_^,0D:DG
M%.&8&%&>/H&9G<F>-)$HVUD42CD<[X,=($5[E?(4)X0NJJ&("0&5!;AT ;F3
M(RD5./D0/5D</]8>U\<68>EOD&(?[W8J!,@[] 418E=>1V1%V<<A"I&@/!F9
MOA>%>#(M1%BA]A.?;;F'G!1,J1<X:'17@;$? &E7+KI[9T>-7#>#1QE6!T)7
MAG)[@E(5(-I;K3=S[T,@O042WD: U01M"1)@UB-]8!1O\(B-]%>28O,44?I&
MWD%<X#)WS(8FXW9R9HAZAI896(HE;*(6**JB++&DDFAQ>91Z;;,D]!*C'-4F
M3!-VE$0I"*<N[@-V2NB46$./LL(A[.4J8/\Q,R?%EU,96S8*:A:3/%WQ/3K)
M'I]3D&]:7QI6'X]V+E1B.G>!32Y#CB"#3]%(/6EE@QJY>R1G*F(%(FX%1V:'
M;K?U*'_63IUG2\1UB0R(=S2(5G *$PUJE@<"-\1133%V>MM$*;BA;0L$E=46
M1.T3<95G36LXK4RW0 HJ01#C*A.CGY3&E.=B< J:6DY(69DF8NX)&I6'?!NU
M7J=3H[<J/ZNU. SW+@L#62-73: 7+W#3<]D2-98JCT3SI7 $K&R(07&B,248
M/9R#8F(R;V,)''3">[V:?W[UH,4J$E"(-[,6*MJ%IRH3'O>6I8,Y..L(J0E"
MA4J%.Z91/"R%+?;_PJ.*I"AF$B >J3N=,E)9RF#9A$GPA2RA%',,Z['EQ2>Q
M>BX0@HYV0E!1:JHDPFN-F"WSE5;R,B:U@D2&-6LBPCE78[6IMB]FB%'I8G 0
M2Q]).RAD"B<B-+.=5K,C6F^&-C0?VQ(A6QQ<=RIZ9)?'HRS$P3T@\BR;\ZG?
MN6Z(A(*72FF+^DN\ S0@RG]AFD_>9*, $VH&"4+>@K(;))/IX:SJTC:7*Q']
M21_RM5=\$BU1NULSDZ_R0X7HQD8JDX<HQ(.=4Z8D5R_4HRL0]D:41%QR)"8\
MB&5LV(AC(2U[)'(CQWKA12]+(T&3$RF3$7-YBQ=5::T'$RI0Y1^C(4,<_T>X
M9'BNRM5'5X$MTS<E#]1UFC=TZX(:%.1ASL&GSZH]\K$C4@.S8V(<14FL>-B)
M>@<J2ZJT^MF(^%@5@EN[0TEE, 1H*8DVKV*I_LIW@@&W_G6\ZY:!A&<YG8@:
MVOML48*-1"<?M68?SLJ\ A61DO(>TW47E<&^+'J])?%0_RD]@]DQYN&(MD%M
M^5)QN%IFOH%E=DLEV*8F=[)3(82SGV-EM,1_WY9/"WQH<%1 FXM_<-BO2G4D
M&(.W1WF6'J@0DB9G1F:84Z23&!/#D&-O_GJSBFF(F\-MDN:%_1M8N[>KDWC'
M/K*V)GRFK^4O9#E\D!0^DKA5:"S#(3&!8(S @?_42C +7KE1*!%#:5&V;FI3
M6%9U+')JP:AC6*,Z,Y8LP83R=.QC?V$,&%\#,Q,"JE,2-6':=2A$Q8(\DQNI
MG@KA)-%A*)HQ,4PU>52+78 28V":5^_315%$;O.[=@OQP;;ZB#]<Q/V&Q2PT
MM]VQP"L50S4">WN5?&<:+YQLR",!/&B<AV BIU^B?JP+5RV"*+SSB;P"OY<\
M7\9G'+38>I9T-YJ;7*),/^Y#PV\DP<9"<>(D)#1"?K;!1-U8PQOYKI[D)ILJ
MLF#4RY((B=0(IIA[D%]HOX!RH/93K]>B%TG#A3GDT9'&/#!S:B&,E516=E3,
M.^3"Q\+6J=[<$4W7JT3_^A;D;%20L:- B<']*'%N!EXX+;N7(E\/ Z F!,>@
M/#1[R"-0^<_T\A8OP[^H54:V-KZ)P9*7XH$VUHF&)#-/F5.O!]$\F4E6N<:^
MO&EF@HJ+(H)>0:<VN;QYTJ"U\ROJA\$]Q:)SI+&=JT Y5UY8&-,FX85$@V%Q
MF'!'I[#FUT;2K$I;@26R"#\8,Q[45G)^YW\:#7JCRL0<QZ+,;&P9_4M13<(C
MHS/ )UF:B+,!FL%XB-IXHFZ1]V>;A59BC3?OUH@!S<>97:/I W.L7<1J"[E1
MF:7#(I-^!<KK/*PNAGJ:P83(IW[ T3#;>Y2%#-@-X4@,51T8'3.C<V8M,MI.
M_YD:X^C<Y,9_DNV4= T@=SJQXIG92:AUJL*F,4*Y?&TQ_'- J2VT4VRK]PL=
M96D['HP^T'JA_ZDBBW9=[IC*>^B1.,W*$@:)LGPF0(,V]A8]OY,V<$>/!FG:
M:WRL #DLKR.#4513->=C.<6@RKBT>TO=5[UW#OY[6:>C/64RYA>3Z/:5L>K<
MA0JZMB;.#LXC@0*-L:+-L/J?/;B-OWQ$UQV%]>RBN/9_**AW/[>]PX*PK#&Y
MB>S&N9N74P%R #;=BVMQ%.U*)/1VJ])ZY,KCERW7A6N RMM(?PTN;=Q8. (K
M9]E0Q<*G_&S;\H-50E*7*NZ@+F?=,ZNC:+8WIR7=D?_#D+3]C'#NE3Y"/%E(
MAK@8%[U8Y_V=H'&<Q= 1M<'J22D+R.%C.$!%L$<%.+['++@UW5RGS<T<8-0G
MV#-96E5;3@LHO2FB0 Q;':R8+-%]<^XUD:+-AE=GX:C;5)OUUW6FR5!>.AT$
M*RHSR\?ZY\6%+GD9'7%>''LC<>75$>(I5?@RCVA1MX.#':)1,IWSK9>A+@5R
M>]?^G?]1KSM:2/+WZ.*>1!5)P!3%8R>TWOR*AQ'FYPUA+<E2NFZV[_Q>SNO1
M:NRQ2_[9K\"#0<1W@L7WD'FG=&K6?-^WZ:O>BGDN[1[OFPV9EFQ7$FZIF.M]
:[3,1\G;Y\2S?\B[_\C ?\S(&/_,>$1   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>image_093.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_093.gif
M1TE&.#EAM@(X /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M(V*TL=(9E)OA"*2-GV&8F$5CB4;9@65NMB*5[9V977L@[@=9="D&HN1P6@+
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MVV;[%!COP2E7HR=Q\DG-QXA!^ZXR,AV>:+->6Y?.*H.%@E?C,Y\^^'NZ435
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$ 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>image_094.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_094.gif
M1TE&.#EAN@)3 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MN1B6X(ZI5,/F):N0@]P2MR[.;F\\::Z+:J6H1'/#_ZK7HTX*AZ=M7^M76VP
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M5VF?L;"E=?,_7[FK3#$-=Q,5*U))%C(OVO*,552JJ;##%O,_S3@M*HJJ(41
M"<N9U<B@/#RNP_"N>J$XI%N4YHBGU[.5FLRF&@N9G2L88\Q&/'2+"^P4?F.F
MDN"<RM@DQ@ BLA FS_ <3,J/5A%*/..33E0)LZR8)4E*MJ AKR2,TNA(Y(@-
MH2"7. H2MYB,?T(=]PF,U( -JZ2-L]0510P2N=05FQ05Q!R2%@FUG],+%JD/
H ^..IJ#,[*"7S.3,SO3,SP3-T!3-T23-TC3-TT3-U%3-U2R1@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>image_095.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_095.gif
M1TE&.#EANP(V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MUL&4W[*Q8G(:2^Z0/>; G/EFL*!CN7YWNRL;/GK(*(VLO$0H9X<U3I2W^E8
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A42YZ(8U$/9[G>@Z3_;GG?O[G@![H@C[HA%[H2!$0   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>image_096.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_096.gif
M1TE&.#EAJ@(T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M-Q9NB_)\OQ=JKZN[.]C 0FG2OA<<L$(;_# 7Z^\?[=__F;$YDL9WX((S)G)
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FE5-Y.^]A&=RZ-)9!K^W:K_[ZKP ;L ([L 1;L 9[L C;$ $! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>image_097.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_097.gif
M1TE&.#EAO *. /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MI@;1K!FK+9?,C\!X-)65B7)%O>QHNQ#)R!/QJ*.1<Q0.=2.L#78G><A+VG_
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M")UY(HNSR*J7MYZSE4NITFY+V7@(Y'\K*WGO^G&; 42<$K/X0R7JM&&>6[>
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M2H-P%RT!BH*BOF/1DN9SREBL#KS N1P[&5%:GJ2+M[_\Q$RYM/]JSW:CIO=
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MQ5^$ ZIC*BE7RR?OZ9*,-&)I95*C\%''<PJ3RJ%;PBT67""3^=!WJ[[9<H\
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M6"UTG6(:#[64TU0%O-E-5/E%9,1Q#90AM%/_E=Q-5H_DTM)#+SVW4S%MQ+.
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3',XA'=:A'=XA'N:A'L9*0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>image_098.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_098.gif
M1TE&.#EAKP(V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MNM_8QT&RJI.(8J<84:WSHVRK$'L*AD6BFBY/@-G5T6B*1ES^LZ%QA9M/66E
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MC$9DO >2FK&"G>* U'I<H>Y+.DD+F:B5*;Y\5DQW3]$.@1 T)-9=65$)H[-
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=RQ*FN;10&[52.[546[56>[58F[5:N[47&1   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>image_099.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_099.gif
M1TE&.#EAMP(T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     MP(T   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#<ERQ0F#1AD0A'IT8*!!#*P17.!4J,FG,I51U8LVJ<"L
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MER.N(S2E,4-H(F!NI)M0L2L>)&Q4HB[KJ'/4DGVWV9VGN):Z&1[%_SA+E%1
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7$ITX(R.Q0/7*KOJZK_S:K_XJ$@$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>image_100.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_100.gif
M1TE&.#EAO )7 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MV+H*QI&(7DL)';D20@.BS7EW.MY'%A/_2&KB:G%9H8P6$V,Y%,:2?!BZW_?
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:P1>$P1B4P1FDP1JTP1O$P1S4P1V4EH   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>image_101.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_101.gif
M1TE&.#EA2@ U /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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<=9%);C75Z;Z>@74FPBB#V^.'++?L\LL%!00 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>image_102.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_102.gif
M1TE&.#EAO@)Q /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     O@)Q   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3KERA%*855DP'/HT:,A!4@2M8C:2*E>O
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M?^?JCM>2Q,$6UHL[[7%/I;A$(B:QIECA>V*HR*6P_7A)6O B6\?^DB'*I<^
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M!C/X"VP!':,FGUAJ74YZB4'R/:D/<A]*V[,A?%4&9SZ3$^ =&^(35>36QHB
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3PQ_\Q6?\QG?\QX?\R"^+@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>image_103.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_103.gif
M1TE&.#EAOP)Q /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MOYW;RUZ1L8@YSW#QG/-<O(C(S%M1$M-"EB,)CS3)SMG\C]XP/A$MBE[T%MW
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M!]>8%_PU9G1O4JL2<P?OAVEA E(:<8XK&IOB0@8)=F'(E7Q;9H?V E_Y@#Y
M+#U>?\^Y-B+*QX1O*F<C9S5EXS8D ,?<9CZH8&MKFKK%*'Y+^U'?S$140B<\
M ^:T[GL<27^T1 MYW'$O6W&OW8T-KN-(MQEV#&R.]VBASZE9E#B8Q?N;F%+*
MU?#N(F6JZX&5B@6L-NL>7EHNGPYQQ;UPP1E2R$X/W7BVPPJL:P*--J1,OZ9?
MSCM76AG5/5N_<W39^5X:G+I%U&MVV]:,:Z*@/42*=,99% FA9#-L$ E>S9[1
M%))C:!0C&;SKQ7+I5B1R9D6H!$Z4!J,L_[09>$^Z8)\_<'D'1A9?<@B^K%3W
MRNZ!T:LR\JSG]C3_I(3+?9(@F6C;/T=Y9L-A^YQ]/Z"E2^S*7,QW)UU>^_V[
M<8=<[;@D2EO-<K[115]_,33/F2$I\<ZG/CTM0#4C;] 1YR]+RPZ#X9!R8V<V
M/5\&B$#75@ H6' %08,*!294Z/#@M8B!"K)B!2 B1E96#K**J'#%M4 =634$
M8$5BP8@$K9 $(#"B18<@8RX,63-0PA4B-3X\&9,EQJ#76CXL:K3FQJ,*3TX\
M:D4DSH=0DSH4N;1C4Z?7J'ZT.1)K0J!-2V+D6G2H0*(<;:Y@%>@MW+AQ#9Y$
MJ?0NWH=;:^Y=6M(R[T6:"BM^M&+EKT&$A0TS;LP8,6"#.,TF1FSX(V3* %8\
M_4N0\\J>FMNJS7L2LM.WFB,?1%VT;:"-41>_7OT0I.;9K'>[%DU5,6C./?_&
M%GX[J^+;EXL>9GZ;=?/=TJ^R]CC]>E[K=Y,B1JVS=\'FHVT#!H_]//KTZM>S
M;^^^:M;W\N?3KV__/O[\2D'&UV^4J7\!"C@@@04:>""""2JX((,)LK2@50U*
K."&%%5IX(889:K@AAQUZ^"&((8HX(HDEFG@BBBFJN"*++;KX(HSW!00 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>image_104.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_104.gif
M1TE&.#EANP*L /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     NP*L   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AVY8L50DT6/*EW*=*51B"NL0)6Y(M#!I FE'K7"ZJE
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MENH]TRYW@:^K:&'HR=5+G[G9-Q;0H\>T4])1RT*9?9C-GMV3HIQI-T;!T-5
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M495+#QWT><R"2ACGYTI,PTRJZ8OACDJ8M3/5QB\&U/B<R@VWJ_+[DU'\(6'
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M(E_:Q%F3KLW2(!_J+(A3H4ZFE@,1O@JV:M"4+ZT<M&+7,%!6N_5:#LGQID[
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MZA3 H=S)(MLFEULK1FWC?E(LQ\)QWV#14K QTC8U8V (.W%NP@M/Y%!)[;[
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MZ48+CD>?-"&!X-OF!>94+4;Z:=G[F(H<BD</2B/*(:*0"=D>_AI/"I]B6..
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M306^>C@OV/P&$KY?-=.+RDTI<=Y><,8)X^ZDQ>(L':,1AGZMHL)KJ0'RHW!
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$/R  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>image_105.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_105.gif
M1TE&.#EA&@$8 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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,]\D'SW[Z\R4! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>image_106.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_106.gif
M1TE&.#EAN@*L /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M@8K?O&>O-2_:>^.F'9:4)>?HRJJ31?;0!SV>FW=FR]UC6!Z#Z%Q;(/<HG6V
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M3Q!+5KH5;&ROZL4O<X'9<H Z'HU\,C3%R7&SYL09:@]%XZ-R[UY?M(^0TZ9
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M+,([;>T%75.12[/\D[<ECLPGK>'?]A1$O\.E#2CS0MG7@A63NJUK)@?Q#VW
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&=*,&!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>image_107.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_107.gif
M1TE&.#EANP*K /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MDG7L^:B>.[%HE2MBG.6YV6..;+:>F_GD[BA7J/FPW0\\=Z*J?TUF_Y:OMN+
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$!P0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>image_108.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_108.gif
M1TE&.#EAOP)4 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MYTEW+2'V-8V&E9=3$8AJ\G)8NQ5-]SS[(=E5(ME#!7(=AX?/8]F)-!_LHF^
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2.4QB%M.8QT1F,I6YS#0%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>image_109.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_109.gif
M1TE&.#EAO0(U /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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<-8'';[S'?-S'?OS'@!S(@CS(A%S(AJP1 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>image_110.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_110.gif
M1TE&.#EAN *F /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MDJ,9CE)[OB.U.-Z=APW.Z6=?&G)KO''\X6:#05[<"U6X7I?/\F'-QISW-N>
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MX:RXNRD;S)AW61@EPKYVLSIW1*9D^B:W YHV0L+9$IF'<CARVS=FQ" (V2K
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K+Z$I^MR)):%I%$0TE7A7F/YIH YJH1YJHBYJHSYJI$YJI5YJIF:+@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>image_111.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_111.gif
M1TE&.#EANP+. /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MZ<5[8TRVC&=7"RT5$Y"IS<%WF_D;2PJQQR&3C<^+T_=U46,8Q@N7D%^Z/;!
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M@:"6DYG-:)J6Z#B?$BCVBY1,F9DK3"Q2&3+ :+5BHZP4 3"EPXL>2T$H\PT
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M*\.7-\O;9\B?W&V^)NFYXS70&+<[91UZH3EW5WD >J<>>;@E%AQBIVW%GVU
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MNPFLP.4!IW'%MV.NP@\:P9/TZ$;XKS>K/49USU.\ %G[ D0@5@.O71MX<"
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+>=QC'_\8I@$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>image_112.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_112.gif
M1TE&.#EAO0)Q /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M.:LWR\D-M3;A[\<&6>^0@]FG[I:[N6RJ=Y%94)@T]###+?!PF0/*MCA%G<6
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M*7N5YIK7LZLY)%AJ6U:EF*:4E_%N@ N+B64B132@@>];>'J8QMITI*BUB7Y
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M)G$9?6)%L#HO'3JR]GE#GXLC9IDD.B*NA7*9S$L:H>N;<M3!7Q/(8C+*@PG
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" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>image_113.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_113.gif
M1TE&.#EARP$9 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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A_O"(3[SB%\_XQCO^\9"/O.0G3_G*6_[RF,^\YBT?$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>image_114.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_114.gif
M1TE&.#EAN0(V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M;A)4(P+$V(\N)CJ8F2BER"R1"_.E4%@%[J(O8JH8$>8TJ:)HJ[=IVV.RMI?
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2//1&OQ0]?_1*O_1,+X\! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>image_115.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_115.gif
M1TE&.#EAO (U /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M$(0]]2.=;-2#IF*N(#QWGN.7"24E3GN_J64F"55T][>IE6>E&$<T$D&&IDC
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M0[@[*$+.PT9JO%WC1S4YRH&S"BO;.RY?V277>2_3L98LXEK Q\?J53)6Z9Y
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>YU"%*UC!))I4Z5*F39T^A1I5ZE2J5:U>Q0HQ(  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>image_116.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_116.gif
M1TE&.#EAN (U /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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$ 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>image_117.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_117.gif
M1TE&.#EAMP 8 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     MP 8   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3(%293JEQY,= U@BNNL1H9,]!
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K=C3[0K:Q*S=FMZD\F_9X1:\6]S ]]OR8/'45K/<LI:_^^NRW[W[Z 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>90
<FILENAME>image_118.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_118.gif
M1TE&.#EAO@)4 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     O@)4   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"N6Y8JC1HTB3*EW*M"G-%8&B!BH*8,6U:PZM!$IH=>M
MJU8<0J7ZD-6U%6$/KF!%MBHKKP:M7$L+(-!9AV\;MFU[$:J5%8 #"U9HA6Y"
M*ZP(VN6+$3'C@U,K&D8XEJ!6IQT?QPPT>:%FS*!3VKUZ+3$ LW,;FM5LU;1
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MP4UFJ<K)I96V-M]&*VXNIKPT:73=Z5&W85Z^\[U@K>YY=G=:RK'3E?):VG(
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M>Y1! IA.:0<Y+/0H:Z$V9+%H-Y)<T)<1]==)'L@D=!4\.6,GU4<F\M(7Z-%
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MG'A;;?U=9'/,JYB>N*>.XZP*:*VW]NQFIURDFFAS8TTXP*KN71!?J'GLD5\
MDSKQ)0J%Y+INNTDC=2M4\P6K6[>A1NGJ&CT*^6[##]\M,*\4IZMQO@4N''')
3)Z>\<LLOQSQSS3?GO/.Z P( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>91
<FILENAME>image_119.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_119.gif
M1TE&.#EAO (T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M9A<$0I.<V(%G-4EPDG6BY#6E1)Q%Z$J]*8!C]'NVITG(%%<8,X4 _ZAXM[5
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J*%0<L88?B95WH85:V-9P69130Y%DS=5V?=>S"R5XO==\W==^W8P! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>92
<FILENAME>image_120.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_120.gif
M1TE&.#EAQ0)Q /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     Q0)Q   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT!IKC XE&11@4>#*LV9%&)3D4\U1ETYM6'5I5BS:GT8Z%J@
M%6 !=+4"]JK%KD71;@6PP@K!0' #D46H=FU%M67SACTXEJ';@2OBRBVXXAHK
M@W4Y)E9HQ:O#MJP",1Q:^&E? %8D Q9[K>;7@59810V<M/!AJX85[D4*ULI?
MHJ+M$BV=-R'<DY\%AC;+\)KOWZQ^ ^?HFO/?NKQS!C\NW/'!YK\URV;8-SCT
MSGROF6U\&H#UWP9]2_\7&#QYP\SDM3M<KA#N=]&"<P\T7/CUP,O!-3?.C%UF
M8^GL(>;;4=P]%.!SZF'67%1=11;?6H7UUY5PXQ'DFX-QV;=180!>HV%$#0;'
MBG4D1F90< T%TAT U[58X5D#)M28> E=)Q]2OKGU7V#.%53BB#1JU&!!_WG$
MH7<)+M15>D".B.)\+3:W8G[I\=<?8+X5M)A%67(V57QPB2?8:Q/^YE:9%[YE
M6%=QM>5A8NR%:%AD3T7XX5LBWHED<X-IZ>% 3V:7('MZHGG=BC,.Q1V03\UX
M'6^[\75F4MQ=I6*?![T7V8=#*A@9E0(>JF9H?Q)6:GM)EG>7<XZE=F2H#%G_
M1U!F<N7GGE=PZ4E1= C-V"1"%SIIG89']L6FJ;\5%:%Y*:9Y7VH=%;GEB<+)
M>NR2@ (YI[!.5CAB>N#.YB>S"XFY7&:N'14E= 25U26;;G87(71?X9KD?G)N
M:YFSV6D;5;!.!JF@<&1!I^%^G!W6J4!HB2B:7B-6B/#$2>IF9ED+RPBMG_PE
M9=V+4/Z*H+;\/CN4L3T""AZ42;$)JH\5^TGPO,E&Y"APP>;8[G>J"4=7J8V1
MZ]#-/VO697@K<G;EN)S)592OB48(\JHZ,[SQ1D6RU=MU_,F%+<Q"(UDE8*[-
M-6I&-[?8U'YELVVV;J[ER)];ICW+2M?%<7ALNS$&_YJIF<#^N3?8:@[:7-Q\
M@H:40#&N\+)IJ7VX6KM6ZWBJTA-:GC1"JE++&=\K&U3DLL_).^.+::DW.),3
M#O4RCG*EC.74>T;'79@QHX;KA X^?N'1(P,OEK9QV1JV0LM5[>=A,P9.K8Y.
M*@JMHZ=URIW 0OIL-:(1WQ<;P](%MBEHCJ&'V5<JFGCV=\V%JNW'>-[-%JAE
M6ITFSH;53)&M*NX>%U%5Z]RLHD2WC8W%35]IC;TH4Q:QD,5QVJD-EKQR-0O]
MZ4 $$6!Z-',9"O8G:R*B3 AII3S>L:]]NFG3P"@#.#L-S#J0DIW*PB0=-BEO
M@$;+'8N2UKSS]:F'ON(@??^4]CJK07 J,?I; 8%$ON/Y23.O8DNKEK8SMPAO
M7=B[R+(*!$ /ZJF"35.:5TB70DR]AF9.M(U7Z+<Q]L6F4YTZX6F*Q)X37JTZ
M<UJ3\.8E(A0.+$LB>LMMV-*_PY#H=TF4"!>]E)# ]&^-ABE;RPIYJR7B"(L=
M8Q'^UH2[.TZ107FD(N-B-J'*C=* SB&5=K!XE ;12C#\HE"BO%<J^91)5V?+
M3MS4I9U%@HY4FQLEM8;BLQF1Z7^$S&#)[C,I-4Z-2HZJH0ZILRV' 0EDPG->
MNQX(+["L[B)#(B/,LFA! $I&@9)ATZ7@4IK,P#"(:7QBA+;')+ $$DGU4EV.
M>*3_'CI><)^SK!RIPOBU]"12F(!QG,+6%#%,X2AIEZF(+Z?U+"Q2<4*205C=
M4D@6>)5M@</+3[K:11IENDZ&4@3<WYHR3^.<\DFK4Z?3$JC HVQT@/?JFM3&
M)#K>14A^"LGF0J)VT(J"<3Z;@V;_I(@A%1()HZ?#9:^.BJ0"_NYDHFS(<KSI
MH;)\KR!"#4]6PV@UVDDD0-^LG7K^1<4H'HF/PX*2+%7)*W ZID$\.DQ+1\G"
MNJKH*(1*31U[)$!#4=)O?8S2B?1J(U-!=)H/<=PK,2H8(G55+WH1JYC^=%.Q
MQ&5W!0L3F?Y43?U93#_9I%DPT\/2=TDI7F0EF_BXI3Y"_R[SGD\4HW!25ZV.
M)JZ+$6'CBVY6E6R^#%N&$M@)'[C<R(;5CK M*$2.=BQ%W2FL8!WKX-)*$:FY
M1E:% ^9>H22Z'KUJ=,!+K(L@RQ56V8MY+6).!1&GLP(-5IH% PY=_1A(,<&2
MBD^"8%D=2SB,I,U@:B+7Q_IHR4L^"J0#CF39%B-2Q(WGIYF+*&N19;_AX/.;
M-+M.R*XV7C4)T6NHM.A1>_@8\;BFE*#[56W)"S-I/NLK+%9KBS"X-<ZQ"TDE
M;K%%GX+=<A;-9(09*422>\,DOD>L @J?<^S$8P5)3S/?(DP#EYQ*\:2&R4#C
M%P039]]_2A,L!,.GB)9*GMCL,_\OQNW.CHK:649F)"];;8N&*%JT ;5P8Z;A
MT5?H!.$P>A)TT%D1'--L4LMBIX-SU&.%QI*E!@;J-B2FZN &I&&^>NF(:ASK
M00[<9/>&CL;*'"V6%CK<KE9*H1-Y;C^/!LF)Z*U:Q<M=D5$=Y>$=%(W3]= K
M<7O3>1$9P$GBT&ZH-^HH)0W8[95FFG*LM90&*4\;5)!D!CO:5I*V,]<2Y;H6
M6]+O2*Z"&LQ>5?A,K<-4VJ. =M4_;^UMR2#RU V*C_)>1J)AUMB4.[Q/_TJ3
M&N'Y3=M\FQJ;BE.F8.8LE%6A]D+X=ZOQ)'%>']HC\);$\/R)<E$EHFJYLJHJ
M%L=.U$/_==AE-8F@;;;\R!@E'$JGNKE$)C*N8%T1!'7NLS%')6@(#[A)H]@L
MBSOKYNK)#^D")36$<QO)E:M;N!$$IFRFF7<'D?I?TNV=U3J$W;M>-3$?+:55
M,[649TH2C?P[<"AIB-_Q!N-!86C*.AM</7<O\&E_!MY36Q!WGX)LD#5&19N?
M*G-(^_<,*VW: 0;^O1(9?%4'QC>O-[),Z;07.<=;1)8?F2U/>=+,$?2AXYJ+
MT7)];8S=Y/%6^_9A648J><S::_)!B[+6@A:5UHQY3TW^0!$=B[3N*N["&Y_X
M^D56 '.7L:'&A^*YLAC**9?2[15R=IY:$Y+'C*L'7MER5 SH_^DZ64& H=Y0
M2=NX>[FE_L<J_$*003W+($@6KEO0/)V'^\/0I"&V^YU$\:=2 T06KQ9[[;5:
M<F1B$I%O1:%TEY)UGO0B!IA;&G--+19,.<8^&74Y7<<M-\(P_/09=.5M._9$
M5<88'+A=U3)VRH(BJA5.Q(=5HZ4C_=-#^2941\-L3Z5*G^%3$P140"8H#J%B
M<G-#0F8Q+'1A  <^Y6$G_*18:45_MF<F 650P/%5'Q9(<O(:N*58!M4RG8<4
M=X-YK)<RZW(5)X@@C9)>O=5\B?:!DL4[..9A'99H"\B!,\1/NG4\>X:'(($P
MR$-.&Z)D&6&$$^45;?-=$KA,@_@V0_]E-I-#%#X62:72%C$'99>$A6J"A>)T
M/DRCAE:1B*)8-K'E%$<U%8!H4*<!A'K6-G(!B9%%BJQQAPT(?DBG+'DW2O:!
M<3V3,A D9<+6-O9'/K274+VR-M&G&RR5B+UX81FS<(EX< V!774Q&&-6C)&%
M$O$D&Z,Q'9/!3I@A+J,F-&D4B;,B5=TE44(C.=NH$E6Q'2Q5&CW%&U.Q-C_7
M8SW!+'=BCD/EA][XCP 9D (YD 1Y$KY4D!$A<@BYD S9D [YD'8A71#9*YHX
MD19YD1B9D1JYD1S9D1[YD2 9DB(YDB19DB9YDBB9DBJYDBS9DB[YDC 9DS(Y
MDS19DS9YDSC_F9,ZN9,\V9,^^9- &91".91$691&>91(F91*N91,V91.^90Q
M45)DLR$?Z!2S@HTIQ!+\"));J1C,TA15>8X041PC$1A^T8Y3B1%MH1KQU)6*
M%#Z]@HX/X8C5-BLB(9>>V$A$(I#Y=ALRY5!WB(V.]%G*Y8]B98GQ$15VQ(A;
MDQR#"2:#Y!.2Q4SUX3R/B2$$TE20.2)]F$Y@0BP]DC40&'Z .4J0F2$<LV'9
MD7G@]S<V<RNG,HQ7^2 )5B/L]6F(R3/A@5JZLGNSYG#3EU"T@ENB&71[1Q0.
M)9$6@BBC9WL5^#2<E(P_(Y>3J2(I$6(>5RTP<G+THC(&4VZW"3ND_]96B.B*
M88>);,&,A1,EE/(A="DD?V$^O5@4E#@U60)F':)B%\9IHJ),K\@?=_-BRP.;
MVK.>SD:!1048:_8F1@@NZY28WDEF6,4;=C0>["9Y$4HOYQ9IM&-,Y8%X4'::
M!!)?85&<&,1=+F0U&C,>N(40\T([][284_-3J.%NP<D1ML*@D#0^JT)^% (8
MQ;,B@F68H_*7, 96+W*>V654V',93IHD("I]1C(@G4AS4A0FW;.D2J- %8-9
M>>)].[-6D-E_%@6,!P:.8*,7M3)&%&A_K1&@]D)3/F*C7 ,:#I)$PT>A_N,8
MW[(8Z1,PU:0^8<&9G]6#V,2A6<=5/$(J"?^$--@9.CL'=T'W2+!T2!5"1LJI
MFG^D*SLU>H.1;[TS3>8V&05WH]F30(@X1L6I2$TB&M2%4@8XI.@X3QJ&@U[8
M+#A#0S2TB>_C+T:%4U.J.EAIG8O92G*(3[\XGU/%6>=!'R4Z1EN6;5K#7;X'
M>I:6;/#A7LJ2H>/&,"02.](15D=3+.&)(NPT17;&)!%#6T"%%G\E/_)V)9]Q
M>S+TJ(WEK2YV0(*6'8#5&45":K?B)))C8Q (']5W@J<CK<B9>U843"X4AI7G
M>2;!?5&"E8)B)J_:K]62([)*30ME'SB8I*:*)EN%'40'9J;5>U+J$0FJ.PBD
M6<E",[0''HI9/G[_N!HN=F^7.# L.G-I<D)!:$2 "%,)\DJ^(A:>%9D&TR,;
M1YBPE'EZND-'<I\5PW0H&";SM!PO4R33XQA1]%]Z-)A_$6*144NG,I@7DFO&
M69EJ AN1U+8K-1:JDJ(39!\M.D.9MT^C&:Y@5%)UTR7R"15T8D_02JV/H70N
M);$Z]C$=JTEK^&71>:061%LMJT8%XR:P8V*$FT"%Y4'0^4$ 2$^J25>?03I9
M\A^C2D@=MX&HLRR*\AUF12%#1%(OY(7&%"(AUQUUI; X9:/^TKEE"!XA)#.(
M!)AH]C!=-V"I)R4Q&"N=,4;H2F']L3% !R7NFJHYQK4X@SC$TB!>QJ;;_]0X
M]#JBAW*Z/9(^C_8QZ6-5$>A4W.$KYB4P45I1]G$LCL*HI1%SDC5FNRAO-JJI
M4.$TO\A5%OHIZ^J!2;%;4H=2.=:X115-NE6@;^%]&&.Q?'5KF6LW 7LK]39+
M0/1PYZ0S;!1*C(5WX&9^21<=BUDR@(0S) *:'M+"N6,GH0&H#S@OC/2ONL<K
M@PJM>\%'GH<BP!LB) ND+WQ 94(I@*,6/"8])AMN40N]]G;"'J,S3UJ_^6-/
M=,,BXZ&]@)I(3R@:Y])O.&7"QZME XQ504=OFI2=*6. AF6%;GR%*;PN]:-)
M4WQXO!*ZU:JR0/:WV*&D&+'"N]O&F,2D4QRTX_^4((UKCI3VL9B17^MYF@+8
M,_ 5)ADL?>QY8_A$>9HTMJY%0:>1HD1EPDJC,G33-2AK=,8D/ORD:&M'=EU*
M3E?#,PMWRZQR-RIFHT/2)4(,I;WD'#CG8$+4@DNS(%.;5;N%<.RF,ER<S.FJ
M24WHRWA886T32=!I;Y$VN_;S/8$R4!:4)@OGA_>KHEESIF 'RVT#I#2BQ7%S
M3M[J39!)2/J1M_3R5RX%G?*2&/!2JDQE$DX&I81QFCSEG0-U/<%D*,1D2$2J
M-9 +LO+J(K")C</W.<;)&H3[0'491HG2/%&#9HPL@'W">ODU=@GS+&=$6,^+
M30 3<OW!O]4G?;S%@9S_5[:/U)\6TZI7R)F>!<BL-<3N)3D8K:\2]$+^U&EU
M&,Q0Z[S/'+T5P[$,#=+E-60(1Z\@0S=>%4&9)7UE6S",@B"\PG%=EK8>0G%-
M<6BCF1F8Y9;1MDYAJ,/;XI[0^[](_1$TS*@O%IEW*!YKN2<;RIE9PJ<-S3B0
MS&OW09^6%X@G9=&#PWMRJ)UD)5)4>Z]-)TB'8[HGC%_8QU>R<TNWD[:Q-S@Y
MMC?R%],F=CN.;1\F.DV C#N*?+TYU%I$^!<^(X*,>3-XU;P3M]+0O!@M+&AU
MUG!I2ZFHI<W*:Z"L9&W@AE5'U4>M(]:3-KV_)7O/,IJ;]*/M0M!A^2U'LJI[
M_Y<VP.G3$Q@2\+O)D2=IA=-%[M0T@IT<Q,=^Y!G"I>68C)MY&:Q07]S2U<.T
M,7S"@?H]2>R=$;-/,4*U,TB,9?56(2PK:DU_EDA]*[L9<(/4V=3/HI&*EM6S
M,UJJNP74M!TS^/W%M(55;.9VZMW"5-+,NMA53IW F8TOYI58>96$."1T:57#
M^1VH)'Y%>'B#\8(BQ0E,/DRWA*T;%BTS="+- 2,QZW)=_DI\(-/=SLJ/?F:C
MWNU44C&'%T.XZBC:A>Q"NG<D:8BDF,&N+X)X^OV5<86[,E3#OP.$QTTTOF0^
M\#O*L^N$!7["!SY@1%6V)LMR=KRL2D+3%8Y\V+7:&_]NHX0+:D;4ETFDURB=
MH&L)Q_#W2RSG.,=2N;,B:.#8I\ LWPY=M=NF3YU!=%R+(5-6D4#&=>C!AA6$
M5ZKBVG -'(::5GITPBZJ*-=G,0<C0W5MX*6(X,V'&/5BY9HHX\2!41^JRXE-
M34)4UO&;0]2'5K33G-3B1Y/!BN86QPK*G_GU5:NCFT'2.GC<R3<U+)B=N.JN
M<J9FAJ5>-M9,>(,.FINS-P'>;#VK)W7SPR=5;^\1T&\7KWH2VI1X+^ZUZ8K\
M5#=&[E 7M&3IW:IY&Z:>JM'A'" &30V*4$AB@2RCR.B!7M >SL5'(YEJ)?DC
M9QQXY7Y(:&1])^C5[/\LKI?_G#T7XA;ED;H]RD\?SM+;)& IA43LRBUCNU6:
M(BSOAQW1]#N\+H8UTQ=C]D8IXRA<#3\P5LHDP^(11+6:3;%3GBX.=7<QE-@1
MA4Z]ME^#BT.S!3 W4F?IB:=\,NH$.*ZJ]+E)GD%Z=4]X]7()%5:D0^X,;V>^
M0KEQK7?':5MSY:P!PE4I5O?D!4SS8UXJ0QO?='!_;]!<]4!DB7E6M"V&^-]
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M[NSY,^C0HD>3+FWZ-.K4JE>S;NWZ->S8LF?3KFW[-N[<NG?S[NW[-W#- 0$
!.P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>93
<FILENAME>image_121.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_121.gif
M1TE&.#EAE@ : /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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=E2]I*84L\L@DEVSRR2BGK/+*++?L\LLP(Q00 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>94
<FILENAME>image_122.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_122.gif
M1TE&.#EANP(T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M:A>/6,*S88!#J'7?>\S;\,*DC[\EX",ZF(R,[+Z*%S"^)](DB+5?]19\ZU9
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M)8/+@KZ:>,L ;24':+L\8] QL\_OES15K#X^_'\ED[B7,R<RC(*_%B6D!K"
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MG-53@*9"A\,OZ<.=L&?+S+,;&&>Y72DOTHK-NM;@6)5<N7D2Z%)$3Q*(B'*
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2W_N^__O '_S"/_S$7Q$! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>95
<FILENAME>image_123.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_123.gif
M1TE&.#EAO *M /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M"N7_GS_E#W#]@ETA.0*Y'X'3?C@\%854"$3QH">ALE1/R<9GM4 **BL%?9I
M:4<T[@V-,2"J$/,TD[^ZK;([1>E*@KK)+!K^S3$C'(A$<=F63OTS<H$AIR([
M^3#ZL92%!I-EZHPR)3KV*FV@BJ5,U08_'$:*FB?D)*I6=I9I/H5/ %+=R7(8
M&P.RSC$X5&3%&/4[OZDRJ8R,:%4(B$*E0/*?%TL616JEHH6"%'4G':A'C*K
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M&EV2*FZV6A@'&SK_5R&>Y%'?IZSX6D:O9U0 LZ+<(C3$I;,[J!E\Y7@#U(>
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M <,D7:@UW$H%,KUX+<OP,Z"^+#AF\BG"DV<#?4_.&9PJ^$PQ#3<TK99I92H
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MXY"WN)J,,JXE,1P01X3F"ZLZO+Q*K,,8>2Q(2*Z\>G"%-35$*+\8!8*S/]R
M>[-,'FLS2[#W"D-+JZX"R\XK(Y__['))+(FKDKL>8SQ/+=D>Y6JZP="LZ,<8
MTYJO3!W3^\\]V>Y+;RQ*]=K2S.$\Y-(@00-C$SDQQPQ2Q^]J),X^%4%M+K=4
MF:R1.R<-56TVWAYECK!5<V7(PUK-FO/%@KA;<EK_%#J20JV6K)'$)0\*K-00
M<ZQ2*R>KE,_)U<**<MK-]*RU.8>N)4M,XF(ER,48/SVKL_W4]6^LLHH$H,^
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MDQ8T09,!&[R^$9C-,"2KZ\8[6CRH(9O"LZ]M\B@) KJY@D(RN8_0F:C1*S>
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MQ',7-BK;%.3H%QY;5@;9JPSH'(J/3Z*B)F[IP%8BEP14LL"4 Q$/\@B2NZ!
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M-("P<@T @$ #"2),J##AM14 6#4D>.W@BFN!$JXP&/'AQH4*(7HD:-"A058
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BKTS9>FW7<O[TMVP/4__U8W_V:__V<W_W>__W@W_V!P0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>96
<FILENAME>image_124.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_124.gif
M1TE&.#EANP)4 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M\3E+)I-M.50)U)O@](QXDTE.T80BA('(B"JVXA1 AE$3]5X/5QI0_R-IP#%
MG"0]I&8P;E(LWY8DGF=Z@IDA99%G3(=6<_1Z>G& =],_:C*;SU4IYU$ZL+4Z
MSV08HZ)ED[291PF=TBDP^20PVUB;XCDE28F ISE.#K,5+B-8"6HT+%0LTSDF
MU2<FHT-S%$<Q=Q:#PN%DMR$L&I<Q6'AZ*I)!,I9)'G(K^Q.A%#.+LN04"[24
M3>(GKW0FN>(Z%=(B+#1E:O,=FI5GKW%R$=$S=!8? **?B84K@^A,PU9RGA)#
M*A0O.Z<PL]@F[TAXWV&A56= ]2%+V<%@J6>"AX4:'C)B3\B@-Z=:"V8YP1-"
MOW(>YQ)$8,$LD(*@A.,8$D.4$H%ZP5ESM_\"=^^4&/PTFWCA8G855NYU7'K4
M7D$EJ$ET(GADH>AV04K7$9?!2D-"98G%I!DUH\.!/K5$ARZXBA"6<M 4@GD4
M*G=E;#%X,QSJFXMA3K]:+DNA/LJA,E-B1) R&H[S?8 ).>:F>U)E*-'%-AHX
M?<FVB_#UFU))2Z"')\QW*+ET2RZJ1E2$&9$!5=>WGJ=X+%7I/U6'=/7Q'7QB
MF*@S8O8!*"HV8(=2G!F!A.+GEJ]9B)+('JJ"8!83'^XU8%[4I;+J&=)#((L!
M.3OB)7TG0BR:+NQZC!<KDT-U.D=D0[TI() I9+*:01Z#+J ".XXW*FSR'%ZW
M74<S,FK7)2'T/E__JDM#IJ5]$K'@9D1PU"=QU)TS5:/EY8%>E)ZD6"&4N"<F
MU2$K1%N49"':=QTJ$Z NM202ZVA1UVPSMWU_!T^1<6F3 3.C!Z_Z$BZ,4UO\
M$Z6UU2$>X[:GTQ[@:C_6<QUBTYSN.%.?X[7T]1U%NG?OEC%MR%JTXQ8@@G]
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0)Z>\<LLOQSQSS3>7/"  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>97
<FILENAME>image_125.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_125.gif
M1TE&.#EAP )R /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MIJHHI%HK_VPBIV76.3QY6>.XIF0M6IJVK(EB2N:H4B*(7YMMVQ8DCW]C=EV
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M4O.:O^&J[;,;OK,P4QI'_=$--CL(^U/ R$$URC,=H5B,CP,G*'N+.SNI^UA
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>U0WEI[<[GF<EW_B5W_FEW_JUW_O%W_S57W0-"  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>98
<FILENAME>image_126.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_126.gif
M1TE&.#EAO0(X /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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J&<RE)(KYWO_]X!_^XC_^Y%_^YG_^Z)_^ZK_^[-_^[O_^\!__N1D0   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>99
<FILENAME>image_127.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_127.gif
M1TE&.#EAS0 : /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     S0 :   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ*M6!FX(A#$C1D].@P$<F%'B"0QJES)$B&K:P-?/EQQ3:1!
M*S8+7KO&RF8@5D!9E:3)JJ&5:R49 F6Y(NE$C0YQKE@8*"7"CE6S.@4P5:;
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:UV___?CGK__^_/?O__\ #*  !TC @@0$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>100
<FILENAME>image_128.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_128.gif
M1TE&.#EAN0(V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M]_P(/\G)I9N_V8OA1B>Y]Q@)7__BI-N*Y;V\!$=61X+GF=Y5ENSESX#_BY0
M#=G_S,' A9P2:Y,QQ\,U_]7I*!ARY& *%$G%/.Z> $)/M! #POYDQXAQ>5P3
M,U:_S!13.@;:9^JJ-\PR-725'CD7K^02L8,D3%'[NHU:;-1/ 4G&0&=Y$/44
MPS1! K.EY4087=BDK >%<C\4#8Y/(1?-/T7HJ6.S4Z:BZ1HR>F9=Q_-0ZR)R
M%ZYU,#E'R207G3.P^5RIC4"U8KO0!B*VV7.-9B$.AOX"5#P)%4]3@]BD(N:\
M="FT1)X#U1 ;DYU<UG,QI)/>W,**NCM>;)KLJ:N_LE@NTAVNE'O$S]:B1D.4
M4@2<J^*DKYHD*^"5%H%<Y)S7)#@80&)F+].[X>7<13CA_SW*A1+-G8&\IC-H
MFBF :V7=BBSCU7D%$GR?M>L(]28S.0[N(2VS5",="#2O>N4XZJ)-RQ;CIOI
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BK5$W;4,>M7FC1GJD/)&'2+JD3-JD3OJD4!JE4KH[ 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>101
<FILENAME>image_129.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_129.gif
M1TE&.#EA'0$8 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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E-\K1CGKTHR -J4A'2M*2FO2D*$VI2E?*TI:Z]*4PC6E! @( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>102
<FILENAME>image_130.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_130.gif
M1TE&.#EA&@$7 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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B]\D=SPEAI)S]#*A !TK0@AKTH A-J$(7RM"&.E2A 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>103
<FILENAME>image_131.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_131.gif
M1TE&.#EAN (T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M:?*3&A;'2/3%399J'Q)XG_AY41-[SQ&/S_@AP?9W*OD@$?F6G_F:O^$X$1
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>104
<FILENAME>image_132.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_132.gif
M1TE&.#EAN@(X /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M'2S/4VY[N]S2AHT .B6-GK0F6S%IA)!-B(R )[0K+BU3S@V6=S@460["36=
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MI25<'-,L$J&Z@!87BZ$<S=S<S;*8C=X<SN(\SN1<SN9\SNB<SNJ\SIP8$
!.P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>105
<FILENAME>image_133.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_133.gif
M1TE&.#EAO (T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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E_M,C*=)_:QJH@HJ+)S*HAGJHPBB6B+JHC G:J([ZJ!(1$   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>106
<FILENAME>image_134.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_134.gif
M1TE&.#EAP (V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     P (V   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*EW*M*G3IU"C2IU*M>I$*RL4KKC&*F$@
M*P2M!"J9]2'8CV<3KF!55J"5:VT]OK62UF"@N$U7X"VX8NS#NR'KNA7LUN_
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M?6==KP3JJX2:EJQ5+9+N?-I\S'9:.S$6-$^M[,5<>M9C;:R+; J>&;?KI.1
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ME4E5935T<R(>N)(V9T)\"\.1#[*'^70U)64L8.$;(MH]/T.:?,,N7_@XU/E
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M]S$Q.BL^"VT?%W#1BZ(;YAPIZF Z6U]]<67G$7.)"LIS)H%Q*HKG5EF"_7M
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..\*"8\ S?\ Y_D $! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>107
<FILENAME>image_135.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_135.gif
M1TE&.#EA&0(: /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MY$^_^M?/_O:[__WPC[_\YT__^MO__OC/O_[WS__^^___ !B  CB !%B !GB
'"&@0 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>108
<FILENAME>image_136.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_136.gif
M1TE&.#EA)@(; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     )@(;   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASMK2RXJ"50!!76'D8:"C!0#T]6C'J,!#0ADDG1CTX=2'/HU49KF"U(JO
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*8CB&9'@0 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>109
<FILENAME>image_137.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_137.gif
M1TE&.#EA @(9 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P      @(9   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LB7*%58:K@BTPN5&
M*S$_SJPIDN?"0-=\*L1)D"9(HR%G@E2Z4*A0A(&0#MQI\.E$JS:SZKP6D]4U
M *P"*?1*$R?.0$0' KW&MBM;MF()6@D;M:[=NAS9DBTX\Z[?J%@! (V;<.W;
MPUBM?!W(EJ'7P 4;"U1,F."*H)/-:DXK\++1RZP$1O4(U"NKIV@WJ[826#%D
MP8MAO[[<=NICOM<(YV88*'3GW57I<@70MW=EXJE7FWV-$6?MAJP/,OW)'';,
MQJ:QE@9[^"UAP[N[^_\>:#KJM;!Z>TM&"!,BJ[![U7:?[WWJBOLS<^/'7Y#L
MW?C]Q:;8> 79!==?.4T&''>8X38<?6_YI!A;,'&5WW$94;:6A!#29Q]^BK&V
MGU!>,7;>>Z=!12%L"PY$F8(GAH70>?)AR.);-ZXGD%?G=:BC917-]9YW,Z$H
MHT&W&0070RLJ1", 3PYFT';(175694 !\&)CH%45TX"PB76?0ET>9,5=K'GE
MW'!3%<:F:#X>%N"(%_)5VIBEV>5BG'*2UR!93SJHI94#6CEE4$#E1^!5(NXW
MF*(.O2@?GP1F&:9Y;_)%&6U2[1G7@3Q6]6A-@YV)EGS7A0:46P9%!^:*. 7_
M%FA$H*D7$Z=2%B3IH3;JVF*KNX&YXZV3UE1=HEM^!=IT4/*I4*)F\HEC0]"Z
M^%=OIHY&$(_T54:;G-Q.F]D*29(IV794\O649P>5UN.);R4HD;1+,E1F9]>J
M:NB-Z&%&&T+A=F?986@!MZJO GL(9ZK6<3>FB3XN6M2O$D%;YI$$_9@QQ0=I
M/#&?.:W8%IWMP>G=A,3!FR"%GEWX+WNSZDKRJ _OV5U,U1YJ;+U(YO9?B[A2
M>!Y^)3J(8(&[W;GCK&;9IR7'O:'X+HKRTCKST/P-/-_3$L-9TX3'J?<N?1(?
M:%RH4[T5[I#QVCPD*X5B.NF2D@&J&U>ES94;RC#'_P91<?Y1B;&"O38;EVD(
M[2HJIF=>"5AG-9G6H6^#A;NSN(:OM5:_;E:M*YH']X9:;E*+E;-M"^J=Z=)^
M 9CRISTF6/3&IDD]*VW<?M>V8; _C>%.]SVF)DR%R^07F"$:+7>ZVZ:.>(&G
M@>KS[";J[.N$\,)+F*0J^RG?V_4:YM.!YVF^UK.KI]WU@#Q*[=O@W!6^)(^M
MQ3PC5YII1Z.I9YYW)D]9"I'_SF*AB2GG?/=;2,#,<YT&R0> 27,@C%*'J:<$
MK'R98E>SRL>3'_'H./?Z%OE"QKE! :<QV'O3!;M5$?#0J#&Y4E_UF'<CPL#M
M>>0)S8J*9JF-64\N7]E.E_]VQ;VV"60]T-(+_IR3(A,I!X?1ZA7?^G:K)\&O
M21WSV="<Y+?$0>A0JU-<F/PS'ZO\#R;[X0RPNM@SGH1E4_;+E91.-R&]51%1
MOZJ0!*.3-M+!94(UF15XC/0V/\&%5"<4"Q]?=\2OI) P?2E/5"19'3<9I3<.
M4Q-N?/,OYG%*D_\J5_QJ4S<VFJTN6%00>D(SQ-25;W-4"E2IAC8?$-9,5TQB
MHUH\]S']6/$X'H-8,)O''&X1T%O< E;8",8=UFC,,W_19+OL-Z<=Z9 KZ:O6
M'"5(G-^H"CB>2V$M^]@G*06*?F,[S'A,93 V44R#*.08BQ)$&UY"1(Y!><PS
M P7_PYB-"4S23%#_WA7(Q?10F%LK2OMH=)DON5)@S;S7(+G3KZH-YB_/20CU
M_J:VW/PR,KI$:/&::2[TN,4I&%3FG+99L..8BF3$.]6ANM:\A&%N;O4Y'=(0
M:"?3Z,T\Z($DUM;3EB?1)I @C!D^._B[$SJ28IN;G#VI%:/'&,9SN&,;;&@Z
MRJ;J19QC:V)GG%.PT\CKJIK3"]OB,J U_0:;XYDE*VDDRI?.+"ROV:A#R(6C
M]NT(F"%M9/32USQS829W*E*I#U\DPJ=T5)UCFR9718,B;,VSFQ,S4@1?$Z%H
MP6VK#DO>;WI'N$#Q!*QJV^G2F%J5O:%,C,LRX=[@DDJ(_PBILBEC*$ICU,_)
MHJTJY+JA[:IJE8-1<#*5&RZ\?%/$&IT3,U;T*&#)%EF-!C8A=5R5WMX'6,@L
MB:<'T6OSXH([-RG6F[Z#T>]B]9Y'66B1']OK=A$HR 9M$S+8ZY2+GD8C*94+
MGET4(W_)IMIF,<:K[THO7P;6NY)9!"9@FY_?[M5?:DY0OSGL95ZA>[><$+$^
MOB+M6!=TFR=-2&(0+M3>X!:KL5SW?J8;C@A_E5$E[893"1DFE?AZR&F>-V6A
M86S[$I.=V?:XM=<M4NYR=Z_. $DV9OK@!YTBMAA#=\)J_='!?+6H)H>)H@=&
ML@[G.E7BS&Z8G8&?9<[$+;;1]?_%<+*1ZM0#-ZN\IT8#"DPL[^:IM_*U:B?^
M[<+\%$CFZH7(LQWH9[E8&%ZF!93=6:;\@'/4*$9+/U7.#P<G)A?-&7"^Y-N;
M(3$-SNQD$3(?I(FB>$S8J11LCVN=VY$*I:7:%;*/R01+O\QHVB%)&HI08[,2
MATW>2;9%."-]V:7Q.D_>_:1_E1GH@@PSN#MO%Y'Z48M?EZ9.3^E13%\];4+?
MV*1-Y>V#?YQ;C&^U.>S*<XKWJR)W!<4>;]E3FK@1B]HDM&TX;2R5PE.GAW];
MOD:VR#66=LCSOO4:\/CD6Q@6F^>6A#V4'FXQS&SM>' W.KU$AJLNC#2WAVI$
M%S^DT@SPFDW&<PNUSFZNWS6\D;Q8W43O@-C,'E>P9%:^*A>RE4<ARS;0B:DB
M>P9W(<^1J1J75F;H6%@N\'4UE:%^2^(82]7AM&?4*KFTD\\<PZUZG&6JKBGI
M/#PQ5KF/3,WDE'H[6"U<3\A,%KD?>]WYY$YI^J#6#CG(9"UOY,*JV/F.]*&)
M72X80\K#B@1"T;"&\&=R&NNJTK>QC%1;"N=F1$2I%9$(N/.@#_W)Q2KZTIL>
M?5,E5]PCI7F(R//T&1$O[&=/^]K;OO.OO[WN=\_[WOO^]UE9/?"'3_SB&__X
7R$^^\I?/_.8[__G0C[[TIT]]Z <$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>110
<FILENAME>image_138.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_138.gif
M1TE&.#EAN )4 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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J:&S;T+BF!)]K#6J"2,=ZUK6^=:YWW>M?!WO8Q3YVLI?=[&='.Z0" @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>111
<FILENAME>image_139.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_139.gif
M1TE&.#EA-  Y /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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2Y6F"]CD5*(6XYJKKK@L&!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>112
<FILENAME>image_140.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_140.gif
M1TE&.#EAO )4 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M#6HAH5KU1>HH!T$W:Q7F\K<?^%3$4!0+%QLUJ*,'.4]P3TF8U?J3(\9D[(@
M(LP(I?1(1+[,29';U84H9!2TZ25*L#J1?HB5QN1M,7<',=%[1E='+")M(#[S
M5\7Z9)PF<6=/\"%*CU*TI.K8,(1:FUK4)E(J7.IN6\T+&J:FY44#\DE:,<0)
M*$/5S-T)[HGP(TO8KKE,TG!.D@\D#U%VV2=;L2@YZW0@OHK5GU1&4(]+<N47
M-T7_):XA!IAO:B)QQG6S_5@Q0*,C4F^6<A^I+"=AB#H.(&_))0G=*)7U.="%
MB/84/B4P@ER2%;=$V3IC66<XZ.2F:DI%)3HQLG;/E*4G5>A,?,D%:;D4HEDX
MTQS-[2MRR[MEQ,QBI+55QD7;HU@Y(\*Q-5%+@\,Q7T@E6$T9;:U!N.-)ODY'
M,:1LE3H**=E9=K5)C0C(7BM\RN,<ED&\L:M (*SH+_M$4>?ARY;#69:@FDJK
MMR[I:/6YR%YU8R]5BFR?=RD.;0IW.BJ5YG<[G2/ IE:[4C[5B[C3S:X$-4=%
MY5!PT+$0_OID):GBT)D4PY:_%E@E^.5T7R#3W/Q<.DQ,_TD4.C1;E/^>PQSO
M0,U\O6DIA,*#):EVKFN&R>I.X"15\JCF<6V*&[V*A3B^Z":-7ZH@-^&#(;>>
MKFFPC69$O;0F.B));:GL&S'9M4"+)+!B-$R1<J9E*:%-C63'2<X?G5.:A-TF
MCM7-7?14ZK0_43%DLL*,9N=E)%MU)9RKL11;_AC=X?5'4&PZK3=QNS;5YI"T
M[E++:RD76=5,B;/"I&@-U^; DM$KD8[CR+0>U\B.0>^DP\6O+>4GLLLZA;)F
MRIQT%Q4ROND+-8*C'GK0)9<#V<>*2\I/E%V&2\.8Z)(OVU>5?8I<6DG.>!MJ
M;YP@,B+C[-1V)U9R42N%,79YZ/]31+E4DWEZRPOA,&>SB^*2GMHC_Y7/S8\J
MT&9;)T)C9I!&:KF,[<Q42K:Q;&Z-CN5=SI4<6(VGSV:!57F8:Q;SU<^!T6$>
M>Y:RR/+";J<NADNY>"7BQ"):2C!CL36'*[BJ(HJ@QG2@CVDBICMMM:E'+J^0
M VSJ"=U)K;QEZM*Z>.A.[G'#5SN.BE^F&ZGJT;G#?.$^'S0^M>!MA=,&4J(4
MFBRVEMO7DTWNH0%,/D0YQZH5I"![P]VCM=(%4:3N"GEW9:+PF#(],!3I93.K
MNX::)C0:UC)-=\?72R-M, IOE4Z#VVGBZN=@9>Z1<SH[/-WM-K0[H_)0O.D?
M'SM;8<;_/)JWI3= =>^:)G3F#J84#F'?23HA9>+POYK;F/N5J:S:3JK:IA25
M%,M**O<:4?U$OM$<]>R9X9-J5M/B+A3N3M'$ALO<I!RMX=@G6@3E^= 7'2NK
M467H+ES4R\3:K]4^$X7C@Z4S&9[,I#?H[C&LY-QGA^[RWGSAN"22GNJ)IQ -
MD7345)YGX]<]->[,3[,\ZIZRV1!88;E0BIX;V?DG<5LGSBC^I#S,Z3HF?2]R
MH7<"D_0@/%U80\C*2]7>B_Y(7%7NM[YCQE6AQR9.]IF>PA4%N5%<A2^S-%GJ
M3],.OHH=HN,"*.SLC"J@=DNV=IHTOGY?C9CE[JW"DI"8CRD9_\&*V1O98?)L
M[>&:)M4S_G4]QKBKC+G666BG!%:&=U9];MKWKC4AOM_XS_-]7@1B<K,TP;<U
M @(NN'9/K?-VE;=3& ,CV9-E%,@0<>4FH?=R,?$B *0_9-=@%?AYC-8MIA=[
MXR4OCA510 1P6)5VSM8=MT97(;9HI[-.('<XY+,ZB65H68=M?F%O7S<[O)<A
MXP9=]/)9S[0BCJ=>57<ZAA4EGF)&,F4J&(1OJ5=0^>)-+$) 1P51(&@Y#C5N
MWH1UZX1US^)#A/="[4* ^<=\=64DOE9\-C@U>W%6HE<7AZ5*OM1-825E3'%
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M298PFAAA"?+*:[QU C,N_>+0UWLS@.9OA1=:>I=%V2-^!_+&;!8R(>JL+VA
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DZ6([;KFWA6CB*^?&.V^]]^:[;[__!CQPP0<GO'###W\V(  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>113
<FILENAME>image_141.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_141.gif
M1TE&.#EAN@)3 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     N@)3   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#&EQAI>"*%20#(148J&C0I0.5?H0*T8K3@RL"%6PZD:K0
MAU:\(I1*4.M(LTS%;D3;T0I;AE<=JKWH-6S)0&\G6MTZEZ#=AV07JLT:-^>U
M:P59L2)Y#>VUQ1ZS#B2,];#ERY>--IY\K7!"K@J)!F+U6"$KJ7CQDDY=.%#G
MU"L4IPZ\\/3!T00/"_8KU@KFWY;[4M2]T+?2HP!<'T?N<3. %:4-SH8]T,IJ
M@5F]NK;.RC. SM6O"?\?>-@[ -_@GS^>'CJZ8+.@$3H7:-MA?,%N70?O&A:Z
M^*-9-4947\0UI!Q#KHF6FF5YV83>9?I=9AY^A5EEU6,6EF?5>! =MA1TD&D&
M'&94)1@59K4UR-1O;I$X$&F=C5C@<S!:5F-F#2EV4('&I?ABB.$!=]IC'G8T
M7T(W$HG98D19:.%X5#5Y85,M=F?ABK]U5R,K'[JWHG7E;34?:0W9^%F1$4)X
MIG@,05?4D6*B]6"1"4&G(I; T091DC*RR:>,\M&YYF_WY40:C*,=ABA9W"DF
M&U9;.C5GGXAE!&)NE49DXH^<H6C:G?I=EYR+)S9EEFYN015;8\JY=IJK\?7_
MQQQ!]4WF&Y=(*0=@;_-M:I!;OE68GD6C.?J8H\A>!>MZAR5Z6E%_WGG>L&E2
MBE16T^'%8&N; :BK=7&M^I>' $+*ZF-SN35J8ZR**AV10"+DYG=WDODB9A.J
M)RV$>.7K4'[^E<4@?+)II5]RYZ5V&[ML#E44;JE!%INT,9%6E'$F^KJNFB(N
MV/!LZVG+:J$56>R7E_0AJ_*K#8]JE58P$@6G0%?5JI!SKM'<,'( "DFK@-@:
M=]21DVX(X&G,^9=9DO$&S%F\ "AVF:/A45PFI8IBAS.7SM6:G\<3ZG<5MDV%
M#&N_!.V*5(\(#2ECB-66C6_'.G,YEGX!+C:CP(O=_RH8>#/K'!:7!W\']7-=
M[GMX1FY[S*Y70C+8=FE^OYM5=X ;'#A-HZEV;+M''JB0JU4;-!_*&%7^\ULV
MNJJDME"AFV2BGFUJ<T'Y'>IYK@V3=FUVWR'6%'.I]LE6CPF.*'&SI&NH.GTM
MKV@W>5*OQN/F$VU7G;F4>B?Z4#6:E]ZEOV)6MK^YES?;B:>M=K;VG1X?9IS'
M;:N6JTL=^JM9\SJWU[VKVM+W<K.\?2EI1%8+%%&"UQU5Y89_Q'%:G,(#-3OE
MC$P>0A=/&B6U8TD-4^/I' &QLZ#VZ0<O'&J(?ZXU-D$A;BC(V92KK"<>R5DN
M9;.)2YINQ+NEG+!ULJE1VO]&-AMW34MS:HL-KK0&&99=Q3UB6]CI+F2=J!$.
M=AHAWZ@&@ZP '6N 6LN4070WK/,8RX2*>LL,5W.K8BDF5VB#GI:X=2TEY499
MBDKB"?F6, P=2EC1216B!%:4_ITJ1" ZE,5"%2@FS@9RGYN:HOPE17@IREB"
M(A=Z@+6WC0&G,-:;EE6X1DF9& T]WA)CLYI52O@IL8/(<B%%\ 8]5<T/.RO3
M4=1Z9Z9KP<A[O"05=@)TG(RU3(F[2ENYGF8=;8%)?IHS8_Z 1#X8(4T@@5PE
M @OTFLXLAF6#Q$@ 3]27X>7M*&#<Y83V C^:Q=*#,!+3BN1F3;N9Z8C>+*.)
ME(;_%ZTYA8Q"*ASIK-F?&FF%G^0TXRU+8TALRNDRUUJ7BG09/(Y1+S+:\MS(
MUJ/#XZ 2G6PYH1L=%2JH-+-2+?P)UC E3(2@\B 4W64*%[+0>!4NC+]9D4GI
M-*F\V*XS3]I1<(SIE5R]*F)E5 _3FG4RB)+.BD.T$J*(XY[^R&B9A@-G8WR#
M3DM9$ZFF4B.EWB+!T25UA/<2$^_*!C,Q8K.)[ K+C)33HG.M+3VC69N3KI0P
M7'HQ2^"B$:Y\V+)@D;.AA@V24U;%(+&X!T-\'6&_]IK A$QJ248IV***%;NS
M3L:(+J/L5F?:$@N*[#GGN<I+UZ6034[N9Z2UK&IGIJZG__U,I_=23?C\TQV!
MY<^M[X(748<(IA(E%3IB&>"MI(84D\54:9:9)[W&PDM( HZ5T;-( !D&G,0T
M++$($U,K/>M03(GI<VS=I>GZQJR']0JSJW*949*(5?J!;**56J-/.]-0C9VP
M@_^!56(<<R<0778_L[QDLZR).R(R+U%H66,N96/<L>ZD52(KXITZ>2+RJC>M
M';$7VX;B)7O)<&K%P]!-MP@]L[9J/_[-YR=%A,"3(?&M4'W:4>RE7O+ZKL4%
MR2-RGI7=R<165PP55WUW";*COA&$!O+PD?86*L6T"&900Y=NX$=1$U6NC66$
M;I86UES(;,[$%N6,4C*G14^^IO^N(J-*?>Q4)RTO9\=%!@QX_',Q][P29"-3
M9%3 FBV_"-%DTYI53JHUHH1P>)=Y)H\88RK'V):.1I[USP\K]>/D7!.US]FC
M6NE3KPQB.;_1TTVG_9DVA)E(?51!WG?%\]SH\)BK>58=ZA#(5?#=LB&%=,^J
MAQA)X.QT<>^:T)3%.FI*9Y5-\(LVF[2XREB;#:G 9;%SSHQJX63P32V*B]""
MVR#GT%E>YWK+L#75)T0.+%'L2A.),^49/N>,S]/R2:K2M"O_33G;^*L-8A#*
M-]1=S99%%G-T99HV9PE-B3>,FHI6>.X9"JI'BHPE'B,)2QNV<=5ECBJ0L?,=
MM73ZW"#_['?9ZN@4Y:R[3<*.- H/!;15026=U%7V02T#2K>:B-*\;?FP\%A'
M1%ZNP>4^7(+8QFW<?F9H;U+80>KZ<!X_4&N@ZJ:Z(PULT#6F>JI*U5$^2DR8
M#DN#97&OSJ*I[U^J.MQA)"Q\4..\#9D=>GK:3*_E B;NVE#D(.YTT1YD'MLA
M6RH5%V:1F(9H&FE49*_J[;0@FAAJ,H_*V5T5HV96=^/TFNFG*B7@&3[UDFX5
M<T!ZN<;D*Y^="XC80>9TO,*GL_MA%JV7#G*#K,/8N+Z6Q7^+>F4@I+0)S1E[
M'J*KJ8IK62E;N,/&>Y=97B;+%4W&^CM18K.0HIM[RK%ZDH:6_\_&F.T'RHRT
MC/Y-;V)]M(]Q=#*B=F<]Y^^HNG0-VKS\YS';F<KJEJ]]V64S"D<C@T-->Q1)
MGH% K<)C;P1><@%/EU1_GA1L(C,L*T1^W*)S+F9C*?-9YP)/*@,?F)4J(U8W
MN00GZ+0HK=-P?"8N.<04*L-QR*(S6]54\<(=$1B!CR)?Z5=][#-UJ1)&RE);
MH08;#X9"M%)/W?4N1I$S//$LYO4<GN$64%@=TY<M)!,\Q?%W]K$<HP9S"T=R
MD_-0'@2!2J(=YA9A41$B@H=@%?5ZM70;)&1H1T(^3B@AG2)Y8'([V#1P3 1=
M:$%P$)%()SAMGW9$B%,7WD&$\'<S!?\V(Q>88XY'0G^",].F=Y1W,D=U7TVU
M??#'5-"#-9#A.I\32_HCA@L34EBS<-&A*[OR<DEH=JN85 ^";&:$A;Q3.V(4
M(5^1')65$5F(._W$$;]('?9A:4]7%6S1&WK25U7Q:\DQ%X7R%_]2(>,A>B2&
MC2QH$LU8%E$2'\$H%PV"+6(Q+]+1&MU(,[%F%QNR5]JH*<CH%_!7%])BCL08
MCA;!B.38B_S8C_X8CT_ACSH!D )Y%K]8D B9D JYD S9D [YD! 9D1(YD119
MD19YD1B9D1JYD1S9D1[YD2 9DB(YDB19DB9YDBB9DBJYDBS9DB[YDC 9DS(Y
MDS19DS9YDSC_F9,ZN9,\V9,^^9- &91".91$691&>91(F91*N91,V90028VH
MN!#X>!+_,Q.Q]8Y465HY4953ASND!94/J482 3S%T1<+I$Q\-XB]>)8B05H$
M^1Y%-3TNY4*/=AY%AR"%012@52>KUX=PX8Y[%26 &1=G-SWV"&I3ASUC>6T1
M W;>-403-YA@"8,=@E+N:'+"DQX&ATU+447H9C<B1C0\!5F1)50<,HRDAA54
M(A5.DHZ4Z1'@U2I0<B%AF!R2DB% !9;MI(574V>!V"VG:8MI(RDA5!;"R9NM
M!9A0T674PG6Q]Y9S&3V[N3!P@WP[=YRK@4DV9'&-]5?>49=XTB<W_U=C3'8O
MJ,8B2.)A98$65D>#6!,N7O)4Y <H3"A8(1A[ZK&$0;88HK.9)1>'W ,FZ_*-
MMI8GS8>=.V-P-_(F:;9,SQ.5"=8?TW(HVO%.C?4S;C,B<F8^8R:+YC%.D.8I
MPU=*OH-R"P-E0R%I?S-^\OE2"E>7Z/$1,<I$Z<E=L'2*I>,W ](V ,8JY]%A
MG5.!H!A&'91^BS4=:;0^GPA4&()WCZEI'QAAT[%94C=ZC7=]R>- N\E_7)A6
M.\HU #>*&FI>;=:>B @__NE_9P)Q:(<[[E4]8()'2,J8FO%0WN$[AJ4A_[:*
M6$ELVR(>)2AFKW(F4.@TJ#FAUK1@S$.=5_\Z8)/W8N4'73GR'XK)8R;:*5@3
M86S4I*,BE^K17.L!3E8XIYOHFBHT2AO%*I@9@V78IFXF3//R+$KA98JI*^!S
MH[F$7^-!55J!'N.X0G?8,K,8@(6%.E08;X&QFUL&JLSG786X%2+5,__Q8]AR
M>69H.J^A.R+5:O])>GY*<P;J%Z1S((*2J*5(*@.8)#53*?S%J\:)JRO3I^PC
M->?CB\2U9"XE5QW7,D_53UV#7W U(3+#I$,SCNJCF+5TJ>9Y+ .+(_:I@_=Y
M(M#2-Q0*0P,U<._%I\1"*<>)B <:%K<B&O!):[!#9XW'0;.JGH8C$; 8A1C"
M5&AH90]"EL-4L*G_)"O>U7.L,WZLMT7!<B"1"$!J,Z,XA6#$L4]30Z'22C_S
M=TFEXW]$^&<0PB42F%LI6QZ*9EN"@XKHT4&\1:\+RZ2GLG+/^:-KL1Y_):)*
M-5(A"*HW)S>4,6@2ADEYH7GQ8W9YU;4T&R0BF'#Z5[#JB"E>FW&=U&9F)7[!
MPS_$UD\,EI<[-EB&@Z\1<;-#\Q]]48E[(T&&>S+-="G6DWKX0E=.XETCDB\M
MJZ+391=:%*->]$OI^5O#=S@5ZU#]TA0Z0GU/!*8XBF]AFU-HN;+YZ71^:6 6
MTIZ@B*8WN!DV@J>RU'<'!):KT;![6'C=8J:C8A86,RRU<B.TTX<N-*[E_Z<7
M&<1SX;.,JWA7,:*H7^>&Z01&OMJ$W\M0FZ:+>]96</)SE'I(49A7\^$;\SEC
MX@55S'%R1=*UKF(>E3.=&+$IX(E#)@1OFK&)1T@;7^1IJ:4Q/[8=Z3>>H1I+
M@;@R$&MEZD@NZ.)+_B8>HL98<OE*"N9!$!3"VDD> 2(9 ,ASX;F\[R18'.NI
M,M5GG)9J&)MA,Q)._9F\6I$E@G(Y>>0[H8)'8%ISM(=+^^K"I>*]PLJ>&*NT
M>5,8:.*<STBIX"%$FB$KY9),-,@:ZWFH/3BD&S-AUL0[_.F)!JS#_A<J=BI3
MYU9&1VO#V-=A[1-$=?A,2B8]0MAWTY=&[]K"7?\$C W3P'BL-IF[BL<S,1AX
M6RY#5Y 5)#6'3O/Q2K(QP=?THI,TI+'1L"&X:@>F?DPA5QI*A Q3RH1C5T":
M6H&F%#X<:$0416%$.Y5#EZ,U7X1UO-MFQ-T:3I(&AQ0U8NK2@Z;"P912*I7+
M+NR%Q3+CO+6))^;*QA-!<W'L3&-,7_BZ-J4Z&MPRS@/T1DJD87AF5&UL+)QU
M*X4$H)TZ0B6Z&1I#+HEJ9F)4BT-[))@;0!_20$E+),7"4GTBKXFH9!0WF:'8
M://EE]8;))BK?P (=Z*9ON&:F%6*.UKH)@_2(,L"@+S2IVSCA"S%RBB<;0'#
M%>(F7JA*&/GAITPE.JC_+,D)HWS:NJAK5\Q>G)H"IRT N%^5Q6C0,R5AR\IN
M(WV0!V\'&2B9R221W'OF8SH!@G035*>,/"1N8WN@>E3)16OY^V'';,/D2F_E
M(2-O$:=0U:6[[#[5A[ 6@;E3,SE?XS&^*=;!A:N7I'].E3F*Y7E(6FK VTCT
M B+7PFS?X11%YH /P4W E35]5-4TIDU3+6ETJRCSPVB:H]AL,B?53'%8Y7+1
MAXAJ^C.S^*0,-3,X1YVGI50CYM;N58#R@D2F"A%B$W#E&1Z:-U+WF](@+%83
M-C,34RS387NIV9?RI:[)EB!V<JDM'&PU5"GXABZLT;X_'#S$"9DL]G)P71']
M_V:YY)*U5CNG9\*@B4G0N;V;)3ID;-+)+)W+&3671XQLY-,M]Z)#F=EGO"*^
MF=)).,S$P 4K=N$A&<(6FJ1JWT1OA .F#"=!:Q;$B?MDT P@_>&%.UW::_A.
M&;?1ZM4C"KO:TN>7\Z2]&!ML0[*(R9>^'=M:60-&.)H@9@HG *XV8%3*>NI-
M7PV"4@-,9YIGVF,QDNLFS'TN7(QJ0J<Z[SW.G-=$3%+%:K;=F=?=%Z%KX=N[
M:@M[R!D;TF4;FM:SR ED@9/*@7.!7O)>BJV*S*8]A]G'>W)VCVUL3EC*-.-.
MM;FGF2&()X(XE5-6'5T:<^/D*XTR/;)5B=*9AQ,P_O^IA6JNVE+>G_N\=^IE
MCHQ4/O:,L8[<'N"A+L"S6NH5X]!TO464L0P3U-[GL81T=P>"W#_NQ6!=L,ZV
MQZJEL&).5@4J,-%#9P5:5%(>UV[.$#J21!QFMV*-&XZJ+SW+Y]$1.*(+4L(M
M*E4U)HW,/SA:'51[+)".NK;M9TL>9)(M.LX;3XCS;V$4BHZ5*:)BN%MVUN5'
MTY8())XG2;]E?YW-J?LS)XWJK5+9JOB)=>K!UV1%Q.:>Z(Q8/N(G,U"M2FU%
MQB68P4MRLAI.?Y\>P-*ANQ^T, 4_J8 K5"(C;K0%WV#$962HZW4ETE>=/5:S
M8H[L/N2=63%70J:S7WC$\6/_J]%6O;CCW6G?TRV0G==38VTKCDNE <AYH:'$
MP?">&*ZB/'F<-W 4:N+X22@6$F&5#KI2OX*(=G&NBR6'F#[9RH5$BR"^*Q77
MTZO\=2-R.;NC\C/*AGQ&KDX>>QV5*/4BV&!3B&@F_7_9<N^AIKXHF-R15M<*
MMHE/-#=VH< CQLGFRX8'%3-#X2P1<CL^Z!!Z3^>>ZLC/;.ON_N=79X4%TF87
MJ+#7"WT5)C\<0TL.9<Q%FX:,/WG8"/!N:-D>G"2X1(TZ:&Z7].";%B_C&\<V
M5*WQ9LUA^&)-4R3+NW$V9%!%%2&W#(=[[WXJ*S#U8^D+E9G$!VF0$828)D9L
M:7;F_W'NF9X>S!NP7_/:(7(]=")FG=5\,L+Q-G*D83BLOW7:?:B78>RPF@A]
M<;%JG^RJ;PB'K;O+&_NA ''M6B  !0T*-)A0(:M *QP^7,&*E<) K*PH! !Q
M!48  Q,&$CBQ8,2+!JUXS(A2X<F2&0,%:EFPXD:%&@U&I%GPFI67.3]:]&E2
M)("3!#D>[9GPX5&&"G<"J-CT:,>A'8UR9"7P*=1K/J]-E I5XM45(2N2U9@3
M9-2@&2V*C6GR94.#%:VT36BE)4R\!5M:>3L5(\F1- &'=>D6)BN?@*_F%?A8
ML,RN2!^WS+GBX@JZ8C$B5EM5K\^S#G].+:J4<^6/?#GRE/\[5_9LM&EM)Y2J
MV>]8O&4QOXP+LS5AC(Y-%R\94?+DU]<$W^7XDOETZH*/FXS+T6??ZMV]?P<?
M7GSAO-QU<\^(7O7W[./=OX<?/_Q7^?7EZ]9N7_]^_OP1]P<P0 $')+!  P]$
M,$'XU%.P00<?A#!""2>DL$(++\0P0PTWY+!##S\$,4011R2Q1!-/1#%%%5=D
ML4477X0Q1AEGI+%&&V_$,4<==^2Q1Q]_!#)((8<DLD@CCT0R22679+)))Y^$
M,DHIIZ2R2BNOQ#)++;?DLDLOOP0S3#'')--*Z91B;#H&I[INP<"JDX[!,[O[
M3SO8[K,MK?466JZNJ@"HD[H[\R+_*,_H'INS3$47]0ZAC[:B:#:M)GV,L^S*
M$HTV33LK3B7J)DUS*HD$&]6EE[Z:JS&>0!+H+KU&>VVOY5B=M%:M<FJU+%M#
M6FB@N4[R%3B_-*4I(H&V.W97UG"K*JO).-MT34:GE=+1N;*2[:9:#PLIJZK6
M&HP^@[)2MM8^B?)TNJ^,_7/5E\;ZE2+Z0)*H6Y5H#>DN6SERM*-E1V+(VZZN
MK0A28*/2MR%Z'R475$HIL[7>?'O5E[&'6O5+6<"<6TFVAD/2JCUJ1YXRHHGP
MK;78=1W%-*7+?%UW)'$+@RBKNVPJZ.-R4=H4WJ_^VCDR>2_B:]U$+3599L:
MQ0@DH/M<_PVD-IU&D^B*-8N)7H<&*DJS@;9+BU[HE!):5XDDWDLO7WG"-%Y_
MM>K,69+GSG)7F&#2*RN5P7*.W8T;^YK<C5H6]5]Y@Q8:6,19.\DBM1U7>[F2
ME&5*),+E-FEFG0Q7]BJJB7KL*W+!E3E8T7W5NZ97]>*JO<@X*PMOM2'%^N>;
M]P688Y0QIKOW* O^ZMC8*5,Y^(%0);==E)@FG"G#C_)MLIZ#%2[CO:I2::F,
MH/,(UHR-%UBD?M$-5=LWK4K>V[J>TE7AL;Q]-["+L*4-VUXGY2E=F0C2VU.;
M_91-9+KBM<?(S5MGLQ^;I.4[!MI(*@3Y'&>TY3#''6LE*H$-Z?^<MR:6@.=S
M%SP>J^J5P+<=KUQ&:1RKHB*N?K$*+RH\2-3XQY!3;85=9I'4^ YHMUX%S#F[
M6U;C,#4ZWA5N5?[CF+-@EYK"G:N!3[R11Z 5&=GL#5#.T=F_-#@N2&$EA.BA
M%VUJLJDN9BYXZ1O=N,@E%AJ^ZVLUP=CE.-:V$_:K*_0#E.**")6&L TB?L0-
MJL)8,,FD[B1<D9A$BC<X\DQ-=!*#V4P"F;,?[H2)2 D4%#5)(Y"=4&FZ$LM#
MI 89HYS'@D9TX53P)3$X.FQAG?(<]B0#$LH@<'RY"XD<;[*_]%D05]YJW,"Z
M,JBZ(-*693P@ M,82*(),V&000B]WB?_.)II9'X<ZQ4EN4+ 379S2(I;#-?6
M@IE:7?%5J5L?!.ESR0VBJXSKB\DM,W<5>:)+=G9Y5;IH":BA@/)PP7ME/5NG
M3:<([U;[;!K,2(-,; :RD.9RVO!*AQ"LC49L$+M6KD[)S(UMDYW>!&F.C.5+
M%C8T)0Q!R*X AS:SH0>=3,/*GP1Z271"<V>S3.*NY'6V*Y;T*'8TJ;\LMK75
M($68NPK.SN*"+=Y$-'L-82IM1%>HN0BR(;H*RDCK=45NAM2K.7(C)16F/[KH
M1B)W*5AF:'75CW&GIJP+5Z4$NA:'1*Y3;837J7":LW[J$"'.RI_%,/<H>@95
M644=R02W^:C?_VBF90?K8R!]8C.),M->M1J*&V-VL(1HI2G.TMM'OSK:&2G1
M5FTIBV9$(LE2I817E.3;\RC)H)J2SZ@-@VEG8*?&CP1EGUG$)E;]-5&M\"NX
M\M1<:O?9P8$"$5+ Y>'F"KJUY9C6AIYJW%G_>JMQ<<IFJ *,R$@[7A:Q3%>O
MHUCC;)M 3)5D8YG5G&2M8S\)<D4R^>N6<,"E/[Y*SX2/9%5YI.M:5J)I)Z81
M[;IN=A)C468SXI+F^VA7-/"V:BZ9$PU]*GL0CKW7GF9,VEI^%E\#HY3$\G(B
M>56LH5%YK57DV@N$GT*UVD+L3__[C&R_)Q(],I1K.=XCLR;S,<O!%. C+!,7
MYD;*OX<5]+21 =9&<#Q*B/T%OT,9+!=C0E_]^35_GAM@J8PEY71I1H2#HZ;S
M4KQB-D]H8_\%LQ1/F9KAB7:+(SG71D&(J&76A$W%==YD4E,JS_X4FYV!Z]O<
MVV?SK2JP^#+*G*@,K*'H,71!52^&9;:<6]+*MT*[8BGWV.3U_4DI:VYSJA^T
M,)Y<"M%L,DE\B%F<!0K*.N)%SDC&%BOFM(DYB?;+X+0WF+@$A6VYIO6I/Y(=
J8.\/M7-J=ER.S6M5#ZG6U<9VMK6];6YWV]O?!G>XQ3UN<I?;W% *"  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>114
<FILENAME>image_142.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_142.gif
M1TE&.#EA P(: /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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J]*A/O>I7S_K6N_[UL(^][&=/^]K;_O:XS[WN=\_[WOO^]\ //D0" @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>115
<FILENAME>image_143.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_143.gif
M1TE&.#EAO (X /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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:PIU,^[10&[52.[546[56>[58F[6Z&!   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>116
<FILENAME>image_144.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_144.gif
M1TE&.#EAAP$: /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M0(A7B.Z+=F!5T)%57PL:MS-N *(;W@6 .+5NSYB)#V:5?/)N@JL9UD8HV[/
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M%]Y,7DBI,XNZZ& @)EKPCN?@J&CH<PPYTACIEL 9ES>"T+6K2SY<F1[[^,=
HMLC =$;B(!OYR$A.LI*7S.0F._G)4(ZRE*=,Y2I;^<I8SC*4 P( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>117
<FILENAME>image_145.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_145.gif
M1TE&.#EAO@*K /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MC=-9VBQS%RN*]YU)8GBP?#=47<-A+8;!1<*&R#9/E%^OP5;8U*-'0M/'ZTV
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M]5)"L_V%/.L"$6QV=K*W,21IOZ')U!)DK,$L\3L*T55-:+A%CGCN91Q!DH7
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<IS_[M[_[OS_\Q[_JG+_\U[_]]XTEWS\ ! 0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>118
<FILENAME>image_146.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_146.gif
M1TE&.#EA$@$: /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     $@$:   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DR@+KK@6B. *5E9&OHPI$&9*
MABTAKJ2I,*= *]=6- QTC:?*0$('(KUI<44@HQ>)LF3%*A#1JE1]<@3JDV5'
MH-?"7@,@56S2@ZR*,N3)=> *J&2]"@S;$*Q6@F!IVLW*ZBS!M&[5&BPKMK!9
M@81;$AZK\AJKC88CBRUH=6E"J5652I;\&"-FNE>EGK52.5!:EJ73=JX9]*?C
M@6'] MAL&&%AN*X?KY1\=RYC $!7NWQ*VHKQXV UBWU\>G)CF)N%XV09?';1
MX"O.[EZ.L'G8G(MIM_^.ZM5TW)9ISX:G?3:]ZZ[C$3NNK+HR78-ID8;%#3S[
M]YT  #:87*S)!D!V F6G((+WG;<2<XPU&-A3T4$TGQ54!4<:5=K]E]> J^U7
M4%MS]49>5:_%%F!03XU(EX&4C5>=;WB%5955]55FD%T)BCC8:?IY16!@\0'W
M&D'K%2:59A1"Z)M3"38'DX!&FJB0>#9JMAI1<*DH'UM5PF9E181!QYAJ0ZYH
M!8"7R4B@>T;::-]\5\4XY$M'!M:7?]RA)=A?=Y8FJ%7)R;?<;K[=MQUU1"7%
M941O*7A5=H6J"5Q,,+Z%I&!)%K8144'Z"%9?-;:TTI@KED:G:/*!*BE+E/+_
MA.=W@XJ5$UAO >G4=T;E]Y.L7CK4(*B$T2255I.&N:)$P5%E(U6GP<9283 V
M-IY3]L$TYZ="HNBLKR[1&EI6EK&&I5]70?MLM/*9&1F.:L565FI 'IBEO?'M
MIM6B?0X+ZU2H6?6GN:W%=JI$H#H&Y+3P?7=80OH>]""@W![ZKK7B^?76<: B
M)QNH3 YD7((T;8P<F <*11M2)><Y(Y$U2D:CH3:"I63,2W+Y:$1PDIBRM*N!
M>]"H"$T,FW06E1GFSBXA"-2:"[J4V7MNV:0<EOM"O2""!^TW;IH%I56R6RYJ
M=:2_W+45[(JH!;4=T@UAZ>-W6B)$=-%Y&IT1R/?%_R9AN'U-"[;>/C,=IH'8
M^B4>W"^6!S;,Y]D]Y-F_B3WQP7G&=:^A_"UDHV'JRD5WNT./CK=N DMG<^<(
M\=W9O!+O=RJ/@(M,H.&S.?NL8W];!^WOO5NW]..L^02GBY%UUF!Z1J-IU'Z9
M2P67S=4*]9FI*SIZNURCK1W[8ZL#CF&1T\5TY&YP2V^OJ:IUN%KA ULWJ,"_
M22L;H@:]YBK(I0N'ZXX*4Y?R?F.P(]'.+?[9$K4 MR2#S*HHQ/)4CZCSO^1L
M1U"(,^#(PA631EDH0JBS5;A\=+ #L<M>,#&.:HXCM)GEKWZ^(0['@O>6\!AH
M?"L#H$]*V*#&=:8Y<"FA:.%8)1^A *5K_XE+X-:VF%LUCC,.S%P4^W*\M<2F
M/K:24[N2\I8_O62'<HN?W/ CGN&$#ELBW!1GZN1 E:"1,5S!$U;FPZMP(>4T
MVA-,'*F$%Z/XS&Y6T1@7M\:UQJ J3O%;R-/0YR/-!?%AWR.D@EHHO_GU3ERJ
MJM^\H#(^V:RI=>23G',:M9B2G=!(IY&.^C272+NAI%I,<6"Y6M<YIWR,/U;Y
MT4%:%,O!\')$"6KC<+)C(M*XY).]3*8RE\G,9CKSF=",IC2G2<UJ6O.:V,RF
3-K?)S6YZ\YO@#*<XQ[F0@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>119
<FILENAME>image_147.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_147.gif
M1TE&.#EANP)O /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M( 9/F+,I&=8?RV$_D92@9>99!F-.=!F'I;4Q,,.;-K,MN0&;L D6;:DOWF>
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M!IK:8>1<O:R;\,8H+G$EI(]%! O"0BG_19=DSV =V24=)5>^V@4P?XP*C?
M)9:7[.]$XJ-61&1WR@[IS6XD\ATQ22E%^\GE6YS+B%2B-;Z4[-)G1TG+D,#R
MOZ-11)LE.^99))D5*7IOE,-+R1/_"3AR>HYS9'-)%M&%K_ U3IXBX6'&O+<1
MM"3$E8=RYD,EAT4!;F8Y@_+H3OHUN-J9-*!0XB5".,)!#IGL@P.5%]H65ZO!
MJ:DJK+1A"]M$H[=XI%5+52/EDCA%M<RK?O.;H#!%93=,->RCV!HFX""X.XO2
MI' +[>!5/M2SG=9K7+GCG%K8=ZX4\419RI(:O%:"L&C2SEK33)>^ZI>6H;[J
M@"USG$#12,^/_P[4*V'=IEW4)!#1Q11/#NS*GDAWRM19="=N$^79X$(_[YF2
M,/N4U)UP,[I'(99J1)H:X!J".:=8$8B4K5VE="([&](4K[2Q+-.L9A0F5@J>
M'A16UM#&+Z2U9&H-<U-9M*<FSYDO><*E6DTL<\D.3M)-53'7%VM"N[+ S5#]
MC(@VF^DHJ^6&<1EEG%H0:;#6!==X@:G+&R<;E>))4+B52JDCG8K "<Z+D6?\
M&V0#5\>+4$6.$#E64O[FN:@U*JV>%1EH)W59GW1*OC_MBW9[-9>ZC>MO0\6:
MM!J,J+?-R*?J.@U1"@<JG127AL#=5JW:-Y9D[8ZRT\(I?T,U%$*)U/]^9"GA
M/Y>$$="$*KW.3%]5 J82_A5%NXF)8$^A:L_P?JIHH7+K1*02,^%-&"6O.BNL
M_.M8L 1Y1"UY6UA^"\+8WC%]]EUOB#LD.[6:%RL&9E:D3-B^.^V0I-M3ITL
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HA$"IMR3,M<7;2YU1E$ )XR"V^F38+LS;P27<PC7<PT7<Q(W4@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>120
<FILENAME>image_148.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_148.gif
M1TE&.#EAO@(U /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     O@(U   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"HUI)=!0CBL$KD@*@&G"HH&N.65E%"&K:U82+ETZ<*M3
MA%:RDK3"ZBA(L5P%!OK:=2W!0%7!BFVX@M5<CVX)KLBKE]77NAR+2JR:MRA;
MLX@3%[SZ,.JUQY AQ_6Y(K)EK'HO0W9Z;?+;QV4/.GZ<U;+G@H\SCI;\^7!/
MJ@7O#ERMV:F5S@ 8-\5M,.KDU FOE:U\N7?GVYJE&EPQESG"RJ'M KAME.QL
MS -ON]Y]5W#"J$EI"_\_2!T [ZO;%:O_R+>O[(-UT^M6RZH^;()7ZSNV/Y[^
MUT#W#00;@$P!:%]]=]5UX(%9*;A@>[MU!M>$5WD&UU["S06@>:<!L%J'%59H
MGH3 T7<@: M*!]%5E@T7GG+3^540@1[%UY2,*_8W'6]=/185514ZYA1XN0EG
M%&X!CO@BB_5A1Q!NXCDI$'4_&M@DC/C!&-5[.ZZ%''-(:BGE;5KY*""/QB45
M)%R/'=8FAP*A1Y!W>G6(45U9D97>>C#):5!^#<VG%W1;(1?98EBI>4U3T)TY
M&8M#CO=FD9?A2)QF645)6F9430B7B+-UFE^*</8EW(M2%KG;D8N.^&1RE]G_
MF1!C3$FZ*)&4?N4G1S]ZB"9#5F!8U54);MJ4AZ']U5^G6'5665Q;[F4@BC@R
M^BR&&F*YE&^^>84A6XU.J>-GD.5'I8Y;*H7M5LL1N]6F?"TE)WI;[2KN6M?6
ME>A D"$J:T7/CO@OGRV5)]JX3_T:I6\"E1@GK#H:O*.QOF;EYZ[Z5A7NP:$I
M!:I2/GH*()H_=F:RD;"AB=Q=CCW:F8C M=GQ=5Q.U"9NMN[(%)-9[DE1KWO5
MC-!XX&T\L5@LFD;SIV5)ABMR(R+=ZHR:=3HR9Q!'QM:D#[OI5["^/HMN?B/7
MUF[ MX7%8](0LU4AQ&*QYFB-N-%),$WV?E966 O9_ZL@RE+QYG"1_ G79,<;
M^]8?<4E-*FC#RAE-]=3\4BYYE^V:QV&P*5=EJ.$H1B:UTX*;'!O1,U.4&LYE
M,8:KZ&<*K6Y!/O=ZK%)3@AV;><.5A>O1TXVX(&^W^06:450)M[:163-%UJA1
MVL8FFR?:YY2^LC&N-UQY!J*=BI>6.S*;6!K47YY.ELV?5WZW.7+A]>V\V=P*
M@;N<LD8YAWO0=Q>,L-Y:FU6J,+>ATB%*?OR:V7Q6%[G^.*Y\%=M-ZLA%.X>%
M+U9S HWFQ'>D83DK.=-[6%$"2*G4$4M5%UG=D7QW*QCYJ$2[,E3'S!2A!JU&
M++TJCV^2-IFH\"X[XT);X/\6I9V C0@R9"D7[(Y(FI9QCVL$/$Y8?B<N8:D%
M@LCI4!;%91K-:,PWNB.3JRKW)D$]SE</\Q37+L4OJ>DJ>1W[F*'R,BFH16A^
MJRI2II37K_ZIA&$(&0WYME.\/RFG/J4:W*B8=+C/Y"\UZ0+D XVS*$)Y*2PX
M+)&\>!2>8'F*.?@"HJ1X%T).(DJ JS(<?SR3Q?%1R&<'46&C(.G"EYT'1DS2
M8(04595R0<I71F&8((54N1_>$4)?HF6P2J=!MC$/+2V+D82:YAG2X>M;5!MA
M]?0#.2NEB)@A.@ZW)L2C=.4&0]T\TZ;2!K()^A!9GMI5TOCEP:^0YH1%\F!D
M0N/_F A5AUIO"IB(G/@Q/YH$BE3K&""7\[^8&:^7E(,G^2C4'2A9%'G8F>3D
M[E@<7U6-*>%+460T]CP.V1)G<=F+U7RD'Y<U*8F6D8VFY 81%?Z0EK7"&6;D
M5,@K>NZ%K;(=,'W%PF"BBWBL$Z%0@:=,(W8M-WM#T7_&\[G4Z(Z+;9M<\Z:3
M*?6-+W@W6M<X0WC%/281<E(RYWT6>AW[B,Q 28%.B6YIST25L6Y']6"3/!@7
M.0G4HG/YGT%%,KB$]FB"((NH#H]CP.SH:FJ8/*P>(U2DG")PH\1Y*V$P52>1
MA4QD#R.-5!C9P>MD;2YLPRCDR+.SF<DN.(OZ8.M:F--__RYJ7MI:'M>:,U"B
M712('BS-;/EZQ8RV<)EQ*5Y1$-E1CW:JD&<\HOI81!9H)0V?5#2(P23&4;C1
MK+(QH^%3PS;&MSC3;,%S']GVXSW([7&X0TU@8G6D/X_&-4Q&#6Q$#0I+BQ16
M;Y(=6OD !1Z#E6BF,3T3<2JW,8T"^')M951^P$770LUI+>P%6^?FQ)QE8N5"
MCP73/]5F)_#$[U<UC>U:<O:Z6UZ-4LW=8G9H8]0:QQ=S/06=R\"$F;*%S8CZ
MVN?;R'I=OP#(0!,JD,F\YZY3!10T'Y:0*^T$JNQ^:IJ)6HK$MM0M!XXL2X?M
MJ3I[O&*IL.M5XKDNY.X;98QJ1O^4L7'F?3&:WV(.]J#[S1+B!+O+.:G9P%,+
M&H]%!\HL+73(#'Z8(1O$YQL3KH+1N0R%H8PD:M*.,0RLEJN,>"77],IU%$MQ
MV@*&TW1&"+=3#%9:2JAD(XW0QL+D47GH)#<]$8DKBKO5<'C#WB![K])3LDM2
MJLK#AEDZ7<56EW9R;9G#+%C1!_.I&J&%%5MCIC)3!+-I)Q@6W3 7=+))C9;Q
MI3$[3TQ$%8(*]^:KT./I:\[YC.!J[UP2A.HYPO#Y[V@&W<?,V')EVD6B:;'D
M8"ZV\SMH(@[+S$0L3,HFBQ]\F:5-6YI*.D:_>?3H:?05:2[VEW89ZP]<R"LP
M41XRK6+_*1Z@Y#W46-OX7J9*WP"3.43EH05L/&9T_KXRPFHGT2YA<9Z((_BC
MPX '/&:V& 3C/6]#%C?!9;6S.<'L0^(@%HT_9%NXIX:>+[V*7+^=C?Q8!%'4
M-I!5=6XZO47"5D0Y"^#YGB#'7\@LRT63,<A146)=VV\EI9%"QH*.NB>T1PMQ
M+3]\M)]'2=QG(%^\Z0 O#[9O!!J>ZQ*%?;;*TM,M7JQ'+4O* ;@5M<=PXK&H
MY6''G#0O7]G373N)^ZE3L8?.E2#3\$,!SV_.TW0S]D&PZ.;V%Q)!N5!S G+J
M8_9+LJEVM.C.^_A<LR!KO![O+WE]4QC"3'G@Y:3_KKTC8C:D_]("F?!HI@T[
M(P\MCG23?<IUON2)AO$2N[M/1S^L=]K/*B)5[Q7C$Z^?0*1TW48B!+A^O+%)
M%Z80H?9SB=4@^E(Y%24F?+1K2%5ME-8O#--;R651C*5*!65U30%3FW5R/F)[
M+>)/6U$V/*9IU-%^)Y,7F]1ES<5C&+57FL<\<84MWS50Q)10/:=\&3(C3<-'
M'O@;+30SVN-WHC2"G9:$0K(P0[4I%.-]W[<12;@<7G(A"F$OU.405%%7G:47
M[[%J2M$<#L<E4^0]F.06>^%I2C<9@^<IN0=V7'(H!X%(;*,B,-45VP81VO$J
M2!@F)6(W:M%#1P8MAC@EW.(AU<&&CO]X/8_H,?6W&/Q$4ZWG5"T5)+_R.2X#
MAR=C),-V>\U&)8,46B-X*N2W1XI",5PF;N5R@ZPX/^_36^/73:@(8--Q&H8Q
M8T:BB"Q#&/JQ+3C4/8HX)Z]5A1B!?!3!7;GX<8$T,#KAC+W!%NM&'MZS';6G
M:N]Q57X&(7U3/NU%.U>4)/QUC=J5C.:X.XOA2>!2&%016=8Q&\D%(60('U<4
M5]R4'3+BCM[83O1X0E42(-ZR-2_C&N2(C B)>17A? G9D%MXC X9D1,AC0]!
MD1!1CQ*9D;MAD9D!D1KYD2 9DB(YDB19DB9YDBB9DBJYDBS9DB[YDC 9DS(Y
MDS19DS9YDSC_F9,ZN9,\V9,^^9- &91".91$691&>91(F91*N91,V91.^910
M&952.9546956>958F95:N95<V95>61'IMQ #Z15/X9':!8W?P9%?N99L:9/X
ME#"P,BMR%QOOP9!BB6)MF9=ZJ9//AG ITB1R>4#XH6D*V1;>PHW%HUE:N)>,
MV9@FB6 D=(\,A4K%Y1E]"6VHD1R@!RMFZ9B>^9D&556P,E7.EF=Q$E6A=AUI
M5FN>54X'V"8=II:@.9NTB1A&@Y<5,Y!B=(=\U(]3<D&UF$&0Y3!46)O&>9P$
M\RY2\25G-G!OIGEZAX7I>)H,,2Y E1R=B9S:N9TV 9SH98]^Z41E__.*HZ%
MTVD<<*A-Y&,UV<F=[OF>+*%R?VD?>L9-S\,S3Y<UE:0V>]:#%;1T[U1>\#F@
M!&H3S*B EN%1=H@[JL).P=%NK\8QT:9V!5JA%LH23E6=/R5O :IMQ;DXP*&,
MDV5>BT0M^7BA*)JB'W&@P?%3.NAYVA9^J$&!^J4L$'1>FADJOJFB/-JC8(&;
ML>2B_L>;;56:S4(R*@.D7T=^>.2C3OJD&626I_(MW7)63F<8T:2/*/)PT5E0
ML-6BW &E8NJDEUF="2H>O%EYJV=;$Z68/=,05(@;DS>F=)JBJ;D0&3)"PC*
M:<I*I::@STD?#D&%;".;=7JHC)FA#1&.@"BA)\$&']#X%XK9GA0JA#N*J)B:
7J3QAJ)K:J9[ZJ: :JJ(ZJJ0Z6 $! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>121
<FILENAME>image_149.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_149.gif
M1TE&.#EAO@(Y /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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>^AAL6KFJ6WXCZI*WNKJPVY([*I/#&;NV>Q0! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>122
<FILENAME>image_150.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_150.gif
M1TE&.#EAO (W /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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ME71"9')T.C5C[Q$DW:5,A7D_[Z:C3JJC5K4@@7$I*!5WOE.A7Z@\W=0;,RE
MG/5H^/10F"EMKFD<Y/6D:/J;%!8XE((_)RI33@*$Q<,@8#1P=K%#8H5C<%1P
MH6@PC#=ZG/)9:3JH\DF>-7@F4A)^8EJ&K5OR9[B5I>[)3MWI%\_9%VG2CH2:
MJ:8)F[&I)U)S.*Y#:.U&6,SA1C&%3>P!9YTT>?NEJ:X*G,\X1S^U%@J143#F
=&#@J&+GZJKS:J[[ZJ\ :K,(ZK,1:K,:*D0$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>123
<FILENAME>image_151.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_151.gif
M1TE&.#EAI0 T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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>5%H20^[CJVH]2"$6.\@?.?>0,AKID(A,9(\" @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>124
<FILENAME>image_152.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_152.gif
M1TE&.#EAB0$: /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     B0$:   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFR2ML%I!T$J@G#\%K@BZ<845@H&(=EQQ[2C"0#P'0H6X(NI-5DX/9A5HQ6I#
MKRRK]@2+$^.U:X&LJ 7 JJG:KA_;#K1RK2,K5@3//FRZ%RU"NGP!T,7Z%BY"
MIG@;LOK)M&2@:XD-,@T, '+AK9+]*F9<]^#CQ8N3BAY=\&[>R QW+I3+T.C;
MJ)<-9SQ+NW;MH*/3^EPH5NK=MI!_![^+62)3HI.!*SVH.?59U5HA"[1->SG!
MMJ@3(@;PF.3CL\4%?O_G^=UV>('8OTJGBY"Z^[-6Z2)_?I<L0:;G![(66K7W
M]/?4V2=16X&TI=99!4(V57FV"?A?5),!>-M%W>FG(((+-:=0>O#]=12'4!GX
M%&0:'B9=A2$!IM,U NXVV&?CC?A<:](U-F!=6[5E%7#5*81?AI$!1EMDN7U7
MI'43T>646X&Q.-!0O]TEW6' 6=7?"CI6]=B5#JH'55/??>AD048-5.)!Z0G6
MH60)UO78A]E)=>*99.JU94@Q3M:BBI.Q-69!XQ'(6XV=:<=<H4)!-I11X&&)
MZ$$_0IJ4@KK1IU=[CW(D)( "KFD0@_:AR)Y&.F)W&YV75H;DDQ@^*6AI:/W_
M5!Y4]F$759J \K1=A;MQ%&.B9SY6X($(RH:4HNA-F2L V]GH$U@,7IJJ>&Z2
MB*"PS 45Z:?N'?=?0M-ZA-9;!JHEHD'G'OHKLQ*V:I%M.I:'J9E@)N75=X05
M5AZ$@I8G)&: )9:4GR42BE>%;VKDZ)AK)6?59\P:22!80HK7%7"8Z=5L9]A>
M%QQMW[)JK8$\MN?4<861*2R61VD6;EZ9^DA9:UU5-?%0,W.EK&?L_ADA@*L^
M]+.NW+E;4*K4!8G@>XMA**AR_?'(F')F"OP<406R>S#'<5(4,(!4 [8P=/CJ
M"EQD4^*+=5,;4PN6CLF&3&UU91II,K"U878G6MY6_Q;S?\\JMG.&[1:7KG:>
MPFIESA2)R"A:MAJ$]$Y5;3445T?R%/CET5:W^6+]B8=:QVIV-2=/@U<D'W>Y
M$5<ZLW@)R>.%FBO:V\ZDR[=K9R_#[:?<7+V*,VWA:8;8:&!)BY7+?_L=)D,^
MY2=Y9.F2I2>-?RK.:I<.29QWT0472J=%PA8HVOB7EC_P]+NS*[UC%X:&/N^Q
MKG\TBX2ZC^Z8K(7[V5#[<MC1M,6XN:QG7,P#5[7&5Y%K):A(@&+@?1+GL?AD
M;R(_BY5/KN4[N4G0;TSS3%V\U3?)T:\V9-'+G(K&/8E\YFR_05+"%H.>54FK
M02:LS-98N#_AT*\G\&K:N/^JE)>@*"DAV-K2ZORF0&"]CRH? Q"L''(]-/WI
M3A=9#%RRLB+*W<],0?M/E'PH0C5QQH:=J4_HN+6[[0"*AHVSUI!>5C33!65^
MTZ&<?XXUF**IRHID9"*K0&<EC)6IB(G*3W4.>,>_N5%_&X'*IK(R+<!0D8[)
M0AUM6NB0%34%61VD%QB!=*@R'K&$7]3A0@K4QISQJ&N"2V',WM0W/*I2(3II
MWP4SR4LZ/FXH1[&DY(Q80*&4)W:6$69F8)D1HV!L2^=3RA)[ AV1)01N.DE+
M07(9D3;QK4?V05H8;YG*-R9'2FA$#S,GN,-L\?!&LHS.\-)23.6I!YD^RLHA
M_3?_NX!5CCE.29A"_+4I3/9):'M$XI#$M+#LD8Y>F*GB_KIT..QAY5C(DLJD
M8H4="!I0CK8ADS/!\\J("M(T3Q&-<@A$FND$<Y>""\UH,)D@*2$HG+QCYFA6
M6C][-:225X,-QE3V&9]@QR>BN=?2T$(I@V(2(;C")>@L5+FI4),LW 14T$)I
MD*PB%*JX:U=M@!C%YP!U2!#R)"7%.J6"2FA)UN+D_J0HLAY%C(C_82N]V"J]
MV0$J/"KR&%LYMDG!A @VYSEH]SZ(Q'5VQ*LFL9]0M'.EHW5M<&E)J#'O4S,N
MY<9*7 KM&N]JU1MUMC_\U&97JUF@,;H6CLP2K6@7HI.[08SS/K"-V&E%:YB)
M83!UO"F+<(TS7)%H-K;%+<I%CBNTY#KWN="-KG2G2]WJ6O>ZV,VN=K?+W>YZ
+][O@#:]X/1(0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>125
<FILENAME>image_153.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_153.gif
M1TE&.#EA@@(Y /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     @@(Y   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GP2OL0*:<(45@E:.'K02J.E1IDVC'EP!P,HUJ@4##1T8Z*I
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M!0PS<;S)6";*L,EF(%BHU;W7R/V:"M6# 4Y)TZXQ#IJ::#''B1YZ<S8UULR
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)=%[G#A$0   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>126
<FILENAME>image_154.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_154.gif
M1TE&.#EAV  ; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     V  ;   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LN3'%2176(EH!:7)AH&NO9R),>:*
M0*P"Z=2YDB"KGZQD @ :U.5!FQ"O"040J.= G$1S1LWY=.I4IP)7:-4:M.76
MB"M881UXTZC"IC07KKC&:JC2MTH)KF4;%X#2H-<"#;2R4Z?2OCO'$JQK-R]9
MN(@3HYR;&'';PXWAZGV(U&#,R0N+IDU8F: 5MG)!?T8)>BUFO)$1R[7"NC
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81R_]]-17;_WUV&>O_?;<=^_]]R$%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>127
<FILENAME>image_155.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_155.gif
M1TE&.#EAAP$8 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     AP$8   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CP2M@!Q)LJ3)DRA3JER),="U0"PYLF(E<(7-
MFS8-KGA9\!I-C:Q$+EP!$P#.HSD)[BP:LZE15H&2)EP!U>&*BU>=@G3)M&!6
MI5\'9I5J%.=!LS6_7EU+=N"U:P+?RI4K5"RK:W6Y:K3R$NG-@7QIWIT[MRL
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2OOKUKX -K& '2]C"&C8@   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>128
<FILENAME>image_156.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_156.gif
M1TE&.#EA\@$; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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)Z$^_^C\2$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>129
<FILENAME>image_157.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_157.gif
M1TE&.#EANP)5 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MVQH^;.J+0K.:D06GOUF.X=LNL9)X$J6AD06F588R!UJL'D6Z%B:*!@Q%4/>
MT_NJ]%=9[YHEC^,>Y3>O,[4MAGJ@&Q3$N*%@=BEG*J2$EZJ)B:>#,!.#%*LH
M]5%AJ;2UIQ>@AZM@M[,5_R8SXK)"@Q1T4?*]TR,CE\2+&6' XB9,MVNE=N).
MM\6K@[A-5]$A*(>RIQ0E8^H@W<8[\WNC9L(S'O\EKLN1-"HE4X'Y0^^7B8KB
M22];53ZR=,8[N"48)0QEPFK<5A=LB67ZFL.3?_N2)J$#LR!W(RJ%Q5G2NP G
MJ+,9,]!KK_-V1\ZTCDKF-_,73,4Q<E-<+UMT,$5R(="2@YB40:2*L?T1PY%W
M/14U12C[1\]!<RP%NFLL8BTJ2NL:QUTV:ACRQL,:'![L4PRLEG3C2-UR:Y)R
M184%C,OTPCNB'+\Z)+8W?4*J5"KL@V;C4\GB/B1E7JLRIN3VBGG**BRC+:<G
M6RXJI<"8GL@A>OG+PUYLKAW6&J'BK>]'RZ^Y+(G$6"639M<)217&RE",&.KE
M74?+2_]AK@H;G\;1(A[_TEP'#:R;(;%K)*'KVW0B!R^]E7BMJJG(#)J3BIU:
M-DC;:JM/_%NJC+FF^1<M,L=;O"Y!3(TR8W'=]F%QQE%M<[9M0TTX SMQV8WH
M#!S %IQOX;1H8=5XAKD;M%8UIV(1QUOQT6!'K'A".J@;DSQ8.#BDNSQ&#<VW
MFT_=;"'BM%,+QJ,3=5IMR&%PT2@W_7C705AZ"JJ&N6DA=+!APL:8JTU8B].+
M*3'_94HN1JDYM\K9)</]6V[[RF;#@=2*&*-,5ZL06*IJP=@">A\P#$R?TSO*
M!-/">V_WC#225\D@^ILI!S'(";1)HG0^1;S<",P=""Y^^F!X3$+;2F:O$K<6
M_R)M7+5JMT66!AJ\;U-K%R0R5\N)SXN\U?<S\K:$'_+2@_HJL^)"R"$N(,T?
M)H2W"O(F:>>:X)F99LHJ=K7:OPI>L<PE7F0]%SU-JM(M@0M OP336=EW)H=(
MVXQP<1-:^5*,_U?6YG1K<%N9J*,6MM8H ?.=V;%D[=HIB"%ZM4U_T3S<UI-7
MX6)^6!Q$'$A)V^H:#!:F$G%#)(Q1=GRM/6IY5'V@<>M [9H@KCEXQD?C>&=.
M-@1NL)F"%DW8%IYA#R3?;>ISWXED]5-06B%1\SRJ[;EV0NI@GCS,$*%,&DRN
M($1T5_,C_ZW'P(IL.Q*XO6JGX8%:2KI)R06 96SDF/]]S#/S'^?H(O]M,KZB
MZ'>]SZNS<T2R'7GSBQIV/B/8S7Y[(MLLMTB6',NRPC5-%5KYS*IKYT/N4U73
M/]9J$0.I.X+4'-V<3>V6:W9>'!QS/L#5>%7N&J5$Z)N[Y<C;?J'UJO9<67[=
M?UF!;>9JP&L#O[_&C7G#2(A[59SCS\:&3'#!%@C;2OO\+YW5' ].&S$,3E4K
MM"R5AJI;?:-U18GW-HJ+W<JH,7\#IG.)[6[A%FX#@-X>84@#(9;E9?Q*/%6!
MA9]UK[AE57K](ES1;5(K'0J8,MZ45P=*/4:T@Y=-%^_50L\B-=9IUZQKG^,K
M,=R-6?O<HOKU3%3TR(OQH=C_K=?TSC_XX</0V9[/U1F%?O/JD8'4A"%'-+]Y
M)M5VQ%#QUG25"K'?445HV;WER>79)(?YH8! &EC@)6M)Q1 %:D3<XM_'37:/
MQEX:2HP2HH=/HT4 Z5TK2\7+EIQG.*19S6S/!%TEQ5H&C7S*:&;&\D2EXR;E
M)/'D"HRS,HAK\H.34;*FWC$>?SN-VU:4TDH3(_4+P=A4:T3DQ/'=Y(/1(7R0
M@R1U/,FO6)YI#]N1)SY3T=_A]>Y:RUG&A>G-PU;",]IZT=;3'=-E$7T[AFL/
M-.V_DH"N'RPH[7F62W6]CVZ5@]I'XD6MG6YB_31.:QR7.8SHM$@_QTY!YRAQ
MA\7!_[B$!+8WUU^"G -^Y0W=HFZM]0B-L"QYEEB@3.B];#;$ESQ)2+[,=GK+
M2#B";#1]:V^V\?&(IZ:> !'H6B  !0T>-&CE&JN#*P(]A!@QX@J$!5=0M%A1
MH\$55A!VQ)AQXTB$K$*N8$C22DB2%1T&8EE1H,>6!5?6Q)E3Y\@5 W<F=$F3
M(\&$1#_&Y-BRX\V?%:\)#0HUY\6F.Y$"N"JR*D<K79U>VPI (=B-@5*&U>A5
M8]:"K,BN?8I6KLJT)RUZI(J0J=Y 4OEZA(G3YT8K9VOFG9M8\6+&(UD9;AQY
MIUNVDBU?QIQ9\\AK"XWJ--MY<V*3HTV?1IU:]>JJ#BNS1O^+\C5LVK5M5^V\
ML&ENR+=]_P8>7/APXL6-'T>>7/ERYLV=/X<>7?ITZM6M7\>>7?MV[MV]?P<?
M7OQX\N7-GT>?7OUZ]NW=OX<?7_Y\^O7MW\>?7_]^_OW]_P<P0 $')+!  P]$
M,$$%%V20N]G6>K!!"2>DL,*#X@) HHC\TLU"#S\$L4&W/,IM(;<Z@ZPGR"3R
M*T077X2QO9[ NJBSOFR,22%6)"JQPQA_!#)(\03"R@J!<NM+JA-['*@C'X6$
M,DHIJ3N220RQ6D@AF%:*2\4IOP0S3.'&>DH@BB@3Z\H1 1BL)[R>%#-..>?,
MK#"W'C(1Q1-IZHFH-KN$DTY!!R6^="N%,C1IQI5F,FA))M_LK5!))Z4T(;#,
M6FE$)X6R,C=(*P4UU$(/K?)1C3!T$\M(166U52%)9273IQRZTM)8L?PTH5M=
MY;77#V%MZYJ+UD2H1)@ /6O)57UEMED!9S2+J(=F[.U.,GM,245:G>6V6P"/
M/'+'B,0-+%BB'')+W [[3--;=]^]KS.*4.I47BP#+7?'1DN$MU]_W=O+(@W+
AU=*J$R/\-V&%U4-X88<?ACABB2>FN&*++\8XXXD# @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>130
<FILENAME>image_158.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_158.gif
M1TE&.#EAO@(Y /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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8XCN^Y%N^YGN^Z)N^ZKN^[-N^'!$0   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>131
<FILENAME>image_159.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_159.gif
M1TE&.#EA4P(< /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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4D19YD1B9D1JYD1S9D1YID0$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>132
<FILENAME>image_160.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_160.gif
M1TE&.#EAO (V /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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EX!EP.XA^0X<=.['!$S[B)$[B$E[B*)[B*K[B+-[B+AZP 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>133
<FILENAME>image_161.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_161.gif
M1TE&.#EA>P ? /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     >P ?   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#3@RT8J$5*R([!EJY4F @5B\#*;1R#67"
M%3AS#@QT3:9"GC8ODJRXPJ?":]=8(5U!,ZG2H !8KE0JE:7-%4BSUL3)DR3.
MA$I+6N0I=B)65@M[ @A+4R;0G5KCRA5[,NE)I7+1 F@J=R[$LQ?#'I7)5BW0
MKT59(JTJM:#:M3V5PDPJD&]?K5 9DL7X&&'<%4^C1M8+UVWF@C2ME S;%4#G
M@4BOOAY8-B'EGUF-&MSL>7+2VWQU8[W&='9!O)&)=\5:6^#PU<0- D[X%BQ2
MO*0+MO9,>#+,0#1A:O]7BU5FSMI-62?_?OPR<IM-<3<G&+[D\-, AMMF9845
MJ^%Q&7295F(-A]8UHOD%VX!9!7724=$A5-U>0QV$E&T$\O3=A=I)E515 V'G
MVDI.X;040;=A])QU^%F(8&\O1:>4:/.Y)%-/*\WWTH%1D6AB=JX!2=2)"(76
M$(<6$A9=6RF.!UY/3>DFD'^NC3CBA (U>1&1!TV8FF<O&O2E8)#5=)!D^:D5
MY7C7&7:=@$)6Q-M!\65IIG1(CH>28*#%AIID8G5&%8HXSIB@E.4]U%)";4&H
M59RBM1A6G\5I5>&:L.G6))5M]9D;060RI-]1D#K'TV+410BG:VV:Z:E-X(59
M..A JKF(EWF 0E;JF6%*J&I%QM%:DA4D$5M0435NIQFQ_-$W%)40&4JJ4+^F
M9*V ->HYI)37=NN<0RT^%*ZWY)9K[KGHIJONNNRVZ^Z[\,8K[[STU@M20
!.P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>134
<FILENAME>image_162.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_162.gif
M1TE&.#EAO (X /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M+':#>88XJH1FJ9(R12-J4(0O4M2"%L4D[K=*1N5SM?0J/C0IUO->;(4C4+A
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,/=JD7=JFO18! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>135
<FILENAME>image_163.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_163.gif
M1TE&.#EAP )9 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M6@T(6]-^S]&C!=!L#,6@ME($,3I#9Z;<Q<@ PKBS:[.PW]CVF@5ZUTFELF[
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MI36/)'ZU@1LWF#5V1#UQUREO<5:#)(T,TFSIZ$:"N97+QU33B6>8_P,D9D5
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4QT5N<I6[7.8VU[G/A6YT#Q40 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>136
<FILENAME>image_164.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_164.gif
M1TE&.#EA3P S /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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B]MEG-"[5(%GVR8CR9WB9A"FF&55E9$)QNFCUU5@O%!  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>137
<FILENAME>image_165.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_165.gif
M1TE&.#EANP*0 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M[CP:"P0R.M\8(JU'!2=RLDTB;V3_S,H.@1PT3(&B;.Y/&#<D\;$:9?.(4O"
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M'+NB>CLQN3NI*+$,@UP3$Z-(C>*8X]+"6APFDHPC03&;?0+$LW.(J;P8D"!
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MK0T[9>N9 TVW.2W&I3\;>^=@1A+)LUD38Y[YHP*WPA; 6*^4:6GDSI+6LN*
M;F@8Y!'&CF*W1O9FH5BYW$+Y=\E#&F1X(=,?F HDQH_M,R8U^8L6GQ)1!GZE
MC>@TW.# !+S0((<EAN3=4<H33NN!+'AS3,@Q/YC3NHC0BBF\#1"?R3WR^-%N
ME('+WSQJ'!SB$P & ^?:$D=%ZS!0HP 4U73X").J_RJ31^C\C?:$^)WGZ5 T
MF2/9Z6ACHJ\!L2\A:TQ4_A*3^"1QD5PTS_UFE[JM3?.1]2*:P?)512CV9H+
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IU\S%44Q+0Y19%'[IP-RIE.*IGNXIG_:IG_XIH :JH XJH1;JFP0$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>138
<FILENAME>image_166.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_166.gif
M1TE&.#EAO0*O /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MYB+A89Q->R84VW[TY4A7.H]]6!GZ6G^B%$__-U2X2G_#Q;?M*+ *5K>1_S*
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M5=-ZZWY]F[7_U,\ZE-C 1"1IF;Z-5])DR7#4H='8R[2XO7LA)Q\@YB3,-(G
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M D_TFIGUPICK@O%>QF:O,0H+H,RKZA1;O*6!C/'+H[;JZLO_"<3KD+^NBNW
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>139
<FILENAME>image_167.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_167.gif
M1TE&.#EA2P T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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B*!)UGG6V6LU YW:F;5NJE-9D$>[YF]0PHVCUU5AW%!  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>140
<FILENAME>image_168.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_168.gif
M1TE&.#EA9@(: /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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3B[S8B[[XB\ 8C,(XC*88$   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>141
<FILENAME>image_169.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_169.gif
M1TE&.#EAO )4 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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>D)AD-K?9S6^&<YSE/&<ZU]G.=\9SGO6\YSH'!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>142
<FILENAME>image_170.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_170.gif
M1TE&.#EANP)6 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     NP)6   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#*@Q4<,4*DD8')M6X%.)1FD^%2IU*M:K5JSP#7;-"\-HU
MDEX'LOJJD16KB"NN$6VHE2O;M0 "N5VH-6I#*X'RYK5+,=!9IZSF&DP+-^XU
MODH% T",T,K6ABL$RV5YM.G=PA(5$US*62!CB($^'UP1.B1>D:4G6A&-T8KF
MCI'ISLT;-*W7VV-O>\5L&2+>O+OSCM7[^J%6W5Y9L2;L<"SKKF1M#]:K=SCU
MR0)_[W6,G*S%:W\?.O_&O!D\P;8(=P]T''[H8X;./9LW>+Q[]Z?U[=^.FE__
M^_7F^676@*DEI!5Y /B'7$7H$?0;8L===]UG#28TEE*V)>?9@!QV:!9F!VK%
MH5>"L5)86NT5Q)U_O!46UD (%J76:"865"%]:OT67'$VY99<?SG"B!N/*RJ7
MG8+(\;C0BO=M1AQ>)$[HF5QRD>C:E:X=]&*"W@&(Y&T#(5=E8*YMZ126X&%Y
MI5UVC>=9EDK-*&1QMH6G7F]HYJBF8B@*B>!X/MIGI&%?SJ;GGE8,5]YA  2Z
MWWF,^JGE5FI1-Y:)2BZ4G'[D.6I?C/&-UAV09#&)Y**VJ2FG0,-=&:%>-B+_
M">)\7(JUZF*1RI>B?+0:QF-8G&8UXPIDSNB87<>9Y15CR>;VE';!^54I;1-E
M")>BD'XI)ZGV;7;4EF8F5IEA_*T6IHD',B=0N YINZ6GGP(8FH#)?3AIHD:%
M=:&0VLZ6FUG$@L>A:#="2O!_0)IXJ7I'_L<0>DD=J*5RMZ:5*5TYBEE@G&<9
MY7&^NQ(4*HZ?SD@K7R)^%O"WTP)WHH_*HAMNP9XA9MM:+QZGHIR5]1IKAP+7
M*#*CKDFGKDX" A>SM(-RZ9:(][)ZJ]1"7A1PHC->>I"K5N[I()2'8AE5G^"2
M1:W4"KKXEUHH1B:=1*1)VS)ULU&''+K8P=OD077%_T74LN<!!YZ$9YM*Z>#.
M(J2SXG-?-Y:A)NYF)ES<<;6Q@8\Y)[%!X 4<WN/?W;HOWU.?J]#("%W8UGAN
MBIJKC%NQ?)W/IYG.^'-%@1X6=WRY.=[1?',;7L!$V:U6;I?;E.B(09.H*W1\
M]2D0U-,+-ZUUN#/.58:=*R3]PSR7CNM7T89%??4??^R78(.GVVU%H"\68T'@
MU:^9W"8:-=S*,.;%5>NX"AE[Q/(GMA&/5JCSDG*2)R(D&6HUYJF7LM;BNVA)
M2"G[J\N!H!25^:1L@ QB&-5<!T'=_"UDMF(,L03WJJWT;3"Y <!K5DB8<(F/
M/?_"UIS0LBQ@.>Q(Q6/;C/_V,J6Y>"Q=;!)B\P1VFXO%9#7ZBQUIW@/"=8EO
M:&OA7K H\BP?):\\@:';U@ 70-=Q:5.XX4O0//0Z,:$(+]P)H7=H%JMC^4P^
M%/15HZBHFS).KW3\L^(8_^*CH2&F2)6+5?K25Z&V# =>?$J3?X[2GT<BIX/A
MJ0\*'5*?PHRN(+DIH;*X<D?HC;%^:"11*0,FR1_:BCO"<5F8=A,W$3TH5@KJ
M775@21POW29$2=I0]W:8NJVLAG< W(G>FGBDX8G0(/_:S)4>Q[7Y,62*NT&D
M"O43R=U!23F6D4[9Q!<<3]DE38D*S:K8Y1!8 F@YD@2.9I@S'JU8T3ME,END
M$GC_QL5\2X#S"=1:$GB< 4;(8+7L92.U!;O_35-/;[).H +SR5X=E(N;DLM#
MQ?9'$JF+4:7DU7(4=93QW/%F9B$4>: 6&[?),"K(0Q.9BI8MY#&Q2_=44)Q^
M5$DR2FVF4-*HN6RESGCU)%K6@=4LE;.B&#'I-9],YD-8F:,CZB8P/S.>8#(4
M&&[NM%:"3(]W MI&0JHS-/G":3M_*:!+#:B;D5%B]+)VN/'=ZD7,^9XP52DH
M!2(O57N,"M8.([U$_C&N=]/C80W71W[MBI]MB9"B>F719Z(EC-I"+'KD!-)-
MNG-KGBJ3M)"EGOD0ST&T_)"EA)93_QALCW$BCW8(%R['_^13+>;Y9/5.M9C$
M$<5H7[3)S:QW05Z)"6.O&^%A^R*X[H3Q<JB+W_B.4\OV%4B<8U7K4I5UTW,R
ML:A7E8B(-J@PQ$'76.A]'6'8TR<4I726*2S8;C3'0J7*,#C.D\[H"OJ\%"[6
M@,0Z2X6&$Z7W$>J./MVAYH38'EI%Z(K&F5M2J876V''VGQ9Z%"Y;EK$3&M<M
M9L*6%_VFEYNQ[[FVM-YK-\?/A>C63?LSF78C0USJ/*60Z7P5:Y'&T, %\6(O
M')HABT)$\+5,:ZX;6X(#\S8_P@ZL4.9<+J'#5NN&5"'' F!:5(@\IEFO:82)
M[+ JE:LM<16:1*EH 0?ZG@.=[/]$9B(-?@YC6[$(^#^!PN:"ID>Q727XCY8[
MS'CO^A?J.LTBFU/N8"Q,9E*B$)CDB=M[UCO$Z-RU2]+S7_M45:D.PN5[[UVN
M;4!&(^/)#*=U=M]9[EAG<HT&2G&)7#F3>Y-$W5:*3<:.%>?:'G[NRWIMT@WN
M$CT^QL$Y9$W6*\=J]3=\GG-7C.G<"J7+SK52SI6\Y*;S</7;P')[,=")"R6W
M?9"*:A>$H4HGA)N,H[CB+4#_(=&%&,LY/],Z1 MFYKFPZ1;>A="3V@5TG;16
M2G^W&$A5"N)G?,9K!\)75Y)V4:0:2.O[\E9>0>5>IQC5IU9#RI]A]5A/P"9/
MO=!JV]C_PDO/^$CK7]NK*^"$L*2\1+KH--.,_951L_EJNSTZ$=Q??7ACB+2J
M8QDDG35+61?=HJ[6T4PWJ_G79\P]2&"79W[*-AC"%5LK N,&3&"4<N_^M:P-
MQBU,HMU9]HPM9.U]U,,[F_2?#1.:H'('R1-;"',N]90$CUI7*S(B92WK+9'7
M3+?]42>ZY"PO0$M-,6U!TMI9<DF?^X@_>R/CUJ$9<-.MT,@&SDXH+?[9AIJ\
M9<_J#BF-Z?0K>V_;:4?(W\<HU-5=*2%2O;K%P<W/)L(2>>46=#ZUD_K*/ZWB
M.6^W#-7D>+HW*G+LX6_8Z?<Z'P6ZI+/L>Y5<\R073MV5S5?T_\ZVIY3[IJCT
MI(^54#/VRX2X_MO89!DHD[,]8PT5CWLE]T-&ATB)I69DRY)/CD):<3-\W&=-
M,;%!KU2 &U8@?H%Y^L9Y&#-*1C8@C=4PD:)%VR0K!\8VLR1LA#)Y.Y5%[2=[
MU69Q"E(<N1=;B72!D,)=:Y$LF+%,#!-]U.5>)^ADRI<[,20U1^$<>I9-TR=#
M@D-DD()61A%'K<4BQ00J+F2!:T1:?"(MGS9ZN%08".<FK/%^1_,[(49F:_0A
M+P>$]0$V3+8>'@(TWD%#?X2$431G.W=5YP-;X585?G$2=[@D:7(7%>,S._8F
M/-(VB#)4;$ADO42$/R<CDE%DC=%Y]?]$.&=S=.LF1&P&?A;7-+T5+LXQB()'
M03$8@:*R27-W9NN",QIC?<O643*'@L&T+D UB+AW1=;A6I ">1&8,K*G0^-%
MA2M(?7K7AQIR<S*T3+\%AD4'@JQ(BZ<T*@U3/;JF:+J5@UC1$S:S$?=7%:X7
M7 ^S'*JA,KV3B G1&ULC&HDB>^&T'I$!11C2.VPBCJ.Q2.T80BJ317>!B?+S
MC$"'94YR'OHS; A(+/21/P[2CO (([%V.9&Q8^[X1T/A(2?R')91._TSC119
MD1UQC1:9D5,!)QK9D1[YD2 9DB(YDB19DB9YDBB9DBJYDBS9DB[YDC 9DS(Y
MDS19DS9YDSC_F9,ZN9,\V9,^^9- &91".91$691&>91(F91*N91,V91.^910
M&952.9546956>958F95:N95<V95>^95@&99B.99D69;3")$BF(^0411I&8[1
M XX>68TVV99)29=F29&LY7'!%SWNN"SP:'CR42+(MX_AZ#-!-G\ULTCNX1&1
M"!%_Z(N-]VI%<4V2D2D6PTGM\8"YF#W$$FP(2!\J])?I,QAM0B?EQAIY.(P7
M(Y'M])F<\W.-.1K2Y!&LV1PB")<6L9"-03"N>73VB'NX4YH. 6J6.#XT=GJT
M]B6_I5%5%740A3F:4FAWMG!DX2F;1(?E=Q'OYW[7:2:]&(SFAS$P_^=B5Q4D
MTK0R6=)BN.)$;8-!5]8[XD.#)>A?Q38Q212( 9AQ&(E:URF!!J(E/_=^'J=;
M&2&-DCAY<WAT0O4;-.68G;=HHCB8F,.97+A.#ZH4 X9KG"<WN(&/=#=;H;$_
M'3AEC!.=/GB8TX,UJV%[5;1'RJF=X6$J#RERPP*8805$N;@J\1-M<$%'C@6%
MF,%-ZOF(D/B";94LSW28*_@XZ7@=O\%Y3Y%U'<4^//(X"X-&A1<Q ":.?4.@
M .)G,Z0MYX=G%RI>^L$0$HHC,:)%W1$14>6D0Y@=FH9B-K9KBE1JS--66'6$
M0H<YX<6,7[H85P)AU=8@Z1A39LB18W0Z^_\QBT)E7+AQ%C72*Q,F(3J$%F5"
M)D&(0.X2;FPZ=P#3,66':7(XHCA5AL+TC2I:-!.V89/D8TRX0Z1Q7PAR(=+U
M? J*3I?H%[QQ4WO3AH)*=U.T4R\Z9%Y*5,LG6FM"K!>'6%F2*K=G-6PE-ZY*
MHLEXIHG1*JYQJ8"HJ(H6>GK%+8"*9$53%^D(@4@R/)4#8C-%(<TS)B8'<"ER
M17&DIS^6+>JA27,U9X49J=@J:=-"/N338-=); ZJ>H_Q/;,U4=2ABLLT3U-$
M2:O6)8;SJ>Y)4>QG,S4&7F!'5)!X-H;7=W\!(9E#9SSS<89EL&S:7!J&(7J#
M>4218Y?B9<XX84G_E40WU2$S*&M]A7^-8HH^J(I6 JA<)'6/5ZVO*K1)*R0P
ME5Q:Y(8K\RR6@DJHU#2G][$P*ZX]:FD@]A7?DW@52SHX(RU=L;4^<T5@XBB*
MQ:$<*CE]V&^$9:,B(FL+I*%M=X<FDYEZFH;%J7=8(Q>/D["K=#P&2X1"2*M<
MES3?UG.(FR!=M;6Q92OZAX:6LGVN.'_#5H+M:4\8-+-U@4/2Q;E[U&>(D3.'
MP:DWMJ==\1I*U#SE]8>;PVZH=7% )$4&%&J=>36[YFY28W*58Q2%&V$FB[&L
MT8M\&JR;(;;-U!N5)CS9^7Q'FASP2:>QZ:+HDE2K,JN!Y)>A$B*.!$X1_ZN\
M9U0@<E(D] -5:<LH]@0QTLMHY**$@:FTN2*&_H:B@_H5R\,<"!:KB,8HF"*X
M(1-YLOMPQU1I< MV6Y),K8.,A@%:5_4:"]IL)C6#UG4=_&D>U@*>(SJWK8B=
M9P1^IDMNW6M9Q;D_*UIIQ71]..?!$[HN3],>V&2V);@O[.%@JXAE$S>?C?B9
MF[-0P>>_)E2VPMIV_:60I42,@X$7A18I4V-H2SAG/1.Z 8=$/X)>;#9>JF5!
M@19#\;&^DQ9HL?2W(!<GQ]<A4;H5 +,MR04OD0-WYSE%4&2784=I]0=M*=5A
MDQ) ;K(X+_5K.2P8"RPY+[P>')H_G71B>;HZ:O^D4SKWP2WK3^N3>,-J*XL2
M(R%LGE&5)G9CP4(BJ?KA71QH17-QK(GQ0FVVALQD,0/W?Z7R2\?7F]Y#<8_)
MG\7U@FN37:7K46CD(D%$)3>&4ZW"-J61=<F2/KEG.4NL?3ME)!I4+UN[<A[8
MP#771Z.F9>[%/!Q2/!3S%?'A&%QG&&EXJ_$KS;))5JJ7F-PK3XXK90QIC5;,
MOBD"6+F5G/B;,8$F.JT,M+,+@O%Q<K0T;I ,=G"4A .-HN;G,5 $OY&['04F
MA1'B)I1*L8^\7;0$.*%6,Y*7B0D+O !&?94K)<Y'R1^#(X]X/3",>?=L%Q+5
M.>@1O*WY2Y7A19K!6,G_%7EWIL]@%(#R1V7X920$6A_%IFSYD32R!$H"(C]Q
M>RNZ!H3<ZKVM)+'&ED]MF$QZ=9EBM4=4\A4W$AM)+"K'9Z(NVL&N2$GJO+_R
MBYM#PQ6J \#SAS.BZF=I=AC[\B%=,CIKK1B&L[PG4\/.U2I+J"$&[5+L+",Q
MJLNO@QZ;F+=$?#-SQXQ]\ICIF*G,=V 0)#CE)7'B\:DNR&<T_693RYRTA#:I
M/*IV*:/5L6=#YD\$=3PR=KF$W<-G"X/.YZ5(IFI#<SA&%5M(W*W;JB>AK;0Q
M&R"/QEG>8194W2O XXMJVR!S&\X42,;MS)VQTH@%MA]F;:JP''Q=I=5LO5=?
M__9ESZ:_9"%)BXU*\(G3@9LB4%B>N>(_*45$S[0\SOTC83=8:OU#B#V\Q$;#
MH).@ZQS2CD0>Y3LLAFAAWTUL!NHDI\W)(M/&+J,T_%*L #-%GP@<%I$EP>*M
M43; YAI!]7P_CV'8:M3+/NBE?-Q#SD184V/5[Z1:V'LM[C)G_R,GCY.:ZG>C
MZ8A355V<^E(I=RUZQ&5! %,>7UV8*6+0N.H<"T,:W;1<&C%8S9NIO-*V,$UN
M6[(Y&"QDI6%8J(73MG5#&24^S3UFO=+9OTII-%XZ'&RRCVRK(MR'2TR"!ML@
M0*CF4@2L_M1!99IA.+RB:)<=6Y44.(1K,!7G>"2ZH?]SO&JJ>]/]OMQ,SU%L
M6<RQ.<?BI27XY>UA+@,W(HKA34ZN:VX312P%F'VC+C4TW*>&F''*XNQ<.[-:
M,%"C+[-LU=YLY'>Z,\5X*;5N&<6,Y+('9/M123@JQ-#MVF"5=0MSS[L"0N'"
MZF@#:[I.RW(M:/:S5M!F,I)[(E0>5^:2FLXQ3+PR?<1VW*ULZ+68KHSKI@]Z
MT2[\B]0>,N]EL F.IEWBTGY7.B_2.LD=G@T3,IH\-01JI6LHI9KM,%+EZS1'
M1Z4^-2$%),$JNQT7K_;5IVVG9T:R+#"#'P].A2 ]UFECG/<45]&-(D,-IRO,
M.+B%6R8W/)QC36$!6-_\4U7_<E. W*:O):?2*\TR:)P70BR\,W>T!Z'F<7=\
MAS9R$;YZ3E1X0SA,1[3>-B=*C#B@&%DCTB%PB];BU^6OZ1YI_E@W%:0/JIF:
M$K<4'GR_]<JX#B-0G#OXY$6+K,,L##5:-KC@ZS$.L]K%FU^$-^9P5AP;9%!!
M#$:=/:\ZWE@9@LRF]5GNDKV=\_&*LB(E%5X@7_ !-\"^%/F=">@*(7,^Y,ES
MYTC!:+061ZU<PL>$8BCNZ;7&M"^ZZV^*PWVETU3 YZ*5<7\I]F62^R60JA[&
M[9T>KHS?7+BSUQ"+_X/).4.!1ZP%XBC%D]5*0GA2YO2$LL0,;$4]M2DCZU%-
MM?U _Q14JMY18?)I@TLY4&(H&_<9D.]+DG%<JX]\1O=2\H-WD0NBATCQK&1$
MQ=?$4ONQ#3N>OW@6I<=* ,%J!0  @:X%(DC02B"&#1DFA$C08$2(K*X)I)A1
MXT6-!*]=6\&*E<2/"#,:O&@%HI6/( &L."AQ) "+'U5V+'@-)TN..4W2C+FQ
MI<N(,!FVO$G0XD"*/(=^9 ITQ50K4U=8J<J0*<R9+ ?6#*K4Y<) 5:-Z36@P
MJ<^B)7%2M @V[E"1 [%FO+8V84M6>G.ZI=DU[]^>'5G^[%BRH47$/'^&;(G8
M)\JG3P<:%,@W*N6;@0:&/!LW(4RB+_<RSF@T;<O0&9=2)/]],"K!%2C[DK0;
MD^Y;WKW?5O6]LFQPXL5?SC9L/&)8V'Z+>\:)W/?PC'=I=Y2>VCG$J:/U9A_=
M$'Q"Z\2M6BTZ/K7&VM+57P]?%'K$\LKM%\R^4#W#F_7):WW+H/<*6JN]B.:;
MKKC.)/N/-\<@8C M5A#DCCJ)@',0HZ8B#&^^JZI[Z#X11R2Q1!.?.S%%%5=D
ML4477X0Q1AD3FG!&&V_$,4<==^2Q1Q]_!#)((8<DLD@CCT0R22679+)))Y^$
M,DHIIZ2R2BNOQ#)++;?DLDLOOP0S3#'')+-,,\]$,TTUUV2S33??A#-..>>D
MLTX[[\0S3SWWY+-//_\$-%!!!R7_M%!##T4T44479;111Q^%-%)))Z6T4DLO
MQ31333<=%*W>!)00QH5V8HY%HSX,D$-.5V7UTH]$@E7#T:92J[O7FJK,LN5T
M@FLP]FSJ**Y8AX55U=@*XXY&V<XC=<!6GX76SIJ*A8J[7 ^RB#V''&)M5P#J
M4ZLB8E\=5L()&U+,H>T\\LP@R:Y]:MUPHZ6W7CLAJY:M]*Q8ZJYT.80.,EGW
M @DPH-;B"]Y\%<(*JY0:WFQ;AN(ZRE>/S@U$I(POXJ^C>>T%.>0U'7,,-=@F
M9$RKBT3ZR+6G*"3XVYH&:IF[JSQ;2JVRNAM-X;!LXPNLBYB3#:2)N')OOH]%
M9KKI,-U5_X@OC5AJF*4)\YH*6>%>38Q7H#RK^4"=6A9P8=H>MAHKJ-\*FR)L
M"^9U;6M-6MIIN^_6LC:A+;1YM,#("HLL_FJSJ2&$O2[H):W9:KG?BV;C"EV,
M2\TX5M*4>G=CE"273+6<8H49;]%'1Y)?L#SC-[*HCAWJ* ,5][DEB-HF::;5
M>&U\+&0CW_A<DPEF^6V:;??HY<6 [=DDIY BO7GGAZ1LOAH)([XIH)J[[O*7
M#IO=:Y,LTLLFA_-B[#+$N3I[)L]/._NHH\*G^Z"&(_0<U.?OQ]_'FU>F*_C;
M2!N6;DK3M=4<[B^P0\[^<J4^:ZUL6BQ[E_H.XJY;[>5[E6%0_?\LEC\.=G!&
M(0E>_QJ#,Y#H!P &(^#%=L6\FM!O<U=!7EL<2*ZZK# R3NE<4%@#&;]H<%T>
M!&(03;0\LTGH58/A2?7PXC7(1<]\D9F:342C$?#EY(?N,MP)JY64<$6/)ZD)
M2MVZ5RHAEM&,L,%,2, FFY7PCR>$JR).:'>VDC %);#CD%,&5I2Y#) ]ICN(
M[.8E(/2!)3L^U AF*GA&1I9Q(5P[(4)B$[#"Z>0P4%F<MTYRFY?,C([ND<L/
MM9C)M%"&8ZU;&T>@EL1#!L53;C/)!ALYRPZ^*BD]T1M'J':]3@YFBD)QT*MF
MLS; O:IB$]3+(^EBN*V0RRQQ65YNCB)_$*#)3UET21CS O,M6=+2F\_CF073
M0Q[9Z>MKO8)D=*9'G\_PQ4*Y!-:Q^G*5$$(RG%I4'F!*\A2,*)-7Q *HQJ*6
MSF\6U(/WK Z&:L-.7+&Q1 W#SJCP*!VUB9$VD$L*5D!CO_"(,CHA,FA(13I2
2DI;4I"=%:4I5NE*6MBH@   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>143
<FILENAME>image_171.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_171.gif
M1TE&.#EAO@)T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M&K1OTL53]+=@=#-IVH9_?O-9_%=U7V<N%Y,W\O0JL 43C1<XGF,?K3=M>[:
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M./6=+S5I&S9IFK*1C??C%WU9EZKH2I]!6\NGJ)#DYYL?'OF6F,)<VBX]HEA
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(J)9J@0@( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>144
<FILENAME>image_172.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_172.gif
M1TE&.#EAO0(Y /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MG8RVLS*4^M7U1C6T I?HN5<B*!]!B+ K@X:,DF=#.U>S*7(,$9M+'VS#Z^9
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57OQX\N7-GT>?7OUZ]NW=O_\>$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>145
<FILENAME>image_173.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_173.gif
M1TE&.#EA*0(9 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MKM"IDO+2-"EFJ]SHSY0J7)/Y'F*;,'+L7B)*RW1H>DYD_SFS:=URS5L"PUG
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-1%B$1GB$2*@0 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>146
<FILENAME>image_175.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_175.gif
M1TE&.#EAN@)R /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M;*=7\]"T'P%")2*\:AQZ,$- RX5K?W!"T/*0)Y\&^>I0?VN?2O\8QYL)MBU
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M6P(K1\7F,<:^MMS$I36AI:@83(3+49' R P!FWN]:0OV:;1(:0:ALAT)0N4
MZG&\#5$L'<];R51D;UTEY/=%E#\,P].P;1##+A@<P!OIGF9L13I.X^<S0"+D
M5D+UWWQ%[JX5[&ENY0$AC\^X9)@JWOS9N:;;"TSYS/>K4F-34NKQ;.Z(,>\:
M$3AI$IZ4/5;K$7\IDZ!*M>S8J--PE/)[2T:Z..4TR9IV+$.[#J3"Z[GCDR'A
MNRI%+@61W*/,;BS>W 27VFNJ2=>+BPD&FU!6T3!$#2:,G7C9IY48R]K1(>?*
MJMG)#.^VD/^*)L+\BTM+!(JJ:+\=+R_"FM4L&;N!^*=VWDT6>Q(;/SYG1)#5
M-%?UV&(U!CD%]+R/<D 1V]Q;IE$EAUI.+*$2A284?%BTL$(<J9(&QD*+%MU!
MUL&:\F?BW>_@74#V0J]"/7,"'L7(=-*8F#<0&@H6>Y/:^JE$):ST).X\7^1:
M# M4Z5_FQ5!6RC,]==&(0.SY:F]2HQ00(;?3572GY5'S>][VJ2FQJA7,L&1B
M1L3<D]%G,I7.*U/_&A4(G0K_DX]=IY\XW140I/9EHA=C3H^KV&&N."?,NK.L
MD#1D_^C^2[ &HF34P9,\%\ZID"T;Z[R@\G7GGCA(Y3O3ZKW1B.G5T*(F'5_V
MJQWNHT9D2-^0@4.T=I*.%FG5 +/3*BJBBW<SQ4;>O[@E7'I7IUI,$E<>UO[#
M,TT.;)*M&@^2_NA,&B^R594K".?>VS5 7 ]W(DG#O8PZ" 5$O 1*WETN\8CX
MJP4-8>&^<(JTS=G< =:3$^1 ZI.V$AF.GAW7B$47>.?7BEVN9BER79$16/%@
M@ >-A>.L>=$5YY"?N&!9HB ;7L'[L*^6CM5N:P%=OO]B9>'CIK_:P2F8P1U\
=PE?\Q6?\QG?\QX?\R)?\R:?\RK?\R\?\A@@( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>147
<FILENAME>image_176.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_176.gif
M1TE&.#EA1 (; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M.PD+"M//?J6Y%/WMC[_\,3_X^=O__OC/O_[WS__^^___ !B  CB !%B !GB
G")B "KB #-B #OB $!B!$CB!%%B!%GB!&)B!&KB!'-B!$A@0   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>148
<FILENAME>image_177.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_177.gif
M1TE&.#EANP(T /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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=?-JG?OJG@!JH@CJHA%JHAGJHB)JHBKJH 0$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>149
<FILENAME>image_178.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_178.gif
M1TE&.#EANP+H /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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M2FS>:P93Q\+<BR4-REX8=^>-.6&Q(/-2K/*QR&K;H=F43UHE*A78<#M9Y/Z
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MH:#B&P94NMT+E4YS40JIGX3VJ!YI>O=WPZLY&K0_,5:\+]FDM4FN:[E$3SO
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MII=-#(YGHTVO\?@CB3&69A<K?Z7UXI#'&=>3C-WUZ*13[56VI(HX,NG_%TM
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M+,$6K,$&BG;^2)E4R[)FZJX*:[0&1S7^89YH:I>T:K(J"9CH:I7(C;62R:
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M-XN:M0)-FE7V9KR)X5-1!T<WX,:HNV#>R?]TVU1)YL:J(RU3'A.5STY2JK"
M_&-54+TI,R63FP\1M169VQ?EL)@Q[)&(D?5$[#M6)+\7VK.>ZG(:"),E7%+2
M"563*T?6P)0HQDD*,KLFN29J:D$+CZP99>+8;V[*D#7I<YL:;NY(55">GKZT
M3[Q237U*B,F#,?"I5 ;JT?10D^DZ-6"F9*(F4EJ/+IF.FU3F5;70"J&3"R)>
MF.0B55TQGY[IJY;FC=PMS2BC5IIUC6%.205E][4A_4A4L3UR85+[1ABWLW_T
MN')QPFK(MV+1_SK#*&KS0,M-:[>.7J:4WIUC*#="!8^+D'25>Z^%,/_]LX>S
M12(+27)@A!GXQ?WX[)I:459X5QIN..Y*]23<7Z/1S,Z^9&"-\ 9'(\G*2Z3:
MF* A^^$;(8VP')XS<)^4@WIAFF>R>I%V-[(FZ-DZ7PXO84TFJZE!MCI*=T/<
MI2:5+B0=B7Z>RMJF$LSFT1+12@++(3:A13KM25#>\T+[!^N&4ADBT.Q]L]^=
M3$2*B%&9@R,?-%3!S2<Z@;6!?&,>V;MVU\9994PXXJZY&B;S?Z?W@-+J27RJ
MK);*],9J/H8ODPSO)68*CL #4 HN2'!%)X3I_?1%T@B,/'(K0*J(E/]V9$"R
M2C<^Q2QV:JJ(S^M$ZT%2R>I&R5=,K#%:Y*#N#/3,Z>K*JDGF12Z,8D#V:"IP
M3JZZY?N"\+)R2_@"1$#6HOWZ;OU.ILF:L.B<KS+"34'^:J1.C%;(:B0"YJ9
MC>K 3KH\S[AJ(N1P;_%L S+N3>46 N%PI*/8QC^&HKLPPR0<PS'^+4=J3Y\V
M9B5"@_RJD&":"O!,C5. Y*+.I$K4L 6!;\,F;[$4KZ+6Z)^.XUC<,)]"QJD
M0]Q6*KN("P?I34W4@@W]2-<\ ^_T3RZ PB):K3FZB].R)95B,*!V[RT&S=:Z
M;L1@I%EPS23^1SJ@XG_,R91<!A+5#4E02O+_\DDY/&:,[$_/>$LS7D.'7LT/
MM>01*XZWL(ZF9&)%IHA.*HPLRL_;1"T]N(,[0N]1-E%K@&9*JLH-54:D4 I3
MZ&3%>LDY3./2>&4;51$2*?"36$*0$$ZT%+'71,7O,E'FB%&9 ,P!]^)!',4H
M  R=T,. 7HN9E(NB_)%.HB,3\\:GL(LZM((IW JT0$OEVD(9C4F77#$Y)*D5
M5P\<M46GZDM63L]E("1!=I%66FOG /*N!(8,PR8?)8/UN*@2UX51Z :I'@3)
M&&-LN,CV!@)-9O+RDL5G#"HS;% ?P[ A&^*^*JNS0H2/R&SQR L$%ZE-QN5<
M *=$* H]:"REX#"<_S)-9CR&,D+N"A-O*:(Q2X!J#2.OB"(.$G]QS"ZMUX["
M-)[J,>@PT3)+^11R.GQD5#!26?2E,GL)0HK* N-2[VSD="#H'X5C) %)29;F
M%?L2,%RQ+! E7EH+14*$B[H-NG0R&=4#YW92-QR3$1VP^##F*ZZ,CY"Q[S",
M[L@JZ5[L7_B%WB9+$G=N(G,C1:[RVK31$E\K;2SSQ9:D. 1PY@!P/DX$(P+*
M+3MFW%)FLU+(2HRJ-A[1Y(@"ZTJS8QXC"4]**?"DLI)S3/J2Q@33(G3)1L)D
ML>2/*KQ$A[8CIUQI%GFO4T;1A'PFREX-U00+"ATP)PPKY^YDV$AHFAIJG_]*
M$9#*SSLD3+,*KBU<L?QT(KZ"8U!"I$_^<T@>5(^V,"=[$>J8Y#I%=!19<=H6
MDT0V,:$&DHV@T,LD4%#\1#E1KJDD9.&Z$3C;T2^RD1:IT[E6M),"0Y2^)>?X
MSHAH!%.^(EA<4SG6$B039@[5100GS*OZI?.,"CX(3RS0-%]"<_UHB;INE#F7
MB5_8TNA:K^^D+5-^,Y=.S2F\23J RY1<+DV+++ZL:#*OD546,0+=J$.W1 [A
MCT@@SJXPB\OBC>=:$$'S1$PH\SN)C5>&)-=X$3Q\40SC;XS:;$2YY Y;B2^
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&G7@" @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>150
<FILENAME>image_179.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_179.gif
M1TE&.#EAP0*0 /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MY$L3?60L"P%D3B[22DN:$"M#!,G61"?_F$N:,I,< E(47;+"33931SNA8F,
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MZI698!) 4\738K3X6@H^099'!*9,FJ0[$K-N:B+_U:+&! HC"5(+2V% AY%
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AKQP$;Z[SG?.\YS[_.="#+O2A$[WH1C\ZTI.N]-(%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>151
<FILENAME>image_180.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_180.gif
M1TE&.#EA?  ; /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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@Y/%'6!E;Y((?EYS1;P</9?+*&*G,\LLPQRRS1P$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>152
<FILENAME>image_181.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_181.gif
M1TE&.#EAMP(W /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MSH9TPY4D"H-PV/=#E!(F2^4L@S%BQ"8K:65\XR9#X)== Z(FM_9*S*1L5E9
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M\(6 C:,UZ2B@"KJ@#&H2<^@?,1=B?R4>&Y48"=J@&)JA&EHL$-JA<8%^$YJ
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M$W91%/P9K=JZK=S:K=[ZK> :KN(ZKN1:KN9ZKNB:KNJZKNS:KN[ZKA,1$
!.P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>153
<FILENAME>image_182.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_182.gif
M1TE&.#EA/ !' /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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JN[%Y$GKU\42UC4P1@B;/*V_*$77)<F,-ORQ@S#*KIG#-..>L\T@! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>154
<FILENAME>image_183.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_183.gif
M1TE&.#EA=P C /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     =P C   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@KKEB1L2-$*QP]3K1R[5I(D2@-DF25DN!&A22OL6Q)4R"K
M:X%JKBB9\V#,GC5;[C2ILZ3,DP-Y!AUIA6$@G$N'\K02L^3,I0Q76 ETTRBK
M0$@'#@TKM*M1KUBS/CW+%BC!IU>Q6KGYU2C9M"Z-!@*[L6I3@R7ORBWY%R]"
MKH7%*E4ITS#!GXXC#F5U]V9BPV<%1S8X^>Y8AYXGK@V\V>GB@T_= E@1Z#(
MN 4M1QQ=$O4UUP[GJOYX^N!-I&OC H"L&.K#L589&X]H%C?#KKL?-QXX.NZ*
MKHFASP;9VR;I@52?G_^-KK#SPM_4QQ?_#L L^85K$TNU3KC@6H[QDS\D7K[V
MZJY# 45;2%4M!]%:L1F5G7_I\13?9*#1Y5Q!)/4$8$Q_%3C39-TYU!5!9EWS
MEE'2Z94<A S%))Q"Z'W8GG\8WF1A8QTV1*) <-%%T%G%A4@4 /HI%!]$M=$5
M$HD!O@B674 :^)!^,;$VW8LWODC967^A>!A/'&VD%55>OI0>5]\-!9*.''Y7
M)9%0?9::=W6)^%IMHP&5Y$'7654@6V==U5:#<QVU&ELG(2@9EXO5=Q^&]\W)
MX*!."K0GGY0NA^6(F34(%J;O(13@8@%J)Q64."&%H4]6L?(52&*RJ&""3+I7
MA)!>JFJ&J54AC;I<=;8V*I)4N^D%D:X.#0CBJ_;9ZMV/'MUI'RL3)I3GI@V-
L=MEUU$X$8$H@E69?C1AMZ^U2;[84Z[CH6J1CNNQ6E&V[\,8K[[STRAL0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>155
<FILENAME>image_184.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_184.gif
M1TE&.#EAW !H /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
M                     "P     W !H   (_P !"!Q(L*#!@P@3*ES(L*'#
MAQ C2IR(D-6U%117L&*%D:+'CR!#BAQ)<J!%*QZM7%N)LJ3+ES!CRBRH\5J@
MCRI77HS8<:;/GT!'6KSI<<7*FBT=!K(9M*G3IPJ'@C1Z#4!.B$NK0MW*%2A+
MD18%'GU(M6?7LVA#2@6K=2G1AF73RIT;<2DKDDL%7G5(-2G=OX )6KR+5RN
ML7!7O@W,>*Y=EWD%KFTXN+'EM(\A7VNIDC#E:YXOBW::V:7*MZ ?6C0\NK7/
MK&9)&GT;N2%LU[AAUMRIFZE MTH1YQXN<F7HE[,')K<MG+ASB;MCOUPI>+'"
MG-*?:[^N^"=5P:P54O^UOKV\P9SD8PI7F=W@>//PSW</:K&G4;\)J8:/7SYK
M>IGU"78<0E0-R-]SZ#TU&0"!&'B03NT=B)M_4)5FE8,&986?A+CMMB%0G17$
MVT(:<DB<?O]Y1QU!@7R8X5<FXI;3B%#%-5 @*1)48(RN%1@A?32JY)!._!F%
M86 Y<829;P(9]>- .KE(7(FC976D4R$21&-".N68VVI>R@7F7ZFQ*"6+\YFW
MVI5H[1;F4S V>>:-QL6GTWYT[<8F5">)^*151#(TIYB!(MDE8UG>..2*"@%W
M&2L-XKDD:']R]1U!@XH5)T)9U9BI9%8L]6E3JVT)6',/'=HHJE-9\>.""MG_
MY*AC=8JVX J94KA0FFP=N=JBO)ZEWZAGS8I5H5PR"5>.JT78:4-WOOG3C,2>
ME:A>#<W(4+ +P8KF9@E1N:NJPD:9&Z--)K;I0<\Z5!FGZV+*+;MWHI5DI62"
MJQRP7K;[F:2 *FO0O"]"V-6,^/[E+;0$#[270]@1V/!A L-K\%99F=K:P\>6
MF5^\'VL,P([) BSOQ4[M9O)HK J*\D'O\07RR,@6K"ZZ05FQ9L*,W>KNS%!Z
MS/!_^G$GLH@O3TNN=J>Q^'/%!?F[K= %_9I0@E.W'%/&THIF(T1)+L0Q0^_2
M:S+6)"8=DYX\VZJO5946;737S5I\9LT2:UW2C%V[_U;:"M):'2O54<VL:T5Z
M@[>R2%QS>&W@0$N6^+?_H7U0W61/#E+&U>(6YZ>67Q[YR9)F7/C;I_?=,:4\
MEK8GS3@7_+K<!9MLY;^O0Z1R[@@B1G?L!85]L\6H1UVK>'>V+?:=G3L'8]?B
MPJRV]"#S'?+1>MW)NWBE*LDCFH2UF"K4RBU]?7KZ 3SL\J"-SISYWP>LU^]>
MZO2Z_0@EGS?A55,W?7!=4IYYQA*JATC-(*7*5*D.,B/RI>]'==(63QJ(O>\!
M1R,&!)[B-&B\EK&D9>G+T7RLA"_ W:EX\7//BE"8K!R=ID]IF]=10)8^%C)(
M.*4*Q JR@ZN-:*]Y'.H3___R1[XF@<98Q,/34<J&-)+9[%OVPQ&.3@B_%*[J
M)AP<6!:--#9Z84Y+LO)@&%GH+9U1\8RL .+WRK)#U32L+!.[81I1Q9*8(>TN
M> N=<GJXD3Y"JHU6G A+:L.0PZGP(EWL8$[\$A<F!NTNH1-<((/B%D!FZW]]
M 0 ,$;)()D:,8ANJU6J2<KM)-N5KE]2;5"Q4L%"MAU$'/%X ,R9 4WIDD_P*
M5VKLV$HG/FR1=W38&6MI2XI<BV$<?)==VG.;3-Z0-9*DF'4BQ;IB.D5S&W31
MNWCYK9:($EUH<R9-B&G-6]J0> XJS6U:F3VFU QSJ"RGM;"9O7C^1FB.O"=K
M-!3_3?U@Y)/R3$L<=13&#W&,F_+;( JI=<" <F5A$ILCGL:V3B/B[(%FJZ)#
M*Y1%+2)T;#4)C? (6D25D7.C)*$GQ6I"GBZB+7K0.2E*A5)$+5H!F"<S6TLJ
M.E.F=10\6!080!4'J>/U=#L!^LQ-I";._NGOJ/VI*7@( RN@Z>R/4#6//;UX
MS^.X+ZOQP:4N/</$KX+5/*SDI,=PRM.SQJBI>5,<1AKJUB!*-:$6M0E$ZWH@
MNI(T>">4*5]9=DZ+#M:A::6)2@_+H4N%3+",=1XFZQ798IKP:#BM;#&32D3(
M:G8XB;6H9S_;(:UME;3QV^MB40N?8Y:O@JR5T%9/&]L8/"V,MK4U$:MPFUL)
MY=.QO4WA4 'EO>"FT)&#&:UQ+2/. JEQN5^J)ERARZ,<MI6Z)@)<J0:*W>YZ
&]R ! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>156
<FILENAME>image_185.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_185.gif
M1TE&.#EAF@ > /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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(+?30#P4$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>157
<FILENAME>image_186.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_186.gif
M1TE&.#EAP@ I /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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9\%8LN: &-\C!#GKP@R ,H0A'2,*!! 0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>158
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" $X 5H# 2(  A$! Q$!_\0
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MKW7S/G,?C,12JVA+W7JM%L?K=_Q%&0_]$,T3_P #%_\ B:/^(HR'_HAFB?\
M@8O_ ,37Y(T5ZG]@X'^3\7_F<7]J8G^;\$?K=_Q%&0_]$,T3_P #%_\ B:TO
M!?\ P<^:1K'C+2K/6/@OI%AI5W=Q07=TETK&UB9@&DQMYV@YQ[5^/](R[UP:
M3R# M?!^+_S'_:F)_F_!']3GC?\ L_X,?$_PMX[\.K##X9\4*EO?"W 6%ED
M9),#@9!!_#WK)^,DW_#0'[5NA^'+=A+I>@!9KHCE>"';Z@X5:^;?^"$O[2 _
M;<_X)Z:S\-=?N4F\1^ O^)<CR/ND>W8;K>4YYX(8$^PKM_%GQ-/[$?[#'Q8^
M)^ML]OKPM9M+TL2MMF>?!C0IGD_.P;Z)7R'LG3J2@_XL?<7G?9_<>_[12@I+
MX'[S\K;H_*O_ (+X_M3+^TI_P4 UFQTZX\WP[X @30;!4;=$77YIG7ZL=O\
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MH9U8<\'$_)'_ (.-_P!G>+X__LI^"_COHL7F77A=4LM4VC!%M,0-S?[LG'_
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M  9XX@]RX&#+*W+L??.:ZBOS?$U%*?N[+1>B_JY]?2BU'7=A1117.:!1110
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MT44 ?.'[0]D_PB_:0\+>-8 8[&^<6=^5&U>?E)8_[IS_ ,!K\=_^#DW]F/\
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M.]K7G5CM'W8_JQY=AO9THP>[]Y_H>@C@4445\N>R%%%% !1110 V2FTZ2FT
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M.1VKP:+I*7[Y-KR:3_%/^NI[]55'']TTGYJ_Y-?UT.)_X;F^"?\ T6'X6?\
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MNQ]S&]O>W"N!\:_M6?"[X;>))]&\1?$CP#H&KVNWS['4O$%I:W,.Y0R[HY)
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M!4C@@CS>M:W@7]J3X9?%'Q%'H_AGXB^!/$6K3*SQV6F:_:7=Q(JC+$1QR%B
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M_P"3+] _[&NW_P#2:YKR3_@VL_X_?C!_N:1_.\KUO_@X?_Y,OT#_ +&NW_\
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M.TLQZYN%!Z5]L_\ !3&^N/VT_P!NCX7?LZ:7([Z-ILZ^(/%;1,0(X]I;:Q'
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M"OE>%*]2A7Q%:D[2C1J-/LURGU7$E*%7#TZ557C*I337=.2/S1^#'Q:^(?\
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M>5]AE,Y0X,Q,X.S4MU_BIGRV>PC/BW"1FKKD_P#EA]_?\,,_!/\ Z(]\+/\
MPD[#_P"-5\N_\%5O^"9/PNOOV6?%'C+PCX/TCPEXG\(VIU.-]$M4LX+J&/;Y
ML<D* 1D>6"P(4,"O7E@?O6BOS_ YWC<+B(8B%25XM/XGK;H_)[,^\Q.48.O1
ME1G2C:2MLOZ]#-\&_P#(H:5_UYP_^@"M*N9^,?Q:T;X$_"W7?&'B&9H-&\/6
MCWERR %V51PB D NQPJC(RS 5K^%]<_X2?PUI^I?9+NP_M"VCN?LUTJK/;[U
M#;) I90XS@X8C(.":\^<9R3K6T;_ !WL==+EIJ-"^J7Y65R_5'Q-XEL/!OAV
M^U;5;N"PTW38'N;JYF;;'!&@+,S'L  :O5^=_P"V;\6-=_X*5_M+1_LZ?#2_
MEM_!.A3+<>/?$-LV8\1MS;JW1@K# 7G?+VVQL:[,JRV6-K^SORQ2O*3VC%;M
M_HNKLCGS+,(8.C[62NV[1BMY2>T5Z_@KOH>&?M+^ ?B#_P %G/$GC7XD^#=-
MCL? GPVLI+#PS'/:A;OQ'(C!Y44\-N9<N 20I,: ;G=AX_\ \$D/V\9?V+OV
M@1IFO7$D7@7Q=*EGJZ2'"Z=,#MCN\'IL)*OZH3U*J*_<#X2?"C0O@;\-]'\)
M^&;&/3=#T.W6VM8$[*.2S'^)F)+,QY)8D]:_(S_@N'_P3W;X(?$:3XK>%K-5
M\)>*[G&J00KQIE^^27P.!',<D>C[A_$HK]*X=XAP6-G/(:T.7#S7+3[_ #?\
MTG[R?26BO='YUQ#P_C</3CGM*5\3!\T[;6[17\L%[K[QNWL?LG;W,=Y;I+$Z
M2Q2J'1T.5=3R"#W!I]?G1_P0D_;\_P"%G^!?^%/>*+W=K_AFW,F@32M\U]8+
MU@R>KP]AWC(X^0FOT7K\YSS)ZV68R>$K=-GW71_UL[H^]R/.*69X..*I==&N
MSZK_ "[JS"L+XG?$/3OA+\.M<\3ZO*(-,T"QFO[ISV2-"QQ[G&![D5NU\)_\
M%M/BOJ?B/PMX'^!/A9]WB7XL:K#%.B,<QVB2J!NQT5I2I/;;$]8Y5@)8[%T\
M)'3F>K[+=OY*[.O,,=#!86IBZFJ@KV[OHOF[+YGFO_!([XS?#^Y\;_$[XX?$
MOXA> M!\:^/M5DM[2RU3Q!:6MS9688.V(WD5E5FV(,C[MNI'!Y^X_P#AN;X)
M_P#18?A9_P"%78?_ !VL?X?_ /!._P""W@;P+HVC2?"[X>ZO)I5E#:/?7_AN
MRGNKQD0*999&C+,[$9))Y)-;'_##/P3_ .B/?"S_ ,).P_\ C5>WG&897C,4
MZOOJ*M&*7+91BK)+Y(\'*,#FF%PR@^1RDW*3?-=RD[N]O/0_'_\ X+6:!X$O
MOVJ5\:> /%OA+Q/I_C.T$^H)HFK6]]]DO(L(Y<1.VT2+L8$]3O\ 2OT5_P""
M*/[3_P#PT+^QCINEWMQYVO\ @!QH=V&;+O HS;2=2<&+"9/5HFJI_P %)/\
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MVII)1<I:K7KR:;OO\SZFK/\ $OBS2_!>E/?:QJ5AI-C'DO<7EPD$28!)RS$
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MX=:IH6D3W$]M+K'PUO);I?.E:5U+1:U$I&]FQ\N>>IKUKX&? 'QMX3^+NO\
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M:_L]^!?#NHL[W^@^'K#3KEF.298K>.-\GZJ:X#0OV,/^$M^,&A_$'XJ>)?\
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M;XK:UXKLOAQXQO?".GZ;_8NDV5O=)"2/M$S06B2F3[N LBJ.<JV1C[LKQ?\
M8P_8FT+]BW0?%D.E:SK?B#5/'.O3^)=;U#4C$K7%Y-]\I'$B)&G'"@'J>:]H
MJ,=5A4J)T[62BM%;515WTW=PP\)1B^;JY/5WTN[?A8^,?^"YOP&TWQ]^Q/JO
MQ"AN)]'\;_!UE\4>&M9M0!<6<T;H6C!_N. ,CLR(V#MP?4O^":ML_B+]DGPK
MX^U.7[=XM^*=A;>*O$.H-&J-=W=Q!'A0% "QQ1A(HU'1(QU))-O]O;]E_P 7
M_MB? W5_A]H7CG0O!.A^)K1[+6)KKPS)J]Y*A9& @<7D"1<*P;<DA.X8*D<Z
M'[$G[/?B[]EGX&Z+X#\1^,]"\::;X6T^WTO1[FR\.2:/<1P1*5 G+7=PLK8V
M %%CQM.0Q.1K3JQ6!G2<O>YDTM;VM[VMK6;47:_2^Y-6,GB(32TLTWIY<OW7
MFMM+]CV&BBBO..H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
4@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>159
<FILENAME>smallnexalin.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 smallnexalin.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  H "0# 2(  A$! Q$!_\0
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MDS3PJTMK)(H/EJV,@+TXK3\?_$+0M7M];\,>(]$6]%GIJ:C<V;7$;!IDV2M
M/5D#1/NQ@@\=*Z#QM\6K/P'XHTO1[O3YY(+I5>6]B(V6L9\S,CKUV+Y?S$=
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-%%9MN3NS:*44DMC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>COVER
<SEQUENCE>160
<FILENAME>filename160.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0"><FONT STYLE="font-family: Garamond, Times, Serif"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 102px; width: 102px"></FONT></P>

<P STYLE="font: 10pt Garamond, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Courier New, Courier, Monospace; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 74%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">Warshaw Burstein, LLP</FONT></TD>
    <TD STYLE="width: 26%"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">Kyle Taylor</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">575 Lexington Avenue</FONT></TD>
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">Counsel</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">New York, NY&nbsp;&nbsp;10022</FONT></TD>
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">(212) 984-7797</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">(212) 984-7700</FONT></TD>
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">ktaylor@wbny.com</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif">www.wbny.com</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Courier New, Courier, Monospace; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="font-family: Times New Roman, Times, Serif">November 1, 2021</FONT></P>


<P STYLE="font: 10pt Garamond, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.3pt 0pt 0pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt">Securities and Exchange <BR>
Commission Division of <BR>
Corporation
Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0pt 0pt">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt">Attention:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt 0pt">Gary Newberry <BR>
Terence O&rsquo;Brien <BR>
Deanna Virginio <BR>
Jeffrey
Gabor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 44.70pt"><B>Re: Nexalin Technology, Inc. Draft Registration Statement
on Form S-1 Submitted <BR>
September 17, 2021 CIK No. 0001527352</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6.95pt 0 0 0pt">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 4.9pt 0 0pt; text-align: justify; text-indent: 18.70pt">We are
submitting this letter on behalf of Nexalin Technology, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo; or
&ldquo;<B><I>Nexalin</I></B>&rdquo;) in response to comments from the staff (the &ldquo;<B><I>Staff</I></B>&rdquo;) of the
Securities and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;) received by electronic mail dated October 15, 2021
relating to the Company&rsquo;s draft Registration Statement on Form S-1 (Registration No. 333-_______) filed with the Commission on
September 17, 2021 (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;). Amendment No. 1 to the Pre-Effective Registration
Statement (&ldquo;<B><I>Amendment No. 1</I></B>&rdquo;) is being filed concurrently herewith. The numbered paragraphs below
correspond to the numbered comments in the Staff&rsquo;s letter and the Staff&rsquo;s comments are presented in bold italics. In
addition to addressing the comments raised by the Staff in its letter, the Company has revised the Registration Statement to update
other disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">November 1, 2021</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page
</FONT>2</P>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 0pt; text-indent: -0.70pt"><B><I><U>Prospectus Summary</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 0pt; text-indent: -0.70pt"><B><I><U>Overview, page 6</U></I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 10.7pt 0pt 0pt; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B><I>1.</I></B></FONT><B><I><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">We note your disclosure that you provide an FDA-cleared, easy-to-administer treatment that utilizes
bioelectronic medical technology to safely and successfully treat various mental health disorders. Please revise to clearly disclose the
indications for use from the device clearance. Please also clarify which device version has been cleared.</FONT></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 21.85pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 3 of Amendment No. 1.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 10.7pt 0pt 0pt; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B><I>2.</I></B></FONT><B><I><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Please revise to provide the basis for your statements that your proprietary waveform &ldquo;distinguishes
[y]our devices from all comparable neurostimulation technologies currently available,&rdquo; and that &ldquo;[t]he stigma of expensive psychotherapy
or pharmaceutical medication with side effects and dependency issues will be replaced with clinically proven, safe and cost-effective
technology that is undetectable to the patient during treatment.&rdquo;</FONT></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.7pt 0.3in 0 0pt">In response to the Staff&rsquo;s comment, the
Company has revised its disclosure on page 3 of Amendment No. 1.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>3.</I></B></FONT></TD><TD STYLE="width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that prior to a regulatory change, your Gen-1 device was also used to treat depression.
Please revise to clarify, if true, that your device was subject to a reclassification by the FDA and that in order to receive approval
for the treatment of depression, a new pre-market application is required for this indication. With respect to your insomnia and anxiety
indications, please also revise to clarify whether you have completed the required special control trials and the new 510(k) filing
that you reference on page 14.</I></B></FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.7pt 0.3in 0 0pt">In response to the Staff&rsquo;s comment, the
Company has revised its disclosure on pages 12 and 51 of Amendment No. 1.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>4.</I></B></FONT></TD><TD STYLE="padding-right: 18.3pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your statements that you develop products &ldquo;to uniquely
and effectively help combat the ongoing global mental health epidemic;&rdquo; that your waveform is &ldquo;proven to be highly effective
in stimulating a positive response from the mid-brain structures;&rdquo; that your advanced waveform &ldquo;is safely administered to the
human brain,&rdquo; that your Gen-2 device &ldquo;will generate enhanced patient response,&rdquo; and that you are able to &ldquo;preserve
product safety and integrity&rdquo; with respect to your Gen-3 device. Although we note your disclosure that the FDA has cleared your Gen-1
device, it is premature for you to suggest that all of your products, including your Gen-2 and Gen-3 devices, will be determined to be
safe and effective. Please revise these statements throughout the prospectus to eliminate conclusions or predictions that such devices
are safe and effective as determinations of safety and efficacy are solely within the authority of the FDA. You may provide
a summary of the data that you used to draw these conclusions, and such discussion is more appropriate in the Business section where full
and proper</I></B></FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">November 1, 2021</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page
3</FONT></P>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.35pt 18.35pt 0 0.25in"><B><I>context can be provided.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8.1pt 21.85pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on pages 3, 34, 43, and 46 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.3pt 0 0 0pt; text-align: justify"><I><U>Chinese Market, page 7</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>5.</I></B></FONT></TD><TD STYLE="padding-right: 19.6pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please revise to describe the material steps you must complete
in order to form the joint venture. Please also file the joint venture agreement as an exhibit to your registration statement pursuant
to Item 601(b)(10). Alternatively, please explain to us why such disclosure is not required. Please also remove statements that treatment
clearance by the China National Medical Products Administration (NMPA) for the 15 milliamps power parameters is expected in the next six
months, as this statement appears to be speculative.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.6pt 21.85pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on pages 4, 36, and 48 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.35pt 0 0 0pt"><B><I><U>Risks Associated with Our Business, page 7</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0 7.20pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10.7pt 0pt 0pt; text-indent: 0in"><B><I>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please
revise to highlight your auditor&rsquo;s explanatory paragraph regarding your ability to continue as a going concern.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8.4pt 21.85pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on pages 5 and 10 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.3pt 0 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 0pt; text-align: justify"><B><I><U>Risk Factors</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2.2pt 0pt 0pt; text-align: justify"><B><I><U>We may require substantial
additional funding to meet our financial needs and to pursue our business objectives, page 13</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>7.</I></B></FONT></TD><TD STYLE="text-align: justify; padding-right: 18.8pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that you are currently
not cash &#64258;ow positive and do not expect to be cash &#64258;ow positive until 2023. Please revise to provide the basis for your
statements that you expect to be cash &#64258;ow positive in 2023.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.5pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 10 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 0 0 0pt; text-align: justify"><B><I><U>We rely on collaborations with
third parties for the development of our products, page 15</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.35pt 0 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>8.</I></B></FONT></TD><TD STYLE="padding-right: 23.3pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that you rely on collaborations with third
parties for the development of your products. Please identify any material strategic collaboration you continue to rely on in this risk
factor. In addition, to the extent you have not done so, in your Business section, please describe the material terms of the collaboration
agreements you have entered into and also file the agreements as exhibits to your registration statement pursuant to Item 601(b)(10)
of Regulation S-K. Alternatively,</I></B></FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">November 1, 2021</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page
4</FONT></P>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 23.3pt 0 22pt"><B><I>please explain to us why such disclosure is not
required.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.6pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 13 of Amendment No. 1 and filed such agreements as exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.4pt 0 0 0pt; text-align: justify"><I><U>Risks Related to Doing Business
in China, page 19</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>9.</I></B></FONT></TD><TD STYLE="padding-right: 19.6pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your risk factor disclosure that a material portion of your
operations and assets are located in China. However, we also note that your principal executive offices are located in the United
States and that the joint venture with Wider has not yet been completed. Please explain to us in greater detail the operations and assets
of the Company that are located in China.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 17 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.45pt 0 0 0pt; text-align: justify"><B><I><U>&ldquo;We are an emerging
growth company . . . &#148;, page 29</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>10.</I></B></FONT></TD><TD STYLE="padding-right: 23.4pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>On the cover page, you have indicated you have elected to use the
extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of
the Securities Act. On page 30, you state you have irrevocably elected <U>not </U>to avail yourselves of this exemption from new or revised
accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are
not emerging growth companies. Please revise these con&#64258;icting statements here and throughout the filing.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0pt 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 27 and throughout Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.35pt 43.8pt 0 0pt; text-align: justify; text-indent: 0.70pt"><B><I><U>Our
amended and restated certificate of incorporation will provide that the Court of</U></I><U> Chancery of the State of Delaware and
the, page 29</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>11.</I></B></FONT></TD><TD STYLE="padding-right: 24.6pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note that your forum selection provision identifies the
Court of Chancery of the State of Delaware as the exclusive forum for certain litigation, including any &ldquo;derivative action,&rdquo;
and the U.S. federal district courts as the exclusive forum for resolving any complaint asserting a cause of action arising under the
Securities Act. Please revise to disclose whether this provision applies to actions arising under the Exchange Act. Additionally, please
revise your risk factor to disclose that that there is uncertainty as to whether a court would enforce such provision and that there is
also a risk that your exclusive forum provision may result in increased costs for investors to bring a claim.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.65pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 26 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.25pt 0 0 0pt; text-align: justify"><B><I><U>Use of Proceeds, page 33</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">November 1, 2021</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page
5</FONT></P>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>12.</I></B></FONT></TD><TD STYLE="padding-right: 32.1pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that you intend to use the net proceeds
from the offering to, among other things, fund clinical research, trials and development work for future product candidates and
for working capital. Please revise your disclosure to describe how far the proceeds are expected to enable you to progress in the clinical
development of your product candidates. With respect to the proceeds used for working capital, please revise to provide more meaningful
and specific disclosure of the intended use of proceeds.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.6pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 30 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.4pt 0 0 0pt; text-align: justify"><B><I><U>Management Discussion and Analysis
.. . .Year Ended December 31, 2020 Compared to the Year Ended December 31, 2019, page 38</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>13.</I></B></FONT></TD><TD STYLE="padding-right: 29.6pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Your table includes two line items for stock-based compensation
expense and for selling, general and administrative expense. Your financial statement classifies these two line items as selling,
general and administrative expense and as a loss on impairment of right of use asset, respectively. Please revise your discussion of these
expenses to be consistent with the financial statement presentation.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.6pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 37 of Amendment No. 1.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>14.</I></B></FONT></TD><TD STYLE="padding-right: 24.4pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>On page 6, you state that you have devoted substantially all your
financial resources and efforts to research and development. Please quantify and provide a discussion of your research and
development expenses as part of this discussion and disclose the amount of these expenses in your financial statements or the related
footnotes or, otherwise, explain to us why such discussion and disclosure is not required. Refer to Item 303(a) of Regulation S-K.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.75pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 37 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.75pt 15.3pt 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.75pt 0 0 0pt; text-align: justify"><B><I><U>Depression Market, page 45</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>15.</I></B></FONT></TD><TD STYLE="padding-right: 25.1pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please revise to provide the basis for your statement that any
decline in the depression medication market will indirectly accelerate the growth of the neurostimulator market and that prior to 2019,
your existing Gen-1 medical device had been used to successfully treat depression in the USA.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.5pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 44 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.45pt 0 0 0pt; text-align: justify"><B><I><U>Substance Use Disorders (Opioid
Addiction) Market, page 46</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>16.</I></B></FONT></TD><TD STYLE="padding-right: 15.7pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your statements that your pilot study &ldquo;will provide
a source of validation&rdquo; for</I></B></FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">November 1, 2021</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page
6</FONT></P>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 15.75pt 0 27pt"><B><I>your treatment approach, that &ldquo;initial
anecdotal research with [y]our products in the addiction treatment model is promising,&rdquo; that your new advanced waveform allows
you to &ldquo;increase the power of the device exponentially without creating any safety risks,&rdquo; that &ldquo;deeper penetration
also enhances patient response. . .&rdquo; and that the new advanced waveform at 15 milliamps &ldquo;has been proven to be safe and highly
effective in the treatment mental illness.&rdquo; Please revise these and similar statements to eliminate conclusions or predictions
that your device is safe and effective as determinations of safety and efficacy are solely within the authority of the FDA.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.7pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 45 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 0pt; text-align: justify"><B><I><U>Marketing and Growth Strategy,
page 48</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>17.</I></B></FONT></TD><TD STYLE="padding-right: 12.8pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please revise to clarify, if true, that the Company is currently
in Phase 1 and indicate if any of the Phase 1 activities have been completed. We also note that in 2020 and 2019, the Company generated
revenues from licensing and treatment fee agreements with customers and from equipment by selling additional individual nodes to customers
for use with your device. Please revise to clarify if the Phase 1 pricing has been implemented and clearly describe the material terms
of the licensing and treatment fee arrangements with your customers.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.65pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 48 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.35pt 0 0 0pt; text-align: justify"><B><I><U>Summary of Current Clinical
Trials in the United States, page 49</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>18.</I></B></FONT></TD><TD STYLE="padding-right: 17.7pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that the endpoint of the first UCSD
study will provide pilot data to validate your benefits in treating opiate addiction and that a primary endpoint of the second UCSD
study is validating your treatment for veterans diagnosed with mTBI and PTSD. Please revise to clearly identify the trial endpoints in
each study. Please also revise to clarify if the trials are currently still paused.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 48 of Amendment No. 1.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>19.</I></B></FONT></TD><TD STYLE="padding-right: 23.7pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please revise your statements that &ldquo;providing this type of
data will accelerate [y]our acceptance and approval in the regulatory and treatment community&rdquo; to remove any implication that you
will be successful in advancing your product candidate in a rapid or accelerated manner as such statements are speculative.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.95pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 48 of Amendment No. 1.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>20.</I></B></FONT></TD><TD STYLE="padding-right: 27.2pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that the UPenn pilot data demonstrated that
73% of patients that received your treatment had a 50% reduction in depression symptoms in a 5-day treatment window. Please revise to
disclose the total number of patients enrolled in</I></B></FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">November 1, 2021</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page
7</FONT></P>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.45pt 27.2pt 0 22.0pt"><B><I>the study.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.6pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 49 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 0 0 0pt; text-align: justify"><B><I><U>Summary of Current Clinical
Trial Strategy for the Joint Venture, page 50</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.35pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>21.</I></B></FONT></TD><TD STYLE="text-align: justify; padding-right: 19.9pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please revise statements that your device has
been shown in multiple trials &ldquo;to be highly effective in the treatment of depression&rdquo; and that trial results &ldquo;would
further bolster your FDA approval process demonstrating both safety and efficacy,&rdquo; to eliminate conclusions or predictions that
your product candidates are effective as determinations of efficacy are solely within the authority of the FDA.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 49 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.25pt 0 0 0pt; text-align: justify"><B><I><U>Regulatory Strategy, page 52</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>22.</I></B></FONT></TD><TD STYLE="padding-right: 43.4pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that as a result of the pandemic, the deadline
for submitting clinical testing data to the FDA was extended. Please revise to disclose the new deadline. Please also revise to clarify
whether you are permitted to continue marketing your Gen-1 device for the treatment of anxiety and insomnia before the amended 510(k)
application is approved by the FDA.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.6pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 51of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.4pt 0 0 0pt; text-align: justify"><B><I><U>Intellectual Property Matrix,
page 53</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>23.</I></B></FONT></TD><TD STYLE="padding-right: 71pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please revise to clarify the patent expiration dates and expected
expiration dates for pending patent applications</I></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9.45pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has revised its disclosure on page 52 of Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9.1pt 0 0 0pt; text-align: justify"><B><I><U>Narrative to Summary Compensation
Table, page 67</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.3pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>24.</I></B></FONT></TD><TD STYLE="padding-right: 34.8pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please file the employment agreement with Mark White and David
Owens as exhibits to the Registration Statement pursuant to Item 601(b)(10) of Regulation S-K. Alternatively, please explain to us why
such disclosure is not required.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.5pt 15.3pt 0 0pt">In response to the Staff&rsquo;s comment, the Company
has filed such agreements as exhibits to Amendment No. 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 0 0 0pt; text-align: justify"><B><I><U>Issuances of Share Capital,
page F-21</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 0 0 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">November 1, 2021</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page
8</FONT></P>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>25.</I></B></FONT></TD><TD STYLE="padding-right: 53.7pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please revise your disclosure to provide the information required
under Item 701 of Regulation S-K.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Courier New, Courier, Monospace; margin: 7.45pt 21.85pt 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
response to the Staff&rsquo;s comment, the Company has revised its disclosure on page F-21 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.9pt 0 0 0pt; text-align: justify"><B><I><U>General</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 7.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><B><I>26.</I></B></FONT></TD><TD STYLE="padding-right: 19.6pt; width: 96%"><FONT STYLE="font-size: 10pt"><B><I>Please provide us with copies of all written communications, as
defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors
in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 6.0pt">The Company advises that there have been no such communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt">Should the Staff have additional questions or comments regarding
the foregoing, please do not hesitate to contact the undersigned at (212) 984-7700.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Courier New, Courier, Monospace; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WARSHAW BURSTEIN, LLP</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Kyle A. Taylor</FONT></TD>
    <TD STYLE="width: 18%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kyle A. Taylor, Esq.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt">cc: Mark White, Nexalin Technology, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0pt">&nbsp;</P>






</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
